data_2kne_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kne _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.5 p -80.03 136.98 36.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.324 0.965 . . . . 0.0 110.32 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 9' ' ' ILE . 46.3 tt0 -51.86 -53.65 38.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 122.072 0.939 . . . . 0.0 110.201 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -32.84 -36.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.108 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.52 ' OE1' ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -69.62 -37.77 76.96 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.286 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.3 mt -58.58 -44.9 90.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.67 -49.23 62.78 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.108 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.56 -46.37 90.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.339 0.59 . . . . 0.0 111.535 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.52 ' CD2' ' OE1' ' A' ' 8' ' ' GLN . 28.2 m-85 -58.41 -42.37 87.05 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.781 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -49.21 -58.1 5.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.378 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.48 -44.97 62.63 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.031 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.22 -38.16 70.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.222 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.16 -41.84 84.65 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 t -64.41 -15.78 61.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.421 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.08 -42.82 96.81 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -105.64 -14.52 15.24 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -75.45 94.94 3.18 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.137 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -68.25 -47.43 67.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.226 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.2 p-10 -102.38 14.18 32.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.46 46.17 1.03 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.035 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -85.35 -4.0 59.02 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.694 -0.298 . . . . 0.0 110.961 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.38 -2.0 82.71 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.5 p -137.51 152.24 49.29 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.103 0.478 . . . . 0.0 109.891 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.64 124.53 45.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.9 p -114.31 165.27 12.87 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.801 0.81 . . . . 0.0 112.393 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.4 p -58.85 -35.82 73.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.715 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.59 -61.4 2.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.565 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.92 -30.48 71.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.795 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.16 -55.73 30.3 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.015 0.912 . . . . 0.0 109.667 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.65 -37.69 93.87 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.975 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 m -58.75 -53.03 63.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 119.047 1.423 . . . . 0.0 108.624 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.427 ' O ' ' OG ' ' A' ' 38' ' ' SER . 46.2 t -57.0 -46.47 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 121.228 -0.92 . . . . 0.0 111.523 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.6 ttt -59.0 -39.93 83.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 120.054 1.297 . . . . 0.0 109.461 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -51.56 -38.36 54.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.531 0.681 . . . . 0.0 110.183 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 25.1 p -63.54 -21.08 66.14 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.376 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.73 -1.72 20.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.536 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.34 13.77 67.57 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.127 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -107.14 158.01 17.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 117.611 0.705 . . . . 0.0 109.854 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -114.74 64.77 1.58 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.286 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.05 143.29 94.78 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.19 1.927 . . . . 0.0 112.156 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.631 ' HG1' ' H ' ' A' ' 45' ' ' GLU . 7.9 t -80.58 166.74 20.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.438 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.631 ' H ' ' HG1' ' A' ' 44' ' ' THR . 80.6 tt0 -58.15 -44.12 87.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.72 -24.2 33.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.558 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -65.63 -39.15 91.16 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.069 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.2 mp -56.42 -41.59 76.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.463 0.649 . . . . 0.0 109.759 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.25 -56.67 6.2 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.757 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.45 -48.81 71.29 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 41.2 mmm -65.85 -50.17 65.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.9 mm -59.44 -47.69 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.672 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -56.45 -34.97 67.35 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -66.18 -40.01 90.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.8 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.404 ' CG2' ' CD2' ' B' 1110 ' ' PHE . 71.4 t -86.35 -20.37 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.503 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.3 t0 -78.49 85.93 4.55 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.21 -38.0 87.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.326 -1.761 . . . . 0.0 114.066 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 36.8 p-10 -86.26 -2.89 58.79 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.98 23.55 63.82 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 118.476 0.58 . . . . 0.0 112.927 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.419 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.4 p-10 -87.36 2.38 50.51 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.234 0.517 . . . . 0.0 110.578 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.526 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.2 1.39 89.54 Favored Glycine 0 CA--C 1.521 0.442 0 O-C-N 121.585 -0.697 . . . . 0.0 114.448 175.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.0 p -145.85 165.33 29.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.9 mm -108.91 126.64 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -103.38 -176.33 3.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -57.3 -59.11 13.81 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -47.25 -49.62 12.6 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.37 1.38 . . . . 0.0 111.243 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.57 -19.77 62.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.348 0.594 . . . . 0.0 110.641 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 65' ' ' PHE . 22.7 t80 -74.55 -58.24 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.962 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.18 -45.21 83.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -44.24 -49.88 9.1 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.61 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 72.8 mtm -66.98 -44.5 80.28 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.656 -0.417 . . . . 0.0 112.026 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.8 mmt -57.62 -39.42 76.88 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.46 77.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.548 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -95.74 -9.05 32.82 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.434 ' C ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -85.98 63.84 8.25 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.154 0.502 . . . . 0.0 110.685 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.56 17.24 22.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.41 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -48.31 135.02 14.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.175 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -89.41 108.94 19.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.827 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -93.75 119.68 33.04 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 82' ' ' GLU . 36.8 t0 -67.02 112.89 4.61 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 174.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 m -37.68 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.522 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 80' ' ' ASP . 95.3 mt-10 -72.09 -31.51 66.15 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -50.38 -39.14 45.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.878 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.48 ' OE2' ' CG ' ' B' 1101 ' ' GLN . 9.2 pt-20 -89.53 -11.04 43.98 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.4 mm -62.43 -74.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.798 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -62.01 -40.75 96.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.91 -41.3 97.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.571 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.41 -21.26 63.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -73.81 -48.41 31.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -54.95 -40.55 70.09 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.815 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.3 t -65.54 -44.1 94.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -69.02 -38.7 79.34 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.264 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -85.55 81.11 8.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.37 -49.4 77.36 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -176.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -91.32 4.83 51.38 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.175 -0.328 . . . . 0.0 111.168 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.61 48.13 50.39 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -90.22 6.25 43.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.674 0.273 . . . . 0.0 110.745 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.18 2.13 85.91 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -142.98 156.18 44.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.751 0.786 . . . . 0.0 111.593 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -94.08 115.37 32.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 t -89.05 151.1 22.45 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.23 -46.54 82.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.201 0.91 . . . . 0.0 110.723 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.42 -40.59 65.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.951 0.405 . . . . 0.0 110.554 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.22 -41.13 94.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.168 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.19 -44.64 94.82 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.614 0.721 . . . . 0.0 110.949 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -44.55 -44.01 8.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.548 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.92 -29.71 70.99 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 122.456 -0.152 . . . . 0.0 110.747 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.5 t -57.64 -41.32 79.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.837 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.5 mtt -50.84 -45.54 59.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.075 0.94 . . . . 0.0 111.526 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 m -56.68 -41.41 77.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.537 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -66.55 -41.55 88.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.132 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 74.8 mt -80.87 -16.36 53.86 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.24 30.52 58.67 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.51 -23.1 27.87 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.962 2.381 . . . . 0.0 110.481 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.9 tptp 45.02 60.37 3.01 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.067 0.937 . . . . 0.0 110.326 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.9 mt -79.95 147.2 31.71 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.566 -1.652 . . . . 0.0 112.463 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 81.5 p -81.99 175.35 10.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.468 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -57.41 -44.79 84.86 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -56.49 -47.91 78.28 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.196 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 123' ' ' GLU . 64.3 mm-40 -71.35 -28.44 64.06 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.73 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.4 t -63.91 -42.43 95.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.669 0.747 . . . . 0.0 109.288 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.53 -35.09 65.5 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.382 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 120' ' ' GLU . 82.5 tt0 -59.66 -51.28 70.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 93.0 mtp -56.08 -44.47 78.98 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.35 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.74 -43.66 88.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.189 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -58.63 -39.45 80.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.953 0.406 . . . . 0.0 111.212 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.37 -40.92 79.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.059 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.41 -20.15 22.1 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.9 t0 -72.88 87.69 1.32 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.301 0.572 . . . . 0.0 112.072 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 tt -70.5 -15.18 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.374 1.083 . . . . 0.0 113.242 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.7 p-10 -142.65 144.78 32.92 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 112.322 -2.217 . . . . 0.0 109.172 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.1 52.27 1.35 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-N 116.736 -0.211 . . . . 0.0 113.255 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -90.79 -9.21 47.37 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.973 0.387 . . . . 0.0 110.013 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.34 1.02 68.41 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.995 -0.621 . . . . 0.0 114.262 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -134.43 153.87 51.69 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.395 0.598 . . . . 0.0 110.422 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.68 118.38 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.366 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.454 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 60.6 t30 -84.44 174.55 9.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 0.0 111.149 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.454 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 72.0 t80 -61.05 -40.8 95.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.202 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.64 -44.6 96.68 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.701 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.94 -35.64 81.81 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.599 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -60.75 -44.75 96.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.076 0.465 . . . . 0.0 110.574 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.11 -47.01 89.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.365 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.405 ' O ' ' CG2' ' A' ' 146' ' ' THR . 52.6 tt0 -49.34 -40.73 36.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.78 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 mmt -74.9 -38.58 61.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.1 mmt -80.69 4.5 18.59 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.168 0.587 . . . . 0.0 111.18 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.405 ' CG2' ' O ' ' A' ' 143' ' ' GLN . 5.0 t . . . . . 0 N--CA 1.468 0.473 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.303 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 111.481 0.178 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 4.6 m95 -60.77 -57.86 10.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.681 0.753 . . . . 0.0 112.127 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1094 ' ' PHE . . . . . 0.513 ' CE2' ' OD1' ' B' 1098 ' ' ASN . 26.1 t80 -58.88 -45.51 90.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.224 -1.353 . . . . 0.0 114.55 -173.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -38.53 -52.65 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.61 -39.55 98.02 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.052 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 46.7 tp -56.26 -42.44 77.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.54 1.17 . . . . 0.0 109.798 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1098 ' ' ASN . . . . . 0.513 ' OD1' ' CE2' ' B' 1094 ' ' PHE . 8.4 m-20 -56.92 -43.08 81.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.378 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -64.07 -36.92 85.58 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.26 -42.03 91.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.853 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1101 ' ' GLN . . . . . 0.48 ' CG ' ' OE2' ' A' ' 84' ' ' GLU . 41.8 mt-30 -50.78 -46.21 59.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.51 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.7 m -63.56 -48.19 78.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.99 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.44 ' C ' ' O ' ' B' 1102 ' ' THR . 84.2 mt-30 -27.55 -57.81 0.1 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.556 1.169 . . . . 0.0 112.715 -176.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.2 mt -84.8 -15.14 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 112.161 -2.29 . . . . 0.0 112.691 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.51 ' N ' ' O ' ' B' 1102 ' ' THR . 64.3 tttp -60.23 -44.8 94.89 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.003 -1.479 . . . . 0.0 107.899 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 73.3 t -61.31 -49.05 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -66.41 -36.25 76.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.429 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 90.4 mttt -49.65 -39.21 35.37 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.53 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.86 -45.52 67.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.914 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1110 ' ' PHE . . . . . 0.404 ' CD2' ' CG2' ' A' ' 55' ' ' VAL . 46.4 m-85 -63.65 -49.68 72.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.378 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.622 0 CA-C-O 119.417 -0.325 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.3 m -75.21 139.26 42.5 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.271 0.941 . . . . 0.0 109.492 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 9' ' ' ILE . 10.3 tm-20 -48.47 -56.8 7.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.969 0.89 . . . . 0.0 110.473 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -34.59 -37.88 0.06 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.971 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -69.34 -37.15 77.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.613 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' GLU . 63.8 mt -57.25 -47.6 83.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.29 -49.88 60.41 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.124 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -61.72 -46.85 87.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.099 0.476 . . . . 0.0 112.276 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -59.8 -41.01 90.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.949 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -51.46 -56.55 12.67 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.055 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.43 -45.19 55.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.007 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.26 -38.68 66.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.434 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.77 -40.54 80.04 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.9 m -65.05 -15.37 62.27 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.651 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.2 -41.04 94.92 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -105.96 -14.36 15.21 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.91 94.42 2.8 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.325 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -67.85 -51.85 43.6 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.181 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.6 p30 -100.84 15.73 27.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 37.17 51.98 1.65 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.108 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 26' ' ' THR . 12.3 p30 -88.33 -5.43 58.33 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.925 0.362 . . . . 0.0 111.079 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.93 -0.72 76.74 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.436 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 1.9 t -141.22 157.63 44.99 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.151 0.5 . . . . 0.0 110.49 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.5 mp -90.52 123.99 42.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.8 p -111.21 161.46 15.96 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.28 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.5 p -59.84 -38.07 81.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.212 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -61.38 -59.28 5.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.325 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.72 -28.3 69.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.762 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 tp -61.67 -55.39 30.93 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.977 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.49 92.04 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.186 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -57.98 -55.4 35.39 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.052 1.426 . . . . 0.0 108.198 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.63 -46.56 72.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 118.798 0.727 . . . . 0.0 111.29 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.1 tpt -58.0 -39.86 79.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 120.38 1.445 . . . . 0.0 109.85 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -51.1 -33.55 26.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.346 0.593 . . . . 0.0 110.999 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.9 p -64.9 -20.01 66.22 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.85 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 1.5 mm? -76.27 3.24 11.25 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.143 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.92 27.58 40.84 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.279 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.422 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 9.1 tt0 -131.51 170.41 14.75 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.65 0.725 . . . . 0.0 109.469 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.422 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 16.1 m-20 -131.33 78.23 72.53 Favored Pre-proline 0 N--CA 1.466 0.351 0 CA-C-O 120.739 0.304 . . . . 0.0 110.217 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.07 147.03 96.87 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.698 2.265 . . . . 0.0 111.876 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.2 p -77.78 163.39 26.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.401 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.03 -45.43 90.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.721 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.1 -24.68 26.89 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.626 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -65.63 -40.16 92.25 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.662 -0.415 . . . . 0.0 109.989 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.1 mp -56.14 -41.7 75.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.382 0.611 . . . . 0.0 109.939 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -72.57 -56.02 6.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.682 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -55.76 -50.2 71.06 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.4 mmm -64.05 -50.61 67.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.4 mm -57.72 -45.11 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.77 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -55.44 -34.43 64.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -67.0 -40.94 87.45 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.071 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.2 t -85.99 -21.54 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.155 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.5 t0 -79.42 83.71 5.4 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -174.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.53 79.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.816 -1.538 . . . . 0.0 114.442 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.8 p-10 -85.71 -2.47 58.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.331 -0.547 . . . . 0.0 112.463 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.8 23.02 60.6 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.867 -0.521 . . . . 0.0 112.507 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.435 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -86.61 3.83 42.8 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.335 0.568 . . . . 0.0 110.565 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.521 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.15 2.01 89.45 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 118.657 0.662 . . . . 0.0 114.664 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.2 p -148.19 167.79 24.16 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.0 mm -110.06 127.38 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.228 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -102.57 -177.39 3.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.54 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.413 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -58.19 -46.3 99.67 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.191 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 33.3 Cg_exo -56.6 -52.62 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.393 1.395 . . . . 0.0 111.297 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' O ' ' SD ' ' A' ' 71' ' ' MET . 97.4 mt-10 -61.16 -18.91 60.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.26 0.553 . . . . 0.0 110.941 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -76.77 -59.11 2.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.814 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.8 mt -56.05 -47.41 77.94 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.1 t -46.39 -43.58 16.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.071 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 67' ' ' GLU . 39.5 mtp -66.92 -47.76 70.74 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.0 mmm -62.07 -40.71 96.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.13 -33.92 76.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.573 0.225 . . . . 0.0 111.463 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -91.99 -20.76 21.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 111.178 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.58 67.84 5.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.15 0.5 . . . . 0.0 110.178 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.2 mmt -107.81 15.83 24.15 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.578 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -48.33 132.98 16.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.311 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -89.85 107.6 19.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.964 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.491 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 3.2 m -93.64 120.42 33.89 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.5 m-20 -69.63 111.97 5.8 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 m -36.89 -20.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.864 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.6 mm-40 -68.26 -37.49 80.8 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.794 0.33 . . . . 0.0 111.615 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -48.65 -36.41 15.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.144 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -88.09 -16.55 33.23 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.5 mm -61.96 -74.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.563 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 74.4 mtt85 -62.02 -41.35 97.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.86 -41.5 97.91 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.848 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.07 -17.97 55.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.817 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -72.69 -50.7 23.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -54.95 -42.13 71.94 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.5 t -65.1 -44.38 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -69.33 -37.81 77.9 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.159 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -86.25 80.75 8.64 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.81 -48.91 78.37 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -90.59 4.99 49.73 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.264 -0.273 . . . . 0.0 111.351 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.17 47.19 50.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -90.27 7.03 40.35 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.75 0.31 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.33 2.02 89.25 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -140.68 153.42 45.97 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.636 0.731 . . . . 0.0 111.835 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -93.34 116.4 34.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.3 m -89.65 149.31 22.85 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.93 79.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.166 0.894 . . . . 0.0 110.683 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.19 -40.79 64.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.815 0.341 . . . . 0.0 110.673 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.12 -41.4 94.9 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.204 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.74 -45.73 88.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.233 0.54 . . . . 0.0 110.843 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -43.24 -44.44 5.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.857 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.4 ' O ' ' OG1' ' A' ' 110' ' ' THR . 58.6 t-80 -64.82 -28.83 69.83 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.662 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.503 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 85.0 t -58.11 -41.82 81.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.134 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.626 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.27 -46.73 65.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.953 0.882 . . . . 0.0 111.705 -177.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.414 ' HG1' ' N ' ' A' ' 111' ' ' ASN . 71.9 p -53.43 -35.89 60.93 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 113.771 -1.559 . . . . 0.0 110.882 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -68.51 -39.88 81.07 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.473 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.86 -13.29 59.06 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.45 30.45 60.31 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -87.68 -24.67 23.81 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.681 2.241 . . . . 0.0 110.779 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 45.25 64.39 1.42 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.713 0.768 . . . . 0.0 110.155 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.3 mt -80.5 148.13 30.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.374 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.5 p -82.07 174.61 11.07 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.693 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -57.2 -45.83 83.44 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.16 -47.81 77.51 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -71.96 -30.36 65.2 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.588 -0.445 . . . . 0.0 112.108 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.04 -42.69 95.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -70.61 -34.98 72.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.099 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -59.99 -49.12 78.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.041 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 29.8 mmm -52.46 -47.37 66.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.023 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 40.7 mm -57.44 -44.33 84.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.695 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -58.0 -40.23 80.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.89 0.376 . . . . 0.0 111.394 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -57.98 -40.82 81.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.056 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.89 -17.94 24.5 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.716 0.293 . . . . 0.0 111.645 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.2 t0 -73.83 89.56 1.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.436 0.636 . . . . 0.0 111.816 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 80.1 mt -70.73 -17.63 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.063 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.9 p-10 -141.59 145.55 35.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.743 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.45 52.27 1.48 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.76 -0.257 . . . . 0.0 113.117 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -90.66 -9.16 47.91 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.023 0.412 . . . . 0.0 110.219 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.0 1.89 75.43 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.961 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -134.75 154.33 51.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.234 0.517 . . . . 0.0 110.39 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.76 118.58 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.038 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -84.26 174.71 9.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.775 0.321 . . . . 0.0 110.924 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -61.62 -40.03 93.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.095 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.96 -44.66 95.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.54 -38.5 89.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.733 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -60.82 -44.38 96.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.139 0.495 . . . . 0.0 110.807 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.22 -46.42 87.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.233 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -48.43 -45.56 36.51 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.164 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 88.1 mmm -74.68 -38.3 62.45 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 18.6 mmt -72.8 -46.55 52.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 120.66 0.267 . . . . 0.0 111.441 -179.288 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.72 -54.55 41.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.265 0.555 . . . . 0.0 112.029 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 37.9 t80 -57.97 -46.08 85.69 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -42.16 -52.01 4.47 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.49 -42.11 99.69 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.162 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.55 -46.1 80.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.391 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.21 -48.73 79.45 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.26 -38.17 90.1 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.96 -42.16 91.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.795 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -51.3 -46.42 62.51 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.498 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.8 m -63.38 -48.45 77.82 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.422 ' C ' ' O ' ' B' 1102 ' ' THR . 84.5 mt-30 -27.31 -60.2 0.1 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.603 1.192 . . . . 0.0 112.741 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -82.01 -14.59 12.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 112.67 -2.059 . . . . 0.0 112.344 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.498 ' N ' ' O ' ' B' 1102 ' ' THR . 65.8 tttm -57.69 -43.34 85.06 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 117.874 -1.53 . . . . 0.0 108.059 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.8 t -61.88 -47.04 95.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.55 0.69 . . . . 0.0 112.818 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 65.8 t -65.38 -41.18 90.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.097 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1108 ' ' LYS . . . . . 0.491 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 96.1 mttt -49.03 -38.14 22.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.396 0.617 . . . . 0.0 109.634 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -54.09 -46.91 72.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.343 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -62.35 -49.81 74.07 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 23.4 m-70 . . . . . 0 C--N 1.326 -0.45 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.037 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.3 mt . . . . . 0 CA--C 1.532 0.273 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.8 p -80.64 137.83 36.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.461 1.028 . . . . 0.0 110.454 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' A' ' 7' ' ' GLU . 18.0 pt-20 -52.65 -50.06 63.95 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.123 0.963 . . . . 0.0 110.893 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.507 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 43.4 tp10 -36.44 -38.13 0.15 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.033 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -70.63 -35.34 72.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.66 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.1 mt -58.92 -45.6 91.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 175.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.59 -49.02 62.95 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.08 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.26 -47.88 83.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.225 0.535 . . . . 0.0 112.083 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -60.58 -41.96 95.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.988 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -49.52 -59.5 3.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.367 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -47.62 -42.5 24.4 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.414 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.6 -39.15 70.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.294 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -56.91 -41.52 78.29 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 m -65.09 -13.43 58.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.387 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.44 -43.47 97.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -106.73 -13.21 15.33 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -76.05 94.04 3.39 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.073 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -68.33 -46.7 69.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.41 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.7 p-10 -102.77 14.17 32.62 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.62 49.67 1.35 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.018 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -87.06 -5.01 59.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.944 0.372 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.02 -2.05 81.19 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.6 p -137.32 151.61 48.83 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.143 0.496 . . . . 0.0 110.307 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.498 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 mp -93.34 125.24 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -114.1 165.04 13.05 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.671 0.748 . . . . 0.0 112.575 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.6 p -58.85 -35.34 72.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.823 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -61.25 -61.89 2.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.158 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.12 -29.54 70.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.773 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tp -60.57 -56.77 17.31 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.123 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.66 -39.18 93.12 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.107 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.9 m -58.26 -54.65 44.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.05 1.425 . . . . 0.0 108.517 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -55.63 -47.04 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.014 -0.675 . . . . 0.0 111.674 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -58.65 -41.04 85.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 120.143 1.338 . . . . 0.0 110.085 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -51.97 -40.06 60.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.434 0.635 . . . . 0.0 110.351 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 23.0 t -63.57 -20.74 65.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.041 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 tp -73.91 -2.16 22.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.744 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.17 13.44 63.98 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.308 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -106.67 156.44 18.62 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.537 0.669 . . . . 0.0 110.045 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -115.67 63.44 2.07 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.376 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.07 144.2 92.15 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.244 1.962 . . . . 0.0 112.192 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.8 p -80.46 166.63 21.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.393 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -57.37 -44.63 84.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.13 -23.71 22.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.636 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -65.9 -39.4 90.59 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.147 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.2 mp -56.84 -42.34 79.49 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.311 0.577 . . . . 0.0 109.779 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -70.97 -57.07 4.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.851 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -54.95 -48.76 72.78 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 42.7 mmm -65.68 -50.64 64.19 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.4 mm -58.32 -47.13 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.789 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -55.68 -34.53 65.12 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -66.28 -39.82 89.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.86 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.3 t -87.22 -20.09 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.388 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.0 t0 -78.1 85.61 4.29 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.2 85.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.541 -1.663 . . . . 0.0 114.359 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.7 p-10 -86.65 -2.48 58.55 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.16 23.28 61.74 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 118.452 0.569 . . . . 0.0 112.597 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.438 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.1 p-10 -87.21 2.85 48.75 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.294 0.547 . . . . 0.0 110.568 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.44 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.6 1.92 89.0 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.3 p -148.14 168.55 22.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.4 mt -112.69 128.4 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.518 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 43.9 t0 -103.59 -175.51 2.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.647 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.518 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -56.31 -56.88 26.86 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -177.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.26 -49.54 16.07 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 CA-C-N 120.522 1.222 . . . . 0.0 111.673 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -62.04 -18.85 61.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.262 0.553 . . . . 0.0 110.753 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -75.56 -58.81 3.06 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.748 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.9 mt -56.1 -45.24 79.52 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.8 m -44.05 -50.28 8.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.513 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 74.5 mtm -66.05 -43.93 86.04 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.48 ' O ' ' CE ' ' A' ' 76' ' ' MET . 15.2 mmt -57.52 -37.54 73.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.63 -35.23 72.83 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -93.76 -17.25 23.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 111.727 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.31 68.11 5.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.213 0.53 . . . . 0.0 110.456 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.48 ' CE ' ' O ' ' A' ' 72' ' ' MET . 24.3 mmt -108.81 15.47 23.54 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.608 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -52.89 131.62 35.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.637 0.732 . . . . 0.0 111.706 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -132.07 143.95 50.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.372 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.504 ' O ' ' CB ' ' A' ' 80' ' ' ASP . 35.8 p -127.14 -45.14 1.56 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 82' ' ' GLU . 99.8 m-20 126.15 134.84 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 125.357 1.66 . . . . 0.0 109.62 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.1 m -37.61 -17.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.212 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.9 mm-40 -68.51 -37.22 79.87 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.855 0.359 . . . . 0.0 111.653 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.432 ' OE1' ' OG1' ' A' ' 79' ' ' THR . 77.2 tt0 -47.67 -36.14 10.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.312 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -89.57 -16.73 29.97 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.064 0.459 . . . . 0.0 111.916 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.3 mm -61.1 -74.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.541 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -61.58 -41.63 97.69 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.63 -41.01 94.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.587 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.36 -19.53 61.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.118 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -72.57 -51.26 20.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.841 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.95 -42.28 72.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.678 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.92 -43.88 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -68.86 -38.04 79.47 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.916 -0.313 . . . . 0.0 111.471 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -90.71 83.39 5.76 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.85 -44.65 96.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -90.53 4.32 51.5 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 122.179 -0.326 . . . . 0.0 111.584 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.18 48.71 46.23 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -91.45 6.25 46.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.676 0.274 . . . . 0.0 110.402 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.11 0.14 90.08 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -137.94 151.91 48.43 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.611 0.72 . . . . 0.0 111.454 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.14 115.28 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 92.1 p -91.53 154.58 19.0 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.91 -48.24 78.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 119.024 0.829 . . . . 0.0 111.071 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.52 -41.44 61.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.998 0.428 . . . . 0.0 110.594 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.67 -41.2 92.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.894 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 108' ' ' VAL . 9.2 tp -63.56 -46.7 84.72 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.974 -0.454 . . . . 0.0 111.22 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -44.25 -35.99 2.53 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.943 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -66.8 -26.7 67.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.033 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.46 ' N ' ' O ' ' A' ' 105' ' ' LEU . 83.0 t -58.19 -43.13 85.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.798 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.9 mtp -50.13 -47.24 54.23 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.901 0.858 . . . . 0.0 111.781 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 m -58.1 -41.64 83.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.682 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 38' ' ' SER . 2.9 m-80 -66.13 -41.81 89.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.823 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.6 mt -81.46 -15.47 54.93 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.86 30.18 61.94 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -86.06 -24.26 26.41 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.957 2.379 . . . . 0.0 110.691 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 45.57 60.08 3.28 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.689 0.756 . . . . 0.0 110.457 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.2 148.38 32.28 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.938 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.7 p -82.12 174.69 10.98 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.344 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -57.89 -45.47 86.37 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.92 -49.95 74.03 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.584 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -68.52 -29.58 68.2 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.955 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.7 t -63.84 -41.51 92.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -66.65 -36.99 83.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.102 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -59.43 -53.32 59.5 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -44.64 76.6 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.334 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.48 -44.32 92.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.027 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -60.05 -38.56 83.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.829 0.347 . . . . 0.0 111.292 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.12 -41.76 84.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.25 -22.11 21.78 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.811 0.338 . . . . 0.0 111.687 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.7 t0 -73.7 87.69 1.7 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.33 0.586 . . . . 0.0 112.014 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.6 tp -69.3 -15.77 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 122.611 1.196 . . . . 0.0 113.495 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.6 p-10 -142.44 145.43 33.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.111 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.58 52.59 1.54 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.576 -0.345 . . . . 0.0 113.12 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -90.88 -9.25 46.96 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.089 0.445 . . . . 0.0 110.076 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.88 1.7 73.92 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.984 -0.627 . . . . 0.0 114.133 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -134.54 154.48 51.43 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.372 0.586 . . . . 0.0 110.202 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.9 t -100.39 118.47 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.438 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -84.0 173.87 10.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.787 0.327 . . . . 0.0 110.844 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -61.76 -39.41 91.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.018 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.29 -44.75 94.13 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.878 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.83 -38.69 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.591 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.64 -44.66 96.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.859 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.19 -47.01 89.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.4 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -49.37 -44.54 44.97 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.25 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.1 mmm -75.44 -39.31 59.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.6 mmt -74.36 -48.04 30.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.605 -0.146 . . . . 0.0 110.605 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.686 0.279 . . . . 0.0 111.591 -179.39 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.0 m95 -59.99 -57.63 12.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.402 0.62 . . . . 0.0 112.077 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 41.5 t80 -57.54 -44.96 85.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -40.82 -51.11 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.57 99.7 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.514 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 46.0 tp -56.11 -46.24 79.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.517 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 65.8 t30 -59.21 -49.28 78.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -65.22 -38.4 90.32 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 88.0 mt -60.79 -42.33 91.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.71 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -50.25 -44.73 53.67 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.519 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.0 m -63.6 -48.39 77.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.416 ' C ' ' O ' ' B' 1102 ' ' THR . 23.8 mt-30 -27.57 -60.18 0.1 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.738 1.256 . . . . 0.0 112.747 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.1 mt -82.43 -14.8 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 112.33 -2.214 . . . . 0.0 111.968 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.519 ' N ' ' O ' ' B' 1102 ' ' THR . 17.3 ttmm -59.1 -45.04 91.91 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 117.845 -1.542 . . . . 0.0 107.937 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.2 t -60.78 -49.26 85.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.97 -36.35 77.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.305 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.0 mttt -49.35 -38.15 27.2 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.641 -0.662 . . . . 0.0 109.659 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.19 -45.99 68.81 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.341 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -62.87 -49.8 73.41 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 25.1 m-70 . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.945 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 119.366 -0.349 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.6 p -79.33 135.98 36.88 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.371 0.987 . . . . 0.0 110.36 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ILE . 48.6 tp10 -51.94 -55.43 20.33 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.97 0.891 . . . . 0.0 110.467 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -34.8 -36.33 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.773 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -70.1 -33.96 72.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.598 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.4 mm -59.2 -45.42 92.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.52 -51.36 59.96 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.383 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.92 -46.64 89.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.422 0.629 . . . . 0.0 112.221 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.81 -38.86 92.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.771 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -52.59 -53.67 43.57 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.177 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.85 -41.27 61.7 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.041 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.95 -37.88 69.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.355 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.61 -41.76 81.9 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 t -64.6 -14.85 59.77 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.476 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.97 -42.78 97.16 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -106.14 -13.82 15.33 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -76.4 95.09 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.422 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -68.35 -46.89 68.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.227 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 23' ' ' GLY . 35.4 p30 -101.89 14.17 32.71 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.02 46.47 0.94 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.031 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -85.77 -4.17 59.09 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.898 0.38 . . . . 0.0 111.044 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.69 80.79 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.9 p -137.64 152.09 48.98 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.078 0.466 . . . . 0.0 110.068 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.12 124.51 44.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.8 p -112.51 163.4 14.52 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.521 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.7 p -59.42 -36.62 76.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.052 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -61.73 -59.58 4.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.317 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.82 -28.92 70.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.558 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 tp -61.17 -54.41 44.73 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.461 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.53 -38.36 93.5 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.192 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.36 -53.92 52.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.835 1.318 . . . . 0.0 108.729 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.409 ' O ' ' OG ' ' A' ' 38' ' ' SER . 52.7 t -56.2 -45.92 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 O-C-N 121.341 -0.85 . . . . 0.0 111.223 -176.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 ttt -58.76 -38.98 79.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 120.157 1.344 . . . . 0.0 109.946 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -52.48 -40.41 62.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 110.725 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 53.2 p -63.08 -20.83 65.72 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.037 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.79 -1.43 19.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.805 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.0 23.97 39.44 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.389 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -125.76 166.81 16.12 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 117.369 0.585 . . . . 0.0 109.669 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 14.1 p30 -131.38 76.75 75.17 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.461 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -63.87 148.85 91.69 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.941 2.427 . . . . 0.0 112.175 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.4 p -79.03 165.2 23.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.115 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -58.71 -45.0 90.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.85 -24.73 53.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.876 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -64.53 -40.92 96.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.139 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.5 mp -54.18 -38.79 65.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.222 0.534 . . . . 0.0 109.707 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -72.74 -55.34 6.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.797 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -54.68 -50.44 68.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 73.2 mtp -66.87 -49.35 65.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mm -59.01 -47.78 88.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.769 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -57.33 -32.85 67.13 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -67.35 -40.25 85.83 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.8 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.12 -21.03 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.171 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.47 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.5 t0 -78.27 86.06 4.39 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -174.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.1 81.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 113.427 -1.715 . . . . 0.0 114.184 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -86.47 -2.46 58.47 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.52 23.17 60.17 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 118.543 0.611 . . . . 0.0 112.707 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -87.47 4.72 42.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.205 0.503 . . . . 0.0 110.54 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.47 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.32 1.17 89.49 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.737 -0.602 . . . . 0.0 114.599 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.5 p -148.35 168.42 22.64 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.4 mt -112.91 128.67 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 45.7 t0 -104.03 -174.57 2.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.604 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.534 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -57.12 -57.21 26.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -50.47 -49.86 15.32 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 CA-C-N 120.541 1.229 . . . . 0.0 111.569 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.89 -18.59 60.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.273 0.559 . . . . 0.0 110.72 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -73.47 -57.59 3.89 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.123 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' THR . 78.3 mt -57.74 -45.27 86.06 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 53.6 m -38.59 -64.57 0.42 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.749 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.487 ' SD ' ' N ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -63.17 -42.03 99.32 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.487 ' N ' ' SD ' ' A' ' 71' ' ' MET . 97.9 mmm -58.73 -40.69 84.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.02 -33.51 76.21 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 122.395 0.278 . . . . 0.0 111.022 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -95.21 -10.22 31.03 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.112 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.4 65.85 8.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.974 0.416 . . . . 0.0 110.375 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.5 mmt -108.24 16.22 23.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.569 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -49.1 133.34 18.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.394 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -90.75 106.86 18.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.968 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.454 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 15.7 m -91.8 120.18 32.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.6 m-20 -68.74 112.71 5.64 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.4 m -37.42 -20.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.768 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 80' ' ' ASP . 94.9 mt-10 -68.13 -39.8 82.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.733 0.302 . . . . 0.0 111.648 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -46.93 -35.32 6.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -87.71 -19.4 27.67 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.954 0.407 . . . . 0.0 111.78 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 30.4 mm -61.04 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.735 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -61.47 -41.2 96.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.05 -40.54 94.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.5 -178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.05 -20.5 64.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -71.57 -51.6 22.58 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.03 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -54.8 -42.34 71.7 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.347 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.73 -43.74 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -68.89 -39.07 79.95 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.326 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -85.3 81.09 8.93 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -57.63 -49.46 76.37 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -91.85 4.82 52.03 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 122.181 -0.324 . . . . 0.0 111.42 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.76 48.31 50.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -90.37 6.34 43.57 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.739 0.304 . . . . 0.0 110.715 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.19 2.1 88.1 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -142.34 155.99 45.21 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.487 0.66 . . . . 0.0 111.463 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.0 mt -93.57 114.93 31.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 t -88.98 150.98 22.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.47 78.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 119.085 0.857 . . . . 0.0 110.815 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.21 -40.08 61.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.942 0.401 . . . . 0.0 110.419 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.37 -42.11 88.47 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.69 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 108' ' ' VAL . 59.8 tp -62.84 -47.16 84.6 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.249 0.547 . . . . 0.0 111.079 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -43.01 -43.31 4.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.652 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -64.23 -28.63 69.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.005 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 105' ' ' LEU . 92.9 t -57.78 -42.38 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.602 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.624 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -50.96 -44.12 60.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.699 0.761 . . . . 0.0 111.253 -177.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 m -56.28 -40.91 75.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.781 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -65.51 -41.02 93.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.79 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.8 mt -81.82 -13.77 57.23 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.905 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.2 31.36 59.55 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -85.31 -22.63 28.45 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.55 2.175 . . . . 0.0 111.286 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 44.16 60.93 2.55 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.71 0.767 . . . . 0.0 109.675 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 88.9 mt -80.7 148.23 30.24 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 113.527 -1.67 . . . . 0.0 112.462 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 65.4 p -82.85 175.5 10.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.3 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 119' ' ' GLU . 18.9 p-10 -58.41 -43.99 88.87 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 176.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.491 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 67.5 mm-40 -57.85 -49.16 77.6 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -70.87 -30.3 66.64 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.627 -0.429 . . . . 0.0 112.039 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.97 -41.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.6 0.714 . . . . 0.0 109.1 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -70.78 -35.6 72.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.339 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.41 -51.33 69.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 37.9 mmm -55.98 -44.62 78.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.253 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.96 -43.49 88.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.404 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -60.73 -35.22 75.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.848 0.356 . . . . 0.0 111.153 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -59.45 -41.36 89.5 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.938 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.95 -20.51 22.09 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 21.4 t0 -73.09 89.05 1.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.528 0.68 . . . . 0.0 111.706 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 76.4 mt -70.08 -16.35 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.021 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 49.1 p-10 -140.48 144.82 36.25 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 112.644 -2.071 . . . . 0.0 108.805 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.27 52.17 1.41 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.899 -0.191 . . . . 0.0 113.154 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 22.0 p-10 -91.24 -8.84 47.29 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.966 0.383 . . . . 0.0 110.057 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.86 3.17 79.64 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.117 -0.564 . . . . 0.0 114.125 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -136.09 155.2 50.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.444 0.622 . . . . 0.0 110.383 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.9 t -101.56 119.01 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.207 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -84.79 175.64 9.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.597 0.237 . . . . 0.0 110.89 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -61.64 -41.12 97.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.306 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -61.61 -45.0 95.93 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.704 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.59 -38.0 88.25 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.668 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 90.9 t80 -58.57 -44.64 89.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.999 0.428 . . . . 0.0 110.796 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.03 -46.13 88.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.411 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -48.35 -44.58 34.49 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.03 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 77.3 mmm -75.73 -36.48 59.92 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.585 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.6 mmt -65.96 -50.98 62.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 m . . . . . 0 C--N 1.326 -0.441 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.08 -179.612 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 9.3 mt . . . . . 0 C--O 1.24 0.562 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.8 m95 -63.4 -47.29 82.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1094 ' ' PHE . . . . . 0.532 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 2.4 m-85 -58.02 -46.3 85.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -40.51 -53.46 2.67 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.85 -42.11 99.71 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.129 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 50.8 tp -56.85 -44.6 82.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.217 1.008 . . . . 0.0 109.592 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 12.4 m120 -58.8 -47.6 84.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -65.06 -37.46 87.63 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.12 -42.43 93.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.772 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -50.83 -45.88 59.74 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 118.863 -1.135 . . . . 0.0 108.039 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.519 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.8 m -63.64 -48.22 78.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.434 -0.506 . . . . 0.0 112.152 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.429 ' C ' ' O ' ' B' 1102 ' ' THR . 84.3 mt-30 -27.79 -57.78 0.11 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 122.457 1.122 . . . . 0.0 112.451 -176.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.5 mt -83.98 -14.45 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.365 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.519 ' N ' ' O ' ' B' 1102 ' ' THR . 65.7 tttm -59.72 -46.28 89.59 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 118.152 -1.419 . . . . 0.0 107.972 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 86.2 t -61.08 -49.31 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.64 -35.97 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.329 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1108 ' ' LYS . . . . . 0.454 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 88.8 mttt -49.31 -37.75 25.28 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.646 0.657 . . . . 0.0 109.641 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.59 -45.91 66.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.295 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -62.9 -50.23 71.7 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 78.5 m-70 . . . . . 0 C--N 1.325 -0.467 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.198 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 CA--C 1.534 0.338 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.7 m -81.07 136.43 35.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.093 0.861 . . . . 0.0 110.366 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.1 tt0 -51.01 -58.84 5.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.795 0.807 . . . . 0.0 110.991 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -33.8 -38.64 0.05 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.855 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -68.86 -35.06 76.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.49 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.6 mt -58.32 -45.11 89.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.55 -51.28 63.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.097 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -59.82 -48.27 82.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.283 0.564 . . . . 0.0 112.384 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -61.37 -40.4 94.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.952 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -51.63 -56.9 10.93 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.734 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.35 -43.65 23.26 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.462 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.82 -39.04 65.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.987 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -56.92 -42.37 79.86 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -64.25 -15.49 60.2 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.056 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.96 -41.34 95.56 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -105.99 -13.65 15.42 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -74.4 95.84 2.77 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.565 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -68.86 -49.46 58.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.111 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.0 p-10 -101.84 15.76 28.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 33.87 47.82 0.51 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.035 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 33.9 p-10 -85.24 -5.18 59.34 Favored 'General case' 0 N--CA 1.461 0.106 0 O-C-N 122.69 -0.3 . . . . 0.0 111.038 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.72 -1.93 79.3 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.0 p -138.25 153.89 49.08 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.489 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 2.0 mp -93.0 125.46 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 t -116.86 166.37 12.24 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.5 p -56.79 -32.45 65.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.407 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -59.78 -63.61 1.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.298 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -62.54 -30.49 71.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 119.326 -0.369 . . . . 0.0 111.882 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 tp -58.25 -61.3 2.67 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 118.821 -1.151 . . . . 0.0 108.69 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.19 72.96 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.098 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.8 m -56.67 -53.64 55.4 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.782 1.791 . . . . 0.0 108.431 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.71 -45.64 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 119.196 0.907 . . . . 0.0 111.563 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.2 tpt -58.2 -41.69 84.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 120.355 1.434 . . . . 0.0 109.698 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -52.3 -39.85 61.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.506 0.67 . . . . 0.0 111.32 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 t -62.96 -20.52 65.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.706 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 80.4 mt -74.98 2.21 11.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.167 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.1 26.81 47.29 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.978 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -125.8 166.65 16.45 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 117.41 0.605 . . . . 0.0 109.91 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -124.11 81.07 57.63 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.23 146.76 52.02 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.802 1.668 . . . . 0.0 112.204 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -80.29 163.19 24.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.84 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -58.02 -44.48 87.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.097 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.74 -24.49 35.42 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.771 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -65.25 -40.62 94.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.895 0.378 . . . . 0.0 110.657 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 6.8 mp -56.2 -41.05 74.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.638 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -70.01 -56.93 5.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.826 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -55.27 -49.69 71.43 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.5 mtp -66.21 -51.4 58.04 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.7 mm -57.64 -49.18 81.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -56.15 -32.57 64.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -67.26 -40.39 86.22 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.868 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.7 t -86.27 -20.32 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.425 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.404 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 43.5 t0 -78.69 83.64 4.83 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -174.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.7 75.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 113.595 -1.639 . . . . 0.0 114.748 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.454 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 26.1 p30 -88.61 -1.66 58.18 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.17 23.84 60.22 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 118.664 0.666 . . . . 0.0 112.95 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.587 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -87.52 2.97 49.21 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 117.42 0.61 . . . . 0.0 110.368 179.316 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 86.18 1.73 86.2 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 114.831 0.692 . . . . 0.0 114.831 176.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.587 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 19.2 p -147.66 169.65 19.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -112.22 128.17 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.097 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 9.1 p30 -102.46 -178.99 3.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.761 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.96 99.78 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -54.13 -51.83 9.73 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.071 1.181 . . . . 0.0 111.978 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.24 -23.19 66.53 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.388 0.613 . . . . 0.0 111.269 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -71.18 -61.11 1.89 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.514 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.5 mt -56.69 -43.81 80.85 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.1 p -44.0 -51.72 7.56 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.605 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.0 mtm -64.9 -44.65 88.9 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.6 mmm -61.23 -41.06 96.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.91 79.31 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.415 0.286 . . . . 0.0 111.623 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -91.91 -16.25 26.91 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.722 0.296 . . . . 0.0 111.331 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -80.49 71.62 7.34 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.819 0.819 . . . . 0.0 110.631 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 20.6 mmt -109.5 15.35 23.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.255 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -47.77 131.27 14.88 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.237 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -89.28 109.62 20.49 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.927 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.412 ' CG2' ' NZ ' ' B' 1108 ' ' LYS . 17.2 p -97.98 114.79 27.02 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -64.99 115.5 5.46 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 62.6 m -37.44 -21.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.845 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 80' ' ' ASP . 42.5 tp10 -68.26 -35.86 78.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.028 0.442 . . . . 0.0 111.707 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 80.2 tt0 -49.6 -37.2 26.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.341 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -87.35 -16.3 35.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.128 0.49 . . . . 0.0 111.701 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.5 mm -62.57 -73.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.735 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -60.39 -44.21 95.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 87' ' ' GLU . 7.1 mp0 -61.05 -41.29 96.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.364 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.5 -17.84 47.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.188 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -75.15 -49.67 18.79 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.476 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -55.4 -42.94 74.76 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.932 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.9 t -65.13 -44.12 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -69.82 -38.16 76.47 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.635 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.561 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 31.4 t0 -88.32 82.59 7.01 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.12 -48.59 78.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 40.7 p-10 -91.65 5.47 49.56 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.1 50.13 40.56 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.686 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -92.62 5.11 52.17 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.416 0.287 . . . . 0.0 110.818 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.434 ' N ' HD21 ' A' ' 97' ' ' ASN . . . 85.25 0.21 88.61 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.686 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 87.0 m-85 -138.74 152.12 47.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.944 0.878 . . . . 0.0 111.887 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 95.8 mt -94.79 117.37 38.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.1 m -89.46 148.12 23.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.529 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.29 -48.03 74.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 119.66 1.118 . . . . 0.0 110.17 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.38 -42.61 53.71 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.75 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.91 -41.05 97.78 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.34 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.33 -45.28 92.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.552 0.691 . . . . 0.0 111.203 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 74.5 ttp85 -44.28 -44.94 8.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.551 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -63.63 -31.33 72.47 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.331 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.5 t -56.05 -42.15 71.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.004 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.465 ' SD ' ' CD1' ' A' ' 116' ' ' LEU . 16.0 mmt -51.31 -44.38 61.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.795 0.807 . . . . 0.0 111.222 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 m -53.76 -42.03 67.81 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.952 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -66.4 -41.17 89.72 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.521 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.31 -16.03 53.65 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.08 30.39 59.15 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-O 118.258 -1.301 . . . . 0.0 110.546 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -85.66 -22.27 27.98 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.341 2.571 . . . . 0.0 110.982 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 43.76 60.42 2.69 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 122.18 0.99 . . . . 0.0 110.056 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.465 ' CD1' ' SD ' ' A' ' 109' ' ' MET . 40.4 mt -80.49 147.24 30.97 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.64 -1.618 . . . . 0.0 111.799 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.5 p -82.14 174.89 10.78 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -56.55 -44.98 81.45 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -57.7 -47.25 82.89 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.594 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -73.22 -30.18 63.31 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.762 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.5 t -64.68 -41.71 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.463 0.649 . . . . 0.0 109.864 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 67.7 t0 -73.45 -34.8 65.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.291 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -59.5 -50.01 75.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.934 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.0 mtp -53.58 -46.6 70.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.285 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.8 mm -56.41 -43.54 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -60.1 -36.5 77.56 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.288 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -58.68 -41.18 85.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.846 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.91 -17.16 25.61 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.8 t0 -72.54 90.74 1.36 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.737 0.78 . . . . 0.0 112.213 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 79.3 mt -71.74 -17.63 19.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.158 -1.383 . . . . 0.0 113.123 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 50.4 p-10 -142.72 144.28 32.62 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 112.65 -2.068 . . . . 0.0 108.813 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.41 53.82 1.53 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.129 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -90.85 -8.87 48.35 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.051 0.425 . . . . 0.0 110.14 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.52 1.64 71.73 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.997 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -134.76 155.33 50.78 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.159 0.479 . . . . 0.0 110.439 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.3 t -100.91 118.42 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.322 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.471 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 53.3 t30 -84.46 173.7 10.65 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 111.258 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.471 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 82.5 t80 -61.0 -40.6 94.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.96 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.06 -44.63 96.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.794 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.48 -37.24 86.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.549 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -61.12 -45.04 96.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.046 0.451 . . . . 0.0 111.046 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.69 -47.18 89.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.829 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -50.58 -41.93 55.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.145 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.6 mmt -74.67 -38.57 62.39 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 19.9 mmt -73.17 -46.12 52.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 120.576 0.227 . . . . 0.0 111.456 -179.764 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 111.417 0.154 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.7 m95 -61.33 -55.76 28.02 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.462 0.649 . . . . 0.0 112.172 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 50.3 t80 -57.94 -46.98 84.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1095 ' ' ARG . . . . . 0.671 HH21 ' NH2' ' B' 1099 ' ' ARG . 59.4 ttt85 -40.31 -52.75 2.65 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.4 -40.62 98.91 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 48.7 tp -56.0 -46.32 78.78 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.689 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -58.63 -49.88 75.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1099 ' ' ARG . . . . . 0.671 ' NH2' HH21 ' B' 1095 ' ' ARG . 91.2 mtt180 -63.87 -39.76 94.95 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.77 -42.61 89.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.14 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -52.29 -47.42 65.91 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 118.605 -1.238 . . . . 0.0 107.677 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.527 ' O ' ' N ' ' B' 1105 ' ' LYS . 18.8 m -61.58 -48.87 78.99 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 25.2 mt-30 -27.57 -57.95 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 122.709 1.242 . . . . 0.0 113.382 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.0 mt -81.68 -14.42 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 112.434 -2.166 . . . . 0.0 112.389 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.527 ' N ' ' O ' ' B' 1102 ' ' THR . 93.4 mttt -59.28 -41.87 89.9 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.27 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 90.8 t -60.39 -46.7 94.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.994 0.902 . . . . 0.0 112.24 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 55.5 t -65.59 -42.34 92.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.877 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1108 ' ' LYS . . . . . 0.412 ' NZ ' ' CG2' ' A' ' 79' ' ' THR . 94.0 mttt -49.25 -41.32 37.2 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.848 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.25 61.66 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.693 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -60.44 -65.65 0.65 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.848 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 35.4 p80 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.929 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 119.346 -0.359 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -80.92 140.21 35.43 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.15 0.886 . . . . 0.0 110.196 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.5 tt0 -50.39 -56.26 12.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 122.167 0.984 . . . . 0.0 110.642 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -34.83 -37.77 0.07 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.189 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -68.9 -38.59 79.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.72 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 6' ' ' GLU . 66.6 mt -56.85 -45.74 83.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.62 -51.27 63.61 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.455 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -61.43 -47.33 86.25 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.466 0.65 . . . . 0.0 112.246 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -62.83 -37.7 87.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.897 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -54.59 -52.21 62.86 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.777 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -51.08 -39.99 57.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.082 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.84 -38.0 72.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.309 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -58.04 -42.31 85.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.1 t -65.03 -14.79 61.32 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.6 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.74 -43.05 99.81 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.39 -12.56 15.97 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.72 94.84 3.32 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.265 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -65.04 -47.89 75.78 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.521 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 8.9 p30 -109.69 14.5 23.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.31 59.78 1.47 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.303 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -87.54 -6.79 58.19 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.804 0.335 . . . . 0.0 110.237 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.91 -1.63 74.8 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.0 p -139.77 156.66 46.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.015 0.436 . . . . 0.0 109.998 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.463 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 mp -89.2 123.1 41.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -111.46 162.71 14.8 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.91 0.757 . . . . 0.0 112.41 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.8 p -60.33 -38.52 84.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.859 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -59.75 -62.21 2.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.821 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -62.0 -28.1 69.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.652 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.43 -52.66 64.28 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.471 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.91 91.81 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.891 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.67 -52.42 65.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.828 1.314 . . . . 0.0 108.632 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' A' ' 38' ' ' SER . 43.8 t -58.65 -45.06 90.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 119.267 0.94 . . . . 0.0 111.231 -176.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.484 ' SD ' ' O ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -59.54 -40.29 86.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 119.782 1.173 . . . . 0.0 109.789 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -52.58 -38.12 59.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.403 0.621 . . . . 0.0 110.041 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 25.2 p -62.27 -20.01 63.84 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.177 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -73.82 2.24 8.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.99 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.24 26.23 40.97 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.132 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -131.75 171.3 13.67 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.356 0.578 . . . . 0.0 109.817 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 16.9 p-10 -132.77 76.79 70.34 Favored Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.409 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.46 146.27 97.13 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.783 2.322 . . . . 0.0 111.93 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.2 p -76.28 163.85 26.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.173 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -58.59 -43.64 89.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.848 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.78 -24.25 49.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.378 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -65.38 -39.51 92.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.154 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.0 mp -56.71 -41.03 76.71 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.395 0.617 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -72.1 -56.12 6.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.008 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -55.99 -49.72 72.84 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 40.8 mmm -64.59 -50.86 65.57 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.8 mm -59.23 -45.37 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.346 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -56.97 -34.68 68.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.35 -40.68 85.85 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.872 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.8 t -84.93 -21.95 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.471 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.496 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.6 t0 -78.6 87.15 4.55 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -175.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.68 -37.19 85.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.356 -1.747 . . . . 0.0 113.669 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.416 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 39.9 p-10 -86.05 -2.46 58.34 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.66 23.09 60.39 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.313 0.506 . . . . 0.0 112.942 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -88.26 4.13 47.01 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.3 0.55 . . . . 0.0 110.354 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.496 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.05 0.87 88.89 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 121.091 -0.576 . . . . 0.0 114.383 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.1 p -147.87 169.2 20.32 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.5 mt -111.93 128.11 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.555 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 23.7 t0 -102.29 -178.14 3.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.658 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.555 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -57.03 -48.31 97.64 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.387 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -55.79 -49.34 16.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.26 1.306 . . . . 0.0 111.824 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.01 -20.65 64.14 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.487 0.661 . . . . 0.0 110.662 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -74.8 -57.0 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.131 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 72.8 mt -58.08 -45.23 87.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -47.29 -46.59 25.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.321 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 81.4 mtp -66.62 -45.29 79.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.6 mmt -60.13 -40.68 90.63 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -34.8 78.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.531 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -92.3 -16.86 25.53 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.64 0.257 . . . . 0.0 111.461 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 67.31 7.11 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.197 0.522 . . . . 0.0 110.709 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.9 mmt -107.99 16.8 23.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.517 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -49.3 132.59 20.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.981 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.57 109.11 20.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.871 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -95.28 118.88 32.83 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -66.65 113.32 4.71 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 174.318 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.8 m -37.8 -20.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.751 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 80' ' ' ASP . 5.3 mp0 -66.87 -41.9 86.52 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -45.21 -35.64 3.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.319 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -87.52 -20.3 26.7 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.003 0.43 . . . . 0.0 111.865 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 30.4 mm -60.11 -74.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.669 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -63.09 -40.21 96.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.09 -40.76 94.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.434 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.8 -20.75 63.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.136 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -70.74 -50.43 36.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.075 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -55.38 -41.84 73.18 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.414 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.11 -45.05 97.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -68.94 -39.67 79.42 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.423 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -85.52 81.29 8.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.81 -48.89 79.72 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -91.31 4.87 51.28 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.344 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.55 48.3 49.58 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -90.7 7.32 40.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.665 0.269 . . . . 0.0 110.51 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.64 1.93 88.95 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -142.39 155.77 45.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.716 0.77 . . . . 0.0 111.491 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.3 mt -93.33 114.26 29.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.3 m -88.83 151.52 22.32 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.54 -48.98 77.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.838 0.745 . . . . 0.0 110.895 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.77 -40.81 60.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.9 0.381 . . . . 0.0 110.726 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -64.98 -40.86 95.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.027 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 108' ' ' VAL . 7.4 tt -63.42 -45.02 92.87 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.337 0.589 . . . . 0.0 111.408 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -40.7 -37.87 0.81 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.71 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.579 ' CE1' HD22 ' A' ' 111' ' ' ASN . 56.8 t-80 -69.31 -25.32 64.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.783 0.325 . . . . 0.0 111.46 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 105' ' ' LEU . 90.1 t -59.01 -44.88 92.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.625 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.519 ' SD ' ' CD1' ' A' ' 116' ' ' LEU . 16.4 mmt -52.02 -44.95 64.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.12 0.962 . . . . 0.0 111.234 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.5 m -58.62 -42.73 88.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.706 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.579 HD22 ' CE1' ' A' ' 107' ' ' HIS . 1.1 m-80 -65.73 -41.49 92.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.148 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.7 mt -81.52 -15.88 53.5 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.879 -0.329 . . . . 0.0 111.812 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.53 30.65 57.95 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.418 ' OE1' ' SD ' ' A' ' 109' ' ' MET . 96.9 mt-10 -85.66 -23.24 27.55 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.552 2.176 . . . . 0.0 110.578 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt 43.84 59.62 3.05 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.927 0.87 . . . . 0.0 110.366 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.519 ' CD1' ' SD ' ' A' ' 109' ' ' MET . 44.6 mt -79.69 148.83 31.42 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.519 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.6 p -82.91 174.78 10.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.197 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -57.99 -44.5 87.2 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.81 -48.81 78.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.484 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.0 -31.54 69.27 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.821 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.3 t -63.17 -43.29 98.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.487 0.66 . . . . 0.0 109.343 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.06 -37.74 84.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.582 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -59.77 -50.36 74.13 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 20.1 mmm -57.12 -44.08 82.94 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.342 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.9 mt -59.9 -43.41 92.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.044 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -58.94 -38.63 79.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.999 0.428 . . . . 0.0 111.199 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -58.73 -40.61 84.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.006 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.6 -21.44 21.72 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.0 t0 -74.23 88.55 2.0 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.486 0.66 . . . . 0.0 111.883 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 42.7 mm -71.93 -14.19 17.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 122.624 1.202 . . . . 0.0 113.13 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.6 p-10 -142.84 144.59 32.58 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 112.414 -2.176 . . . . 0.0 109.251 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.02 52.23 1.32 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.784 -0.246 . . . . 0.0 112.968 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -90.85 -10.07 44.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.061 0.431 . . . . 0.0 110.056 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.12 1.11 67.62 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.195 -0.526 . . . . 0.0 114.221 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -134.9 153.76 51.94 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.435 0.618 . . . . 0.0 110.433 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.21 118.61 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.243 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.1 174.86 9.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.733 0.301 . . . . 0.0 110.858 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -61.65 -40.16 93.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.965 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.54 -44.64 95.86 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.837 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.26 -37.85 88.47 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.505 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -60.26 -45.42 93.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 110.721 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.55 -46.59 89.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.458 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -48.78 -47.12 42.2 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.893 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.7 mmm -72.33 -37.57 68.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.431 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 24.2 mmt -72.11 -45.23 61.4 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.857 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.066 -179.357 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.7 m95 -58.11 -65.01 0.72 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.752 0.787 . . . . 0.0 111.875 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1094 ' ' PHE . . . . . 0.431 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 38.0 m-85 -56.68 -43.35 80.36 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -174.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 12.3 tpp85 -39.73 -51.49 2.34 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.12 99.94 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.47 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.0 tp -56.35 -45.69 80.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.501 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -59.79 -49.09 79.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.878 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -65.77 -37.67 86.95 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.11 -42.04 91.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.903 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -51.47 -45.39 62.75 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.507 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.1 m -64.27 -47.99 77.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.825 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 84.0 mt-30 -27.98 -57.08 0.11 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.83 1.3 . . . . 0.0 112.597 -176.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.89 -13.94 11.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 CA-C-N 112.519 -2.128 . . . . 0.0 112.578 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.507 ' N ' ' O ' ' B' 1102 ' ' THR . 88.6 tttt -57.51 -41.65 81.25 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 118.316 -1.354 . . . . 0.0 107.95 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 77.5 t -62.74 -46.82 95.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.724 0.773 . . . . 0.0 112.814 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 37.1 t -65.83 -42.08 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.209 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 97.0 mttt -48.79 -38.07 20.96 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.833 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.87 -45.04 67.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.076 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -63.25 -50.0 71.9 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 69.8 m-70 . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.285 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.3 p -79.81 133.22 36.28 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.643 1.111 . . . . 0.0 111.12 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.7 tt0 -54.66 -51.3 65.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.769 0.795 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -34.17 -36.01 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.129 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.61 -32.87 70.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.475 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' A' ' 6' ' ' GLU . 93.7 mt -57.83 -45.73 87.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.89 -50.14 61.62 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.412 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.15 -44.76 91.15 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -62.98 -40.79 98.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.753 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -52.14 -55.58 19.99 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.204 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -49.87 -41.84 46.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.116 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.83 -35.66 64.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.503 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.434 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 2.5 m-85 -57.73 -39.61 77.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.4 m -65.95 -16.06 63.54 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.255 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 2.7 mm? -64.23 -41.99 96.75 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.78 -15.25 14.78 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.897 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -74.99 94.72 2.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.145 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -67.15 -48.22 68.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.802 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.0 p30 -103.25 14.68 31.07 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 38.08 50.48 2.14 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.961 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -87.57 -5.17 58.88 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.925 0.362 . . . . 0.0 111.572 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.43 -0.59 78.01 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.7 p -140.07 157.9 44.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.981 0.42 . . . . 0.0 109.954 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mm -88.03 122.81 40.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 p -111.57 161.56 16.07 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.012 0.82 . . . . 0.0 112.276 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 p -59.26 -38.4 79.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.708 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -60.99 -60.05 4.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.06 -30.16 71.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.766 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 tp -60.54 -55.92 27.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.322 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.99 -37.56 91.66 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.806 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -58.5 -53.71 55.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 119.317 1.558 . . . . 0.0 108.434 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.7 t -56.97 -46.69 84.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.598 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.0 ttt -58.51 -42.26 87.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 120.27 1.395 . . . . 0.0 110.189 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -52.27 -37.62 55.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.481 0.658 . . . . 0.0 110.15 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.0 t -63.69 -21.22 66.28 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.517 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.52 0.4 17.4 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.756 -0.777 . . . . 0.0 109.935 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 18.21 62.59 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.173 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -109.81 157.91 18.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.72 0.76 . . . . 0.0 110.038 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -113.0 66.15 0.96 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.443 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.74 142.68 90.11 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.075 1.85 . . . . 0.0 112.302 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -82.36 166.78 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.447 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -58.29 -44.77 88.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.851 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.43 -23.59 25.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.635 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.65 -39.02 90.95 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.273 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 7.8 mp -56.45 -41.31 76.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.23 0.538 . . . . 0.0 109.662 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.425 ' OE1' ' ND2' ' A' ' 53' ' ' ASN . 8.9 tp-100 -68.78 -58.52 4.08 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.71 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -55.05 -49.37 71.78 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.9 mmm -63.81 -53.91 43.38 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.4 mm -58.31 -47.63 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.83 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.425 ' ND2' ' OE1' ' A' ' 49' ' ' GLN . 34.3 m-80 -56.49 -33.64 66.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -66.41 -40.31 89.49 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.596 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.3 t -86.65 -19.8 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.42 -178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 40.6 t0 -78.98 84.59 4.98 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -174.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.28 -37.39 83.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.626 -1.625 . . . . 0.0 114.238 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.454 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.7 p-10 -86.1 -2.35 58.25 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.5 23.34 62.55 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 118.383 0.538 . . . . 0.0 112.696 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.454 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.4 p-10 -87.5 1.96 52.02 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.27 0.535 . . . . 0.0 110.606 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.552 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 86.73 1.58 85.17 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.685 0.634 . . . . 0.0 114.685 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.3 p -148.84 170.9 17.22 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mm -110.85 128.29 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -102.35 -178.27 3.64 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.434 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -58.06 -48.96 96.16 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -55.94 -51.86 8.67 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.536 1.491 . . . . 0.0 111.537 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.1 -19.99 62.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.607 0.717 . . . . 0.0 110.354 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -75.95 -58.99 2.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.2 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.87 -44.94 78.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.9 p -45.75 -44.29 13.66 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.561 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.5 mtp -71.89 -49.48 37.55 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.4 mmm -61.01 -40.72 94.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.16 -33.58 76.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.66 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -93.45 -14.82 26.27 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.627 0.251 . . . . 0.0 111.529 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 mmpp? -77.87 71.91 4.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.163 0.506 . . . . 0.0 111.311 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.7 mmt -107.03 18.33 21.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.858 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -51.73 129.87 27.25 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.197 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -90.69 105.18 17.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.135 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.495 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 3.1 m -88.45 123.18 32.74 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 82' ' ' GLU . 15.5 t0 -69.43 109.86 4.43 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 174.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.8 m -37.04 -21.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 80' ' ' ASP . 50.6 mp0 -70.33 -34.14 72.32 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 111.835 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.444 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 81.1 tt0 -50.32 -39.14 45.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.266 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -88.34 -5.57 58.24 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.9 mm -70.79 -74.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.85 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -61.48 -50.39 72.95 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 83' ' ' GLU . 16.1 pt-20 -54.41 -38.77 66.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.79 -20.03 60.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.014 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -73.99 -48.1 32.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.771 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -54.59 -41.01 69.39 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.418 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.91 -43.29 92.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -68.78 -39.03 80.38 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.248 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 30.1 t0 -87.36 82.8 7.46 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.88 -49.45 76.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 35.6 p-10 -90.91 5.28 49.27 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.629 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.07 48.49 46.15 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.648 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -90.31 6.48 42.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.678 0.275 . . . . 0.0 110.634 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.54 1.45 89.21 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.648 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 97.9 m-85 -140.72 153.91 46.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.671 0.748 . . . . 0.0 111.612 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.7 mt -97.07 117.28 41.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.3 m -90.46 152.67 20.86 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.1 80.03 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.974 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.97 -39.93 60.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.89 0.376 . . . . 0.0 110.463 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -66.01 -41.54 90.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.357 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.3 tp -63.07 -46.55 86.91 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.267 0.556 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -43.57 -44.35 6.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.65 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -63.54 -29.26 70.55 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 121.281 -0.168 . . . . 0.0 110.99 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.6 t -57.54 -41.81 79.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.842 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.623 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.54 -45.27 62.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.958 0.885 . . . . 0.0 111.543 -177.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.9 m -55.91 -40.73 73.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.853 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.33 -40.46 93.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.759 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.5 -13.0 58.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.739 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.65 29.09 60.07 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -85.34 -21.78 28.76 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.805 2.302 . . . . 0.0 111.111 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mttm 42.82 60.58 2.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.952 0.882 . . . . 0.0 110.013 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 81.5 mt -80.04 148.38 31.1 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.48 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.7 p -82.96 175.17 10.26 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.376 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -57.98 -45.12 87.25 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -57.21 -51.15 70.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.456 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.405 ' OE1' ' OE1' ' A' ' 123' ' ' GLU . 78.7 mm-40 -67.3 -30.55 70.43 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.484 -0.486 . . . . 0.0 112.001 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.6 t -63.72 -41.53 92.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -66.94 -38.22 85.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.407 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.405 ' OE1' ' OE1' ' A' ' 120' ' ' GLU . 94.6 mt-10 -59.21 -52.51 65.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.46 ' SD ' ' CD1' ' B' 1093 ' ' TRP . 17.6 mmm -54.72 -45.04 74.0 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.682 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 91.3 mt -59.05 -44.71 92.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.234 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -61.35 -36.4 80.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.685 0.279 . . . . 0.0 111.553 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.45 -41.3 84.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.88 -16.86 24.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.723 0.297 . . . . 0.0 111.746 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.8 t0 -71.09 91.76 0.93 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.491 0.662 . . . . 0.0 111.991 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.1 mt -70.48 -17.26 20.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 122.591 1.186 . . . . 0.0 113.317 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 51.4 p-10 -142.24 144.12 33.2 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 112.404 -2.18 . . . . 0.0 108.905 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.18 53.07 1.05 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.699 -0.286 . . . . 0.0 113.118 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -90.9 -8.13 50.27 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.002 0.401 . . . . 0.0 110.222 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.92 3.87 81.55 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.671 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -136.67 157.86 45.79 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.562 0.681 . . . . 0.0 110.439 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.9 p -103.98 119.63 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.718 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -85.92 177.24 7.67 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.737 0.303 . . . . 0.0 111.079 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.98 -42.08 98.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.213 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.44 -45.33 94.74 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.902 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.94 -36.86 84.51 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.356 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -61.15 -45.39 94.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.2 t -65.7 -46.33 89.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.932 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -50.26 -44.14 53.55 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.994 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.2 mmt -72.92 -39.31 66.4 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 21.1 mmt -74.66 -47.04 34.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.877 -0.147 . . . . 0.0 110.823 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 120.689 0.28 . . . . 0.0 111.678 -179.282 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 CA--C 1.537 0.481 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B 1093 ' ' TRP . . . . . 0.46 ' CD1' ' SD ' ' A' ' 124' ' ' MET . 6.2 m95 -61.9 -53.51 54.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.366 0.603 . . . . 0.0 111.908 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 48.5 t80 -58.19 -46.34 85.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -40.38 -52.3 2.73 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.5 -41.08 99.48 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.106 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.7 tp -56.84 -45.36 82.44 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.484 -0.887 . . . . 0.0 109.562 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 40.9 t30 -58.65 -49.33 77.91 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -64.28 -38.14 90.0 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.3 mt -60.65 -41.91 89.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.68 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -50.37 -48.34 55.8 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.002 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.512 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.2 m -64.19 -47.9 78.0 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.42 ' C ' ' O ' ' B' 1102 ' ' THR . 25.5 mt-30 -27.61 -59.46 0.1 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 122.565 1.174 . . . . 0.0 112.612 -176.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.8 mt -83.02 -12.79 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 112.954 -1.93 . . . . 0.0 112.381 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.512 ' N ' ' O ' ' B' 1102 ' ' THR . 63.8 tttm -57.46 -43.28 83.87 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 118.001 -1.479 . . . . 0.0 108.024 176.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 57.5 t -61.92 -47.36 93.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 41.2 t -65.53 -41.52 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.074 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1108 ' ' LYS . . . . . 0.495 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 95.4 mttt -47.56 -37.11 11.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.659 0.742 . . . . 0.0 109.782 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -55.29 -46.63 76.19 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.63 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -63.77 -48.91 75.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 27.5 m-70 . . . . . 0 C--N 1.327 -0.4 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.539 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.1 tp . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.6 p -77.79 141.01 39.49 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.03 0.832 . . . . 0.0 110.628 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.1 tt0 -50.4 -55.95 13.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.166 0.984 . . . . 0.0 110.46 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -35.21 -38.45 0.09 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.886 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -68.27 -38.74 82.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.208 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.0 mt -58.7 -44.92 90.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 176.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.26 -50.38 67.37 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.797 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -60.23 -48.55 81.25 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.174 0.512 . . . . 0.0 112.228 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -61.72 -39.4 91.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.612 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -52.19 -56.19 16.19 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.999 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -50.42 -42.81 54.46 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.295 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.64 -36.83 64.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.125 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.56 -40.74 79.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -63.56 -16.31 60.46 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.205 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.442 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 2.9 mm? -64.7 -41.14 96.22 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -106.1 -15.08 14.97 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.49 92.99 1.93 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.192 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -67.81 -49.83 60.15 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.884 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.8 p-10 -101.89 15.74 28.07 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.7 45.37 0.52 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.2 p30 -85.35 -4.51 59.18 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 122.676 -0.308 . . . . 0.0 110.802 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.96 -2.2 81.54 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 p -137.91 152.73 49.29 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.975 0.417 . . . . 0.0 109.95 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.47 124.47 44.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -113.21 164.91 12.94 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.992 0.807 . . . . 0.0 112.37 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.3 p -59.73 -34.7 73.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.872 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -62.38 -61.58 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.757 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -60.4 -31.42 70.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.845 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 tp -60.56 -55.53 32.24 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.991 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.32 -39.41 92.63 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.988 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.2 m -57.71 -53.91 52.9 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.921 1.361 . . . . 0.0 108.704 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.92 -46.87 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 118.694 0.679 . . . . 0.0 111.527 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.5 ttt -59.24 -40.85 87.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 120.082 1.31 . . . . 0.0 109.868 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -52.15 -39.2 59.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.63 0.729 . . . . 0.0 110.358 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.0 t -63.32 -21.35 66.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.086 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.45 -2.18 21.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.54 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.35 14.63 65.81 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.097 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -106.38 156.45 18.51 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 117.356 0.578 . . . . 0.0 110.095 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -116.43 63.06 2.6 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.355 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.08 144.95 93.63 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.229 1.952 . . . . 0.0 112.169 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.6 p -80.23 166.73 21.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.522 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -57.7 -43.68 85.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.604 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.73 -24.26 33.93 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.398 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -65.97 -39.33 90.29 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.174 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.6 mp -57.23 -42.75 82.0 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.657 0.741 . . . . 0.0 109.867 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -68.81 -56.09 9.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.494 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.05 -49.21 74.38 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.7 mmm -63.91 -50.72 67.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.9 mm -59.3 -48.06 88.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.619 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -55.9 -34.62 65.73 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.95 -39.83 90.77 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.728 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -87.1 -20.18 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.299 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 44.6 t0 -79.38 84.3 5.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.45 82.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.619 -1.628 . . . . 0.0 114.263 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -86.41 -2.36 58.37 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.047 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.9 23.97 59.76 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.407 0.548 . . . . 0.0 112.463 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -87.91 3.74 47.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.421 0.61 . . . . 0.0 110.199 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.44 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.06 1.43 88.66 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 118.578 0.626 . . . . 0.0 114.573 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.9 p -148.9 170.97 17.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.2 mt -114.82 129.05 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -103.27 -175.32 2.77 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.604 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.438 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -59.27 -45.79 99.15 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 41.9 Cg_exo -55.49 -53.72 5.31 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.298 1.332 . . . . 0.0 111.513 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.88 -20.9 64.23 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.492 0.663 . . . . 0.0 110.763 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -72.87 -57.94 3.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.579 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.07 -44.81 87.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.6 m -40.53 -57.96 1.7 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.015 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.6 ptp -63.78 -39.29 93.89 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.811 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.1 mmt -59.06 -41.14 87.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.11 -35.49 78.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.429 0.291 . . . . 0.0 111.663 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -94.05 -12.45 28.53 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -81.61 72.91 8.66 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.704 0.764 . . . . 0.0 110.376 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 21.6 mmt -110.33 17.77 20.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.056 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -53.08 129.72 31.79 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.487 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -107.45 143.96 35.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.674 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.0 p -130.55 135.71 48.19 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.4 m-20 -61.2 116.07 4.29 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 175.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.2 m -36.91 -20.08 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 80' ' ' ASP . 45.1 tp10 -69.44 -31.55 69.94 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -51.86 -40.38 60.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.745 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -86.91 -9.17 56.33 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.1 mm -67.88 -73.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.915 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -61.97 -40.99 97.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.94 -41.67 98.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.379 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.56 -21.35 60.16 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.966 0.412 . . . . 0.0 111.425 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -74.71 -47.29 32.26 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.744 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -55.61 -43.08 75.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.923 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.54 -45.73 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.546 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -70.01 -39.05 76.06 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.595 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.56 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 32.3 t0 -89.56 84.83 6.38 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.01 -48.63 79.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.4 p-10 -92.24 5.03 51.98 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.99 50.4 51.31 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.62 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -95.02 6.28 49.52 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 122.416 0.286 . . . . 0.0 110.798 179.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.56 -0.19 89.7 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.62 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 4.4 m-85 -136.86 149.66 47.81 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.984 0.897 . . . . 0.0 111.299 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 80.7 mt -97.17 119.38 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t -89.88 151.08 21.92 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.66 78.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.112 0.869 . . . . 0.0 110.159 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.09 -41.73 62.65 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.698 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -65.28 -42.04 93.54 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.697 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.2 -45.65 90.74 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.51 0.671 . . . . 0.0 111.072 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -44.07 -42.76 6.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.366 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.403 ' O ' ' OG1' ' A' ' 110' ' ' THR . 62.2 t-80 -65.47 -30.48 71.27 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.671 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.2 t -57.62 -42.38 81.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.943 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.13 -46.9 65.54 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.971 0.891 . . . . 0.0 111.284 -177.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 72.3 p -55.33 -39.19 69.68 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.567 -177.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -66.38 -41.23 89.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.763 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.0 mt -81.77 -14.51 56.33 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.01 31.05 60.31 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -87.33 -25.71 23.75 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.77 2.285 . . . . 0.0 110.463 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.0 mttp 45.96 63.16 1.93 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.102 0.953 . . . . 0.0 110.377 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.74 148.31 31.55 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.923 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.4 p -82.67 174.2 11.22 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -57.57 -45.56 85.05 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.71 -46.72 84.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.172 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -70.66 -30.67 67.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.919 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 43.3 t -64.03 -41.99 94.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.471 0.653 . . . . 0.0 109.436 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.64 -35.69 75.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.349 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -59.56 -52.59 64.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.815 0.817 . . . . 0.0 112.837 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.2 mtp -55.64 -44.09 76.85 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.291 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.5 mt -59.11 -43.85 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.43 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -59.72 -38.32 81.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.95 0.405 . . . . 0.0 111.253 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -58.4 -41.61 85.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.168 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.55 -21.42 22.89 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.7 t0 -78.44 84.64 4.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.283 0.563 . . . . 0.0 112.051 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.9 pt -70.66 -11.52 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 122.674 1.226 . . . . 0.0 113.515 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 53.8 p-10 -142.08 145.01 33.84 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.157 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.45 52.35 2.27 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.656 -0.307 . . . . 0.0 113.357 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -90.9 -9.28 46.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 117.188 0.494 . . . . 0.0 110.1 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.8 -0.57 65.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 114.409 0.524 . . . . 0.0 114.409 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -132.95 150.85 52.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.304 0.552 . . . . 0.0 109.881 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 t -98.21 118.46 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.825 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.422 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 16.5 t-20 -85.14 174.51 9.63 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.721 0.296 . . . . 0.0 110.965 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -60.96 -42.15 97.72 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.456 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.13 -44.12 95.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.699 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.67 -38.03 89.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.462 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -60.94 -45.28 95.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.096 0.474 . . . . 0.0 111.019 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.17 -46.88 89.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.039 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -51.05 -44.51 61.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.025 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmt -72.02 -36.99 69.83 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 25.5 mmt -71.91 -45.88 59.63 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.489 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 p . . . . . 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.033 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.9 mt . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.3 m95 -63.23 -56.11 19.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.625 0.726 . . . . 0.0 112.346 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.1 t80 -58.4 -46.18 86.91 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 46.9 ttt85 -41.97 -52.04 4.26 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.71 -40.41 98.74 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.679 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.41 -44.72 80.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.977 0.888 . . . . 0.0 109.829 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 38.8 t30 -58.03 -47.72 82.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -176.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -65.01 -38.25 90.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.392 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.9 mt -60.36 -42.37 90.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.718 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -51.37 -45.42 62.4 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.586 -1.245 . . . . 0.0 107.67 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.508 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.7 m -62.16 -48.79 78.5 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.417 ' C ' ' O ' ' B' 1102 ' ' THR . 84.5 mt-30 -27.75 -59.61 0.11 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.913 1.339 . . . . 0.0 113.101 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -83.08 -13.72 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 112.514 -2.13 . . . . 0.0 111.643 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.508 ' N ' ' O ' ' B' 1102 ' ' THR . 66.3 tttm -59.93 -47.8 84.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 118.358 -1.337 . . . . 0.0 107.906 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.6 t -60.71 -48.85 86.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.9 m -65.76 -35.72 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.986 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 83.2 mttt -49.67 -39.08 35.18 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.72 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -50.56 -44.41 56.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.315 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -63.55 -49.46 73.35 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.725 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 78.2 m-70 . . . . . 0 C--N 1.328 -0.356 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.544 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.02 144.28 43.15 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.002 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.591 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -51.29 -43.82 61.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 122.574 1.178 . . . . 0.0 110.574 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 81.2 tt0 -43.35 -41.23 4.0 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 112.718 -2.037 . . . . 0.0 110.662 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -69.36 -38.06 77.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.504 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.1 -44.81 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.44 -50.27 62.92 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.667 -178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -62.61 -45.57 92.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.387 0.613 . . . . 0.0 112.039 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -62.27 -40.9 97.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.817 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -52.89 -55.23 24.73 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.275 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -50.31 -42.39 52.59 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.957 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.3 -36.3 66.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.409 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.79 -38.76 79.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.3 p -65.33 -15.95 63.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.22 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 6.7 mp -65.42 -40.72 93.68 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -106.05 -14.75 15.08 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -73.04 93.2 1.74 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.486 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -67.72 -49.41 62.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.934 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.0 p-10 -103.11 14.9 30.72 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.16 46.27 0.96 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.131 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -86.57 -4.55 59.19 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 122.673 -0.31 . . . . 0.0 110.934 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 -1.83 80.74 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.4 p -138.21 153.56 49.14 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.189 0.519 . . . . 0.0 110.02 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -91.12 123.6 43.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.8 p -113.79 164.22 14.02 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.926 0.87 . . . . 0.0 112.455 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 p -58.34 -37.88 76.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.827 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.19 -61.83 2.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.732 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -60.63 -29.48 69.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.448 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.37 -53.61 54.35 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.571 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.07 97.9 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.545 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 m -58.66 -54.33 48.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.912 1.356 . . . . 0.0 108.605 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' A' ' 38' ' ' SER . 50.4 t -56.72 -46.01 82.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 118.979 0.808 . . . . 0.0 111.297 -176.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.5 ttt -59.18 -40.22 85.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 120.111 1.323 . . . . 0.0 109.822 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -53.43 -41.53 66.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.42 0.629 . . . . 0.0 110.46 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 52.8 p -63.73 -21.49 66.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.941 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 tp -73.86 -3.54 29.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.748 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.74 20.7 46.23 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.332 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -117.77 158.65 24.37 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.662 0.731 . . . . 0.0 109.671 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -119.65 74.85 18.28 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.87 145.79 57.54 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.064 1.843 . . . . 0.0 112.405 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -80.16 165.83 22.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.309 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.4 pt-20 -58.83 -45.07 90.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.417 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -56.55 -24.36 46.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.501 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -65.65 -40.25 92.27 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.218 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.25 -39.67 70.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.223 0.535 . . . . 0.0 109.793 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -73.98 -55.17 6.48 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.238 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -54.84 -48.56 72.7 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 60.6 mtp -65.76 -52.06 54.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.02 -44.07 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -56.33 -35.16 67.29 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -67.3 -40.71 86.05 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.963 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.0 t -86.07 -21.34 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.383 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.493 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.1 t0 -78.2 86.16 4.33 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -174.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.3 82.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.342 -1.754 . . . . 0.0 114.081 -175.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 40.1 p-10 -86.82 -2.41 58.55 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.1 23.47 61.86 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 118.526 0.603 . . . . 0.0 112.839 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -87.87 3.57 47.91 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.273 0.536 . . . . 0.0 110.517 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.493 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.1 1.36 88.61 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 121.556 -0.715 . . . . 0.0 114.495 175.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.0 p -148.26 169.0 21.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -113.06 128.61 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.026 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -103.94 -174.83 2.63 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.801 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -58.09 19.55 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.51 -49.39 15.83 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.2 1.267 . . . . 0.0 111.661 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.79 -19.64 62.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.498 0.666 . . . . 0.0 110.628 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -75.71 -59.55 2.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.235 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.58 -44.15 80.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 m -44.92 -49.93 10.77 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.803 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 58.8 mtm -66.91 -45.6 77.43 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.4 mmm -61.08 -41.02 95.88 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.88 -34.16 77.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.567 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -93.42 -13.69 27.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.637 0.256 . . . . 0.0 111.343 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.452 ' C ' ' SD ' ' A' ' 76' ' ' MET . 2.4 mmmt -80.74 69.82 7.36 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.415 0.626 . . . . 0.0 110.765 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -105.88 18.72 21.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.851 179.158 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -49.94 131.44 22.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.418 0.627 . . . . 0.0 111.403 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 46.3 p-10 -91.99 109.05 20.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.875 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.5 p -97.81 114.21 26.19 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 82' ' ' GLU . 37.2 t0 -63.16 117.44 6.53 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 175.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.3 m -37.39 -20.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.772 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.7 mm-40 -69.8 -34.8 74.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.809 0.337 . . . . 0.0 111.718 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -49.34 -37.48 24.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.427 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.435 ' OE1' ' CD1' ' B' 1097 ' ' LEU . 9.3 pt-20 -89.11 -13.97 37.32 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.2 mm -62.29 -74.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.176 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -62.04 -39.67 93.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -64.03 -40.68 96.87 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.515 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.1 -19.25 62.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.091 0.472 . . . . 0.0 111.127 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -71.97 -50.25 30.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.949 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -54.9 -40.71 70.09 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.757 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.22 -44.67 97.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.524 -0.471 . . . . 0.0 109.779 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -69.44 -39.1 78.02 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.463 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -89.74 83.12 6.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.55 -45.06 95.74 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.9 p30 -91.42 4.02 53.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.623 0.249 . . . . 0.0 111.459 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.71 50.23 43.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -92.23 6.37 46.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.64 0.257 . . . . 0.0 110.516 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.14 0.76 89.64 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -140.38 154.16 46.61 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.695 0.76 . . . . 0.0 111.533 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.6 mt -96.92 115.82 37.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.2 p -91.7 156.13 17.8 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.34 -47.99 80.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 118.726 0.694 . . . . 0.0 111.14 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.8 -40.59 60.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 110.448 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.89 -41.29 91.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.511 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.23 -46.29 87.6 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.505 0.669 . . . . 0.0 111.358 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -44.38 -44.22 8.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.698 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -63.24 -28.82 70.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.784 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.7 t -57.99 -41.85 81.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.837 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.629 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.48 -46.22 63.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.074 0.94 . . . . 0.0 111.212 -177.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.8 m -57.68 -41.36 81.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.76 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.46 -40.75 93.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.975 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.3 mt -81.73 -14.06 57.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.699 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.05 29.82 58.27 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -85.68 -22.51 27.84 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.721 2.26 . . . . 0.0 110.878 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 43.14 60.48 2.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.116 0.96 . . . . 0.0 109.912 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.5 mt -79.74 148.76 31.38 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.511 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.4 p -82.99 174.61 10.73 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.405 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -58.06 -45.17 87.49 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.3 mp0 -58.15 -49.84 75.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.706 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -67.3 -31.23 71.4 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.937 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.13 -41.98 94.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.29 -39.15 89.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.62 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -59.44 -51.12 71.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.9 mmm -55.81 -45.05 78.37 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.274 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.99 -43.89 93.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.405 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -61.66 -36.77 81.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.031 0.443 . . . . 0.0 111.186 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.54 -40.19 86.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.833 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.52 -27.97 19.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.2 t0 -68.88 89.33 0.4 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.631 0.729 . . . . 0.0 111.811 -176.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.3 mm -71.4 -15.84 18.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.994 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 47.0 p-10 -141.44 144.42 34.42 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 112.465 -2.152 . . . . 0.0 108.967 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.32 51.47 1.05 Allowed Glycine 0 CA--C 1.531 1.042 0 CA-C-O 120.313 -0.159 . . . . 0.0 113.018 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -90.67 -12.23 37.39 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.035 0.418 . . . . 0.0 110.011 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.0 1.66 74.44 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.998 -0.62 . . . . 0.0 114.276 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -134.06 153.16 51.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.376 0.588 . . . . 0.0 110.481 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.6 t -100.46 118.4 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.448 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 57.0 t30 -83.65 173.85 11.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.988 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.448 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 88.7 t80 -61.41 -40.06 93.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.024 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.94 -44.29 97.08 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.805 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -65.48 -39.37 91.87 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.571 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.433 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 90.0 t80 -60.66 -44.17 96.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.035 0.445 . . . . 0.0 111.219 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.15 -45.0 95.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.018 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.24 -40.16 46.88 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.176 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.59 ' SD ' ' CE2' ' B' 1093 ' ' TRP . 78.1 mtm -79.05 -46.11 18.78 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.433 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -73.39 -47.03 45.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.081 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.469 0.514 0 CA-C-O 120.793 0.33 . . . . 0.0 111.332 -179.03 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B 1093 ' ' TRP . . . . . 0.59 ' CE2' ' SD ' ' A' ' 144' ' ' MET . 6.6 m95 -61.88 -53.42 56.06 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.675 0.75 . . . . 0.0 111.817 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 47.5 t80 -57.79 -46.5 84.53 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1095 ' ' ARG . . . . . 0.438 ' HE ' ' NH1' ' B' 1099 ' ' ARG . 77.4 ttt180 -39.93 -52.43 2.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.39 -40.43 99.05 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.272 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1097 ' ' LEU . . . . . 0.435 ' CD1' ' OE1' ' A' ' 84' ' ' GLU . 50.8 tp -56.35 -44.45 80.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 118.196 0.998 . . . . 0.0 109.214 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -57.74 -47.64 81.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1099 ' ' ARG . . . . . 0.438 ' NH1' ' HE ' ' B' 1095 ' ' ARG . 76.7 mtt85 -65.14 -37.43 87.4 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 82.4 mt -60.75 -42.36 91.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.666 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1101 ' ' GLN . . . . . 0.405 ' CD ' ' OE2' ' A' ' 84' ' ' GLU . 41.8 mt-30 -50.1 -45.12 52.43 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 118.744 -1.182 . . . . 0.0 108.025 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.508 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.9 m -63.56 -48.2 78.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.426 ' C ' ' O ' ' B' 1102 ' ' THR . 83.7 mt-30 -27.61 -58.97 0.11 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.647 1.213 . . . . 0.0 112.578 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -83.62 -14.89 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 112.198 -2.274 . . . . 0.0 112.314 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.508 ' N ' ' O ' ' B' 1102 ' ' THR . 65.0 tttm -59.59 -45.22 92.53 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 117.96 -1.496 . . . . 0.0 108.135 176.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.7 t -60.67 -48.99 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -66.28 -36.53 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.346 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 89.3 mttt -49.52 -38.82 32.06 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.606 -0.684 . . . . 0.0 109.562 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.95 -45.19 64.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.95 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -63.42 -50.2 70.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 77.8 m-70 . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.019 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.6 tp . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p -76.25 139.43 41.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.482 1.037 . . . . 0.0 110.744 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.568 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -50.83 -47.81 60.02 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.993 0.902 . . . . 0.0 110.684 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.437 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 83.6 tt0 -38.5 -38.32 0.37 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.474 -178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.462 ' NE2' ' CE1' ' A' ' 12' ' ' PHE . 45.0 tp60 -68.74 -39.14 80.48 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 118.31 -0.853 . . . . 0.0 110.298 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.8 mt -58.97 -46.0 91.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 175.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.55 -50.65 62.48 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.114 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.02 -48.34 82.12 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.158 0.504 . . . . 0.0 112.282 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.462 ' CE1' ' NE2' ' A' ' 8' ' ' GLN . 2.0 m-85 -62.45 -40.63 97.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.835 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -50.86 -56.53 11.78 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.151 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -50.92 -41.88 59.02 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.95 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.21 -36.96 64.04 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.42 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.457 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 2.9 m-85 -58.42 -38.94 78.44 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -65.36 -15.52 62.65 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.455 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 2.8 mm? -65.59 -40.81 93.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -106.29 -14.6 15.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -72.13 93.21 1.4 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.642 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -68.17 -49.49 60.55 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.715 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.1 p-10 -102.32 15.68 28.46 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.53 44.0 0.41 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.451 -0.404 . . . . 0.0 112.171 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -85.35 -3.82 58.96 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.952 0.406 . . . . 0.0 110.978 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.76 -1.68 81.38 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.3 p -137.8 152.69 49.4 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.079 0.466 . . . . 0.0 110.035 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.26 124.74 44.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -113.95 163.91 14.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.427 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.9 p -58.14 -35.5 71.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.052 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -60.71 -60.39 3.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.209 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -62.39 -30.07 70.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.63 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.05 -55.53 31.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.255 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.75 -39.76 94.08 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.267 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -58.32 -54.99 40.71 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.954 1.377 . . . . 0.0 108.569 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -55.98 -46.75 80.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 118.859 0.754 . . . . 0.0 111.29 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.9 ttt -58.71 -40.05 82.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 120.413 1.46 . . . . 0.0 110.276 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -51.7 -38.38 54.89 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.344 0.592 . . . . 0.0 110.583 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.0 t -62.52 -19.89 64.07 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.047 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 tp -73.87 1.1 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.859 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.1 25.99 38.58 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.226 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -130.5 169.64 15.28 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.275 0.537 . . . . 0.0 109.887 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -133.28 77.29 66.79 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.295 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.74 148.08 93.86 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.823 2.349 . . . . 0.0 111.985 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.2 p -77.11 165.29 24.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.328 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 21.3 pt-20 -58.76 -44.99 90.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.66 -24.12 32.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.761 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -65.74 -39.8 91.49 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.174 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.2 mp -56.17 -41.5 75.59 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.175 0.512 . . . . 0.0 110.03 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -71.7 -56.42 5.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.48 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -55.65 -50.34 70.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.7 mmm -63.52 -52.08 62.75 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.5 mm -58.29 -46.97 88.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.105 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -55.91 -34.22 65.39 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -66.72 -40.07 88.27 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.669 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.75 -20.06 7.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.178 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.2 t0 -78.61 84.74 4.7 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -174.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.81 83.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.323 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.0 p-10 -86.17 -2.44 58.36 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.55 23.1 60.15 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.323 0.51 . . . . 0.0 112.686 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -86.71 3.84 43.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 117.189 0.494 . . . . 0.0 110.504 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.447 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.4 1.44 89.34 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 118.637 0.653 . . . . 0.0 114.702 175.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.8 p -148.14 167.92 23.77 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.25 128.35 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -103.03 -176.41 3.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.743 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.457 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -57.07 -46.75 99.83 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -176.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 31.4 Cg_exo -57.66 -51.9 7.27 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 121.462 1.442 . . . . 0.0 111.852 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.21 -20.97 64.75 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.43 0.633 . . . . 0.0 110.727 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -74.88 -59.87 2.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.687 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -54.98 -45.16 74.96 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 m -44.9 -50.51 10.39 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.912 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.6 mtm -65.42 -44.33 87.75 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 35.3 mmm -60.82 -41.46 95.78 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.16 77.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.337 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -92.43 -19.25 22.24 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.39 67.4 5.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.128 0.489 . . . . 0.0 110.297 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.5 mmt -107.76 15.3 24.71 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.356 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -48.29 133.89 15.27 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.37 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -89.68 107.89 19.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.943 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 m -93.83 120.57 34.28 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 82' ' ' GLU . 90.7 m-20 -70.28 112.28 6.49 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m -37.06 -20.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.828 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.579 ' N ' ' O ' ' A' ' 80' ' ' ASP . 96.2 mt-10 -69.15 -36.64 77.63 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.756 0.312 . . . . 0.0 111.585 -178.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -48.63 -35.86 14.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.25 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -89.07 -18.72 26.7 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.103 0.477 . . . . 0.0 111.794 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.9 mm -58.92 -75.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.827 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -61.51 -37.53 84.05 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -63.66 -40.75 97.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.466 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.58 -20.84 63.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.001 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -72.22 -51.59 20.35 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.779 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -54.88 -41.77 71.25 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.67 -44.26 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -69.28 -38.55 78.41 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.211 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.519 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 29.3 t0 -88.51 83.5 6.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.42 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 88.4 tttt -57.78 -49.41 76.69 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.2 p-10 -91.89 5.02 51.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.703 0.287 . . . . 0.0 111.59 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.28 49.55 50.31 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.638 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -91.33 5.27 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.488 0.315 . . . . 0.0 110.713 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.418 ' N ' HD21 ' A' ' 97' ' ' ASN . . . 84.87 0.72 89.09 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.638 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 79.9 m-85 -138.38 151.26 47.35 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.72 0.771 . . . . 0.0 111.783 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.2 mt -93.83 117.21 36.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 t -89.99 150.08 22.29 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.76 -46.34 77.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.109 0.868 . . . . 0.0 110.788 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.31 62.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.836 0.35 . . . . 0.0 110.636 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.42 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.2 mt-10 -66.2 -41.46 90.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.557 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 108' ' ' VAL . 57.4 tp -63.0 -46.9 85.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.264 0.554 . . . . 0.0 110.822 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -42.89 -43.09 3.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.683 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.404 ' O ' ' OG1' ' A' ' 110' ' ' THR . 59.2 t-80 -65.19 -29.24 70.04 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.005 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 105' ' ' LEU . 96.7 t -58.08 -42.67 83.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.73 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.63 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.15 -45.96 61.85 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.784 0.802 . . . . 0.0 111.668 -177.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 68.6 p -55.84 -38.49 70.12 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.825 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -66.58 -40.89 89.17 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.892 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 73.4 mt -82.15 -13.14 57.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.79 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.21 30.83 62.25 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -86.17 -23.19 26.63 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 121.0 2.4 . . . . 0.0 110.856 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.9 mtmt 45.2 61.77 2.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.571 0.7 . . . . 0.0 110.497 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.1 mt -80.2 148.36 30.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.266 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -82.67 176.78 9.08 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.403 179.002 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.458 ' N ' ' OG1' ' A' ' 117' ' ' THR . 45.4 m-20 -59.7 -45.48 91.98 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.79 -46.95 81.23 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.405 ' H ' HG23 ' A' ' 117' ' ' THR . 76.4 mm-40 -70.38 -30.59 67.54 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.08 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.73 -42.18 95.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.34 -35.98 73.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.209 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -60.07 -53.2 60.61 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 81.9 mtp -54.96 -44.47 74.41 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.269 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.6 mt -58.18 -43.88 86.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.598 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -60.13 -36.38 77.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.836 0.35 . . . . 0.0 111.486 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -59.53 -41.06 89.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.055 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.6 -18.42 24.07 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.6 t0 -74.87 87.88 2.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.108 0.48 . . . . 0.0 111.868 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.8 tt -69.87 -15.1 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 122.523 1.154 . . . . 0.0 113.524 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.2 p-10 -143.07 145.71 33.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.159 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.79 52.35 1.6 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.883 -0.199 . . . . 0.0 113.213 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -90.74 -8.9 48.54 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 117.054 0.427 . . . . 0.0 110.219 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.85 1.36 72.38 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.986 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -134.67 154.43 51.54 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.227 0.514 . . . . 0.0 110.399 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.86 118.27 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.186 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.464 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 51.9 t30 -84.11 174.17 10.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.352 . . . . 0.0 111.065 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.464 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 84.0 t80 -61.15 -40.66 94.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.041 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.28 -44.62 96.11 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.946 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.87 -38.53 91.29 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.707 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -61.3 -44.7 96.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.907 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.22 -46.95 89.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.055 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -50.05 -43.05 50.81 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.891 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.7 mmt -74.93 -39.62 61.29 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.2 mmt -72.9 -47.42 45.94 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.802 0.334 . . . . 0.0 111.601 -179.377 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 8.8 m95 -62.65 -55.69 24.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.257 0.551 . . . . 0.0 112.419 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.4 t80 -59.46 -46.55 88.45 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -43.05 -51.3 5.82 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.52 -41.89 99.65 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.1 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1097 ' ' LEU . . . . . 0.43 ' O ' ' NE2' ' B' 1101 ' ' GLN . 56.7 tp -56.91 -45.78 82.41 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.595 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 39.6 t30 -57.93 -47.47 82.77 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -64.69 -37.32 87.18 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.2 mt -61.33 -42.61 94.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.824 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1101 ' ' GLN . . . . . 0.43 ' NE2' ' O ' ' B' 1097 ' ' LEU . 2.8 mp0 -50.27 -46.47 55.1 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.524 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.7 m -63.19 -48.45 78.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.43 ' C ' ' O ' ' B' 1102 ' ' THR . 24.8 mt-30 -27.31 -59.64 0.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 122.745 1.26 . . . . 0.0 112.642 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -83.31 -14.72 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 112.475 -2.148 . . . . 0.0 112.198 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.524 ' N ' ' O ' ' B' 1102 ' ' THR . 66.3 tttm -59.93 -46.51 89.14 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 117.829 -1.548 . . . . 0.0 107.895 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.7 t -61.32 -49.31 85.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.6 m -65.54 -36.14 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.406 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 87.8 mttt -49.01 -38.15 22.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.642 0.656 . . . . 0.0 109.82 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.58 -45.5 66.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.289 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -62.59 -50.02 72.92 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 69.7 m-70 . . . . . 0 C--N 1.329 -0.322 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.375 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.7 tp . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 119.351 -0.356 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.3 p -77.95 139.96 39.21 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.321 0.964 . . . . 0.0 110.317 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ILE . 45.8 tp10 -49.7 -57.23 7.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 122.281 1.039 . . . . 0.0 110.449 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -34.7 -38.33 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.218 -1.81 . . . . 0.0 111.066 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -68.9 -37.05 78.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 118.07 -0.966 . . . . 0.0 110.65 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.3 mt -59.0 -44.75 91.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 175.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.92 -52.66 59.87 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.356 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.42 -47.77 84.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.441 0.639 . . . . 0.0 112.004 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -62.36 -38.68 90.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.677 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -52.61 -54.84 27.67 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.467 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.31 -40.76 49.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.966 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.45 -37.65 70.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.095 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.406 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 3.4 m-85 -58.37 -41.12 84.07 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 t -64.04 -15.54 59.7 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.505 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.53 -42.25 95.87 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -106.01 -14.0 15.31 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -72.29 93.28 1.47 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.482 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -67.41 -49.49 63.58 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.983 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 23' ' ' GLY . 37.0 p30 -102.31 14.73 31.19 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.88 43.78 0.66 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.105 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -84.87 -3.47 58.7 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.764 0.316 . . . . 0.0 110.972 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.42 -1.72 82.3 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.7 p -137.87 153.04 49.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.225 0.536 . . . . 0.0 109.801 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.4 mp -91.59 123.8 43.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.5 p -114.53 165.25 12.96 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 124.124 0.89 . . . . 0.0 112.335 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.7 p -58.62 -36.84 74.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.578 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.86 -60.65 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.496 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -62.06 -30.26 70.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.426 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tp -60.73 -53.78 53.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.219 1.009 . . . . 0.0 109.804 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.16 -37.68 94.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 113.593 -1.639 . . . . 0.0 111.825 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.6 m -58.69 -53.88 53.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 119.005 1.402 . . . . 0.0 108.537 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.88 -46.12 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 121.254 -0.904 . . . . 0.0 111.561 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.9 ttt -58.87 -41.57 87.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 119.99 1.268 . . . . 0.0 109.628 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -51.77 -34.81 41.3 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.648 0.737 . . . . 0.0 110.165 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.1 t -63.07 -20.34 65.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.589 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -75.82 2.81 11.31 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.163 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.52 17.0 74.48 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.956 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -109.26 160.99 15.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.462 0.631 . . . . 0.0 110.013 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -116.05 68.71 3.46 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.165 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.07 143.88 91.46 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.041 1.827 . . . . 0.0 112.291 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.7 p -81.01 165.28 21.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.42 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -58.69 -43.76 90.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.029 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.53 -23.64 27.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.536 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -66.0 -38.48 88.58 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.242 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.43 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.6 mp -56.57 -41.31 76.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.404 0.621 . . . . 0.0 109.733 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -71.09 -56.48 6.03 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.722 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -55.03 -49.55 71.29 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.9 mmm -66.0 -50.91 62.59 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.9 mm -59.43 -48.18 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.618 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -57.79 -34.01 69.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -66.49 -40.43 89.26 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.547 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.6 t -85.73 -20.88 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.544 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.517 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.16 86.56 4.29 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.81 87.46 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 113.308 -1.769 . . . . 0.0 113.906 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 37.8 p-10 -86.44 -2.46 58.46 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.35 23.05 61.86 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 118.451 0.568 . . . . 0.0 112.89 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -87.99 2.43 51.78 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.229 0.515 . . . . 0.0 110.335 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.517 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 86.0 0.97 87.07 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 121.714 -0.616 . . . . 0.0 114.572 175.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.8 p -148.51 170.42 18.09 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.79 129.48 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -103.67 -175.54 2.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.854 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.7 -46.99 99.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.725 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -55.49 -51.95 8.77 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.282 1.321 . . . . 0.0 111.76 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.74 -18.53 55.18 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.446 0.641 . . . . 0.0 110.617 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -76.36 -57.82 3.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.553 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.84 -46.08 85.27 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.3 m -45.31 -49.37 12.78 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.369 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 72.5 mtm -66.16 -44.53 83.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.2 mmt -58.75 -41.65 87.03 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.77 -34.02 77.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.551 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -94.9 -9.29 34.62 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.527 0.203 . . . . 0.0 111.304 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.671 ' HZ2' ' N ' ' B' 1109 ' ' ALA . 0.3 OUTLIER -82.01 69.36 8.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.55 0.69 . . . . 0.0 111.047 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.26 18.29 21.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.126 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -51.19 130.2 25.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.034 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -89.62 108.74 19.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.055 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.7 m -93.59 119.38 32.55 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.2 m-20 -69.32 111.66 5.37 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 173.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.9 m -37.48 -21.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.642 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.5 mp0 -69.42 -35.33 75.62 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -48.83 -37.21 18.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.393 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' OE2' ' NE2' ' B' 1101 ' ' GLN . 10.6 pt-20 -89.28 -13.24 38.5 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.5 mm -63.14 -74.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.993 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -63.02 -39.41 94.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -63.05 -40.95 99.25 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.436 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.54 -18.4 59.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.937 0.398 . . . . 0.0 111.062 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -74.45 -48.74 25.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.012 0.434 . . . . 0.0 111.327 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -55.16 -41.77 72.28 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.64 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -64.84 -43.9 96.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -69.02 -38.54 79.28 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.518 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -85.48 81.22 8.8 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -58.24 -49.32 77.51 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -91.23 5.23 49.93 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.365 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.84 48.35 51.24 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -91.37 6.79 43.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.752 0.31 . . . . 0.0 110.673 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.73 1.95 89.9 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.696 -0.561 . . . . 0.0 111.696 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -140.51 153.95 46.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.686 0.755 . . . . 0.0 111.521 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.6 mt -93.97 114.61 30.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.1 t -89.07 151.61 22.14 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.82 -47.03 83.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 119.067 0.849 . . . . 0.0 110.638 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.02 -35.35 61.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.894 0.378 . . . . 0.0 110.278 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.56 -39.52 73.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.076 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.45 -47.36 76.43 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.231 0.539 . . . . 0.0 112.187 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.4 -33.71 2.71 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.235 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.413 ' O ' ' OG1' ' A' ' 110' ' ' THR . 66.0 t-80 -72.49 -28.91 63.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 75.0 t -58.08 -41.42 80.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.734 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.6 mmt -53.22 -47.24 69.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.301 1.048 . . . . 0.0 111.789 -176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 72.1 p -55.56 -35.52 65.81 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 113.115 -1.857 . . . . 0.0 110.925 -176.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -36.45 82.59 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.043 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.0 mt -84.5 -11.25 56.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.94 36.71 51.66 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.46 -22.8 23.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.827 2.314 . . . . 0.0 111.18 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.7 tptt 44.78 59.78 3.23 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.549 1.166 . . . . 0.0 109.993 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.57 150.96 36.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.602 -2.09 . . . . 0.0 113.386 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.3 p -84.35 175.43 9.37 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.973 0.416 . . . . 0.0 109.927 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -56.36 -45.13 80.61 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.77 -40.81 69.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.027 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.77 -30.13 68.66 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.619 -0.432 . . . . 0.0 112.105 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.34 -43.57 98.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.501 0.667 . . . . 0.0 109.504 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -74.13 -35.82 64.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.816 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -60.77 -55.27 35.08 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 97.7 mmm -48.83 -60.39 2.79 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.472 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.3 pt -50.57 -40.74 19.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.719 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -61.98 -35.36 78.25 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.704 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -57.21 -40.68 77.96 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.219 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.24 -12.91 25.44 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.3 t0 -73.51 87.34 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.425 0.631 . . . . 0.0 111.789 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.0 pt -71.49 -11.86 15.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 122.484 1.135 . . . . 0.0 113.561 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 52.5 p-10 -143.21 142.59 31.46 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 112.265 -2.243 . . . . 0.0 109.035 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.67 52.46 0.9 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.692 -0.29 . . . . 0.0 113.436 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -91.29 -11.19 38.79 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.172 0.486 . . . . 0.0 110.111 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.69 2.79 70.92 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.195 -0.526 . . . . 0.0 114.385 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -134.13 152.94 52.07 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.134 0.467 . . . . 0.0 110.318 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.48 118.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.455 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -84.58 173.79 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 0.0 110.877 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -61.05 -40.08 92.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.026 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.5 -44.81 95.47 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.914 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.39 -37.96 89.31 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.419 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.17 -45.69 93.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.3 t -65.69 -48.58 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.767 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -49.02 -45.96 43.34 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.972 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.475 ' O ' ' CE1' ' B' 1094 ' ' PHE . 13.2 mmt -72.73 -38.99 67.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 18.1 mmt -75.56 -45.09 39.9 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.795 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 5.5 m95 -60.55 -62.51 1.81 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.238 0.542 . . . . 0.0 112.415 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B 1094 ' ' PHE . . . . . 0.475 ' CE1' ' O ' ' A' ' 144' ' ' MET . 48.8 m-85 -57.78 -44.69 86.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -39.37 -52.04 2.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.52 -41.66 99.77 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.178 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 50.8 tp -56.35 -45.22 80.55 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.454 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 12.2 m120 -59.07 -47.32 85.68 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.651 -175.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -65.38 -37.48 87.13 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.22 -42.01 91.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.868 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B 1101 ' ' GLN . . . . . 0.458 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 68.7 mt-30 -51.34 -45.95 62.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.528 ' O ' ' N ' ' B' 1105 ' ' LYS . 93.9 m -63.47 -47.95 79.67 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.912 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 84.3 mt-30 -28.06 -57.62 0.11 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.741 1.258 . . . . 0.0 112.572 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.7 mt -84.27 -14.81 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 112.085 -2.325 . . . . 0.0 112.313 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.552 ' O ' ' NZ ' ' A' ' 75' ' ' LYS . 88.8 tttt -59.54 -44.72 93.13 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.954 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 67.5 t -61.49 -49.11 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.83 -36.09 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.322 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 89.7 mttt -49.88 -37.55 31.7 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.682 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B 1109 ' ' ALA . . . . . 0.671 ' N ' ' HZ2' ' A' ' 75' ' ' LYS . . . -51.41 -45.06 62.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.784 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -63.88 -49.73 71.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 71.5 m-70 . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.223 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -79.14 137.26 37.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.365 0.984 . . . . 0.0 110.306 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 9' ' ' ILE . 21.3 mt-10 -54.42 -49.98 68.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.132 0.968 . . . . 0.0 110.43 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -34.32 -36.39 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.569 -1.65 . . . . 0.0 111.102 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -69.12 -36.04 77.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.265 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 6' ' ' GLU . 88.4 mt -58.82 -43.95 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.81 -50.53 65.94 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.893 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -63.49 -45.79 89.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.325 0.583 . . . . 0.0 112.05 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.51 -40.42 96.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.888 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -49.95 -57.19 8.02 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.472 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -49.66 -40.43 39.69 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.04 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.7 -37.58 71.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.203 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.518 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 3.0 m-85 -57.79 -41.62 82.47 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.1 t -64.37 -15.7 60.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.65 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.87 -42.59 97.47 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -106.07 -13.97 15.3 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -74.08 95.65 2.58 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.203 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -68.74 -52.83 26.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.44 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.5 p-10 -98.77 13.97 30.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.72 45.22 1.01 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.024 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 32.7 p-10 -85.28 -3.82 58.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.665 0.269 . . . . 0.0 110.875 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.5 -0.79 78.11 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -139.99 153.99 47.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.11 0.481 . . . . 0.0 110.025 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 mp -93.2 124.56 45.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -112.79 165.29 12.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.513 0.673 . . . . 0.0 112.405 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.7 p -59.5 -35.83 74.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.322 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -61.6 -61.73 2.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.77 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.53 -30.12 70.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.715 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 tp -60.42 -53.63 55.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.875 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.55 93.54 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.927 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.63 -51.47 69.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.816 1.308 . . . . 0.0 108.936 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.439 ' O ' ' OG ' ' A' ' 38' ' ' SER . 46.0 t -59.33 -46.01 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 118.739 0.699 . . . . 0.0 111.042 -176.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.0 ttt -59.01 -41.48 87.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.552 1.069 . . . . 0.0 109.654 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -52.1 -37.08 52.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.733 0.778 . . . . 0.0 110.247 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 19.5 p -62.71 -20.6 65.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.702 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.7 mt -75.53 1.6 13.82 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.104 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.1 17.44 67.17 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.154 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -109.11 158.7 17.53 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 117.498 0.649 . . . . 0.0 109.955 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -114.2 65.47 1.43 Allowed Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.13 142.4 91.92 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.03 1.82 . . . . 0.0 112.081 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -80.94 165.27 21.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.246 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -58.17 -43.88 87.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.74 -24.57 50.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.484 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -64.85 -40.19 94.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.209 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.7 mp -55.41 -38.5 69.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.404 0.621 . . . . 0.0 109.354 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -71.66 -56.01 6.64 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.095 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -54.06 -49.23 69.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.5 mtp -68.4 -48.61 64.22 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.3 mm -59.46 -47.58 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.7 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -58.49 -33.8 70.21 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.93 -39.85 90.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.539 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.2 t -86.69 -20.27 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 121.154 -0.218 . . . . 0.0 111.33 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.461 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.53 87.44 4.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -175.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.98 -37.33 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 113.535 -1.666 . . . . 0.0 113.987 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.4 p-10 -86.35 -2.69 58.64 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.2 23.27 61.81 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 118.338 0.517 . . . . 0.0 112.709 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.4 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 51.5 p-10 -88.15 3.63 48.49 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.422 0.611 . . . . 0.0 110.423 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.461 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.46 0.72 89.39 Favored Glycine 0 CA--C 1.522 0.525 0 O-C-N 121.74 -0.6 . . . . 0.0 114.423 175.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.7 p -147.74 169.78 18.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.8 mt -114.66 128.77 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -103.88 -173.94 2.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.705 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.518 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -58.84 -46.62 99.54 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.34 -51.72 7.93 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 121.245 1.297 . . . . 0.0 111.85 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.55 -18.36 61.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.485 0.659 . . . . 0.0 110.687 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -75.19 -58.76 3.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.907 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.8 mt -57.49 -42.6 83.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -46.04 -49.35 16.37 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.566 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.21 -45.23 77.44 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.5 mmm -61.06 -40.34 93.3 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.4 78.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.229 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -94.34 -10.05 33.93 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.831 0.348 . . . . 0.0 111.467 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.19 67.45 8.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.249 0.547 . . . . 0.0 110.487 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 mmt -108.63 15.19 23.94 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.696 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -49.46 133.45 20.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.061 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 45.2 p-10 -92.66 105.2 17.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.932 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.7 m -88.24 123.04 32.46 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 82' ' ' GLU . 96.6 m-20 -69.87 112.05 6.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.0 m -37.6 -21.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.726 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 80' ' ' ASP . 54.2 mp0 -69.14 -36.32 77.32 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -48.67 -36.45 16.09 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.252 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.514 ' OE2' ' NE2' ' B' 1101 ' ' GLN . 11.1 pt-20 -89.11 -13.86 37.56 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.9 mm -62.84 -74.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.279 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -62.41 -41.12 98.44 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -62.98 -40.39 97.59 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.488 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.83 -17.02 54.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.003 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -73.79 -49.3 25.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.021 0.438 . . . . 0.0 111.35 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -55.09 -41.74 71.99 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.604 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.54 -43.96 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -68.52 -39.41 81.22 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.486 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -85.28 81.84 8.62 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.13 -50.18 74.41 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -90.88 5.4 48.68 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.216 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.15 48.49 46.59 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -89.93 6.23 42.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.756 0.312 . . . . 0.0 110.609 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.54 2.76 84.63 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -144.23 157.7 44.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.742 0.782 . . . . 0.0 111.553 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -94.63 114.32 30.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -87.49 151.75 22.77 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.89 78.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 119.036 0.834 . . . . 0.0 110.842 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.01 -40.89 64.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.993 0.425 . . . . 0.0 110.238 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.91 -44.09 86.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.734 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 108' ' ' VAL . 7.1 tt -62.84 -47.56 82.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.83 0.348 . . . . 0.0 111.764 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -41.16 -45.02 2.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.101 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -57.14 -26.99 61.44 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.529 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' A' ' 105' ' ' LEU . 2.0 p -56.45 -41.34 71.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.22 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -50.32 59.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 122.248 1.023 . . . . 0.0 111.245 -177.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.8 m -51.44 -40.85 60.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.483 -1.689 . . . . 0.0 110.775 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.99 -41.25 95.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.06 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.9 mt -82.91 -14.41 54.23 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.79 55.77 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.553 -1.137 . . . . 0.0 110.42 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -86.72 -22.42 26.03 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.385 2.092 . . . . 0.0 110.866 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 43.49 60.34 2.66 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.281 1.039 . . . . 0.0 110.172 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.1 mt -80.87 148.69 29.81 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.599 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 76.5 p -83.0 175.36 10.1 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -57.63 -44.67 85.74 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.31 -48.58 80.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.324 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -70.49 -31.07 68.03 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.916 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.19 -42.29 95.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -68.04 -36.56 80.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.792 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.22 -50.53 73.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.706 0.765 . . . . 0.0 112.916 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 19.3 mmm -57.85 -42.75 85.09 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.89 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.3 mt -60.08 -43.65 93.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.048 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -59.67 -38.67 82.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.743 0.306 . . . . 0.0 111.168 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.75 -41.62 86.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.16 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.46 -25.49 21.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.0 t0 -71.58 88.47 0.95 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.451 0.643 . . . . 0.0 111.842 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.5 tp -70.11 -14.58 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 122.844 1.307 . . . . 0.0 113.147 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 37.2 p-10 -141.04 144.15 34.81 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 112.402 -2.181 . . . . 0.0 109.486 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.34 52.22 1.08 Allowed Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.403 -0.427 . . . . 0.0 113.0 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.408 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 37.5 p-10 -91.63 -9.85 42.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.259 0.529 . . . . 0.0 110.167 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.55 3.41 78.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 114.168 0.427 . . . . 0.0 114.168 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -135.14 154.56 51.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 117.243 0.522 . . . . 0.0 110.422 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.6 t -101.19 118.64 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.462 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.459 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 51.9 t30 -84.21 173.18 11.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.922 0.392 . . . . 0.0 110.981 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.459 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 80.4 t80 -60.82 -40.98 94.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.222 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.11 -44.55 97.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.152 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.92 -38.37 90.74 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.654 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -61.33 -45.68 93.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.952 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.404 ' O ' ' OG1' ' A' ' 146' ' ' THR . 73.2 t -64.76 -46.39 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.5 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -51.0 -43.22 60.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.805 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.4 mmt -75.15 -39.88 60.04 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.7 mmt -71.43 -47.76 53.81 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.837 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 3.1 p . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.904 0.383 . . . . 0.0 110.945 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.9 m95 -62.04 -55.6 27.47 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.541 0.686 . . . . 0.0 112.626 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.6 t80 -60.51 -47.41 86.28 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -173.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -39.65 -50.78 2.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.69 -40.15 98.82 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.269 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.5 tp -56.44 -45.02 81.0 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.993 0.896 . . . . 0.0 109.702 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 42.1 t30 -59.23 -46.91 87.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.515 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -65.42 -38.41 89.81 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.7 mt -60.88 -41.94 90.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.271 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B 1101 ' ' GLN . . . . . 0.514 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 66.5 mt-30 -52.48 -46.58 66.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.505 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.0 m -63.71 -48.28 77.72 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.835 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.447 ' C ' ' O ' ' B' 1102 ' ' THR . 25.3 mt-30 -28.0 -55.5 0.11 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 123.11 1.433 . . . . 0.0 112.758 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.1 mt -84.75 -14.88 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 112.193 -2.276 . . . . 0.0 112.641 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.505 ' N ' ' O ' ' B' 1102 ' ' THR . 87.6 mttt -59.74 -42.7 93.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 117.97 -1.492 . . . . 0.0 108.86 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 81.7 t -61.42 -48.91 86.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.2 m -66.97 -36.64 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.906 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.5 mttt -49.79 -38.34 33.9 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.623 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.02 -44.42 64.15 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.217 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -63.95 -50.64 67.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 21.7 t-80 . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.188 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 50.7 tp . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 119.217 -0.42 . . . . 0.0 110.501 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.1 p -77.08 140.02 40.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.332 0.969 . . . . 0.0 109.863 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ILE . 47.9 tp10 -47.28 -63.48 1.03 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 122.149 0.976 . . . . 0.0 110.319 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -34.16 -37.4 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.087 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -70.18 -36.14 74.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.577 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 6' ' ' GLU . 93.1 mt -59.57 -44.29 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 175.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.39 -49.42 64.47 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.401 -177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -63.49 -45.14 92.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.51 0.671 . . . . 0.0 112.379 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -63.15 -41.28 99.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.987 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -52.62 -57.04 11.3 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.442 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -46.8 -41.8 16.04 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.597 . . . . 0.0 110.363 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.38 -35.88 65.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.27 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.81 -39.73 81.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -64.77 -15.88 62.24 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.083 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 7.3 mp -65.01 -40.81 95.46 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -106.13 -14.39 15.16 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -72.56 92.79 1.53 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.211 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -67.63 -49.84 61.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.76 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.0 p-10 -102.41 15.42 29.26 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.26 44.24 0.55 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.171 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.8 p30 -85.3 -4.24 59.09 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.282 . . . . 0.0 110.932 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.95 -2.26 81.65 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.2 p -137.33 152.12 49.38 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.106 0.479 . . . . 0.0 109.767 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.5 mp -91.61 123.98 43.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.3 p -113.07 163.88 14.17 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.492 0.663 . . . . 0.0 112.425 -177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -58.59 -36.32 73.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.487 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -62.04 -61.51 2.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.43 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -61.03 -30.69 70.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.576 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 tp -60.62 -54.5 44.67 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.243 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.14 95.32 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.17 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 m -58.22 -53.59 56.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.759 1.279 . . . . 0.0 108.794 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.434 ' O ' ' OG ' ' A' ' 38' ' ' SER . 42.0 t -57.36 -46.47 85.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 121.414 -0.804 . . . . 0.0 111.405 -176.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.0 ttt -59.38 -40.15 85.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 119.888 1.222 . . . . 0.0 109.727 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -53.72 -41.77 67.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.529 0.681 . . . . 0.0 110.229 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 50.6 p -63.4 -21.6 66.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.125 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.91 -2.7 24.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.835 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.24 14.81 59.8 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.495 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -107.88 155.29 20.45 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.541 0.671 . . . . 0.0 109.825 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -114.93 63.95 1.57 Allowed Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.339 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -62.85 144.24 93.11 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.214 1.943 . . . . 0.0 112.251 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 t -80.31 167.69 19.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.111 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 15.6 pt-20 -58.85 -44.75 91.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.001 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.436 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -56.08 -23.52 34.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.43 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -65.82 -39.45 90.86 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.584 -0.446 . . . . 0.0 109.964 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 10.2 mp -56.53 -41.41 76.72 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.525 0.678 . . . . 0.0 109.468 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -70.39 -57.1 5.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.863 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -53.69 -48.69 69.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.338 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 31.7 mmm -66.74 -50.19 63.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.9 mm -58.71 -48.33 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.622 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -56.53 -34.83 67.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -66.07 -39.68 90.26 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.852 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.5 t -86.07 -20.46 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.577 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.3 t0 -79.22 85.33 5.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -175.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.37 84.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.391 -1.731 . . . . 0.0 114.187 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 39.7 p-10 -86.47 -2.72 58.69 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.27 23.06 63.88 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 118.398 0.544 . . . . 0.0 112.752 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.429 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -87.89 2.06 52.47 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 117.418 0.609 . . . . 0.0 110.664 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.51 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.53 1.82 87.49 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 118.603 0.638 . . . . 0.0 114.552 175.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.3 p -146.36 166.63 25.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.35 126.7 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -102.93 -177.09 3.27 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -47.01 99.55 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -176.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.45 -51.51 9.09 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 120.995 1.13 . . . . 0.0 111.66 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.63 -18.77 60.84 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.416 0.627 . . . . 0.0 110.521 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -75.8 -59.28 2.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.063 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.02 -44.45 82.87 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.7 m -45.92 -48.06 16.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.399 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.1 mtm -66.88 -45.02 79.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.0 mmm -61.3 -41.31 96.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.12 -35.16 79.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.41 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -92.12 -16.36 26.45 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.813 0.339 . . . . 0.0 111.414 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.448 ' C ' ' SD ' ' A' ' 76' ' ' MET . 28.4 tptp -80.18 72.09 6.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.612 0.72 . . . . 0.0 110.562 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.9 19.39 20.12 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.983 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -49.87 129.99 20.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.146 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.52 109.35 20.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.861 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.2 p -99.3 111.75 24.06 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.582 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -60.4 117.85 5.75 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.013 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 m -37.37 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.711 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 80' ' ' ASP . 80.5 tt0 -68.67 -35.57 77.41 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -49.98 -38.8 38.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.259 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -87.21 -19.44 28.38 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.092 0.473 . . . . 0.0 111.671 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.8 mm -60.41 -74.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.679 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.6 mtm180 -62.77 -41.55 99.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.7 -40.57 92.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.408 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.53 -17.48 46.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.007 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -74.17 -49.59 22.95 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.223 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -55.68 -43.18 76.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.435 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.82 -43.56 93.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -68.68 -38.8 80.62 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.393 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -86.23 82.36 8.06 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -57.64 -50.21 73.91 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -91.04 5.83 47.3 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.277 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.21 47.81 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -90.32 7.47 38.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.667 0.27 . . . . 0.0 110.616 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.18 2.16 89.37 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -141.48 153.62 45.05 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.809 0.814 . . . . 0.0 111.756 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -96.05 117.04 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.3 p -91.34 153.69 19.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.73 83.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 119.227 0.921 . . . . 0.0 110.906 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.64 -41.9 64.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.891 0.377 . . . . 0.0 110.617 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -64.35 -43.26 95.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.54 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 108' ' ' VAL . 11.5 mt -62.76 -44.95 94.85 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.324 0.583 . . . . 0.0 111.391 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -42.5 -43.17 3.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.651 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -63.28 -27.33 69.26 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.035 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 105' ' ' LEU . 94.0 t -58.07 -42.83 83.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.651 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.5 ' SD ' ' OE1' ' A' ' 114' ' ' GLU . 15.1 mmt -51.35 -44.46 62.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.204 1.002 . . . . 0.0 111.458 -177.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.6 m -55.36 -41.1 72.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.885 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -64.73 -39.84 94.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.538 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.3 mt -83.44 -13.56 54.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.63 35.89 50.09 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.396 -1.224 . . . . 0.0 110.482 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.5 ' OE1' ' SD ' ' A' ' 109' ' ' MET . 80.7 tt0 -89.78 -24.57 21.45 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.729 2.265 . . . . 0.0 110.879 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.0 tptp 45.89 63.0 1.99 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.551 1.167 . . . . 0.0 110.096 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.418 ' O ' ' CD2' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -76.31 150.92 36.85 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.955 -1.929 . . . . 0.0 112.854 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.2 p -86.3 174.16 9.25 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.367 0.603 . . . . 0.0 109.952 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -54.42 -44.02 72.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -55.83 -41.63 74.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.219 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -68.4 -28.98 67.57 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.721 -178.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 52.6 t -63.8 -44.07 98.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.33 0.586 . . . . 0.0 109.773 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.66 -37.33 65.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.292 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -58.73 -54.95 41.29 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 95.1 mtp -57.17 -43.19 82.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.746 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.6 mm -58.7 -44.0 88.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.132 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -60.65 -35.68 76.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.348 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.98 -42.23 89.49 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.69 -20.15 21.88 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.6 t0 -70.45 90.29 0.72 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.539 0.685 . . . . 0.0 112.069 -177.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.0 -16.12 19.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 122.711 1.243 . . . . 0.0 113.219 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.6 p-10 -143.82 144.99 32.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 112.334 -2.212 . . . . 0.0 109.443 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.05 52.74 1.36 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.961 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -91.17 -9.29 45.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.087 0.443 . . . . 0.0 110.145 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.64 2.14 74.38 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.401 -0.428 . . . . 0.0 114.115 176.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -133.75 153.05 52.0 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 117.36 0.58 . . . . 0.0 110.477 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.1 t -99.15 118.23 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.145 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.459 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 52.2 t30 -84.0 173.61 11.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.977 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.459 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 82.9 t80 -61.37 -39.33 90.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.929 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.72 -44.66 92.95 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.015 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.17 -38.67 91.29 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.567 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -61.04 -44.74 96.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.799 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 82.8 t -65.86 -46.27 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.471 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -49.23 -44.87 43.83 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.008 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.3 mmm -75.66 -39.98 56.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.2 mmt -76.21 -46.86 26.28 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.341 -0.144 . . . . 0.0 111.069 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 111.446 -178.945 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 4.7 m95 -58.6 -60.65 3.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.574 0.702 . . . . 0.0 112.095 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -46.64 82.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -174.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B 1095 ' ' ARG . . . . . 0.631 HH11 ' NH2' ' B' 1099 ' ' ARG . 63.7 ttm-85 -36.51 -51.97 0.84 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.79 -40.1 98.35 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.179 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.65 -44.18 81.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 118.031 0.916 . . . . 0.0 109.628 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -59.63 -49.52 77.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.767 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B 1099 ' ' ARG . . . . . 0.631 ' NH2' HH11 ' B' 1095 ' ' ARG . 3.2 mpt_? -65.72 -39.22 90.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.302 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.74 -43.33 94.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.509 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -55.49 -45.15 77.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.513 ' O ' ' C ' ' B' 1103 ' ' GLN . 90.4 m -60.9 -48.56 81.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.955 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.513 ' C ' ' O ' ' B' 1102 ' ' THR . 86.1 mt-30 -28.29 -97.54 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 123.238 1.494 . . . . 0.0 112.137 -175.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -39.47 -14.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 111.806 -2.452 . . . . 0.0 111.752 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.49 ' N ' ' O ' ' B' 1103 ' ' GLN . 52.5 tttp -60.4 -44.63 95.5 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 118.01 -1.476 . . . . 0.0 107.476 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.5 t -61.45 -48.97 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.2 m -66.83 -37.88 80.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.96 -177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 63.4 mttt -49.87 -39.41 39.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.205 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -50.86 -44.91 59.63 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.035 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -63.46 -48.53 77.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 19.4 t-80 . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.428 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.467 0.396 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.2 p -80.45 139.31 36.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.256 0.935 . . . . 0.0 110.384 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 9' ' ' ILE . 48.4 tp10 -50.98 -54.65 22.59 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.798 0.808 . . . . 0.0 110.519 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -35.77 -37.57 0.1 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.096 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -68.99 -37.54 78.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.605 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.8 mt -58.64 -45.64 90.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 175.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.39 -51.58 62.1 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.393 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -61.6 -47.06 87.15 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.468 0.651 . . . . 0.0 112.622 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -62.9 -36.86 84.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.556 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -55.16 -51.51 66.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.373 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.77 -41.82 61.93 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.31 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.47 -39.14 67.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.212 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -56.29 -41.51 76.04 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -65.28 -14.69 61.32 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.441 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.2 tp -63.25 -43.45 97.96 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -107.06 -13.73 15.11 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.99 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -76.27 95.43 3.74 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.098 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -68.34 -46.99 68.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.297 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.5 p-10 -101.63 14.84 30.76 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.65 46.85 0.6 Allowed Glycine 0 CA--C 1.533 1.195 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -84.15 -3.44 58.13 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.43 -1.58 82.13 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.7 p -137.39 151.88 49.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.918 0.389 . . . . 0.0 110.168 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.528 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 1.6 mp -93.49 125.73 46.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 30' ' ' LYS . 1.9 t -115.29 164.27 14.48 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.176 -0.92 . . . . 0.0 113.182 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.0 p -57.66 -36.08 71.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.83 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' H ' HG23 ' A' ' 28' ' ' THR . 34.5 ttpt -60.97 -58.5 8.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.85 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -64.36 -28.68 69.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.41 -56.1 24.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.78 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.22 -37.64 87.43 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.365 -1.288 . . . . 0.0 112.11 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.7 m -57.85 -54.57 45.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.911 1.356 . . . . 0.0 107.619 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.9 t -55.96 -46.05 80.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 118.852 0.751 . . . . 0.0 111.515 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.1 mmm -58.35 -42.34 86.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 119.963 1.256 . . . . 0.0 110.229 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -54.48 -41.77 69.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.441 0.639 . . . . 0.0 110.786 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -63.6 -21.32 66.29 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.83 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 tp -73.95 -2.54 24.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.851 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.78 14.51 62.98 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.164 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -109.31 156.79 19.55 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.537 0.669 . . . . 0.0 109.518 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -119.67 65.67 9.42 Favored Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.53 145.45 76.56 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.163 1.909 . . . . 0.0 112.03 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 m -78.22 159.29 28.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.268 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -52.49 -41.84 63.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.696 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.79 -25.21 26.61 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -65.61 -39.73 91.85 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.065 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.7 mp -56.19 -41.45 75.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.327 0.585 . . . . 0.0 109.909 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -67.31 -57.35 6.81 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.071 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -54.98 -49.53 71.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.5 mmm -64.17 -51.63 62.88 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.5 mm -59.23 -49.58 82.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.092 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -56.66 -33.96 66.89 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -66.28 -40.35 90.02 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.786 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.401 ' CG2' ' CD2' ' B' 1110 ' ' PHE . 69.0 t -86.6 -20.03 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.335 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.523 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 44.0 t0 -78.68 84.61 4.76 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -175.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.62 79.6 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.842 -1.526 . . . . 0.0 114.36 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.414 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 36.1 p-10 -85.11 -2.79 58.4 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.342 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.06 22.75 60.85 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.901 -0.499 . . . . 0.0 112.316 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.414 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -86.24 3.51 42.78 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.313 0.556 . . . . 0.0 110.441 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 83.12 2.33 90.53 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 114.8 0.68 . . . . 0.0 114.8 175.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 69.0 p -147.06 165.94 28.39 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.7 mm -109.42 126.81 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -102.99 -177.25 3.32 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.838 0.352 . . . . 0.0 110.731 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.02 -57.71 22.72 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.08 -50.59 12.44 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.158 1.238 . . . . 0.0 111.336 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.3 -20.78 60.58 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.279 0.562 . . . . 0.0 110.708 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -75.64 -58.31 3.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.962 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -55.74 -47.9 76.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.3 p -44.22 -48.21 9.32 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.309 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.5 mtp -65.52 -45.57 82.98 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 31.4 mmt -59.92 -40.78 90.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.6 -34.1 77.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.332 0.253 . . . . 0.0 111.538 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.8 mtp85 -95.24 -12.35 26.39 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.569 0.223 . . . . 0.0 111.355 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.84 68.54 7.14 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 110.481 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 21.5 mmt -108.69 15.47 23.64 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.684 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -52.82 129.78 31.03 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.535 0.683 . . . . 0.0 111.6 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 79' ' ' THR . 61.6 t0 -105.57 146.35 29.76 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.694 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.521 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 75.3 p -132.81 133.97 44.07 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 82' ' ' GLU . 1.1 p30 -61.12 115.95 4.17 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 175.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 m -36.44 -19.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 80' ' ' ASP . 46.0 tp10 -70.54 -32.09 69.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.941 0.401 . . . . 0.0 111.513 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -51.16 -41.12 59.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.668 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -83.96 -17.45 40.58 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 111.872 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.6 mm -59.21 -73.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.46 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -58.57 -55.87 29.44 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.47 ' CD ' ' N ' ' A' ' 88' ' ' ALA . 3.1 pp20? -52.83 -36.36 58.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.297 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.47 ' N ' ' CD ' ' A' ' 87' ' ' GLU . . . -60.71 -23.49 64.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.812 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -72.37 -48.84 38.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.24 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -54.79 -41.55 70.71 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.896 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.25 -45.06 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.745 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -70.02 -38.55 75.94 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.349 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.517 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 31.6 t0 -88.69 82.48 6.84 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 176.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.503 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 65.2 tttm -58.46 -48.42 80.8 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 40.2 p-10 -90.65 4.88 50.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.664 0.269 . . . . 0.0 111.652 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.2 47.52 49.53 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.662 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -90.61 5.98 45.68 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 122.35 0.26 . . . . 0.0 110.742 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.422 ' N ' HD21 ' A' ' 97' ' ' ASN . . . 85.11 0.96 88.76 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.662 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 74.1 m-85 -139.22 152.29 47.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.611 0.72 . . . . 0.0 111.708 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.6 mt -94.51 117.72 38.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 t -91.06 150.12 21.55 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.49 -45.96 76.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 119.159 0.891 . . . . 0.0 110.481 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.44 62.67 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.892 0.377 . . . . 0.0 110.745 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.503 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.1 mt-10 -65.84 -40.59 91.88 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.227 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.3 tp -62.93 -46.14 89.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.216 0.531 . . . . 0.0 110.543 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -43.54 -43.11 5.36 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.573 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -64.96 -30.81 71.82 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.646 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.6 t -56.99 -41.8 77.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.643 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.628 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -50.6 -44.43 57.02 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.786 0.803 . . . . 0.0 111.276 -178.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 m -57.2 -41.29 79.12 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 114.046 -1.434 . . . . 0.0 111.013 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -65.96 -41.31 91.38 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.564 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.1 mt -81.52 -13.81 57.67 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.8 31.98 57.61 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.556 -1.136 . . . . 0.0 110.401 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -85.44 -21.51 28.72 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.628 2.214 . . . . 0.0 111.744 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt 43.27 61.05 2.32 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.892 0.854 . . . . 0.0 109.948 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.7 mt -81.51 147.72 29.54 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.404 -1.726 . . . . 0.0 112.317 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 65.3 p -82.48 175.74 9.97 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.839 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -57.75 -46.44 84.5 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -55.98 -48.58 75.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.983 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -71.66 -30.85 66.17 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.288 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.51 -41.4 92.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.522 0.677 . . . . 0.0 109.408 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -72.64 -33.26 66.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.78 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.42 -50.98 71.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 76.3 mtp -52.85 -48.07 67.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.641 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.8 mm -57.76 -43.48 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.882 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -62.17 -35.3 78.39 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.808 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -57.06 -41.02 77.98 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.42 -11.66 29.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.791 0.329 . . . . 0.0 111.358 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.2 t0 -75.12 89.1 2.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.507 0.67 . . . . 0.0 111.855 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.77 -18.36 20.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.596 -1.184 . . . . 0.0 113.105 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.461 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.3 p-10 -140.32 145.73 37.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 112.781 -2.009 . . . . 0.0 108.678 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.96 52.2 1.65 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.696 -0.288 . . . . 0.0 113.031 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -90.72 -9.48 46.56 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.978 0.389 . . . . 0.0 110.089 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.74 1.49 72.3 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.957 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -135.5 154.19 51.49 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.127 0.463 . . . . 0.0 110.471 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.44 118.37 47.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.175 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.43 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 57.7 t30 -83.84 173.26 11.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 0.0 111.093 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.43 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 86.8 t80 -61.35 -40.85 95.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.046 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -61.76 -44.41 96.95 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.744 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.81 -39.71 94.02 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.58 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.565 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 92.1 t80 -61.3 -46.44 90.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.976 0.417 . . . . 0.0 111.175 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.48 -46.65 92.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.383 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -49.54 -47.62 48.92 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.714 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 88.2 mmm -71.22 -35.2 71.42 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.565 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.7 mtt -79.56 -46.97 16.32 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.737 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B 1092 ' ' LEU . . . . . 0.465 ' CD2' ' C ' ' B' 1092 ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B 1093 ' ' TRP . . . . . 0.401 ' N ' HD22 ' B' 1092 ' ' LEU . 2.3 m95 -55.31 -62.25 1.8 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.358 0.599 . . . . 0.0 110.864 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 51.6 t80 -56.51 -44.24 80.54 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 61.9 ttt85 -39.94 -53.47 2.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -60.27 -39.95 96.74 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 48.0 tp -56.6 -44.12 80.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 118.494 1.147 . . . . 0.0 109.73 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 46.4 t30 -57.66 -47.61 81.8 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -63.96 -38.15 90.03 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.04 -42.27 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.638 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -51.41 -46.27 62.85 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.628 -1.229 . . . . 0.0 107.874 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.518 ' O ' ' N ' ' B' 1105 ' ' LYS . 96.1 m -62.37 -48.38 80.01 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.59 -0.444 . . . . 0.0 112.047 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.432 ' C ' ' O ' ' B' 1102 ' ' THR . 84.8 mt-30 -27.98 -59.22 0.11 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.591 1.186 . . . . 0.0 112.66 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.0 mt -81.52 -14.34 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 112.711 -2.041 . . . . 0.0 112.089 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' 1102 ' ' THR . 64.0 tttp -58.92 -45.95 89.13 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 118.087 -1.445 . . . . 0.0 108.179 176.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.3 t -60.57 -49.73 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.06 -36.56 78.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.116 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 88.9 mttt -49.09 -37.08 20.37 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.739 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.44 63.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.287 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B 1110 ' ' PHE . . . . . 0.401 ' CD2' ' CG2' ' A' ' 55' ' ' VAL . 44.3 m-85 -62.92 -49.45 74.73 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 70.0 m-70 . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.454 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.417 HD23 ' H ' ' A' ' 5' ' ' THR . 1.9 pt? . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.417 ' H ' HD23 ' A' ' 4' ' ' LEU . 67.7 p -77.2 140.14 40.07 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.865 0.757 . . . . 0.0 110.827 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.1 tt0 -48.73 -60.98 2.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 122.108 0.956 . . . . 0.0 110.497 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -34.61 -37.01 0.05 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.998 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -69.86 -35.78 74.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.403 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.8 mm -59.71 -44.6 94.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 175.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.51 -49.96 63.76 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.282 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -63.1 -44.84 94.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.507 0.67 . . . . 0.0 112.332 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.28 -39.28 94.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.887 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -52.51 -54.02 38.14 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.357 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -50.78 -41.63 57.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.162 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.79 -39.13 68.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.137 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.445 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 3.0 m-85 -57.7 -41.29 81.4 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.3 p -64.55 -15.91 61.73 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.402 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.65 -42.3 95.51 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.79 -178.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -105.95 -14.14 15.28 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -72.72 94.0 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.344 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -67.71 -49.65 61.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.722 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 23' ' ' GLY . 48.2 p-10 -102.72 15.78 28.35 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.88 45.19 0.54 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.132 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -86.01 -4.24 59.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.83 0.347 . . . . 0.0 111.062 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.05 -1.58 80.5 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.3 p -138.01 152.95 49.38 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.17 0.509 . . . . 0.0 110.043 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.69 124.08 44.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.0 p -113.19 163.51 14.68 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.941 0.776 . . . . 0.0 112.559 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.1 p -58.24 -37.11 74.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.884 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.57 -62.09 2.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.185 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -60.58 -29.89 69.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.668 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 tp -61.07 -55.02 37.47 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.026 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.87 -40.32 95.06 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.401 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.11 -54.65 44.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 118.884 1.342 . . . . 0.0 108.423 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.9 t -56.76 -46.78 83.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 118.889 0.768 . . . . 0.0 111.841 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.2 ttt -58.63 -41.5 86.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 120.065 1.302 . . . . 0.0 109.964 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -51.78 -38.28 54.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.512 0.673 . . . . 0.0 110.296 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 t -62.59 -20.58 64.86 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.949 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -74.08 -0.4 16.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.897 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.44 14.56 70.77 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.116 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -107.47 158.5 17.15 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 117.484 0.642 . . . . 0.0 109.992 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -116.1 65.83 2.88 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.272 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.75 144.03 87.96 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.182 1.921 . . . . 0.0 112.111 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.637 ' HG1' ' N ' ' A' ' 45' ' ' GLU . 6.5 t -80.42 165.45 22.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.555 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.637 ' N ' ' HG1' ' A' ' 44' ' ' THR . 15.9 tm-20 -57.9 -44.94 87.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.68 -23.96 31.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.586 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -65.61 -39.99 92.14 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.146 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.8 mp -55.64 -40.8 72.68 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.495 0.664 . . . . 0.0 109.799 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -71.45 -56.22 6.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.815 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -54.52 -49.23 70.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.0 mtp -67.08 -48.65 67.56 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.0 mm -58.47 -46.71 89.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.607 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -55.59 -35.54 65.93 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -66.62 -40.3 88.72 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.146 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -85.58 -20.97 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.39 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.497 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.3 t0 -79.63 84.3 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -175.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.81 -37.1 80.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.64 -1.618 . . . . 0.0 114.319 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -86.57 -2.04 58.16 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.53 23.04 60.03 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 118.44 0.563 . . . . 0.0 112.473 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -87.65 3.81 46.36 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.44 0.62 . . . . 0.0 110.515 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.497 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.72 1.41 89.05 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 175.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.0 p -148.42 168.86 21.55 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.8 mt -113.48 128.79 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 5.9 p30 -103.61 -175.97 2.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.867 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.445 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.16 -47.63 98.49 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.738 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -55.72 -52.06 8.36 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.287 1.325 . . . . 0.0 111.84 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.22 -19.59 61.82 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.506 0.669 . . . . 0.0 110.533 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -75.52 -59.33 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.352 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.5 mt -56.46 -45.16 81.02 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.8 p -45.24 -47.49 12.77 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.404 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 33.6 mtp -67.68 -46.81 71.23 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.6 mmm -61.75 -39.89 93.17 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.64 -34.21 77.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.373 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -94.95 -12.44 26.76 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.441 ' C ' ' SD ' ' A' ' 76' ' ' MET . 3.9 tptt -81.9 67.02 7.72 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.016 0.436 . . . . 0.0 110.237 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.524 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -106.98 17.52 22.97 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.34 179.496 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -49.79 132.39 22.15 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.508 0.67 . . . . 0.0 111.41 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -92.51 108.12 19.73 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.107 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.0 m -93.5 121.29 34.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 82' ' ' GLU . 30.4 m-20 -69.42 113.19 6.51 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.4 m -37.78 -19.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.796 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 80' ' ' ASP . 83.2 tt0 -67.01 -41.05 87.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.863 0.363 . . . . 0.0 111.217 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -56.95 -40.75 77.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.724 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.56 ' O ' ' N ' ' A' ' 87' ' ' GLU . 51.0 tp10 -72.3 -80.52 0.06 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.655 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.504 ' C ' ' O ' ' A' ' 84' ' ' GLU . 1.9 pp -20.56 -60.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 123.684 0.615 . . . . 0.0 111.319 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.4 ' H ' ' CG1' ' A' ' 85' ' ' ILE . 9.1 ptm180 -60.76 -42.21 96.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 84' ' ' GLU . 40.3 mm-40 -61.84 -40.07 94.01 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.939 0.399 . . . . 0.0 111.092 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -17.58 62.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.856 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -71.43 -52.79 16.59 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.735 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.559 HH21 ' CD ' ' A' ' 87' ' ' GLU . 78.9 mtm-85 -55.53 -40.63 72.08 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.874 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.62 -42.92 90.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -68.01 -37.91 81.97 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.417 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -89.34 83.7 6.43 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.43 -46.39 90.2 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.402 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 40.7 p-10 -91.5 4.55 52.27 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.386 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.39 49.9 37.07 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.19 6.7 41.59 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.77 0.55 89.85 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.669 -0.573 . . . . 0.0 111.669 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -139.5 151.92 46.55 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.615 0.722 . . . . 0.0 111.736 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.3 mt -95.9 117.5 40.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 m -91.32 152.81 20.31 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.19 80.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.412 1.005 . . . . 0.0 110.848 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.56 -40.52 62.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 110.676 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -65.33 -42.64 92.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.222 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 108' ' ' VAL . 21.2 mt -63.03 -45.15 93.68 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.29 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -41.53 -45.45 3.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.746 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.427 ' O ' ' OG1' ' A' ' 110' ' ' THR . 52.8 t-80 -59.78 -26.11 65.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.798 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 105' ' ' LEU . 63.4 t -58.33 -43.1 85.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.895 -178.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.3 mmt -51.15 -45.54 61.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.065 0.936 . . . . 0.0 111.098 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 60.0 p -57.92 -38.61 76.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.085 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -40.55 81.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.493 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 70.3 mt -81.32 -13.68 58.14 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.29 29.59 59.98 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.393 -1.226 . . . . 0.0 110.15 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -85.87 -22.62 27.45 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.779 2.29 . . . . 0.0 111.005 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm 44.77 61.81 2.33 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.222 1.01 . . . . 0.0 109.862 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 78.1 mt -80.65 147.0 30.86 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.472 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.8 p -81.95 175.54 10.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.614 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -57.15 -44.87 83.83 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.28 -48.26 79.34 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -72.75 -30.65 64.33 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.103 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.7 t -64.99 -43.22 96.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -69.15 -35.02 75.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.214 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -59.72 -47.57 85.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.059 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 15.8 mmm -55.18 -45.12 75.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.62 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 40.1 mm -58.14 -44.1 86.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.446 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -58.91 -39.57 81.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.746 0.308 . . . . 0.0 111.132 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.99 -41.68 83.52 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.52 -23.1 21.02 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.7 t0 -72.42 87.97 1.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.485 0.66 . . . . 0.0 112.098 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.69 -15.26 19.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.945 1.355 . . . . 0.0 113.265 -178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 37.6 p-10 -141.68 145.0 34.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.214 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.06 52.31 1.7 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.551 -0.357 . . . . 0.0 113.385 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -91.32 -8.76 47.26 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.182 0.491 . . . . 0.0 110.108 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.04 2.54 78.39 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.118 -0.563 . . . . 0.0 114.21 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -134.99 153.87 51.93 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 117.19 0.495 . . . . 0.0 110.551 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.7 118.57 47.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.321 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.428 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 59.9 t30 -83.65 173.0 11.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.06 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.428 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 83.4 t80 -61.8 -39.74 92.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.022 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -61.57 -44.68 96.58 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.621 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.11 -37.76 88.61 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.436 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -61.07 -44.94 96.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.701 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.405 ' O ' ' OG1' ' A' ' 146' ' ' THR . 72.1 t -65.05 -47.77 86.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.371 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -50.24 -44.35 53.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.171 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.4 mmt -73.33 -38.94 65.61 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 22.4 mmt -75.66 -46.92 28.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.911 -0.131 . . . . 0.0 111.021 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 6.7 p . . . . . 0 N--CA 1.47 0.538 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.564 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.51 -53.69 53.1 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.451 0.643 . . . . 0.0 112.111 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 53.8 t80 -58.02 -46.06 85.89 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -174.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -40.69 -52.33 2.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.23 -41.83 99.72 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.084 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.2 tp -55.93 -46.3 78.51 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.446 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 41.2 t30 -58.01 -48.31 80.42 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -64.96 -38.11 89.89 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 87.5 mt -60.91 -42.6 93.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.802 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -50.96 -44.99 60.68 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.505 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.4 m -63.0 -48.28 79.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.92 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.424 ' C ' ' O ' ' B' 1102 ' ' THR . 84.4 mt-30 -28.01 -58.64 0.11 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.805 1.288 . . . . 0.0 112.929 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -82.74 -15.4 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 112.25 -2.25 . . . . 0.0 111.985 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.505 ' N ' ' O ' ' B' 1102 ' ' THR . 88.8 tttt -58.8 -45.92 88.79 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 117.989 -1.484 . . . . 0.0 107.89 176.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.5 t -60.85 -49.06 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.57 -36.84 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.091 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 90.5 mttt -49.74 -37.16 28.25 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.512 0.672 . . . . 0.0 109.661 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.03 -45.53 64.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.285 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -63.13 -50.44 70.44 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 83.9 m-70 . . . . . 0 C--N 1.329 -0.293 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.141 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 119.573 -0.251 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.7 p -79.97 138.62 37.11 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.997 0.817 . . . . 0.0 110.523 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 9' ' ' ILE . 27.1 mm-40 -49.17 -58.1 5.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 122.099 0.952 . . . . 0.0 110.788 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -35.64 -37.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 113.352 -1.749 . . . . 0.0 110.611 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -70.19 -37.18 75.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.468 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.1 mt -59.76 -46.04 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.41 -48.63 62.58 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.51 -177.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.04 -44.36 92.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.551 0.691 . . . . 0.0 112.299 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.19 -39.99 96.22 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.862 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -50.22 -53.67 26.45 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.572 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -51.85 -39.2 58.5 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.174 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.35 -39.91 73.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.379 -178.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -55.55 -42.05 74.12 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.9 t -64.05 -16.54 61.92 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.381 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.67 -43.44 96.68 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -104.67 -15.13 15.36 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.602 -178.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -77.7 93.13 4.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.361 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -66.75 -46.83 74.15 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.706 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -101.7 15.15 29.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.24 50.48 3.65 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.732 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -89.43 -5.55 57.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.171 0.486 . . . . 0.0 111.898 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.12 0.69 73.69 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.849 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.7 p -141.25 159.76 41.54 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.971 0.415 . . . . 0.0 110.07 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.2 mt -92.32 126.19 44.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.419 ' OG1' ' OE1' ' A' ' 31' ' ' GLU . 19.1 p -111.78 162.65 15.03 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.044 0.84 . . . . 0.0 112.256 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 p -60.36 -37.97 82.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.87 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.43 -58.88 6.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.464 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.419 ' OE1' ' OG1' ' A' ' 28' ' ' THR . 10.1 pt-20 -63.38 -29.52 70.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.625 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 tp -61.08 -52.5 64.64 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.3 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.99 -38.09 94.93 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.938 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.2 m -58.76 -54.15 50.36 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.731 1.265 . . . . 0.0 108.593 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.416 ' O ' ' OG ' ' A' ' 38' ' ' SER . 48.5 t -57.79 -46.06 87.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 121.058 -1.026 . . . . 0.0 111.513 -176.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.3 tpt -59.31 -40.33 85.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 119.914 1.234 . . . . 0.0 109.531 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -53.35 -41.56 65.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.307 0.575 . . . . 0.0 110.251 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 47.6 p -63.71 -21.47 66.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.157 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.42 -4.09 31.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.61 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.01 60.74 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.032 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -106.68 155.12 20.0 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.642 0.721 . . . . 0.0 110.094 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 26.1 t-20 -116.46 62.85 2.58 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.37 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.25 145.7 93.37 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.265 1.977 . . . . 0.0 112.204 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.7 p -80.36 167.73 19.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.565 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -58.24 -44.06 88.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.805 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.7 -24.09 32.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.502 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -65.49 -38.6 90.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.016 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 10.8 mp -57.25 -42.26 81.17 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.311 0.577 . . . . 0.0 109.882 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -69.16 -56.48 7.53 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.383 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -55.32 -48.98 73.33 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.9 mmm -65.39 -51.68 58.71 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.6 mm -59.63 -48.9 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.777 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -57.82 -33.47 68.64 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.85 -39.84 94.2 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.53 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.21 -17.73 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.265 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.505 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.37 85.55 4.48 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -174.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.02 88.39 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 113.427 -1.715 . . . . 0.0 113.728 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.1 p-10 -85.6 -3.06 58.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.82 23.82 61.68 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.886 -0.509 . . . . 0.0 112.937 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.433 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.6 p-10 -87.56 3.76 46.26 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.174 0.487 . . . . 0.0 110.26 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.505 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.09 0.54 88.84 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.893 -0.67 . . . . 0.0 114.214 175.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.6 p -149.13 170.38 18.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.0 mt -112.59 128.77 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -104.41 -173.7 2.37 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.433 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.419 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -58.7 -46.11 99.59 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.412 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 35.3 Cg_exo -56.06 -53.39 5.51 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.465 1.443 . . . . 0.0 111.21 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.41 -22.08 66.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.15 0.5 . . . . 0.0 111.161 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.61 -61.41 1.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.9 mt -57.78 -43.83 85.84 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.3 m -40.74 -58.3 1.68 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.943 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -65.66 -41.42 92.55 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.983 -176.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 97.2 mmm -58.94 -41.24 86.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.26 77.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.352 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -93.93 -13.99 26.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.657 0.265 . . . . 0.0 111.239 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.42 ' C ' ' SD ' ' A' ' 76' ' ' MET . 0.1 OUTLIER -80.84 66.65 6.44 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.206 0.527 . . . . 0.0 110.591 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -108.37 15.61 23.83 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.441 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -49.62 134.59 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.245 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.84 108.62 19.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.156 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.9 m -93.33 121.32 34.59 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 82' ' ' GLU . 97.7 m-20 -68.63 112.3 5.32 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.9 m -37.49 -22.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.528 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.9 mp0 -69.43 -35.78 76.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.77 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -48.25 -35.84 12.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.257 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 84' ' ' GLU . 2.4 mp0 -90.95 -16.54 27.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.0 mm -59.99 -74.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.566 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -61.83 -41.2 97.51 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -62.53 -38.92 91.86 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.249 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.63 -20.74 65.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.998 0.427 . . . . 0.0 111.078 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -70.61 -49.93 42.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.053 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -54.85 -41.62 70.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.535 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.57 -43.82 94.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -68.38 -39.68 81.68 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.188 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.492 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 27.1 t0 -87.15 83.54 7.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.511 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 88.6 tttt -58.04 -49.61 76.27 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 35.1 p-10 -91.88 4.51 52.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.696 0.284 . . . . 0.0 111.608 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.56 49.29 53.19 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.681 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -90.61 5.24 48.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.793 0.33 . . . . 0.0 110.83 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.445 ' N ' HD21 ' A' ' 97' ' ' ASN . . . 84.98 2.0 88.56 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.681 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 88.1 m-85 -140.01 152.88 46.62 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.611 0.719 . . . . 0.0 111.506 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.3 mt -94.04 115.31 32.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 t -89.07 150.93 22.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.634 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.32 83.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.981 0.81 . . . . 0.0 110.646 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.74 -39.59 65.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.862 0.363 . . . . 0.0 110.443 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.511 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.2 mt-10 -66.64 -41.18 88.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.338 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.09 -45.71 90.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.456 0.646 . . . . 0.0 110.997 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -44.23 -43.18 7.06 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.422 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -65.49 -28.62 69.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.51 0.195 . . . . 0.0 111.236 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.21 -42.46 83.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.573 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.496 ' SD ' ' CD1' ' A' ' 116' ' ' LEU . 36.8 mmt -51.34 -43.22 61.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.82 0.819 . . . . 0.0 111.107 -177.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 m -57.93 -41.68 83.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.763 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -42.32 82.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.681 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.58 -15.85 56.93 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.475 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.1 28.7 59.91 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -84.43 -22.49 30.36 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.625 2.213 . . . . 0.0 110.59 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 43.07 58.68 3.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.804 0.811 . . . . 0.0 110.301 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.496 ' CD1' ' SD ' ' A' ' 109' ' ' MET . 50.9 mt -79.52 149.15 31.55 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.679 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 70.2 p -82.71 175.29 10.25 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.5 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -58.14 -44.17 87.69 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.47 -49.44 76.28 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.61 -30.68 67.41 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.88 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.51 -42.41 96.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.29 -35.66 73.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.335 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -59.74 -50.89 72.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 90.5 mtp -57.12 -43.52 82.41 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.137 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.38 -44.18 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.286 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -59.57 -38.82 82.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.033 0.444 . . . . 0.0 111.208 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -57.23 -40.45 77.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.848 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.58 -20.09 22.04 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.1 t0 -75.36 86.1 2.52 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.389 0.614 . . . . 0.0 111.916 -177.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.6 pt -71.87 -12.08 15.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.275 -177.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 40.6 p-10 -140.67 142.09 34.95 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 112.504 -2.135 . . . . 0.0 108.771 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.69 52.09 1.55 Allowed Glycine 0 CA--C 1.53 1.012 0 CA-C-O 120.269 -0.184 . . . . 0.0 113.472 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -91.17 -7.92 50.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.281 0.54 . . . . 0.0 110.139 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.68 1.3 66.04 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.131 -0.557 . . . . 0.0 114.296 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -135.01 153.66 52.0 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.426 0.613 . . . . 0.0 110.478 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 51.3 t -100.74 118.54 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.451 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -84.2 174.87 9.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -61.84 -40.85 96.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.133 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.39 -44.82 95.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.891 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -63.91 -38.49 91.29 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.461 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -60.22 -45.54 92.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.594 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.402 ' O ' ' OG1' ' A' ' 146' ' ' THR . 77.9 t -65.57 -47.95 84.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.269 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.71 -46.7 59.07 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.316 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.404 ' O ' ' CE1' ' B' 1094 ' ' PHE . 11.8 mmt -72.08 -39.44 68.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.8 mmt -77.03 -46.58 23.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.391 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 10.8 p . . . . . 0 N--CA 1.47 0.539 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.1 m95 -59.44 -62.67 1.71 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.333 0.587 . . . . 0.0 112.199 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B 1094 ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 144' ' ' MET . 40.1 m-85 -57.71 -42.6 84.1 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -174.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -40.6 -51.51 2.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.602 0.715 . . . . 0.0 112.664 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.36 -41.83 99.74 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.79 -46.32 81.62 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.563 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -59.61 -48.15 82.78 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 24.0 mtp-105 -65.49 -38.08 88.69 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.605 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.98 -42.18 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.884 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -51.12 -46.53 61.95 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.51 ' O ' ' N ' ' B' 1105 ' ' LYS . 99.1 m -63.83 -47.88 79.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.609 -0.436 . . . . 0.0 112.002 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.427 ' C ' ' O ' ' B' 1102 ' ' THR . 84.0 mt-30 -28.24 -57.53 0.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.538 1.161 . . . . 0.0 112.435 -176.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -84.58 -15.5 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 112.202 -2.272 . . . . 0.0 112.449 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.51 ' N ' ' O ' ' B' 1102 ' ' THR . 88.6 tttt -60.24 -46.55 89.4 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 118.077 -1.449 . . . . 0.0 107.951 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 57.7 t -61.89 -48.72 87.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.61 -36.27 77.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.774 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 87.4 mttt -49.54 -36.04 22.24 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 119.919 -0.713 . . . . 0.0 109.488 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.57 -45.65 70.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.059 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -62.49 -50.51 71.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.109 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 58.9 m-70 . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.343 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 118.976 -0.535 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.2 p -76.92 139.73 40.29 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 119.934 1.243 . . . . 0.0 110.35 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.593 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -50.78 -47.99 59.53 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.391 1.091 . . . . 0.0 110.653 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.476 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -38.21 -38.87 0.37 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.884 -179.007 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -68.35 -38.96 81.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.469 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.3 mt -59.76 -44.6 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 175.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.0 -49.17 63.86 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.094 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.449 ' OE2' ' OE2' ' A' ' 7' ' ' GLU . 98.4 mt-10 -60.46 -47.56 85.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 111.748 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -59.0 -42.12 89.32 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.866 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -50.42 -57.31 8.29 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.396 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -51.18 -44.72 61.58 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.847 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.72 -37.79 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.218 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.44 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 2.6 m-85 -58.44 -40.38 82.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.2 p -65.2 -15.56 62.59 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.456 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.7 -42.13 95.51 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -105.61 -13.99 15.42 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -71.92 93.91 1.39 Allowed 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.472 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -67.41 -49.64 62.89 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.833 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.1 p30 -103.62 14.88 30.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.16 44.79 0.82 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.164 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 31.0 p-10 -85.02 -3.17 58.69 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.729 0.299 . . . . 0.0 110.89 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 -0.83 78.87 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 t -140.48 154.9 46.77 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.15 0.5 . . . . 0.0 110.097 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.8 mp -91.41 123.96 43.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.4 p -111.77 162.98 14.66 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.853 0.835 . . . . 0.0 112.064 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.7 p -59.93 -37.57 79.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.629 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -60.47 -57.01 14.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.472 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -64.31 -28.71 69.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.479 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tp -60.8 -53.42 57.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.062 0.934 . . . . 0.0 109.765 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.3 -37.48 94.11 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.124 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -58.81 -52.8 64.15 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.777 1.288 . . . . 0.0 108.813 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.422 ' O ' ' OG ' ' A' ' 38' ' ' SER . 42.3 t -57.93 -45.03 87.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 119.404 1.002 . . . . 0.0 111.278 -176.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.7 tpt -59.07 -38.73 80.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 120.028 1.285 . . . . 0.0 109.555 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -51.46 -38.36 53.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.65 0.738 . . . . 0.0 110.457 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 37.9 p -63.13 -20.94 65.84 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.439 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.81 0.79 12.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.77 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.5 27.05 40.55 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.23 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -130.54 170.04 14.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.415 0.607 . . . . 0.0 109.923 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -133.8 76.42 65.65 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.396 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.14 147.57 95.29 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.764 2.31 . . . . 0.0 111.995 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.2 t -76.0 164.51 26.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.256 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.18 -43.75 87.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.983 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.33 -24.24 42.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.545 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.65 -38.76 90.24 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.057 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.57 -40.86 75.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.298 0.571 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -70.89 -56.38 6.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.803 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -55.25 -50.45 69.44 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.1 mmm -65.02 -51.53 61.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.1 mm -59.54 -48.14 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.821 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -58.37 -33.51 69.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -65.68 -39.62 91.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.215 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.31 -19.43 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.276 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.2 t0 -78.01 86.59 4.19 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -174.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.35 90.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.234 -1.803 . . . . 0.0 113.988 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -86.33 -2.76 58.69 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.0 23.66 61.88 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 118.467 0.576 . . . . 0.0 112.988 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -87.91 3.14 49.62 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.257 0.528 . . . . 0.0 110.333 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.63 0.54 87.9 Favored Glycine 0 CA--C 1.52 0.361 0 O-C-N 121.586 -0.696 . . . . 0.0 114.569 175.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.2 p -147.66 169.22 20.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.8 mt -112.79 128.51 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.558 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 23.6 t0 -103.16 -177.19 3.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.639 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.558 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -56.71 -47.94 98.12 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.513 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.3 -49.54 14.83 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.215 1.277 . . . . 0.0 111.889 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.21 -19.63 64.69 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.476 0.655 . . . . 0.0 110.927 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -74.43 -59.63 2.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.752 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.47 -43.44 79.59 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.0 m -45.59 -48.47 14.53 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.607 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.8 mtm -67.09 -45.59 76.8 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.0 mmm -61.4 -39.2 89.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.02 79.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.644 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -93.6 -14.56 26.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.572 0.225 . . . . 0.0 111.304 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.498 ' O ' ' NZ ' ' B' 1105 ' ' LYS . 0.0 OUTLIER -83.1 64.64 7.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.218 0.532 . . . . 0.0 110.49 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.3 mmt -107.5 16.53 23.72 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.801 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -38.7 141.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.357 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.54 -70.43 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.831 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.5 m 58.99 77.27 0.31 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.8 m-20 -57.61 126.0 25.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.3 m -38.99 -18.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.835 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 80' ' ' ASP . 72.4 mm-40 -68.38 -36.38 79.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.936 0.398 . . . . 0.0 111.757 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -51.37 -39.25 56.73 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.418 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.462 ' OE2' ' NE2' ' B' 1101 ' ' GLN . 12.3 pt-20 -86.12 -4.33 59.15 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.3 mm -69.56 -73.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.883 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -60.29 -51.96 67.31 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 88' ' ' ALA . 3.1 pp20? -55.35 -37.6 67.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.007 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' N ' ' CD ' ' A' ' 87' ' ' GLU . . . -60.51 -22.31 63.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.932 0.396 . . . . 0.0 110.902 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -73.76 -48.61 30.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.304 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -55.29 -42.27 73.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.587 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.13 -44.75 97.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -69.33 -39.07 78.4 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.456 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.523 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 27.9 t0 -88.29 83.49 6.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.17 -48.67 80.75 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -90.9 5.06 50.14 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.66 0.267 . . . . 0.0 111.631 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.76 48.42 50.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.687 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -91.43 4.61 52.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.567 0.223 . . . . 0.0 110.697 179.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.435 ' N ' HD21 ' A' ' 97' ' ' ASN . . . 86.21 0.89 86.71 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.687 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 90.5 m-85 -139.19 152.28 47.26 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.838 0.827 . . . . 0.0 111.622 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -94.12 115.57 33.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.3 t -88.46 150.52 23.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.555 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.33 -45.79 83.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 119.167 0.894 . . . . 0.0 110.741 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.89 -40.86 66.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.984 0.421 . . . . 0.0 110.588 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -65.3 -41.35 94.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.956 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.71 -44.36 93.86 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.605 0.716 . . . . 0.0 111.207 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -45.7 -44.6 13.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.499 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -62.35 -29.0 70.15 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.605 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.6 t -58.32 -41.24 80.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.87 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.626 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.59 -46.54 63.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.179 0.99 . . . . 0.0 111.446 -177.214 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -56.97 -41.42 78.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.442 -1.708 . . . . 0.0 110.675 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -65.2 -40.8 94.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.768 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.535 ' O ' ' NH1' ' B' 1099 ' ' ARG . 76.6 mt -81.5 -14.5 56.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.788 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.11 30.33 57.4 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.566 -1.13 . . . . 0.0 110.366 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -86.49 -22.86 26.19 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.749 2.275 . . . . 0.0 110.75 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 43.43 60.83 2.44 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 122.31 1.052 . . . . 0.0 110.089 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.8 mt -79.06 148.22 32.53 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 113.417 -1.719 . . . . 0.0 112.637 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 62.2 p -82.46 174.99 10.57 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.383 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -57.83 -44.53 86.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -57.84 -50.67 72.51 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.56 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -68.3 -30.79 69.87 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.826 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.18 -42.46 95.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.396 0.617 . . . . 0.0 109.342 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 67.8 t0 -67.03 -37.77 84.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.722 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.28 -48.01 83.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.449 ' SD ' ' CD1' ' B' 1093 ' ' TRP . 20.2 mmm -54.96 -45.69 74.97 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.808 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 46.5 mm -59.62 -44.88 94.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.35 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -58.37 -40.11 81.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.371 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.69 -41.0 76.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.073 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.67 -16.99 24.86 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.5 t0 -73.41 87.97 1.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.457 0.646 . . . . 0.0 112.076 -177.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 tt -70.78 -14.79 18.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.531 1.158 . . . . 0.0 113.241 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.5 p-10 -142.9 144.6 32.5 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.31 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.53 52.49 1.16 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.709 -0.282 . . . . 0.0 113.175 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -91.14 -9.97 43.59 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.098 0.449 . . . . 0.0 110.119 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.66 2.09 74.31 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.162 -0.542 . . . . 0.0 114.293 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -134.57 154.27 51.56 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.413 0.607 . . . . 0.0 110.435 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.49 118.51 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.272 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 46.8 t30 -85.17 175.24 9.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.917 0.389 . . . . 0.0 110.962 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.509 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 74.2 t80 -61.59 -41.02 96.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.492 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 13.1 pt-20 -62.23 -44.45 96.53 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.839 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 139' ' ' GLU . 96.8 mt-10 -64.39 -37.66 88.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.892 0.377 . . . . 0.0 110.566 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -61.12 -45.63 93.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.594 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.65 -47.79 84.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.681 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -47.27 -50.04 22.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.115 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 91.7 mmm -70.04 -35.47 74.32 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.452 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 22.7 mmt -71.79 -43.21 66.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.861 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.628 -179.161 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B 1093 ' ' TRP . . . . . 0.449 ' CD1' ' SD ' ' A' ' 124' ' ' MET . 5.5 m95 -60.95 -57.5 12.36 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.587 0.708 . . . . 0.0 112.095 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B 1094 ' ' PHE . . . . . 0.452 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 17.5 m-85 -57.61 -43.99 85.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -40.05 -51.98 2.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.11 99.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.371 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.9 tp -57.23 -44.86 84.18 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.507 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 16.1 m120 -59.17 -47.32 85.74 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.691 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B 1099 ' ' ARG . . . . . 0.535 ' NH1' ' O ' ' A' ' 112' ' ' LEU . 79.5 mtp180 -65.16 -37.94 88.99 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 4.0 mm -60.58 -41.86 89.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.436 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B 1101 ' ' GLN . . . . . 0.462 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 81.8 mt-30 -52.0 -49.28 63.64 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.468 ' O ' ' N ' ' B' 1105 ' ' LYS . 21.3 m -64.98 -47.81 76.23 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.415 ' C ' ' O ' ' B' 1102 ' ' THR . 36.6 mm-40 -28.18 -59.86 0.12 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.758 1.266 . . . . 0.0 112.324 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.5 mt -83.94 -15.9 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 111.716 -2.493 . . . . 0.0 112.471 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 75' ' ' LYS . 66.1 tttm -59.39 -44.41 92.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.009 -1.477 . . . . 0.0 107.838 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 61.6 t -61.49 -48.98 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -66.36 -36.89 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.161 -177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.6 mttt -49.77 -38.11 32.68 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.661 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.03 62.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.27 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -63.35 -50.0 71.69 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 68.7 m-70 . . . . . 0 C--N 1.327 -0.399 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -178.264 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 119.003 -0.522 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -80.02 135.4 36.36 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.512 1.051 . . . . 0.0 110.055 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.8 tt0 -51.04 -60.2 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.029 0.918 . . . . 0.0 111.373 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -34.55 -38.03 0.07 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.933 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -70.35 -31.63 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.647 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.2 mt -57.22 -44.09 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 121.922 2.146 . . . . 0.0 105.355 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.55 -51.61 62.37 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.286 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -62.29 -46.48 88.6 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.411 0.624 . . . . 0.0 112.312 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -61.68 -40.67 95.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.9 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -52.19 -56.15 16.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.235 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -48.7 -42.69 35.73 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.102 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.36 -37.32 69.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.201 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.406 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 2.0 m-85 -56.42 -40.79 75.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -65.9 -15.61 63.1 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.428 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.34 -43.26 98.22 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -106.41 -14.51 15.06 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.871 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -75.37 96.11 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.252 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -67.96 -48.13 66.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.229 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.2 p-10 -102.89 14.48 31.86 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.96 48.72 1.41 Allowed Glycine 0 N--CA 1.468 0.83 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.091 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 36.1 p-10 -86.49 -4.77 59.22 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.71 0.29 . . . . 0.0 111.237 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.51 -1.55 79.25 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.8 p -139.41 156.11 47.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.22 0.534 . . . . 0.0 109.732 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -93.02 124.34 45.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 30' ' ' LYS . 1.2 t -115.0 165.52 12.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.8 -177.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.0 p -58.04 -39.52 78.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.439 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' H ' HG22 ' A' ' 28' ' ' THR . 62.4 tttp -58.67 -59.93 4.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.724 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -63.11 -30.71 71.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 119.598 -0.239 . . . . 0.0 111.51 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 tp -59.73 -56.39 22.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.501 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.84 -38.96 94.79 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 113.757 -1.565 . . . . 0.0 112.037 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.5 m -58.52 -53.44 58.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.107 1.454 . . . . 0.0 108.656 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.86 -46.23 87.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 118.991 0.814 . . . . 0.0 111.457 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.0 tpt -59.45 -41.84 90.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 120.112 1.324 . . . . 0.0 109.839 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -54.21 -41.98 69.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.602 0.715 . . . . 0.0 110.27 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -64.35 -22.75 67.06 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.944 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 tp -73.04 -3.41 26.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.666 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.09 13.56 58.76 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.547 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -107.75 155.41 20.24 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.66 0.73 . . . . 0.0 109.789 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' C ' HD21 ' A' ' 42' ' ' ASN . 0.3 OUTLIER -117.17 65.19 3.87 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.357 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.05 145.49 85.15 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.172 1.915 . . . . 0.0 112.215 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.1 p -79.86 167.25 20.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.092 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -57.8 -44.26 86.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.014 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.19 -23.15 20.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.489 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -66.79 -38.81 87.26 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.254 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.8 mp -56.08 -40.59 73.86 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -72.08 -57.08 4.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.057 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -54.13 -49.49 69.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 41.7 mmm -66.19 -52.23 50.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.9 mm -57.92 -48.21 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.476 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -56.71 -33.97 67.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -66.45 -40.05 89.19 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.668 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.25 -20.29 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.404 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 41.1 t0 -78.01 86.85 4.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -174.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.74 86.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.377 -1.738 . . . . 0.0 114.302 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 37.7 p-10 -87.62 -2.65 58.76 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.28 23.22 64.08 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 118.632 0.651 . . . . 0.0 112.721 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.42 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -88.04 2.02 52.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.393 0.597 . . . . 0.0 110.688 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.65 0.85 87.76 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 175.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.6 p -148.62 171.39 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.8 mt -115.21 129.2 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -104.33 -173.65 2.36 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -59.68 -48.58 94.98 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -177.287 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.66 -53.22 5.97 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.183 1.255 . . . . 0.0 111.66 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.62 -16.77 41.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.594 0.711 . . . . 0.0 110.312 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -76.08 -58.17 3.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.16 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' THR . 77.4 mt -56.99 -45.36 83.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.2 p -44.07 -49.76 8.69 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.459 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.4 mtm -67.55 -45.43 75.68 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.4 mmt -58.45 -38.78 78.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.95 76.62 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.683 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -94.87 -11.19 29.22 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.8 0.333 . . . . 0.0 111.453 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.45 67.44 8.49 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.278 0.561 . . . . 0.0 110.337 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 mmt -109.26 15.66 22.99 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.747 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -52.31 132.28 33.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.418 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -106.63 159.4 16.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.959 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.437 ' OG1' ' OE1' ' A' ' 83' ' ' GLU . 0.7 OUTLIER -144.9 136.08 25.03 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 82' ' ' GLU . 41.8 t0 -61.55 116.16 4.5 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 174.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.6 m -36.94 -19.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 80' ' ' ASP . 94.8 mt-10 -69.02 -35.21 76.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.437 ' OE1' ' OG1' ' A' ' 79' ' ' THR . 41.5 tt0 -48.7 -38.37 21.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.487 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -86.49 -17.66 33.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.305 0.574 . . . . 0.0 111.761 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 mm -61.37 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.116 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -62.21 -40.8 97.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.98 -42.11 97.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.811 0.338 . . . . 0.0 111.679 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.98 -19.51 52.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -75.44 -49.05 20.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.985 0.421 . . . . 0.0 111.233 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -55.49 -42.52 74.51 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.607 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.7 -44.47 96.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -69.19 -38.25 78.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.553 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -85.94 81.22 8.61 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -58.32 -48.99 78.77 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -176.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.2 p30 -90.99 5.53 48.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.471 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.39 48.33 48.55 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -92.16 6.81 45.2 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.597 0.237 . . . . 0.0 110.603 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.62 1.42 89.14 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -141.12 154.05 45.71 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.893 0.854 . . . . 0.0 111.725 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.7 mt -95.09 115.85 35.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 p -90.58 153.05 20.62 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.31 82.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.28 0.945 . . . . 0.0 110.946 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.41 -43.81 68.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.946 0.403 . . . . 0.0 110.711 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.31 -42.54 99.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.596 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 108' ' ' VAL . 6.2 tt -63.93 -45.28 89.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.226 0.536 . . . . 0.0 111.608 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -41.99 -45.01 3.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.61 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.409 ' O ' ' OG1' ' A' ' 110' ' ' THR . 56.9 t-80 -59.73 -26.88 66.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.714 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 105' ' ' LEU . 86.6 t -57.95 -42.97 83.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.671 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.449 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.17 -49.22 61.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.15 0.976 . . . . 0.0 111.89 -177.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 69.8 p -52.65 -38.89 61.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.622 -1.627 . . . . 0.0 110.901 -177.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.42 ' N ' HD21 ' A' ' 111' ' ' ASN . 1.8 m120 -65.76 -39.08 90.69 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.495 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.2 mt -83.95 -12.96 54.57 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.76 38.24 50.29 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.353 -1.248 . . . . 0.0 110.196 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -89.45 -22.79 22.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.913 2.357 . . . . 0.0 111.118 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt 45.01 58.41 4.05 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.611 1.196 . . . . 0.0 110.065 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.411 ' O ' ' CD2' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -75.63 149.74 38.14 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 112.952 -1.931 . . . . 0.0 112.982 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 33.4 p -84.07 174.67 10.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 110.349 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.86 -44.73 74.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.3 -41.57 72.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.123 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.17 -28.64 65.48 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.519 -0.472 . . . . 0.0 112.037 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 49.2 t -64.03 -43.68 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.297 0.57 . . . . 0.0 109.63 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -74.62 -36.15 62.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.204 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -60.0 -54.11 49.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.8 mmm -51.27 -52.15 47.64 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.01 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -56.22 -42.58 73.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.582 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -60.02 -36.97 78.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.643 0.259 . . . . 0.0 111.428 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -57.62 -40.78 79.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.717 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.71 -15.01 25.67 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.6 t0 -77.57 82.73 3.99 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.642 0.734 . . . . 0.0 111.682 -177.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.7 pt -70.89 -7.56 9.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 122.622 1.201 . . . . 0.0 113.351 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.9 p-10 -144.45 143.32 30.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 112.458 -2.156 . . . . 0.0 109.171 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.13 51.46 1.67 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 122.202 -0.311 . . . . 0.0 113.41 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -90.72 -10.59 42.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.274 0.537 . . . . 0.0 109.835 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.6 -0.45 64.89 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.54 0.576 . . . . 0.0 114.54 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -132.73 153.17 51.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.339 0.57 . . . . 0.0 110.471 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.45 117.96 45.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.232 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.452 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 53.8 t30 -83.99 173.07 11.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.934 0.397 . . . . 0.0 110.949 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.452 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 80.5 t80 -61.16 -39.56 90.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.998 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.23 -44.51 96.39 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.854 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.98 -37.82 88.82 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.626 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -61.21 -44.87 96.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.706 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.7 t -65.1 -47.42 87.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.365 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -50.58 -42.74 56.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.736 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.2 mmt -74.64 -40.13 61.67 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.5 mmt -77.2 -44.57 29.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.884 -0.144 . . . . 0.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.466 0.335 0 CA-C-O 120.587 0.232 . . . . 0.0 111.335 -179.197 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 11.1 mt . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.68 -56.6 18.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.289 0.566 . . . . 0.0 112.357 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B 1094 ' ' PHE . . . . . 0.528 ' CE2' ' OD1' ' B' 1098 ' ' ASN . 11.8 t80 -59.83 -48.47 81.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -174.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -39.33 -51.92 2.04 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.0 -39.39 96.99 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.027 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.1 tp -57.15 -41.95 80.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 118.322 1.061 . . . . 0.0 109.559 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B 1098 ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' B' 1094 ' ' PHE . 6.2 m-20 -59.85 -51.58 69.11 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 76.0 mmt-85 -65.47 -39.81 92.41 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.21 -41.35 83.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.422 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -50.4 -45.36 55.53 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.524 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.3 m -63.69 -47.98 78.98 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.434 ' C ' ' O ' ' B' 1102 ' ' THR . 23.9 mt-30 -27.64 -57.54 0.1 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.61 1.195 . . . . 0.0 112.31 -176.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.8 mt -84.77 -13.81 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.437 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.524 ' N ' ' O ' ' B' 1102 ' ' THR . 38.3 ttmt -59.85 -45.66 91.71 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 118.181 -1.408 . . . . 0.0 108.069 176.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.6 t -60.52 -49.78 83.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.7 m -65.8 -36.0 76.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.967 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 86.6 mttt -50.12 -37.69 35.33 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.608 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.59 -45.62 63.21 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.202 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.99 -49.65 73.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 69.3 m-70 . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -178.351 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 119.462 -0.304 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 m -78.92 136.19 37.19 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.386 0.994 . . . . 0.0 110.138 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 9' ' ' ILE . 9.4 tm-20 -51.43 -55.47 18.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.893 0.854 . . . . 0.0 111.089 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -37.62 -36.89 0.19 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.648 -1.615 . . . . 0.0 110.576 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -70.25 -32.4 70.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 118.45 -0.785 . . . . 0.0 110.723 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.7 mt -59.54 -45.26 94.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 175.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.23 -49.4 64.05 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.617 -177.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.36 -46.56 88.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.359 0.599 . . . . 0.0 111.923 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -62.83 -39.3 93.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.812 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -52.64 -53.2 50.26 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.56 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.26 -39.77 60.81 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.059 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.67 70.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.084 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.441 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 3.8 m-85 -58.49 -40.85 83.92 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.5 m -65.29 -14.61 61.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.782 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.22 -41.64 94.25 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -105.64 -13.56 15.54 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -74.61 93.14 2.48 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.26 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -69.28 -47.24 65.14 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.96 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.5 p-10 -102.19 13.64 34.13 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.945 -0.472 . . . . 0.0 112.195 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.98 46.64 1.23 Allowed Glycine 0 CA--C 1.533 1.199 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.996 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -86.18 -4.19 59.12 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.637 -0.331 . . . . 0.0 110.957 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.12 84.51 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.9 p -137.3 152.13 49.42 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.105 0.479 . . . . 0.0 109.982 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.93 124.36 45.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.7 p -113.48 164.52 13.51 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.941 0.877 . . . . 0.0 112.194 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 p -59.2 -38.25 79.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.541 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.413 ' CB ' ' HZ3' ' A' ' 30' ' ' LYS . 6.2 ttpm? -62.1 -56.63 16.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.556 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -64.24 -30.23 71.29 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.37 -52.25 65.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.264 1.031 . . . . 0.0 109.515 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.85 -35.61 87.26 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.865 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.22 -53.14 61.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.09 1.445 . . . . 0.0 108.661 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.44 -45.66 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 120.731 -1.23 . . . . 0.0 111.636 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.6 ttt -59.06 -40.91 86.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 120.064 1.302 . . . . 0.0 109.643 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -53.16 -37.02 61.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.556 0.693 . . . . 0.0 110.48 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.5 t -62.39 -20.25 64.25 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.735 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.4 mt -75.82 2.9 11.09 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.1 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.58 16.16 74.09 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.91 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -109.55 160.31 16.35 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.582 0.691 . . . . 0.0 109.872 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -112.82 69.2 1.1 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.085 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.7 141.84 67.81 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.845 1.697 . . . . 0.0 112.181 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -81.58 157.36 24.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.029 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.0 -42.13 68.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.762 0.315 . . . . 0.0 110.572 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.9 -25.64 43.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.346 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -65.63 -39.48 91.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.816 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.2 mp -56.06 -40.96 74.34 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.492 0.663 . . . . 0.0 109.847 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -69.12 -56.49 7.53 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.655 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -53.13 -48.69 67.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.412 ' SD ' ' NE2' ' B' 1111 ' ' HIS . 1.5 mtm -71.44 -44.51 64.68 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.1 mm -58.57 -48.41 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -56.58 -34.34 67.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -66.11 -40.41 90.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.669 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -85.52 -21.43 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.275 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.445 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.5 t0 -78.45 86.12 4.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -175.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.28 89.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.179 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 36.4 p-10 -85.58 -3.25 58.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.62 23.73 61.12 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 121.872 -0.518 . . . . 0.0 113.029 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.4 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.1 p-10 -87.51 4.65 42.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.046 0.423 . . . . 0.0 110.348 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.445 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.03 0.66 89.7 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.871 -0.681 . . . . 0.0 114.38 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.4 p -147.79 167.49 24.6 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.2 mt -112.62 128.4 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -103.82 -174.57 2.58 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.66 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.441 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.63 -47.28 99.03 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -176.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -56.61 -51.38 9.26 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.415 1.41 . . . . 0.0 111.354 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.95 -20.51 65.3 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.372 0.606 . . . . 0.0 111.097 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -71.24 -58.33 3.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.871 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.76 -44.3 86.06 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 m -40.5 -59.09 1.42 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.665 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -64.8 -41.6 95.68 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -176.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 98.2 mmm -59.44 -39.6 84.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.36 78.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.286 0.235 . . . . 0.0 111.499 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -96.65 -8.48 31.48 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.228 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 67.18 7.24 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.169 0.509 . . . . 0.0 110.24 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 19.8 mmt -108.54 16.41 23.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.782 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -52.67 130.99 34.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.674 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 54.3 p-10 -105.57 148.07 27.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.781 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.1 p -133.65 134.1 42.75 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 82' ' ' GLU . 22.7 t0 -62.05 117.17 5.62 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.9 m -37.45 -20.49 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.615 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 80' ' ' ASP . 71.3 mm-40 -69.36 -34.32 74.4 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 111.616 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -49.1 -37.88 22.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.596 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -86.87 -19.28 29.15 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.132 0.491 . . . . 0.0 111.671 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.36 -74.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.853 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -62.39 -40.58 96.93 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.98 -40.91 97.23 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.665 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.07 -21.19 63.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.104 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -71.44 -50.55 30.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.091 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -55.28 -43.03 74.37 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.79 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.37 -44.13 94.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -68.22 -38.21 81.66 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.244 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -85.28 81.51 8.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -58.81 -48.76 80.17 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -91.29 4.56 52.03 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 122.236 -0.29 . . . . 0.0 111.274 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.13 46.22 56.56 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -90.08 6.75 41.11 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.679 0.276 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.26 2.0 89.33 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -140.14 152.52 46.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.747 0.784 . . . . 0.0 111.688 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -93.46 114.84 30.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -88.03 150.0 23.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.299 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.71 -45.39 85.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.17 0.896 . . . . 0.0 110.586 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.74 -40.66 72.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.912 0.386 . . . . 0.0 110.568 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.68 -42.54 91.17 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.261 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 108' ' ' VAL . 6.8 tt -63.4 -44.9 93.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.309 0.576 . . . . 0.0 111.052 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -41.25 -44.18 2.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.63 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.25 -25.8 65.95 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.616 0.246 . . . . 0.0 110.998 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 105' ' ' LEU . 67.7 t -58.59 -43.14 86.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.551 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.646 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.26 -45.92 65.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.911 0.863 . . . . 0.0 111.554 -176.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.6 p -62.1 -36.22 81.07 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.178 -176.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.554 ' ND2' ' N ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -65.09 -41.05 95.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.66 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.554 ' N ' ' ND2' ' A' ' 111' ' ' ASN . 0.5 OUTLIER -89.01 -8.6 53.73 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -178.678 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.87 40.41 36.3 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.532 -1.149 . . . . 0.0 111.08 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -89.96 -25.87 20.69 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 121.036 2.418 . . . . 0.0 110.741 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 46.52 63.42 1.9 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.242 1.02 . . . . 0.0 110.494 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 82.3 mt -81.99 147.63 29.09 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.255 -1.793 . . . . 0.0 113.568 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 81.4 p -83.16 175.74 9.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -58.29 -46.07 86.77 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -57.54 -48.32 79.62 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -69.15 -30.81 69.13 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.891 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.3 t -63.75 -41.75 93.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.483 0.659 . . . . 0.0 109.297 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -67.72 -36.98 81.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.299 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -59.65 -51.48 69.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 91.6 mtp -57.1 -43.33 82.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.001 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.0 mm -59.56 -44.29 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.559 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.78 -35.65 78.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 111.463 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.21 -40.71 82.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.712 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.06 -20.61 21.87 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.679 0.276 . . . . 0.0 111.637 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 19.3 t0 -77.63 83.16 4.02 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.469 0.652 . . . . 0.0 112.195 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.6 pt -71.02 -9.66 13.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.496 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 54.7 p-10 -142.8 144.1 32.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 112.621 -2.082 . . . . 0.0 109.054 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.28 51.04 1.7 Allowed Glycine 0 CA--C 1.532 1.147 0 CA-C-N 116.741 -0.209 . . . . 0.0 113.533 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -90.48 -9.87 45.77 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.159 0.48 . . . . 0.0 110.135 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.95 0.13 68.32 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.873 -0.679 . . . . 0.0 114.376 176.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -133.78 154.18 51.18 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.206 0.503 . . . . 0.0 110.606 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.2 t -101.14 118.03 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -84.39 174.51 10.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.938 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.15 -40.52 94.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.292 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -62.35 -44.26 96.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.68 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.47 -37.2 86.7 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.532 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -61.26 -45.22 95.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.135 0.493 . . . . 0.0 110.69 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.45 -47.21 87.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.286 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -49.14 -46.5 45.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.085 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.4 mmt -71.97 -36.88 69.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.483 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 24.5 mmt -71.85 -44.21 64.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.785 -0.189 . . . . 0.0 110.606 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.7 m . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.503 -179.4 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 8.2 m95 -60.0 -58.86 6.72 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.792 0.806 . . . . 0.0 111.973 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B 1094 ' ' PHE . . . . . 0.483 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 29.3 m-85 -59.81 -46.66 88.53 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -174.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -42.2 -52.06 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.68 -40.97 99.49 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.779 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 56.8 tp -57.57 -45.28 85.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.196 0.998 . . . . 0.0 109.73 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 15.3 m120 -61.33 -51.75 67.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -65.66 -38.81 90.36 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 88.6 mt -60.96 -42.35 92.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.765 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -52.11 -45.33 64.87 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.537 ' O ' ' N ' ' B' 1105 ' ' LYS . 90.9 m -63.1 -48.01 80.4 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.699 -0.626 . . . . 0.0 111.502 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.449 ' C ' ' O ' ' B' 1102 ' ' THR . 24.8 mt-30 -27.97 -55.91 0.11 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.541 1.163 . . . . 0.0 112.65 -176.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.0 mt -83.53 -15.04 11.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 112.165 -2.289 . . . . 0.0 112.602 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.537 ' N ' ' O ' ' B' 1102 ' ' THR . 64.0 tttp -59.53 -44.41 93.2 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 118.063 -1.455 . . . . 0.0 108.259 176.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.5 t -61.39 -48.85 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.78 -35.98 76.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.198 -178.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 92.8 mttt -49.92 -36.72 28.73 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.796 0.726 . . . . 0.0 109.756 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.76 -45.75 70.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.247 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -63.07 -48.91 76.64 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.229 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B 1111 ' ' HIS . . . . . 0.412 ' NE2' ' SD ' ' A' ' 51' ' ' MET . 83.3 m-70 . . . . . 0 C--N 1.328 -0.334 0 O-C-N 122.119 -0.363 . . . . 0.0 111.963 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.7 tp . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 119.158 -0.448 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -73.75 141.13 46.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.203 0.911 . . . . 0.0 109.653 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.0 tt0 -45.26 -61.68 1.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.064 0.935 . . . . 0.0 110.375 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -34.1 -36.14 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.627 -1.624 . . . . 0.0 111.18 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.621 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 1.2 tm0? -69.11 -38.75 79.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.414 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.1 mt -59.68 -44.39 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.431 ' O ' ' OE2' ' A' ' 14' ' ' GLU . . . -53.31 -52.16 60.03 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.238 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.53 -45.49 93.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.531 0.682 . . . . 0.0 112.596 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.621 ' CD1' ' NE2' ' A' ' 8' ' ' GLN . 5.2 m-85 -62.67 -38.55 90.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.705 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -53.03 -53.8 44.81 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.432 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 10' ' ' ALA . 1.9 mp0 -48.38 -41.31 28.51 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.199 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.53 -39.06 72.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.237 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -57.64 -42.0 82.56 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 m -64.88 -14.54 59.95 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.469 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.63 -43.15 97.67 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -105.96 -13.34 15.52 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -74.34 93.77 2.44 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.263 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -68.78 -48.0 64.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.791 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.0 p-10 -102.61 13.74 33.72 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.66 48.02 1.26 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.157 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -85.32 -4.33 59.12 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.749 0.309 . . . . 0.0 110.904 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.49 -2.3 82.75 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.7 p -137.37 152.52 49.76 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.467 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 mp -91.81 123.59 43.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.0 p -113.76 166.18 11.81 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.539 0.685 . . . . 0.0 112.418 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.3 p -58.99 -37.3 76.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.372 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -61.22 -60.62 3.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.263 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -61.1 -30.45 70.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.518 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.76 -53.68 54.44 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.727 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.52 -37.97 94.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 113.786 -1.552 . . . . 0.0 112.242 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.68 -52.0 67.56 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.782 1.291 . . . . 0.0 108.919 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.428 ' O ' ' OG ' ' A' ' 38' ' ' SER . 46.2 t -58.17 -45.26 88.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 119.303 0.956 . . . . 0.0 111.275 -177.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 28.2 ttt -59.31 -39.33 82.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 119.805 1.184 . . . . 0.0 109.917 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -52.29 -39.88 61.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.738 0.78 . . . . 0.0 110.259 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 41.1 p -62.52 -20.64 64.83 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.21 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.95 -0.33 15.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.959 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.06 25.39 44.93 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.183 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -124.97 165.12 18.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.317 0.558 . . . . 0.0 109.772 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -125.62 77.09 69.68 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.278 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.37 147.87 72.52 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.99 1.794 . . . . 0.0 112.119 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.4 p -79.4 162.76 25.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.103 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -57.19 -43.15 82.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.996 -179.177 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.533 ' H ' ' CD ' ' A' ' 45' ' ' GLU . . . -57.19 -25.32 58.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.368 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -65.26 -40.72 94.33 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.088 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.411 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.3 mp -55.06 -38.63 68.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.565 0.698 . . . . 0.0 109.46 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -72.97 -55.42 6.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.187 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.41 -49.61 69.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.414 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 63.7 mtp -66.9 -48.98 67.03 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.4 mm -58.54 -45.23 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.433 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -56.42 -35.42 67.8 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.57 -40.63 89.07 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.507 -0.477 . . . . 0.0 112.076 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.4 t -85.53 -21.74 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.651 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.0 t0 -78.69 86.75 4.63 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -175.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.78 87.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.367 -1.742 . . . . 0.0 114.27 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.471 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 39.5 p-10 -86.14 -2.95 58.82 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.26 23.17 63.99 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.548 0.613 . . . . 0.0 112.795 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.471 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.2 p-10 -88.04 2.16 52.53 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.392 0.596 . . . . 0.0 110.66 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.503 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.6 1.75 89.05 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.701 -0.625 . . . . 0.0 114.586 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.4 p -145.78 166.56 25.55 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.1 mm -109.7 126.5 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.85 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -102.78 -176.98 3.25 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.907 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.93 -47.39 98.77 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.21 -51.39 9.53 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.1 1.2 . . . . 0.0 111.613 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.72 -18.33 53.77 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.648 0.737 . . . . 0.0 110.586 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -77.17 -56.75 4.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.441 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.4 mt -58.49 -46.16 87.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.7 p -46.24 -47.33 18.04 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.104 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.7 mtp -66.83 -45.45 78.23 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.6 mmt -59.78 -39.74 85.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.58 78.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.242 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 -94.76 -10.66 30.88 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.727 0.299 . . . . 0.0 111.561 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.31 68.22 8.64 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.13 0.49 . . . . 0.0 110.613 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.5 mmt -107.26 18.62 21.41 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.389 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -50.17 130.43 22.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.239 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -93.57 106.02 18.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.799 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.515 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 2.8 m -90.26 122.08 32.85 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 82' ' ' GLU . 90.3 m-20 -69.66 112.14 5.93 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.0 m -37.58 -21.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.694 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.4 mp0 -68.88 -37.24 78.91 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -47.69 -35.67 9.99 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.266 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -88.97 -17.45 29.45 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.307 0.575 . . . . 0.0 112.039 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 mm -60.87 -74.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.959 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -62.61 -39.1 92.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -62.7 -40.88 98.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.371 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.59 -19.53 62.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -72.92 -50.77 21.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.955 0.407 . . . . 0.0 111.317 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -55.5 -42.48 74.51 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.42 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.23 -43.73 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -68.29 -38.97 82.21 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.475 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -89.22 84.03 6.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.7 -46.19 91.33 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -92.15 4.41 53.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.294 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.43 50.35 48.01 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -92.24 5.72 49.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.637 0.256 . . . . 0.0 110.576 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.98 0.76 89.76 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -139.55 153.07 47.35 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.545 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.46 115.32 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.4 m -89.82 153.23 20.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.35 -47.79 80.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 119.039 0.836 . . . . 0.0 110.986 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.01 -40.17 60.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.994 0.426 . . . . 0.0 110.461 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -66.22 -41.43 90.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.383 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 tp -63.5 -46.33 86.61 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.37 0.605 . . . . 0.0 111.422 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -44.22 -36.89 2.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.753 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.432 ' O ' ' OG1' ' A' ' 110' ' ' THR . 75.2 t60 -69.33 -27.6 65.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.717 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.8 t -58.76 -43.08 87.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.03 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.7 mmt -51.89 -49.69 62.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.219 1.009 . . . . 0.0 111.879 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 65.9 p -52.78 -37.14 59.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.245 -1.798 . . . . 0.0 110.817 -176.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -66.3 -39.6 89.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.949 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.0 mt -82.83 -13.81 55.5 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.49 37.6 53.06 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.26 -1.3 . . . . 0.0 110.058 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -85.12 -20.57 30.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 121.021 2.411 . . . . 0.0 110.976 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt 42.38 50.6 4.68 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.723 1.249 . . . . 0.0 110.367 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.23 153.47 39.42 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.957 -1.928 . . . . 0.0 112.701 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 61.3 p -85.64 174.14 9.63 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -55.93 -43.97 77.88 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -55.59 -41.87 73.99 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.051 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.09 -29.95 68.15 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.979 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 43.8 t -62.75 -43.95 99.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.466 0.651 . . . . 0.0 109.593 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -72.83 -36.45 67.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.994 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -59.22 -54.89 41.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 83.9 mtp -56.74 -43.25 80.49 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.645 -1.162 . . . . 0.0 109.812 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.8 mt -59.28 -43.74 90.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.243 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -59.26 -39.44 82.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.828 0.347 . . . . 0.0 111.106 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.31 -41.28 84.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.187 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.65 -24.88 21.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.1 t0 -71.77 88.73 1.01 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.651 0.739 . . . . 0.0 111.933 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 72.3 mt -70.06 -15.88 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.703 1.24 . . . . 0.0 113.208 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 44.7 p-10 -141.53 144.4 34.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 112.295 -2.23 . . . . 0.0 109.522 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.59 52.28 1.17 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.604 -0.331 . . . . 0.0 112.947 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 32.1 p-10 -91.37 -9.91 43.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.187 0.494 . . . . 0.0 110.19 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.82 2.49 76.9 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.218 -0.515 . . . . 0.0 114.268 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -135.04 154.5 51.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 117.198 0.499 . . . . 0.0 110.445 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.5 t -100.9 118.94 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.357 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -84.55 174.44 10.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.85 0.357 . . . . 0.0 110.816 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -61.24 -40.3 93.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.24 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.1 -44.51 96.5 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.34 -38.49 90.28 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.763 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -61.16 -45.4 94.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.054 0.454 . . . . 0.0 110.849 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.9 t -65.23 -46.21 91.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.353 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -49.8 -45.02 49.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.611 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.6 mmt -72.7 -38.44 67.51 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.4 mmt -71.93 -46.89 55.95 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.341 -0.144 . . . . 0.0 110.909 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.467 0.393 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.725 -179.309 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.6 m95 -62.34 -54.57 38.56 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.57 0.7 . . . . 0.0 112.244 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 8.3 t80 -59.44 -46.6 88.3 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 18.6 mmm-85 -40.69 -51.3 3.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.28 -39.58 97.4 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.33 -44.03 83.9 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.697 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 39.7 t30 -59.46 -49.78 76.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.631 -1.168 . . . . 0.0 114.118 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -65.58 -37.83 87.78 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.7 -41.68 89.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.889 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -51.39 -46.02 62.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B 1102 ' ' THR . . . . . 0.527 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.5 m -63.89 -48.18 77.68 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.886 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B 1103 ' ' GLN . . . . . 0.436 ' C ' ' O ' ' B' 1102 ' ' THR . 83.8 mt-30 -27.47 -56.91 0.1 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.638 1.209 . . . . 0.0 112.569 -176.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.3 mt -85.84 -14.17 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.453 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B 1105 ' ' LYS . . . . . 0.527 ' N ' ' O ' ' B' 1102 ' ' THR . 78.5 tttt -60.32 -45.93 91.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.012 176.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 96.1 t -61.57 -49.06 85.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.7 m -66.04 -35.89 76.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.013 -177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B 1108 ' ' LYS . . . . . 0.515 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 87.0 mttt -49.62 -38.65 32.89 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.571 0.7 . . . . 0.0 109.727 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.71 -45.92 67.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.355 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -63.41 -49.4 73.91 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 68.1 m-70 . . . . . 0 C--N 1.33 -0.249 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.621 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.524 ' OD1' ' NE2' ' A' ' 3' ' ' GLN . 31.0 p-10 -91.32 3.43 54.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.746 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 2' ' ' ASP . 11.0 mp0 -102.04 104.02 14.65 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.98 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.4 mt -113.95 -15.34 12.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.563 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.5 p -80.03 136.98 36.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.324 0.965 . . . . 0.0 110.32 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 9' ' ' ILE . 46.3 tt0 -51.86 -53.65 38.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 122.072 0.939 . . . . 0.0 110.201 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -32.84 -36.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.108 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.52 ' OE1' ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -69.62 -37.77 76.96 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.286 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.3 mt -58.58 -44.9 90.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.67 -49.23 62.78 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.108 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.56 -46.37 90.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.339 0.59 . . . . 0.0 111.535 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.52 ' CD2' ' OE1' ' A' ' 8' ' ' GLN . 28.2 m-85 -58.41 -42.37 87.05 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.781 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -49.21 -58.1 5.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.378 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.48 -44.97 62.63 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.031 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.22 -38.16 70.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.222 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.16 -41.84 84.65 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 t -64.41 -15.78 61.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.421 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.08 -42.82 96.81 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -105.64 -14.52 15.24 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -75.45 94.94 3.18 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.137 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -68.25 -47.43 67.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.226 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.2 p-10 -102.38 14.18 32.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.46 46.17 1.03 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.035 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -85.35 -4.0 59.02 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.694 -0.298 . . . . 0.0 110.961 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.38 -2.0 82.71 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.5 p -137.51 152.24 49.29 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.103 0.478 . . . . 0.0 109.891 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.64 124.53 45.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.9 p -114.31 165.27 12.87 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.801 0.81 . . . . 0.0 112.393 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.4 p -58.85 -35.82 73.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.715 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.59 -61.4 2.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.565 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.92 -30.48 71.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.795 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.16 -55.73 30.3 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.015 0.912 . . . . 0.0 109.667 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.65 -37.69 93.87 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.975 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 m -58.75 -53.03 63.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 119.047 1.423 . . . . 0.0 108.624 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.427 ' O ' ' OG ' ' A' ' 38' ' ' SER . 46.2 t -57.0 -46.47 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 121.228 -0.92 . . . . 0.0 111.523 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.6 ttt -59.0 -39.93 83.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 120.054 1.297 . . . . 0.0 109.461 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -51.56 -38.36 54.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.531 0.681 . . . . 0.0 110.183 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 25.1 p -63.54 -21.08 66.14 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.376 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.73 -1.72 20.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.536 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.34 13.77 67.57 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.127 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -107.14 158.01 17.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 117.611 0.705 . . . . 0.0 109.854 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -114.74 64.77 1.58 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.286 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.05 143.29 94.78 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.19 1.927 . . . . 0.0 112.156 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.631 ' HG1' ' H ' ' A' ' 45' ' ' GLU . 7.9 t -80.58 166.74 20.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.438 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.631 ' H ' ' HG1' ' A' ' 44' ' ' THR . 80.6 tt0 -58.15 -44.12 87.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.72 -24.2 33.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.558 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -65.63 -39.15 91.16 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.069 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.2 mp -56.42 -41.59 76.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.463 0.649 . . . . 0.0 109.759 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.25 -56.67 6.2 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.757 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.45 -48.81 71.29 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 41.2 mmm -65.85 -50.17 65.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.9 mm -59.44 -47.69 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.672 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -56.45 -34.97 67.35 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -66.18 -40.01 90.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.8 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.404 ' CG2' ' CD2' ' B' 1110 ' ' PHE . 71.4 t -86.35 -20.37 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.503 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.3 t0 -78.49 85.93 4.55 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.21 -38.0 87.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.326 -1.761 . . . . 0.0 114.066 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 36.8 p-10 -86.26 -2.89 58.79 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.98 23.55 63.82 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 118.476 0.58 . . . . 0.0 112.927 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.419 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.4 p-10 -87.36 2.38 50.51 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.234 0.517 . . . . 0.0 110.578 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.526 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.2 1.39 89.54 Favored Glycine 0 CA--C 1.521 0.442 0 O-C-N 121.585 -0.697 . . . . 0.0 114.448 175.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.0 p -145.85 165.33 29.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.9 mm -108.91 126.64 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -103.38 -176.33 3.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -57.3 -59.11 13.81 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -47.25 -49.62 12.6 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.37 1.38 . . . . 0.0 111.243 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.57 -19.77 62.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.348 0.594 . . . . 0.0 110.641 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 65' ' ' PHE . 22.7 t80 -74.55 -58.24 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.962 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.18 -45.21 83.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -44.24 -49.88 9.1 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.61 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 72.8 mtm -66.98 -44.5 80.28 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.656 -0.417 . . . . 0.0 112.026 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.8 mmt -57.62 -39.42 76.88 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.46 77.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.548 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -95.74 -9.05 32.82 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.434 ' C ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -85.98 63.84 8.25 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.154 0.502 . . . . 0.0 110.685 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.56 17.24 22.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.41 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -48.31 135.02 14.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.175 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -89.41 108.94 19.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.827 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -93.75 119.68 33.04 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 82' ' ' GLU . 36.8 t0 -67.02 112.89 4.61 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 174.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 m -37.68 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.522 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 80' ' ' ASP . 95.3 mt-10 -72.09 -31.51 66.15 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -50.38 -39.14 45.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.878 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' OE2' ' CG ' ' B' 1101 ' ' GLN . 9.2 pt-20 -89.53 -11.04 43.98 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.4 mm -62.43 -74.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.798 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -62.01 -40.75 96.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.91 -41.3 97.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.571 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.41 -21.26 63.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -73.81 -48.41 31.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -54.95 -40.55 70.09 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.815 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.3 t -65.54 -44.1 94.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -69.02 -38.7 79.34 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.264 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -85.55 81.11 8.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.37 -49.4 77.36 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -176.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -91.32 4.83 51.38 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.175 -0.328 . . . . 0.0 111.168 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.61 48.13 50.39 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -90.22 6.25 43.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.674 0.273 . . . . 0.0 110.745 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.18 2.13 85.91 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -142.98 156.18 44.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.751 0.786 . . . . 0.0 111.593 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -94.08 115.37 32.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 t -89.05 151.1 22.45 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.23 -46.54 82.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.201 0.91 . . . . 0.0 110.723 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.42 -40.59 65.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.951 0.405 . . . . 0.0 110.554 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.22 -41.13 94.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.168 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.19 -44.64 94.82 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.614 0.721 . . . . 0.0 110.949 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -44.55 -44.01 8.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.548 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.92 -29.71 70.99 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 122.456 -0.152 . . . . 0.0 110.747 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.5 t -57.64 -41.32 79.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.837 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.5 mtt -50.84 -45.54 59.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.075 0.94 . . . . 0.0 111.526 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 m -56.68 -41.41 77.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.537 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -66.55 -41.55 88.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.132 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 74.8 mt -80.87 -16.36 53.86 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.24 30.52 58.67 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.51 -23.1 27.87 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.962 2.381 . . . . 0.0 110.481 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.9 tptp 45.02 60.37 3.01 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.067 0.937 . . . . 0.0 110.326 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.9 mt -79.95 147.2 31.71 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.566 -1.652 . . . . 0.0 112.463 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 81.5 p -81.99 175.35 10.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.468 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -57.41 -44.79 84.86 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -56.49 -47.91 78.28 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.196 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 123' ' ' GLU . 64.3 mm-40 -71.35 -28.44 64.06 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.73 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.4 t -63.91 -42.43 95.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.669 0.747 . . . . 0.0 109.288 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.53 -35.09 65.5 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.382 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 120' ' ' GLU . 82.5 tt0 -59.66 -51.28 70.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 93.0 mtp -56.08 -44.47 78.98 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.35 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.74 -43.66 88.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.189 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -58.63 -39.45 80.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.953 0.406 . . . . 0.0 111.212 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.37 -40.92 79.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.059 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.41 -20.15 22.1 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.9 t0 -72.88 87.69 1.32 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.301 0.572 . . . . 0.0 112.072 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 tt -70.5 -15.18 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.374 1.083 . . . . 0.0 113.242 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.7 p-10 -142.65 144.78 32.92 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 112.322 -2.217 . . . . 0.0 109.172 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.1 52.27 1.35 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-N 116.736 -0.211 . . . . 0.0 113.255 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -90.79 -9.21 47.37 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.973 0.387 . . . . 0.0 110.013 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.34 1.02 68.41 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.995 -0.621 . . . . 0.0 114.262 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -134.43 153.87 51.69 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.395 0.598 . . . . 0.0 110.422 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.68 118.38 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.366 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.454 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 60.6 t30 -84.44 174.55 9.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 0.0 111.149 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.454 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 72.0 t80 -61.05 -40.8 95.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.202 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.64 -44.6 96.68 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.701 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.94 -35.64 81.81 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.599 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -60.75 -44.75 96.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.076 0.465 . . . . 0.0 110.574 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.11 -47.01 89.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.365 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.405 ' O ' ' CG2' ' A' ' 146' ' ' THR . 52.6 tt0 -49.34 -40.73 36.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.78 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 mmt -74.9 -38.58 61.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.1 mmt -80.69 4.5 18.59 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.168 0.587 . . . . 0.0 111.18 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 147' ' ' ALA . 5.0 t -79.04 35.91 0.27 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.303 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 146' ' ' THR . . . -47.16 -97.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.217 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.1 tttp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.441 -179.574 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 55.9 tp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -77.31 145.88 37.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.494 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.53 ' C ' ' H ' ' B' 1090 ' ' GLN . 55.0 ttp180 60.96 41.12 14.57 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -63.78 3.83 1.33 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.53 ' H ' ' C ' ' B' 1088 ' ' ARG . 1.3 mp0 -62.34 -44.05 97.38 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.68 -55.41 15.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.975 0.417 . . . . 0.0 111.784 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 9.5 mt -56.16 -54.74 41.59 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.481 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 4.6 m95 -60.77 -57.86 10.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.681 0.753 . . . . 0.0 112.127 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1094 ' ' PHE . . . . . 0.513 ' CE2' ' OD1' ' B' 1098 ' ' ASN . 26.1 t80 -58.88 -45.51 90.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.224 -1.353 . . . . 0.0 114.55 -173.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -38.53 -52.65 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.61 -39.55 98.02 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.052 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 46.7 tp -56.26 -42.44 77.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.54 1.17 . . . . 0.0 109.798 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1098 ' ' ASN . . . . . 0.513 ' OD1' ' CE2' ' B' 1094 ' ' PHE . 8.4 m-20 -56.92 -43.08 81.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.378 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -64.07 -36.92 85.58 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.26 -42.03 91.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.853 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1101 ' ' GLN . . . . . 0.48 ' CG ' ' OE2' ' A' ' 84' ' ' GLU . 41.8 mt-30 -50.78 -46.21 59.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.51 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.7 m -63.56 -48.19 78.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.99 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.44 ' C ' ' O ' ' B' 1102 ' ' THR . 84.2 mt-30 -27.55 -57.81 0.1 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.556 1.169 . . . . 0.0 112.715 -176.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.2 mt -84.8 -15.14 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 112.161 -2.29 . . . . 0.0 112.691 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.51 ' N ' ' O ' ' B' 1102 ' ' THR . 64.3 tttp -60.23 -44.8 94.89 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.003 -1.479 . . . . 0.0 107.899 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 73.3 t -61.31 -49.05 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -66.41 -36.25 76.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.429 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 90.4 mttt -49.65 -39.21 35.37 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.53 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.86 -45.52 67.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.914 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1110 ' ' PHE . . . . . 0.404 ' CD2' ' CG2' ' A' ' 55' ' ' VAL . 46.4 m-85 -63.65 -49.68 72.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -68.19 -42.16 80.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.4 m 68.77 58.67 0.39 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.48 1.044 0 CA-C-N 123.57 2.895 . . . . 0.0 111.929 179.476 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.651 ' O ' ' OE1' ' A' ' 8' ' ' GLN . 90.5 m-20 -40.08 -80.3 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.499 ' O ' ' CB ' ' A' ' 4' ' ' LEU . 83.0 mt-30 -78.15 126.8 31.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.105 0.479 . . . . 0.0 110.916 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.499 ' CB ' ' O ' ' A' ' 3' ' ' GLN . 1.0 OUTLIER 155.58 -32.42 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.155 -178.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.3 m -75.21 139.26 42.5 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.271 0.941 . . . . 0.0 109.492 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 9' ' ' ILE . 10.3 tm-20 -48.47 -56.8 7.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.969 0.89 . . . . 0.0 110.473 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -34.59 -37.88 0.06 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.971 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.651 ' OE1' ' O ' ' A' ' 2' ' ' ASP . 81.3 mt-30 -69.34 -37.15 77.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.613 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' GLU . 63.8 mt -57.25 -47.6 83.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.29 -49.88 60.41 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.124 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -61.72 -46.85 87.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.099 0.476 . . . . 0.0 112.276 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -59.8 -41.01 90.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.949 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -51.46 -56.55 12.67 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.055 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.43 -45.19 55.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.007 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.26 -38.68 66.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.434 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.77 -40.54 80.04 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.9 m -65.05 -15.37 62.27 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.651 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.2 -41.04 94.92 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -105.96 -14.36 15.21 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.91 94.42 2.8 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.325 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -67.85 -51.85 43.6 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.181 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.6 p30 -100.84 15.73 27.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 37.17 51.98 1.65 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.108 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 26' ' ' THR . 12.3 p30 -88.33 -5.43 58.33 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.925 0.362 . . . . 0.0 111.079 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.93 -0.72 76.74 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.436 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 1.9 t -141.22 157.63 44.99 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.151 0.5 . . . . 0.0 110.49 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.5 mp -90.52 123.99 42.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.8 p -111.21 161.46 15.96 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.28 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.5 p -59.84 -38.07 81.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.212 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -61.38 -59.28 5.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.325 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.72 -28.3 69.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.762 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 tp -61.67 -55.39 30.93 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.977 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.49 92.04 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.186 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -57.98 -55.4 35.39 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.052 1.426 . . . . 0.0 108.198 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.63 -46.56 72.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 118.798 0.727 . . . . 0.0 111.29 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.1 tpt -58.0 -39.86 79.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 120.38 1.445 . . . . 0.0 109.85 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -51.1 -33.55 26.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.346 0.593 . . . . 0.0 110.999 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.9 p -64.9 -20.01 66.22 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.85 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 1.5 mm? -76.27 3.24 11.25 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.143 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.92 27.58 40.84 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.279 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.422 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 9.1 tt0 -131.51 170.41 14.75 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.65 0.725 . . . . 0.0 109.469 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.422 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 16.1 m-20 -131.33 78.23 72.53 Favored Pre-proline 0 N--CA 1.466 0.351 0 CA-C-O 120.739 0.304 . . . . 0.0 110.217 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.07 147.03 96.87 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.698 2.265 . . . . 0.0 111.876 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.2 p -77.78 163.39 26.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.401 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.03 -45.43 90.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.721 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.1 -24.68 26.89 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.626 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -65.63 -40.16 92.25 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.662 -0.415 . . . . 0.0 109.989 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.1 mp -56.14 -41.7 75.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.382 0.611 . . . . 0.0 109.939 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -72.57 -56.02 6.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.682 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -55.76 -50.2 71.06 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.4 mmm -64.05 -50.61 67.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.4 mm -57.72 -45.11 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.77 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -55.44 -34.43 64.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -67.0 -40.94 87.45 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.071 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.2 t -85.99 -21.54 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.155 -178.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.5 t0 -79.42 83.71 5.4 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -174.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.53 79.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.816 -1.538 . . . . 0.0 114.442 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.8 p-10 -85.71 -2.47 58.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.331 -0.547 . . . . 0.0 112.463 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.8 23.02 60.6 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.867 -0.521 . . . . 0.0 112.507 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.435 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -86.61 3.83 42.8 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.335 0.568 . . . . 0.0 110.565 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.521 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.15 2.01 89.45 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 118.657 0.662 . . . . 0.0 114.664 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.2 p -148.19 167.79 24.16 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.0 mm -110.06 127.38 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.228 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -102.57 -177.39 3.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.54 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.413 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -58.19 -46.3 99.67 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.191 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 33.3 Cg_exo -56.6 -52.62 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.393 1.395 . . . . 0.0 111.297 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' O ' ' SD ' ' A' ' 71' ' ' MET . 97.4 mt-10 -61.16 -18.91 60.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.26 0.553 . . . . 0.0 110.941 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -76.77 -59.11 2.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.814 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.8 mt -56.05 -47.41 77.94 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.1 t -46.39 -43.58 16.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.071 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 67' ' ' GLU . 39.5 mtp -66.92 -47.76 70.74 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.0 mmm -62.07 -40.71 96.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.13 -33.92 76.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.573 0.225 . . . . 0.0 111.463 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -91.99 -20.76 21.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 111.178 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.58 67.84 5.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.15 0.5 . . . . 0.0 110.178 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.2 mmt -107.81 15.83 24.15 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.578 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -48.33 132.98 16.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.311 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -89.85 107.6 19.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.964 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.491 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 3.2 m -93.64 120.42 33.89 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.5 m-20 -69.63 111.97 5.8 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 m -36.89 -20.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.864 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.6 mm-40 -68.26 -37.49 80.8 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.794 0.33 . . . . 0.0 111.615 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -48.65 -36.41 15.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.144 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -88.09 -16.55 33.23 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.5 mm -61.96 -74.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.563 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 74.4 mtt85 -62.02 -41.35 97.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.86 -41.5 97.91 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.848 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.07 -17.97 55.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.817 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -72.69 -50.7 23.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -54.95 -42.13 71.94 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.5 t -65.1 -44.38 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -69.33 -37.81 77.9 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.159 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -86.25 80.75 8.64 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.81 -48.91 78.37 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -90.59 4.99 49.73 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.264 -0.273 . . . . 0.0 111.351 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.17 47.19 50.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -90.27 7.03 40.35 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.75 0.31 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.33 2.02 89.25 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -140.68 153.42 45.97 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.636 0.731 . . . . 0.0 111.835 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -93.34 116.4 34.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.3 m -89.65 149.31 22.85 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.93 79.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.166 0.894 . . . . 0.0 110.683 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.19 -40.79 64.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.815 0.341 . . . . 0.0 110.673 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.12 -41.4 94.9 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.204 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.74 -45.73 88.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.233 0.54 . . . . 0.0 110.843 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -43.24 -44.44 5.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.857 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.4 ' O ' ' OG1' ' A' ' 110' ' ' THR . 58.6 t-80 -64.82 -28.83 69.83 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.662 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.503 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 85.0 t -58.11 -41.82 81.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.134 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.626 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.27 -46.73 65.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.953 0.882 . . . . 0.0 111.705 -177.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.414 ' HG1' ' N ' ' A' ' 111' ' ' ASN . 71.9 p -53.43 -35.89 60.93 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 113.771 -1.559 . . . . 0.0 110.882 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -68.51 -39.88 81.07 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.473 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.86 -13.29 59.06 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.45 30.45 60.31 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -87.68 -24.67 23.81 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.681 2.241 . . . . 0.0 110.779 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 45.25 64.39 1.42 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.713 0.768 . . . . 0.0 110.155 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.3 mt -80.5 148.13 30.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.374 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.5 p -82.07 174.61 11.07 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.693 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -57.2 -45.83 83.44 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.16 -47.81 77.51 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -71.96 -30.36 65.2 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.588 -0.445 . . . . 0.0 112.108 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.04 -42.69 95.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -70.61 -34.98 72.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.099 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -59.99 -49.12 78.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.041 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 29.8 mmm -52.46 -47.37 66.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.023 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 40.7 mm -57.44 -44.33 84.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.695 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -58.0 -40.23 80.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.89 0.376 . . . . 0.0 111.394 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -57.98 -40.82 81.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.056 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.89 -17.94 24.5 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.716 0.293 . . . . 0.0 111.645 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.2 t0 -73.83 89.56 1.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.436 0.636 . . . . 0.0 111.816 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 80.1 mt -70.73 -17.63 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.063 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.9 p-10 -141.59 145.55 35.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.743 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.45 52.27 1.48 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.76 -0.257 . . . . 0.0 113.117 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -90.66 -9.16 47.91 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.023 0.412 . . . . 0.0 110.219 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.0 1.89 75.43 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.961 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -134.75 154.33 51.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.234 0.517 . . . . 0.0 110.39 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.76 118.58 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.038 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -84.26 174.71 9.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.775 0.321 . . . . 0.0 110.924 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -61.62 -40.03 93.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.095 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.96 -44.66 95.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.54 -38.5 89.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.733 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -60.82 -44.38 96.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.139 0.495 . . . . 0.0 110.807 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.22 -46.42 87.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.233 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -48.43 -45.56 36.51 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.164 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 88.1 mmm -74.68 -38.3 62.45 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 18.6 mmt -72.8 -46.55 52.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 m -87.53 32.39 0.72 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.66 0.267 . . . . 0.0 111.441 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.14 96.65 10.44 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.683 0.278 . . . . 0.0 110.893 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.8 pttp . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.079 -0.963 . . . . 0.0 110.608 179.759 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 10.5 tpp85 -76.8 138.02 39.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.539 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.579 ' C ' ' H ' ' B' 1090 ' ' GLN . 2.5 mpp_? -82.08 97.1 8.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -53.2 -5.78 0.32 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.579 ' H ' ' C ' ' B' 1088 ' ' ARG . 73.0 mt-30 -63.84 -50.13 70.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.859 0.361 . . . . 0.0 111.484 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 58.8 mt -58.56 -50.94 77.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.204 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 14.4 mt -55.42 -61.95 2.0 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.349 -0.54 . . . . 0.0 112.021 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.72 -54.55 41.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.265 0.555 . . . . 0.0 112.029 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 37.9 t80 -57.97 -46.08 85.69 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -42.16 -52.01 4.47 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.49 -42.11 99.69 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.162 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.55 -46.1 80.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.391 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.21 -48.73 79.45 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.26 -38.17 90.1 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.96 -42.16 91.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.795 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -51.3 -46.42 62.51 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.498 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.8 m -63.38 -48.45 77.82 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.422 ' C ' ' O ' ' B' 1102 ' ' THR . 84.5 mt-30 -27.31 -60.2 0.1 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.603 1.192 . . . . 0.0 112.741 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -82.01 -14.59 12.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 112.67 -2.059 . . . . 0.0 112.344 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.498 ' N ' ' O ' ' B' 1102 ' ' THR . 65.8 tttm -57.69 -43.34 85.06 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 117.874 -1.53 . . . . 0.0 108.059 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.8 t -61.88 -47.04 95.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.55 0.69 . . . . 0.0 112.818 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 65.8 t -65.38 -41.18 90.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.097 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1108 ' ' LYS . . . . . 0.491 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 96.1 mttt -49.03 -38.14 22.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.396 0.617 . . . . 0.0 109.634 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -54.09 -46.91 72.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.343 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -62.35 -49.81 74.07 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -68.84 -40.55 79.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.2 t 66.81 59.25 0.58 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 116.781 -1.581 . . . . 0.0 107.741 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 25.8 p . . . . . 0 N--CA 1.47 0.544 0 CA-C-N 124.194 3.179 . . . . 0.0 111.897 179.377 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 56.99 27.84 13.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.395 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 168.08 88.77 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.993 0.808 . . . . 0.0 109.325 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.17 -25.3 14.06 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.065 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.8 p -80.64 137.83 36.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.461 1.028 . . . . 0.0 110.454 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' A' ' 7' ' ' GLU . 18.0 pt-20 -52.65 -50.06 63.95 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.123 0.963 . . . . 0.0 110.893 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.507 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 43.4 tp10 -36.44 -38.13 0.15 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.033 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -70.63 -35.34 72.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.66 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.1 mt -58.92 -45.6 91.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 175.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.59 -49.02 62.95 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.08 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.26 -47.88 83.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.225 0.535 . . . . 0.0 112.083 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -60.58 -41.96 95.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.988 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -49.52 -59.5 3.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.367 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -47.62 -42.5 24.4 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.414 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.6 -39.15 70.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.294 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -56.91 -41.52 78.29 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 m -65.09 -13.43 58.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.387 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.44 -43.47 97.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -106.73 -13.21 15.33 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -76.05 94.04 3.39 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.073 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -68.33 -46.7 69.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.41 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.7 p-10 -102.77 14.17 32.62 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.62 49.67 1.35 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.018 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -87.06 -5.01 59.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.944 0.372 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.02 -2.05 81.19 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.6 p -137.32 151.61 48.83 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.143 0.496 . . . . 0.0 110.307 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.498 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 mp -93.34 125.24 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -114.1 165.04 13.05 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.671 0.748 . . . . 0.0 112.575 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.6 p -58.85 -35.34 72.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.823 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -61.25 -61.89 2.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.158 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.12 -29.54 70.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.773 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tp -60.57 -56.77 17.31 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.123 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.66 -39.18 93.12 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.107 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.9 m -58.26 -54.65 44.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.05 1.425 . . . . 0.0 108.517 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -55.63 -47.04 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.014 -0.675 . . . . 0.0 111.674 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -58.65 -41.04 85.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 120.143 1.338 . . . . 0.0 110.085 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -51.97 -40.06 60.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.434 0.635 . . . . 0.0 110.351 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 23.0 t -63.57 -20.74 65.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.041 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 tp -73.91 -2.16 22.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.744 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.17 13.44 63.98 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.308 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -106.67 156.44 18.62 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.537 0.669 . . . . 0.0 110.045 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -115.67 63.44 2.07 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.376 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.07 144.2 92.15 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.244 1.962 . . . . 0.0 112.192 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.8 p -80.46 166.63 21.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.393 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -57.37 -44.63 84.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.13 -23.71 22.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.636 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -65.9 -39.4 90.59 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.147 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.2 mp -56.84 -42.34 79.49 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.311 0.577 . . . . 0.0 109.779 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -70.97 -57.07 4.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.851 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -54.95 -48.76 72.78 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 42.7 mmm -65.68 -50.64 64.19 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.4 mm -58.32 -47.13 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.789 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -55.68 -34.53 65.12 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -66.28 -39.82 89.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.86 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.3 t -87.22 -20.09 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.388 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.0 t0 -78.1 85.61 4.29 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.2 85.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.541 -1.663 . . . . 0.0 114.359 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.7 p-10 -86.65 -2.48 58.55 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.16 23.28 61.74 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 118.452 0.569 . . . . 0.0 112.597 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.438 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.1 p-10 -87.21 2.85 48.75 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.294 0.547 . . . . 0.0 110.568 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.44 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.6 1.92 89.0 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.3 p -148.14 168.55 22.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.4 mt -112.69 128.4 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.518 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 43.9 t0 -103.59 -175.51 2.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.647 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.518 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -56.31 -56.88 26.86 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -177.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.26 -49.54 16.07 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 CA-C-N 120.522 1.222 . . . . 0.0 111.673 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -62.04 -18.85 61.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.262 0.553 . . . . 0.0 110.753 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -75.56 -58.81 3.06 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.748 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.9 mt -56.1 -45.24 79.52 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.8 m -44.05 -50.28 8.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.513 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 74.5 mtm -66.05 -43.93 86.04 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.48 ' O ' ' CE ' ' A' ' 76' ' ' MET . 15.2 mmt -57.52 -37.54 73.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.63 -35.23 72.83 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -93.76 -17.25 23.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 111.727 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.31 68.11 5.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.213 0.53 . . . . 0.0 110.456 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.48 ' CE ' ' O ' ' A' ' 72' ' ' MET . 24.3 mmt -108.81 15.47 23.54 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.608 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -52.89 131.62 35.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.637 0.732 . . . . 0.0 111.706 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -132.07 143.95 50.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.372 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.504 ' O ' ' CB ' ' A' ' 80' ' ' ASP . 35.8 p -127.14 -45.14 1.56 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 82' ' ' GLU . 99.8 m-20 126.15 134.84 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 125.357 1.66 . . . . 0.0 109.62 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.1 m -37.61 -17.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.212 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.9 mm-40 -68.51 -37.22 79.87 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.855 0.359 . . . . 0.0 111.653 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.432 ' OE1' ' OG1' ' A' ' 79' ' ' THR . 77.2 tt0 -47.67 -36.14 10.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.312 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -89.57 -16.73 29.97 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.064 0.459 . . . . 0.0 111.916 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.3 mm -61.1 -74.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.541 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -61.58 -41.63 97.69 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.63 -41.01 94.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.587 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.36 -19.53 61.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.118 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -72.57 -51.26 20.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.841 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.95 -42.28 72.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.678 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.92 -43.88 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -68.86 -38.04 79.47 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.916 -0.313 . . . . 0.0 111.471 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -90.71 83.39 5.76 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.85 -44.65 96.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -90.53 4.32 51.5 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 122.179 -0.326 . . . . 0.0 111.584 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.18 48.71 46.23 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -91.45 6.25 46.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.676 0.274 . . . . 0.0 110.402 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.11 0.14 90.08 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -137.94 151.91 48.43 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.611 0.72 . . . . 0.0 111.454 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.14 115.28 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 92.1 p -91.53 154.58 19.0 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.91 -48.24 78.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 119.024 0.829 . . . . 0.0 111.071 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.52 -41.44 61.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.998 0.428 . . . . 0.0 110.594 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.67 -41.2 92.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.894 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 108' ' ' VAL . 9.2 tp -63.56 -46.7 84.72 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.974 -0.454 . . . . 0.0 111.22 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -44.25 -35.99 2.53 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.943 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -66.8 -26.7 67.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.033 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.46 ' N ' ' O ' ' A' ' 105' ' ' LEU . 83.0 t -58.19 -43.13 85.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.798 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.9 mtp -50.13 -47.24 54.23 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.901 0.858 . . . . 0.0 111.781 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 m -58.1 -41.64 83.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.682 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 38' ' ' SER . 2.9 m-80 -66.13 -41.81 89.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.823 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.6 mt -81.46 -15.47 54.93 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.86 30.18 61.94 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -86.06 -24.26 26.41 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.957 2.379 . . . . 0.0 110.691 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 45.57 60.08 3.28 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.689 0.756 . . . . 0.0 110.457 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.2 148.38 32.28 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.938 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.7 p -82.12 174.69 10.98 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.344 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -57.89 -45.47 86.37 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.92 -49.95 74.03 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.584 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -68.52 -29.58 68.2 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.955 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.7 t -63.84 -41.51 92.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -66.65 -36.99 83.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.102 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -59.43 -53.32 59.5 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -44.64 76.6 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.334 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.48 -44.32 92.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.027 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -60.05 -38.56 83.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.829 0.347 . . . . 0.0 111.292 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.12 -41.76 84.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.25 -22.11 21.78 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.811 0.338 . . . . 0.0 111.687 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.7 t0 -73.7 87.69 1.7 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.33 0.586 . . . . 0.0 112.014 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.6 tp -69.3 -15.77 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 122.611 1.196 . . . . 0.0 113.495 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.6 p-10 -142.44 145.43 33.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.111 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.58 52.59 1.54 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.576 -0.345 . . . . 0.0 113.12 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -90.88 -9.25 46.96 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.089 0.445 . . . . 0.0 110.076 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.88 1.7 73.92 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.984 -0.627 . . . . 0.0 114.133 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -134.54 154.48 51.43 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.372 0.586 . . . . 0.0 110.202 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.9 t -100.39 118.47 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.438 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -84.0 173.87 10.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.787 0.327 . . . . 0.0 110.844 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -61.76 -39.41 91.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.018 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.29 -44.75 94.13 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.878 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.83 -38.69 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.591 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.64 -44.66 96.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.859 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.19 -47.01 89.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.4 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -49.37 -44.54 44.97 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.25 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.1 mmm -75.44 -39.31 59.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.6 mmt -74.36 -48.04 30.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.605 -0.146 . . . . 0.0 110.605 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 p -89.27 33.47 0.81 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.686 0.279 . . . . 0.0 111.591 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.04 85.57 4.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.789 0.328 . . . . 0.0 111.156 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.351 179.732 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -75.72 153.28 37.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.733 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.568 ' C ' ' H ' ' B' 1090 ' ' GLN . 21.9 ttm180 65.43 40.84 4.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.868 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -60.14 3.86 0.27 Allowed Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.568 ' H ' ' C ' ' B' 1088 ' ' ARG . 84.8 mt-30 -60.5 -45.06 95.16 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.664 0.268 . . . . 0.0 111.602 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 59.6 mt -57.43 -51.9 63.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.025 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.2 mt -57.22 -62.22 1.92 Allowed 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.244 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.0 m95 -59.99 -57.63 12.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.402 0.62 . . . . 0.0 112.077 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 41.5 t80 -57.54 -44.96 85.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -40.82 -51.11 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.57 99.7 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.514 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 46.0 tp -56.11 -46.24 79.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.517 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 65.8 t30 -59.21 -49.28 78.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -65.22 -38.4 90.32 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 88.0 mt -60.79 -42.33 91.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.71 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -50.25 -44.73 53.67 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.519 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.0 m -63.6 -48.39 77.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.416 ' C ' ' O ' ' B' 1102 ' ' THR . 23.8 mt-30 -27.57 -60.18 0.1 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.738 1.256 . . . . 0.0 112.747 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.1 mt -82.43 -14.8 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 112.33 -2.214 . . . . 0.0 111.968 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.519 ' N ' ' O ' ' B' 1102 ' ' THR . 17.3 ttmm -59.1 -45.04 91.91 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 117.845 -1.542 . . . . 0.0 107.937 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.2 t -60.78 -49.26 85.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.97 -36.35 77.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.305 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.0 mttt -49.35 -38.15 27.2 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.641 -0.662 . . . . 0.0 109.659 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.19 -45.99 68.81 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.341 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -62.87 -49.8 73.41 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -68.84 -40.96 79.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.2 t 67.48 59.26 0.5 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 116.906 -1.521 . . . . 0.0 107.743 -177.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 22.6 p . . . . . 0 N--CA 1.471 0.581 0 CA-C-N 124.105 3.138 . . . . 0.0 111.811 179.396 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -79.17 -5.0 53.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.995 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.453 ' NE2' ' CZ ' ' A' ' 12' ' ' PHE . 73.4 mt-30 -98.86 98.08 9.21 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.419 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.4 mt -113.44 -17.24 12.28 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.872 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.6 p -79.33 135.98 36.88 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.371 0.987 . . . . 0.0 110.36 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ILE . 48.6 tp10 -51.94 -55.43 20.33 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.97 0.891 . . . . 0.0 110.467 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -34.8 -36.33 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.773 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -70.1 -33.96 72.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.598 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.4 mm -59.2 -45.42 92.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.52 -51.36 59.96 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.383 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.92 -46.64 89.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.422 0.629 . . . . 0.0 112.221 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.453 ' CZ ' ' NE2' ' A' ' 3' ' ' GLN . 2.2 m-85 -62.81 -38.86 92.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.771 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -52.59 -53.67 43.57 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.177 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.85 -41.27 61.7 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.041 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.95 -37.88 69.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.355 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.61 -41.76 81.9 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 t -64.6 -14.85 59.77 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.476 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.97 -42.78 97.16 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -106.14 -13.82 15.33 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -76.4 95.09 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.422 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -68.35 -46.89 68.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.227 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 23' ' ' GLY . 35.4 p30 -101.89 14.17 32.71 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.02 46.47 0.94 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.031 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -85.77 -4.17 59.09 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.898 0.38 . . . . 0.0 111.044 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.69 80.79 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.9 p -137.64 152.09 48.98 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.078 0.466 . . . . 0.0 110.068 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.12 124.51 44.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.8 p -112.51 163.4 14.52 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.521 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.7 p -59.42 -36.62 76.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.052 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -61.73 -59.58 4.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.317 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.82 -28.92 70.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.558 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 tp -61.17 -54.41 44.73 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.461 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.53 -38.36 93.5 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.192 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.36 -53.92 52.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.835 1.318 . . . . 0.0 108.729 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.409 ' O ' ' OG ' ' A' ' 38' ' ' SER . 52.7 t -56.2 -45.92 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 O-C-N 121.341 -0.85 . . . . 0.0 111.223 -176.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 ttt -58.76 -38.98 79.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 120.157 1.344 . . . . 0.0 109.946 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -52.48 -40.41 62.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 110.725 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 53.2 p -63.08 -20.83 65.72 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.037 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.79 -1.43 19.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.805 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.0 23.97 39.44 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.389 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -125.76 166.81 16.12 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 117.369 0.585 . . . . 0.0 109.669 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 14.1 p30 -131.38 76.75 75.17 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.461 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -63.87 148.85 91.69 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.941 2.427 . . . . 0.0 112.175 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.4 p -79.03 165.2 23.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.115 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -58.71 -45.0 90.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.85 -24.73 53.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.876 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -64.53 -40.92 96.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.139 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.5 mp -54.18 -38.79 65.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.222 0.534 . . . . 0.0 109.707 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -72.74 -55.34 6.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.797 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -54.68 -50.44 68.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 73.2 mtp -66.87 -49.35 65.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mm -59.01 -47.78 88.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.769 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -57.33 -32.85 67.13 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -67.35 -40.25 85.83 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.8 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.12 -21.03 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.171 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.47 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.5 t0 -78.27 86.06 4.39 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -174.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.1 81.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 113.427 -1.715 . . . . 0.0 114.184 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -86.47 -2.46 58.47 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.52 23.17 60.17 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 118.543 0.611 . . . . 0.0 112.707 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -87.47 4.72 42.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.205 0.503 . . . . 0.0 110.54 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.47 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.32 1.17 89.49 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.737 -0.602 . . . . 0.0 114.599 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.5 p -148.35 168.42 22.64 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.4 mt -112.91 128.67 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 45.7 t0 -104.03 -174.57 2.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.604 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.534 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -57.12 -57.21 26.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -50.47 -49.86 15.32 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 CA-C-N 120.541 1.229 . . . . 0.0 111.569 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.89 -18.59 60.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.273 0.559 . . . . 0.0 110.72 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -73.47 -57.59 3.89 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.123 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' THR . 78.3 mt -57.74 -45.27 86.06 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 53.6 m -38.59 -64.57 0.42 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.749 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.487 ' SD ' ' N ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -63.17 -42.03 99.32 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.487 ' N ' ' SD ' ' A' ' 71' ' ' MET . 97.9 mmm -58.73 -40.69 84.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.02 -33.51 76.21 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 122.395 0.278 . . . . 0.0 111.022 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -95.21 -10.22 31.03 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.112 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.4 65.85 8.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.974 0.416 . . . . 0.0 110.375 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.5 mmt -108.24 16.22 23.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.569 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -49.1 133.34 18.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.394 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -90.75 106.86 18.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.968 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.454 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 15.7 m -91.8 120.18 32.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.6 m-20 -68.74 112.71 5.64 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.4 m -37.42 -20.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.768 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 80' ' ' ASP . 94.9 mt-10 -68.13 -39.8 82.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.733 0.302 . . . . 0.0 111.648 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -46.93 -35.32 6.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -87.71 -19.4 27.67 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.954 0.407 . . . . 0.0 111.78 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 30.4 mm -61.04 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.735 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -61.47 -41.2 96.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.05 -40.54 94.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.5 -178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.05 -20.5 64.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -71.57 -51.6 22.58 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.03 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -54.8 -42.34 71.7 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.347 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.73 -43.74 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -68.89 -39.07 79.95 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.326 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -85.3 81.09 8.93 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -57.63 -49.46 76.37 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -91.85 4.82 52.03 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 122.181 -0.324 . . . . 0.0 111.42 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.76 48.31 50.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -90.37 6.34 43.57 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.739 0.304 . . . . 0.0 110.715 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.19 2.1 88.1 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -142.34 155.99 45.21 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.487 0.66 . . . . 0.0 111.463 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.0 mt -93.57 114.93 31.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 t -88.98 150.98 22.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.47 78.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 119.085 0.857 . . . . 0.0 110.815 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.21 -40.08 61.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.942 0.401 . . . . 0.0 110.419 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.37 -42.11 88.47 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.69 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 108' ' ' VAL . 59.8 tp -62.84 -47.16 84.6 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.249 0.547 . . . . 0.0 111.079 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -43.01 -43.31 4.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.652 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -64.23 -28.63 69.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.005 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.405 ' N ' ' O ' ' A' ' 105' ' ' LEU . 92.9 t -57.78 -42.38 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.602 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.624 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -50.96 -44.12 60.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.699 0.761 . . . . 0.0 111.253 -177.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 m -56.28 -40.91 75.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.781 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -65.51 -41.02 93.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.79 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.8 mt -81.82 -13.77 57.23 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.905 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.2 31.36 59.55 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -85.31 -22.63 28.45 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.55 2.175 . . . . 0.0 111.286 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 44.16 60.93 2.55 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.71 0.767 . . . . 0.0 109.675 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 88.9 mt -80.7 148.23 30.24 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 113.527 -1.67 . . . . 0.0 112.462 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 65.4 p -82.85 175.5 10.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.3 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 119' ' ' GLU . 18.9 p-10 -58.41 -43.99 88.87 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 176.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.491 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 67.5 mm-40 -57.85 -49.16 77.6 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -70.87 -30.3 66.64 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.627 -0.429 . . . . 0.0 112.039 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.97 -41.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.6 0.714 . . . . 0.0 109.1 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -70.78 -35.6 72.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.339 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.41 -51.33 69.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 37.9 mmm -55.98 -44.62 78.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.253 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.96 -43.49 88.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.404 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -60.73 -35.22 75.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.848 0.356 . . . . 0.0 111.153 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.453 ' OE1' ' NH2' ' B' 1087 ' ' ARG . 38.5 tp10 -59.45 -41.36 89.5 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.938 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.95 -20.51 22.09 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 21.4 t0 -73.09 89.05 1.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.528 0.68 . . . . 0.0 111.706 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 76.4 mt -70.08 -16.35 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.021 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 49.1 p-10 -140.48 144.82 36.25 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 112.644 -2.071 . . . . 0.0 108.805 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.27 52.17 1.41 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.899 -0.191 . . . . 0.0 113.154 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 22.0 p-10 -91.24 -8.84 47.29 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.966 0.383 . . . . 0.0 110.057 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.86 3.17 79.64 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.117 -0.564 . . . . 0.0 114.125 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -136.09 155.2 50.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.444 0.622 . . . . 0.0 110.383 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.9 t -101.56 119.01 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.207 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -84.79 175.64 9.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.597 0.237 . . . . 0.0 110.89 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -61.64 -41.12 97.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.306 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -61.61 -45.0 95.93 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.704 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.59 -38.0 88.25 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.668 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 90.9 t80 -58.57 -44.64 89.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.999 0.428 . . . . 0.0 110.796 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.03 -46.13 88.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.411 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -48.35 -44.58 34.49 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.03 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 77.3 mmm -75.73 -36.48 59.92 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.585 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.6 mmt -65.96 -50.98 62.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 m -85.67 -124.65 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.08 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.04 139.1 31.38 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.673 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.9 tttm . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.748 -179.936 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B 1086 ' ' LEU . . . . . 0.551 ' CD1' ' H3 ' ' B' 1086 ' ' LEU . 10.4 mp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1087 ' ' ARG . . . . . 0.453 ' NH2' ' OE1' ' A' ' 127' ' ' GLU . 84.0 mtp180 -64.06 -40.42 96.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.364 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.554 ' C ' ' H ' ' B' 1090 ' ' GLN . 43.8 ttt-85 40.45 48.65 2.49 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -61.86 2.69 0.86 Allowed Glycine 0 CA--C 1.529 0.967 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.554 ' H ' ' C ' ' B' 1088 ' ' ARG . 77.7 mt-30 -61.43 -49.78 75.48 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1091 ' ' ILE . . . . . 0.582 ' CD1' ' H ' ' B' 1092 ' ' LEU . 0.6 OUTLIER -51.21 -56.94 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B 1092 ' ' LEU . . . . . 0.582 ' H ' ' CD1' ' B' 1091 ' ' ILE . 9.3 mt -49.53 -55.36 13.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -175.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.8 m95 -63.4 -47.29 82.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1094 ' ' PHE . . . . . 0.532 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 2.4 m-85 -58.02 -46.3 85.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -40.51 -53.46 2.67 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.85 -42.11 99.71 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.129 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 50.8 tp -56.85 -44.6 82.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.217 1.008 . . . . 0.0 109.592 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 12.4 m120 -58.8 -47.6 84.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -65.06 -37.46 87.63 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.12 -42.43 93.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.772 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -50.83 -45.88 59.74 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 118.863 -1.135 . . . . 0.0 108.039 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.519 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.8 m -63.64 -48.22 78.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.434 -0.506 . . . . 0.0 112.152 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.429 ' C ' ' O ' ' B' 1102 ' ' THR . 84.3 mt-30 -27.79 -57.78 0.11 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 122.457 1.122 . . . . 0.0 112.451 -176.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.5 mt -83.98 -14.45 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.365 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.519 ' N ' ' O ' ' B' 1102 ' ' THR . 65.7 tttm -59.72 -46.28 89.59 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 118.152 -1.419 . . . . 0.0 107.972 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 86.2 t -61.08 -49.31 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.64 -35.97 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.329 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1108 ' ' LYS . . . . . 0.454 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 88.8 mttt -49.31 -37.75 25.28 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.646 0.657 . . . . 0.0 109.641 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.59 -45.91 66.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.295 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -62.9 -50.23 71.7 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -67.81 -41.81 82.53 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.3 m 68.24 58.01 0.46 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 117.209 -1.377 . . . . 0.0 107.414 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 47.6 p . . . . . 0 N--CA 1.476 0.87 0 CA-C-N 123.78 2.991 . . . . 0.0 111.846 179.608 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 92.6 m-20 -62.62 -40.62 97.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.966 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.472 ' CD ' ' O ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER 157.68 99.97 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.37 -16.7 10.85 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.166 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.7 m -81.07 136.43 35.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.093 0.861 . . . . 0.0 110.366 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.1 tt0 -51.01 -58.84 5.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.795 0.807 . . . . 0.0 110.991 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -33.8 -38.64 0.05 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.855 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -68.86 -35.06 76.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.49 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.6 mt -58.32 -45.11 89.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.55 -51.28 63.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.097 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -59.82 -48.27 82.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.283 0.564 . . . . 0.0 112.384 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -61.37 -40.4 94.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.952 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -51.63 -56.9 10.93 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.734 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.35 -43.65 23.26 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.462 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.82 -39.04 65.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.987 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -56.92 -42.37 79.86 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -64.25 -15.49 60.2 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.056 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.96 -41.34 95.56 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -105.99 -13.65 15.42 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -74.4 95.84 2.77 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.565 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -68.86 -49.46 58.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.111 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.0 p-10 -101.84 15.76 28.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 33.87 47.82 0.51 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.035 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 33.9 p-10 -85.24 -5.18 59.34 Favored 'General case' 0 N--CA 1.461 0.106 0 O-C-N 122.69 -0.3 . . . . 0.0 111.038 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.72 -1.93 79.3 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.0 p -138.25 153.89 49.08 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.489 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 2.0 mp -93.0 125.46 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 t -116.86 166.37 12.24 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.5 p -56.79 -32.45 65.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.407 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -59.78 -63.61 1.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.298 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -62.54 -30.49 71.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 119.326 -0.369 . . . . 0.0 111.882 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 tp -58.25 -61.3 2.67 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 118.821 -1.151 . . . . 0.0 108.69 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.19 72.96 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.098 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.8 m -56.67 -53.64 55.4 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.782 1.791 . . . . 0.0 108.431 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.71 -45.64 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 119.196 0.907 . . . . 0.0 111.563 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.2 tpt -58.2 -41.69 84.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 120.355 1.434 . . . . 0.0 109.698 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -52.3 -39.85 61.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.506 0.67 . . . . 0.0 111.32 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 t -62.96 -20.52 65.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.706 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 80.4 mt -74.98 2.21 11.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.167 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.1 26.81 47.29 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.978 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -125.8 166.65 16.45 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 117.41 0.605 . . . . 0.0 109.91 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -124.11 81.07 57.63 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.23 146.76 52.02 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.802 1.668 . . . . 0.0 112.204 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -80.29 163.19 24.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.84 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -58.02 -44.48 87.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.097 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.74 -24.49 35.42 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.771 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -65.25 -40.62 94.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.895 0.378 . . . . 0.0 110.657 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 6.8 mp -56.2 -41.05 74.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.638 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -70.01 -56.93 5.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.826 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -55.27 -49.69 71.43 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.5 mtp -66.21 -51.4 58.04 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.7 mm -57.64 -49.18 81.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -56.15 -32.57 64.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -67.26 -40.39 86.22 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.868 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.7 t -86.27 -20.32 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.425 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.404 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 43.5 t0 -78.69 83.64 4.83 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -174.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.7 75.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 113.595 -1.639 . . . . 0.0 114.748 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.454 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 26.1 p30 -88.61 -1.66 58.18 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.17 23.84 60.22 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 118.664 0.666 . . . . 0.0 112.95 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.587 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -87.52 2.97 49.21 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 117.42 0.61 . . . . 0.0 110.368 179.316 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 86.18 1.73 86.2 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 114.831 0.692 . . . . 0.0 114.831 176.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.587 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 19.2 p -147.66 169.65 19.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -112.22 128.17 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.097 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 9.1 p30 -102.46 -178.99 3.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.761 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.96 99.78 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -54.13 -51.83 9.73 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.071 1.181 . . . . 0.0 111.978 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.24 -23.19 66.53 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.388 0.613 . . . . 0.0 111.269 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -71.18 -61.11 1.89 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.514 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.5 mt -56.69 -43.81 80.85 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.1 p -44.0 -51.72 7.56 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.605 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.0 mtm -64.9 -44.65 88.9 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.6 mmm -61.23 -41.06 96.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.91 79.31 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.415 0.286 . . . . 0.0 111.623 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -91.91 -16.25 26.91 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.722 0.296 . . . . 0.0 111.331 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -80.49 71.62 7.34 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.819 0.819 . . . . 0.0 110.631 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 20.6 mmt -109.5 15.35 23.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.255 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -47.77 131.27 14.88 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.237 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -89.28 109.62 20.49 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.927 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.412 ' CG2' ' NZ ' ' B' 1108 ' ' LYS . 17.2 p -97.98 114.79 27.02 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -64.99 115.5 5.46 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 62.6 m -37.44 -21.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.845 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 80' ' ' ASP . 42.5 tp10 -68.26 -35.86 78.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.028 0.442 . . . . 0.0 111.707 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 80.2 tt0 -49.6 -37.2 26.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.341 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -87.35 -16.3 35.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.128 0.49 . . . . 0.0 111.701 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.5 mm -62.57 -73.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.735 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -60.39 -44.21 95.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 87' ' ' GLU . 7.1 mp0 -61.05 -41.29 96.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.364 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.5 -17.84 47.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.188 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -75.15 -49.67 18.79 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.476 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -55.4 -42.94 74.76 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.932 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.9 t -65.13 -44.12 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -69.82 -38.16 76.47 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.635 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.561 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 31.4 t0 -88.32 82.59 7.01 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.12 -48.59 78.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 40.7 p-10 -91.65 5.47 49.56 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.1 50.13 40.56 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.686 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -92.62 5.11 52.17 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.416 0.287 . . . . 0.0 110.818 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.434 ' N ' HD21 ' A' ' 97' ' ' ASN . . . 85.25 0.21 88.61 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.686 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 87.0 m-85 -138.74 152.12 47.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.944 0.878 . . . . 0.0 111.887 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 95.8 mt -94.79 117.37 38.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.1 m -89.46 148.12 23.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.529 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.29 -48.03 74.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 119.66 1.118 . . . . 0.0 110.17 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.38 -42.61 53.71 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.75 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.91 -41.05 97.78 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.34 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.33 -45.28 92.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.552 0.691 . . . . 0.0 111.203 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 74.5 ttp85 -44.28 -44.94 8.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.551 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -63.63 -31.33 72.47 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.331 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.5 t -56.05 -42.15 71.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.004 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.465 ' SD ' ' CD1' ' A' ' 116' ' ' LEU . 16.0 mmt -51.31 -44.38 61.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.795 0.807 . . . . 0.0 111.222 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 m -53.76 -42.03 67.81 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.952 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -66.4 -41.17 89.72 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.521 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.31 -16.03 53.65 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.08 30.39 59.15 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-O 118.258 -1.301 . . . . 0.0 110.546 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -85.66 -22.27 27.98 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.341 2.571 . . . . 0.0 110.982 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 43.76 60.42 2.69 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 122.18 0.99 . . . . 0.0 110.056 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.465 ' CD1' ' SD ' ' A' ' 109' ' ' MET . 40.4 mt -80.49 147.24 30.97 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.64 -1.618 . . . . 0.0 111.799 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.5 p -82.14 174.89 10.78 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -56.55 -44.98 81.45 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -57.7 -47.25 82.89 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.594 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -73.22 -30.18 63.31 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.762 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.5 t -64.68 -41.71 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.463 0.649 . . . . 0.0 109.864 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 67.7 t0 -73.45 -34.8 65.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.291 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -59.5 -50.01 75.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.934 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.0 mtp -53.58 -46.6 70.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.285 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.8 mm -56.41 -43.54 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -60.1 -36.5 77.56 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.288 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -58.68 -41.18 85.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.846 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.91 -17.16 25.61 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.8 t0 -72.54 90.74 1.36 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.737 0.78 . . . . 0.0 112.213 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 79.3 mt -71.74 -17.63 19.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.158 -1.383 . . . . 0.0 113.123 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 50.4 p-10 -142.72 144.28 32.62 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 112.65 -2.068 . . . . 0.0 108.813 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.41 53.82 1.53 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.129 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -90.85 -8.87 48.35 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.051 0.425 . . . . 0.0 110.14 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.52 1.64 71.73 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.997 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -134.76 155.33 50.78 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.159 0.479 . . . . 0.0 110.439 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.3 t -100.91 118.42 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.322 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.471 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 53.3 t30 -84.46 173.7 10.65 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 111.258 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.471 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 82.5 t80 -61.0 -40.6 94.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.96 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.06 -44.63 96.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.794 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.48 -37.24 86.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.549 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -61.12 -45.04 96.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.046 0.451 . . . . 0.0 111.046 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.69 -47.18 89.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.829 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -50.58 -41.93 55.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.145 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.6 mmt -74.67 -38.57 62.39 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 19.9 mmt -73.17 -46.12 52.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.0 p -87.93 29.94 0.88 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.576 0.227 . . . . 0.0 111.456 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.79 84.54 5.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.727 0.299 . . . . 0.0 110.819 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.0 tptp . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.24 179.746 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B 1086 ' ' LEU . . . . . 0.519 ' N ' ' CD2' ' B' 1086 ' ' LEU . 3.5 mm? . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 61.3 ttt85 -61.82 -41.74 98.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.395 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.555 ' C ' ' H ' ' B' 1090 ' ' GLN . 8.0 mpt_? -82.78 93.22 7.39 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.94 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -50.98 -9.4 0.3 Allowed Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.555 ' H ' ' C ' ' B' 1088 ' ' ARG . 20.8 mp0 -63.51 -47.36 82.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.848 -0.176 . . . . 0.0 111.46 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.19 -51.79 66.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.689 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 15.0 mt -55.24 -60.09 3.88 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.417 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.7 m95 -61.33 -55.76 28.02 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.462 0.649 . . . . 0.0 112.172 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 50.3 t80 -57.94 -46.98 84.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1095 ' ' ARG . . . . . 0.671 HH21 ' NH2' ' B' 1099 ' ' ARG . 59.4 ttt85 -40.31 -52.75 2.65 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.4 -40.62 98.91 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 48.7 tp -56.0 -46.32 78.78 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.689 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -58.63 -49.88 75.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1099 ' ' ARG . . . . . 0.671 ' NH2' HH21 ' B' 1095 ' ' ARG . 91.2 mtt180 -63.87 -39.76 94.95 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.77 -42.61 89.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.14 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -52.29 -47.42 65.91 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 118.605 -1.238 . . . . 0.0 107.677 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.527 ' O ' ' N ' ' B' 1105 ' ' LYS . 18.8 m -61.58 -48.87 78.99 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 25.2 mt-30 -27.57 -57.95 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 122.709 1.242 . . . . 0.0 113.382 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.0 mt -81.68 -14.42 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 112.434 -2.166 . . . . 0.0 112.389 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.527 ' N ' ' O ' ' B' 1102 ' ' THR . 93.4 mttt -59.28 -41.87 89.9 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.27 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 90.8 t -60.39 -46.7 94.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.994 0.902 . . . . 0.0 112.24 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 55.5 t -65.59 -42.34 92.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.877 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1108 ' ' LYS . . . . . 0.412 ' NZ ' ' CG2' ' A' ' 79' ' ' THR . 94.0 mttt -49.25 -41.32 37.2 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.848 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.25 61.66 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.693 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -60.44 -65.65 0.65 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.848 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1111 ' ' HIS . . . . . 0.649 ' ND1' ' N ' ' B' 1112 ' ' SER . 35.4 p80 -89.78 -54.22 4.16 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1112 ' ' SER . . . . . 0.649 ' N ' ' ND1' ' B' 1111 ' ' HIS . 2.9 p 85.75 92.51 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 117.642 -1.171 . . . . 0.0 109.858 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1113 ' ' SER . . . . . 0.425 ' OG ' ' O ' ' B' 1112 ' ' SER . 17.9 p . . . . . 0 C--O 1.219 -0.515 0 CA-C-N 123.526 2.876 . . . . 0.0 110.724 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 3' ' ' GLN . 37.5 p-10 -63.88 -41.87 97.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.262 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.482 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 0.0 OUTLIER 156.18 92.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.86 0.725 . . . . 0.0 109.282 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.91 -25.37 13.07 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.306 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -80.92 140.21 35.43 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.15 0.886 . . . . 0.0 110.196 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.5 tt0 -50.39 -56.26 12.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 122.167 0.984 . . . . 0.0 110.642 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -34.83 -37.77 0.07 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.189 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -68.9 -38.59 79.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.72 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 6' ' ' GLU . 66.6 mt -56.85 -45.74 83.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.62 -51.27 63.61 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.455 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -61.43 -47.33 86.25 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.466 0.65 . . . . 0.0 112.246 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -62.83 -37.7 87.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.897 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -54.59 -52.21 62.86 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.777 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -51.08 -39.99 57.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.082 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.84 -38.0 72.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.309 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -58.04 -42.31 85.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.1 t -65.03 -14.79 61.32 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.6 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.74 -43.05 99.81 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.39 -12.56 15.97 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.72 94.84 3.32 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.265 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -65.04 -47.89 75.78 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.521 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 8.9 p30 -109.69 14.5 23.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.31 59.78 1.47 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.303 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -87.54 -6.79 58.19 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.804 0.335 . . . . 0.0 110.237 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.91 -1.63 74.8 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.0 p -139.77 156.66 46.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.015 0.436 . . . . 0.0 109.998 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.463 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 mp -89.2 123.1 41.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -111.46 162.71 14.8 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.91 0.757 . . . . 0.0 112.41 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.8 p -60.33 -38.52 84.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.859 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -59.75 -62.21 2.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.821 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -62.0 -28.1 69.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.652 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.43 -52.66 64.28 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.471 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.91 91.81 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.891 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.67 -52.42 65.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.828 1.314 . . . . 0.0 108.632 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' A' ' 38' ' ' SER . 43.8 t -58.65 -45.06 90.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 119.267 0.94 . . . . 0.0 111.231 -176.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.484 ' SD ' ' O ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -59.54 -40.29 86.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 119.782 1.173 . . . . 0.0 109.789 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -52.58 -38.12 59.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.403 0.621 . . . . 0.0 110.041 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 25.2 p -62.27 -20.01 63.84 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.177 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -73.82 2.24 8.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.99 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.24 26.23 40.97 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.132 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -131.75 171.3 13.67 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.356 0.578 . . . . 0.0 109.817 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 16.9 p-10 -132.77 76.79 70.34 Favored Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.409 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.46 146.27 97.13 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.783 2.322 . . . . 0.0 111.93 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.2 p -76.28 163.85 26.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.173 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -58.59 -43.64 89.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.848 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.78 -24.25 49.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.378 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -65.38 -39.51 92.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.154 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.0 mp -56.71 -41.03 76.71 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.395 0.617 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -72.1 -56.12 6.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.008 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -55.99 -49.72 72.84 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 40.8 mmm -64.59 -50.86 65.57 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.8 mm -59.23 -45.37 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.346 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -56.97 -34.68 68.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.35 -40.68 85.85 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.872 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.8 t -84.93 -21.95 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.471 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.496 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.6 t0 -78.6 87.15 4.55 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -175.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.68 -37.19 85.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.356 -1.747 . . . . 0.0 113.669 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 39.9 p-10 -86.05 -2.46 58.34 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.66 23.09 60.39 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.313 0.506 . . . . 0.0 112.942 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -88.26 4.13 47.01 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.3 0.55 . . . . 0.0 110.354 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.496 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.05 0.87 88.89 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 121.091 -0.576 . . . . 0.0 114.383 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.1 p -147.87 169.2 20.32 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.5 mt -111.93 128.11 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.555 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 23.7 t0 -102.29 -178.14 3.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.658 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.555 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -57.03 -48.31 97.64 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.387 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -55.79 -49.34 16.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.26 1.306 . . . . 0.0 111.824 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.01 -20.65 64.14 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.487 0.661 . . . . 0.0 110.662 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -74.8 -57.0 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.131 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 72.8 mt -58.08 -45.23 87.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -47.29 -46.59 25.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.321 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 81.4 mtp -66.62 -45.29 79.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.6 mmt -60.13 -40.68 90.63 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -34.8 78.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.531 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -92.3 -16.86 25.53 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.64 0.257 . . . . 0.0 111.461 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 67.31 7.11 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.197 0.522 . . . . 0.0 110.709 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.9 mmt -107.99 16.8 23.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.517 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -49.3 132.59 20.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.981 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.57 109.11 20.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.871 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -95.28 118.88 32.83 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -66.65 113.32 4.71 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 174.318 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.8 m -37.8 -20.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.751 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 80' ' ' ASP . 5.3 mp0 -66.87 -41.9 86.52 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -45.21 -35.64 3.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.319 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -87.52 -20.3 26.7 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.003 0.43 . . . . 0.0 111.865 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 30.4 mm -60.11 -74.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.669 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -63.09 -40.21 96.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.09 -40.76 94.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.434 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.8 -20.75 63.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.136 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -70.74 -50.43 36.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.075 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -55.38 -41.84 73.18 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.414 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.11 -45.05 97.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -68.94 -39.67 79.42 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.423 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -85.52 81.29 8.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.81 -48.89 79.72 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -91.31 4.87 51.28 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.344 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.55 48.3 49.58 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -90.7 7.32 40.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.665 0.269 . . . . 0.0 110.51 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.64 1.93 88.95 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -142.39 155.77 45.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.716 0.77 . . . . 0.0 111.491 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.3 mt -93.33 114.26 29.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.3 m -88.83 151.52 22.32 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.54 -48.98 77.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.838 0.745 . . . . 0.0 110.895 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.77 -40.81 60.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.9 0.381 . . . . 0.0 110.726 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -64.98 -40.86 95.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.027 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 108' ' ' VAL . 7.4 tt -63.42 -45.02 92.87 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.337 0.589 . . . . 0.0 111.408 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -40.7 -37.87 0.81 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.71 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.579 ' CE1' HD22 ' A' ' 111' ' ' ASN . 56.8 t-80 -69.31 -25.32 64.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.783 0.325 . . . . 0.0 111.46 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 105' ' ' LEU . 90.1 t -59.01 -44.88 92.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.625 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.519 ' SD ' ' CD1' ' A' ' 116' ' ' LEU . 16.4 mmt -52.02 -44.95 64.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.12 0.962 . . . . 0.0 111.234 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.5 m -58.62 -42.73 88.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.706 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.579 HD22 ' CE1' ' A' ' 107' ' ' HIS . 1.1 m-80 -65.73 -41.49 92.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.148 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.7 mt -81.52 -15.88 53.5 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.879 -0.329 . . . . 0.0 111.812 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.53 30.65 57.95 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.418 ' OE1' ' SD ' ' A' ' 109' ' ' MET . 96.9 mt-10 -85.66 -23.24 27.55 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.552 2.176 . . . . 0.0 110.578 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt 43.84 59.62 3.05 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.927 0.87 . . . . 0.0 110.366 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.519 ' CD1' ' SD ' ' A' ' 109' ' ' MET . 44.6 mt -79.69 148.83 31.42 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.519 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.6 p -82.91 174.78 10.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.197 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -57.99 -44.5 87.2 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.81 -48.81 78.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.484 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.0 -31.54 69.27 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.821 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 30.3 t -63.17 -43.29 98.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.487 0.66 . . . . 0.0 109.343 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.06 -37.74 84.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.582 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -59.77 -50.36 74.13 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 20.1 mmm -57.12 -44.08 82.94 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.342 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.9 mt -59.9 -43.41 92.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.044 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -58.94 -38.63 79.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.999 0.428 . . . . 0.0 111.199 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -58.73 -40.61 84.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.006 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.6 -21.44 21.72 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.0 t0 -74.23 88.55 2.0 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.486 0.66 . . . . 0.0 111.883 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 42.7 mm -71.93 -14.19 17.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 122.624 1.202 . . . . 0.0 113.13 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.6 p-10 -142.84 144.59 32.58 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 112.414 -2.176 . . . . 0.0 109.251 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.02 52.23 1.32 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.784 -0.246 . . . . 0.0 112.968 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -90.85 -10.07 44.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.061 0.431 . . . . 0.0 110.056 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.12 1.11 67.62 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.195 -0.526 . . . . 0.0 114.221 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -134.9 153.76 51.94 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.435 0.618 . . . . 0.0 110.433 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.21 118.61 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.243 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.1 174.86 9.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.733 0.301 . . . . 0.0 110.858 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -61.65 -40.16 93.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.965 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.54 -44.64 95.86 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.837 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.26 -37.85 88.47 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.505 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -60.26 -45.42 93.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 110.721 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.55 -46.59 89.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.458 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.446 ' O ' ' CB ' ' A' ' 147' ' ' ALA . 51.9 tt0 -48.78 -47.12 42.2 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.893 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.7 mmm -72.33 -37.57 68.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.431 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 24.2 mmt -72.11 -45.23 61.4 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.857 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 147' ' ' ALA . 4.8 m -82.62 -30.98 29.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.066 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 143' ' ' GLN . . . -35.46 100.12 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.195 0.521 . . . . 0.0 111.397 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.594 179.341 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -158.76 -157.47 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.558 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.549 ' C ' ' H ' ' B' 1090 ' ' GLN . 53.0 ttt85 61.3 41.2 13.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.573 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -64.31 5.47 1.01 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.549 ' H ' ' C ' ' B' 1088 ' ' ARG . 85.7 mt-30 -56.84 -41.09 77.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.871 0.367 . . . . 0.0 111.277 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 64.6 mt -44.19 -65.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.5 mt -55.71 -51.28 67.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.549 -0.46 . . . . 0.0 112.162 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.7 m95 -58.11 -65.01 0.72 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.752 0.787 . . . . 0.0 111.875 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1094 ' ' PHE . . . . . 0.431 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 38.0 m-85 -56.68 -43.35 80.36 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -174.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 12.3 tpp85 -39.73 -51.49 2.34 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.12 99.94 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.47 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.0 tp -56.35 -45.69 80.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.501 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -59.79 -49.09 79.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.878 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -65.77 -37.67 86.95 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.11 -42.04 91.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.903 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -51.47 -45.39 62.75 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.507 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.1 m -64.27 -47.99 77.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.825 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 84.0 mt-30 -27.98 -57.08 0.11 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.83 1.3 . . . . 0.0 112.597 -176.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.89 -13.94 11.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 CA-C-N 112.519 -2.128 . . . . 0.0 112.578 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.507 ' N ' ' O ' ' B' 1102 ' ' THR . 88.6 tttt -57.51 -41.65 81.25 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 118.316 -1.354 . . . . 0.0 107.95 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 77.5 t -62.74 -46.82 95.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.724 0.773 . . . . 0.0 112.814 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 37.1 t -65.83 -42.08 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.209 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 97.0 mttt -48.79 -38.07 20.96 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.833 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.87 -45.04 67.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.076 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -63.25 -50.0 71.9 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -68.17 -42.38 80.08 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.2 t 68.97 59.87 0.35 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 20.3 t . . . . . 0 N--CA 1.473 0.712 0 CA-C-N 123.228 2.74 . . . . 0.0 112.017 179.392 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 3' ' ' GLN . 24.7 p30 -64.53 -34.86 79.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.298 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.618 ' NE2' ' N ' ' A' ' 5' ' ' THR . 27.4 tp60 159.54 103.08 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 O-C-N 124.136 0.897 . . . . 0.0 109.437 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.9 mt -119.32 -9.76 9.85 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.271 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.618 ' N ' ' NE2' ' A' ' 3' ' ' GLN . 61.3 p -79.81 133.22 36.28 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.643 1.111 . . . . 0.0 111.12 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.7 tt0 -54.66 -51.3 65.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.769 0.795 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -34.17 -36.01 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.129 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.61 -32.87 70.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.475 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' A' ' 6' ' ' GLU . 93.7 mt -57.83 -45.73 87.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.89 -50.14 61.62 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.412 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.15 -44.76 91.15 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -62.98 -40.79 98.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.753 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -52.14 -55.58 19.99 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.204 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -49.87 -41.84 46.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.116 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.83 -35.66 64.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.503 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.434 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 2.5 m-85 -57.73 -39.61 77.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.4 m -65.95 -16.06 63.54 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.255 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 2.7 mm? -64.23 -41.99 96.75 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.78 -15.25 14.78 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.897 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -74.99 94.72 2.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.145 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -67.15 -48.22 68.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.802 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.0 p30 -103.25 14.68 31.07 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 38.08 50.48 2.14 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.961 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -87.57 -5.17 58.88 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.925 0.362 . . . . 0.0 111.572 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.43 -0.59 78.01 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.7 p -140.07 157.9 44.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.981 0.42 . . . . 0.0 109.954 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mm -88.03 122.81 40.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 p -111.57 161.56 16.07 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.012 0.82 . . . . 0.0 112.276 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 p -59.26 -38.4 79.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.708 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -60.99 -60.05 4.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.06 -30.16 71.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.766 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 tp -60.54 -55.92 27.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.322 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.99 -37.56 91.66 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.806 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -58.5 -53.71 55.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 119.317 1.558 . . . . 0.0 108.434 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.7 t -56.97 -46.69 84.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.598 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.0 ttt -58.51 -42.26 87.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 120.27 1.395 . . . . 0.0 110.189 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -52.27 -37.62 55.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.481 0.658 . . . . 0.0 110.15 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.0 t -63.69 -21.22 66.28 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.517 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.52 0.4 17.4 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.756 -0.777 . . . . 0.0 109.935 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 18.21 62.59 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.173 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -109.81 157.91 18.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.72 0.76 . . . . 0.0 110.038 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -113.0 66.15 0.96 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.443 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.74 142.68 90.11 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.075 1.85 . . . . 0.0 112.302 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -82.36 166.78 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.447 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -58.29 -44.77 88.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.851 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.43 -23.59 25.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.635 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.65 -39.02 90.95 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.273 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 7.8 mp -56.45 -41.31 76.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.23 0.538 . . . . 0.0 109.662 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.425 ' OE1' ' ND2' ' A' ' 53' ' ' ASN . 8.9 tp-100 -68.78 -58.52 4.08 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.71 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -55.05 -49.37 71.78 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.9 mmm -63.81 -53.91 43.38 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.4 mm -58.31 -47.63 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.83 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.425 ' ND2' ' OE1' ' A' ' 49' ' ' GLN . 34.3 m-80 -56.49 -33.64 66.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -66.41 -40.31 89.49 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.596 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.3 t -86.65 -19.8 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.42 -178.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 40.6 t0 -78.98 84.59 4.98 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -174.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.28 -37.39 83.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.626 -1.625 . . . . 0.0 114.238 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.454 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.7 p-10 -86.1 -2.35 58.25 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.5 23.34 62.55 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 118.383 0.538 . . . . 0.0 112.696 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.454 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.4 p-10 -87.5 1.96 52.02 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.27 0.535 . . . . 0.0 110.606 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.552 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 86.73 1.58 85.17 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.685 0.634 . . . . 0.0 114.685 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.3 p -148.84 170.9 17.22 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mm -110.85 128.29 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -102.35 -178.27 3.64 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.434 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -58.06 -48.96 96.16 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -55.94 -51.86 8.67 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.536 1.491 . . . . 0.0 111.537 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.1 -19.99 62.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.607 0.717 . . . . 0.0 110.354 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -75.95 -58.99 2.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.2 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.87 -44.94 78.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.9 p -45.75 -44.29 13.66 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.561 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.5 mtp -71.89 -49.48 37.55 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.4 mmm -61.01 -40.72 94.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.16 -33.58 76.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.66 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -93.45 -14.82 26.27 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.627 0.251 . . . . 0.0 111.529 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 mmpp? -77.87 71.91 4.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.163 0.506 . . . . 0.0 111.311 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.7 mmt -107.03 18.33 21.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.858 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -51.73 129.87 27.25 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.197 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -90.69 105.18 17.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.135 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.495 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 3.1 m -88.45 123.18 32.74 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 82' ' ' GLU . 15.5 t0 -69.43 109.86 4.43 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 174.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.8 m -37.04 -21.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 80' ' ' ASP . 50.6 mp0 -70.33 -34.14 72.32 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 111.835 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.444 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 81.1 tt0 -50.32 -39.14 45.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.266 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -88.34 -5.57 58.24 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.9 mm -70.79 -74.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.85 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -61.48 -50.39 72.95 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 83' ' ' GLU . 16.1 pt-20 -54.41 -38.77 66.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.79 -20.03 60.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.014 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -73.99 -48.1 32.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.771 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -54.59 -41.01 69.39 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.418 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.91 -43.29 92.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -68.78 -39.03 80.38 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.248 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 30.1 t0 -87.36 82.8 7.46 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.88 -49.45 76.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 35.6 p-10 -90.91 5.28 49.27 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.629 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.07 48.49 46.15 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.648 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -90.31 6.48 42.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.678 0.275 . . . . 0.0 110.634 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.54 1.45 89.21 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.648 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 97.9 m-85 -140.72 153.91 46.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.671 0.748 . . . . 0.0 111.612 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.7 mt -97.07 117.28 41.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.3 m -90.46 152.67 20.86 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.1 80.03 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.974 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.97 -39.93 60.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.89 0.376 . . . . 0.0 110.463 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -66.01 -41.54 90.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.357 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.3 tp -63.07 -46.55 86.91 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.267 0.556 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -43.57 -44.35 6.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.65 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -63.54 -29.26 70.55 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 121.281 -0.168 . . . . 0.0 110.99 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.6 t -57.54 -41.81 79.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.842 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.623 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.54 -45.27 62.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.958 0.885 . . . . 0.0 111.543 -177.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.9 m -55.91 -40.73 73.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.853 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.33 -40.46 93.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.759 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.5 -13.0 58.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.739 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.65 29.09 60.07 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -85.34 -21.78 28.76 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.805 2.302 . . . . 0.0 111.111 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mttm 42.82 60.58 2.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.952 0.882 . . . . 0.0 110.013 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 81.5 mt -80.04 148.38 31.1 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.48 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.7 p -82.96 175.17 10.26 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.376 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -57.98 -45.12 87.25 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -57.21 -51.15 70.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.456 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.405 ' OE1' ' OE1' ' A' ' 123' ' ' GLU . 78.7 mm-40 -67.3 -30.55 70.43 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.484 -0.486 . . . . 0.0 112.001 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.6 t -63.72 -41.53 92.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -66.94 -38.22 85.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.407 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.405 ' OE1' ' OE1' ' A' ' 120' ' ' GLU . 94.6 mt-10 -59.21 -52.51 65.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.46 ' SD ' ' CD1' ' B' 1093 ' ' TRP . 17.6 mmm -54.72 -45.04 74.0 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.682 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 91.3 mt -59.05 -44.71 92.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.234 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -61.35 -36.4 80.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.685 0.279 . . . . 0.0 111.553 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.45 -41.3 84.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.88 -16.86 24.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.723 0.297 . . . . 0.0 111.746 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.8 t0 -71.09 91.76 0.93 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.491 0.662 . . . . 0.0 111.991 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.1 mt -70.48 -17.26 20.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 122.591 1.186 . . . . 0.0 113.317 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 51.4 p-10 -142.24 144.12 33.2 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 112.404 -2.18 . . . . 0.0 108.905 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.18 53.07 1.05 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.699 -0.286 . . . . 0.0 113.118 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -90.9 -8.13 50.27 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.002 0.401 . . . . 0.0 110.222 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.92 3.87 81.55 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.671 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -136.67 157.86 45.79 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.562 0.681 . . . . 0.0 110.439 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.9 p -103.98 119.63 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.718 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -85.92 177.24 7.67 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.737 0.303 . . . . 0.0 111.079 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.98 -42.08 98.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.213 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.44 -45.33 94.74 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.902 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.94 -36.86 84.51 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.356 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -61.15 -45.39 94.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.2 t -65.7 -46.33 89.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.932 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -50.26 -44.14 53.55 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.994 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.2 mmt -72.92 -39.31 66.4 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 21.1 mmt -74.66 -47.04 34.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.877 -0.147 . . . . 0.0 110.823 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 p -89.97 32.17 0.93 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.689 0.28 . . . . 0.0 111.678 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.95 89.26 6.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.716 0.293 . . . . 0.0 111.363 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 35.5 tptt . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.416 179.653 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 61.8 mt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -79.43 40.5 0.43 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.556 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.57 ' C ' ' H ' ' B' 1090 ' ' GLN . 55.1 ttp180 56.46 43.07 26.6 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -60.81 3.86 0.36 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.57 ' H ' ' C ' ' B' 1088 ' ' ARG . 84.3 mt-30 -60.82 -45.29 95.05 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -177.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 73.8 mt -58.99 -49.05 84.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 17.6 mt -56.71 -62.26 1.86 Allowed 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.002 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1093 ' ' TRP . . . . . 0.46 ' CD1' ' SD ' ' A' ' 124' ' ' MET . 6.2 m95 -61.9 -53.51 54.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.366 0.603 . . . . 0.0 111.908 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 48.5 t80 -58.19 -46.34 85.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -40.38 -52.3 2.73 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.5 -41.08 99.48 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.106 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.7 tp -56.84 -45.36 82.44 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.484 -0.887 . . . . 0.0 109.562 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 40.9 t30 -58.65 -49.33 77.91 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -64.28 -38.14 90.0 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.3 mt -60.65 -41.91 89.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.68 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -50.37 -48.34 55.8 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.002 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.512 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.2 m -64.19 -47.9 78.0 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.42 ' C ' ' O ' ' B' 1102 ' ' THR . 25.5 mt-30 -27.61 -59.46 0.1 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 122.565 1.174 . . . . 0.0 112.612 -176.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.8 mt -83.02 -12.79 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 112.954 -1.93 . . . . 0.0 112.381 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.512 ' N ' ' O ' ' B' 1102 ' ' THR . 63.8 tttm -57.46 -43.28 83.87 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 118.001 -1.479 . . . . 0.0 108.024 176.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 57.5 t -61.92 -47.36 93.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 41.2 t -65.53 -41.52 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.074 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1108 ' ' LYS . . . . . 0.495 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 95.4 mttt -47.56 -37.11 11.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.659 0.742 . . . . 0.0 109.782 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -55.29 -46.63 76.19 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.63 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1110 ' ' PHE . . . . . 0.43 ' C ' ' H ' ' B' 1112 ' ' SER . 56.1 m-85 -63.77 -48.91 75.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -68.78 20.46 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1112 ' ' SER . . . . . 0.449 ' O ' ' OG ' ' B' 1113 ' ' SER . 1.1 m 60.86 84.58 0.13 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.805 -0.559 . . . . 0.0 109.831 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1113 ' ' SER . . . . . 0.449 ' OG ' ' O ' ' B' 1112 ' ' SER . 5.3 p . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.818 -1.087 . . . . 0.0 109.852 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -63.28 -40.33 97.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.179 0.514 . . . . 0.0 111.219 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -94.39 179.79 5.17 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.1 tp 166.88 -26.33 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.773 0.671 . . . . 0.0 109.452 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.6 p -77.79 141.01 39.49 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.03 0.832 . . . . 0.0 110.628 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.1 tt0 -50.4 -55.95 13.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.166 0.984 . . . . 0.0 110.46 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -35.21 -38.45 0.09 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.886 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -68.27 -38.74 82.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.208 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.0 mt -58.7 -44.92 90.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 176.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.26 -50.38 67.37 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.797 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -60.23 -48.55 81.25 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.174 0.512 . . . . 0.0 112.228 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -61.72 -39.4 91.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.612 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -52.19 -56.19 16.19 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.999 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -50.42 -42.81 54.46 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.295 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.64 -36.83 64.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.125 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.56 -40.74 79.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -63.56 -16.31 60.46 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.205 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.442 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 2.9 mm? -64.7 -41.14 96.22 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -106.1 -15.08 14.97 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.49 92.99 1.93 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.192 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -67.81 -49.83 60.15 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.884 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.8 p-10 -101.89 15.74 28.07 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.7 45.37 0.52 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.2 p30 -85.35 -4.51 59.18 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 122.676 -0.308 . . . . 0.0 110.802 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.96 -2.2 81.54 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 p -137.91 152.73 49.29 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.975 0.417 . . . . 0.0 109.95 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.47 124.47 44.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -113.21 164.91 12.94 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.992 0.807 . . . . 0.0 112.37 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.3 p -59.73 -34.7 73.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.872 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -62.38 -61.58 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.757 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -60.4 -31.42 70.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.845 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 tp -60.56 -55.53 32.24 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.991 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.32 -39.41 92.63 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.988 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.2 m -57.71 -53.91 52.9 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.921 1.361 . . . . 0.0 108.704 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.92 -46.87 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 118.694 0.679 . . . . 0.0 111.527 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.5 ttt -59.24 -40.85 87.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 120.082 1.31 . . . . 0.0 109.868 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -52.15 -39.2 59.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.63 0.729 . . . . 0.0 110.358 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.0 t -63.32 -21.35 66.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.086 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.45 -2.18 21.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.54 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.35 14.63 65.81 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.097 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -106.38 156.45 18.51 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 117.356 0.578 . . . . 0.0 110.095 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -116.43 63.06 2.6 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.355 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.08 144.95 93.63 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.229 1.952 . . . . 0.0 112.169 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.6 p -80.23 166.73 21.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.522 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -57.7 -43.68 85.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.604 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.73 -24.26 33.93 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.398 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -65.97 -39.33 90.29 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.174 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.6 mp -57.23 -42.75 82.0 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.657 0.741 . . . . 0.0 109.867 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -68.81 -56.09 9.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.494 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.05 -49.21 74.38 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.7 mmm -63.91 -50.72 67.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.9 mm -59.3 -48.06 88.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.619 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -55.9 -34.62 65.73 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.95 -39.83 90.77 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.728 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -87.1 -20.18 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.299 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 44.6 t0 -79.38 84.3 5.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.45 82.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.619 -1.628 . . . . 0.0 114.263 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -86.41 -2.36 58.37 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.047 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.9 23.97 59.76 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.407 0.548 . . . . 0.0 112.463 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -87.91 3.74 47.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.421 0.61 . . . . 0.0 110.199 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.44 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.06 1.43 88.66 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 118.578 0.626 . . . . 0.0 114.573 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.9 p -148.9 170.97 17.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.2 mt -114.82 129.05 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -103.27 -175.32 2.77 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.604 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.438 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -59.27 -45.79 99.15 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 41.9 Cg_exo -55.49 -53.72 5.31 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.298 1.332 . . . . 0.0 111.513 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.88 -20.9 64.23 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.492 0.663 . . . . 0.0 110.763 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -72.87 -57.94 3.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.579 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.07 -44.81 87.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.6 m -40.53 -57.96 1.7 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.015 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.6 ptp -63.78 -39.29 93.89 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.811 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.1 mmt -59.06 -41.14 87.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.11 -35.49 78.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.429 0.291 . . . . 0.0 111.663 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -94.05 -12.45 28.53 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -81.61 72.91 8.66 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.704 0.764 . . . . 0.0 110.376 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 21.6 mmt -110.33 17.77 20.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.056 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -53.08 129.72 31.79 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.487 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -107.45 143.96 35.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.674 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.0 p -130.55 135.71 48.19 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.4 m-20 -61.2 116.07 4.29 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 175.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.2 m -36.91 -20.08 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 80' ' ' ASP . 45.1 tp10 -69.44 -31.55 69.94 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -51.86 -40.38 60.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.745 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -86.91 -9.17 56.33 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.1 mm -67.88 -73.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.915 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -61.97 -40.99 97.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.94 -41.67 98.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.379 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.56 -21.35 60.16 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.966 0.412 . . . . 0.0 111.425 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -74.71 -47.29 32.26 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.744 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -55.61 -43.08 75.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.923 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.54 -45.73 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.546 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -70.01 -39.05 76.06 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.595 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.56 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 32.3 t0 -89.56 84.83 6.38 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.01 -48.63 79.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.4 p-10 -92.24 5.03 51.98 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.99 50.4 51.31 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.62 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -95.02 6.28 49.52 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 122.416 0.286 . . . . 0.0 110.798 179.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.56 -0.19 89.7 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.62 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 4.4 m-85 -136.86 149.66 47.81 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.984 0.897 . . . . 0.0 111.299 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 80.7 mt -97.17 119.38 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t -89.88 151.08 21.92 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.66 78.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.112 0.869 . . . . 0.0 110.159 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.09 -41.73 62.65 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.698 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -65.28 -42.04 93.54 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.697 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.2 -45.65 90.74 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.51 0.671 . . . . 0.0 111.072 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -44.07 -42.76 6.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.366 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.403 ' O ' ' OG1' ' A' ' 110' ' ' THR . 62.2 t-80 -65.47 -30.48 71.27 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.671 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.2 t -57.62 -42.38 81.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.943 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.13 -46.9 65.54 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.971 0.891 . . . . 0.0 111.284 -177.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 72.3 p -55.33 -39.19 69.68 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.567 -177.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -66.38 -41.23 89.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.763 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.0 mt -81.77 -14.51 56.33 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.01 31.05 60.31 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -87.33 -25.71 23.75 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.77 2.285 . . . . 0.0 110.463 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.0 mttp 45.96 63.16 1.93 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.102 0.953 . . . . 0.0 110.377 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.74 148.31 31.55 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.923 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.4 p -82.67 174.2 11.22 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -57.57 -45.56 85.05 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.71 -46.72 84.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.172 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -70.66 -30.67 67.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.919 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 43.3 t -64.03 -41.99 94.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.471 0.653 . . . . 0.0 109.436 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.64 -35.69 75.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.349 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -59.56 -52.59 64.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.815 0.817 . . . . 0.0 112.837 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.2 mtp -55.64 -44.09 76.85 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.291 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.5 mt -59.11 -43.85 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.43 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -59.72 -38.32 81.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.95 0.405 . . . . 0.0 111.253 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -58.4 -41.61 85.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.168 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.55 -21.42 22.89 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.7 t0 -78.44 84.64 4.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.283 0.563 . . . . 0.0 112.051 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.9 pt -70.66 -11.52 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 122.674 1.226 . . . . 0.0 113.515 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 53.8 p-10 -142.08 145.01 33.84 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.157 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.45 52.35 2.27 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.656 -0.307 . . . . 0.0 113.357 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -90.9 -9.28 46.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 117.188 0.494 . . . . 0.0 110.1 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.8 -0.57 65.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 114.409 0.524 . . . . 0.0 114.409 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -132.95 150.85 52.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.304 0.552 . . . . 0.0 109.881 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 t -98.21 118.46 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.825 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.422 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 16.5 t-20 -85.14 174.51 9.63 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.721 0.296 . . . . 0.0 110.965 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -60.96 -42.15 97.72 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.456 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.13 -44.12 95.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.699 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.67 -38.03 89.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.462 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -60.94 -45.28 95.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.096 0.474 . . . . 0.0 111.019 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.17 -46.88 89.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.039 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -51.05 -44.51 61.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.025 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmt -72.02 -36.99 69.83 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 25.5 mmt -71.91 -45.88 59.63 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.489 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 p -81.33 -28.86 34.34 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.033 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -41.83 109.24 0.12 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.627 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.404 ' O ' ' OE1' ' B' 1090 ' ' GLN . 63.5 tttp . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.206 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 81.8 mt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -80.0 133.03 36.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.79 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.553 ' C ' ' H ' ' B' 1090 ' ' GLN . 73.5 mtt180 -90.13 92.39 8.94 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.537 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -51.91 -8.78 0.44 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.553 ' H ' ' C ' ' B' 1088 ' ' ARG . 71.3 mt-30 -65.69 -52.06 54.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 111.377 -178.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 60.9 mt -59.13 -50.58 79.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.848 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.9 mt -55.61 -59.13 5.28 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.606 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.3 m95 -63.23 -56.11 19.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.625 0.726 . . . . 0.0 112.346 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.1 t80 -58.4 -46.18 86.91 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 46.9 ttt85 -41.97 -52.04 4.26 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.71 -40.41 98.74 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.679 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.41 -44.72 80.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.977 0.888 . . . . 0.0 109.829 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 38.8 t30 -58.03 -47.72 82.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -176.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -65.01 -38.25 90.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.392 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.9 mt -60.36 -42.37 90.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.718 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -51.37 -45.42 62.4 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.586 -1.245 . . . . 0.0 107.67 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.508 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.7 m -62.16 -48.79 78.5 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.417 ' C ' ' O ' ' B' 1102 ' ' THR . 84.5 mt-30 -27.75 -59.61 0.11 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.913 1.339 . . . . 0.0 113.101 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -83.08 -13.72 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 112.514 -2.13 . . . . 0.0 111.643 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.508 ' N ' ' O ' ' B' 1102 ' ' THR . 66.3 tttm -59.93 -47.8 84.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 118.358 -1.337 . . . . 0.0 107.906 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.6 t -60.71 -48.85 86.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.9 m -65.76 -35.72 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.986 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 83.2 mttt -49.67 -39.08 35.18 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.72 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -50.56 -44.41 56.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.315 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -63.55 -49.46 73.35 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.725 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -67.85 -42.54 81.22 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1112 ' ' SER . . . . . 0.426 ' O ' ' OG ' ' B' 1113 ' ' SER . 1.6 t 68.51 59.48 0.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 117.014 -1.47 . . . . 0.0 107.319 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1113 ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' 1112 ' ' SER . 26.6 p . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 124.011 3.096 . . . . 0.0 111.513 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.404 ' H3 ' ' H ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.471 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 55.3 t0 56.74 25.34 10.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.129 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 2' ' ' ASP . 52.7 tt0 94.42 118.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 124.329 1.018 . . . . 0.0 110.35 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 173.22 -34.81 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.23 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.02 144.28 43.15 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.002 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.591 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -51.29 -43.82 61.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 122.574 1.178 . . . . 0.0 110.574 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 81.2 tt0 -43.35 -41.23 4.0 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 112.718 -2.037 . . . . 0.0 110.662 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -69.36 -38.06 77.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.504 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.1 -44.81 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.44 -50.27 62.92 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.667 -178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -62.61 -45.57 92.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.387 0.613 . . . . 0.0 112.039 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -62.27 -40.9 97.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.817 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -52.89 -55.23 24.73 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.275 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -50.31 -42.39 52.59 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.957 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.3 -36.3 66.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.409 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.79 -38.76 79.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.3 p -65.33 -15.95 63.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.22 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 6.7 mp -65.42 -40.72 93.68 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -106.05 -14.75 15.08 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -73.04 93.2 1.74 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.486 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -67.72 -49.41 62.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.934 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.0 p-10 -103.11 14.9 30.72 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.16 46.27 0.96 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.131 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -86.57 -4.55 59.19 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 122.673 -0.31 . . . . 0.0 110.934 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 -1.83 80.74 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.4 p -138.21 153.56 49.14 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.189 0.519 . . . . 0.0 110.02 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -91.12 123.6 43.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.8 p -113.79 164.22 14.02 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.926 0.87 . . . . 0.0 112.455 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 p -58.34 -37.88 76.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.827 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.19 -61.83 2.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.732 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -60.63 -29.48 69.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.448 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.37 -53.61 54.35 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.571 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.07 97.9 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.545 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 m -58.66 -54.33 48.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.912 1.356 . . . . 0.0 108.605 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.429 ' O ' ' OG ' ' A' ' 38' ' ' SER . 50.4 t -56.72 -46.01 82.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 118.979 0.808 . . . . 0.0 111.297 -176.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.5 ttt -59.18 -40.22 85.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 120.111 1.323 . . . . 0.0 109.822 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -53.43 -41.53 66.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.42 0.629 . . . . 0.0 110.46 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 52.8 p -63.73 -21.49 66.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.941 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 tp -73.86 -3.54 29.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.748 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.74 20.7 46.23 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.332 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -117.77 158.65 24.37 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.662 0.731 . . . . 0.0 109.671 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -119.65 74.85 18.28 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.87 145.79 57.54 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.064 1.843 . . . . 0.0 112.405 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -80.16 165.83 22.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.309 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.4 pt-20 -58.83 -45.07 90.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.417 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -56.55 -24.36 46.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.501 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -65.65 -40.25 92.27 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.218 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.25 -39.67 70.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.223 0.535 . . . . 0.0 109.793 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -73.98 -55.17 6.48 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.238 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -54.84 -48.56 72.7 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 60.6 mtp -65.76 -52.06 54.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.02 -44.07 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -56.33 -35.16 67.29 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -67.3 -40.71 86.05 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.963 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.0 t -86.07 -21.34 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.383 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.493 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.1 t0 -78.2 86.16 4.33 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -174.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.3 82.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.342 -1.754 . . . . 0.0 114.081 -175.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 40.1 p-10 -86.82 -2.41 58.55 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.1 23.47 61.86 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 118.526 0.603 . . . . 0.0 112.839 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -87.87 3.57 47.91 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.273 0.536 . . . . 0.0 110.517 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.493 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.1 1.36 88.61 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 121.556 -0.715 . . . . 0.0 114.495 175.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.0 p -148.26 169.0 21.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -113.06 128.61 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.026 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -103.94 -174.83 2.63 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.801 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -58.09 19.55 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.51 -49.39 15.83 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.2 1.267 . . . . 0.0 111.661 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.79 -19.64 62.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.498 0.666 . . . . 0.0 110.628 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -75.71 -59.55 2.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.235 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.58 -44.15 80.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 m -44.92 -49.93 10.77 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.803 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 58.8 mtm -66.91 -45.6 77.43 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.4 mmm -61.08 -41.02 95.88 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.88 -34.16 77.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.567 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -93.42 -13.69 27.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.637 0.256 . . . . 0.0 111.343 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.452 ' C ' ' SD ' ' A' ' 76' ' ' MET . 2.4 mmmt -80.74 69.82 7.36 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.415 0.626 . . . . 0.0 110.765 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -105.88 18.72 21.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.851 179.158 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -49.94 131.44 22.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.418 0.627 . . . . 0.0 111.403 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 46.3 p-10 -91.99 109.05 20.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.875 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.5 p -97.81 114.21 26.19 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 82' ' ' GLU . 37.2 t0 -63.16 117.44 6.53 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 175.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.3 m -37.39 -20.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.772 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.7 mm-40 -69.8 -34.8 74.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.809 0.337 . . . . 0.0 111.718 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -49.34 -37.48 24.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.427 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.435 ' OE1' ' CD1' ' B' 1097 ' ' LEU . 9.3 pt-20 -89.11 -13.97 37.32 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.2 mm -62.29 -74.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.176 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -62.04 -39.67 93.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -64.03 -40.68 96.87 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.515 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.1 -19.25 62.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.091 0.472 . . . . 0.0 111.127 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -71.97 -50.25 30.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.949 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -54.9 -40.71 70.09 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.757 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.22 -44.67 97.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.524 -0.471 . . . . 0.0 109.779 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -69.44 -39.1 78.02 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.463 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -89.74 83.12 6.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.55 -45.06 95.74 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.9 p30 -91.42 4.02 53.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.623 0.249 . . . . 0.0 111.459 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.71 50.23 43.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -92.23 6.37 46.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.64 0.257 . . . . 0.0 110.516 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.14 0.76 89.64 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -140.38 154.16 46.61 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.695 0.76 . . . . 0.0 111.533 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.6 mt -96.92 115.82 37.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.2 p -91.7 156.13 17.8 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.34 -47.99 80.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 118.726 0.694 . . . . 0.0 111.14 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.8 -40.59 60.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 110.448 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.89 -41.29 91.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.511 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.23 -46.29 87.6 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.505 0.669 . . . . 0.0 111.358 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -44.38 -44.22 8.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.698 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -63.24 -28.82 70.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.784 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.7 t -57.99 -41.85 81.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.837 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.629 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.48 -46.22 63.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.074 0.94 . . . . 0.0 111.212 -177.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.8 m -57.68 -41.36 81.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.76 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.46 -40.75 93.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.975 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.3 mt -81.73 -14.06 57.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.699 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.05 29.82 58.27 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -85.68 -22.51 27.84 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.721 2.26 . . . . 0.0 110.878 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 43.14 60.48 2.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.116 0.96 . . . . 0.0 109.912 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.5 mt -79.74 148.76 31.38 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.511 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.4 p -82.99 174.61 10.73 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.405 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -58.06 -45.17 87.49 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.3 mp0 -58.15 -49.84 75.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.706 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -67.3 -31.23 71.4 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.937 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.13 -41.98 94.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.29 -39.15 89.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.62 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -59.44 -51.12 71.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.9 mmm -55.81 -45.05 78.37 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.274 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.99 -43.89 93.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.405 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -61.66 -36.77 81.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.031 0.443 . . . . 0.0 111.186 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.54 -40.19 86.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.833 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.52 -27.97 19.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.2 t0 -68.88 89.33 0.4 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.631 0.729 . . . . 0.0 111.811 -176.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.3 mm -71.4 -15.84 18.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.994 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 47.0 p-10 -141.44 144.42 34.42 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 112.465 -2.152 . . . . 0.0 108.967 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.32 51.47 1.05 Allowed Glycine 0 CA--C 1.531 1.042 0 CA-C-O 120.313 -0.159 . . . . 0.0 113.018 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -90.67 -12.23 37.39 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.035 0.418 . . . . 0.0 110.011 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.0 1.66 74.44 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.998 -0.62 . . . . 0.0 114.276 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -134.06 153.16 51.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.376 0.588 . . . . 0.0 110.481 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.6 t -100.46 118.4 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.448 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 57.0 t30 -83.65 173.85 11.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.988 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.448 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 88.7 t80 -61.41 -40.06 93.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.024 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.94 -44.29 97.08 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.805 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -65.48 -39.37 91.87 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.571 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.433 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 90.0 t80 -60.66 -44.17 96.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.035 0.445 . . . . 0.0 111.219 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.15 -45.0 95.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.018 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.24 -40.16 46.88 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.176 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.59 ' SD ' ' CE2' ' B' 1093 ' ' TRP . 78.1 mtm -79.05 -46.11 18.78 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.433 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -73.39 -47.03 45.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.081 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.3 m -90.07 33.31 0.88 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.793 0.33 . . . . 0.0 111.332 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.48 84.42 5.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.672 0.272 . . . . 0.0 110.976 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.5 tttp . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.408 179.824 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B 1086 ' ' LEU . . . . . 0.457 ' H2 ' ' H ' ' B' 1087 ' ' ARG . 10.5 mp . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1087 ' ' ARG . . . . . 0.457 ' H ' ' H2 ' ' B' 1086 ' ' LEU . 91.4 mtm180 -78.29 142.35 37.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.552 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.607 ' C ' ' H ' ' B' 1090 ' ' GLN . 0.8 OUTLIER -102.92 96.75 7.03 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.421 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -54.96 -2.89 0.23 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.607 ' H ' ' C ' ' B' 1088 ' ' ARG . 70.0 mt-30 -68.72 -56.87 6.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.956 0.408 . . . . 0.0 111.947 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.98 -49.4 84.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.36 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.35 -62.11 1.89 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.966 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1093 ' ' TRP . . . . . 0.59 ' CE2' ' SD ' ' A' ' 144' ' ' MET . 6.6 m95 -61.88 -53.42 56.06 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.675 0.75 . . . . 0.0 111.817 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 47.5 t80 -57.79 -46.5 84.53 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1095 ' ' ARG . . . . . 0.438 ' HE ' ' NH1' ' B' 1099 ' ' ARG . 77.4 ttt180 -39.93 -52.43 2.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.39 -40.43 99.05 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.272 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1097 ' ' LEU . . . . . 0.435 ' CD1' ' OE1' ' A' ' 84' ' ' GLU . 50.8 tp -56.35 -44.45 80.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 118.196 0.998 . . . . 0.0 109.214 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -57.74 -47.64 81.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1099 ' ' ARG . . . . . 0.438 ' NH1' ' HE ' ' B' 1095 ' ' ARG . 76.7 mtt85 -65.14 -37.43 87.4 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 82.4 mt -60.75 -42.36 91.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.666 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1101 ' ' GLN . . . . . 0.405 ' CD ' ' OE2' ' A' ' 84' ' ' GLU . 41.8 mt-30 -50.1 -45.12 52.43 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 118.744 -1.182 . . . . 0.0 108.025 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.508 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.9 m -63.56 -48.2 78.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.426 ' C ' ' O ' ' B' 1102 ' ' THR . 83.7 mt-30 -27.61 -58.97 0.11 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.647 1.213 . . . . 0.0 112.578 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -83.62 -14.89 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 112.198 -2.274 . . . . 0.0 112.314 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.508 ' N ' ' O ' ' B' 1102 ' ' THR . 65.0 tttm -59.59 -45.22 92.53 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 117.96 -1.496 . . . . 0.0 108.135 176.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.7 t -60.67 -48.99 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -66.28 -36.53 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.346 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 89.3 mttt -49.52 -38.82 32.06 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.606 -0.684 . . . . 0.0 109.562 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.95 -45.19 64.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.95 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -63.42 -50.2 70.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -67.79 -41.99 82.32 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1112 ' ' SER . . . . . 0.413 ' O ' ' OG ' ' B' 1113 ' ' SER . 1.2 m 68.53 58.82 0.41 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 117.173 -1.394 . . . . 0.0 107.347 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1113 ' ' SER . . . . . 0.413 ' OG ' ' O ' ' B' 1112 ' ' SER . 56.1 p . . . . . 0 N--CA 1.471 0.588 0 CA-C-N 123.719 2.963 . . . . 0.0 111.809 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 1' ' ' ALA . 98.0 m-20 -36.25 -78.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.323 0.582 . . . . 0.0 111.385 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -93.15 179.49 5.41 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.6 tp 167.38 -27.64 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 123.663 0.602 . . . . 0.0 109.442 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p -76.25 139.43 41.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.482 1.037 . . . . 0.0 110.744 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.568 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -50.83 -47.81 60.02 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.993 0.902 . . . . 0.0 110.684 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.437 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 83.6 tt0 -38.5 -38.32 0.37 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.474 -178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.462 ' NE2' ' CE1' ' A' ' 12' ' ' PHE . 45.0 tp60 -68.74 -39.14 80.48 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 118.31 -0.853 . . . . 0.0 110.298 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.8 mt -58.97 -46.0 91.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 175.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.55 -50.65 62.48 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.114 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.02 -48.34 82.12 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.158 0.504 . . . . 0.0 112.282 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.462 ' CE1' ' NE2' ' A' ' 8' ' ' GLN . 2.0 m-85 -62.45 -40.63 97.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.835 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -50.86 -56.53 11.78 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.151 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -50.92 -41.88 59.02 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.95 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.21 -36.96 64.04 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.42 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.457 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 2.9 m-85 -58.42 -38.94 78.44 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -65.36 -15.52 62.65 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.455 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 2.8 mm? -65.59 -40.81 93.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -106.29 -14.6 15.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -72.13 93.21 1.4 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.642 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -68.17 -49.49 60.55 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.715 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.1 p-10 -102.32 15.68 28.46 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.53 44.0 0.41 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.451 -0.404 . . . . 0.0 112.171 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -85.35 -3.82 58.96 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.952 0.406 . . . . 0.0 110.978 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.76 -1.68 81.38 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.3 p -137.8 152.69 49.4 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.079 0.466 . . . . 0.0 110.035 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.26 124.74 44.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -113.95 163.91 14.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.427 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.9 p -58.14 -35.5 71.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.052 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -60.71 -60.39 3.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.209 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -62.39 -30.07 70.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.63 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.05 -55.53 31.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.255 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.75 -39.76 94.08 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.267 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -58.32 -54.99 40.71 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.954 1.377 . . . . 0.0 108.569 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -55.98 -46.75 80.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 118.859 0.754 . . . . 0.0 111.29 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.9 ttt -58.71 -40.05 82.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 120.413 1.46 . . . . 0.0 110.276 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -51.7 -38.38 54.89 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.344 0.592 . . . . 0.0 110.583 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.0 t -62.52 -19.89 64.07 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.047 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 tp -73.87 1.1 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.859 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.1 25.99 38.58 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.226 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -130.5 169.64 15.28 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.275 0.537 . . . . 0.0 109.887 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -133.28 77.29 66.79 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.295 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.74 148.08 93.86 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.823 2.349 . . . . 0.0 111.985 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.2 p -77.11 165.29 24.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.328 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 21.3 pt-20 -58.76 -44.99 90.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.66 -24.12 32.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.761 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -65.74 -39.8 91.49 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.174 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.2 mp -56.17 -41.5 75.59 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.175 0.512 . . . . 0.0 110.03 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -71.7 -56.42 5.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.48 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -55.65 -50.34 70.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.7 mmm -63.52 -52.08 62.75 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.5 mm -58.29 -46.97 88.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.105 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -55.91 -34.22 65.39 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -66.72 -40.07 88.27 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.669 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.75 -20.06 7.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.178 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.2 t0 -78.61 84.74 4.7 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -174.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.81 83.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.323 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.0 p-10 -86.17 -2.44 58.36 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.55 23.1 60.15 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.323 0.51 . . . . 0.0 112.686 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -86.71 3.84 43.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 117.189 0.494 . . . . 0.0 110.504 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.447 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.4 1.44 89.34 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 118.637 0.653 . . . . 0.0 114.702 175.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.8 p -148.14 167.92 23.77 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.25 128.35 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -103.03 -176.41 3.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.743 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.457 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -57.07 -46.75 99.83 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -176.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 31.4 Cg_exo -57.66 -51.9 7.27 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 121.462 1.442 . . . . 0.0 111.852 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.21 -20.97 64.75 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.43 0.633 . . . . 0.0 110.727 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -74.88 -59.87 2.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.687 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -54.98 -45.16 74.96 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 m -44.9 -50.51 10.39 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.912 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.6 mtm -65.42 -44.33 87.75 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 35.3 mmm -60.82 -41.46 95.78 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.16 77.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.337 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -92.43 -19.25 22.24 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.39 67.4 5.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.128 0.489 . . . . 0.0 110.297 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.5 mmt -107.76 15.3 24.71 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.356 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -48.29 133.89 15.27 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.37 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -89.68 107.89 19.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.943 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 m -93.83 120.57 34.28 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 82' ' ' GLU . 90.7 m-20 -70.28 112.28 6.49 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m -37.06 -20.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.828 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.579 ' N ' ' O ' ' A' ' 80' ' ' ASP . 96.2 mt-10 -69.15 -36.64 77.63 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.756 0.312 . . . . 0.0 111.585 -178.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -48.63 -35.86 14.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.25 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -89.07 -18.72 26.7 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.103 0.477 . . . . 0.0 111.794 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.9 mm -58.92 -75.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.827 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -61.51 -37.53 84.05 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -63.66 -40.75 97.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.466 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.58 -20.84 63.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.001 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -72.22 -51.59 20.35 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.779 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -54.88 -41.77 71.25 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.67 -44.26 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -69.28 -38.55 78.41 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.211 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.519 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 29.3 t0 -88.51 83.5 6.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.42 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 88.4 tttt -57.78 -49.41 76.69 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.2 p-10 -91.89 5.02 51.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.703 0.287 . . . . 0.0 111.59 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.28 49.55 50.31 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.638 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -91.33 5.27 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.488 0.315 . . . . 0.0 110.713 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.418 ' N ' HD21 ' A' ' 97' ' ' ASN . . . 84.87 0.72 89.09 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.638 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 79.9 m-85 -138.38 151.26 47.35 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.72 0.771 . . . . 0.0 111.783 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.2 mt -93.83 117.21 36.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 t -89.99 150.08 22.29 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.76 -46.34 77.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.109 0.868 . . . . 0.0 110.788 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.31 62.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.836 0.35 . . . . 0.0 110.636 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.42 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.2 mt-10 -66.2 -41.46 90.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.557 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 108' ' ' VAL . 57.4 tp -63.0 -46.9 85.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.264 0.554 . . . . 0.0 110.822 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -42.89 -43.09 3.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.683 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.404 ' O ' ' OG1' ' A' ' 110' ' ' THR . 59.2 t-80 -65.19 -29.24 70.04 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.005 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 105' ' ' LEU . 96.7 t -58.08 -42.67 83.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.73 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.63 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.15 -45.96 61.85 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.784 0.802 . . . . 0.0 111.668 -177.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 68.6 p -55.84 -38.49 70.12 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.825 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -66.58 -40.89 89.17 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.892 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 73.4 mt -82.15 -13.14 57.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.79 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.21 30.83 62.25 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -86.17 -23.19 26.63 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 121.0 2.4 . . . . 0.0 110.856 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.9 mtmt 45.2 61.77 2.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.571 0.7 . . . . 0.0 110.497 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.1 mt -80.2 148.36 30.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.266 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 118' ' ' ASP . 0.5 OUTLIER -82.67 176.78 9.08 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.403 179.002 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.458 ' N ' ' OG1' ' A' ' 117' ' ' THR . 45.4 m-20 -59.7 -45.48 91.98 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.79 -46.95 81.23 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.405 ' H ' HG23 ' A' ' 117' ' ' THR . 76.4 mm-40 -70.38 -30.59 67.54 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.08 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.73 -42.18 95.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.34 -35.98 73.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.209 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -60.07 -53.2 60.61 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 81.9 mtp -54.96 -44.47 74.41 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.269 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.6 mt -58.18 -43.88 86.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.598 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -60.13 -36.38 77.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.836 0.35 . . . . 0.0 111.486 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -59.53 -41.06 89.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.055 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.6 -18.42 24.07 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.6 t0 -74.87 87.88 2.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.108 0.48 . . . . 0.0 111.868 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.8 tt -69.87 -15.1 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 122.523 1.154 . . . . 0.0 113.524 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.2 p-10 -143.07 145.71 33.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.159 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.79 52.35 1.6 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.883 -0.199 . . . . 0.0 113.213 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -90.74 -8.9 48.54 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 117.054 0.427 . . . . 0.0 110.219 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.85 1.36 72.38 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.986 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -134.67 154.43 51.54 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.227 0.514 . . . . 0.0 110.399 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.86 118.27 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.186 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.464 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 51.9 t30 -84.11 174.17 10.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.352 . . . . 0.0 111.065 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.464 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 84.0 t80 -61.15 -40.66 94.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.041 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.28 -44.62 96.11 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.946 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.87 -38.53 91.29 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.707 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -61.3 -44.7 96.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.907 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.22 -46.95 89.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.055 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -50.05 -43.05 50.81 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.891 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.7 mmt -74.93 -39.62 61.29 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.2 mmt -72.9 -47.42 45.94 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.9 p -88.71 32.32 0.8 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.802 0.334 . . . . 0.0 111.601 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -42.21 -33.36 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.237 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 82.4 tttt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.98 -179.548 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 53.5 tp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -147.44 78.25 1.46 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.181 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.634 ' C ' ' H ' ' B' 1090 ' ' GLN . 50.7 mtm180 46.43 47.87 13.91 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -56.79 1.61 0.11 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.634 ' H ' ' C ' ' B' 1088 ' ' ARG . 74.7 mt-30 -62.45 -47.55 83.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.918 0.389 . . . . 0.0 111.445 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 61.6 mt -58.72 -50.34 79.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.7 mt -56.32 -63.03 1.32 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 8.8 m95 -62.65 -55.69 24.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.257 0.551 . . . . 0.0 112.419 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.4 t80 -59.46 -46.55 88.45 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -43.05 -51.3 5.82 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.52 -41.89 99.65 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.1 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1097 ' ' LEU . . . . . 0.43 ' O ' ' NE2' ' B' 1101 ' ' GLN . 56.7 tp -56.91 -45.78 82.41 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.595 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 39.6 t30 -57.93 -47.47 82.77 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -64.69 -37.32 87.18 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.2 mt -61.33 -42.61 94.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.824 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1101 ' ' GLN . . . . . 0.43 ' NE2' ' O ' ' B' 1097 ' ' LEU . 2.8 mp0 -50.27 -46.47 55.1 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.524 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.7 m -63.19 -48.45 78.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.43 ' C ' ' O ' ' B' 1102 ' ' THR . 24.8 mt-30 -27.31 -59.64 0.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 122.745 1.26 . . . . 0.0 112.642 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -83.31 -14.72 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 112.475 -2.148 . . . . 0.0 112.198 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.524 ' N ' ' O ' ' B' 1102 ' ' THR . 66.3 tttm -59.93 -46.51 89.14 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 117.829 -1.548 . . . . 0.0 107.895 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.7 t -61.32 -49.31 85.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.6 m -65.54 -36.14 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.406 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 87.8 mttt -49.01 -38.15 22.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.642 0.656 . . . . 0.0 109.82 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.58 -45.5 66.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.289 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -62.59 -50.02 72.92 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -68.17 -41.12 82.0 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.3 m 67.73 58.37 0.5 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 116.709 -1.615 . . . . 0.0 107.583 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 25.3 p . . . . . 0 C--N 1.348 0.539 0 CA-C-N 124.385 3.266 . . . . 0.0 112.036 179.512 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -63.94 -37.7 88.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.017 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.632 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 22.5 mt-30 -98.08 95.96 7.8 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.526 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.7 tp -108.88 -25.14 10.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.648 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.3 p -77.95 139.96 39.21 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.321 0.964 . . . . 0.0 110.317 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ILE . 45.8 tp10 -49.7 -57.23 7.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 122.281 1.039 . . . . 0.0 110.449 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -34.7 -38.33 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.218 -1.81 . . . . 0.0 111.066 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -68.9 -37.05 78.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 118.07 -0.966 . . . . 0.0 110.65 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.3 mt -59.0 -44.75 91.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 175.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.92 -52.66 59.87 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.356 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.42 -47.77 84.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.441 0.639 . . . . 0.0 112.004 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.632 ' CD1' ' NE2' ' A' ' 3' ' ' GLN . 10.1 m-85 -62.36 -38.68 90.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.677 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -52.61 -54.84 27.67 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.467 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.31 -40.76 49.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.966 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.45 -37.65 70.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.095 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.406 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 3.4 m-85 -58.37 -41.12 84.07 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 t -64.04 -15.54 59.7 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.505 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.53 -42.25 95.87 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -106.01 -14.0 15.31 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -72.29 93.28 1.47 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.482 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -67.41 -49.49 63.58 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.983 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 23' ' ' GLY . 37.0 p30 -102.31 14.73 31.19 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.88 43.78 0.66 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.105 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -84.87 -3.47 58.7 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.764 0.316 . . . . 0.0 110.972 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.42 -1.72 82.3 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.7 p -137.87 153.04 49.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.225 0.536 . . . . 0.0 109.801 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.4 mp -91.59 123.8 43.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.5 p -114.53 165.25 12.96 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 124.124 0.89 . . . . 0.0 112.335 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.7 p -58.62 -36.84 74.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.578 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.86 -60.65 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.496 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -62.06 -30.26 70.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.426 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tp -60.73 -53.78 53.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.219 1.009 . . . . 0.0 109.804 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.16 -37.68 94.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 113.593 -1.639 . . . . 0.0 111.825 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.6 m -58.69 -53.88 53.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 119.005 1.402 . . . . 0.0 108.537 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.88 -46.12 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 121.254 -0.904 . . . . 0.0 111.561 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.9 ttt -58.87 -41.57 87.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 119.99 1.268 . . . . 0.0 109.628 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -51.77 -34.81 41.3 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.648 0.737 . . . . 0.0 110.165 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.1 t -63.07 -20.34 65.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.589 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -75.82 2.81 11.31 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.163 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.52 17.0 74.48 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.956 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -109.26 160.99 15.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.462 0.631 . . . . 0.0 110.013 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -116.05 68.71 3.46 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.165 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.07 143.88 91.46 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.041 1.827 . . . . 0.0 112.291 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.7 p -81.01 165.28 21.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.42 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -58.69 -43.76 90.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.029 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.53 -23.64 27.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.536 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -66.0 -38.48 88.58 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.242 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.43 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.6 mp -56.57 -41.31 76.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.404 0.621 . . . . 0.0 109.733 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -71.09 -56.48 6.03 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.722 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -55.03 -49.55 71.29 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.9 mmm -66.0 -50.91 62.59 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.9 mm -59.43 -48.18 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.618 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -57.79 -34.01 69.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -66.49 -40.43 89.26 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.547 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.6 t -85.73 -20.88 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.544 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.517 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.16 86.56 4.29 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.81 87.46 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 113.308 -1.769 . . . . 0.0 113.906 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 37.8 p-10 -86.44 -2.46 58.46 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.35 23.05 61.86 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 118.451 0.568 . . . . 0.0 112.89 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -87.99 2.43 51.78 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.229 0.515 . . . . 0.0 110.335 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.517 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 86.0 0.97 87.07 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 121.714 -0.616 . . . . 0.0 114.572 175.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.8 p -148.51 170.42 18.09 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.79 129.48 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -103.67 -175.54 2.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.854 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.7 -46.99 99.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.725 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -55.49 -51.95 8.77 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.282 1.321 . . . . 0.0 111.76 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.74 -18.53 55.18 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.446 0.641 . . . . 0.0 110.617 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -76.36 -57.82 3.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.553 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.84 -46.08 85.27 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.3 m -45.31 -49.37 12.78 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.369 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 72.5 mtm -66.16 -44.53 83.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.2 mmt -58.75 -41.65 87.03 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.77 -34.02 77.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.551 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -94.9 -9.29 34.62 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.527 0.203 . . . . 0.0 111.304 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.671 ' HZ2' ' N ' ' B' 1109 ' ' ALA . 0.3 OUTLIER -82.01 69.36 8.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.55 0.69 . . . . 0.0 111.047 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.26 18.29 21.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.126 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -51.19 130.2 25.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.034 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -89.62 108.74 19.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.055 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.7 m -93.59 119.38 32.55 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.2 m-20 -69.32 111.66 5.37 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 173.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.9 m -37.48 -21.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.642 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.5 mp0 -69.42 -35.33 75.62 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -48.83 -37.21 18.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.393 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' OE2' ' NE2' ' B' 1101 ' ' GLN . 10.6 pt-20 -89.28 -13.24 38.5 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.5 mm -63.14 -74.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.993 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -63.02 -39.41 94.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -63.05 -40.95 99.25 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.436 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.54 -18.4 59.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.937 0.398 . . . . 0.0 111.062 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -74.45 -48.74 25.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.012 0.434 . . . . 0.0 111.327 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -55.16 -41.77 72.28 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.64 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -64.84 -43.9 96.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -69.02 -38.54 79.28 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.518 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -85.48 81.22 8.8 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -58.24 -49.32 77.51 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -91.23 5.23 49.93 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.365 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.84 48.35 51.24 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -91.37 6.79 43.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.752 0.31 . . . . 0.0 110.673 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.73 1.95 89.9 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.696 -0.561 . . . . 0.0 111.696 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -140.51 153.95 46.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.686 0.755 . . . . 0.0 111.521 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.6 mt -93.97 114.61 30.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.1 t -89.07 151.61 22.14 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.82 -47.03 83.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 119.067 0.849 . . . . 0.0 110.638 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.02 -35.35 61.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.894 0.378 . . . . 0.0 110.278 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.56 -39.52 73.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.076 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.45 -47.36 76.43 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.231 0.539 . . . . 0.0 112.187 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.4 -33.71 2.71 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.235 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.413 ' O ' ' OG1' ' A' ' 110' ' ' THR . 66.0 t-80 -72.49 -28.91 63.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 75.0 t -58.08 -41.42 80.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.734 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.6 mmt -53.22 -47.24 69.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.301 1.048 . . . . 0.0 111.789 -176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 72.1 p -55.56 -35.52 65.81 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 113.115 -1.857 . . . . 0.0 110.925 -176.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -36.45 82.59 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.043 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.0 mt -84.5 -11.25 56.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.94 36.71 51.66 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.46 -22.8 23.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.827 2.314 . . . . 0.0 111.18 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.7 tptt 44.78 59.78 3.23 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.549 1.166 . . . . 0.0 109.993 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.57 150.96 36.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.602 -2.09 . . . . 0.0 113.386 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.3 p -84.35 175.43 9.37 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.973 0.416 . . . . 0.0 109.927 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -56.36 -45.13 80.61 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.77 -40.81 69.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.027 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.77 -30.13 68.66 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.619 -0.432 . . . . 0.0 112.105 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.34 -43.57 98.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.501 0.667 . . . . 0.0 109.504 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -74.13 -35.82 64.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.816 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -60.77 -55.27 35.08 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 97.7 mmm -48.83 -60.39 2.79 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.472 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.3 pt -50.57 -40.74 19.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.719 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -61.98 -35.36 78.25 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.704 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -57.21 -40.68 77.96 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.219 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.24 -12.91 25.44 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.3 t0 -73.51 87.34 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.425 0.631 . . . . 0.0 111.789 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.0 pt -71.49 -11.86 15.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 122.484 1.135 . . . . 0.0 113.561 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 52.5 p-10 -143.21 142.59 31.46 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 112.265 -2.243 . . . . 0.0 109.035 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.67 52.46 0.9 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.692 -0.29 . . . . 0.0 113.436 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -91.29 -11.19 38.79 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.172 0.486 . . . . 0.0 110.111 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.69 2.79 70.92 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.195 -0.526 . . . . 0.0 114.385 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -134.13 152.94 52.07 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.134 0.467 . . . . 0.0 110.318 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.48 118.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.455 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -84.58 173.79 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 0.0 110.877 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -61.05 -40.08 92.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.026 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.5 -44.81 95.47 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.914 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.39 -37.96 89.31 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.419 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.17 -45.69 93.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.3 t -65.69 -48.58 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.767 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -49.02 -45.96 43.34 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.972 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.475 ' O ' ' CE1' ' B' 1094 ' ' PHE . 13.2 mmt -72.73 -38.99 67.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 18.1 mmt -75.56 -45.09 39.9 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 m -91.12 30.43 1.24 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.98 89.43 6.4 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.091 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.7 tttm . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.518 179.828 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 49.3 tp . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B 1087 ' ' ARG . . . . . 0.479 ' C ' ' H ' ' B' 1089 ' ' GLY . 99.9 mtt180 44.67 68.09 0.6 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.345 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.639 ' C ' ' H ' ' B' 1090 ' ' GLN . 68.8 ttt-85 -70.66 6.75 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B 1089 ' ' GLY . . . . . 0.479 ' H ' ' C ' ' B' 1087 ' ' ARG . . . -61.66 9.42 0.1 Allowed Glycine 0 CA--C 1.534 1.228 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.639 ' H ' ' C ' ' B' 1088 ' ' ARG . 76.0 mt-30 -58.67 -44.21 90.12 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B 1091 ' ' ILE . . . . . 0.425 ' CD1' ' NH1' ' B' 1088 ' ' ARG . 56.2 mt -54.88 -53.48 32.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 10.0 mt -57.16 -58.22 9.16 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.222 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 5.5 m95 -60.55 -62.51 1.81 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.238 0.542 . . . . 0.0 112.415 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B 1094 ' ' PHE . . . . . 0.475 ' CE1' ' O ' ' A' ' 144' ' ' MET . 48.8 m-85 -57.78 -44.69 86.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -39.37 -52.04 2.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.52 -41.66 99.77 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.178 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 50.8 tp -56.35 -45.22 80.55 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.454 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 12.2 m120 -59.07 -47.32 85.68 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.651 -175.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -65.38 -37.48 87.13 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.22 -42.01 91.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.868 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B 1101 ' ' GLN . . . . . 0.458 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 68.7 mt-30 -51.34 -45.95 62.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.528 ' O ' ' N ' ' B' 1105 ' ' LYS . 93.9 m -63.47 -47.95 79.67 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.912 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 84.3 mt-30 -28.06 -57.62 0.11 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.741 1.258 . . . . 0.0 112.572 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.7 mt -84.27 -14.81 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 112.085 -2.325 . . . . 0.0 112.313 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.552 ' O ' ' NZ ' ' A' ' 75' ' ' LYS . 88.8 tttt -59.54 -44.72 93.13 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.954 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 67.5 t -61.49 -49.11 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.83 -36.09 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.322 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 89.7 mttt -49.88 -37.55 31.7 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.682 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B 1109 ' ' ALA . . . . . 0.671 ' N ' ' HZ2' ' A' ' 75' ' ' LYS . . . -51.41 -45.06 62.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.784 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -63.88 -49.73 71.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -67.72 -42.47 81.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.2 m 68.82 59.21 0.37 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.476 0.833 0 CA-C-N 123.769 2.986 . . . . 0.0 111.885 179.346 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.9 p30 -87.75 -0.39 56.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.474 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.41 110.14 22.27 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.4 -17.63 13.07 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.554 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -79.14 137.26 37.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.365 0.984 . . . . 0.0 110.306 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 9' ' ' ILE . 21.3 mt-10 -54.42 -49.98 68.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.132 0.968 . . . . 0.0 110.43 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -34.32 -36.39 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.569 -1.65 . . . . 0.0 111.102 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -69.12 -36.04 77.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.265 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 6' ' ' GLU . 88.4 mt -58.82 -43.95 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.81 -50.53 65.94 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.893 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -63.49 -45.79 89.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.325 0.583 . . . . 0.0 112.05 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.51 -40.42 96.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.888 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -49.95 -57.19 8.02 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.472 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -49.66 -40.43 39.69 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.04 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.7 -37.58 71.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.203 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.518 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 3.0 m-85 -57.79 -41.62 82.47 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.1 t -64.37 -15.7 60.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.65 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.87 -42.59 97.47 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -106.07 -13.97 15.3 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -74.08 95.65 2.58 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.203 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -68.74 -52.83 26.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.44 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.5 p-10 -98.77 13.97 30.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.72 45.22 1.01 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.024 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 32.7 p-10 -85.28 -3.82 58.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.665 0.269 . . . . 0.0 110.875 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.5 -0.79 78.11 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -139.99 153.99 47.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.11 0.481 . . . . 0.0 110.025 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 mp -93.2 124.56 45.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -112.79 165.29 12.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.513 0.673 . . . . 0.0 112.405 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.7 p -59.5 -35.83 74.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.322 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -61.6 -61.73 2.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.77 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.53 -30.12 70.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.715 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 tp -60.42 -53.63 55.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.875 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.55 93.54 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.927 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.63 -51.47 69.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.816 1.308 . . . . 0.0 108.936 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.439 ' O ' ' OG ' ' A' ' 38' ' ' SER . 46.0 t -59.33 -46.01 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 118.739 0.699 . . . . 0.0 111.042 -176.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.0 ttt -59.01 -41.48 87.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.552 1.069 . . . . 0.0 109.654 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -52.1 -37.08 52.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.733 0.778 . . . . 0.0 110.247 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 19.5 p -62.71 -20.6 65.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.702 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.7 mt -75.53 1.6 13.82 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.104 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.1 17.44 67.17 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.154 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -109.11 158.7 17.53 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 117.498 0.649 . . . . 0.0 109.955 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -114.2 65.47 1.43 Allowed Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.13 142.4 91.92 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.03 1.82 . . . . 0.0 112.081 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -80.94 165.27 21.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.246 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -58.17 -43.88 87.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.74 -24.57 50.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.484 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -64.85 -40.19 94.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.209 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.7 mp -55.41 -38.5 69.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.404 0.621 . . . . 0.0 109.354 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -71.66 -56.01 6.64 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.095 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -54.06 -49.23 69.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.5 mtp -68.4 -48.61 64.22 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.3 mm -59.46 -47.58 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.7 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -58.49 -33.8 70.21 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.93 -39.85 90.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.539 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.2 t -86.69 -20.27 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 121.154 -0.218 . . . . 0.0 111.33 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.461 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.53 87.44 4.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -175.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.98 -37.33 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 113.535 -1.666 . . . . 0.0 113.987 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.4 p-10 -86.35 -2.69 58.64 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.2 23.27 61.81 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 118.338 0.517 . . . . 0.0 112.709 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.4 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 51.5 p-10 -88.15 3.63 48.49 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.422 0.611 . . . . 0.0 110.423 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.461 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.46 0.72 89.39 Favored Glycine 0 CA--C 1.522 0.525 0 O-C-N 121.74 -0.6 . . . . 0.0 114.423 175.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.7 p -147.74 169.78 18.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.8 mt -114.66 128.77 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -103.88 -173.94 2.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.705 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.518 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -58.84 -46.62 99.54 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.34 -51.72 7.93 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 121.245 1.297 . . . . 0.0 111.85 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.55 -18.36 61.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.485 0.659 . . . . 0.0 110.687 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -75.19 -58.76 3.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.907 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.8 mt -57.49 -42.6 83.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -46.04 -49.35 16.37 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.566 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.21 -45.23 77.44 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.5 mmm -61.06 -40.34 93.3 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.4 78.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.229 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -94.34 -10.05 33.93 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.831 0.348 . . . . 0.0 111.467 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.19 67.45 8.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.249 0.547 . . . . 0.0 110.487 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 mmt -108.63 15.19 23.94 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.696 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -49.46 133.45 20.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.061 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 45.2 p-10 -92.66 105.2 17.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.932 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.7 m -88.24 123.04 32.46 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 82' ' ' GLU . 96.6 m-20 -69.87 112.05 6.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.0 m -37.6 -21.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.726 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 80' ' ' ASP . 54.2 mp0 -69.14 -36.32 77.32 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -48.67 -36.45 16.09 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.252 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.514 ' OE2' ' NE2' ' B' 1101 ' ' GLN . 11.1 pt-20 -89.11 -13.86 37.56 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.9 mm -62.84 -74.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.279 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -62.41 -41.12 98.44 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -62.98 -40.39 97.59 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.488 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.83 -17.02 54.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.003 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -73.79 -49.3 25.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.021 0.438 . . . . 0.0 111.35 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -55.09 -41.74 71.99 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.604 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.54 -43.96 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -68.52 -39.41 81.22 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.486 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -85.28 81.84 8.62 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.13 -50.18 74.41 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -90.88 5.4 48.68 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.216 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.15 48.49 46.59 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -89.93 6.23 42.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.756 0.312 . . . . 0.0 110.609 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.54 2.76 84.63 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -144.23 157.7 44.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.742 0.782 . . . . 0.0 111.553 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -94.63 114.32 30.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -87.49 151.75 22.77 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.89 78.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 119.036 0.834 . . . . 0.0 110.842 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.01 -40.89 64.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.993 0.425 . . . . 0.0 110.238 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.91 -44.09 86.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.734 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 108' ' ' VAL . 7.1 tt -62.84 -47.56 82.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.83 0.348 . . . . 0.0 111.764 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -41.16 -45.02 2.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.101 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -57.14 -26.99 61.44 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.529 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' A' ' 105' ' ' LEU . 2.0 p -56.45 -41.34 71.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.22 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -50.32 59.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 122.248 1.023 . . . . 0.0 111.245 -177.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.8 m -51.44 -40.85 60.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.483 -1.689 . . . . 0.0 110.775 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.99 -41.25 95.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.06 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.9 mt -82.91 -14.41 54.23 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.79 55.77 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.553 -1.137 . . . . 0.0 110.42 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -86.72 -22.42 26.03 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.385 2.092 . . . . 0.0 110.866 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 43.49 60.34 2.66 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.281 1.039 . . . . 0.0 110.172 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.1 mt -80.87 148.69 29.81 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.599 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 76.5 p -83.0 175.36 10.1 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -57.63 -44.67 85.74 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.31 -48.58 80.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.324 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -70.49 -31.07 68.03 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.916 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.19 -42.29 95.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -68.04 -36.56 80.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.792 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.22 -50.53 73.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.706 0.765 . . . . 0.0 112.916 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 19.3 mmm -57.85 -42.75 85.09 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.89 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.3 mt -60.08 -43.65 93.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.048 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -59.67 -38.67 82.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.743 0.306 . . . . 0.0 111.168 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.75 -41.62 86.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.16 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.46 -25.49 21.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.0 t0 -71.58 88.47 0.95 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.451 0.643 . . . . 0.0 111.842 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.5 tp -70.11 -14.58 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 122.844 1.307 . . . . 0.0 113.147 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 37.2 p-10 -141.04 144.15 34.81 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 112.402 -2.181 . . . . 0.0 109.486 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.34 52.22 1.08 Allowed Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.403 -0.427 . . . . 0.0 113.0 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.408 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 37.5 p-10 -91.63 -9.85 42.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.259 0.529 . . . . 0.0 110.167 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.55 3.41 78.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 114.168 0.427 . . . . 0.0 114.168 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -135.14 154.56 51.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 117.243 0.522 . . . . 0.0 110.422 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.6 t -101.19 118.64 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.462 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.459 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 51.9 t30 -84.21 173.18 11.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.922 0.392 . . . . 0.0 110.981 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.459 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 80.4 t80 -60.82 -40.98 94.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.222 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.11 -44.55 97.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.152 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.92 -38.37 90.74 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.654 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -61.33 -45.68 93.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.952 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.404 ' O ' ' OG1' ' A' ' 146' ' ' THR . 73.2 t -64.76 -46.39 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.5 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -51.0 -43.22 60.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.805 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.4 mmt -75.15 -39.88 60.04 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.7 mmt -71.43 -47.76 53.81 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.837 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 3.1 p -87.8 35.02 0.72 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.904 0.383 . . . . 0.0 110.945 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -45.96 -51.8 12.77 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.871 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.4 mttm . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.302 179.874 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B 1087 ' ' ARG . . . . . 0.525 ' C ' ' H ' ' B' 1089 ' ' GLY . 41.7 ttm180 -60.5 -43.37 97.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.466 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.664 ' C ' ' H ' ' B' 1090 ' ' GLN . 56.7 ttt180 -67.15 6.66 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B 1089 ' ' GLY . . . . . 0.525 ' H ' ' C ' ' B' 1087 ' ' ARG . . . -61.07 11.02 0.06 OUTLIER Glycine 0 CA--C 1.534 1.25 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.171 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.664 ' H ' ' C ' ' B' 1088 ' ' ARG . 76.1 mt-30 -60.82 -45.72 93.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.018 0.437 . . . . 0.0 111.304 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 56.1 mt -60.5 -47.98 90.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.338 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 18.8 mt -57.71 -66.83 0.4 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.9 m95 -62.04 -55.6 27.47 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.541 0.686 . . . . 0.0 112.626 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.6 t80 -60.51 -47.41 86.28 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -173.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -39.65 -50.78 2.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.69 -40.15 98.82 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.269 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.5 tp -56.44 -45.02 81.0 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.993 0.896 . . . . 0.0 109.702 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 42.1 t30 -59.23 -46.91 87.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.515 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -65.42 -38.41 89.81 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.7 mt -60.88 -41.94 90.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.271 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B 1101 ' ' GLN . . . . . 0.514 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 66.5 mt-30 -52.48 -46.58 66.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.505 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.0 m -63.71 -48.28 77.72 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.835 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.447 ' C ' ' O ' ' B' 1102 ' ' THR . 25.3 mt-30 -28.0 -55.5 0.11 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 123.11 1.433 . . . . 0.0 112.758 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.1 mt -84.75 -14.88 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 112.193 -2.276 . . . . 0.0 112.641 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.505 ' N ' ' O ' ' B' 1102 ' ' THR . 87.6 mttt -59.74 -42.7 93.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 117.97 -1.492 . . . . 0.0 108.86 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 81.7 t -61.42 -48.91 86.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.2 m -66.97 -36.64 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.906 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.5 mttt -49.79 -38.34 33.9 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.623 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.02 -44.42 64.15 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.217 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -63.95 -50.64 67.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -67.68 -42.87 81.39 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B 1112 ' ' SER . . . . . 0.403 ' O ' ' OG ' ' B' 1113 ' ' SER . 1.0 OUTLIER 69.5 57.88 0.33 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 117.362 -1.304 . . . . 0.0 107.731 -178.144 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B 1113 ' ' SER . . . . . 0.403 ' OG ' ' O ' ' B' 1112 ' ' SER . 84.7 p . . . . . 0 C--O 1.218 -0.583 0 CA-C-N 123.099 2.682 . . . . 0.0 111.853 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 82.3 m-20 -92.16 6.27 47.25 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.202 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.534 ' HB2' ' O ' ' A' ' 2' ' ' ASP . 43.7 mt-30 100.86 18.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.783 1.302 . . . . 0.0 110.907 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 50.7 tp -107.4 -29.17 9.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.501 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.1 p -77.08 140.02 40.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.332 0.969 . . . . 0.0 109.863 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ILE . 47.9 tp10 -47.28 -63.48 1.03 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 122.149 0.976 . . . . 0.0 110.319 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -34.16 -37.4 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.087 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -70.18 -36.14 74.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.577 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 6' ' ' GLU . 93.1 mt -59.57 -44.29 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 175.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.39 -49.42 64.47 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.401 -177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -63.49 -45.14 92.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.51 0.671 . . . . 0.0 112.379 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -63.15 -41.28 99.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.987 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -52.62 -57.04 11.3 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.442 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -46.8 -41.8 16.04 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.597 . . . . 0.0 110.363 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.38 -35.88 65.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.27 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.81 -39.73 81.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -64.77 -15.88 62.24 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.083 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 7.3 mp -65.01 -40.81 95.46 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -106.13 -14.39 15.16 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -72.56 92.79 1.53 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.211 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -67.63 -49.84 61.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.76 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.0 p-10 -102.41 15.42 29.26 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.26 44.24 0.55 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.171 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.8 p30 -85.3 -4.24 59.09 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.282 . . . . 0.0 110.932 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.95 -2.26 81.65 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.2 p -137.33 152.12 49.38 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.106 0.479 . . . . 0.0 109.767 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.5 mp -91.61 123.98 43.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.3 p -113.07 163.88 14.17 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.492 0.663 . . . . 0.0 112.425 -177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -58.59 -36.32 73.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.487 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -62.04 -61.51 2.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.43 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -61.03 -30.69 70.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.576 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 tp -60.62 -54.5 44.67 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.243 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.14 95.32 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.17 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 m -58.22 -53.59 56.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.759 1.279 . . . . 0.0 108.794 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.434 ' O ' ' OG ' ' A' ' 38' ' ' SER . 42.0 t -57.36 -46.47 85.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 121.414 -0.804 . . . . 0.0 111.405 -176.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.0 ttt -59.38 -40.15 85.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 119.888 1.222 . . . . 0.0 109.727 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -53.72 -41.77 67.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.529 0.681 . . . . 0.0 110.229 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 50.6 p -63.4 -21.6 66.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.125 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.91 -2.7 24.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.835 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.24 14.81 59.8 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.495 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -107.88 155.29 20.45 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.541 0.671 . . . . 0.0 109.825 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -114.93 63.95 1.57 Allowed Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.339 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -62.85 144.24 93.11 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.214 1.943 . . . . 0.0 112.251 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 t -80.31 167.69 19.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.111 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 15.6 pt-20 -58.85 -44.75 91.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.001 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.436 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -56.08 -23.52 34.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.43 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -65.82 -39.45 90.86 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.584 -0.446 . . . . 0.0 109.964 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 10.2 mp -56.53 -41.41 76.72 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.525 0.678 . . . . 0.0 109.468 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -70.39 -57.1 5.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.863 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -53.69 -48.69 69.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.338 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 31.7 mmm -66.74 -50.19 63.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.9 mm -58.71 -48.33 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.622 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -56.53 -34.83 67.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -66.07 -39.68 90.26 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.852 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.5 t -86.07 -20.46 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.577 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.3 t0 -79.22 85.33 5.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -175.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.37 84.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.391 -1.731 . . . . 0.0 114.187 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 39.7 p-10 -86.47 -2.72 58.69 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.27 23.06 63.88 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 118.398 0.544 . . . . 0.0 112.752 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.429 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -87.89 2.06 52.47 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 117.418 0.609 . . . . 0.0 110.664 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.51 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.53 1.82 87.49 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 118.603 0.638 . . . . 0.0 114.552 175.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.3 p -146.36 166.63 25.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.35 126.7 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -102.93 -177.09 3.27 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -47.01 99.55 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -176.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.45 -51.51 9.09 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 120.995 1.13 . . . . 0.0 111.66 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.63 -18.77 60.84 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.416 0.627 . . . . 0.0 110.521 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -75.8 -59.28 2.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.063 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.02 -44.45 82.87 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.7 m -45.92 -48.06 16.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.399 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.1 mtm -66.88 -45.02 79.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.0 mmm -61.3 -41.31 96.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.12 -35.16 79.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.41 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -92.12 -16.36 26.45 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.813 0.339 . . . . 0.0 111.414 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.448 ' C ' ' SD ' ' A' ' 76' ' ' MET . 28.4 tptp -80.18 72.09 6.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.612 0.72 . . . . 0.0 110.562 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.9 19.39 20.12 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.983 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -49.87 129.99 20.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.146 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.52 109.35 20.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.861 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.2 p -99.3 111.75 24.06 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.582 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -60.4 117.85 5.75 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.013 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 m -37.37 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.711 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 80' ' ' ASP . 80.5 tt0 -68.67 -35.57 77.41 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -49.98 -38.8 38.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.259 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -87.21 -19.44 28.38 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.092 0.473 . . . . 0.0 111.671 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.8 mm -60.41 -74.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.679 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.6 mtm180 -62.77 -41.55 99.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.7 -40.57 92.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.408 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.53 -17.48 46.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.007 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -74.17 -49.59 22.95 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.223 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -55.68 -43.18 76.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.435 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.82 -43.56 93.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -68.68 -38.8 80.62 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.393 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -86.23 82.36 8.06 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -57.64 -50.21 73.91 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -91.04 5.83 47.3 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.277 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.21 47.81 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -90.32 7.47 38.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.667 0.27 . . . . 0.0 110.616 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.18 2.16 89.37 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -141.48 153.62 45.05 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.809 0.814 . . . . 0.0 111.756 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -96.05 117.04 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.3 p -91.34 153.69 19.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.73 83.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 119.227 0.921 . . . . 0.0 110.906 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.64 -41.9 64.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.891 0.377 . . . . 0.0 110.617 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -64.35 -43.26 95.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.54 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 108' ' ' VAL . 11.5 mt -62.76 -44.95 94.85 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.324 0.583 . . . . 0.0 111.391 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -42.5 -43.17 3.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.651 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -63.28 -27.33 69.26 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.035 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 105' ' ' LEU . 94.0 t -58.07 -42.83 83.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.651 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.5 ' SD ' ' OE1' ' A' ' 114' ' ' GLU . 15.1 mmt -51.35 -44.46 62.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.204 1.002 . . . . 0.0 111.458 -177.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.6 m -55.36 -41.1 72.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.885 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -64.73 -39.84 94.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.538 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.3 mt -83.44 -13.56 54.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.63 35.89 50.09 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.396 -1.224 . . . . 0.0 110.482 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.5 ' OE1' ' SD ' ' A' ' 109' ' ' MET . 80.7 tt0 -89.78 -24.57 21.45 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.729 2.265 . . . . 0.0 110.879 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.0 tptp 45.89 63.0 1.99 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.551 1.167 . . . . 0.0 110.096 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.418 ' O ' ' CD2' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -76.31 150.92 36.85 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.955 -1.929 . . . . 0.0 112.854 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.2 p -86.3 174.16 9.25 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.367 0.603 . . . . 0.0 109.952 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -54.42 -44.02 72.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -55.83 -41.63 74.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.219 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -68.4 -28.98 67.57 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.721 -178.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 52.6 t -63.8 -44.07 98.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.33 0.586 . . . . 0.0 109.773 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.66 -37.33 65.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.292 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -58.73 -54.95 41.29 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 95.1 mtp -57.17 -43.19 82.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.746 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.6 mm -58.7 -44.0 88.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.132 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -60.65 -35.68 76.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.348 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.98 -42.23 89.49 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.69 -20.15 21.88 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.6 t0 -70.45 90.29 0.72 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.539 0.685 . . . . 0.0 112.069 -177.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.0 -16.12 19.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 122.711 1.243 . . . . 0.0 113.219 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.6 p-10 -143.82 144.99 32.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 112.334 -2.212 . . . . 0.0 109.443 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.05 52.74 1.36 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.961 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -91.17 -9.29 45.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.087 0.443 . . . . 0.0 110.145 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.64 2.14 74.38 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.401 -0.428 . . . . 0.0 114.115 176.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -133.75 153.05 52.0 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 117.36 0.58 . . . . 0.0 110.477 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.1 t -99.15 118.23 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.145 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.459 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 52.2 t30 -84.0 173.61 11.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.977 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.459 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 82.9 t80 -61.37 -39.33 90.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.929 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.72 -44.66 92.95 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.015 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.17 -38.67 91.29 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.567 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -61.04 -44.74 96.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.799 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 82.8 t -65.86 -46.27 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.471 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -49.23 -44.87 43.83 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.008 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.3 mmm -75.66 -39.98 56.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.2 mmt -76.21 -46.86 26.28 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.341 -0.144 . . . . 0.0 111.069 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.2 m -91.52 34.14 0.98 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 111.446 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -45.83 -39.23 8.2 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.882 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.7 tttp . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.203 -179.919 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 51.5 tp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B 1087 ' ' ARG . . . . . 0.577 ' C ' ' H ' ' B' 1089 ' ' GLY . 10.3 ptp85 -146.81 166.9 25.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.536 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.632 ' C ' ' H ' ' B' 1090 ' ' GLN . 28.1 ttm180 -64.57 7.87 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B 1089 ' ' GLY . . . . . 0.577 ' H ' ' C ' ' B' 1087 ' ' ARG . . . -61.83 9.49 0.11 Allowed Glycine 0 CA--C 1.534 1.22 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.632 ' H ' ' C ' ' B' 1088 ' ' ARG . 17.4 mt-30 -60.4 -46.11 91.18 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.009 0.433 . . . . 0.0 111.619 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 71.4 mt -55.22 -53.66 32.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.26 -60.82 3.04 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.754 -176.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 4.7 m95 -58.6 -60.65 3.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.574 0.702 . . . . 0.0 112.095 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -46.64 82.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -174.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B 1095 ' ' ARG . . . . . 0.631 HH11 ' NH2' ' B' 1099 ' ' ARG . 63.7 ttm-85 -36.51 -51.97 0.84 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.79 -40.1 98.35 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.179 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.65 -44.18 81.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 118.031 0.916 . . . . 0.0 109.628 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -59.63 -49.52 77.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.767 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B 1099 ' ' ARG . . . . . 0.631 ' NH2' HH11 ' B' 1095 ' ' ARG . 3.2 mpt_? -65.72 -39.22 90.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.302 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.74 -43.33 94.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.509 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -55.49 -45.15 77.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.513 ' O ' ' C ' ' B' 1103 ' ' GLN . 90.4 m -60.9 -48.56 81.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.955 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.513 ' C ' ' O ' ' B' 1102 ' ' THR . 86.1 mt-30 -28.29 -97.54 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 123.238 1.494 . . . . 0.0 112.137 -175.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -39.47 -14.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 111.806 -2.452 . . . . 0.0 111.752 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.49 ' N ' ' O ' ' B' 1103 ' ' GLN . 52.5 tttp -60.4 -44.63 95.5 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 118.01 -1.476 . . . . 0.0 107.476 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.5 t -61.45 -48.97 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.2 m -66.83 -37.88 80.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.96 -177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 63.4 mttt -49.87 -39.41 39.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.205 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -50.86 -44.91 59.63 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.035 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -63.46 -48.53 77.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -68.74 -41.98 78.23 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.74 57.33 0.42 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 117.421 -1.276 . . . . 0.0 107.753 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.218 -0.58 0 CA-C-N 123.823 3.01 . . . . 0.0 110.907 179.962 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.28 -18.37 63.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.77 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -100.47 99.7 10.35 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.0 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.69 -19.52 12.84 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.697 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.2 p -80.45 139.31 36.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.256 0.935 . . . . 0.0 110.384 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 9' ' ' ILE . 48.4 tp10 -50.98 -54.65 22.59 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.798 0.808 . . . . 0.0 110.519 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -35.77 -37.57 0.1 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.096 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -68.99 -37.54 78.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.605 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.8 mt -58.64 -45.64 90.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 175.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.39 -51.58 62.1 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.393 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -61.6 -47.06 87.15 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.468 0.651 . . . . 0.0 112.622 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -62.9 -36.86 84.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.556 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -55.16 -51.51 66.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.373 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.77 -41.82 61.93 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.31 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.47 -39.14 67.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.212 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -56.29 -41.51 76.04 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -65.28 -14.69 61.32 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.441 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.2 tp -63.25 -43.45 97.96 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -107.06 -13.73 15.11 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.99 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -76.27 95.43 3.74 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.098 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -68.34 -46.99 68.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.297 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.5 p-10 -101.63 14.84 30.76 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.65 46.85 0.6 Allowed Glycine 0 CA--C 1.533 1.195 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -84.15 -3.44 58.13 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.43 -1.58 82.13 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.7 p -137.39 151.88 49.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.918 0.389 . . . . 0.0 110.168 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.528 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 1.6 mp -93.49 125.73 46.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 30' ' ' LYS . 1.9 t -115.29 164.27 14.48 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.176 -0.92 . . . . 0.0 113.182 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.0 p -57.66 -36.08 71.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.83 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' H ' HG23 ' A' ' 28' ' ' THR . 34.5 ttpt -60.97 -58.5 8.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.85 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -64.36 -28.68 69.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.41 -56.1 24.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.78 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.22 -37.64 87.43 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.365 -1.288 . . . . 0.0 112.11 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.7 m -57.85 -54.57 45.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.911 1.356 . . . . 0.0 107.619 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.9 t -55.96 -46.05 80.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 118.852 0.751 . . . . 0.0 111.515 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.1 mmm -58.35 -42.34 86.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 119.963 1.256 . . . . 0.0 110.229 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -54.48 -41.77 69.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.441 0.639 . . . . 0.0 110.786 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -63.6 -21.32 66.29 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.83 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 tp -73.95 -2.54 24.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.851 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.78 14.51 62.98 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.164 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -109.31 156.79 19.55 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.537 0.669 . . . . 0.0 109.518 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -119.67 65.67 9.42 Favored Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.53 145.45 76.56 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.163 1.909 . . . . 0.0 112.03 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 m -78.22 159.29 28.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.268 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -52.49 -41.84 63.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.696 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.79 -25.21 26.61 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -65.61 -39.73 91.85 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.065 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.7 mp -56.19 -41.45 75.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.327 0.585 . . . . 0.0 109.909 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -67.31 -57.35 6.81 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.071 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -54.98 -49.53 71.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.5 mmm -64.17 -51.63 62.88 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.5 mm -59.23 -49.58 82.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.092 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -56.66 -33.96 66.89 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -66.28 -40.35 90.02 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.786 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.401 ' CG2' ' CD2' ' B' 1110 ' ' PHE . 69.0 t -86.6 -20.03 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.335 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.523 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 44.0 t0 -78.68 84.61 4.76 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -175.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.62 79.6 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.842 -1.526 . . . . 0.0 114.36 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.414 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 36.1 p-10 -85.11 -2.79 58.4 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.342 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.06 22.75 60.85 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.901 -0.499 . . . . 0.0 112.316 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.414 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -86.24 3.51 42.78 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.313 0.556 . . . . 0.0 110.441 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 83.12 2.33 90.53 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 114.8 0.68 . . . . 0.0 114.8 175.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 69.0 p -147.06 165.94 28.39 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.7 mm -109.42 126.81 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -102.99 -177.25 3.32 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.838 0.352 . . . . 0.0 110.731 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.02 -57.71 22.72 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.08 -50.59 12.44 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.158 1.238 . . . . 0.0 111.336 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.3 -20.78 60.58 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.279 0.562 . . . . 0.0 110.708 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -75.64 -58.31 3.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.962 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -55.74 -47.9 76.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.3 p -44.22 -48.21 9.32 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.309 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.5 mtp -65.52 -45.57 82.98 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 31.4 mmt -59.92 -40.78 90.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.6 -34.1 77.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.332 0.253 . . . . 0.0 111.538 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.8 mtp85 -95.24 -12.35 26.39 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.569 0.223 . . . . 0.0 111.355 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.84 68.54 7.14 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 110.481 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 21.5 mmt -108.69 15.47 23.64 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.684 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -52.82 129.78 31.03 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.535 0.683 . . . . 0.0 111.6 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 79' ' ' THR . 61.6 t0 -105.57 146.35 29.76 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.694 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.521 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 75.3 p -132.81 133.97 44.07 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 82' ' ' GLU . 1.1 p30 -61.12 115.95 4.17 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 175.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 m -36.44 -19.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 80' ' ' ASP . 46.0 tp10 -70.54 -32.09 69.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.941 0.401 . . . . 0.0 111.513 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -51.16 -41.12 59.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.668 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -83.96 -17.45 40.58 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 111.872 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.6 mm -59.21 -73.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.46 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -58.57 -55.87 29.44 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.47 ' CD ' ' N ' ' A' ' 88' ' ' ALA . 3.1 pp20? -52.83 -36.36 58.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.297 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.47 ' N ' ' CD ' ' A' ' 87' ' ' GLU . . . -60.71 -23.49 64.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.812 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -72.37 -48.84 38.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.24 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -54.79 -41.55 70.71 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.896 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.25 -45.06 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.745 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -70.02 -38.55 75.94 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.349 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.517 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 31.6 t0 -88.69 82.48 6.84 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 176.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.503 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 65.2 tttm -58.46 -48.42 80.8 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 40.2 p-10 -90.65 4.88 50.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.664 0.269 . . . . 0.0 111.652 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.2 47.52 49.53 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.662 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -90.61 5.98 45.68 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 122.35 0.26 . . . . 0.0 110.742 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.422 ' N ' HD21 ' A' ' 97' ' ' ASN . . . 85.11 0.96 88.76 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.662 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 74.1 m-85 -139.22 152.29 47.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.611 0.72 . . . . 0.0 111.708 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.6 mt -94.51 117.72 38.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 t -91.06 150.12 21.55 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.49 -45.96 76.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 119.159 0.891 . . . . 0.0 110.481 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.44 62.67 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.892 0.377 . . . . 0.0 110.745 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.503 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.1 mt-10 -65.84 -40.59 91.88 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.227 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.3 tp -62.93 -46.14 89.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.216 0.531 . . . . 0.0 110.543 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -43.54 -43.11 5.36 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.573 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -64.96 -30.81 71.82 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.646 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 93.6 t -56.99 -41.8 77.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.643 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.628 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -50.6 -44.43 57.02 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.786 0.803 . . . . 0.0 111.276 -178.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 m -57.2 -41.29 79.12 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 114.046 -1.434 . . . . 0.0 111.013 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -65.96 -41.31 91.38 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.564 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.1 mt -81.52 -13.81 57.67 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.8 31.98 57.61 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.556 -1.136 . . . . 0.0 110.401 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -85.44 -21.51 28.72 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.628 2.214 . . . . 0.0 111.744 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt 43.27 61.05 2.32 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.892 0.854 . . . . 0.0 109.948 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.7 mt -81.51 147.72 29.54 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.404 -1.726 . . . . 0.0 112.317 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 65.3 p -82.48 175.74 9.97 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.839 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -57.75 -46.44 84.5 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -55.98 -48.58 75.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.983 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -71.66 -30.85 66.17 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.288 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.51 -41.4 92.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.522 0.677 . . . . 0.0 109.408 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -72.64 -33.26 66.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.78 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.42 -50.98 71.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 76.3 mtp -52.85 -48.07 67.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.641 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.8 mm -57.76 -43.48 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.882 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -62.17 -35.3 78.39 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.808 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -57.06 -41.02 77.98 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.42 -11.66 29.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.791 0.329 . . . . 0.0 111.358 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.2 t0 -75.12 89.1 2.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.507 0.67 . . . . 0.0 111.855 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.77 -18.36 20.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.596 -1.184 . . . . 0.0 113.105 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.461 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.3 p-10 -140.32 145.73 37.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 112.781 -2.009 . . . . 0.0 108.678 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.96 52.2 1.65 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.696 -0.288 . . . . 0.0 113.031 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -90.72 -9.48 46.56 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.978 0.389 . . . . 0.0 110.089 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.74 1.49 72.3 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.957 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -135.5 154.19 51.49 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.127 0.463 . . . . 0.0 110.471 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.44 118.37 47.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.175 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.43 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 57.7 t30 -83.84 173.26 11.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 0.0 111.093 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.43 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 86.8 t80 -61.35 -40.85 95.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.046 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -61.76 -44.41 96.95 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.744 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.81 -39.71 94.02 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.58 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.565 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 92.1 t80 -61.3 -46.44 90.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.976 0.417 . . . . 0.0 111.175 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.48 -46.65 92.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.383 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.472 ' O ' ' CB ' ' A' ' 147' ' ' ALA . 52.0 tt0 -49.54 -47.62 48.92 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.714 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 88.2 mmm -71.22 -35.2 71.42 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.565 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.7 mtt -79.56 -46.97 16.32 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.401 ' C ' ' H ' ' A' ' 148' ' ' LYS . 2.6 p -89.28 -40.23 12.95 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 143' ' ' GLN . . . -78.2 41.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.706 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.509 ' C ' ' NE2' ' B' 1090 ' ' GLN . 21.6 pttm . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.526 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B 1086 ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' B' 1086 ' ' LEU . 10.7 mp . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B 1087 ' ' ARG . . . . . 0.543 ' C ' ' H ' ' B' 1089 ' ' GLY . 11.6 ptp85 -62.97 -33.69 75.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.807 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.592 ' C ' ' H ' ' B' 1090 ' ' GLN . 66.0 ttt180 -67.51 10.55 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B 1089 ' ' GLY . . . . . 0.543 ' H ' ' C ' ' B' 1087 ' ' ARG . . . -64.37 8.5 0.46 Allowed Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.592 ' H ' ' C ' ' B' 1088 ' ' ARG . 14.2 mt-30 -63.19 -50.68 69.37 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B 1091 ' ' ILE . . . . . 0.421 ' C ' ' O ' ' B' 1090 ' ' GLN . 80.1 mt -28.75 -77.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.017 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B 1092 ' ' LEU . . . . . 0.465 ' CD2' ' C ' ' B' 1092 ' ' LEU . 0.9 OUTLIER -50.56 -43.13 56.2 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B 1093 ' ' TRP . . . . . 0.401 ' N ' HD22 ' B' 1092 ' ' LEU . 2.3 m95 -55.31 -62.25 1.8 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.358 0.599 . . . . 0.0 110.864 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 51.6 t80 -56.51 -44.24 80.54 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 61.9 ttt85 -39.94 -53.47 2.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -60.27 -39.95 96.74 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 48.0 tp -56.6 -44.12 80.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 118.494 1.147 . . . . 0.0 109.73 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 46.4 t30 -57.66 -47.61 81.8 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -63.96 -38.15 90.03 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.04 -42.27 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.638 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -51.41 -46.27 62.85 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.628 -1.229 . . . . 0.0 107.874 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.518 ' O ' ' N ' ' B' 1105 ' ' LYS . 96.1 m -62.37 -48.38 80.01 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.59 -0.444 . . . . 0.0 112.047 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.432 ' C ' ' O ' ' B' 1102 ' ' THR . 84.8 mt-30 -27.98 -59.22 0.11 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.591 1.186 . . . . 0.0 112.66 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.0 mt -81.52 -14.34 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 112.711 -2.041 . . . . 0.0 112.089 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' 1102 ' ' THR . 64.0 tttp -58.92 -45.95 89.13 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 118.087 -1.445 . . . . 0.0 108.179 176.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.3 t -60.57 -49.73 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.06 -36.56 78.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.116 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 88.9 mttt -49.09 -37.08 20.37 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.739 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.44 63.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.287 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B 1110 ' ' PHE . . . . . 0.401 ' CD2' ' CG2' ' A' ' 55' ' ' VAL . 44.3 m-85 -62.92 -49.45 74.73 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -68.2 -41.06 81.94 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.4 t 67.15 59.38 0.53 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 116.555 -1.688 . . . . 0.0 107.476 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.471 0.577 0 CA-C-N 124.488 3.313 . . . . 0.0 111.878 179.384 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.426 ' O ' ' OE1' ' A' ' 8' ' ' GLN . 25.6 t70 -65.84 -39.18 90.55 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -97.49 124.42 41.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.724 0.297 . . . . 0.0 110.342 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.417 HD23 ' H ' ' A' ' 5' ' ' THR . 1.9 pt? 174.81 -34.71 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.037 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.417 ' H ' HD23 ' A' ' 4' ' ' LEU . 67.7 p -77.2 140.14 40.07 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.865 0.757 . . . . 0.0 110.827 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.1 tt0 -48.73 -60.98 2.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 122.108 0.956 . . . . 0.0 110.497 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -34.61 -37.01 0.05 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.998 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 2' ' ' ASP . 38.9 tt0 -69.86 -35.78 74.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.403 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.8 mm -59.71 -44.6 94.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 175.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.51 -49.96 63.76 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.282 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -63.1 -44.84 94.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.507 0.67 . . . . 0.0 112.332 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.28 -39.28 94.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.887 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -52.51 -54.02 38.14 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.357 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -50.78 -41.63 57.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.162 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.79 -39.13 68.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.137 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.445 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 3.0 m-85 -57.7 -41.29 81.4 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.3 p -64.55 -15.91 61.73 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.402 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.65 -42.3 95.51 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.79 -178.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -105.95 -14.14 15.28 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -72.72 94.0 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.344 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -67.71 -49.65 61.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.722 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 23' ' ' GLY . 48.2 p-10 -102.72 15.78 28.35 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.88 45.19 0.54 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.132 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -86.01 -4.24 59.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.83 0.347 . . . . 0.0 111.062 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.05 -1.58 80.5 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.3 p -138.01 152.95 49.38 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.17 0.509 . . . . 0.0 110.043 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.69 124.08 44.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.0 p -113.19 163.51 14.68 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.941 0.776 . . . . 0.0 112.559 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.1 p -58.24 -37.11 74.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.884 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.57 -62.09 2.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.185 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -60.58 -29.89 69.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.668 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 tp -61.07 -55.02 37.47 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.026 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.87 -40.32 95.06 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.401 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.11 -54.65 44.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 118.884 1.342 . . . . 0.0 108.423 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.9 t -56.76 -46.78 83.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 118.889 0.768 . . . . 0.0 111.841 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.2 ttt -58.63 -41.5 86.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 120.065 1.302 . . . . 0.0 109.964 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -51.78 -38.28 54.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.512 0.673 . . . . 0.0 110.296 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 t -62.59 -20.58 64.86 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.949 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -74.08 -0.4 16.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.897 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.44 14.56 70.77 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.116 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -107.47 158.5 17.15 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 117.484 0.642 . . . . 0.0 109.992 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -116.1 65.83 2.88 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.272 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.75 144.03 87.96 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.182 1.921 . . . . 0.0 112.111 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.637 ' HG1' ' N ' ' A' ' 45' ' ' GLU . 6.5 t -80.42 165.45 22.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.555 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.637 ' N ' ' HG1' ' A' ' 44' ' ' THR . 15.9 tm-20 -57.9 -44.94 87.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.68 -23.96 31.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.586 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -65.61 -39.99 92.14 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.146 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.8 mp -55.64 -40.8 72.68 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.495 0.664 . . . . 0.0 109.799 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -71.45 -56.22 6.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.815 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -54.52 -49.23 70.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.0 mtp -67.08 -48.65 67.56 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.0 mm -58.47 -46.71 89.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.607 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -55.59 -35.54 65.93 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -66.62 -40.3 88.72 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.146 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -85.58 -20.97 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.39 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.497 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.3 t0 -79.63 84.3 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -175.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.81 -37.1 80.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.64 -1.618 . . . . 0.0 114.319 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -86.57 -2.04 58.16 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.53 23.04 60.03 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 118.44 0.563 . . . . 0.0 112.473 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -87.65 3.81 46.36 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.44 0.62 . . . . 0.0 110.515 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.497 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.72 1.41 89.05 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 175.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.0 p -148.42 168.86 21.55 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.8 mt -113.48 128.79 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 5.9 p30 -103.61 -175.97 2.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.867 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.445 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.16 -47.63 98.49 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.738 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -55.72 -52.06 8.36 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.287 1.325 . . . . 0.0 111.84 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.22 -19.59 61.82 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.506 0.669 . . . . 0.0 110.533 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -75.52 -59.33 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.352 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.5 mt -56.46 -45.16 81.02 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.8 p -45.24 -47.49 12.77 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.404 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 33.6 mtp -67.68 -46.81 71.23 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.6 mmm -61.75 -39.89 93.17 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.64 -34.21 77.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.373 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -94.95 -12.44 26.76 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' C ' ' SD ' ' A' ' 76' ' ' MET . 3.9 tptt -81.9 67.02 7.72 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.016 0.436 . . . . 0.0 110.237 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.524 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -106.98 17.52 22.97 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.34 179.496 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -49.79 132.39 22.15 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.508 0.67 . . . . 0.0 111.41 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -92.51 108.12 19.73 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.107 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.0 m -93.5 121.29 34.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 82' ' ' GLU . 30.4 m-20 -69.42 113.19 6.51 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.4 m -37.78 -19.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.796 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 80' ' ' ASP . 83.2 tt0 -67.01 -41.05 87.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.863 0.363 . . . . 0.0 111.217 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -56.95 -40.75 77.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.724 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.56 ' O ' ' N ' ' A' ' 87' ' ' GLU . 51.0 tp10 -72.3 -80.52 0.06 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.655 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.504 ' C ' ' O ' ' A' ' 84' ' ' GLU . 1.9 pp -20.56 -60.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 123.684 0.615 . . . . 0.0 111.319 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.4 ' H ' ' CG1' ' A' ' 85' ' ' ILE . 9.1 ptm180 -60.76 -42.21 96.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.56 ' N ' ' O ' ' A' ' 84' ' ' GLU . 40.3 mm-40 -61.84 -40.07 94.01 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.939 0.399 . . . . 0.0 111.092 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -17.58 62.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.856 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -71.43 -52.79 16.59 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.735 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.559 HH21 ' CD ' ' A' ' 87' ' ' GLU . 78.9 mtm-85 -55.53 -40.63 72.08 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.874 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.62 -42.92 90.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -68.01 -37.91 81.97 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.417 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -89.34 83.7 6.43 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.43 -46.39 90.2 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.402 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 40.7 p-10 -91.5 4.55 52.27 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.386 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.39 49.9 37.07 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.19 6.7 41.59 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.77 0.55 89.85 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.669 -0.573 . . . . 0.0 111.669 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -139.5 151.92 46.55 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.615 0.722 . . . . 0.0 111.736 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.3 mt -95.9 117.5 40.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 m -91.32 152.81 20.31 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.19 80.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.412 1.005 . . . . 0.0 110.848 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.56 -40.52 62.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 110.676 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -65.33 -42.64 92.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.222 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 108' ' ' VAL . 21.2 mt -63.03 -45.15 93.68 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.29 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -41.53 -45.45 3.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.746 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.427 ' O ' ' OG1' ' A' ' 110' ' ' THR . 52.8 t-80 -59.78 -26.11 65.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.798 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 105' ' ' LEU . 63.4 t -58.33 -43.1 85.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.895 -178.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.3 mmt -51.15 -45.54 61.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.065 0.936 . . . . 0.0 111.098 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 60.0 p -57.92 -38.61 76.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.085 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -40.55 81.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.493 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 70.3 mt -81.32 -13.68 58.14 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.29 29.59 59.98 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.393 -1.226 . . . . 0.0 110.15 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -85.87 -22.62 27.45 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.779 2.29 . . . . 0.0 111.005 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm 44.77 61.81 2.33 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.222 1.01 . . . . 0.0 109.862 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 78.1 mt -80.65 147.0 30.86 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.472 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.8 p -81.95 175.54 10.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.614 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -57.15 -44.87 83.83 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.28 -48.26 79.34 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -72.75 -30.65 64.33 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.103 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.7 t -64.99 -43.22 96.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -69.15 -35.02 75.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.214 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -59.72 -47.57 85.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.059 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 15.8 mmm -55.18 -45.12 75.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.62 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 40.1 mm -58.14 -44.1 86.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.446 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -58.91 -39.57 81.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.746 0.308 . . . . 0.0 111.132 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.99 -41.68 83.52 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.52 -23.1 21.02 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.7 t0 -72.42 87.97 1.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.485 0.66 . . . . 0.0 112.098 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.69 -15.26 19.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.945 1.355 . . . . 0.0 113.265 -178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 37.6 p-10 -141.68 145.0 34.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.214 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.06 52.31 1.7 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.551 -0.357 . . . . 0.0 113.385 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -91.32 -8.76 47.26 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.182 0.491 . . . . 0.0 110.108 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.04 2.54 78.39 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.118 -0.563 . . . . 0.0 114.21 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -134.99 153.87 51.93 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 117.19 0.495 . . . . 0.0 110.551 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.7 118.57 47.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.321 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.428 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 59.9 t30 -83.65 173.0 11.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.06 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.428 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 83.4 t80 -61.8 -39.74 92.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.022 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -61.57 -44.68 96.58 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.621 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.11 -37.76 88.61 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.436 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -61.07 -44.94 96.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.701 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.405 ' O ' ' OG1' ' A' ' 146' ' ' THR . 72.1 t -65.05 -47.77 86.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.371 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -50.24 -44.35 53.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.171 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.4 mmt -73.33 -38.94 65.61 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 22.4 mmt -75.66 -46.92 28.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.911 -0.131 . . . . 0.0 111.021 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 6.7 p -89.24 31.51 0.89 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.564 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.86 87.1 5.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.746 0.308 . . . . 0.0 111.133 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.3 tptp . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.372 179.702 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -77.2 142.19 39.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.586 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.724 ' NE ' ' H ' ' B' 1088 ' ' ARG . 0.0 OUTLIER -107.84 95.43 5.68 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.162 0.506 . . . . 0.0 110.684 179.68 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -54.33 -3.62 0.26 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.574 ' H ' ' C ' ' B' 1088 ' ' ARG . 4.6 mt-30 -65.07 -51.9 58.78 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 68.4 mt -58.78 -50.12 80.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.6 mt -55.56 -62.39 1.72 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.659 -0.416 . . . . 0.0 112.026 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.51 -53.69 53.1 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.451 0.643 . . . . 0.0 112.111 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 53.8 t80 -58.02 -46.06 85.89 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -174.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -40.69 -52.33 2.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.23 -41.83 99.72 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.084 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.2 tp -55.93 -46.3 78.51 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.446 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 41.2 t30 -58.01 -48.31 80.42 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -64.96 -38.11 89.89 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 87.5 mt -60.91 -42.6 93.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.802 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -50.96 -44.99 60.68 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.505 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.4 m -63.0 -48.28 79.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.92 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.424 ' C ' ' O ' ' B' 1102 ' ' THR . 84.4 mt-30 -28.01 -58.64 0.11 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.805 1.288 . . . . 0.0 112.929 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -82.74 -15.4 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 112.25 -2.25 . . . . 0.0 111.985 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.505 ' N ' ' O ' ' B' 1102 ' ' THR . 88.8 tttt -58.8 -45.92 88.79 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 117.989 -1.484 . . . . 0.0 107.89 176.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.5 t -60.85 -49.06 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.57 -36.84 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.091 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 90.5 mttt -49.74 -37.16 28.25 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.512 0.672 . . . . 0.0 109.661 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.03 -45.53 64.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.285 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -63.13 -50.44 70.44 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -68.01 -41.8 81.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B 1112 ' ' SER . . . . . 0.408 ' O ' ' OG ' ' B' 1113 ' ' SER . 1.2 t 67.82 60.33 0.45 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 116.749 -1.596 . . . . 0.0 107.619 -176.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B 1113 ' ' SER . . . . . 0.408 ' OG ' ' O ' ' B' 1112 ' ' SER . 38.7 p . . . . . 0 C--O 1.218 -0.582 0 CA-C-N 124.214 3.188 . . . . 0.0 111.771 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -64.55 -35.35 80.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.56 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.731 ' H ' HE21 ' A' ' 3' ' ' GLN . 0.0 OUTLIER -101.32 101.77 12.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.117 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.2 mt -112.09 -21.13 11.67 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.695 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.7 p -79.97 138.62 37.11 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.997 0.817 . . . . 0.0 110.523 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 9' ' ' ILE . 27.1 mm-40 -49.17 -58.1 5.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 122.099 0.952 . . . . 0.0 110.788 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -35.64 -37.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 113.352 -1.749 . . . . 0.0 110.611 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.444 ' NE2' ' CG ' ' A' ' 3' ' ' GLN . 23.3 tt0 -70.19 -37.18 75.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.468 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.1 mt -59.76 -46.04 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.41 -48.63 62.58 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.51 -177.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.04 -44.36 92.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.551 0.691 . . . . 0.0 112.299 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.19 -39.99 96.22 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.862 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -50.22 -53.67 26.45 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.572 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -51.85 -39.2 58.5 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.174 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.35 -39.91 73.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.379 -178.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -55.55 -42.05 74.12 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.9 t -64.05 -16.54 61.92 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.381 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.67 -43.44 96.68 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -104.67 -15.13 15.36 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.602 -178.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -77.7 93.13 4.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.361 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -66.75 -46.83 74.15 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.706 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -101.7 15.15 29.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.24 50.48 3.65 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.732 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -89.43 -5.55 57.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.171 0.486 . . . . 0.0 111.898 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.12 0.69 73.69 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.849 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.7 p -141.25 159.76 41.54 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.971 0.415 . . . . 0.0 110.07 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.2 mt -92.32 126.19 44.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.419 ' OG1' ' OE1' ' A' ' 31' ' ' GLU . 19.1 p -111.78 162.65 15.03 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.044 0.84 . . . . 0.0 112.256 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 p -60.36 -37.97 82.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.87 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.43 -58.88 6.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.464 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.419 ' OE1' ' OG1' ' A' ' 28' ' ' THR . 10.1 pt-20 -63.38 -29.52 70.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.625 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 tp -61.08 -52.5 64.64 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.3 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.99 -38.09 94.93 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.938 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.2 m -58.76 -54.15 50.36 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.731 1.265 . . . . 0.0 108.593 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' O ' ' OG ' ' A' ' 38' ' ' SER . 48.5 t -57.79 -46.06 87.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 121.058 -1.026 . . . . 0.0 111.513 -176.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.3 tpt -59.31 -40.33 85.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 119.914 1.234 . . . . 0.0 109.531 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -53.35 -41.56 65.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.307 0.575 . . . . 0.0 110.251 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 47.6 p -63.71 -21.47 66.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.157 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.42 -4.09 31.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.61 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.01 60.74 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.032 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -106.68 155.12 20.0 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.642 0.721 . . . . 0.0 110.094 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 26.1 t-20 -116.46 62.85 2.58 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.37 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.25 145.7 93.37 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.265 1.977 . . . . 0.0 112.204 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.7 p -80.36 167.73 19.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.565 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -58.24 -44.06 88.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.805 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.7 -24.09 32.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.502 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -65.49 -38.6 90.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.016 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 10.8 mp -57.25 -42.26 81.17 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.311 0.577 . . . . 0.0 109.882 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -69.16 -56.48 7.53 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.383 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -55.32 -48.98 73.33 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.9 mmm -65.39 -51.68 58.71 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.6 mm -59.63 -48.9 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.777 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -57.82 -33.47 68.64 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.85 -39.84 94.2 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.53 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.21 -17.73 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.265 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.505 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.37 85.55 4.48 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -174.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.02 88.39 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 113.427 -1.715 . . . . 0.0 113.728 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.1 p-10 -85.6 -3.06 58.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.82 23.82 61.68 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.886 -0.509 . . . . 0.0 112.937 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.433 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.6 p-10 -87.56 3.76 46.26 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.174 0.487 . . . . 0.0 110.26 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.505 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.09 0.54 88.84 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.893 -0.67 . . . . 0.0 114.214 175.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.6 p -149.13 170.38 18.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.0 mt -112.59 128.77 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -104.41 -173.7 2.37 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.433 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.419 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -58.7 -46.11 99.59 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.412 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 35.3 Cg_exo -56.06 -53.39 5.51 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.465 1.443 . . . . 0.0 111.21 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.41 -22.08 66.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.15 0.5 . . . . 0.0 111.161 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.61 -61.41 1.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.9 mt -57.78 -43.83 85.84 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.3 m -40.74 -58.3 1.68 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.943 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -65.66 -41.42 92.55 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.983 -176.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 97.2 mmm -58.94 -41.24 86.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.26 77.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.352 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -93.93 -13.99 26.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.657 0.265 . . . . 0.0 111.239 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.42 ' C ' ' SD ' ' A' ' 76' ' ' MET . 0.1 OUTLIER -80.84 66.65 6.44 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.206 0.527 . . . . 0.0 110.591 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -108.37 15.61 23.83 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.441 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -49.62 134.59 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.245 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.84 108.62 19.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.156 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.9 m -93.33 121.32 34.59 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 82' ' ' GLU . 97.7 m-20 -68.63 112.3 5.32 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.9 m -37.49 -22.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.528 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.9 mp0 -69.43 -35.78 76.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.77 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -48.25 -35.84 12.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.257 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 84' ' ' GLU . 2.4 mp0 -90.95 -16.54 27.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.0 mm -59.99 -74.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.566 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -61.83 -41.2 97.51 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -62.53 -38.92 91.86 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.249 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.63 -20.74 65.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.998 0.427 . . . . 0.0 111.078 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -70.61 -49.93 42.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.053 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -54.85 -41.62 70.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.535 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.57 -43.82 94.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -68.38 -39.68 81.68 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.188 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.492 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 27.1 t0 -87.15 83.54 7.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.511 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 88.6 tttt -58.04 -49.61 76.27 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 35.1 p-10 -91.88 4.51 52.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.696 0.284 . . . . 0.0 111.608 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.56 49.29 53.19 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.681 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -90.61 5.24 48.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.793 0.33 . . . . 0.0 110.83 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.445 ' N ' HD21 ' A' ' 97' ' ' ASN . . . 84.98 2.0 88.56 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.681 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 88.1 m-85 -140.01 152.88 46.62 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.611 0.719 . . . . 0.0 111.506 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.3 mt -94.04 115.31 32.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 t -89.07 150.93 22.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.634 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.32 83.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.981 0.81 . . . . 0.0 110.646 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.74 -39.59 65.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.862 0.363 . . . . 0.0 110.443 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.511 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.2 mt-10 -66.64 -41.18 88.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.338 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.09 -45.71 90.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.456 0.646 . . . . 0.0 110.997 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -44.23 -43.18 7.06 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.422 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -65.49 -28.62 69.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.51 0.195 . . . . 0.0 111.236 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.21 -42.46 83.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.573 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.496 ' SD ' ' CD1' ' A' ' 116' ' ' LEU . 36.8 mmt -51.34 -43.22 61.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.82 0.819 . . . . 0.0 111.107 -177.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 m -57.93 -41.68 83.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.763 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -42.32 82.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.681 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.58 -15.85 56.93 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.475 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.1 28.7 59.91 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -84.43 -22.49 30.36 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.625 2.213 . . . . 0.0 110.59 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 43.07 58.68 3.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.804 0.811 . . . . 0.0 110.301 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.496 ' CD1' ' SD ' ' A' ' 109' ' ' MET . 50.9 mt -79.52 149.15 31.55 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.679 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 70.2 p -82.71 175.29 10.25 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.5 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -58.14 -44.17 87.69 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.47 -49.44 76.28 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.61 -30.68 67.41 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.88 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.5 t -63.51 -42.41 96.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.29 -35.66 73.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.335 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -59.74 -50.89 72.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 90.5 mtp -57.12 -43.52 82.41 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.137 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.38 -44.18 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.286 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -59.57 -38.82 82.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.033 0.444 . . . . 0.0 111.208 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -57.23 -40.45 77.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.848 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.58 -20.09 22.04 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.1 t0 -75.36 86.1 2.52 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.389 0.614 . . . . 0.0 111.916 -177.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.6 pt -71.87 -12.08 15.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.275 -177.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 40.6 p-10 -140.67 142.09 34.95 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 112.504 -2.135 . . . . 0.0 108.771 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.69 52.09 1.55 Allowed Glycine 0 CA--C 1.53 1.012 0 CA-C-O 120.269 -0.184 . . . . 0.0 113.472 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -91.17 -7.92 50.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.281 0.54 . . . . 0.0 110.139 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.68 1.3 66.04 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.131 -0.557 . . . . 0.0 114.296 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -135.01 153.66 52.0 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.426 0.613 . . . . 0.0 110.478 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 51.3 t -100.74 118.54 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.451 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -84.2 174.87 9.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -61.84 -40.85 96.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.133 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.39 -44.82 95.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.891 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -63.91 -38.49 91.29 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.461 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -60.22 -45.54 92.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.594 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.402 ' O ' ' OG1' ' A' ' 146' ' ' THR . 77.9 t -65.57 -47.95 84.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.269 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.71 -46.7 59.07 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.316 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.404 ' O ' ' CE1' ' B' 1094 ' ' PHE . 11.8 mmt -72.08 -39.44 68.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.8 mmt -77.03 -46.58 23.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.391 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 10.8 p -93.12 34.39 1.12 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -46.67 -40.5 13.27 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.227 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.237 -179.881 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B 1086 ' ' LEU . . . . . 0.513 ' N ' ' CD2' ' B' 1086 ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1087 ' ' ARG . . . . . 0.509 ' C ' ' H ' ' B' 1089 ' ' GLY . 91.5 mtm-85 -78.28 -12.44 60.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.742 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.628 ' C ' ' H ' ' B' 1090 ' ' GLN . 25.2 ttm180 -67.7 8.2 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B 1089 ' ' GLY . . . . . 0.509 ' H ' ' C ' ' B' 1087 ' ' ARG . . . -62.94 9.2 0.17 Allowed Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.628 ' H ' ' C ' ' B' 1088 ' ' ARG . 75.4 mt-30 -59.38 -43.8 92.85 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.927 0.394 . . . . 0.0 111.769 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 61.8 mt -47.78 -62.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.781 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.0 mt -55.7 -52.98 62.04 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.151 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.1 m95 -59.44 -62.67 1.71 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.333 0.587 . . . . 0.0 112.199 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1094 ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 144' ' ' MET . 40.1 m-85 -57.71 -42.6 84.1 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -174.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -40.6 -51.51 2.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.602 0.715 . . . . 0.0 112.664 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.36 -41.83 99.74 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.79 -46.32 81.62 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.563 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -59.61 -48.15 82.78 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 24.0 mtp-105 -65.49 -38.08 88.69 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.605 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.98 -42.18 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.884 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -51.12 -46.53 61.95 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.51 ' O ' ' N ' ' B' 1105 ' ' LYS . 99.1 m -63.83 -47.88 79.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.609 -0.436 . . . . 0.0 112.002 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.427 ' C ' ' O ' ' B' 1102 ' ' THR . 84.0 mt-30 -28.24 -57.53 0.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.538 1.161 . . . . 0.0 112.435 -176.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -84.58 -15.5 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 112.202 -2.272 . . . . 0.0 112.449 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.51 ' N ' ' O ' ' B' 1102 ' ' THR . 88.6 tttt -60.24 -46.55 89.4 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 118.077 -1.449 . . . . 0.0 107.951 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 57.7 t -61.89 -48.72 87.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.61 -36.27 77.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.774 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 87.4 mttt -49.54 -36.04 22.24 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 119.919 -0.713 . . . . 0.0 109.488 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.57 -45.65 70.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.059 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -62.49 -50.51 71.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.109 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -68.48 -41.42 80.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.2 t 67.92 58.44 0.48 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.482 1.127 0 CA-C-N 123.33 2.786 . . . . 0.0 112.383 179.301 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -64.56 -36.85 85.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.457 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -94.38 -175.32 3.61 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 162.23 -24.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 118.976 -0.535 . . . . 0.0 109.569 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.2 p -76.92 139.73 40.29 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 119.934 1.243 . . . . 0.0 110.35 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.593 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -50.78 -47.99 59.53 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.391 1.091 . . . . 0.0 110.653 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.476 ' H ' ' HG2' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -38.21 -38.87 0.37 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.884 -179.007 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -68.35 -38.96 81.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.469 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.3 mt -59.76 -44.6 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 175.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.0 -49.17 63.86 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.094 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.449 ' OE2' ' OE2' ' A' ' 7' ' ' GLU . 98.4 mt-10 -60.46 -47.56 85.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 111.748 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -59.0 -42.12 89.32 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.866 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -50.42 -57.31 8.29 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.396 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -51.18 -44.72 61.58 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.847 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.72 -37.79 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.218 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.44 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 2.6 m-85 -58.44 -40.38 82.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.2 p -65.2 -15.56 62.59 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.456 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.7 -42.13 95.51 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -105.61 -13.99 15.42 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -71.92 93.91 1.39 Allowed 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.472 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -67.41 -49.64 62.89 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.833 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.1 p30 -103.62 14.88 30.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.16 44.79 0.82 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.164 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 31.0 p-10 -85.02 -3.17 58.69 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.729 0.299 . . . . 0.0 110.89 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 -0.83 78.87 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 t -140.48 154.9 46.77 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.15 0.5 . . . . 0.0 110.097 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.8 mp -91.41 123.96 43.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.4 p -111.77 162.98 14.66 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.853 0.835 . . . . 0.0 112.064 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.7 p -59.93 -37.57 79.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.629 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -60.47 -57.01 14.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.472 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -64.31 -28.71 69.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.479 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tp -60.8 -53.42 57.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.062 0.934 . . . . 0.0 109.765 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.3 -37.48 94.11 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.124 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -58.81 -52.8 64.15 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.777 1.288 . . . . 0.0 108.813 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.422 ' O ' ' OG ' ' A' ' 38' ' ' SER . 42.3 t -57.93 -45.03 87.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 119.404 1.002 . . . . 0.0 111.278 -176.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.7 tpt -59.07 -38.73 80.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 120.028 1.285 . . . . 0.0 109.555 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -51.46 -38.36 53.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.65 0.738 . . . . 0.0 110.457 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 37.9 p -63.13 -20.94 65.84 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.439 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.81 0.79 12.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.77 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.5 27.05 40.55 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.23 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -130.54 170.04 14.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.415 0.607 . . . . 0.0 109.923 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -133.8 76.42 65.65 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.396 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.14 147.57 95.29 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.764 2.31 . . . . 0.0 111.995 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.2 t -76.0 164.51 26.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.256 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.18 -43.75 87.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.983 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.33 -24.24 42.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.545 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.65 -38.76 90.24 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.057 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.57 -40.86 75.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.298 0.571 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -70.89 -56.38 6.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.803 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -55.25 -50.45 69.44 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.1 mmm -65.02 -51.53 61.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.1 mm -59.54 -48.14 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.821 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -58.37 -33.51 69.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -65.68 -39.62 91.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.215 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.31 -19.43 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.276 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.2 t0 -78.01 86.59 4.19 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -174.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.35 90.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.234 -1.803 . . . . 0.0 113.988 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -86.33 -2.76 58.69 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.0 23.66 61.88 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 118.467 0.576 . . . . 0.0 112.988 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -87.91 3.14 49.62 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.257 0.528 . . . . 0.0 110.333 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.63 0.54 87.9 Favored Glycine 0 CA--C 1.52 0.361 0 O-C-N 121.586 -0.696 . . . . 0.0 114.569 175.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.2 p -147.66 169.22 20.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.8 mt -112.79 128.51 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.558 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 23.6 t0 -103.16 -177.19 3.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.639 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.558 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -56.71 -47.94 98.12 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.513 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.3 -49.54 14.83 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.215 1.277 . . . . 0.0 111.889 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.21 -19.63 64.69 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.476 0.655 . . . . 0.0 110.927 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -74.43 -59.63 2.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.752 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.47 -43.44 79.59 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.0 m -45.59 -48.47 14.53 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.607 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.8 mtm -67.09 -45.59 76.8 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.0 mmm -61.4 -39.2 89.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.02 79.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.644 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -93.6 -14.56 26.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.572 0.225 . . . . 0.0 111.304 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.498 ' O ' ' NZ ' ' B' 1105 ' ' LYS . 0.0 OUTLIER -83.1 64.64 7.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.218 0.532 . . . . 0.0 110.49 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.3 mmt -107.5 16.53 23.72 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.801 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -38.7 141.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.357 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.54 -70.43 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.831 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.5 m 58.99 77.27 0.31 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.8 m-20 -57.61 126.0 25.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.3 m -38.99 -18.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.835 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 80' ' ' ASP . 72.4 mm-40 -68.38 -36.38 79.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.936 0.398 . . . . 0.0 111.757 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -51.37 -39.25 56.73 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.418 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.462 ' OE2' ' NE2' ' B' 1101 ' ' GLN . 12.3 pt-20 -86.12 -4.33 59.15 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.3 mm -69.56 -73.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.883 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -60.29 -51.96 67.31 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 88' ' ' ALA . 3.1 pp20? -55.35 -37.6 67.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.007 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' N ' ' CD ' ' A' ' 87' ' ' GLU . . . -60.51 -22.31 63.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.932 0.396 . . . . 0.0 110.902 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -73.76 -48.61 30.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.304 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -55.29 -42.27 73.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.587 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.13 -44.75 97.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -69.33 -39.07 78.4 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.456 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.523 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 27.9 t0 -88.29 83.49 6.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.17 -48.67 80.75 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -90.9 5.06 50.14 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.66 0.267 . . . . 0.0 111.631 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.76 48.42 50.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.687 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -91.43 4.61 52.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.567 0.223 . . . . 0.0 110.697 179.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.435 ' N ' HD21 ' A' ' 97' ' ' ASN . . . 86.21 0.89 86.71 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.687 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 90.5 m-85 -139.19 152.28 47.26 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.838 0.827 . . . . 0.0 111.622 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -94.12 115.57 33.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.3 t -88.46 150.52 23.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.555 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.33 -45.79 83.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 119.167 0.894 . . . . 0.0 110.741 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.89 -40.86 66.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.984 0.421 . . . . 0.0 110.588 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -65.3 -41.35 94.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.956 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.71 -44.36 93.86 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.605 0.716 . . . . 0.0 111.207 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -45.7 -44.6 13.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.499 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -62.35 -29.0 70.15 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.605 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 84.6 t -58.32 -41.24 80.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.87 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.626 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.59 -46.54 63.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.179 0.99 . . . . 0.0 111.446 -177.214 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -56.97 -41.42 78.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.442 -1.708 . . . . 0.0 110.675 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -65.2 -40.8 94.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.768 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.535 ' O ' ' NH1' ' B' 1099 ' ' ARG . 76.6 mt -81.5 -14.5 56.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.788 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.11 30.33 57.4 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.566 -1.13 . . . . 0.0 110.366 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -86.49 -22.86 26.19 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.749 2.275 . . . . 0.0 110.75 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 43.43 60.83 2.44 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 122.31 1.052 . . . . 0.0 110.089 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.8 mt -79.06 148.22 32.53 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 113.417 -1.719 . . . . 0.0 112.637 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 62.2 p -82.46 174.99 10.57 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.383 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -57.83 -44.53 86.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -57.84 -50.67 72.51 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.56 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -68.3 -30.79 69.87 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.826 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.18 -42.46 95.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.396 0.617 . . . . 0.0 109.342 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 67.8 t0 -67.03 -37.77 84.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.722 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.28 -48.01 83.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.449 ' SD ' ' CD1' ' B' 1093 ' ' TRP . 20.2 mmm -54.96 -45.69 74.97 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.808 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 46.5 mm -59.62 -44.88 94.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.35 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -58.37 -40.11 81.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.371 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.69 -41.0 76.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.073 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.67 -16.99 24.86 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.5 t0 -73.41 87.97 1.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.457 0.646 . . . . 0.0 112.076 -177.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 tt -70.78 -14.79 18.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.531 1.158 . . . . 0.0 113.241 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.5 p-10 -142.9 144.6 32.5 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.31 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.53 52.49 1.16 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.709 -0.282 . . . . 0.0 113.175 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -91.14 -9.97 43.59 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.098 0.449 . . . . 0.0 110.119 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.66 2.09 74.31 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.162 -0.542 . . . . 0.0 114.293 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -134.57 154.27 51.56 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.413 0.607 . . . . 0.0 110.435 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.49 118.51 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.272 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 46.8 t30 -85.17 175.24 9.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.917 0.389 . . . . 0.0 110.962 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.509 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 74.2 t80 -61.59 -41.02 96.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.492 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 13.1 pt-20 -62.23 -44.45 96.53 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.839 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 139' ' ' GLU . 96.8 mt-10 -64.39 -37.66 88.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.892 0.377 . . . . 0.0 110.566 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -61.12 -45.63 93.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.594 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.65 -47.79 84.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.681 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.438 ' O ' ' CB ' ' A' ' 147' ' ' ALA . 71.5 tp60 -47.27 -50.04 22.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.115 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 91.7 mmm -70.04 -35.47 74.32 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.452 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 22.7 mmt -71.79 -43.21 66.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.861 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.7 m -85.11 -32.84 22.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.628 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 143' ' ' GLN . . . -53.54 133.37 41.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.181 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.39 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B 1086 ' ' LEU . . . . . 0.495 ' N ' ' CD2' ' B' 1086 ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -134.52 139.04 45.15 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.545 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.562 ' C ' ' H ' ' B' 1090 ' ' GLN . 55.2 ttp180 57.56 42.52 24.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.622 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -61.96 2.15 1.07 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.562 ' H ' ' C ' ' B' 1088 ' ' ARG . 84.4 mt-30 -61.2 -44.65 96.94 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 57.8 mt -48.7 -58.76 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 10.3 mt -55.4 -52.21 64.31 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.722 -176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1093 ' ' TRP . . . . . 0.449 ' CD1' ' SD ' ' A' ' 124' ' ' MET . 5.5 m95 -60.95 -57.5 12.36 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.587 0.708 . . . . 0.0 112.095 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B 1094 ' ' PHE . . . . . 0.452 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 17.5 m-85 -57.61 -43.99 85.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -40.05 -51.98 2.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.11 99.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.371 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.9 tp -57.23 -44.86 84.18 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.507 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 16.1 m120 -59.17 -47.32 85.74 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.691 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1099 ' ' ARG . . . . . 0.535 ' NH1' ' O ' ' A' ' 112' ' ' LEU . 79.5 mtp180 -65.16 -37.94 88.99 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 4.0 mm -60.58 -41.86 89.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.436 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1101 ' ' GLN . . . . . 0.462 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 81.8 mt-30 -52.0 -49.28 63.64 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.468 ' O ' ' N ' ' B' 1105 ' ' LYS . 21.3 m -64.98 -47.81 76.23 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.415 ' C ' ' O ' ' B' 1102 ' ' THR . 36.6 mm-40 -28.18 -59.86 0.12 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.758 1.266 . . . . 0.0 112.324 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.5 mt -83.94 -15.9 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 111.716 -2.493 . . . . 0.0 112.471 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 75' ' ' LYS . 66.1 tttm -59.39 -44.41 92.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.009 -1.477 . . . . 0.0 107.838 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 61.6 t -61.49 -48.98 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -66.36 -36.89 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.161 -177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.6 mttt -49.77 -38.11 32.68 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.661 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.03 62.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.27 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -63.35 -50.0 71.69 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -67.92 -42.06 81.67 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.9 58.83 0.37 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.47 0.57 0 CA-C-N 123.728 2.967 . . . . 0.0 112.264 179.408 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 3' ' ' GLN . 33.4 p-10 -90.87 6.03 46.1 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.539 ' OE1' ' CE2' ' A' ' 12' ' ' PHE . 60.3 tt0 51.65 103.44 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.393 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.79 -14.34 8.55 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.041 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -80.02 135.4 36.36 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.512 1.051 . . . . 0.0 110.055 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.8 tt0 -51.04 -60.2 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.029 0.918 . . . . 0.0 111.373 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -34.55 -38.03 0.07 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.933 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -70.35 -31.63 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.647 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.2 mt -57.22 -44.09 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 121.922 2.146 . . . . 0.0 105.355 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.55 -51.61 62.37 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.286 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -62.29 -46.48 88.6 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.411 0.624 . . . . 0.0 112.312 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.539 ' CE2' ' OE1' ' A' ' 3' ' ' GLN . 10.0 m-85 -61.68 -40.67 95.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.9 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -52.19 -56.15 16.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.235 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -48.7 -42.69 35.73 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.102 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.36 -37.32 69.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.201 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.406 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 2.0 m-85 -56.42 -40.79 75.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -65.9 -15.61 63.1 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.428 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.34 -43.26 98.22 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -106.41 -14.51 15.06 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.871 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -75.37 96.11 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.252 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -67.96 -48.13 66.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.229 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.2 p-10 -102.89 14.48 31.86 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.96 48.72 1.41 Allowed Glycine 0 N--CA 1.468 0.83 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.091 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 36.1 p-10 -86.49 -4.77 59.22 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.71 0.29 . . . . 0.0 111.237 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.51 -1.55 79.25 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.8 p -139.41 156.11 47.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.22 0.534 . . . . 0.0 109.732 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -93.02 124.34 45.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 30' ' ' LYS . 1.2 t -115.0 165.52 12.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.8 -177.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.0 p -58.04 -39.52 78.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.439 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' H ' HG22 ' A' ' 28' ' ' THR . 62.4 tttp -58.67 -59.93 4.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.724 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -63.11 -30.71 71.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 119.598 -0.239 . . . . 0.0 111.51 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 tp -59.73 -56.39 22.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.501 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.84 -38.96 94.79 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 113.757 -1.565 . . . . 0.0 112.037 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.5 m -58.52 -53.44 58.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.107 1.454 . . . . 0.0 108.656 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.86 -46.23 87.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 118.991 0.814 . . . . 0.0 111.457 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.0 tpt -59.45 -41.84 90.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 120.112 1.324 . . . . 0.0 109.839 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -54.21 -41.98 69.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.602 0.715 . . . . 0.0 110.27 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -64.35 -22.75 67.06 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.944 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 tp -73.04 -3.41 26.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.666 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.09 13.56 58.76 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.547 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -107.75 155.41 20.24 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.66 0.73 . . . . 0.0 109.789 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' C ' HD21 ' A' ' 42' ' ' ASN . 0.3 OUTLIER -117.17 65.19 3.87 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.357 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.05 145.49 85.15 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.172 1.915 . . . . 0.0 112.215 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.1 p -79.86 167.25 20.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.092 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -57.8 -44.26 86.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.014 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.19 -23.15 20.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.489 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -66.79 -38.81 87.26 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.254 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.8 mp -56.08 -40.59 73.86 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -72.08 -57.08 4.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.057 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -54.13 -49.49 69.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 41.7 mmm -66.19 -52.23 50.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.9 mm -57.92 -48.21 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.476 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -56.71 -33.97 67.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -66.45 -40.05 89.19 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.668 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.25 -20.29 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.404 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 41.1 t0 -78.01 86.85 4.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -174.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.74 86.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.377 -1.738 . . . . 0.0 114.302 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 37.7 p-10 -87.62 -2.65 58.76 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.28 23.22 64.08 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 118.632 0.651 . . . . 0.0 112.721 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.42 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -88.04 2.02 52.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.393 0.597 . . . . 0.0 110.688 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.65 0.85 87.76 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 175.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.6 p -148.62 171.39 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.8 mt -115.21 129.2 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -104.33 -173.65 2.36 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -59.68 -48.58 94.98 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -177.287 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.66 -53.22 5.97 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.183 1.255 . . . . 0.0 111.66 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.62 -16.77 41.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.594 0.711 . . . . 0.0 110.312 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -76.08 -58.17 3.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.16 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' THR . 77.4 mt -56.99 -45.36 83.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.2 p -44.07 -49.76 8.69 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.459 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.4 mtm -67.55 -45.43 75.68 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.4 mmt -58.45 -38.78 78.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.95 76.62 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.683 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -94.87 -11.19 29.22 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.8 0.333 . . . . 0.0 111.453 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.45 67.44 8.49 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.278 0.561 . . . . 0.0 110.337 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 mmt -109.26 15.66 22.99 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.747 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -52.31 132.28 33.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.418 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -106.63 159.4 16.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.959 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.437 ' OG1' ' OE1' ' A' ' 83' ' ' GLU . 0.7 OUTLIER -144.9 136.08 25.03 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 82' ' ' GLU . 41.8 t0 -61.55 116.16 4.5 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 174.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.6 m -36.94 -19.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 80' ' ' ASP . 94.8 mt-10 -69.02 -35.21 76.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' OE1' ' OG1' ' A' ' 79' ' ' THR . 41.5 tt0 -48.7 -38.37 21.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.487 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -86.49 -17.66 33.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.305 0.574 . . . . 0.0 111.761 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 mm -61.37 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.116 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -62.21 -40.8 97.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.98 -42.11 97.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.811 0.338 . . . . 0.0 111.679 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.98 -19.51 52.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -75.44 -49.05 20.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.985 0.421 . . . . 0.0 111.233 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -55.49 -42.52 74.51 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.607 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.7 -44.47 96.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -69.19 -38.25 78.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.553 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -85.94 81.22 8.61 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -58.32 -48.99 78.77 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -176.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.2 p30 -90.99 5.53 48.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.471 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.39 48.33 48.55 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -92.16 6.81 45.2 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.597 0.237 . . . . 0.0 110.603 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.62 1.42 89.14 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -141.12 154.05 45.71 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.893 0.854 . . . . 0.0 111.725 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.7 mt -95.09 115.85 35.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 p -90.58 153.05 20.62 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.31 82.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.28 0.945 . . . . 0.0 110.946 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.41 -43.81 68.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.946 0.403 . . . . 0.0 110.711 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.31 -42.54 99.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.596 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 108' ' ' VAL . 6.2 tt -63.93 -45.28 89.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.226 0.536 . . . . 0.0 111.608 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -41.99 -45.01 3.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.61 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.409 ' O ' ' OG1' ' A' ' 110' ' ' THR . 56.9 t-80 -59.73 -26.88 66.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.714 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 105' ' ' LEU . 86.6 t -57.95 -42.97 83.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.671 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.449 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.17 -49.22 61.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.15 0.976 . . . . 0.0 111.89 -177.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 69.8 p -52.65 -38.89 61.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.622 -1.627 . . . . 0.0 110.901 -177.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.42 ' N ' HD21 ' A' ' 111' ' ' ASN . 1.8 m120 -65.76 -39.08 90.69 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.495 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.2 mt -83.95 -12.96 54.57 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.76 38.24 50.29 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.353 -1.248 . . . . 0.0 110.196 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -89.45 -22.79 22.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.913 2.357 . . . . 0.0 111.118 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt 45.01 58.41 4.05 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.611 1.196 . . . . 0.0 110.065 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.411 ' O ' ' CD2' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -75.63 149.74 38.14 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 112.952 -1.931 . . . . 0.0 112.982 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 33.4 p -84.07 174.67 10.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 110.349 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.86 -44.73 74.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.3 -41.57 72.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.123 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.17 -28.64 65.48 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.519 -0.472 . . . . 0.0 112.037 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 49.2 t -64.03 -43.68 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.297 0.57 . . . . 0.0 109.63 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -74.62 -36.15 62.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.204 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.604 ' CG ' HH22 ' B' 1087 ' ' ARG . 82.5 tt0 -60.0 -54.11 49.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.8 mmm -51.27 -52.15 47.64 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.01 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -56.22 -42.58 73.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.582 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -60.02 -36.97 78.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.643 0.259 . . . . 0.0 111.428 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -57.62 -40.78 79.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.717 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.71 -15.01 25.67 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.6 t0 -77.57 82.73 3.99 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.642 0.734 . . . . 0.0 111.682 -177.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.7 pt -70.89 -7.56 9.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 122.622 1.201 . . . . 0.0 113.351 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.9 p-10 -144.45 143.32 30.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 112.458 -2.156 . . . . 0.0 109.171 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.13 51.46 1.67 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 122.202 -0.311 . . . . 0.0 113.41 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -90.72 -10.59 42.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.274 0.537 . . . . 0.0 109.835 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.6 -0.45 64.89 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.54 0.576 . . . . 0.0 114.54 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -132.73 153.17 51.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.339 0.57 . . . . 0.0 110.471 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.45 117.96 45.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.232 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.452 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 53.8 t30 -83.99 173.07 11.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.934 0.397 . . . . 0.0 110.949 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.452 ' H ' ' CG ' ' A' ' 137' ' ' ASN . 80.5 t80 -61.16 -39.56 90.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.998 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.23 -44.51 96.39 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.854 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.98 -37.82 88.82 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.626 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -61.21 -44.87 96.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.706 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.7 t -65.1 -47.42 87.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.365 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -50.58 -42.74 56.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.736 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.2 mmt -74.64 -40.13 61.67 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.5 mmt -77.2 -44.57 29.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.884 -0.144 . . . . 0.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 m -88.74 31.8 0.83 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.587 0.232 . . . . 0.0 111.335 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -44.76 -45.48 9.98 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.825 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.8 tttm . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.372 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B 1086 ' ' LEU . . . . . 0.497 ' N ' ' CD2' ' B' 1086 ' ' LEU . 3.8 mm? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1087 ' ' ARG . . . . . 0.604 HH22 ' CG ' ' A' ' 123' ' ' GLU . 34.2 ptt180 -161.48 46.02 0.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.459 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.569 ' C ' ' H ' ' B' 1090 ' ' GLN . 35.9 ttm180 48.2 45.79 19.85 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -59.2 1.74 0.35 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.617 ' NE2' ' N ' ' B' 1090 ' ' GLN . 0.1 OUTLIER -59.16 -42.9 91.85 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.559 0.219 . . . . 0.0 111.374 -178.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 57.0 mt -57.29 -51.49 68.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 11.1 mt -56.42 -62.08 1.97 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.68 -56.6 18.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.289 0.566 . . . . 0.0 112.357 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1094 ' ' PHE . . . . . 0.528 ' CE2' ' OD1' ' B' 1098 ' ' ASN . 11.8 t80 -59.83 -48.47 81.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -174.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -39.33 -51.92 2.04 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.0 -39.39 96.99 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.027 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.1 tp -57.15 -41.95 80.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 118.322 1.061 . . . . 0.0 109.559 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1098 ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' B' 1094 ' ' PHE . 6.2 m-20 -59.85 -51.58 69.11 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 76.0 mmt-85 -65.47 -39.81 92.41 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.21 -41.35 83.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.422 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -50.4 -45.36 55.53 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.524 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.3 m -63.69 -47.98 78.98 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.434 ' C ' ' O ' ' B' 1102 ' ' THR . 23.9 mt-30 -27.64 -57.54 0.1 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.61 1.195 . . . . 0.0 112.31 -176.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.8 mt -84.77 -13.81 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.437 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.524 ' N ' ' O ' ' B' 1102 ' ' THR . 38.3 ttmt -59.85 -45.66 91.71 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 118.181 -1.408 . . . . 0.0 108.069 176.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.6 t -60.52 -49.78 83.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.7 m -65.8 -36.0 76.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.967 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 86.6 mttt -50.12 -37.69 35.33 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.608 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.59 -45.62 63.21 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.202 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.99 -49.65 73.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B 1111 ' ' HIS . . . . . 0.437 ' O ' ' OG ' ' B' 1112 ' ' SER . 69.3 m-70 -68.45 -41.69 79.89 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B 1112 ' ' SER . . . . . 0.464 ' OG ' ' O ' ' B' 1112 ' ' SER . 5.6 p 68.32 59.44 0.42 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 117.358 -1.306 . . . . 0.0 107.48 -177.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B 1113 ' ' SER . . . . . 0.4 ' C ' ' O ' ' B' 1112 ' ' SER . 17.9 t . . . . . 0 C--O 1.22 -0.499 0 CA-C-N 123.75 2.977 . . . . 0.0 111.709 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 3' ' ' GLN . 46.5 t0 -104.74 15.27 28.23 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 2' ' ' ASP . 2.5 mp0 51.67 104.29 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.219 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.4 mt -109.5 -22.27 12.08 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.62 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 m -78.92 136.19 37.19 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.386 0.994 . . . . 0.0 110.138 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 9' ' ' ILE . 9.4 tm-20 -51.43 -55.47 18.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.893 0.854 . . . . 0.0 111.089 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -37.62 -36.89 0.19 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.648 -1.615 . . . . 0.0 110.576 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -70.25 -32.4 70.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 118.45 -0.785 . . . . 0.0 110.723 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.7 mt -59.54 -45.26 94.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 175.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.23 -49.4 64.05 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.617 -177.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.36 -46.56 88.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.359 0.599 . . . . 0.0 111.923 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -62.83 -39.3 93.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.812 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -52.64 -53.2 50.26 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.56 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.26 -39.77 60.81 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.059 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.67 70.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.084 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.441 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 3.8 m-85 -58.49 -40.85 83.92 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.5 m -65.29 -14.61 61.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.782 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.22 -41.64 94.25 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -105.64 -13.56 15.54 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -74.61 93.14 2.48 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.26 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -69.28 -47.24 65.14 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.96 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.5 p-10 -102.19 13.64 34.13 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.945 -0.472 . . . . 0.0 112.195 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.98 46.64 1.23 Allowed Glycine 0 CA--C 1.533 1.199 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.996 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -86.18 -4.19 59.12 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.637 -0.331 . . . . 0.0 110.957 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.12 84.51 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.9 p -137.3 152.13 49.42 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.105 0.479 . . . . 0.0 109.982 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.93 124.36 45.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.7 p -113.48 164.52 13.51 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.941 0.877 . . . . 0.0 112.194 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 p -59.2 -38.25 79.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.541 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.413 ' CB ' ' HZ3' ' A' ' 30' ' ' LYS . 6.2 ttpm? -62.1 -56.63 16.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.556 -178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -64.24 -30.23 71.29 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.37 -52.25 65.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.264 1.031 . . . . 0.0 109.515 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.85 -35.61 87.26 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.865 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.22 -53.14 61.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.09 1.445 . . . . 0.0 108.661 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.44 -45.66 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 120.731 -1.23 . . . . 0.0 111.636 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.6 ttt -59.06 -40.91 86.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 120.064 1.302 . . . . 0.0 109.643 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -53.16 -37.02 61.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.556 0.693 . . . . 0.0 110.48 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.5 t -62.39 -20.25 64.25 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.735 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.4 mt -75.82 2.9 11.09 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.1 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.58 16.16 74.09 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.91 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -109.55 160.31 16.35 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.582 0.691 . . . . 0.0 109.872 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -112.82 69.2 1.1 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.085 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.7 141.84 67.81 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.845 1.697 . . . . 0.0 112.181 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -81.58 157.36 24.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.029 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.0 -42.13 68.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.762 0.315 . . . . 0.0 110.572 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.9 -25.64 43.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.346 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -65.63 -39.48 91.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.816 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.2 mp -56.06 -40.96 74.34 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.492 0.663 . . . . 0.0 109.847 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -69.12 -56.49 7.53 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.655 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -53.13 -48.69 67.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.412 ' SD ' ' NE2' ' B' 1111 ' ' HIS . 1.5 mtm -71.44 -44.51 64.68 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.1 mm -58.57 -48.41 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -56.58 -34.34 67.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -66.11 -40.41 90.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.669 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -85.52 -21.43 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.275 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.445 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.5 t0 -78.45 86.12 4.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -175.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.28 89.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.179 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 36.4 p-10 -85.58 -3.25 58.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.62 23.73 61.12 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 121.872 -0.518 . . . . 0.0 113.029 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.4 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.1 p-10 -87.51 4.65 42.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.046 0.423 . . . . 0.0 110.348 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.445 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.03 0.66 89.7 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.871 -0.681 . . . . 0.0 114.38 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.4 p -147.79 167.49 24.6 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.2 mt -112.62 128.4 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -103.82 -174.57 2.58 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.66 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.441 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.63 -47.28 99.03 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -176.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -56.61 -51.38 9.26 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.415 1.41 . . . . 0.0 111.354 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.95 -20.51 65.3 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.372 0.606 . . . . 0.0 111.097 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -71.24 -58.33 3.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.871 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.76 -44.3 86.06 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 m -40.5 -59.09 1.42 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.665 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -64.8 -41.6 95.68 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -176.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 98.2 mmm -59.44 -39.6 84.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.36 78.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.286 0.235 . . . . 0.0 111.499 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -96.65 -8.48 31.48 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.228 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 67.18 7.24 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.169 0.509 . . . . 0.0 110.24 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 19.8 mmt -108.54 16.41 23.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.782 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -52.67 130.99 34.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.674 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 54.3 p-10 -105.57 148.07 27.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.781 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.1 p -133.65 134.1 42.75 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 82' ' ' GLU . 22.7 t0 -62.05 117.17 5.62 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.9 m -37.45 -20.49 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.615 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 80' ' ' ASP . 71.3 mm-40 -69.36 -34.32 74.4 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 111.616 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -49.1 -37.88 22.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.596 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -86.87 -19.28 29.15 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.132 0.491 . . . . 0.0 111.671 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.36 -74.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.853 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -62.39 -40.58 96.93 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.98 -40.91 97.23 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.665 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.07 -21.19 63.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.104 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -71.44 -50.55 30.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.091 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -55.28 -43.03 74.37 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.79 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.37 -44.13 94.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -68.22 -38.21 81.66 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.244 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -85.28 81.51 8.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -58.81 -48.76 80.17 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -91.29 4.56 52.03 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 122.236 -0.29 . . . . 0.0 111.274 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.13 46.22 56.56 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -90.08 6.75 41.11 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.679 0.276 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.26 2.0 89.33 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -140.14 152.52 46.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.747 0.784 . . . . 0.0 111.688 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -93.46 114.84 30.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -88.03 150.0 23.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.299 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.71 -45.39 85.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.17 0.896 . . . . 0.0 110.586 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.74 -40.66 72.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.912 0.386 . . . . 0.0 110.568 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.68 -42.54 91.17 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.261 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 108' ' ' VAL . 6.8 tt -63.4 -44.9 93.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.309 0.576 . . . . 0.0 111.052 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -41.25 -44.18 2.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.63 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.25 -25.8 65.95 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.616 0.246 . . . . 0.0 110.998 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 105' ' ' LEU . 67.7 t -58.59 -43.14 86.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.551 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.646 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.26 -45.92 65.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.911 0.863 . . . . 0.0 111.554 -176.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.6 p -62.1 -36.22 81.07 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.178 -176.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.554 ' ND2' ' N ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -65.09 -41.05 95.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.66 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.554 ' N ' ' ND2' ' A' ' 111' ' ' ASN . 0.5 OUTLIER -89.01 -8.6 53.73 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -178.678 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.87 40.41 36.3 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.532 -1.149 . . . . 0.0 111.08 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -89.96 -25.87 20.69 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 121.036 2.418 . . . . 0.0 110.741 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 46.52 63.42 1.9 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.242 1.02 . . . . 0.0 110.494 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 82.3 mt -81.99 147.63 29.09 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.255 -1.793 . . . . 0.0 113.568 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 81.4 p -83.16 175.74 9.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -58.29 -46.07 86.77 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -57.54 -48.32 79.62 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -69.15 -30.81 69.13 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.891 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.3 t -63.75 -41.75 93.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.483 0.659 . . . . 0.0 109.297 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -67.72 -36.98 81.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.299 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -59.65 -51.48 69.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 91.6 mtp -57.1 -43.33 82.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.001 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.0 mm -59.56 -44.29 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.559 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.78 -35.65 78.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 111.463 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.21 -40.71 82.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.712 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.06 -20.61 21.87 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.679 0.276 . . . . 0.0 111.637 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 19.3 t0 -77.63 83.16 4.02 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.469 0.652 . . . . 0.0 112.195 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.6 pt -71.02 -9.66 13.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.496 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 54.7 p-10 -142.8 144.1 32.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 112.621 -2.082 . . . . 0.0 109.054 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.28 51.04 1.7 Allowed Glycine 0 CA--C 1.532 1.147 0 CA-C-N 116.741 -0.209 . . . . 0.0 113.533 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -90.48 -9.87 45.77 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.159 0.48 . . . . 0.0 110.135 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.95 0.13 68.32 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.873 -0.679 . . . . 0.0 114.376 176.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -133.78 154.18 51.18 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.206 0.503 . . . . 0.0 110.606 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.2 t -101.14 118.03 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -84.39 174.51 10.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.938 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.15 -40.52 94.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.292 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -62.35 -44.26 96.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.68 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.47 -37.2 86.7 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.532 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -61.26 -45.22 95.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.135 0.493 . . . . 0.0 110.69 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.45 -47.21 87.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.286 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.408 ' O ' ' CB ' ' A' ' 147' ' ' ALA . 52.0 tt0 -49.14 -46.5 45.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.085 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.4 mmt -71.97 -36.88 69.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.483 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 24.5 mmt -71.85 -44.21 64.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.785 -0.189 . . . . 0.0 110.606 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 147' ' ' ALA . 88.7 m -83.71 -30.63 26.59 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.503 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 143' ' ' GLN . . . -39.45 108.4 0.08 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.979 0.418 . . . . 0.0 111.398 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 54.6 tttp . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.284 179.765 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.34 -38.57 91.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.377 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.525 ' C ' ' H ' ' B' 1090 ' ' GLN . 68.1 ttt180 58.8 41.46 21.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -64.33 4.15 1.48 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.536 ' N ' ' OE1' ' B' 1090 ' ' GLN . 0.9 OUTLIER -59.45 -41.9 90.73 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -177.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 77.5 mt -38.79 -67.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.017 0.437 . . . . 0.0 111.449 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.5 mt -53.61 -47.89 69.8 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.461 -0.495 . . . . 0.0 112.161 -175.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 8.2 m95 -60.0 -58.86 6.72 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.792 0.806 . . . . 0.0 111.973 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1094 ' ' PHE . . . . . 0.483 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 29.3 m-85 -59.81 -46.66 88.53 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -174.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -42.2 -52.06 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.68 -40.97 99.49 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.779 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 56.8 tp -57.57 -45.28 85.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.196 0.998 . . . . 0.0 109.73 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 15.3 m120 -61.33 -51.75 67.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -65.66 -38.81 90.36 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 88.6 mt -60.96 -42.35 92.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.765 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -52.11 -45.33 64.87 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.537 ' O ' ' N ' ' B' 1105 ' ' LYS . 90.9 m -63.1 -48.01 80.4 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.699 -0.626 . . . . 0.0 111.502 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.449 ' C ' ' O ' ' B' 1102 ' ' THR . 24.8 mt-30 -27.97 -55.91 0.11 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.541 1.163 . . . . 0.0 112.65 -176.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.0 mt -83.53 -15.04 11.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 112.165 -2.289 . . . . 0.0 112.602 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.537 ' N ' ' O ' ' B' 1102 ' ' THR . 64.0 tttp -59.53 -44.41 93.2 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 118.063 -1.455 . . . . 0.0 108.259 176.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.5 t -61.39 -48.85 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.78 -35.98 76.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.198 -178.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 92.8 mttt -49.92 -36.72 28.73 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.796 0.726 . . . . 0.0 109.756 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.76 -45.75 70.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.247 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -63.07 -48.91 76.64 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.229 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B 1111 ' ' HIS . . . . . 0.412 ' NE2' ' SD ' ' A' ' 51' ' ' MET . 83.3 m-70 -71.53 17.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.119 -0.363 . . . . 0.0 111.963 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B 1112 ' ' SER . . . . . 0.441 ' O ' ' OG ' ' B' 1113 ' ' SER . 0.9 OUTLIER 73.29 73.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.716 0.689 . . . . 0.0 109.884 -178.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B 1113 ' ' SER . . . . . 0.441 ' OG ' ' O ' ' B' 1112 ' ' SER . 87.0 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.524 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.01 -44.99 95.54 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -110.0 122.23 47.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.055 0.389 . . . . 0.0 110.426 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.7 tp 172.35 -36.93 0.0 OUTLIER 'General case' 0 C--N 1.341 0.224 0 O-C-N 124.033 0.833 . . . . 0.0 109.836 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -73.75 141.13 46.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.203 0.911 . . . . 0.0 109.653 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.0 tt0 -45.26 -61.68 1.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.064 0.935 . . . . 0.0 110.375 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -34.1 -36.14 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.627 -1.624 . . . . 0.0 111.18 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.621 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 1.2 tm0? -69.11 -38.75 79.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.414 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.1 mt -59.68 -44.39 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.431 ' O ' ' OE2' ' A' ' 14' ' ' GLU . . . -53.31 -52.16 60.03 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.238 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.53 -45.49 93.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.531 0.682 . . . . 0.0 112.596 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.621 ' CD1' ' NE2' ' A' ' 8' ' ' GLN . 5.2 m-85 -62.67 -38.55 90.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.705 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -53.03 -53.8 44.81 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.432 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 10' ' ' ALA . 1.9 mp0 -48.38 -41.31 28.51 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.199 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.53 -39.06 72.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.237 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -57.64 -42.0 82.56 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 m -64.88 -14.54 59.95 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.469 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.63 -43.15 97.67 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -105.96 -13.34 15.52 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -74.34 93.77 2.44 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.263 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -68.78 -48.0 64.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.791 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.0 p-10 -102.61 13.74 33.72 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.66 48.02 1.26 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.157 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -85.32 -4.33 59.12 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.749 0.309 . . . . 0.0 110.904 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.49 -2.3 82.75 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.7 p -137.37 152.52 49.76 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.467 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 mp -91.81 123.59 43.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.0 p -113.76 166.18 11.81 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.539 0.685 . . . . 0.0 112.418 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.3 p -58.99 -37.3 76.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.372 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -61.22 -60.62 3.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.263 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -61.1 -30.45 70.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.518 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.76 -53.68 54.44 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.727 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.52 -37.97 94.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 113.786 -1.552 . . . . 0.0 112.242 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.68 -52.0 67.56 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.782 1.291 . . . . 0.0 108.919 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.428 ' O ' ' OG ' ' A' ' 38' ' ' SER . 46.2 t -58.17 -45.26 88.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 119.303 0.956 . . . . 0.0 111.275 -177.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 28.2 ttt -59.31 -39.33 82.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 119.805 1.184 . . . . 0.0 109.917 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -52.29 -39.88 61.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.738 0.78 . . . . 0.0 110.259 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 35' ' ' VAL . 41.1 p -62.52 -20.64 64.83 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.21 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.95 -0.33 15.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.959 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.06 25.39 44.93 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.183 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -124.97 165.12 18.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.317 0.558 . . . . 0.0 109.772 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -125.62 77.09 69.68 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.278 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.37 147.87 72.52 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.99 1.794 . . . . 0.0 112.119 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.4 p -79.4 162.76 25.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.103 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -57.19 -43.15 82.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.996 -179.177 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.533 ' H ' ' CD ' ' A' ' 45' ' ' GLU . . . -57.19 -25.32 58.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.368 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -65.26 -40.72 94.33 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.088 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.411 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.3 mp -55.06 -38.63 68.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.565 0.698 . . . . 0.0 109.46 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -72.97 -55.42 6.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.187 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.41 -49.61 69.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.414 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 63.7 mtp -66.9 -48.98 67.03 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.4 mm -58.54 -45.23 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.433 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -56.42 -35.42 67.8 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.57 -40.63 89.07 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.507 -0.477 . . . . 0.0 112.076 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.4 t -85.53 -21.74 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.651 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.0 t0 -78.69 86.75 4.63 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -175.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.78 87.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.367 -1.742 . . . . 0.0 114.27 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.471 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 39.5 p-10 -86.14 -2.95 58.82 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.26 23.17 63.99 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.548 0.613 . . . . 0.0 112.795 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.471 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.2 p-10 -88.04 2.16 52.53 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.392 0.596 . . . . 0.0 110.66 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.503 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.6 1.75 89.05 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.701 -0.625 . . . . 0.0 114.586 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.4 p -145.78 166.56 25.55 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.1 mm -109.7 126.5 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.85 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -102.78 -176.98 3.25 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.907 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.93 -47.39 98.77 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.21 -51.39 9.53 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.1 1.2 . . . . 0.0 111.613 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.72 -18.33 53.77 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.648 0.737 . . . . 0.0 110.586 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -77.17 -56.75 4.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.441 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.4 mt -58.49 -46.16 87.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.7 p -46.24 -47.33 18.04 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.104 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.7 mtp -66.83 -45.45 78.23 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.6 mmt -59.78 -39.74 85.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.58 78.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.242 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 -94.76 -10.66 30.88 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.727 0.299 . . . . 0.0 111.561 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.31 68.22 8.64 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.13 0.49 . . . . 0.0 110.613 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.5 mmt -107.26 18.62 21.41 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.389 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -50.17 130.43 22.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.239 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -93.57 106.02 18.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.799 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.515 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 2.8 m -90.26 122.08 32.85 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 82' ' ' GLU . 90.3 m-20 -69.66 112.14 5.93 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.0 m -37.58 -21.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.694 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.4 mp0 -68.88 -37.24 78.91 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -47.69 -35.67 9.99 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.266 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -88.97 -17.45 29.45 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.307 0.575 . . . . 0.0 112.039 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 mm -60.87 -74.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.959 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -62.61 -39.1 92.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -62.7 -40.88 98.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.371 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.59 -19.53 62.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -72.92 -50.77 21.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.955 0.407 . . . . 0.0 111.317 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -55.5 -42.48 74.51 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.42 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.23 -43.73 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -68.29 -38.97 82.21 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.475 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -89.22 84.03 6.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.7 -46.19 91.33 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -92.15 4.41 53.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.294 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.43 50.35 48.01 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -92.24 5.72 49.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.637 0.256 . . . . 0.0 110.576 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.98 0.76 89.76 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -139.55 153.07 47.35 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.545 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.46 115.32 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.4 m -89.82 153.23 20.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.35 -47.79 80.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 119.039 0.836 . . . . 0.0 110.986 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.01 -40.17 60.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.994 0.426 . . . . 0.0 110.461 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -66.22 -41.43 90.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.383 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 tp -63.5 -46.33 86.61 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.37 0.605 . . . . 0.0 111.422 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -44.22 -36.89 2.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.753 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.432 ' O ' ' OG1' ' A' ' 110' ' ' THR . 75.2 t60 -69.33 -27.6 65.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.717 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 94.8 t -58.76 -43.08 87.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.03 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.7 mmt -51.89 -49.69 62.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.219 1.009 . . . . 0.0 111.879 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 107' ' ' HIS . 65.9 p -52.78 -37.14 59.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.245 -1.798 . . . . 0.0 110.817 -176.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -66.3 -39.6 89.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.949 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.0 mt -82.83 -13.81 55.5 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.49 37.6 53.06 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.26 -1.3 . . . . 0.0 110.058 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -85.12 -20.57 30.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 121.021 2.411 . . . . 0.0 110.976 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt 42.38 50.6 4.68 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.723 1.249 . . . . 0.0 110.367 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.23 153.47 39.42 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.957 -1.928 . . . . 0.0 112.701 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 61.3 p -85.64 174.14 9.63 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -55.93 -43.97 77.88 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -55.59 -41.87 73.99 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.051 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.09 -29.95 68.15 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.979 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 43.8 t -62.75 -43.95 99.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.466 0.651 . . . . 0.0 109.593 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -72.83 -36.45 67.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.994 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -59.22 -54.89 41.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 83.9 mtp -56.74 -43.25 80.49 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.645 -1.162 . . . . 0.0 109.812 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.8 mt -59.28 -43.74 90.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.243 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -59.26 -39.44 82.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.828 0.347 . . . . 0.0 111.106 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.31 -41.28 84.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.187 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.65 -24.88 21.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.1 t0 -71.77 88.73 1.01 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.651 0.739 . . . . 0.0 111.933 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 72.3 mt -70.06 -15.88 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.703 1.24 . . . . 0.0 113.208 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 44.7 p-10 -141.53 144.4 34.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 112.295 -2.23 . . . . 0.0 109.522 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.59 52.28 1.17 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.604 -0.331 . . . . 0.0 112.947 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 32.1 p-10 -91.37 -9.91 43.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.187 0.494 . . . . 0.0 110.19 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.82 2.49 76.9 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.218 -0.515 . . . . 0.0 114.268 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -135.04 154.5 51.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 117.198 0.499 . . . . 0.0 110.445 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.5 t -100.9 118.94 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.357 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -84.55 174.44 10.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.85 0.357 . . . . 0.0 110.816 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -61.24 -40.3 93.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.24 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.1 -44.51 96.5 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.34 -38.49 90.28 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.763 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -61.16 -45.4 94.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.054 0.454 . . . . 0.0 110.849 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.9 t -65.23 -46.21 91.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.353 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.426 ' O ' ' CB ' ' A' ' 147' ' ' ALA . 51.6 tt0 -49.8 -45.02 49.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.611 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.6 mmt -72.7 -38.44 67.51 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.4 mmt -71.93 -46.89 55.95 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.341 -0.144 . . . . 0.0 110.909 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 147' ' ' ALA . 22.0 m -80.28 -29.65 38.28 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.725 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 143' ' ' GLN . . . -40.81 110.58 0.16 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.022 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.198 179.726 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 71.0 mt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -148.34 173.15 13.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.433 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1088 ' ' ARG . . . . . 0.59 ' C ' ' H ' ' B' 1090 ' ' GLN . 0.0 OUTLIER -131.18 106.66 8.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.6 -179.576 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -58.85 2.85 0.18 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.15 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1090 ' ' GLN . . . . . 0.59 ' H ' ' C ' ' B' 1088 ' ' ARG . 70.9 mt-30 -61.96 -46.2 90.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.787 0.327 . . . . 0.0 111.483 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 56.3 mt -58.04 -49.89 79.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.8 mt -56.72 -62.04 2.01 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.6 m95 -62.34 -54.57 38.56 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.57 0.7 . . . . 0.0 112.244 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 8.3 t80 -59.44 -46.6 88.3 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 18.6 mmm-85 -40.69 -51.3 3.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.28 -39.58 97.4 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.33 -44.03 83.9 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.697 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 39.7 t30 -59.46 -49.78 76.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.631 -1.168 . . . . 0.0 114.118 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -65.58 -37.83 87.78 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.7 -41.68 89.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.889 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -51.39 -46.02 62.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1102 ' ' THR . . . . . 0.527 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.5 m -63.89 -48.18 77.68 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.886 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B 1103 ' ' GLN . . . . . 0.436 ' C ' ' O ' ' B' 1102 ' ' THR . 83.8 mt-30 -27.47 -56.91 0.1 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.638 1.209 . . . . 0.0 112.569 -176.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.3 mt -85.84 -14.17 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.453 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1105 ' ' LYS . . . . . 0.527 ' N ' ' O ' ' B' 1102 ' ' THR . 78.5 tttt -60.32 -45.93 91.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.012 176.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 96.1 t -61.57 -49.06 85.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.7 m -66.04 -35.89 76.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.013 -177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1108 ' ' LYS . . . . . 0.515 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 87.0 mttt -49.62 -38.65 32.89 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.571 0.7 . . . . 0.0 109.727 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.71 -45.92 67.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.355 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B 1110 ' ' PHE . . . . . 0.417 ' C ' ' H ' ' B' 1112 ' ' SER . 49.7 m-85 -63.41 -49.4 73.91 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B 1111 ' ' HIS . . . . . 0.459 ' O ' ' OG ' ' B' 1112 ' ' SER . 68.1 m-70 -70.36 20.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B 1112 ' ' SER . . . . . 0.506 ' OG ' ' O ' ' B' 1112 ' ' SER . 5.1 p 68.12 77.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.001 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.751 -179.269 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.5 p -80.03 136.98 36.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.324 0.965 . . . . 0.0 110.32 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 9' ' ' ILE . 46.3 tt0 -51.86 -53.65 38.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 122.072 0.939 . . . . 0.0 110.201 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 10.2 pt-20 -32.84 -36.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.108 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.52 ' OE1' ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -69.62 -37.77 76.96 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.286 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.3 mt -58.58 -44.9 90.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.67 -49.23 62.78 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.108 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.56 -46.37 90.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.339 0.59 . . . . 0.0 111.535 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.52 ' CD2' ' OE1' ' A' ' 8' ' ' GLN . 28.2 m-85 -58.41 -42.37 87.05 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.781 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -49.21 -58.1 5.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.378 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.48 -44.97 62.63 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.031 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.22 -38.16 70.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.222 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.16 -41.84 84.65 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 t -64.41 -15.78 61.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.421 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -64.08 -42.82 96.81 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -178.586 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -105.64 -14.52 15.24 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -75.45 94.94 3.18 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.137 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -68.25 -47.43 67.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.226 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.2 p-10 -102.38 14.18 32.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.46 46.17 1.03 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.035 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -85.35 -4.0 59.02 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.694 -0.298 . . . . 0.0 110.961 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.38 -2.0 82.71 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.5 p -137.51 152.24 49.29 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.103 0.478 . . . . 0.0 109.891 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.64 124.53 45.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.9 p -114.31 165.27 12.87 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.801 0.81 . . . . 0.0 112.393 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.4 p -58.85 -35.82 73.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.715 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.59 -61.4 2.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.565 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.92 -30.48 71.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.795 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.412 HD22 HD11 ' A' ' 52' ' ' ILE . 2.9 tp -60.16 -55.73 30.3 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.015 0.912 . . . . 0.0 109.667 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.65 -37.69 93.87 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.975 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 m -58.75 -53.03 63.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 119.047 1.423 . . . . 0.0 108.624 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.0 -46.47 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 121.228 -0.92 . . . . 0.0 111.523 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.6 ttt -59.0 -39.93 83.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 120.054 1.297 . . . . 0.0 109.461 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -51.56 -38.36 54.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.531 0.681 . . . . 0.0 110.183 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.1 p -63.54 -21.08 66.14 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.376 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.473 ' O ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -73.73 -1.72 20.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.536 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.34 13.77 67.57 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.127 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -107.14 158.01 17.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 117.611 0.705 . . . . 0.0 109.854 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -114.74 64.77 1.58 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.286 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.05 143.29 94.78 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.19 1.927 . . . . 0.0 112.156 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 t -80.58 166.74 20.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.438 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.15 -44.12 87.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.72 -24.2 33.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.558 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -65.63 -39.15 91.16 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.069 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.2 mp -56.42 -41.59 76.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.463 0.649 . . . . 0.0 109.759 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.25 -56.67 6.2 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.757 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.45 -48.81 71.29 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 41.2 mmm -65.85 -50.17 65.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.412 HD11 HD22 ' A' ' 32' ' ' LEU . 25.9 mm -59.44 -47.69 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.672 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -56.45 -34.97 67.35 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -66.18 -40.01 90.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.8 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.489 HG21 ' CD2' ' B' 1110 ' ' PHE . 71.4 t -86.35 -20.37 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.503 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.494 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.3 t0 -78.49 85.93 4.55 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.21 -38.0 87.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.326 -1.761 . . . . 0.0 114.066 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 36.8 p-10 -86.26 -2.89 58.79 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.98 23.55 63.82 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 118.476 0.58 . . . . 0.0 112.927 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.419 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.4 p-10 -87.36 2.38 50.51 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.234 0.517 . . . . 0.0 110.578 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.2 1.39 89.54 Favored Glycine 0 CA--C 1.521 0.442 0 O-C-N 121.585 -0.697 . . . . 0.0 114.448 175.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.0 p -145.85 165.33 29.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.9 mm -108.91 126.64 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -103.38 -176.33 3.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -57.3 -59.11 13.81 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.24 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -47.25 -49.62 12.6 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.37 1.38 . . . . 0.0 111.243 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.57 -19.77 62.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.348 0.594 . . . . 0.0 110.641 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 65' ' ' PHE . 22.7 t80 -74.55 -58.24 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.962 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.18 -45.21 83.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -44.24 -49.88 9.1 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.61 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 72.8 mtm -66.98 -44.5 80.28 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.656 -0.417 . . . . 0.0 112.026 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.8 mmt -57.62 -39.42 76.88 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.46 77.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.548 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -95.74 -9.05 32.82 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.434 ' C ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -85.98 63.84 8.25 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.154 0.502 . . . . 0.0 110.685 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.56 17.24 22.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.41 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -48.31 135.02 14.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.175 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -89.41 108.94 19.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.827 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -93.75 119.68 33.04 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 82' ' ' GLU . 36.8 t0 -67.02 112.89 4.61 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 174.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 m -37.68 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.522 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 80' ' ' ASP . 95.3 mt-10 -72.09 -31.51 66.15 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -50.38 -39.14 45.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.878 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.55 ' OE1' HD11 ' B' 1097 ' ' LEU . 9.2 pt-20 -89.53 -11.04 43.98 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.4 mm -62.43 -74.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.798 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -62.01 -40.75 96.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.91 -41.3 97.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.571 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.41 -21.26 63.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -73.81 -48.41 31.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -54.95 -40.55 70.09 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.815 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.3 t -65.54 -44.1 94.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.512 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.4 m-85 -69.02 -38.7 79.34 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.264 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -85.55 81.11 8.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.37 -49.4 77.36 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -176.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -91.32 4.83 51.38 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.175 -0.328 . . . . 0.0 111.168 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.61 48.13 50.39 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -90.22 6.25 43.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.674 0.273 . . . . 0.0 110.745 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.18 2.13 85.91 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -142.98 156.18 44.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.751 0.786 . . . . 0.0 111.593 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -94.08 115.37 32.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 t -89.05 151.1 22.45 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.23 -46.54 82.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.201 0.91 . . . . 0.0 110.723 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.42 -40.59 65.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.951 0.405 . . . . 0.0 110.554 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.22 -41.13 94.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.168 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.19 -44.64 94.82 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.614 0.721 . . . . 0.0 110.949 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -44.55 -44.01 8.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.548 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.92 -29.71 70.99 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 122.456 -0.152 . . . . 0.0 110.747 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.512 HG21 ' CE2' ' A' ' 92' ' ' PHE . 95.5 t -57.64 -41.32 79.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.837 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.604 ' CE ' HG22 ' A' ' 121' ' ' VAL . 8.5 mtt -50.84 -45.54 59.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.075 0.94 . . . . 0.0 111.526 -177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 m -56.68 -41.41 77.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.537 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -66.55 -41.55 88.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.132 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 74.8 mt -80.87 -16.36 53.86 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.24 30.52 58.67 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.51 -23.1 27.87 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.962 2.381 . . . . 0.0 110.481 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.9 tptp 45.02 60.37 3.01 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.067 0.937 . . . . 0.0 110.326 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.9 mt -79.95 147.2 31.71 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.566 -1.652 . . . . 0.0 112.463 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.57 ' O ' HG23 ' A' ' 121' ' ' VAL . 81.5 p -81.99 175.35 10.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.468 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -57.41 -44.79 84.86 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -56.49 -47.91 78.28 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.196 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 123' ' ' GLU . 64.3 mm-40 -71.35 -28.44 64.06 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.73 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.604 HG22 ' CE ' ' A' ' 109' ' ' MET . 54.4 t -63.91 -42.43 95.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.669 0.747 . . . . 0.0 109.288 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.53 -35.09 65.5 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.382 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 120' ' ' GLU . 82.5 tt0 -59.66 -51.28 70.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 93.0 mtp -56.08 -44.47 78.98 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.35 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.74 -43.66 88.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.189 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -58.63 -39.45 80.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.953 0.406 . . . . 0.0 111.212 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.37 -40.92 79.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.059 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.41 -20.15 22.1 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.9 t0 -72.88 87.69 1.32 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.301 0.572 . . . . 0.0 112.072 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 tt -70.5 -15.18 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.374 1.083 . . . . 0.0 113.242 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.7 p-10 -142.65 144.78 32.92 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 112.322 -2.217 . . . . 0.0 109.172 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.1 52.27 1.35 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-N 116.736 -0.211 . . . . 0.0 113.255 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -90.79 -9.21 47.37 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.973 0.387 . . . . 0.0 110.013 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.34 1.02 68.41 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.995 -0.621 . . . . 0.0 114.262 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -134.43 153.87 51.69 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.395 0.598 . . . . 0.0 110.422 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.68 118.38 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.366 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -84.44 174.55 9.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 0.0 111.149 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -61.05 -40.8 95.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.202 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.64 -44.6 96.68 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.701 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.94 -35.64 81.81 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.599 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -60.75 -44.75 96.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.076 0.465 . . . . 0.0 110.574 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.11 -47.01 89.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.365 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.708 ' O ' HG22 ' A' ' 146' ' ' THR . 52.6 tt0 -49.34 -40.73 36.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.78 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 mmt -74.9 -38.58 61.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.1 mmt -80.69 4.5 18.59 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.168 0.587 . . . . 0.0 111.18 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 143' ' ' GLN . 5.0 t . . . . . 0 N--CA 1.468 0.473 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.303 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 111.481 0.178 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 4.6 m95 -60.77 -57.86 10.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.681 0.753 . . . . 0.0 112.127 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1094 ' ' PHE . . . . . 0.513 ' CE2' ' OD1' ' B' 1098 ' ' ASN . 26.1 t80 -58.88 -45.51 90.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.224 -1.353 . . . . 0.0 114.55 -173.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -38.53 -52.65 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.61 -39.55 98.02 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.052 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1097 ' ' LEU . . . . . 0.55 HD11 ' OE1' ' A' ' 84' ' ' GLU . 46.7 tp -56.26 -42.44 77.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.54 1.17 . . . . 0.0 109.798 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1098 ' ' ASN . . . . . 0.513 ' OD1' ' CE2' ' B' 1094 ' ' PHE . 8.4 m-20 -56.92 -43.08 81.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.378 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -64.07 -36.92 85.58 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.26 -42.03 91.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.853 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1101 ' ' GLN . . . . . 0.48 ' CG ' ' OE2' ' A' ' 84' ' ' GLU . 41.8 mt-30 -50.78 -46.21 59.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.51 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.7 m -63.56 -48.19 78.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.99 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.44 ' C ' ' O ' ' B' 1102 ' ' THR . 84.2 mt-30 -27.55 -57.81 0.1 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.556 1.169 . . . . 0.0 112.715 -176.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.2 mt -84.8 -15.14 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 112.161 -2.29 . . . . 0.0 112.691 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.51 ' N ' ' O ' ' B' 1102 ' ' THR . 64.3 tttp -60.23 -44.8 94.89 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.003 -1.479 . . . . 0.0 107.899 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 73.3 t -61.31 -49.05 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1107 ' ' VAL . . . . . 0.408 HG13 ' H ' ' B' 1107 ' ' VAL . 1.3 m -66.41 -36.25 76.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.429 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 90.4 mttt -49.65 -39.21 35.37 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.53 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.86 -45.52 67.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.914 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1110 ' ' PHE . . . . . 0.489 ' CD2' HG21 ' A' ' 55' ' ' VAL . 46.4 m-85 -63.65 -49.68 72.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.378 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.622 0 CA-C-O 119.417 -0.325 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.3 m -75.21 139.26 42.5 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.271 0.941 . . . . 0.0 109.492 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 9' ' ' ILE . 10.3 tm-20 -48.47 -56.8 7.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.969 0.89 . . . . 0.0 110.473 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -34.59 -37.88 0.06 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.971 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -69.34 -37.15 77.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.613 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' GLU . 63.8 mt -57.25 -47.6 83.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.29 -49.88 60.41 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.124 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -61.72 -46.85 87.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.099 0.476 . . . . 0.0 112.276 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -59.8 -41.01 90.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.949 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -51.46 -56.55 12.67 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.055 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.43 -45.19 55.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.007 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.26 -38.68 66.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.434 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.77 -40.54 80.04 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.9 m -65.05 -15.37 62.27 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.651 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.2 -41.04 94.92 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -105.96 -14.36 15.21 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.91 94.42 2.8 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.325 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -67.85 -51.85 43.6 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.181 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.6 p30 -100.84 15.73 27.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 37.17 51.98 1.65 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.108 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 26' ' ' THR . 12.3 p30 -88.33 -5.43 58.33 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.925 0.362 . . . . 0.0 111.079 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.93 -0.72 76.74 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.436 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 1.9 t -141.22 157.63 44.99 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.151 0.5 . . . . 0.0 110.49 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 27' ' ' ILE . 3.5 mp -90.52 123.99 42.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.8 p -111.21 161.46 15.96 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.28 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.413 HG22 HG13 ' A' ' 52' ' ' ILE . 21.5 p -59.84 -38.07 81.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.212 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -61.38 -59.28 5.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.325 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.72 -28.3 69.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.762 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.501 HD22 HD11 ' A' ' 52' ' ' ILE . 3.5 tp -61.67 -55.39 30.93 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.977 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.49 92.04 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.186 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -57.98 -55.4 35.39 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.052 1.426 . . . . 0.0 108.198 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.63 -46.56 72.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 118.798 0.727 . . . . 0.0 111.29 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.1 tpt -58.0 -39.86 79.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 120.38 1.445 . . . . 0.0 109.85 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -51.1 -33.55 26.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.346 0.593 . . . . 0.0 110.999 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.9 p -64.9 -20.01 66.22 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.85 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 1.5 mm? -76.27 3.24 11.25 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.143 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.92 27.58 40.84 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.279 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 9.1 tt0 -131.51 170.41 14.75 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.65 0.725 . . . . 0.0 109.469 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.409 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 16.1 m-20 -131.33 78.23 72.53 Favored Pre-proline 0 N--CA 1.466 0.351 0 CA-C-O 120.739 0.304 . . . . 0.0 110.217 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.07 147.03 96.87 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.698 2.265 . . . . 0.0 111.876 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.2 p -77.78 163.39 26.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.401 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.03 -45.43 90.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.721 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.1 -24.68 26.89 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.626 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -65.63 -40.16 92.25 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.662 -0.415 . . . . 0.0 109.989 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.1 mp -56.14 -41.7 75.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.382 0.611 . . . . 0.0 109.939 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -72.57 -56.02 6.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.682 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -55.76 -50.2 71.06 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.4 mmm -64.05 -50.61 67.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.501 HD11 HD22 ' A' ' 32' ' ' LEU . 26.4 mm -57.72 -45.11 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.77 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -55.44 -34.43 64.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -67.0 -40.94 87.45 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.071 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.477 HG12 HD12 ' A' ' 63' ' ' ILE . 42.2 t -85.99 -21.54 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.155 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.5 t0 -79.42 83.71 5.4 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -174.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.53 79.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.816 -1.538 . . . . 0.0 114.442 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.8 p-10 -85.71 -2.47 58.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.331 -0.547 . . . . 0.0 112.463 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.8 23.02 60.6 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.867 -0.521 . . . . 0.0 112.507 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.435 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -86.61 3.83 42.8 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.335 0.568 . . . . 0.0 110.565 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.521 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.15 2.01 89.45 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 118.657 0.662 . . . . 0.0 114.664 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.2 p -148.19 167.79 24.16 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.477 HD12 HG12 ' A' ' 55' ' ' VAL . 10.0 mm -110.06 127.38 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.228 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -102.57 -177.39 3.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.54 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.413 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -58.19 -46.3 99.67 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.191 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 33.3 Cg_exo -56.6 -52.62 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.393 1.395 . . . . 0.0 111.297 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' O ' ' SD ' ' A' ' 71' ' ' MET . 97.4 mt-10 -61.16 -18.91 60.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.26 0.553 . . . . 0.0 110.941 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -76.77 -59.11 2.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.814 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.8 mt -56.05 -47.41 77.94 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.1 t -46.39 -43.58 16.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.071 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 67' ' ' GLU . 39.5 mtp -66.92 -47.76 70.74 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.0 mmm -62.07 -40.71 96.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.13 -33.92 76.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.573 0.225 . . . . 0.0 111.463 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -91.99 -20.76 21.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 111.178 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.58 67.84 5.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.15 0.5 . . . . 0.0 110.178 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.2 mmt -107.81 15.83 24.15 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.578 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -48.33 132.98 16.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.311 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -89.85 107.6 19.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.964 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.491 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 3.2 m -93.64 120.42 33.89 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.5 m-20 -69.63 111.97 5.8 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 m -36.89 -20.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.864 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.6 mm-40 -68.26 -37.49 80.8 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.794 0.33 . . . . 0.0 111.615 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -48.65 -36.41 15.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.144 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -88.09 -16.55 33.23 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 85' ' ' ILE . 26.5 mm -61.96 -74.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.563 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 74.4 mtt85 -62.02 -41.35 97.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.86 -41.5 97.91 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.848 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.07 -17.97 55.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.817 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -72.69 -50.7 23.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -54.95 -42.13 71.94 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.5 t -65.1 -44.38 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.421 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.1 m-85 -69.33 -37.81 77.9 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.159 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -86.25 80.75 8.64 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.81 -48.91 78.37 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -90.59 4.99 49.73 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.264 -0.273 . . . . 0.0 111.351 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.17 47.19 50.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -90.27 7.03 40.35 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.75 0.31 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.33 2.02 89.25 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -140.68 153.42 45.97 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.636 0.731 . . . . 0.0 111.835 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -93.34 116.4 34.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.3 m -89.65 149.31 22.85 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.93 79.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.166 0.894 . . . . 0.0 110.683 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.19 -40.79 64.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.815 0.341 . . . . 0.0 110.673 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.12 -41.4 94.9 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.204 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.74 -45.73 88.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.233 0.54 . . . . 0.0 110.843 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -43.24 -44.44 5.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.857 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -64.82 -28.83 69.83 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.662 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.503 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 85.0 t -58.11 -41.82 81.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.134 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.626 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.27 -46.73 65.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.953 0.882 . . . . 0.0 111.705 -177.08 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 71.9 p -53.43 -35.89 60.93 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 113.771 -1.559 . . . . 0.0 110.882 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -68.51 -39.88 81.07 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.473 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.86 -13.29 59.06 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.45 30.45 60.31 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -87.68 -24.67 23.81 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.681 2.241 . . . . 0.0 110.779 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 45.25 64.39 1.42 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.713 0.768 . . . . 0.0 110.155 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.3 mt -80.5 148.13 30.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.374 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 121' ' ' VAL . 30.5 p -82.07 174.61 11.07 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.693 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -57.2 -45.83 83.44 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.16 -47.81 77.51 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -71.96 -30.36 65.2 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.588 -0.445 . . . . 0.0 112.108 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 117' ' ' THR . 42.5 t -65.04 -42.69 95.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -70.61 -34.98 72.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.099 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -59.99 -49.12 78.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.041 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 29.8 mmm -52.46 -47.37 66.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.023 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 40.7 mm -57.44 -44.33 84.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.695 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -58.0 -40.23 80.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.89 0.376 . . . . 0.0 111.394 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -57.98 -40.82 81.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.056 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.89 -17.94 24.5 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.716 0.293 . . . . 0.0 111.645 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.2 t0 -73.83 89.56 1.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.436 0.636 . . . . 0.0 111.816 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 80.1 mt -70.73 -17.63 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.063 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.9 p-10 -141.59 145.55 35.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.743 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.45 52.27 1.48 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.76 -0.257 . . . . 0.0 113.117 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -90.66 -9.16 47.91 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.023 0.412 . . . . 0.0 110.219 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.0 1.89 75.43 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.961 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -134.75 154.33 51.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.234 0.517 . . . . 0.0 110.39 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.76 118.58 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.038 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -84.26 174.71 9.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.775 0.321 . . . . 0.0 110.924 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -61.62 -40.03 93.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.095 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.96 -44.66 95.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.54 -38.5 89.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.733 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -60.82 -44.38 96.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.139 0.495 . . . . 0.0 110.807 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.22 -46.42 87.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.233 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -48.43 -45.56 36.51 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.164 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 88.1 mmm -74.68 -38.3 62.45 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 18.6 mmt -72.8 -46.55 52.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 120.66 0.267 . . . . 0.0 111.441 -179.288 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.72 -54.55 41.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.265 0.555 . . . . 0.0 112.029 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 37.9 t80 -57.97 -46.08 85.69 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -42.16 -52.01 4.47 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.49 -42.11 99.69 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.162 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.55 -46.1 80.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.391 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.21 -48.73 79.45 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.26 -38.17 90.1 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.96 -42.16 91.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.795 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -51.3 -46.42 62.51 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.517 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.8 m -63.38 -48.45 77.82 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.422 ' C ' ' O ' ' B' 1102 ' ' THR . 84.5 mt-30 -27.31 -60.2 0.1 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.603 1.192 . . . . 0.0 112.741 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -82.01 -14.59 12.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 112.67 -2.059 . . . . 0.0 112.344 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.517 ' N ' ' O ' ' B' 1102 ' ' THR . 65.8 tttm -57.69 -43.34 85.06 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 117.874 -1.53 . . . . 0.0 108.059 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.8 t -61.88 -47.04 95.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.55 0.69 . . . . 0.0 112.818 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 65.8 t -65.38 -41.18 90.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.097 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1108 ' ' LYS . . . . . 0.491 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 96.1 mttt -49.03 -38.14 22.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.396 0.617 . . . . 0.0 109.634 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -54.09 -46.91 72.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.343 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1110 ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 55' ' ' VAL . 54.8 m-85 -62.35 -49.81 74.07 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 23.4 m-70 . . . . . 0 C--N 1.326 -0.45 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.037 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.3 mt . . . . . 0 CA--C 1.532 0.273 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.8 p -80.64 137.83 36.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.461 1.028 . . . . 0.0 110.454 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' A' ' 7' ' ' GLU . 18.0 pt-20 -52.65 -50.06 63.95 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.123 0.963 . . . . 0.0 110.893 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.507 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 43.4 tp10 -36.44 -38.13 0.15 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.033 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -70.63 -35.34 72.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.66 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.1 mt -58.92 -45.6 91.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 175.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.59 -49.02 62.95 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.08 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.26 -47.88 83.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.225 0.535 . . . . 0.0 112.083 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.426 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 10.0 m-85 -60.58 -41.96 95.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.988 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -49.52 -59.5 3.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.367 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -47.62 -42.5 24.4 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.414 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -55.6 -39.15 70.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.294 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -56.91 -41.52 78.29 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 m -65.09 -13.43 58.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.387 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.44 -43.47 97.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -106.73 -13.21 15.33 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -76.05 94.04 3.39 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.073 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -68.33 -46.7 69.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.41 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.7 p-10 -102.77 14.17 32.62 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.62 49.67 1.35 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.018 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -87.06 -5.01 59.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.944 0.372 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.02 -2.05 81.19 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.6 p -137.32 151.61 48.83 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.143 0.496 . . . . 0.0 110.307 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.8 mp -93.34 125.24 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -114.1 165.04 13.05 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.671 0.748 . . . . 0.0 112.575 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.426 HG22 HG13 ' A' ' 52' ' ' ILE . 21.6 p -58.85 -35.34 72.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.823 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -61.25 -61.89 2.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.158 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.12 -29.54 70.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.773 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.549 HD22 HD11 ' A' ' 52' ' ' ILE . 2.8 tp -60.57 -56.77 17.31 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.123 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.66 -39.18 93.12 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.107 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.9 m -58.26 -54.65 44.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.05 1.425 . . . . 0.0 108.517 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -55.63 -47.04 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.014 -0.675 . . . . 0.0 111.674 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -58.65 -41.04 85.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 120.143 1.338 . . . . 0.0 110.085 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -51.97 -40.06 60.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.434 0.635 . . . . 0.0 110.351 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 23.0 t -63.57 -20.74 65.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.041 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 tp -73.91 -2.16 22.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.744 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.17 13.44 63.98 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.308 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -106.67 156.44 18.62 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.537 0.669 . . . . 0.0 110.045 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -115.67 63.44 2.07 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.376 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.07 144.2 92.15 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.244 1.962 . . . . 0.0 112.192 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.8 p -80.46 166.63 21.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.393 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -57.37 -44.63 84.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.13 -23.71 22.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.636 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -65.9 -39.4 90.59 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.147 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.48 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.2 mp -56.84 -42.34 79.49 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.311 0.577 . . . . 0.0 109.779 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -70.97 -57.07 4.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.851 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -54.95 -48.76 72.78 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 42.7 mmm -65.68 -50.64 64.19 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.549 HD11 HD22 ' A' ' 32' ' ' LEU . 26.4 mm -58.32 -47.13 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.789 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -55.68 -34.53 65.12 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -66.28 -39.82 89.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.86 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.416 HG21 ' CE2' ' B' 1110 ' ' PHE . 39.3 t -87.22 -20.09 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.388 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.0 t0 -78.1 85.61 4.29 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.2 85.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.541 -1.663 . . . . 0.0 114.359 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.7 p-10 -86.65 -2.48 58.55 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.16 23.28 61.74 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 118.452 0.569 . . . . 0.0 112.597 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.438 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.1 p-10 -87.21 2.85 48.75 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.294 0.547 . . . . 0.0 110.568 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.44 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.6 1.92 89.0 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.3 p -148.14 168.55 22.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.4 mt -112.69 128.4 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 43.9 t0 -103.59 -175.51 2.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.647 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.515 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -56.31 -56.88 26.86 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -177.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 9.9 Cg_endo -50.26 -49.54 16.07 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 CA-C-N 120.522 1.222 . . . . 0.0 111.673 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -62.04 -18.85 61.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.262 0.553 . . . . 0.0 110.753 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -75.56 -58.81 3.06 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.748 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.9 mt -56.1 -45.24 79.52 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.8 m -44.05 -50.28 8.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.513 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 74.5 mtm -66.05 -43.93 86.04 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.48 ' O ' ' CE ' ' A' ' 76' ' ' MET . 15.2 mmt -57.52 -37.54 73.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.63 -35.23 72.83 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -93.76 -17.25 23.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 111.727 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.31 68.11 5.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.213 0.53 . . . . 0.0 110.456 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.48 ' CE ' ' O ' ' A' ' 72' ' ' MET . 24.3 mmt -108.81 15.47 23.54 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.608 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -52.89 131.62 35.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.637 0.732 . . . . 0.0 111.706 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -132.07 143.95 50.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.372 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.504 ' O ' ' CB ' ' A' ' 80' ' ' ASP . 35.8 p -127.14 -45.14 1.56 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 82' ' ' GLU . 99.8 m-20 126.15 134.84 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 125.357 1.66 . . . . 0.0 109.62 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.1 m -37.61 -17.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.212 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.9 mm-40 -68.51 -37.22 79.87 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.855 0.359 . . . . 0.0 111.653 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -47.67 -36.14 10.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.312 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -89.57 -16.73 29.97 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.064 0.459 . . . . 0.0 111.916 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 85' ' ' ILE . 26.3 mm -61.1 -74.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.541 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -61.58 -41.63 97.69 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.63 -41.01 94.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.587 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.36 -19.53 61.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.118 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -72.57 -51.26 20.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.841 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.95 -42.28 72.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.678 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.92 -43.88 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.0 m-85 -68.86 -38.04 79.47 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.916 -0.313 . . . . 0.0 111.471 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -90.71 83.39 5.76 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.85 -44.65 96.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -90.53 4.32 51.5 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 122.179 -0.326 . . . . 0.0 111.584 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.18 48.71 46.23 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -91.45 6.25 46.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.676 0.274 . . . . 0.0 110.402 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.11 0.14 90.08 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -137.94 151.91 48.43 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.611 0.72 . . . . 0.0 111.454 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.14 115.28 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 92.1 p -91.53 154.58 19.0 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.91 -48.24 78.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 119.024 0.829 . . . . 0.0 111.071 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.52 -41.44 61.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.998 0.428 . . . . 0.0 110.594 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.67 -41.2 92.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.894 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 108' ' ' VAL . 9.2 tp -63.56 -46.7 84.72 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.974 -0.454 . . . . 0.0 111.22 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -44.25 -35.99 2.53 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.943 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -66.8 -26.7 67.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.033 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.582 HG21 ' CE2' ' A' ' 92' ' ' PHE . 83.0 t -58.19 -43.13 85.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.798 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.9 mtp -50.13 -47.24 54.23 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.901 0.858 . . . . 0.0 111.781 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 m -58.1 -41.64 83.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.682 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 38' ' ' SER . 2.9 m-80 -66.13 -41.81 89.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.823 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.6 mt -81.46 -15.47 54.93 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.86 30.18 61.94 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -86.06 -24.26 26.41 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.957 2.379 . . . . 0.0 110.691 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 45.57 60.08 3.28 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.689 0.756 . . . . 0.0 110.457 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.2 148.38 32.28 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.938 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 121' ' ' VAL . 80.7 p -82.12 174.69 10.98 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.344 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -57.89 -45.47 86.37 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.92 -49.95 74.03 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.584 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -68.52 -29.58 68.2 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.955 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 117' ' ' THR . 39.7 t -63.84 -41.51 92.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -66.65 -36.99 83.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.102 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -59.43 -53.32 59.5 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -44.64 76.6 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.334 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.48 -44.32 92.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.027 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -60.05 -38.56 83.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.829 0.347 . . . . 0.0 111.292 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.12 -41.76 84.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.25 -22.11 21.78 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.811 0.338 . . . . 0.0 111.687 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.7 t0 -73.7 87.69 1.7 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.33 0.586 . . . . 0.0 112.014 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.6 tp -69.3 -15.77 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 122.611 1.196 . . . . 0.0 113.495 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.6 p-10 -142.44 145.43 33.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.111 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.58 52.59 1.54 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.576 -0.345 . . . . 0.0 113.12 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -90.88 -9.25 46.96 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.089 0.445 . . . . 0.0 110.076 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.88 1.7 73.92 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.984 -0.627 . . . . 0.0 114.133 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -134.54 154.48 51.43 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.372 0.586 . . . . 0.0 110.202 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.9 t -100.39 118.47 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.438 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -84.0 173.87 10.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.787 0.327 . . . . 0.0 110.844 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -61.76 -39.41 91.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.018 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.29 -44.75 94.13 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.878 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.83 -38.69 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.591 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.64 -44.66 96.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.859 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.19 -47.01 89.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.4 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -49.37 -44.54 44.97 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.25 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.1 mmm -75.44 -39.31 59.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.6 mmt -74.36 -48.04 30.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.605 -0.146 . . . . 0.0 110.605 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.686 0.279 . . . . 0.0 111.591 -179.39 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.0 m95 -59.99 -57.63 12.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.402 0.62 . . . . 0.0 112.077 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 41.5 t80 -57.54 -44.96 85.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -40.82 -51.11 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.57 99.7 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.514 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 46.0 tp -56.11 -46.24 79.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.517 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 65.8 t30 -59.21 -49.28 78.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -65.22 -38.4 90.32 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 88.0 mt -60.79 -42.33 91.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.71 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -50.25 -44.73 53.67 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.519 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.0 m -63.6 -48.39 77.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.416 ' C ' ' O ' ' B' 1102 ' ' THR . 89.3 mt-30 -27.57 -60.18 0.1 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.738 1.256 . . . . 0.0 112.747 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.1 mt -82.43 -14.8 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 112.33 -2.214 . . . . 0.0 111.968 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.519 ' N ' ' O ' ' B' 1102 ' ' THR . 17.3 ttmm -59.1 -45.04 91.91 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 117.845 -1.542 . . . . 0.0 107.937 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.2 t -60.78 -49.26 85.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.97 -36.35 77.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.305 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.0 mttt -49.35 -38.15 27.2 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.641 -0.662 . . . . 0.0 109.659 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.19 -45.99 68.81 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.341 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1110 ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 55' ' ' VAL . 47.8 m-85 -62.87 -49.8 73.41 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 25.1 m-70 . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.945 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 119.366 -0.349 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.6 p -79.33 135.98 36.88 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.371 0.987 . . . . 0.0 110.36 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ILE . 48.6 tp10 -51.94 -55.43 20.33 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.97 0.891 . . . . 0.0 110.467 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -34.8 -36.33 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.773 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -70.1 -33.96 72.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.598 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.4 mm -59.2 -45.42 92.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.52 -51.36 59.96 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.383 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.92 -46.64 89.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.422 0.629 . . . . 0.0 112.221 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.2 m-85 -62.81 -38.86 92.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.771 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -52.59 -53.67 43.57 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.177 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.85 -41.27 61.7 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.041 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -55.95 -37.88 69.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.355 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.61 -41.76 81.9 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 t -64.6 -14.85 59.77 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.476 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.97 -42.78 97.16 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -106.14 -13.82 15.33 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -76.4 95.09 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.422 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -68.35 -46.89 68.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.227 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 23' ' ' GLY . 35.4 p30 -101.89 14.17 32.71 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.02 46.47 0.94 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.031 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -85.77 -4.17 59.09 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.898 0.38 . . . . 0.0 111.044 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.69 80.79 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.9 p -137.64 152.09 48.98 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.078 0.466 . . . . 0.0 110.068 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.12 124.51 44.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.8 p -112.51 163.4 14.52 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.521 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.428 HG22 HG13 ' A' ' 52' ' ' ILE . 18.7 p -59.42 -36.62 76.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.052 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -61.73 -59.58 4.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.317 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.82 -28.92 70.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.558 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.521 HD22 HD11 ' A' ' 52' ' ' ILE . 3.1 tp -61.17 -54.41 44.73 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.461 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.53 -38.36 93.5 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.192 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.36 -53.92 52.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.835 1.318 . . . . 0.0 108.729 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.7 t -56.2 -45.92 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 O-C-N 121.341 -0.85 . . . . 0.0 111.223 -176.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 ttt -58.76 -38.98 79.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 120.157 1.344 . . . . 0.0 109.946 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -52.48 -40.41 62.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 110.725 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.2 p -63.08 -20.83 65.72 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.037 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.79 -1.43 19.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.805 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.0 23.97 39.44 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.389 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -125.76 166.81 16.12 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 117.369 0.585 . . . . 0.0 109.669 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 14.1 p30 -131.38 76.75 75.17 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.461 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -63.87 148.85 91.69 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.941 2.427 . . . . 0.0 112.175 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.4 p -79.03 165.2 23.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.115 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -58.71 -45.0 90.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.85 -24.73 53.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.876 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -64.53 -40.92 96.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.139 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.5 mp -54.18 -38.79 65.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.222 0.534 . . . . 0.0 109.707 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -72.74 -55.34 6.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.797 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -54.68 -50.44 68.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 73.2 mtp -66.87 -49.35 65.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.521 HD11 HD22 ' A' ' 32' ' ' LEU . 27.6 mm -59.01 -47.78 88.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.769 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -57.33 -32.85 67.13 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -67.35 -40.25 85.83 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.8 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.12 -21.03 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.171 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.47 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.5 t0 -78.27 86.06 4.39 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -174.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.1 81.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 113.427 -1.715 . . . . 0.0 114.184 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -86.47 -2.46 58.47 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.52 23.17 60.17 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 118.543 0.611 . . . . 0.0 112.707 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -87.47 4.72 42.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.205 0.503 . . . . 0.0 110.54 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.47 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.32 1.17 89.49 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.737 -0.602 . . . . 0.0 114.599 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.5 p -148.35 168.42 22.64 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.4 mt -112.91 128.67 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 45.7 t0 -104.03 -174.57 2.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.604 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.527 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -57.12 -57.21 26.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 10.4 Cg_endo -50.47 -49.86 15.32 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 CA-C-N 120.541 1.229 . . . . 0.0 111.569 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.89 -18.59 60.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.273 0.559 . . . . 0.0 110.72 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -73.47 -57.59 3.89 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.123 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' THR . 78.3 mt -57.74 -45.27 86.06 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 53.6 m -38.59 -64.57 0.42 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.749 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.487 ' SD ' ' N ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -63.17 -42.03 99.32 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.487 ' N ' ' SD ' ' A' ' 71' ' ' MET . 97.9 mmm -58.73 -40.69 84.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.02 -33.51 76.21 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 122.395 0.278 . . . . 0.0 111.022 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -95.21 -10.22 31.03 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.112 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.4 65.85 8.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.974 0.416 . . . . 0.0 110.375 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.5 mmt -108.24 16.22 23.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.569 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -49.1 133.34 18.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.394 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -90.75 106.86 18.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.968 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.454 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 15.7 m -91.8 120.18 32.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.6 m-20 -68.74 112.71 5.64 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.4 m -37.42 -20.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.768 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 80' ' ' ASP . 94.9 mt-10 -68.13 -39.8 82.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.733 0.302 . . . . 0.0 111.648 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -46.93 -35.32 6.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -87.71 -19.4 27.67 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.954 0.407 . . . . 0.0 111.78 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 85' ' ' ILE . 30.4 mm -61.04 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.735 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -61.47 -41.2 96.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.05 -40.54 94.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.5 -178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.05 -20.5 64.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -71.57 -51.6 22.58 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.03 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -54.8 -42.34 71.7 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.347 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.73 -43.74 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.526 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.5 m-85 -68.89 -39.07 79.95 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.326 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -85.3 81.09 8.93 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -57.63 -49.46 76.37 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -91.85 4.82 52.03 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 122.181 -0.324 . . . . 0.0 111.42 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.76 48.31 50.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -90.37 6.34 43.57 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.739 0.304 . . . . 0.0 110.715 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.19 2.1 88.1 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -142.34 155.99 45.21 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.487 0.66 . . . . 0.0 111.463 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.0 mt -93.57 114.93 31.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 t -88.98 150.98 22.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.47 78.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 119.085 0.857 . . . . 0.0 110.815 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.21 -40.08 61.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.942 0.401 . . . . 0.0 110.419 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.37 -42.11 88.47 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.69 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.8 tp -62.84 -47.16 84.6 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.249 0.547 . . . . 0.0 111.079 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -43.01 -43.31 4.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.652 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -64.23 -28.63 69.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.005 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.526 HG21 ' CE2' ' A' ' 92' ' ' PHE . 92.9 t -57.78 -42.38 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.602 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.624 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -50.96 -44.12 60.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.699 0.761 . . . . 0.0 111.253 -177.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 m -56.28 -40.91 75.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.781 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -65.51 -41.02 93.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.79 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.8 mt -81.82 -13.77 57.23 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.905 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.2 31.36 59.55 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -85.31 -22.63 28.45 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.55 2.175 . . . . 0.0 111.286 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 44.16 60.93 2.55 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.71 0.767 . . . . 0.0 109.675 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.432 HD12 ' CG ' ' A' ' 109' ' ' MET . 88.9 mt -80.7 148.23 30.24 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 113.527 -1.67 . . . . 0.0 112.462 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 121' ' ' VAL . 65.4 p -82.85 175.5 10.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.3 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 119' ' ' GLU . 18.9 p-10 -58.41 -43.99 88.87 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 176.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.491 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 67.5 mm-40 -57.85 -49.16 77.6 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -70.87 -30.3 66.64 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.627 -0.429 . . . . 0.0 112.039 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 117' ' ' THR . 40.7 t -63.97 -41.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.6 0.714 . . . . 0.0 109.1 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -70.78 -35.6 72.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.339 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.41 -51.33 69.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 37.9 mmm -55.98 -44.62 78.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.253 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.96 -43.49 88.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.404 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -60.73 -35.22 75.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.848 0.356 . . . . 0.0 111.153 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -59.45 -41.36 89.5 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.938 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.95 -20.51 22.09 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 21.4 t0 -73.09 89.05 1.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.528 0.68 . . . . 0.0 111.706 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 76.4 mt -70.08 -16.35 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.021 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 49.1 p-10 -140.48 144.82 36.25 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 112.644 -2.071 . . . . 0.0 108.805 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.27 52.17 1.41 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.899 -0.191 . . . . 0.0 113.154 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 22.0 p-10 -91.24 -8.84 47.29 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.966 0.383 . . . . 0.0 110.057 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.86 3.17 79.64 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.117 -0.564 . . . . 0.0 114.125 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -136.09 155.2 50.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.444 0.622 . . . . 0.0 110.383 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.9 t -101.56 119.01 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.207 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -84.79 175.64 9.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.597 0.237 . . . . 0.0 110.89 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -61.64 -41.12 97.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.306 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -61.61 -45.0 95.93 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.704 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.59 -38.0 88.25 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.668 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 90.9 t80 -58.57 -44.64 89.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.999 0.428 . . . . 0.0 110.796 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.03 -46.13 88.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.411 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -48.35 -44.58 34.49 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.03 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 77.3 mmm -75.73 -36.48 59.92 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.585 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.6 mmt -65.96 -50.98 62.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 m . . . . . 0 C--N 1.326 -0.441 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.08 -179.612 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 9.3 mt . . . . . 0 C--O 1.24 0.562 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.8 m95 -63.4 -47.29 82.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1094 ' ' PHE . . . . . 0.532 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 2.4 m-85 -58.02 -46.3 85.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -40.51 -53.46 2.67 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.85 -42.11 99.71 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.129 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 50.8 tp -56.85 -44.6 82.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.217 1.008 . . . . 0.0 109.592 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -58.8 -47.6 84.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -65.06 -37.46 87.63 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.12 -42.43 93.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.772 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -50.83 -45.88 59.74 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 118.863 -1.135 . . . . 0.0 108.039 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.527 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.8 m -63.64 -48.22 78.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.434 -0.506 . . . . 0.0 112.152 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.429 ' C ' ' O ' ' B' 1102 ' ' THR . 84.3 mt-30 -27.79 -57.78 0.11 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 122.457 1.122 . . . . 0.0 112.451 -176.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1104 ' ' ILE . . . . . 0.404 HG21 HD13 ' B' 1104 ' ' ILE . 1.5 mt -83.98 -14.45 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.365 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.527 ' N ' ' O ' ' B' 1102 ' ' THR . 65.7 tttm -59.72 -46.28 89.59 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 118.152 -1.419 . . . . 0.0 107.972 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 86.2 t -61.08 -49.31 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.64 -35.97 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.329 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1108 ' ' LYS . . . . . 0.454 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 88.8 mttt -49.31 -37.75 25.28 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.646 0.657 . . . . 0.0 109.641 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.59 -45.91 66.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.295 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -62.9 -50.23 71.7 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 78.5 m-70 . . . . . 0 C--N 1.325 -0.467 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.198 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 CA--C 1.534 0.338 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.7 m -81.07 136.43 35.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.093 0.861 . . . . 0.0 110.366 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.1 tt0 -51.01 -58.84 5.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.795 0.807 . . . . 0.0 110.991 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -33.8 -38.64 0.05 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.855 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -68.86 -35.06 76.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.49 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.6 mt -58.32 -45.11 89.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.55 -51.28 63.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.097 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -59.82 -48.27 82.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.283 0.564 . . . . 0.0 112.384 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -61.37 -40.4 94.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.952 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -51.63 -56.9 10.93 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.734 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.35 -43.65 23.26 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.462 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.82 -39.04 65.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.987 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -56.92 -42.37 79.86 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -64.25 -15.49 60.2 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.056 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.96 -41.34 95.56 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -105.99 -13.65 15.42 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -74.4 95.84 2.77 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.565 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -68.86 -49.46 58.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.111 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.0 p-10 -101.84 15.76 28.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 33.87 47.82 0.51 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.035 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 33.9 p-10 -85.24 -5.18 59.34 Favored 'General case' 0 N--CA 1.461 0.106 0 O-C-N 122.69 -0.3 . . . . 0.0 111.038 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.72 -1.93 79.3 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.0 p -138.25 153.89 49.08 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.693 ' N ' HD12 ' A' ' 27' ' ' ILE . 2.0 mp -93.0 125.46 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.519 HG22 ' OE1' ' A' ' 31' ' ' GLU . 10.0 t -116.86 166.37 12.24 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.421 HG22 HG13 ' A' ' 52' ' ' ILE . 37.5 p -56.79 -32.45 65.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.407 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -59.78 -63.61 1.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.298 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' OE1' HG22 ' A' ' 28' ' ' THR . 4.7 pt-20 -62.54 -30.49 71.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 119.326 -0.369 . . . . 0.0 111.882 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.404 HD22 HD11 ' A' ' 52' ' ' ILE . 4.1 tp -58.25 -61.3 2.67 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 118.821 -1.151 . . . . 0.0 108.69 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.19 72.96 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.098 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.8 m -56.67 -53.64 55.4 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.782 1.791 . . . . 0.0 108.431 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.71 -45.64 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 119.196 0.907 . . . . 0.0 111.563 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.417 ' SD ' HD12 ' A' ' 39' ' ' LEU . 9.2 tpt -58.2 -41.69 84.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 120.355 1.434 . . . . 0.0 109.698 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -52.3 -39.85 61.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.506 0.67 . . . . 0.0 111.32 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 t -62.96 -20.52 65.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.706 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.417 HD12 ' SD ' ' A' ' 36' ' ' MET . 80.4 mt -74.98 2.21 11.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.167 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.1 26.81 47.29 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.978 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -125.8 166.65 16.45 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 117.41 0.605 . . . . 0.0 109.91 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -124.11 81.07 57.63 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.23 146.76 52.02 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.802 1.668 . . . . 0.0 112.204 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -80.29 163.19 24.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.84 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -58.02 -44.48 87.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.097 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.74 -24.49 35.42 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.771 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -65.25 -40.62 94.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.895 0.378 . . . . 0.0 110.657 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 6.8 mp -56.2 -41.05 74.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.638 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -70.01 -56.93 5.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.826 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -55.27 -49.69 71.43 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.5 mtp -66.21 -51.4 58.04 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.421 HG13 HG22 ' A' ' 29' ' ' THR . 25.7 mm -57.64 -49.18 81.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -56.15 -32.57 64.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -67.26 -40.39 86.22 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.868 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.7 t -86.27 -20.32 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.425 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.404 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 43.5 t0 -78.69 83.64 4.83 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -174.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.7 75.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 113.595 -1.639 . . . . 0.0 114.748 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.853 ' CG ' HD21 ' A' ' 60' ' ' ASN . 26.1 p30 -88.61 -1.66 58.18 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.17 23.84 60.22 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 118.664 0.666 . . . . 0.0 112.95 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.853 HD21 ' CG ' ' A' ' 58' ' ' ASP . 13.0 p30 -87.52 2.97 49.21 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 117.42 0.61 . . . . 0.0 110.368 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.18 1.73 86.2 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 114.831 0.692 . . . . 0.0 114.831 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.2 p -147.66 169.65 19.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -112.22 128.17 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.097 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -102.46 -178.99 3.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.761 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.96 99.78 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -54.13 -51.83 9.73 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.071 1.181 . . . . 0.0 111.978 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.24 -23.19 66.53 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.388 0.613 . . . . 0.0 111.269 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -71.18 -61.11 1.89 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.514 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.5 mt -56.69 -43.81 80.85 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.1 p -44.0 -51.72 7.56 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.605 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.0 mtm -64.9 -44.65 88.9 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.6 mmm -61.23 -41.06 96.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.91 79.31 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.415 0.286 . . . . 0.0 111.623 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -91.91 -16.25 26.91 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.722 0.296 . . . . 0.0 111.331 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 27.8 tptp -80.49 71.62 7.34 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.819 0.819 . . . . 0.0 110.631 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 20.6 mmt -109.5 15.35 23.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.255 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -47.77 131.27 14.88 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.237 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -89.28 109.62 20.49 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.927 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.518 HG21 ' NZ ' ' B' 1108 ' ' LYS . 17.2 p -97.98 114.79 27.02 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -64.99 115.5 5.46 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 62.6 m -37.44 -21.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.845 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 80' ' ' ASP . 42.5 tp10 -68.26 -35.86 78.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.028 0.442 . . . . 0.0 111.707 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 80.2 tt0 -49.6 -37.2 26.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.341 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -87.35 -16.3 35.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.128 0.49 . . . . 0.0 111.701 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 85' ' ' ILE . 29.5 mm -62.57 -73.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.735 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -60.39 -44.21 95.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 87' ' ' GLU . 7.1 mp0 -61.05 -41.29 96.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.364 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.5 -17.84 47.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.188 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -75.15 -49.67 18.79 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.476 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -55.4 -42.94 74.76 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.932 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.9 t -65.13 -44.12 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.488 ' CE2' HG21 ' A' ' 108' ' ' VAL . 8.0 m-85 -69.82 -38.16 76.47 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.635 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.402 ' OD1' ' OD1' ' A' ' 97' ' ' ASN . 31.4 t0 -88.32 82.59 7.01 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.12 -48.59 78.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 40.7 p-10 -91.65 5.47 49.56 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.1 50.13 40.56 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.402 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 32.3 p30 -92.62 5.11 52.17 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.416 0.287 . . . . 0.0 110.818 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.25 0.21 88.61 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -138.74 152.12 47.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.944 0.878 . . . . 0.0 111.887 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 95.8 mt -94.79 117.37 38.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.1 m -89.46 148.12 23.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.529 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.29 -48.03 74.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 119.66 1.118 . . . . 0.0 110.17 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.38 -42.61 53.71 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.75 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.91 -41.05 97.78 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.34 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.33 -45.28 92.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.552 0.691 . . . . 0.0 111.203 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 74.5 ttp85 -44.28 -44.94 8.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.551 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -63.63 -31.33 72.47 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.331 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.488 HG21 ' CE2' ' A' ' 92' ' ' PHE . 84.5 t -56.05 -42.15 71.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.004 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.736 ' SD ' HD12 ' A' ' 116' ' ' LEU . 16.0 mmt -51.31 -44.38 61.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.795 0.807 . . . . 0.0 111.222 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 m -53.76 -42.03 67.81 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.952 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -66.4 -41.17 89.72 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.521 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.31 -16.03 53.65 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.08 30.39 59.15 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-O 118.258 -1.301 . . . . 0.0 110.546 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -85.66 -22.27 27.98 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.341 2.571 . . . . 0.0 110.982 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 43.76 60.42 2.69 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 122.18 0.99 . . . . 0.0 110.056 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.736 HD12 ' SD ' ' A' ' 109' ' ' MET . 40.4 mt -80.49 147.24 30.97 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.64 -1.618 . . . . 0.0 111.799 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 121' ' ' VAL . 28.5 p -82.14 174.89 10.78 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -56.55 -44.98 81.45 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -57.7 -47.25 82.89 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.594 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -73.22 -30.18 63.31 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.762 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 117' ' ' THR . 44.5 t -64.68 -41.71 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.463 0.649 . . . . 0.0 109.864 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 67.7 t0 -73.45 -34.8 65.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.291 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -59.5 -50.01 75.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.934 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.0 mtp -53.58 -46.6 70.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.285 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.8 mm -56.41 -43.54 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -60.1 -36.5 77.56 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.288 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -58.68 -41.18 85.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.846 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.91 -17.16 25.61 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.8 t0 -72.54 90.74 1.36 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.737 0.78 . . . . 0.0 112.213 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.405 ' O ' HG22 ' A' ' 130' ' ' ILE . 79.3 mt -71.74 -17.63 19.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.158 -1.383 . . . . 0.0 113.123 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 50.4 p-10 -142.72 144.28 32.62 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 112.65 -2.068 . . . . 0.0 108.813 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.41 53.82 1.53 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.129 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -90.85 -8.87 48.35 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.051 0.425 . . . . 0.0 110.14 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.52 1.64 71.73 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.997 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -134.76 155.33 50.78 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.159 0.479 . . . . 0.0 110.439 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.3 t -100.91 118.42 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.322 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.42 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 53.3 t30 -84.46 173.7 10.65 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 111.258 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.42 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 82.5 t80 -61.0 -40.6 94.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.96 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.06 -44.63 96.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.794 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.48 -37.24 86.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.549 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -61.12 -45.04 96.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.046 0.451 . . . . 0.0 111.046 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.69 -47.18 89.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.829 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -50.58 -41.93 55.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.145 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.6 mmt -74.67 -38.57 62.39 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 19.9 mmt -73.17 -46.12 52.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 120.576 0.227 . . . . 0.0 111.456 -179.764 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 111.417 0.154 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.7 m95 -61.33 -55.76 28.02 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.462 0.649 . . . . 0.0 112.172 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 50.3 t80 -57.94 -46.98 84.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1095 ' ' ARG . . . . . 0.684 HH21 ' NH2' ' B' 1099 ' ' ARG . 59.4 ttt85 -40.31 -52.75 2.65 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.4 -40.62 98.91 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 48.7 tp -56.0 -46.32 78.78 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.689 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -58.63 -49.88 75.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1099 ' ' ARG . . . . . 0.684 ' NH2' HH21 ' B' 1095 ' ' ARG . 91.2 mtt180 -63.87 -39.76 94.95 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.77 -42.61 89.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.14 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -52.29 -47.42 65.91 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 118.605 -1.238 . . . . 0.0 107.677 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.527 ' O ' ' N ' ' B' 1105 ' ' LYS . 18.8 m -61.58 -48.87 78.99 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 93.4 mt-30 -27.57 -57.95 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 122.709 1.242 . . . . 0.0 113.382 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.0 mt -81.68 -14.42 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 112.434 -2.166 . . . . 0.0 112.389 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.527 ' N ' ' O ' ' B' 1102 ' ' THR . 93.4 mttt -59.28 -41.87 89.9 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.27 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 90.8 t -60.39 -46.7 94.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.994 0.902 . . . . 0.0 112.24 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 55.5 t -65.59 -42.34 92.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.877 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1108 ' ' LYS . . . . . 0.518 ' NZ ' HG21 ' A' ' 79' ' ' THR . 94.0 mttt -49.25 -41.32 37.2 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.848 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.25 61.66 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.693 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -60.44 -65.65 0.65 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.848 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 35.4 p80 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.929 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 119.346 -0.359 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -80.92 140.21 35.43 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.15 0.886 . . . . 0.0 110.196 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.5 tt0 -50.39 -56.26 12.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 122.167 0.984 . . . . 0.0 110.642 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -34.83 -37.77 0.07 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.189 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -68.9 -38.59 79.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.72 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 6' ' ' GLU . 66.6 mt -56.85 -45.74 83.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.62 -51.27 63.61 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.455 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -61.43 -47.33 86.25 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.466 0.65 . . . . 0.0 112.246 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.0 m-85 -62.83 -37.7 87.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.897 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -54.59 -52.21 62.86 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.777 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -51.08 -39.99 57.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.082 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.84 -38.0 72.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.309 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -58.04 -42.31 85.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.1 t -65.03 -14.79 61.32 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.6 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.74 -43.05 99.81 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.39 -12.56 15.97 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.72 94.84 3.32 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.265 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -65.04 -47.89 75.78 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.521 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 8.9 p30 -109.69 14.5 23.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.31 59.78 1.47 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.303 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -87.54 -6.79 58.19 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.804 0.335 . . . . 0.0 110.237 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.91 -1.63 74.8 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.0 p -139.77 156.66 46.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.015 0.436 . . . . 0.0 109.998 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.639 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.8 mp -89.2 123.1 41.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -111.46 162.71 14.8 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.91 0.757 . . . . 0.0 112.41 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.425 HG22 HG13 ' A' ' 52' ' ' ILE . 18.8 p -60.33 -38.52 84.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.859 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -59.75 -62.21 2.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.821 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -62.0 -28.1 69.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.652 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.476 HD22 HD11 ' A' ' 52' ' ' ILE . 2.9 tp -60.43 -52.66 64.28 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.471 178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.91 91.81 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.891 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.67 -52.42 65.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.828 1.314 . . . . 0.0 108.632 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.8 t -58.65 -45.06 90.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 119.267 0.94 . . . . 0.0 111.231 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.484 ' SD ' ' O ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -59.54 -40.29 86.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 119.782 1.173 . . . . 0.0 109.789 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -52.58 -38.12 59.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.403 0.621 . . . . 0.0 110.041 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.2 p -62.27 -20.01 63.84 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.177 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -73.82 2.24 8.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.99 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.24 26.23 40.97 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.132 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -131.75 171.3 13.67 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.356 0.578 . . . . 0.0 109.817 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 16.9 p-10 -132.77 76.79 70.34 Favored Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.409 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.46 146.27 97.13 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.783 2.322 . . . . 0.0 111.93 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.2 p -76.28 163.85 26.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.173 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -58.59 -43.64 89.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.848 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.78 -24.25 49.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.378 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -65.38 -39.51 92.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.154 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.0 mp -56.71 -41.03 76.71 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.395 0.617 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -72.1 -56.12 6.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.008 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -55.99 -49.72 72.84 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 40.8 mmm -64.59 -50.86 65.57 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.476 HD11 HD22 ' A' ' 32' ' ' LEU . 25.8 mm -59.23 -45.37 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.346 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -56.97 -34.68 68.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.35 -40.68 85.85 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.872 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.437 HG21 ' CE2' ' B' 1110 ' ' PHE . 54.8 t -84.93 -21.95 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.471 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.496 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.6 t0 -78.6 87.15 4.55 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -175.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.68 -37.19 85.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.356 -1.747 . . . . 0.0 113.669 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.416 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 39.9 p-10 -86.05 -2.46 58.34 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.66 23.09 60.39 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.313 0.506 . . . . 0.0 112.942 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -88.26 4.13 47.01 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.3 0.55 . . . . 0.0 110.354 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.496 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.05 0.87 88.89 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 121.091 -0.576 . . . . 0.0 114.383 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.1 p -147.87 169.2 20.32 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.5 mt -111.93 128.11 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 23.7 t0 -102.29 -178.14 3.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.658 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.546 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -57.03 -48.31 97.64 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.387 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -55.79 -49.34 16.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.26 1.306 . . . . 0.0 111.824 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.01 -20.65 64.14 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.487 0.661 . . . . 0.0 110.662 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -74.8 -57.0 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.131 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 72.8 mt -58.08 -45.23 87.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -47.29 -46.59 25.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.321 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 81.4 mtp -66.62 -45.29 79.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.6 mmt -60.13 -40.68 90.63 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -34.8 78.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.531 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -92.3 -16.86 25.53 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.64 0.257 . . . . 0.0 111.461 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 67.31 7.11 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.197 0.522 . . . . 0.0 110.709 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.9 mmt -107.99 16.8 23.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.517 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -49.3 132.59 20.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.981 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.57 109.11 20.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.871 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -95.28 118.88 32.83 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -66.65 113.32 4.71 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 174.318 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.8 m -37.8 -20.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.751 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 80' ' ' ASP . 5.3 mp0 -66.87 -41.9 86.52 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -45.21 -35.64 3.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.319 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -87.52 -20.3 26.7 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.003 0.43 . . . . 0.0 111.865 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 30.4 mm -60.11 -74.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.669 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -63.09 -40.21 96.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.09 -40.76 94.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.434 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.8 -20.75 63.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.136 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -70.74 -50.43 36.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.075 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -55.38 -41.84 73.18 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.414 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.11 -45.05 97.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.559 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.5 m-85 -68.94 -39.67 79.42 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.423 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -85.52 81.29 8.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.81 -48.89 79.72 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -91.31 4.87 51.28 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.344 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.55 48.3 49.58 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -90.7 7.32 40.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.665 0.269 . . . . 0.0 110.51 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.64 1.93 88.95 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -142.39 155.77 45.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.716 0.77 . . . . 0.0 111.491 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.3 mt -93.33 114.26 29.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.3 m -88.83 151.52 22.32 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.54 -48.98 77.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.838 0.745 . . . . 0.0 110.895 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.77 -40.81 60.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.9 0.381 . . . . 0.0 110.726 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -64.98 -40.86 95.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.027 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 108' ' ' VAL . 7.4 tt -63.42 -45.02 92.87 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.337 0.589 . . . . 0.0 111.408 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.485 ' HE ' HG11 ' A' ' 121' ' ' VAL . 24.5 mmt85 -40.7 -37.87 0.81 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.71 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -69.31 -25.32 64.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.783 0.325 . . . . 0.0 111.46 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.559 HG21 ' CE2' ' A' ' 92' ' ' PHE . 90.1 t -59.01 -44.88 92.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.625 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.708 ' SD ' HD12 ' A' ' 116' ' ' LEU . 16.4 mmt -52.02 -44.95 64.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.12 0.962 . . . . 0.0 111.234 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.5 m -58.62 -42.73 88.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.706 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -65.73 -41.49 92.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.148 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.7 mt -81.52 -15.88 53.5 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.879 -0.329 . . . . 0.0 111.812 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.53 30.65 57.95 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.418 ' OE1' ' SD ' ' A' ' 109' ' ' MET . 96.9 mt-10 -85.66 -23.24 27.55 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.552 2.176 . . . . 0.0 110.578 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt 43.84 59.62 3.05 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.927 0.87 . . . . 0.0 110.366 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.708 HD12 ' SD ' ' A' ' 109' ' ' MET . 44.6 mt -79.69 148.83 31.42 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.519 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.6 p -82.91 174.78 10.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.197 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -57.99 -44.5 87.2 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.81 -48.81 78.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.484 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.0 -31.54 69.27 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.821 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.485 HG11 ' HE ' ' A' ' 106' ' ' ARG . 30.3 t -63.17 -43.29 98.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.487 0.66 . . . . 0.0 109.343 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.06 -37.74 84.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.582 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -59.77 -50.36 74.13 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 20.1 mmm -57.12 -44.08 82.94 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.342 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.9 mt -59.9 -43.41 92.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.044 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -58.94 -38.63 79.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.999 0.428 . . . . 0.0 111.199 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -58.73 -40.61 84.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.006 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.6 -21.44 21.72 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.0 t0 -74.23 88.55 2.0 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.486 0.66 . . . . 0.0 111.883 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 42.7 mm -71.93 -14.19 17.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 122.624 1.202 . . . . 0.0 113.13 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.6 p-10 -142.84 144.59 32.58 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 112.414 -2.176 . . . . 0.0 109.251 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.02 52.23 1.32 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.784 -0.246 . . . . 0.0 112.968 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -90.85 -10.07 44.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.061 0.431 . . . . 0.0 110.056 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.12 1.11 67.62 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.195 -0.526 . . . . 0.0 114.221 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -134.9 153.76 51.94 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.435 0.618 . . . . 0.0 110.433 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.21 118.61 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.243 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.1 174.86 9.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.733 0.301 . . . . 0.0 110.858 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -61.65 -40.16 93.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.965 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.54 -44.64 95.86 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.837 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.26 -37.85 88.47 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.505 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -60.26 -45.42 93.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 110.721 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.55 -46.59 89.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.458 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -48.78 -47.12 42.2 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.893 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.7 mmm -72.33 -37.57 68.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.431 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 24.2 mmt -72.11 -45.23 61.4 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.857 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.066 -179.357 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.7 m95 -58.11 -65.01 0.72 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.752 0.787 . . . . 0.0 111.875 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1094 ' ' PHE . . . . . 0.431 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 38.0 m-85 -56.68 -43.35 80.36 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -174.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 12.3 tpp85 -39.73 -51.49 2.34 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.12 99.94 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.47 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.0 tp -56.35 -45.69 80.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.501 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -59.79 -49.09 79.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.878 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -65.77 -37.67 86.95 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.11 -42.04 91.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.903 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -51.47 -45.39 62.75 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.507 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.1 m -64.27 -47.99 77.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.825 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 84.0 mt-30 -27.98 -57.08 0.11 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.83 1.3 . . . . 0.0 112.597 -176.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.89 -13.94 11.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 CA-C-N 112.519 -2.128 . . . . 0.0 112.578 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.507 ' N ' ' O ' ' B' 1102 ' ' THR . 88.6 tttt -57.51 -41.65 81.25 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 118.316 -1.354 . . . . 0.0 107.95 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 77.5 t -62.74 -46.82 95.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.724 0.773 . . . . 0.0 112.814 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 37.1 t -65.83 -42.08 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.209 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 97.0 mttt -48.79 -38.07 20.96 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.833 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.87 -45.04 67.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.076 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1110 ' ' PHE . . . . . 0.437 ' CE2' HG21 ' A' ' 55' ' ' VAL . 48.7 m-85 -63.25 -50.0 71.9 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 69.8 m-70 . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.285 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.3 p -79.81 133.22 36.28 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.643 1.111 . . . . 0.0 111.12 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.7 tt0 -54.66 -51.3 65.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.769 0.795 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -34.17 -36.01 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.129 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.521 ' NE2' ' OE1' ' A' ' 11' ' ' GLU . 39.5 tp60 -70.61 -32.87 70.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.475 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' A' ' 6' ' ' GLU . 93.7 mt -57.83 -45.73 87.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.89 -50.14 61.62 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.412 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.521 ' OE1' ' NE2' ' A' ' 8' ' ' GLN . 97.4 mt-10 -64.15 -44.76 91.15 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.439 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.1 m-85 -62.98 -40.79 98.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.753 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -52.14 -55.58 19.99 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.204 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -49.87 -41.84 46.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.116 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -54.83 -35.66 64.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.503 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.434 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 2.5 m-85 -57.73 -39.61 77.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.4 m -65.95 -16.06 63.54 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.255 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 2.7 mm? -64.23 -41.99 96.75 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.78 -15.25 14.78 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.897 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -74.99 94.72 2.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.145 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -67.15 -48.22 68.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.802 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.0 p30 -103.25 14.68 31.07 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 38.08 50.48 2.14 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.961 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -87.57 -5.17 58.88 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.925 0.362 . . . . 0.0 111.572 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.43 -0.59 78.01 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.7 p -140.07 157.9 44.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.981 0.42 . . . . 0.0 109.954 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mm -88.03 122.81 40.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 p -111.57 161.56 16.07 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.012 0.82 . . . . 0.0 112.276 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 p -59.26 -38.4 79.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.708 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -60.99 -60.05 4.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.06 -30.16 71.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.766 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 tp -60.54 -55.92 27.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.322 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.99 -37.56 91.66 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.806 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -58.5 -53.71 55.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 119.317 1.558 . . . . 0.0 108.434 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.7 t -56.97 -46.69 84.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.598 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.0 ttt -58.51 -42.26 87.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 120.27 1.395 . . . . 0.0 110.189 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -52.27 -37.62 55.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.481 0.658 . . . . 0.0 110.15 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.0 t -63.69 -21.22 66.28 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.517 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.52 0.4 17.4 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.756 -0.777 . . . . 0.0 109.935 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 18.21 62.59 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.173 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -109.81 157.91 18.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.72 0.76 . . . . 0.0 110.038 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -113.0 66.15 0.96 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.443 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.74 142.68 90.11 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.075 1.85 . . . . 0.0 112.302 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -82.36 166.78 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.447 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -58.29 -44.77 88.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.851 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.43 -23.59 25.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.635 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.65 -39.02 90.95 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.273 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 7.8 mp -56.45 -41.31 76.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.23 0.538 . . . . 0.0 109.662 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.425 ' OE1' ' ND2' ' A' ' 53' ' ' ASN . 8.9 tp-100 -68.78 -58.52 4.08 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.71 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -55.05 -49.37 71.78 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.9 mmm -63.81 -53.91 43.38 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 52' ' ' ILE . 26.4 mm -58.31 -47.63 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.83 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.425 ' ND2' ' OE1' ' A' ' 49' ' ' GLN . 34.3 m-80 -56.49 -33.64 66.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -66.41 -40.31 89.49 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.596 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.47 HG21 ' CD2' ' B' 1110 ' ' PHE . 76.3 t -86.65 -19.8 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.42 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 40.6 t0 -78.98 84.59 4.98 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -174.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.28 -37.39 83.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.626 -1.625 . . . . 0.0 114.238 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.454 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.7 p-10 -86.1 -2.35 58.25 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.5 23.34 62.55 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 118.383 0.538 . . . . 0.0 112.696 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.454 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.4 p-10 -87.5 1.96 52.02 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.27 0.535 . . . . 0.0 110.606 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.552 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 86.73 1.58 85.17 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.685 0.634 . . . . 0.0 114.685 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.3 p -148.84 170.9 17.22 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.416 HD12 HG12 ' A' ' 55' ' ' VAL . 15.9 mm -110.85 128.29 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -102.35 -178.27 3.64 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.434 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -58.06 -48.96 96.16 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.202 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -55.94 -51.86 8.67 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.536 1.491 . . . . 0.0 111.537 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.1 -19.99 62.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.607 0.717 . . . . 0.0 110.354 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -75.95 -58.99 2.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.2 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.87 -44.94 78.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.9 p -45.75 -44.29 13.66 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.561 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.5 mtp -71.89 -49.48 37.55 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.4 mmm -61.01 -40.72 94.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.16 -33.58 76.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.66 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -93.45 -14.82 26.27 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.627 0.251 . . . . 0.0 111.529 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 mmpp? -77.87 71.91 4.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.163 0.506 . . . . 0.0 111.311 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.7 mmt -107.03 18.33 21.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.858 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -51.73 129.87 27.25 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.197 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -90.69 105.18 17.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.135 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.495 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 3.1 m -88.45 123.18 32.74 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 82' ' ' GLU . 15.5 t0 -69.43 109.86 4.43 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 174.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.8 m -37.04 -21.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 80' ' ' ASP . 50.6 mp0 -70.33 -34.14 72.32 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 111.835 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.444 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 81.1 tt0 -50.32 -39.14 45.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.266 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 76.7 mt-10 -88.34 -5.57 58.24 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 85' ' ' ILE . 26.9 mm -70.79 -74.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.85 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -61.48 -50.39 72.95 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 83' ' ' GLU . 16.1 pt-20 -54.41 -38.77 66.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -60.79 -20.03 60.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.014 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -73.99 -48.1 32.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.771 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -54.59 -41.01 69.39 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.418 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.91 -43.29 92.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.553 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.6 m-85 -68.78 -39.03 80.38 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.248 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -87.36 82.8 7.46 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.88 -49.45 76.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 35.6 p-10 -90.91 5.28 49.27 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.629 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.07 48.49 46.15 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -90.31 6.48 42.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.678 0.275 . . . . 0.0 110.634 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.54 1.45 89.21 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -140.72 153.91 46.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.671 0.748 . . . . 0.0 111.612 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.422 ' HB ' HG13 ' A' ' 136' ' ' VAL . 96.7 mt -97.07 117.28 41.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.3 m -90.46 152.67 20.86 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.1 80.03 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.974 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.97 -39.93 60.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.89 0.376 . . . . 0.0 110.463 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -66.01 -41.54 90.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.357 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.3 tp -63.07 -46.55 86.91 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.267 0.556 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -43.57 -44.35 6.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.65 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -63.54 -29.26 70.55 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 121.281 -0.168 . . . . 0.0 110.99 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.553 HG21 ' CE2' ' A' ' 92' ' ' PHE . 96.6 t -57.54 -41.81 79.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.842 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.623 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.54 -45.27 62.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.958 0.885 . . . . 0.0 111.543 -177.523 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.9 m -55.91 -40.73 73.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.853 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.33 -40.46 93.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.759 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.5 -13.0 58.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.739 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.65 29.09 60.07 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -85.34 -21.78 28.76 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.805 2.302 . . . . 0.0 111.111 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mttm 42.82 60.58 2.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.952 0.882 . . . . 0.0 110.013 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.446 HD12 ' HG3' ' A' ' 109' ' ' MET . 81.5 mt -80.04 148.38 31.1 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.48 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 121' ' ' VAL . 58.7 p -82.96 175.17 10.26 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.376 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -57.98 -45.12 87.25 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -57.21 -51.15 70.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.456 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.405 ' OE1' ' OE1' ' A' ' 123' ' ' GLU . 78.7 mm-40 -67.3 -30.55 70.43 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.484 -0.486 . . . . 0.0 112.001 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 117' ' ' THR . 39.6 t -63.72 -41.53 92.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -66.94 -38.22 85.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.407 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.405 ' OE1' ' OE1' ' A' ' 120' ' ' GLU . 94.6 mt-10 -59.21 -52.51 65.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.46 ' SD ' ' CD1' ' B' 1093 ' ' TRP . 17.6 mmm -54.72 -45.04 74.0 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.682 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 91.3 mt -59.05 -44.71 92.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.234 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -61.35 -36.4 80.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.685 0.279 . . . . 0.0 111.553 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.45 -41.3 84.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.88 -16.86 24.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.723 0.297 . . . . 0.0 111.746 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.8 t0 -71.09 91.76 0.93 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.491 0.662 . . . . 0.0 111.991 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.1 mt -70.48 -17.26 20.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 122.591 1.186 . . . . 0.0 113.317 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 51.4 p-10 -142.24 144.12 33.2 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 112.404 -2.18 . . . . 0.0 108.905 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.18 53.07 1.05 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.699 -0.286 . . . . 0.0 113.118 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -90.9 -8.13 50.27 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.002 0.401 . . . . 0.0 110.222 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.92 3.87 81.55 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.671 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -136.67 157.86 45.79 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.562 0.681 . . . . 0.0 110.439 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 136' ' ' VAL . 7.9 p -103.98 119.63 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.718 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -85.92 177.24 7.67 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.737 0.303 . . . . 0.0 111.079 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.98 -42.08 98.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.213 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.44 -45.33 94.74 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.902 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.94 -36.86 84.51 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.356 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -61.15 -45.39 94.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.2 t -65.7 -46.33 89.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.932 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -50.26 -44.14 53.55 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.994 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.2 mmt -72.92 -39.31 66.4 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 21.1 mmt -74.66 -47.04 34.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.877 -0.147 . . . . 0.0 110.823 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 120.689 0.28 . . . . 0.0 111.678 -179.282 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 CA--C 1.537 0.481 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B 1093 ' ' TRP . . . . . 0.46 ' CD1' ' SD ' ' A' ' 124' ' ' MET . 6.2 m95 -61.9 -53.51 54.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.366 0.603 . . . . 0.0 111.908 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 48.5 t80 -58.19 -46.34 85.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -40.38 -52.3 2.73 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.5 -41.08 99.48 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.106 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.7 tp -56.84 -45.36 82.44 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.484 -0.887 . . . . 0.0 109.562 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 40.9 t30 -58.65 -49.33 77.91 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -64.28 -38.14 90.0 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.3 mt -60.65 -41.91 89.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.68 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -50.37 -48.34 55.8 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.002 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.512 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.2 m -64.19 -47.9 78.0 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.42 ' C ' ' O ' ' B' 1102 ' ' THR . 85.3 mt-30 -27.61 -59.46 0.1 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 122.565 1.174 . . . . 0.0 112.612 -176.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.8 mt -83.02 -12.79 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 112.954 -1.93 . . . . 0.0 112.381 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.512 ' N ' ' O ' ' B' 1102 ' ' THR . 63.8 tttm -57.46 -43.28 83.87 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 118.001 -1.479 . . . . 0.0 108.024 176.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 57.5 t -61.92 -47.36 93.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 41.2 t -65.53 -41.52 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.074 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1108 ' ' LYS . . . . . 0.495 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 95.4 mttt -47.56 -37.11 11.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.659 0.742 . . . . 0.0 109.782 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -55.29 -46.63 76.19 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.63 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1110 ' ' PHE . . . . . 0.47 ' CD2' HG21 ' A' ' 55' ' ' VAL . 56.1 m-85 -63.77 -48.91 75.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 27.5 m-70 . . . . . 0 C--N 1.327 -0.4 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.539 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.1 tp . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.407 ' H ' ' HG1' ' A' ' 5' ' ' THR . 33.6 p -77.79 141.01 39.49 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.03 0.832 . . . . 0.0 110.628 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.1 tt0 -50.4 -55.95 13.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.166 0.984 . . . . 0.0 110.46 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -35.21 -38.45 0.09 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.886 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -68.27 -38.74 82.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.208 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.0 mt -58.7 -44.92 90.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 176.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.26 -50.38 67.37 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.797 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -60.23 -48.55 81.25 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.174 0.512 . . . . 0.0 112.228 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -61.72 -39.4 91.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.612 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -52.19 -56.19 16.19 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.999 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -50.42 -42.81 54.46 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.295 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.64 -36.83 64.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.125 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.56 -40.74 79.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -63.56 -16.31 60.46 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.205 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.445 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.9 mm? -64.7 -41.14 96.22 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -106.1 -15.08 14.97 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.49 92.99 1.93 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.192 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -67.81 -49.83 60.15 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.884 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.8 p-10 -101.89 15.74 28.07 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.7 45.37 0.52 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.2 p30 -85.35 -4.51 59.18 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 122.676 -0.308 . . . . 0.0 110.802 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.96 -2.2 81.54 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 p -137.91 152.73 49.29 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.975 0.417 . . . . 0.0 109.95 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 27' ' ' ILE . 4.6 mp -91.47 124.47 44.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -113.21 164.91 12.94 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.992 0.807 . . . . 0.0 112.37 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.3 p -59.73 -34.7 73.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.872 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -62.38 -61.58 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.757 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -60.4 -31.42 70.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.845 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 52' ' ' ILE . 3.7 tp -60.56 -55.53 32.24 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.991 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.32 -39.41 92.63 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.988 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.2 m -57.71 -53.91 52.9 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.921 1.361 . . . . 0.0 108.704 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.92 -46.87 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 118.694 0.679 . . . . 0.0 111.527 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.5 ttt -59.24 -40.85 87.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 120.082 1.31 . . . . 0.0 109.868 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -52.15 -39.2 59.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.63 0.729 . . . . 0.0 110.358 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.0 t -63.32 -21.35 66.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.086 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.466 ' O ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -73.45 -2.18 21.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.54 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.35 14.63 65.81 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.097 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -106.38 156.45 18.51 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 117.356 0.578 . . . . 0.0 110.095 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -116.43 63.06 2.6 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.355 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.08 144.95 93.63 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.229 1.952 . . . . 0.0 112.169 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.6 p -80.23 166.73 21.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.522 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -57.7 -43.68 85.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.604 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.73 -24.26 33.93 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.398 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -65.97 -39.33 90.29 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.174 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.6 mp -57.23 -42.75 82.0 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.657 0.741 . . . . 0.0 109.867 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -68.81 -56.09 9.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.494 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.05 -49.21 74.38 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.7 mmm -63.91 -50.72 67.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.505 HD11 HD22 ' A' ' 32' ' ' LEU . 26.9 mm -59.3 -48.06 88.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.619 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -55.9 -34.62 65.73 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.95 -39.83 90.77 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.728 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.411 HG21 ' CE2' ' B' 1110 ' ' PHE . 41.7 t -87.1 -20.18 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.299 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 44.6 t0 -79.38 84.3 5.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.45 82.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.619 -1.628 . . . . 0.0 114.263 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -86.41 -2.36 58.37 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.047 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.9 23.97 59.76 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.407 0.548 . . . . 0.0 112.463 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -87.91 3.74 47.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.421 0.61 . . . . 0.0 110.199 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.44 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.06 1.43 88.66 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 118.578 0.626 . . . . 0.0 114.573 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.9 p -148.9 170.97 17.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.2 mt -114.82 129.05 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -103.27 -175.32 2.77 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.604 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.438 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -59.27 -45.79 99.15 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.035 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 41.9 Cg_exo -55.49 -53.72 5.31 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.298 1.332 . . . . 0.0 111.513 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.88 -20.9 64.23 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.492 0.663 . . . . 0.0 110.763 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -72.87 -57.94 3.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.579 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.07 -44.81 87.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.405 HG23 HH12 ' A' ' 74' ' ' ARG . 8.6 m -40.53 -57.96 1.7 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.015 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.6 ptp -63.78 -39.29 93.89 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.811 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.1 mmt -59.06 -41.14 87.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.11 -35.49 78.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.429 0.291 . . . . 0.0 111.663 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.405 HH12 HG23 ' A' ' 70' ' ' THR . 84.8 mtt85 -94.05 -12.45 28.53 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -81.61 72.91 8.66 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.704 0.764 . . . . 0.0 110.376 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 21.6 mmt -110.33 17.77 20.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.056 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -53.08 129.72 31.79 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.487 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -107.45 143.96 35.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.674 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.0 p -130.55 135.71 48.19 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.4 m-20 -61.2 116.07 4.29 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 175.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.2 m -36.91 -20.08 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 80' ' ' ASP . 45.1 tp10 -69.44 -31.55 69.94 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -51.86 -40.38 60.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.745 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -86.91 -9.17 56.33 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.1 mm -67.88 -73.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.915 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -61.97 -40.99 97.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.94 -41.67 98.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.379 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.56 -21.35 60.16 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.966 0.412 . . . . 0.0 111.425 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -74.71 -47.29 32.26 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.744 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -55.61 -43.08 75.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.923 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.54 -45.73 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.546 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.463 ' CE2' HG21 ' A' ' 108' ' ' VAL . 11.5 m-85 -70.01 -39.05 76.06 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.595 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' A' ' 97' ' ' ASN . 32.3 t0 -89.56 84.83 6.38 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.01 -48.63 79.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.4 p-10 -92.24 5.03 51.98 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.99 50.4 51.31 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.405 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 27.0 p30 -95.02 6.28 49.52 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 122.416 0.286 . . . . 0.0 110.798 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.56 -0.19 89.7 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.422 ' CZ ' ' CG ' ' A' ' 137' ' ' ASN . 4.4 m-85 -136.86 149.66 47.81 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.984 0.897 . . . . 0.0 111.299 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 80.7 mt -97.17 119.38 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t -89.88 151.08 21.92 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.66 78.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.112 0.869 . . . . 0.0 110.159 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.09 -41.73 62.65 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.698 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -65.28 -42.04 93.54 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.697 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.2 -45.65 90.74 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.51 0.671 . . . . 0.0 111.072 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -44.07 -42.76 6.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.366 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -65.47 -30.48 71.27 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.671 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' A' ' 92' ' ' PHE . 93.2 t -57.62 -42.38 81.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.943 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.13 -46.9 65.54 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.971 0.891 . . . . 0.0 111.284 -177.126 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.3 p -55.33 -39.19 69.68 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.567 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -66.38 -41.23 89.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.763 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.0 mt -81.77 -14.51 56.33 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.01 31.05 60.31 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -87.33 -25.71 23.75 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.77 2.285 . . . . 0.0 110.463 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.0 mttp 45.96 63.16 1.93 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.102 0.953 . . . . 0.0 110.377 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.74 148.31 31.55 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.923 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 121' ' ' VAL . 32.4 p -82.67 174.2 11.22 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -57.57 -45.56 85.05 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.71 -46.72 84.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.172 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -70.66 -30.67 67.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.919 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 117' ' ' THR . 43.3 t -64.03 -41.99 94.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.471 0.653 . . . . 0.0 109.436 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.64 -35.69 75.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.349 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -59.56 -52.59 64.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.815 0.817 . . . . 0.0 112.837 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.2 mtp -55.64 -44.09 76.85 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.291 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.5 mt -59.11 -43.85 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.43 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -59.72 -38.32 81.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.95 0.405 . . . . 0.0 111.253 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -58.4 -41.61 85.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.168 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.55 -21.42 22.89 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.7 t0 -78.44 84.64 4.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.283 0.563 . . . . 0.0 112.051 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.9 pt -70.66 -11.52 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 122.674 1.226 . . . . 0.0 113.515 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 53.8 p-10 -142.08 145.01 33.84 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.157 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.45 52.35 2.27 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.656 -0.307 . . . . 0.0 113.357 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -90.9 -9.28 46.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 117.188 0.494 . . . . 0.0 110.1 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.8 -0.57 65.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 114.409 0.524 . . . . 0.0 114.409 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -132.95 150.85 52.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.304 0.552 . . . . 0.0 109.881 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 t -98.21 118.46 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.825 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.422 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 16.5 t-20 -85.14 174.51 9.63 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.721 0.296 . . . . 0.0 110.965 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -60.96 -42.15 97.72 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.456 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.13 -44.12 95.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.699 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.67 -38.03 89.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.462 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -60.94 -45.28 95.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.096 0.474 . . . . 0.0 111.019 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.17 -46.88 89.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.039 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -51.05 -44.51 61.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.025 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmt -72.02 -36.99 69.83 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 25.5 mmt -71.91 -45.88 59.63 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.489 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 p . . . . . 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.033 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.9 mt . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.3 m95 -63.23 -56.11 19.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.625 0.726 . . . . 0.0 112.346 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.1 t80 -58.4 -46.18 86.91 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 46.9 ttt85 -41.97 -52.04 4.26 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.71 -40.41 98.74 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.679 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.41 -44.72 80.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.977 0.888 . . . . 0.0 109.829 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 38.8 t30 -58.03 -47.72 82.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -176.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -65.01 -38.25 90.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.392 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.9 mt -60.36 -42.37 90.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.718 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -51.37 -45.42 62.4 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.586 -1.245 . . . . 0.0 107.67 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.508 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.7 m -62.16 -48.79 78.5 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.417 ' C ' ' O ' ' B' 1102 ' ' THR . 84.5 mt-30 -27.75 -59.61 0.11 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.913 1.339 . . . . 0.0 113.101 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -83.08 -13.72 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 112.514 -2.13 . . . . 0.0 111.643 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.508 ' N ' ' O ' ' B' 1102 ' ' THR . 66.3 tttm -59.93 -47.8 84.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 118.358 -1.337 . . . . 0.0 107.906 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.6 t -60.71 -48.85 86.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.9 m -65.76 -35.72 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.986 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 83.2 mttt -49.67 -39.08 35.18 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.72 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -50.56 -44.41 56.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.315 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1110 ' ' PHE . . . . . 0.411 ' CE2' HG21 ' A' ' 55' ' ' VAL . 41.8 m-85 -63.55 -49.46 73.35 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.725 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 78.2 m-70 . . . . . 0 C--N 1.328 -0.356 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.544 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.02 144.28 43.15 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.002 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.672 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -51.29 -43.82 61.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 122.574 1.178 . . . . 0.0 110.574 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 81.2 tt0 -43.35 -41.23 4.0 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 112.718 -2.037 . . . . 0.0 110.662 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -69.36 -38.06 77.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.504 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.1 -44.81 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.44 -50.27 62.92 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.667 -178.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -62.61 -45.57 92.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.387 0.613 . . . . 0.0 112.039 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 8.7 m-85 -62.27 -40.9 97.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.817 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -52.89 -55.23 24.73 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.275 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -50.31 -42.39 52.59 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.957 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -55.3 -36.3 66.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.409 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.79 -38.76 79.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.3 p -65.33 -15.95 63.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.22 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 18' ' ' LEU . 6.7 mp -65.42 -40.72 93.68 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -106.05 -14.75 15.08 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -73.04 93.2 1.74 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.486 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -67.72 -49.41 62.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.934 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.0 p-10 -103.11 14.9 30.72 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.16 46.27 0.96 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.131 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -86.57 -4.55 59.19 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 122.673 -0.31 . . . . 0.0 110.934 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 -1.83 80.74 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.4 p -138.21 153.56 49.14 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.189 0.519 . . . . 0.0 110.02 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 27' ' ' ILE . 4.2 mp -91.12 123.6 43.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.8 p -113.79 164.22 14.02 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.926 0.87 . . . . 0.0 112.455 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 p -58.34 -37.88 76.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.827 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.19 -61.83 2.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.732 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -60.63 -29.48 69.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.448 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.537 HD22 HD13 ' A' ' 52' ' ' ILE . 3.0 tp -61.37 -53.61 54.35 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.571 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.07 97.9 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.545 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 m -58.66 -54.33 48.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.912 1.356 . . . . 0.0 108.605 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.4 t -56.72 -46.01 82.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 118.979 0.808 . . . . 0.0 111.297 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.5 ttt -59.18 -40.22 85.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 120.111 1.323 . . . . 0.0 109.822 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -53.43 -41.53 66.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.42 0.629 . . . . 0.0 110.46 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.8 p -63.73 -21.49 66.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.941 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 tp -73.86 -3.54 29.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.748 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.74 20.7 46.23 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.332 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -117.77 158.65 24.37 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.662 0.731 . . . . 0.0 109.671 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -119.65 74.85 18.28 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.87 145.79 57.54 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.064 1.843 . . . . 0.0 112.405 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -80.16 165.83 22.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.309 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.4 pt-20 -58.83 -45.07 90.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.417 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -56.55 -24.36 46.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.501 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -65.65 -40.25 92.27 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.218 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.25 -39.67 70.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.223 0.535 . . . . 0.0 109.793 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -73.98 -55.17 6.48 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.238 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -54.84 -48.56 72.7 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 60.6 mtp -65.76 -52.06 54.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.537 HD13 HD22 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -56.02 -44.07 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -56.33 -35.16 67.29 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -67.3 -40.71 86.05 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.963 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.0 t -86.07 -21.34 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.383 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.493 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.1 t0 -78.2 86.16 4.33 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -174.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.3 82.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.342 -1.754 . . . . 0.0 114.081 -175.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 40.1 p-10 -86.82 -2.41 58.55 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.1 23.47 61.86 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 118.526 0.603 . . . . 0.0 112.839 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -87.87 3.57 47.91 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.273 0.536 . . . . 0.0 110.517 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.493 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.1 1.36 88.61 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 121.556 -0.715 . . . . 0.0 114.495 175.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.0 p -148.26 169.0 21.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -113.06 128.61 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.026 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -103.94 -174.83 2.63 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.801 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -58.09 19.55 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.51 -49.39 15.83 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.2 1.267 . . . . 0.0 111.661 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.79 -19.64 62.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.498 0.666 . . . . 0.0 110.628 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -75.71 -59.55 2.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.235 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.58 -44.15 80.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 m -44.92 -49.93 10.77 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.803 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 58.8 mtm -66.91 -45.6 77.43 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.4 mmm -61.08 -41.02 95.88 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.88 -34.16 77.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.567 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -93.42 -13.69 27.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.637 0.256 . . . . 0.0 111.343 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.452 ' C ' ' SD ' ' A' ' 76' ' ' MET . 2.4 mmmt -80.74 69.82 7.36 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.415 0.626 . . . . 0.0 110.765 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -105.88 18.72 21.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.851 179.158 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -49.94 131.44 22.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.418 0.627 . . . . 0.0 111.403 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 46.3 p-10 -91.99 109.05 20.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.875 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.518 HG21 ' NZ ' ' B' 1108 ' ' LYS . 8.5 p -97.81 114.21 26.19 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 82' ' ' GLU . 37.2 t0 -63.16 117.44 6.53 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 175.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.3 m -37.39 -20.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.772 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.7 mm-40 -69.8 -34.8 74.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.809 0.337 . . . . 0.0 111.718 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -49.34 -37.48 24.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.427 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.532 ' OE1' HD11 ' B' 1097 ' ' LEU . 9.3 pt-20 -89.11 -13.97 37.32 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 85' ' ' ILE . 24.2 mm -62.29 -74.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.176 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -62.04 -39.67 93.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -64.03 -40.68 96.87 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.515 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.1 -19.25 62.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.091 0.472 . . . . 0.0 111.127 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -71.97 -50.25 30.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.949 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -54.9 -40.71 70.09 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.757 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.22 -44.67 97.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.524 -0.471 . . . . 0.0 109.779 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.55 ' CE2' HG21 ' A' ' 108' ' ' VAL . 8.4 m-85 -69.44 -39.1 78.02 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.463 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -89.74 83.12 6.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.55 -45.06 95.74 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.9 p30 -91.42 4.02 53.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.623 0.249 . . . . 0.0 111.459 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.71 50.23 43.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -92.23 6.37 46.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.64 0.257 . . . . 0.0 110.516 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.14 0.76 89.64 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -140.38 154.16 46.61 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.695 0.76 . . . . 0.0 111.533 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.6 mt -96.92 115.82 37.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.2 p -91.7 156.13 17.8 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.34 -47.99 80.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 118.726 0.694 . . . . 0.0 111.14 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.8 -40.59 60.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 110.448 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.89 -41.29 91.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.511 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.23 -46.29 87.6 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.505 0.669 . . . . 0.0 111.358 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -44.38 -44.22 8.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.698 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -63.24 -28.82 70.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.784 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.55 HG21 ' CE2' ' A' ' 92' ' ' PHE . 98.7 t -57.99 -41.85 81.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.837 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.629 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.48 -46.22 63.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.074 0.94 . . . . 0.0 111.212 -177.209 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.8 m -57.68 -41.36 81.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.76 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.46 -40.75 93.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.975 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.3 mt -81.73 -14.06 57.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.699 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.05 29.82 58.27 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -85.68 -22.51 27.84 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.721 2.26 . . . . 0.0 110.878 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 43.14 60.48 2.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.116 0.96 . . . . 0.0 109.912 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.5 mt -79.74 148.76 31.38 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.511 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.4 p -82.99 174.61 10.73 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.405 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -58.06 -45.17 87.49 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.3 mp0 -58.15 -49.84 75.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.706 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -67.3 -31.23 71.4 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.937 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.13 -41.98 94.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.29 -39.15 89.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.62 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -59.44 -51.12 71.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.9 mmm -55.81 -45.05 78.37 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.274 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.99 -43.89 93.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.405 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -61.66 -36.77 81.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.031 0.443 . . . . 0.0 111.186 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.54 -40.19 86.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.833 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.758 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -89.52 -27.97 19.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.2 t0 -68.88 89.33 0.4 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.631 0.729 . . . . 0.0 111.811 -176.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.3 mm -71.4 -15.84 18.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.994 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 47.0 p-10 -141.44 144.42 34.42 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 112.465 -2.152 . . . . 0.0 108.967 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.32 51.47 1.05 Allowed Glycine 0 CA--C 1.531 1.042 0 CA-C-O 120.313 -0.159 . . . . 0.0 113.018 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -90.67 -12.23 37.39 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.035 0.418 . . . . 0.0 110.011 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.0 1.66 74.44 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.998 -0.62 . . . . 0.0 114.276 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -134.06 153.16 51.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.376 0.588 . . . . 0.0 110.481 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.6 t -100.46 118.4 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -83.65 173.85 11.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.988 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -61.41 -40.06 93.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.024 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.94 -44.29 97.08 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.805 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -65.48 -39.37 91.87 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.571 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.433 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 90.0 t80 -60.66 -44.17 96.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.035 0.445 . . . . 0.0 111.219 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.15 -45.0 95.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.018 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.24 -40.16 46.88 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.176 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.758 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 78.1 mtm -79.05 -46.11 18.78 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.433 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -73.39 -47.03 45.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.081 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.469 0.514 0 CA-C-O 120.793 0.33 . . . . 0.0 111.332 -179.03 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B 1093 ' ' TRP . . . . . 0.59 ' CE2' ' SD ' ' A' ' 144' ' ' MET . 6.6 m95 -61.88 -53.42 56.06 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.675 0.75 . . . . 0.0 111.817 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 47.5 t80 -57.79 -46.5 84.53 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1095 ' ' ARG . . . . . 0.47 ' HE ' ' NH1' ' B' 1099 ' ' ARG . 77.4 ttt180 -39.93 -52.43 2.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.39 -40.43 99.05 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.272 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1097 ' ' LEU . . . . . 0.532 HD11 ' OE1' ' A' ' 84' ' ' GLU . 50.8 tp -56.35 -44.45 80.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 118.196 0.998 . . . . 0.0 109.214 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -57.74 -47.64 81.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1099 ' ' ARG . . . . . 0.47 ' NH1' ' HE ' ' B' 1095 ' ' ARG . 76.7 mtt85 -65.14 -37.43 87.4 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 82.4 mt -60.75 -42.36 91.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.666 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1101 ' ' GLN . . . . . 0.405 ' CD ' ' OE2' ' A' ' 84' ' ' GLU . 41.8 mt-30 -50.1 -45.12 52.43 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 118.744 -1.182 . . . . 0.0 108.025 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.518 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.9 m -63.56 -48.2 78.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.426 ' C ' ' O ' ' B' 1102 ' ' THR . 83.7 mt-30 -27.61 -58.97 0.11 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.647 1.213 . . . . 0.0 112.578 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -83.62 -14.89 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 112.198 -2.274 . . . . 0.0 112.314 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' 1102 ' ' THR . 65.0 tttm -59.59 -45.22 92.53 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 117.96 -1.496 . . . . 0.0 108.135 176.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.7 t -60.67 -48.99 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1107 ' ' VAL . . . . . 0.402 HG13 ' H ' ' B' 1107 ' ' VAL . 1.3 m -66.28 -36.53 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.346 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1108 ' ' LYS . . . . . 0.518 ' NZ ' HG21 ' A' ' 79' ' ' THR . 89.3 mttt -49.52 -38.82 32.06 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.606 -0.684 . . . . 0.0 109.562 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.95 -45.19 64.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.95 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -63.42 -50.2 70.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 77.8 m-70 . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.019 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.6 tp . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p -76.25 139.43 41.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.482 1.037 . . . . 0.0 110.744 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.65 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -50.83 -47.81 60.02 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.993 0.902 . . . . 0.0 110.684 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -38.5 -38.32 0.37 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.474 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.462 ' NE2' ' CE1' ' A' ' 12' ' ' PHE . 45.0 tp60 -68.74 -39.14 80.48 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 118.31 -0.853 . . . . 0.0 110.298 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.8 mt -58.97 -46.0 91.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 175.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.55 -50.65 62.48 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.114 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.02 -48.34 82.12 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.158 0.504 . . . . 0.0 112.282 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.0 m-85 -62.45 -40.63 97.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.835 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -50.86 -56.53 11.78 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.151 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -50.92 -41.88 59.02 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.95 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -54.21 -36.96 64.04 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.42 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.457 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 2.9 m-85 -58.42 -38.94 78.44 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -65.36 -15.52 62.65 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.458 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.8 mm? -65.59 -40.81 93.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -106.29 -14.6 15.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -72.13 93.21 1.4 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.642 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -68.17 -49.49 60.55 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.715 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.1 p-10 -102.32 15.68 28.46 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.53 44.0 0.41 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.451 -0.404 . . . . 0.0 112.171 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -85.35 -3.82 58.96 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.952 0.406 . . . . 0.0 110.978 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.76 -1.68 81.38 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.3 p -137.8 152.69 49.4 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.079 0.466 . . . . 0.0 110.035 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.26 124.74 44.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -113.95 163.91 14.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.427 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.412 HG22 HG13 ' A' ' 52' ' ' ILE . 20.9 p -58.14 -35.5 71.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.052 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -60.71 -60.39 3.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.209 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -62.39 -30.07 70.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.63 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 52' ' ' ILE . 3.2 tp -61.05 -55.53 31.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.255 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.75 -39.76 94.08 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.267 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -58.32 -54.99 40.71 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.954 1.377 . . . . 0.0 108.569 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -55.98 -46.75 80.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 118.859 0.754 . . . . 0.0 111.29 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.9 ttt -58.71 -40.05 82.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 120.413 1.46 . . . . 0.0 110.276 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -51.7 -38.38 54.89 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.344 0.592 . . . . 0.0 110.583 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.0 t -62.52 -19.89 64.07 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.047 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 tp -73.87 1.1 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.859 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.1 25.99 38.58 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.226 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -130.5 169.64 15.28 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.275 0.537 . . . . 0.0 109.887 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -133.28 77.29 66.79 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.295 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.74 148.08 93.86 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.823 2.349 . . . . 0.0 111.985 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.2 p -77.11 165.29 24.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.328 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 21.3 pt-20 -58.76 -44.99 90.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.66 -24.12 32.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.761 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -65.74 -39.8 91.49 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.174 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.2 mp -56.17 -41.5 75.59 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.175 0.512 . . . . 0.0 110.03 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -71.7 -56.42 5.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.48 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -55.65 -50.34 70.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.7 mmm -63.52 -52.08 62.75 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 32' ' ' LEU . 29.5 mm -58.29 -46.97 88.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.105 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -55.91 -34.22 65.39 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -66.72 -40.07 88.27 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.669 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.417 HG21 ' CE2' ' B' 1110 ' ' PHE . 40.0 t -86.75 -20.06 7.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.178 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.2 t0 -78.61 84.74 4.7 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -174.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.81 83.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.323 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.0 p-10 -86.17 -2.44 58.36 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.55 23.1 60.15 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.323 0.51 . . . . 0.0 112.686 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -86.71 3.84 43.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 117.189 0.494 . . . . 0.0 110.504 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.447 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.4 1.44 89.34 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 118.637 0.653 . . . . 0.0 114.702 175.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.8 p -148.14 167.92 23.77 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.25 128.35 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -103.03 -176.41 3.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.743 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.457 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -57.07 -46.75 99.83 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -176.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 31.4 Cg_exo -57.66 -51.9 7.27 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 121.462 1.442 . . . . 0.0 111.852 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.21 -20.97 64.75 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.43 0.633 . . . . 0.0 110.727 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -74.88 -59.87 2.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.687 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -54.98 -45.16 74.96 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 m -44.9 -50.51 10.39 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.912 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.6 mtm -65.42 -44.33 87.75 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 35.3 mmm -60.82 -41.46 95.78 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.16 77.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.337 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -92.43 -19.25 22.24 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.39 67.4 5.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.128 0.489 . . . . 0.0 110.297 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.5 mmt -107.76 15.3 24.71 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.356 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -48.29 133.89 15.27 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.37 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -89.68 107.89 19.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.943 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 m -93.83 120.57 34.28 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 82' ' ' GLU . 90.7 m-20 -70.28 112.28 6.49 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m -37.06 -20.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.828 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.579 ' N ' ' O ' ' A' ' 80' ' ' ASP . 96.2 mt-10 -69.15 -36.64 77.63 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.756 0.312 . . . . 0.0 111.585 -178.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -48.63 -35.86 14.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.25 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -89.07 -18.72 26.7 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.103 0.477 . . . . 0.0 111.794 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 85' ' ' ILE . 25.9 mm -58.92 -75.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.827 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -61.51 -37.53 84.05 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -63.66 -40.75 97.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.466 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.58 -20.84 63.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.001 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -72.22 -51.59 20.35 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.779 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -54.88 -41.77 71.25 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.67 -44.26 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.7 m-85 -69.28 -38.55 78.41 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.211 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -88.51 83.5 6.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.42 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 88.4 tttt -57.78 -49.41 76.69 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.2 p-10 -91.89 5.02 51.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.703 0.287 . . . . 0.0 111.59 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.28 49.55 50.31 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -91.33 5.27 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.488 0.315 . . . . 0.0 110.713 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.87 0.72 89.09 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -138.38 151.26 47.35 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.72 0.771 . . . . 0.0 111.783 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.2 mt -93.83 117.21 36.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 t -89.99 150.08 22.29 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.76 -46.34 77.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.109 0.868 . . . . 0.0 110.788 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.31 62.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.836 0.35 . . . . 0.0 110.636 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.42 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.2 mt-10 -66.2 -41.46 90.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.557 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.0 -46.9 85.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.264 0.554 . . . . 0.0 110.822 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -42.89 -43.09 3.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.683 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -65.19 -29.24 70.04 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.005 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' A' ' 92' ' ' PHE . 96.7 t -58.08 -42.67 83.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.73 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.63 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.15 -45.96 61.85 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.784 0.802 . . . . 0.0 111.668 -177.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.6 p -55.84 -38.49 70.12 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.825 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -66.58 -40.89 89.17 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.892 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 73.4 mt -82.15 -13.14 57.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.79 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.21 30.83 62.25 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -86.17 -23.19 26.63 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 121.0 2.4 . . . . 0.0 110.856 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.9 mtmt 45.2 61.77 2.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.571 0.7 . . . . 0.0 110.497 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.1 mt -80.2 148.36 30.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.266 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.529 HG23 ' H ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -82.67 176.78 9.08 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.403 179.002 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.458 ' N ' ' OG1' ' A' ' 117' ' ' THR . 45.4 m-20 -59.7 -45.48 91.98 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.79 -46.95 81.23 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.529 ' H ' HG23 ' A' ' 117' ' ' THR . 76.4 mm-40 -70.38 -30.59 67.54 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.08 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.73 -42.18 95.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.34 -35.98 73.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.209 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -60.07 -53.2 60.61 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 81.9 mtp -54.96 -44.47 74.41 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.269 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.6 mt -58.18 -43.88 86.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.598 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -60.13 -36.38 77.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.836 0.35 . . . . 0.0 111.486 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -59.53 -41.06 89.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.055 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.6 -18.42 24.07 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.6 t0 -74.87 87.88 2.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.108 0.48 . . . . 0.0 111.868 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.406 HG22 ' OE2' ' A' ' 140' ' ' GLU . 10.8 tt -69.87 -15.1 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 122.523 1.154 . . . . 0.0 113.524 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.2 p-10 -143.07 145.71 33.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.159 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.79 52.35 1.6 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.883 -0.199 . . . . 0.0 113.213 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -90.74 -8.9 48.54 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 117.054 0.427 . . . . 0.0 110.219 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.85 1.36 72.38 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.986 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -134.67 154.43 51.54 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.227 0.514 . . . . 0.0 110.399 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.86 118.27 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.186 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.417 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 51.9 t30 -84.11 174.17 10.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.352 . . . . 0.0 111.065 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.417 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 84.0 t80 -61.15 -40.66 94.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.041 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.28 -44.62 96.11 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.946 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.406 ' OE2' HG22 ' A' ' 130' ' ' ILE . 96.8 mt-10 -64.87 -38.53 91.29 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.707 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -61.3 -44.7 96.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.907 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.22 -46.95 89.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.055 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -50.05 -43.05 50.81 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.891 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.7 mmt -74.93 -39.62 61.29 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.2 mmt -72.9 -47.42 45.94 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.802 0.334 . . . . 0.0 111.601 -179.377 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 8.8 m95 -62.65 -55.69 24.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.257 0.551 . . . . 0.0 112.419 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.4 t80 -59.46 -46.55 88.45 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -43.05 -51.3 5.82 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.52 -41.89 99.65 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.1 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1097 ' ' LEU . . . . . 0.43 ' O ' ' NE2' ' B' 1101 ' ' GLN . 56.7 tp -56.91 -45.78 82.41 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.595 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 39.6 t30 -57.93 -47.47 82.77 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -64.69 -37.32 87.18 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.2 mt -61.33 -42.61 94.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.824 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1101 ' ' GLN . . . . . 0.43 ' NE2' ' O ' ' B' 1097 ' ' LEU . 2.8 mp0 -50.27 -46.47 55.1 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.524 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.7 m -63.19 -48.45 78.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.43 ' C ' ' O ' ' B' 1102 ' ' THR . 90.2 mt-30 -27.31 -59.64 0.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 122.745 1.26 . . . . 0.0 112.642 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -83.31 -14.72 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 112.475 -2.148 . . . . 0.0 112.198 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.524 ' N ' ' O ' ' B' 1102 ' ' THR . 66.3 tttm -59.93 -46.51 89.14 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 117.829 -1.548 . . . . 0.0 107.895 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.7 t -61.32 -49.31 85.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.6 m -65.54 -36.14 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.406 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 87.8 mttt -49.01 -38.15 22.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.642 0.656 . . . . 0.0 109.82 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.58 -45.5 66.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.289 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1110 ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 55' ' ' VAL . 45.0 m-85 -62.59 -50.02 72.92 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 69.7 m-70 . . . . . 0 C--N 1.329 -0.322 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.375 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.7 tp . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 119.351 -0.356 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.3 p -77.95 139.96 39.21 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.321 0.964 . . . . 0.0 110.317 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ILE . 45.8 tp10 -49.7 -57.23 7.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 122.281 1.039 . . . . 0.0 110.449 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 83.5 tt0 -34.7 -38.33 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.218 -1.81 . . . . 0.0 111.066 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -68.9 -37.05 78.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 118.07 -0.966 . . . . 0.0 110.65 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.3 mt -59.0 -44.75 91.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 175.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -53.92 -52.66 59.87 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.356 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.42 -47.77 84.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.441 0.639 . . . . 0.0 112.004 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 10.1 m-85 -62.36 -38.68 90.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.677 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -52.61 -54.84 27.67 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.467 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.31 -40.76 49.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.966 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.45 -37.65 70.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.095 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.406 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 3.4 m-85 -58.37 -41.12 84.07 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 t -64.04 -15.54 59.7 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.505 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.53 -42.25 95.87 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -106.01 -14.0 15.31 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -72.29 93.28 1.47 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.482 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -67.41 -49.49 63.58 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.983 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 23' ' ' GLY . 37.0 p30 -102.31 14.73 31.19 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.88 43.78 0.66 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.105 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -84.87 -3.47 58.7 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.764 0.316 . . . . 0.0 110.972 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.42 -1.72 82.3 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.7 p -137.87 153.04 49.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.225 0.536 . . . . 0.0 109.801 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 27' ' ' ILE . 4.4 mp -91.59 123.8 43.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.5 p -114.53 165.25 12.96 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 124.124 0.89 . . . . 0.0 112.335 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.415 HG22 HG13 ' A' ' 52' ' ' ILE . 23.7 p -58.62 -36.84 74.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.578 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.86 -60.65 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.496 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -62.06 -30.26 70.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.426 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tp -60.73 -53.78 53.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.219 1.009 . . . . 0.0 109.804 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.16 -37.68 94.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 113.593 -1.639 . . . . 0.0 111.825 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.6 m -58.69 -53.88 53.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 119.005 1.402 . . . . 0.0 108.537 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.88 -46.12 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 121.254 -0.904 . . . . 0.0 111.561 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.9 ttt -58.87 -41.57 87.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 119.99 1.268 . . . . 0.0 109.628 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -51.77 -34.81 41.3 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.648 0.737 . . . . 0.0 110.165 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.1 t -63.07 -20.34 65.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.589 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -75.82 2.81 11.31 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.163 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.52 17.0 74.48 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.956 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -109.26 160.99 15.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.462 0.631 . . . . 0.0 110.013 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -116.05 68.71 3.46 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.165 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.07 143.88 91.46 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.041 1.827 . . . . 0.0 112.291 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.7 p -81.01 165.28 21.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.42 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -58.69 -43.76 90.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.029 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.53 -23.64 27.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.536 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -66.0 -38.48 88.58 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.242 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.6 mp -56.57 -41.31 76.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.404 0.621 . . . . 0.0 109.733 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -71.09 -56.48 6.03 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.722 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -55.03 -49.55 71.29 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.9 mmm -66.0 -50.91 62.59 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 52' ' ' ILE . 26.9 mm -59.43 -48.18 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.618 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -57.79 -34.01 69.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -66.49 -40.43 89.26 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.547 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.409 HG21 ' CE2' ' B' 1110 ' ' PHE . 56.6 t -85.73 -20.88 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.544 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.16 86.56 4.29 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.81 87.46 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 113.308 -1.769 . . . . 0.0 113.906 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 37.8 p-10 -86.44 -2.46 58.46 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.35 23.05 61.86 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 118.451 0.568 . . . . 0.0 112.89 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -87.99 2.43 51.78 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.229 0.515 . . . . 0.0 110.335 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.483 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 86.0 0.97 87.07 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 121.714 -0.616 . . . . 0.0 114.572 175.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.8 p -148.51 170.42 18.09 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.79 129.48 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -103.67 -175.54 2.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.854 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.7 -46.99 99.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.725 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -55.49 -51.95 8.77 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.282 1.321 . . . . 0.0 111.76 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.74 -18.53 55.18 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.446 0.641 . . . . 0.0 110.617 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -76.36 -57.82 3.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.553 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.84 -46.08 85.27 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.3 m -45.31 -49.37 12.78 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.369 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 72.5 mtm -66.16 -44.53 83.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.2 mmt -58.75 -41.65 87.03 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.77 -34.02 77.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.551 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -94.9 -9.29 34.62 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.527 0.203 . . . . 0.0 111.304 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.691 ' HZ2' ' N ' ' B' 1109 ' ' ALA . 0.3 OUTLIER -82.01 69.36 8.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.55 0.69 . . . . 0.0 111.047 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.26 18.29 21.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.126 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -51.19 130.2 25.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.034 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -89.62 108.74 19.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.055 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.7 m -93.59 119.38 32.55 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.2 m-20 -69.32 111.66 5.37 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 173.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.9 m -37.48 -21.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.642 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.5 mp0 -69.42 -35.33 75.62 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -48.83 -37.21 18.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.393 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' OE2' ' NE2' ' B' 1101 ' ' GLN . 10.6 pt-20 -89.28 -13.24 38.5 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 85' ' ' ILE . 24.5 mm -63.14 -74.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.993 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -63.02 -39.41 94.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -63.05 -40.95 99.25 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.436 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.54 -18.4 59.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.937 0.398 . . . . 0.0 111.062 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -74.45 -48.74 25.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.012 0.434 . . . . 0.0 111.327 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -55.16 -41.77 72.28 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.64 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -64.84 -43.9 96.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.4 m-85 -69.02 -38.54 79.28 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.518 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -85.48 81.22 8.8 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -58.24 -49.32 77.51 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -91.23 5.23 49.93 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.365 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.84 48.35 51.24 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -91.37 6.79 43.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.752 0.31 . . . . 0.0 110.673 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.73 1.95 89.9 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.696 -0.561 . . . . 0.0 111.696 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -140.51 153.95 46.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.686 0.755 . . . . 0.0 111.521 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.6 mt -93.97 114.61 30.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.1 t -89.07 151.61 22.14 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.82 -47.03 83.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 119.067 0.849 . . . . 0.0 110.638 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.02 -35.35 61.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.894 0.378 . . . . 0.0 110.278 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.56 -39.52 73.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.076 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.45 -47.36 76.43 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.231 0.539 . . . . 0.0 112.187 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.4 -33.71 2.71 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.235 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -72.49 -28.91 63.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.567 HG21 ' CE2' ' A' ' 92' ' ' PHE . 75.0 t -58.08 -41.42 80.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.734 -178.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.536 ' HG3' HD13 ' A' ' 116' ' ' LEU . 4.6 mmt -53.22 -47.24 69.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.301 1.048 . . . . 0.0 111.789 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.1 p -55.56 -35.52 65.81 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 113.115 -1.857 . . . . 0.0 110.925 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -36.45 82.59 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.043 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.0 mt -84.5 -11.25 56.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.94 36.71 51.66 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.46 -22.8 23.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.827 2.314 . . . . 0.0 111.18 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.7 tptt 44.78 59.78 3.23 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.549 1.166 . . . . 0.0 109.993 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.536 HD13 ' HG3' ' A' ' 109' ' ' MET . 0.8 OUTLIER -76.57 150.96 36.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.602 -2.09 . . . . 0.0 113.386 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.3 p -84.35 175.43 9.37 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.973 0.416 . . . . 0.0 109.927 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -56.36 -45.13 80.61 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.77 -40.81 69.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.027 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.77 -30.13 68.66 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.619 -0.432 . . . . 0.0 112.105 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.34 -43.57 98.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.501 0.667 . . . . 0.0 109.504 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -74.13 -35.82 64.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.816 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -60.77 -55.27 35.08 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 97.7 mmm -48.83 -60.39 2.79 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.472 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.3 pt -50.57 -40.74 19.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.719 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -61.98 -35.36 78.25 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.704 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -57.21 -40.68 77.96 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.219 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.24 -12.91 25.44 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.3 t0 -73.51 87.34 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.425 0.631 . . . . 0.0 111.789 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.0 pt -71.49 -11.86 15.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 122.484 1.135 . . . . 0.0 113.561 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 52.5 p-10 -143.21 142.59 31.46 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 112.265 -2.243 . . . . 0.0 109.035 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.67 52.46 0.9 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.692 -0.29 . . . . 0.0 113.436 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -91.29 -11.19 38.79 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.172 0.486 . . . . 0.0 110.111 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.69 2.79 70.92 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.195 -0.526 . . . . 0.0 114.385 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -134.13 152.94 52.07 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.134 0.467 . . . . 0.0 110.318 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.48 118.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.455 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -84.58 173.79 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 0.0 110.877 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -61.05 -40.08 92.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.026 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.5 -44.81 95.47 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.914 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.39 -37.96 89.31 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.419 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.17 -45.69 93.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.3 t -65.69 -48.58 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.767 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -49.02 -45.96 43.34 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.972 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.475 ' O ' ' CE1' ' B' 1094 ' ' PHE . 13.2 mmt -72.73 -38.99 67.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 18.1 mmt -75.56 -45.09 39.9 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.795 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 5.5 m95 -60.55 -62.51 1.81 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.238 0.542 . . . . 0.0 112.415 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B 1094 ' ' PHE . . . . . 0.475 ' CE1' ' O ' ' A' ' 144' ' ' MET . 48.8 m-85 -57.78 -44.69 86.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -39.37 -52.04 2.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.52 -41.66 99.77 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.178 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B 1097 ' ' LEU . . . . . 0.429 HD11 ' OE1' ' A' ' 84' ' ' GLU . 50.8 tp -56.35 -45.22 80.55 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.454 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -59.07 -47.32 85.68 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.651 -175.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -65.38 -37.48 87.13 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.22 -42.01 91.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.868 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B 1101 ' ' GLN . . . . . 0.458 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 68.7 mt-30 -51.34 -45.95 62.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.528 ' O ' ' N ' ' B' 1105 ' ' LYS . 93.9 m -63.47 -47.95 79.67 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.912 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 84.3 mt-30 -28.06 -57.62 0.11 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.741 1.258 . . . . 0.0 112.572 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.7 mt -84.27 -14.81 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 112.085 -2.325 . . . . 0.0 112.313 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.538 ' O ' ' NZ ' ' A' ' 75' ' ' LYS . 88.8 tttt -59.54 -44.72 93.13 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.954 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 67.5 t -61.49 -49.11 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B 1107 ' ' VAL . . . . . 0.402 HG13 ' H ' ' B' 1107 ' ' VAL . 1.4 m -65.83 -36.09 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.322 -177.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 89.7 mttt -49.88 -37.55 31.7 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.682 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B 1109 ' ' ALA . . . . . 0.691 ' N ' ' HZ2' ' A' ' 75' ' ' LYS . . . -51.41 -45.06 62.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.784 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B 1110 ' ' PHE . . . . . 0.409 ' CE2' HG21 ' A' ' 55' ' ' VAL . 46.8 m-85 -63.88 -49.73 71.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 71.5 m-70 . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.223 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -79.14 137.26 37.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.365 0.984 . . . . 0.0 110.306 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 9' ' ' ILE . 21.3 mt-10 -54.42 -49.98 68.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.132 0.968 . . . . 0.0 110.43 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 42.8 tp10 -34.32 -36.39 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.569 -1.65 . . . . 0.0 111.102 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -69.12 -36.04 77.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.265 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 6' ' ' GLU . 88.4 mt -58.82 -43.95 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -53.81 -50.53 65.94 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.893 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -63.49 -45.79 89.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.325 0.583 . . . . 0.0 112.05 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.5 m-85 -62.51 -40.42 96.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.888 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -49.95 -57.19 8.02 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.472 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -49.66 -40.43 39.69 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.04 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.7 -37.58 71.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.203 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.518 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 3.0 m-85 -57.79 -41.62 82.47 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.1 t -64.37 -15.7 60.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.65 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.87 -42.59 97.47 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -106.07 -13.97 15.3 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -74.08 95.65 2.58 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.203 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -68.74 -52.83 26.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.44 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.5 p-10 -98.77 13.97 30.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.72 45.22 1.01 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.024 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 32.7 p-10 -85.28 -3.82 58.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.665 0.269 . . . . 0.0 110.875 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.5 -0.79 78.11 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -139.99 153.99 47.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.11 0.481 . . . . 0.0 110.025 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 27' ' ' ILE . 5.1 mp -93.2 124.56 45.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -112.79 165.29 12.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.513 0.673 . . . . 0.0 112.405 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.7 p -59.5 -35.83 74.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.322 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -61.6 -61.73 2.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.77 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.53 -30.12 70.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.715 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.457 HD22 HD11 ' A' ' 52' ' ' ILE . 2.7 tp -60.42 -53.63 55.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.875 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.55 93.54 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.927 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.63 -51.47 69.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.816 1.308 . . . . 0.0 108.936 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.0 t -59.33 -46.01 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 118.739 0.699 . . . . 0.0 111.042 -176.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.0 ttt -59.01 -41.48 87.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.552 1.069 . . . . 0.0 109.654 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -52.1 -37.08 52.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.733 0.778 . . . . 0.0 110.247 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 p -62.71 -20.6 65.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.702 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.7 mt -75.53 1.6 13.82 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.104 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.1 17.44 67.17 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.154 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -109.11 158.7 17.53 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 117.498 0.649 . . . . 0.0 109.955 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -114.2 65.47 1.43 Allowed Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.13 142.4 91.92 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.03 1.82 . . . . 0.0 112.081 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -80.94 165.27 21.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.246 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -58.17 -43.88 87.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.74 -24.57 50.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.484 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -64.85 -40.19 94.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.209 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.7 mp -55.41 -38.5 69.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.404 0.621 . . . . 0.0 109.354 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -71.66 -56.01 6.64 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.095 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -54.06 -49.23 69.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.5 mtp -68.4 -48.61 64.22 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.457 HD11 HD22 ' A' ' 32' ' ' LEU . 24.3 mm -59.46 -47.58 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.7 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -58.49 -33.8 70.21 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.93 -39.85 90.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.539 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.2 t -86.69 -20.27 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 121.154 -0.218 . . . . 0.0 111.33 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.53 87.44 4.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -175.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.98 -37.33 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 113.535 -1.666 . . . . 0.0 113.987 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.4 p-10 -86.35 -2.69 58.64 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.2 23.27 61.81 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 118.338 0.517 . . . . 0.0 112.709 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.4 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 51.5 p-10 -88.15 3.63 48.49 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.422 0.611 . . . . 0.0 110.423 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.46 0.72 89.39 Favored Glycine 0 CA--C 1.522 0.525 0 O-C-N 121.74 -0.6 . . . . 0.0 114.423 175.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.7 p -147.74 169.78 18.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.8 mt -114.66 128.77 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -103.88 -173.94 2.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.705 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.518 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -58.84 -46.62 99.54 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.34 -51.72 7.93 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 121.245 1.297 . . . . 0.0 111.85 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.55 -18.36 61.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.485 0.659 . . . . 0.0 110.687 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -75.19 -58.76 3.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.907 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.8 mt -57.49 -42.6 83.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -46.04 -49.35 16.37 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.566 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.21 -45.23 77.44 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.5 mmm -61.06 -40.34 93.3 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.4 78.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.229 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -94.34 -10.05 33.93 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.831 0.348 . . . . 0.0 111.467 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.19 67.45 8.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.249 0.547 . . . . 0.0 110.487 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 mmt -108.63 15.19 23.94 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.696 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -49.46 133.45 20.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.061 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 45.2 p-10 -92.66 105.2 17.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.932 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.7 m -88.24 123.04 32.46 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 82' ' ' GLU . 96.6 m-20 -69.87 112.05 6.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.0 m -37.6 -21.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.726 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 80' ' ' ASP . 54.2 mp0 -69.14 -36.32 77.32 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -48.67 -36.45 16.09 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.252 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.514 ' OE2' ' NE2' ' B' 1101 ' ' GLN . 11.1 pt-20 -89.11 -13.86 37.56 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 85' ' ' ILE . 24.9 mm -62.84 -74.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.279 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -62.41 -41.12 98.44 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -62.98 -40.39 97.59 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.488 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.83 -17.02 54.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.003 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -73.79 -49.3 25.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.021 0.438 . . . . 0.0 111.35 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -55.09 -41.74 71.99 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.604 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.54 -43.96 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -68.52 -39.41 81.22 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.486 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -85.28 81.84 8.62 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.13 -50.18 74.41 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -90.88 5.4 48.68 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.216 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.15 48.49 46.59 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -89.93 6.23 42.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.756 0.312 . . . . 0.0 110.609 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.54 2.76 84.63 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -144.23 157.7 44.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.742 0.782 . . . . 0.0 111.553 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -94.63 114.32 30.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -87.49 151.75 22.77 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.89 78.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 119.036 0.834 . . . . 0.0 110.842 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.01 -40.89 64.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.993 0.425 . . . . 0.0 110.238 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.91 -44.09 86.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.734 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.501 ' O ' HG12 ' A' ' 108' ' ' VAL . 7.1 tt -62.84 -47.56 82.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.83 0.348 . . . . 0.0 111.764 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -41.16 -45.02 2.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.101 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -57.14 -26.99 61.44 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.529 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 105' ' ' LEU . 2.0 p -56.45 -41.34 71.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.22 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -50.32 59.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 122.248 1.023 . . . . 0.0 111.245 -177.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.8 m -51.44 -40.85 60.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.483 -1.689 . . . . 0.0 110.775 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.99 -41.25 95.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.06 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.9 mt -82.91 -14.41 54.23 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.79 55.77 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.553 -1.137 . . . . 0.0 110.42 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -86.72 -22.42 26.03 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.385 2.092 . . . . 0.0 110.866 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 43.49 60.34 2.66 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.281 1.039 . . . . 0.0 110.172 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.1 mt -80.87 148.69 29.81 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.599 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 76.5 p -83.0 175.36 10.1 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -57.63 -44.67 85.74 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.31 -48.58 80.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.324 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -70.49 -31.07 68.03 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.916 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.19 -42.29 95.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -68.04 -36.56 80.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.792 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.22 -50.53 73.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.706 0.765 . . . . 0.0 112.916 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 19.3 mmm -57.85 -42.75 85.09 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.89 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.3 mt -60.08 -43.65 93.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.048 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -59.67 -38.67 82.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.743 0.306 . . . . 0.0 111.168 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.75 -41.62 86.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.16 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.46 -25.49 21.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.0 t0 -71.58 88.47 0.95 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.451 0.643 . . . . 0.0 111.842 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.5 tp -70.11 -14.58 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 122.844 1.307 . . . . 0.0 113.147 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 37.2 p-10 -141.04 144.15 34.81 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 112.402 -2.181 . . . . 0.0 109.486 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.34 52.22 1.08 Allowed Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.403 -0.427 . . . . 0.0 113.0 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.408 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 37.5 p-10 -91.63 -9.85 42.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.259 0.529 . . . . 0.0 110.167 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.55 3.41 78.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 114.168 0.427 . . . . 0.0 114.168 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -135.14 154.56 51.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 117.243 0.522 . . . . 0.0 110.422 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.6 t -101.19 118.64 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.462 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.414 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 51.9 t30 -84.21 173.18 11.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.922 0.392 . . . . 0.0 110.981 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.414 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 80.4 t80 -60.82 -40.98 94.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.222 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.11 -44.55 97.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.152 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.92 -38.37 90.74 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.654 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -61.33 -45.68 93.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.952 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.404 ' O ' ' OG1' ' A' ' 146' ' ' THR . 73.2 t -64.76 -46.39 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.5 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -51.0 -43.22 60.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.805 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.4 mmt -75.15 -39.88 60.04 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.7 mmt -71.43 -47.76 53.81 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.837 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 3.1 p . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.904 0.383 . . . . 0.0 110.945 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.9 m95 -62.04 -55.6 27.47 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.541 0.686 . . . . 0.0 112.626 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.6 t80 -60.51 -47.41 86.28 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -173.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -39.65 -50.78 2.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.69 -40.15 98.82 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.269 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.5 tp -56.44 -45.02 81.0 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.993 0.896 . . . . 0.0 109.702 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 42.1 t30 -59.23 -46.91 87.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.515 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -65.42 -38.41 89.81 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.7 mt -60.88 -41.94 90.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.271 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B 1101 ' ' GLN . . . . . 0.514 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 66.5 mt-30 -52.48 -46.58 66.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.505 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.0 m -63.71 -48.28 77.72 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.835 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.447 ' C ' ' O ' ' B' 1102 ' ' THR . 90.6 mt-30 -28.0 -55.5 0.11 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 123.11 1.433 . . . . 0.0 112.758 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.1 mt -84.75 -14.88 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 112.193 -2.276 . . . . 0.0 112.641 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.505 ' N ' ' O ' ' B' 1102 ' ' THR . 87.6 mttt -59.74 -42.7 93.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 117.97 -1.492 . . . . 0.0 108.86 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 81.7 t -61.42 -48.91 86.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.2 m -66.97 -36.64 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.906 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.5 mttt -49.79 -38.34 33.9 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.623 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.02 -44.42 64.15 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.217 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -63.95 -50.64 67.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 21.7 t-80 . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.188 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 50.7 tp . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 119.217 -0.42 . . . . 0.0 110.501 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.1 p -77.08 140.02 40.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.332 0.969 . . . . 0.0 109.863 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ILE . 47.9 tp10 -47.28 -63.48 1.03 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 122.149 0.976 . . . . 0.0 110.319 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 84.2 tt0 -34.16 -37.4 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.087 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -70.18 -36.14 74.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.577 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 6' ' ' GLU . 93.1 mt -59.57 -44.29 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 175.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.39 -49.42 64.47 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.401 -177.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -63.49 -45.14 92.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.51 0.671 . . . . 0.0 112.379 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.453 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.6 m-85 -63.15 -41.28 99.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.987 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -52.62 -57.04 11.3 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.442 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -46.8 -41.8 16.04 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.597 . . . . 0.0 110.363 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -55.38 -35.88 65.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.27 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.81 -39.73 81.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -64.77 -15.88 62.24 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.083 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 18' ' ' LEU . 7.3 mp -65.01 -40.81 95.46 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -106.13 -14.39 15.16 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -72.56 92.79 1.53 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.211 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -67.63 -49.84 61.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.76 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.0 p-10 -102.41 15.42 29.26 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.26 44.24 0.55 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.171 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.8 p30 -85.3 -4.24 59.09 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.282 . . . . 0.0 110.932 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.95 -2.26 81.65 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.2 p -137.33 152.12 49.38 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.106 0.479 . . . . 0.0 109.767 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.5 mp -91.61 123.98 43.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.3 p -113.07 163.88 14.17 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.492 0.663 . . . . 0.0 112.425 -177.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -58.59 -36.32 73.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.487 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -62.04 -61.51 2.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.43 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -61.03 -30.69 70.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.576 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 tp -60.62 -54.5 44.67 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.243 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.14 95.32 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.17 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 m -58.22 -53.59 56.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.759 1.279 . . . . 0.0 108.794 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -57.36 -46.47 85.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 121.414 -0.804 . . . . 0.0 111.405 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.0 ttt -59.38 -40.15 85.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 119.888 1.222 . . . . 0.0 109.727 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -53.72 -41.77 67.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.529 0.681 . . . . 0.0 110.229 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 p -63.4 -21.6 66.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.125 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.91 -2.7 24.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.835 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.24 14.81 59.8 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.495 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -107.88 155.29 20.45 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.541 0.671 . . . . 0.0 109.825 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.93 63.95 1.57 Allowed Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.339 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -62.85 144.24 93.11 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.214 1.943 . . . . 0.0 112.251 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 44' ' ' THR . 1.7 t -80.31 167.69 19.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.111 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 15.6 pt-20 -58.85 -44.75 91.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.001 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.436 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -56.08 -23.52 34.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.43 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -65.82 -39.45 90.86 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.584 -0.446 . . . . 0.0 109.964 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -56.53 -41.41 76.72 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.525 0.678 . . . . 0.0 109.468 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -70.39 -57.1 5.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.863 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -53.69 -48.69 69.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.338 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 31.7 mmm -66.74 -50.19 63.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.9 mm -58.71 -48.33 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.622 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -56.53 -34.83 67.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -66.07 -39.68 90.26 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.852 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.454 HG21 ' CE2' ' B' 1110 ' ' PHE . 73.5 t -86.07 -20.46 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.577 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.479 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.3 t0 -79.22 85.33 5.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -175.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.37 84.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.391 -1.731 . . . . 0.0 114.187 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 39.7 p-10 -86.47 -2.72 58.69 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.27 23.06 63.88 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 118.398 0.544 . . . . 0.0 112.752 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.429 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -87.89 2.06 52.47 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 117.418 0.609 . . . . 0.0 110.664 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.479 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.53 1.82 87.49 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 118.603 0.638 . . . . 0.0 114.552 175.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.3 p -146.36 166.63 25.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.35 126.7 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -102.93 -177.09 3.27 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -47.01 99.55 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -176.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.45 -51.51 9.09 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 120.995 1.13 . . . . 0.0 111.66 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.63 -18.77 60.84 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.416 0.627 . . . . 0.0 110.521 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -75.8 -59.28 2.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.063 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.02 -44.45 82.87 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.7 m -45.92 -48.06 16.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.399 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.1 mtm -66.88 -45.02 79.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.0 mmm -61.3 -41.31 96.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.12 -35.16 79.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.41 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -92.12 -16.36 26.45 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.813 0.339 . . . . 0.0 111.414 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.493 ' HZ1' ' HG3' ' B' 1105 ' ' LYS . 28.4 tptp -80.18 72.09 6.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.612 0.72 . . . . 0.0 110.562 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.9 19.39 20.12 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.983 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -49.87 129.99 20.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.146 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.52 109.35 20.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.861 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.2 p -99.3 111.75 24.06 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.582 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -60.4 117.85 5.75 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.013 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 m -37.37 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.711 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 80' ' ' ASP . 80.5 tt0 -68.67 -35.57 77.41 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -49.98 -38.8 38.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.259 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -87.21 -19.44 28.38 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.092 0.473 . . . . 0.0 111.671 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.8 mm -60.41 -74.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.679 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.6 mtm180 -62.77 -41.55 99.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.7 -40.57 92.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.408 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.53 -17.48 46.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.007 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -74.17 -49.59 22.95 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.223 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -55.68 -43.18 76.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.435 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.82 -43.56 93.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.7 m-85 -68.68 -38.8 80.62 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.393 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -86.23 82.36 8.06 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -57.64 -50.21 73.91 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -91.04 5.83 47.3 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.277 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.21 47.81 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -90.32 7.47 38.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.667 0.27 . . . . 0.0 110.616 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.18 2.16 89.37 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -141.48 153.62 45.05 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.809 0.814 . . . . 0.0 111.756 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -96.05 117.04 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.3 p -91.34 153.69 19.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.73 83.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 119.227 0.921 . . . . 0.0 110.906 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.64 -41.9 64.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.891 0.377 . . . . 0.0 110.617 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -64.35 -43.26 95.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.54 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 108' ' ' VAL . 11.5 mt -62.76 -44.95 94.85 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.324 0.583 . . . . 0.0 111.391 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -42.5 -43.17 3.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.651 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -63.28 -27.33 69.26 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.035 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.567 HG21 ' CE2' ' A' ' 92' ' ' PHE . 94.0 t -58.07 -42.83 83.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.651 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.649 ' HG3' HD13 ' A' ' 116' ' ' LEU . 15.1 mmt -51.35 -44.46 62.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.204 1.002 . . . . 0.0 111.458 -177.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.6 m -55.36 -41.1 72.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.885 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -64.73 -39.84 94.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.538 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.3 mt -83.44 -13.56 54.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.63 35.89 50.09 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.396 -1.224 . . . . 0.0 110.482 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.5 ' OE1' ' SD ' ' A' ' 109' ' ' MET . 80.7 tt0 -89.78 -24.57 21.45 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.729 2.265 . . . . 0.0 110.879 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.0 tptp 45.89 63.0 1.99 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.551 1.167 . . . . 0.0 110.096 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.872 HD23 ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -76.31 150.92 36.85 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.955 -1.929 . . . . 0.0 112.854 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.2 p -86.3 174.16 9.25 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.367 0.603 . . . . 0.0 109.952 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -54.42 -44.02 72.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -55.83 -41.63 74.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.219 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -68.4 -28.98 67.57 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.721 -178.724 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.477 ' CG2' HD11 ' A' ' 116' ' ' LEU . 52.6 t -63.8 -44.07 98.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.33 0.586 . . . . 0.0 109.773 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.66 -37.33 65.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.292 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -58.73 -54.95 41.29 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.422 ' CE ' HD12 ' B' 1092 ' ' LEU . 95.1 mtp -57.17 -43.19 82.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.746 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.6 mm -58.7 -44.0 88.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.132 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -60.65 -35.68 76.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.348 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.98 -42.23 89.49 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.69 -20.15 21.88 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.6 t0 -70.45 90.29 0.72 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.539 0.685 . . . . 0.0 112.069 -177.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.0 -16.12 19.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 122.711 1.243 . . . . 0.0 113.219 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.6 p-10 -143.82 144.99 32.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 112.334 -2.212 . . . . 0.0 109.443 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.05 52.74 1.36 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.961 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -91.17 -9.29 45.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.087 0.443 . . . . 0.0 110.145 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.64 2.14 74.38 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.401 -0.428 . . . . 0.0 114.115 176.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -133.75 153.05 52.0 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 117.36 0.58 . . . . 0.0 110.477 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.1 t -99.15 118.23 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.145 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.416 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 52.2 t30 -84.0 173.61 11.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.977 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.416 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 82.9 t80 -61.37 -39.33 90.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.929 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.72 -44.66 92.95 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.015 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.17 -38.67 91.29 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.567 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -61.04 -44.74 96.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.799 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 82.8 t -65.86 -46.27 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.471 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -49.23 -44.87 43.83 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.008 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.3 mmm -75.66 -39.98 56.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.2 mmt -76.21 -46.86 26.28 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.341 -0.144 . . . . 0.0 111.069 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 111.446 -178.945 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B 1092 ' ' LEU . . . . . 0.511 ' O ' HD13 ' B' 1092 ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 4.7 m95 -58.6 -60.65 3.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.574 0.702 . . . . 0.0 112.095 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -46.64 82.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -174.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B 1095 ' ' ARG . . . . . 0.646 HH11 ' NH2' ' B' 1099 ' ' ARG . 63.7 ttm-85 -36.51 -51.97 0.84 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.79 -40.1 98.35 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.179 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.65 -44.18 81.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 118.031 0.916 . . . . 0.0 109.628 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -59.63 -49.52 77.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.767 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B 1099 ' ' ARG . . . . . 0.646 ' NH2' HH11 ' B' 1095 ' ' ARG . 3.2 mpt_? -65.72 -39.22 90.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.302 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.74 -43.33 94.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.509 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -55.49 -45.15 77.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.513 ' O ' ' C ' ' B' 1103 ' ' GLN . 90.4 m -60.9 -48.56 81.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.955 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.513 ' C ' ' O ' ' B' 1102 ' ' THR . 86.1 mt-30 -28.29 -97.54 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 123.238 1.494 . . . . 0.0 112.137 -175.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -39.47 -14.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 111.806 -2.452 . . . . 0.0 111.752 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.493 ' HG3' ' HZ1' ' A' ' 75' ' ' LYS . 52.5 tttp -60.4 -44.63 95.5 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 118.01 -1.476 . . . . 0.0 107.476 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.5 t -61.45 -48.97 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B 1107 ' ' VAL . . . . . 0.407 ' H ' HG13 ' B' 1107 ' ' VAL . 1.2 m -66.83 -37.88 80.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.96 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 63.4 mttt -49.87 -39.41 39.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.205 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -50.86 -44.91 59.63 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.035 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B 1110 ' ' PHE . . . . . 0.454 ' CE2' HG21 ' A' ' 55' ' ' VAL . 45.2 m-85 -63.46 -48.53 77.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 19.4 t-80 . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.428 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.467 0.396 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.2 p -80.45 139.31 36.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.256 0.935 . . . . 0.0 110.384 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 9' ' ' ILE . 48.4 tp10 -50.98 -54.65 22.59 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.798 0.808 . . . . 0.0 110.519 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -35.77 -37.57 0.1 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.096 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -68.99 -37.54 78.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.605 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.8 mt -58.64 -45.64 90.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 175.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.39 -51.58 62.1 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.393 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -61.6 -47.06 87.15 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.468 0.651 . . . . 0.0 112.622 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -62.9 -36.86 84.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.556 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -55.16 -51.51 66.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.373 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.77 -41.82 61.93 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.31 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.47 -39.14 67.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.212 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -56.29 -41.51 76.04 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -65.28 -14.69 61.32 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.441 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.2 tp -63.25 -43.45 97.96 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -107.06 -13.73 15.11 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.99 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -76.27 95.43 3.74 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.098 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -68.34 -46.99 68.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.297 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.5 p-10 -101.63 14.84 30.76 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.65 46.85 0.6 Allowed Glycine 0 CA--C 1.533 1.195 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -84.15 -3.44 58.13 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.43 -1.58 82.13 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.425 ' C ' HD12 ' A' ' 27' ' ' ILE . 57.7 p -137.39 151.88 49.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.918 0.389 . . . . 0.0 110.168 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.7 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -93.49 125.73 46.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.509 HG23 ' H ' ' A' ' 30' ' ' LYS . 1.9 t -115.29 164.27 14.48 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.176 -0.92 . . . . 0.0 113.182 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.4 HG22 HG13 ' A' ' 52' ' ' ILE . 20.0 p -57.66 -36.08 71.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.83 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.509 ' H ' HG23 ' A' ' 28' ' ' THR . 34.5 ttpt -60.97 -58.5 8.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.85 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -64.36 -28.68 69.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.448 HD22 HD11 ' A' ' 52' ' ' ILE . 3.2 tp -61.41 -56.1 24.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.78 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.22 -37.64 87.43 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.365 -1.288 . . . . 0.0 112.11 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.7 m -57.85 -54.57 45.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.911 1.356 . . . . 0.0 107.619 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.9 t -55.96 -46.05 80.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 118.852 0.751 . . . . 0.0 111.515 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.1 mmm -58.35 -42.34 86.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 119.963 1.256 . . . . 0.0 110.229 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -54.48 -41.77 69.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.441 0.639 . . . . 0.0 110.786 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -63.6 -21.32 66.29 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.83 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 tp -73.95 -2.54 24.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.851 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.78 14.51 62.98 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.164 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -109.31 156.79 19.55 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.537 0.669 . . . . 0.0 109.518 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -119.67 65.67 9.42 Favored Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.53 145.45 76.56 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.163 1.909 . . . . 0.0 112.03 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 m -78.22 159.29 28.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.268 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -52.49 -41.84 63.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.696 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.79 -25.21 26.61 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -65.61 -39.73 91.85 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.065 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.52 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.7 mp -56.19 -41.45 75.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.327 0.585 . . . . 0.0 109.909 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -67.31 -57.35 6.81 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.071 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -54.98 -49.53 71.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.5 mmm -64.17 -51.63 62.88 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.448 HD11 HD22 ' A' ' 32' ' ' LEU . 28.5 mm -59.23 -49.58 82.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.092 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -56.66 -33.96 66.89 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -66.28 -40.35 90.02 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.786 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.479 HG21 ' CD2' ' B' 1110 ' ' PHE . 69.0 t -86.6 -20.03 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.335 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.523 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 44.0 t0 -78.68 84.61 4.76 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -175.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.62 79.6 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.842 -1.526 . . . . 0.0 114.36 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.414 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 36.1 p-10 -85.11 -2.79 58.4 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.342 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.06 22.75 60.85 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.901 -0.499 . . . . 0.0 112.316 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.414 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -86.24 3.51 42.78 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.313 0.556 . . . . 0.0 110.441 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 83.12 2.33 90.53 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 114.8 0.68 . . . . 0.0 114.8 175.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 69.0 p -147.06 165.94 28.39 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.7 mm -109.42 126.81 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -102.99 -177.25 3.32 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.838 0.352 . . . . 0.0 110.731 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.412 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -57.02 -57.71 22.72 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 9.7 Cg_endo -49.08 -50.59 12.44 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.158 1.238 . . . . 0.0 111.336 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.3 -20.78 60.58 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.279 0.562 . . . . 0.0 110.708 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -75.64 -58.31 3.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.962 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -55.74 -47.9 76.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.3 p -44.22 -48.21 9.32 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.309 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.5 mtp -65.52 -45.57 82.98 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 31.4 mmt -59.92 -40.78 90.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.6 -34.1 77.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.332 0.253 . . . . 0.0 111.538 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.8 mtp85 -95.24 -12.35 26.39 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.569 0.223 . . . . 0.0 111.355 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.84 68.54 7.14 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 110.481 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 21.5 mmt -108.69 15.47 23.64 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.684 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -52.82 129.78 31.03 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.535 0.683 . . . . 0.0 111.6 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 79' ' ' THR . 61.6 t0 -105.57 146.35 29.76 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.694 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.521 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 75.3 p -132.81 133.97 44.07 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 82' ' ' GLU . 1.1 p30 -61.12 115.95 4.17 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 175.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 m -36.44 -19.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 80' ' ' ASP . 46.0 tp10 -70.54 -32.09 69.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.941 0.401 . . . . 0.0 111.513 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -51.16 -41.12 59.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.668 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 37.0 tp10 -83.96 -17.45 40.58 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 111.872 -178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.6 mm -59.21 -73.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.46 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -58.57 -55.87 29.44 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.47 ' CD ' ' N ' ' A' ' 88' ' ' ALA . 3.1 pp20? -52.83 -36.36 58.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.297 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -60.71 -23.49 64.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.812 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -72.37 -48.84 38.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.24 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -54.79 -41.55 70.71 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.896 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.25 -45.06 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.745 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.525 ' CE2' HG21 ' A' ' 108' ' ' VAL . 9.5 m-85 -70.02 -38.55 75.94 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.349 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -88.69 82.48 6.84 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.503 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 65.2 tttm -58.46 -48.42 80.8 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 40.2 p-10 -90.65 4.88 50.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.664 0.269 . . . . 0.0 111.652 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.2 47.52 49.53 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -90.61 5.98 45.68 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 122.35 0.26 . . . . 0.0 110.742 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.11 0.96 88.76 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -139.22 152.29 47.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.611 0.72 . . . . 0.0 111.708 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.6 mt -94.51 117.72 38.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 t -91.06 150.12 21.55 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.49 -45.96 76.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 119.159 0.891 . . . . 0.0 110.481 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.44 62.67 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.892 0.377 . . . . 0.0 110.745 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.503 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.1 mt-10 -65.84 -40.59 91.88 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.227 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.3 tp -62.93 -46.14 89.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.216 0.531 . . . . 0.0 110.543 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -43.54 -43.11 5.36 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.573 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -64.96 -30.81 71.82 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.646 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.525 HG21 ' CE2' ' A' ' 92' ' ' PHE . 93.6 t -56.99 -41.8 77.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.643 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.628 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -50.6 -44.43 57.02 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.786 0.803 . . . . 0.0 111.276 -178.046 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 m -57.2 -41.29 79.12 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 114.046 -1.434 . . . . 0.0 111.013 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -65.96 -41.31 91.38 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.564 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.1 mt -81.52 -13.81 57.67 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.8 31.98 57.61 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.556 -1.136 . . . . 0.0 110.401 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -85.44 -21.51 28.72 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.628 2.214 . . . . 0.0 111.744 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt 43.27 61.05 2.32 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.892 0.854 . . . . 0.0 109.948 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.453 HD12 ' CG ' ' A' ' 109' ' ' MET . 87.7 mt -81.51 147.72 29.54 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.404 -1.726 . . . . 0.0 112.317 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 121' ' ' VAL . 65.3 p -82.48 175.74 9.97 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.839 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -57.75 -46.44 84.5 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -55.98 -48.58 75.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.983 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -71.66 -30.85 66.17 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.288 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 117' ' ' THR . 39.0 t -63.51 -41.4 92.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.522 0.677 . . . . 0.0 109.408 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -72.64 -33.26 66.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.78 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.42 -50.98 71.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.684 ' CE ' HD21 ' B' 1092 ' ' LEU . 76.3 mtp -52.85 -48.07 67.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.641 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.8 mm -57.76 -43.48 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.882 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -62.17 -35.3 78.39 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.808 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -57.06 -41.02 77.98 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.42 -11.66 29.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.791 0.329 . . . . 0.0 111.358 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.2 t0 -75.12 89.1 2.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.507 0.67 . . . . 0.0 111.855 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.77 -18.36 20.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.596 -1.184 . . . . 0.0 113.105 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.461 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.3 p-10 -140.32 145.73 37.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 112.781 -2.009 . . . . 0.0 108.678 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.96 52.2 1.65 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.696 -0.288 . . . . 0.0 113.031 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -90.72 -9.48 46.56 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.978 0.389 . . . . 0.0 110.089 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.74 1.49 72.3 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.957 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -135.5 154.19 51.49 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.127 0.463 . . . . 0.0 110.471 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.44 118.37 47.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.175 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -83.84 173.26 11.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 0.0 111.093 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -61.35 -40.85 95.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.046 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -61.76 -44.41 96.95 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.744 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.81 -39.71 94.02 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.58 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.565 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 92.1 t80 -61.3 -46.44 90.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.976 0.417 . . . . 0.0 111.175 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.48 -46.65 92.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.383 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -49.54 -47.62 48.92 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.714 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 88.2 mmm -71.22 -35.2 71.42 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.565 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.7 mtt -79.56 -46.97 16.32 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.737 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B 1092 ' ' LEU . . . . . 0.75 HD23 ' N ' ' B' 1093 ' ' TRP . 0.9 OUTLIER . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B 1093 ' ' TRP . . . . . 0.75 ' N ' HD23 ' B' 1092 ' ' LEU . 2.3 m95 -55.31 -62.25 1.8 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.358 0.599 . . . . 0.0 110.864 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 51.6 t80 -56.51 -44.24 80.54 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 61.9 ttt85 -39.94 -53.47 2.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -60.27 -39.95 96.74 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 48.0 tp -56.6 -44.12 80.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 118.494 1.147 . . . . 0.0 109.73 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 46.4 t30 -57.66 -47.61 81.8 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -63.96 -38.15 90.03 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.04 -42.27 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.638 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -51.41 -46.27 62.85 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.628 -1.229 . . . . 0.0 107.874 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.518 ' O ' ' N ' ' B' 1105 ' ' LYS . 96.1 m -62.37 -48.38 80.01 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.59 -0.444 . . . . 0.0 112.047 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.432 ' C ' ' O ' ' B' 1102 ' ' THR . 84.8 mt-30 -27.98 -59.22 0.11 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.591 1.186 . . . . 0.0 112.66 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B 1104 ' ' ILE . . . . . 0.402 HG21 HD13 ' B' 1104 ' ' ILE . 2.0 mt -81.52 -14.34 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 112.711 -2.041 . . . . 0.0 112.089 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' 1102 ' ' THR . 64.0 tttp -58.92 -45.95 89.13 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 118.087 -1.445 . . . . 0.0 108.179 176.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.3 t -60.57 -49.73 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.06 -36.56 78.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.116 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 88.9 mttt -49.09 -37.08 20.37 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.739 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.44 63.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.287 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B 1110 ' ' PHE . . . . . 0.479 ' CD2' HG21 ' A' ' 55' ' ' VAL . 44.3 m-85 -62.92 -49.45 74.73 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 70.0 m-70 . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.454 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 4' ' ' LEU . 1.9 pt? . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.7 p -77.2 140.14 40.07 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.865 0.757 . . . . 0.0 110.827 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.1 tt0 -48.73 -60.98 2.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 122.108 0.956 . . . . 0.0 110.497 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 81.1 tt0 -34.61 -37.01 0.05 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.998 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -69.86 -35.78 74.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.403 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.8 mm -59.71 -44.6 94.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 175.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.51 -49.96 63.76 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.282 -177.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -63.1 -44.84 94.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.507 0.67 . . . . 0.0 112.332 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.8 m-85 -63.28 -39.28 94.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.887 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -52.51 -54.02 38.14 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.357 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -50.78 -41.63 57.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.162 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -54.79 -39.13 68.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.137 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.445 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 3.0 m-85 -57.7 -41.29 81.4 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.3 p -64.55 -15.91 61.73 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.402 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.586 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -64.65 -42.3 95.51 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.79 -178.614 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -105.95 -14.14 15.28 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -72.72 94.0 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.344 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -67.71 -49.65 61.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.722 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 23' ' ' GLY . 48.2 p-10 -102.72 15.78 28.35 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.88 45.19 0.54 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.132 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -86.01 -4.24 59.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.83 0.347 . . . . 0.0 111.062 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.05 -1.58 80.5 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.3 p -138.01 152.95 49.38 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.17 0.509 . . . . 0.0 110.043 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.69 124.08 44.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.0 p -113.19 163.51 14.68 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.941 0.776 . . . . 0.0 112.559 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.1 p -58.24 -37.11 74.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.884 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.57 -62.09 2.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.185 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -60.58 -29.89 69.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.668 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.461 HD22 HD11 ' A' ' 52' ' ' ILE . 3.1 tp -61.07 -55.02 37.47 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.026 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.87 -40.32 95.06 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.401 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.11 -54.65 44.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 118.884 1.342 . . . . 0.0 108.423 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.9 t -56.76 -46.78 83.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 118.889 0.768 . . . . 0.0 111.841 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.2 ttt -58.63 -41.5 86.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 120.065 1.302 . . . . 0.0 109.964 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -51.78 -38.28 54.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.512 0.673 . . . . 0.0 110.296 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 t -62.59 -20.58 64.86 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.949 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -74.08 -0.4 16.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.897 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.44 14.56 70.77 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.116 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -107.47 158.5 17.15 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 117.484 0.642 . . . . 0.0 109.992 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -116.1 65.83 2.88 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.272 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.75 144.03 87.96 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.182 1.921 . . . . 0.0 112.111 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.5 t -80.42 165.45 22.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.555 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -57.9 -44.94 87.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.68 -23.96 31.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.586 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -65.61 -39.99 92.14 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.146 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.8 mp -55.64 -40.8 72.68 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.495 0.664 . . . . 0.0 109.799 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -71.45 -56.22 6.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.815 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -54.52 -49.23 70.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.0 mtp -67.08 -48.65 67.56 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.461 HD11 HD22 ' A' ' 32' ' ' LEU . 26.0 mm -58.47 -46.71 89.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.607 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -55.59 -35.54 65.93 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -66.62 -40.3 88.72 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.146 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' B' 1110 ' ' PHE . 59.4 t -85.58 -20.97 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.39 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.446 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.3 t0 -79.63 84.3 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -175.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.81 -37.1 80.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.64 -1.618 . . . . 0.0 114.319 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -86.57 -2.04 58.16 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.53 23.04 60.03 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 118.44 0.563 . . . . 0.0 112.473 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -87.65 3.81 46.36 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.44 0.62 . . . . 0.0 110.515 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.446 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.72 1.41 89.05 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 175.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.0 p -148.42 168.86 21.55 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.8 mt -113.48 128.79 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 5.9 p30 -103.61 -175.97 2.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.867 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.445 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.16 -47.63 98.49 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.738 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -55.72 -52.06 8.36 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.287 1.325 . . . . 0.0 111.84 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.22 -19.59 61.82 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.506 0.669 . . . . 0.0 110.533 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -75.52 -59.33 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.352 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.5 mt -56.46 -45.16 81.02 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.8 p -45.24 -47.49 12.77 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.404 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 33.6 mtp -67.68 -46.81 71.23 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.6 mmm -61.75 -39.89 93.17 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.64 -34.21 77.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.373 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -94.95 -12.44 26.76 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.441 ' C ' ' SD ' ' A' ' 76' ' ' MET . 3.9 tptt -81.9 67.02 7.72 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.016 0.436 . . . . 0.0 110.237 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.524 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -106.98 17.52 22.97 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.34 179.496 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -49.79 132.39 22.15 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.508 0.67 . . . . 0.0 111.41 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -92.51 108.12 19.73 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.107 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.0 m -93.5 121.29 34.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 82' ' ' GLU . 30.4 m-20 -69.42 113.19 6.51 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.4 m -37.78 -19.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.796 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 80' ' ' ASP . 83.2 tt0 -67.01 -41.05 87.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.863 0.363 . . . . 0.0 111.217 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -56.95 -40.75 77.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.724 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.56 ' O ' ' N ' ' A' ' 87' ' ' GLU . 51.0 tp10 -72.3 -80.52 0.06 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.655 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.614 HD12 ' N ' ' A' ' 86' ' ' ARG . 1.9 pp -20.56 -60.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 123.684 0.615 . . . . 0.0 111.319 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.614 ' N ' HD12 ' A' ' 85' ' ' ILE . 9.1 ptm180 -60.76 -42.21 96.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.581 ' CD ' HH21 ' A' ' 90' ' ' ARG . 40.3 mm-40 -61.84 -40.07 94.01 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.939 0.399 . . . . 0.0 111.092 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -17.58 62.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.856 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -71.43 -52.79 16.59 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.735 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.581 HH21 ' CD ' ' A' ' 87' ' ' GLU . 78.9 mtm-85 -55.53 -40.63 72.08 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.874 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.62 -42.92 90.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.527 ' CE2' HG21 ' A' ' 108' ' ' VAL . 4.8 m-85 -68.01 -37.91 81.97 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.417 -178.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -89.34 83.7 6.43 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.43 -46.39 90.2 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -91.5 4.55 52.27 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.386 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.39 49.9 37.07 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.19 6.7 41.59 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.77 0.55 89.85 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.669 -0.573 . . . . 0.0 111.669 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -139.5 151.92 46.55 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.615 0.722 . . . . 0.0 111.736 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.3 mt -95.9 117.5 40.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 m -91.32 152.81 20.31 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.19 80.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.412 1.005 . . . . 0.0 110.848 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.56 -40.52 62.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 110.676 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -65.33 -42.64 92.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.222 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 108' ' ' VAL . 21.2 mt -63.03 -45.15 93.68 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.29 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -41.53 -45.45 3.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.746 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -59.78 -26.11 65.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.798 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.527 HG21 ' CE2' ' A' ' 92' ' ' PHE . 63.4 t -58.33 -43.1 85.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.895 -178.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.44 ' SD ' HD12 ' A' ' 116' ' ' LEU . 8.3 mmt -51.15 -45.54 61.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.065 0.936 . . . . 0.0 111.098 -177.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.0 p -57.92 -38.61 76.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.085 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -40.55 81.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.493 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 70.3 mt -81.32 -13.68 58.14 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.29 29.59 59.98 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.393 -1.226 . . . . 0.0 110.15 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -85.87 -22.62 27.45 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.779 2.29 . . . . 0.0 111.005 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm 44.77 61.81 2.33 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.222 1.01 . . . . 0.0 109.862 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.44 HD12 ' SD ' ' A' ' 109' ' ' MET . 78.1 mt -80.65 147.0 30.86 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.472 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 121' ' ' VAL . 30.8 p -81.95 175.54 10.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.614 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -57.15 -44.87 83.83 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.28 -48.26 79.34 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -72.75 -30.65 64.33 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.103 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 117' ' ' THR . 42.7 t -64.99 -43.22 96.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -69.15 -35.02 75.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.214 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -59.72 -47.57 85.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.059 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 15.8 mmm -55.18 -45.12 75.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.62 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 40.1 mm -58.14 -44.1 86.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.446 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -58.91 -39.57 81.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.746 0.308 . . . . 0.0 111.132 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.99 -41.68 83.52 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.52 -23.1 21.02 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.7 t0 -72.42 87.97 1.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.485 0.66 . . . . 0.0 112.098 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.69 -15.26 19.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.945 1.355 . . . . 0.0 113.265 -178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 37.6 p-10 -141.68 145.0 34.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.214 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.06 52.31 1.7 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.551 -0.357 . . . . 0.0 113.385 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -91.32 -8.76 47.26 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.182 0.491 . . . . 0.0 110.108 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.04 2.54 78.39 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.118 -0.563 . . . . 0.0 114.21 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -134.99 153.87 51.93 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 117.19 0.495 . . . . 0.0 110.551 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.7 118.57 47.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.321 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -83.65 173.0 11.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.06 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -61.8 -39.74 92.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.022 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -61.57 -44.68 96.58 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.621 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.11 -37.76 88.61 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.436 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -61.07 -44.94 96.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.701 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.05 -47.77 86.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.371 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -50.24 -44.35 53.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.171 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.4 mmt -73.33 -38.94 65.61 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 22.4 mmt -75.66 -46.92 28.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.911 -0.131 . . . . 0.0 111.021 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.47 0.538 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.564 -179.299 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.51 -53.69 53.1 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.451 0.643 . . . . 0.0 112.111 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 53.8 t80 -58.02 -46.06 85.89 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -174.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -40.69 -52.33 2.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.23 -41.83 99.72 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.084 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.2 tp -55.93 -46.3 78.51 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.446 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 41.2 t30 -58.01 -48.31 80.42 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -64.96 -38.11 89.89 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 87.5 mt -60.91 -42.6 93.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.802 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -50.96 -44.99 60.68 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.514 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.4 m -63.0 -48.28 79.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.92 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.424 ' C ' ' O ' ' B' 1102 ' ' THR . 84.4 mt-30 -28.01 -58.64 0.11 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.805 1.288 . . . . 0.0 112.929 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -82.74 -15.4 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 112.25 -2.25 . . . . 0.0 111.985 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.514 ' N ' ' O ' ' B' 1102 ' ' THR . 88.8 tttt -58.8 -45.92 88.79 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 117.989 -1.484 . . . . 0.0 107.89 176.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.5 t -60.85 -49.06 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.57 -36.84 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.091 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 90.5 mttt -49.74 -37.16 28.25 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.512 0.672 . . . . 0.0 109.661 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.03 -45.53 64.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.285 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B 1110 ' ' PHE . . . . . 0.46 ' CE2' HG21 ' A' ' 55' ' ' VAL . 49.3 m-85 -63.13 -50.44 70.44 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 83.9 m-70 . . . . . 0 C--N 1.329 -0.293 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.141 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 119.573 -0.251 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.7 p -79.97 138.62 37.11 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.997 0.817 . . . . 0.0 110.523 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 9' ' ' ILE . 27.1 mm-40 -49.17 -58.1 5.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 122.099 0.952 . . . . 0.0 110.788 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -35.64 -37.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 113.352 -1.749 . . . . 0.0 110.611 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -70.19 -37.18 75.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.468 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.1 mt -59.76 -46.04 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.41 -48.63 62.58 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.51 -177.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.04 -44.36 92.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.551 0.691 . . . . 0.0 112.299 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.456 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.5 m-85 -63.19 -39.99 96.22 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.862 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -50.22 -53.67 26.45 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.572 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -51.85 -39.2 58.5 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.174 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.35 -39.91 73.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.379 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -55.55 -42.05 74.12 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.9 t -64.05 -16.54 61.92 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.381 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.613 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -63.67 -43.44 96.68 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.487 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -104.67 -15.13 15.36 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.602 -178.856 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -77.7 93.13 4.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.361 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -66.75 -46.83 74.15 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.706 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -101.7 15.15 29.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.24 50.48 3.65 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.732 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -89.43 -5.55 57.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.171 0.486 . . . . 0.0 111.898 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.12 0.69 73.69 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.849 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.469 HG22 ' OD1' ' A' ' 64' ' ' ASP . 31.7 p -141.25 159.76 41.54 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.971 0.415 . . . . 0.0 110.07 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.2 mt -92.32 126.19 44.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.419 ' OG1' ' OE1' ' A' ' 31' ' ' GLU . 19.1 p -111.78 162.65 15.03 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.044 0.84 . . . . 0.0 112.256 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 p -60.36 -37.97 82.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.87 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.43 -58.88 6.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.464 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.419 ' OE1' ' OG1' ' A' ' 28' ' ' THR . 10.1 pt-20 -63.38 -29.52 70.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.625 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.48 HD22 HD11 ' A' ' 52' ' ' ILE . 3.5 tp -61.08 -52.5 64.64 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.3 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.99 -38.09 94.93 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.938 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.2 m -58.76 -54.15 50.36 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.731 1.265 . . . . 0.0 108.593 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.79 -46.06 87.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 121.058 -1.026 . . . . 0.0 111.513 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.3 tpt -59.31 -40.33 85.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 119.914 1.234 . . . . 0.0 109.531 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -53.35 -41.56 65.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.307 0.575 . . . . 0.0 110.251 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.6 p -63.71 -21.47 66.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.157 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.42 -4.09 31.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.61 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.01 60.74 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.032 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -106.68 155.12 20.0 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.642 0.721 . . . . 0.0 110.094 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.581 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 4.6 t30 -116.46 62.85 2.58 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.37 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.25 145.7 93.37 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.265 1.977 . . . . 0.0 112.204 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.7 p -80.36 167.73 19.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.565 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -58.24 -44.06 88.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.805 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.7 -24.09 32.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.502 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -65.49 -38.6 90.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.016 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.8 mp -57.25 -42.26 81.17 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.311 0.577 . . . . 0.0 109.882 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -69.16 -56.48 7.53 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.383 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -55.32 -48.98 73.33 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.9 mmm -65.39 -51.68 58.71 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.48 HD11 HD22 ' A' ' 32' ' ' LEU . 28.6 mm -59.63 -48.9 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.777 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -57.82 -33.47 68.64 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.85 -39.84 94.2 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.53 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.21 -17.73 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.265 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.45 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.37 85.55 4.48 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -174.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.02 88.39 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 113.427 -1.715 . . . . 0.0 113.728 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.1 p-10 -85.6 -3.06 58.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.82 23.82 61.68 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.886 -0.509 . . . . 0.0 112.937 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.433 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.6 p-10 -87.56 3.76 46.26 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.174 0.487 . . . . 0.0 110.26 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.45 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.09 0.54 88.84 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.893 -0.67 . . . . 0.0 114.214 175.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.6 p -149.13 170.38 18.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.0 mt -112.59 128.77 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.469 ' OD1' HG22 ' A' ' 26' ' ' THR . 92.1 m-20 -104.41 -173.7 2.37 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.433 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.419 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -58.7 -46.11 99.59 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.412 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 35.3 Cg_exo -56.06 -53.39 5.51 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.465 1.443 . . . . 0.0 111.21 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.41 -22.08 66.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.15 0.5 . . . . 0.0 111.161 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.61 -61.41 1.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.9 mt -57.78 -43.83 85.84 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.3 m -40.74 -58.3 1.68 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.943 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -65.66 -41.42 92.55 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.983 -176.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 97.2 mmm -58.94 -41.24 86.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.26 77.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.352 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -93.93 -13.99 26.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.657 0.265 . . . . 0.0 111.239 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.42 ' C ' ' SD ' ' A' ' 76' ' ' MET . 0.1 OUTLIER -80.84 66.65 6.44 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.206 0.527 . . . . 0.0 110.591 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -108.37 15.61 23.83 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.441 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -49.62 134.59 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.245 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.84 108.62 19.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.156 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.9 m -93.33 121.32 34.59 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 82' ' ' GLU . 97.7 m-20 -68.63 112.3 5.32 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.9 m -37.49 -22.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.528 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.9 mp0 -69.43 -35.78 76.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.77 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -48.25 -35.84 12.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.257 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 84' ' ' GLU . 2.4 mp0 -90.95 -16.54 27.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 85' ' ' ILE . 26.0 mm -59.99 -74.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.566 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -61.83 -41.2 97.51 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -62.53 -38.92 91.86 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.249 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.63 -20.74 65.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.998 0.427 . . . . 0.0 111.078 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -70.61 -49.93 42.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.053 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -54.85 -41.62 70.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.535 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.57 -43.82 94.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.3 m-85 -68.38 -39.68 81.68 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.188 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -87.15 83.54 7.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.511 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 88.6 tttt -58.04 -49.61 76.27 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 35.1 p-10 -91.88 4.51 52.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.696 0.284 . . . . 0.0 111.608 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.56 49.29 53.19 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -90.61 5.24 48.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.793 0.33 . . . . 0.0 110.83 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.98 2.0 88.56 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -140.01 152.88 46.62 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.611 0.719 . . . . 0.0 111.506 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.3 mt -94.04 115.31 32.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 t -89.07 150.93 22.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.634 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.32 83.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.981 0.81 . . . . 0.0 110.646 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.74 -39.59 65.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.862 0.363 . . . . 0.0 110.443 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.511 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.2 mt-10 -66.64 -41.18 88.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.338 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.09 -45.71 90.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.456 0.646 . . . . 0.0 110.997 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -44.23 -43.18 7.06 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.422 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -65.49 -28.62 69.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.51 0.195 . . . . 0.0 111.236 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.524 HG21 ' CE2' ' A' ' 92' ' ' PHE . 96.1 t -58.21 -42.46 83.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.573 -177.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.709 ' SD ' HD12 ' A' ' 116' ' ' LEU . 36.8 mmt -51.34 -43.22 61.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.82 0.819 . . . . 0.0 111.107 -177.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 m -57.93 -41.68 83.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.763 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -42.32 82.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.681 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.58 -15.85 56.93 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.475 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.1 28.7 59.91 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -84.43 -22.49 30.36 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.625 2.213 . . . . 0.0 110.59 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 43.07 58.68 3.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.804 0.811 . . . . 0.0 110.301 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.709 HD12 ' SD ' ' A' ' 109' ' ' MET . 50.9 mt -79.52 149.15 31.55 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.679 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 121' ' ' VAL . 70.2 p -82.71 175.29 10.25 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.5 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -58.14 -44.17 87.69 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.47 -49.44 76.28 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.61 -30.68 67.41 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.88 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 117' ' ' THR . 39.5 t -63.51 -42.41 96.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.29 -35.66 73.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.335 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -59.74 -50.89 72.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 90.5 mtp -57.12 -43.52 82.41 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.137 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.38 -44.18 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.286 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -59.57 -38.82 82.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.033 0.444 . . . . 0.0 111.208 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -57.23 -40.45 77.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.848 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.58 -20.09 22.04 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.1 t0 -75.36 86.1 2.52 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.389 0.614 . . . . 0.0 111.916 -177.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 130' ' ' ILE . 25.6 pt -71.87 -12.08 15.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.275 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 40.6 p-10 -140.67 142.09 34.95 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 112.504 -2.135 . . . . 0.0 108.771 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.69 52.09 1.55 Allowed Glycine 0 CA--C 1.53 1.012 0 CA-C-O 120.269 -0.184 . . . . 0.0 113.472 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -91.17 -7.92 50.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.281 0.54 . . . . 0.0 110.139 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.68 1.3 66.04 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.131 -0.557 . . . . 0.0 114.296 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -135.01 153.66 52.0 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.426 0.613 . . . . 0.0 110.478 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 51.3 t -100.74 118.54 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.451 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -84.2 174.87 9.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -61.84 -40.85 96.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.133 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.39 -44.82 95.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.891 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -63.91 -38.49 91.29 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.461 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -60.22 -45.54 92.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.594 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.57 -47.95 84.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.269 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.71 -46.7 59.07 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.316 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.404 ' O ' ' CE1' ' B' 1094 ' ' PHE . 11.8 mmt -72.08 -39.44 68.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.8 mmt -77.03 -46.58 23.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.391 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.47 0.539 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.94 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.1 m95 -59.44 -62.67 1.71 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.333 0.587 . . . . 0.0 112.199 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B 1094 ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 144' ' ' MET . 40.1 m-85 -57.71 -42.6 84.1 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -174.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -40.6 -51.51 2.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.602 0.715 . . . . 0.0 112.664 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.36 -41.83 99.74 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.79 -46.32 81.62 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.563 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -59.61 -48.15 82.78 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 24.0 mtp-105 -65.49 -38.08 88.69 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.605 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.98 -42.18 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.884 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -51.12 -46.53 61.95 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.51 ' O ' ' N ' ' B' 1105 ' ' LYS . 99.1 m -63.83 -47.88 79.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.609 -0.436 . . . . 0.0 112.002 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.427 ' C ' ' O ' ' B' 1102 ' ' THR . 84.0 mt-30 -28.24 -57.53 0.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.538 1.161 . . . . 0.0 112.435 -176.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -84.58 -15.5 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 112.202 -2.272 . . . . 0.0 112.449 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.51 ' N ' ' O ' ' B' 1102 ' ' THR . 88.6 tttt -60.24 -46.55 89.4 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 118.077 -1.449 . . . . 0.0 107.951 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 57.7 t -61.89 -48.72 87.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.61 -36.27 77.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.774 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 87.4 mttt -49.54 -36.04 22.24 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 119.919 -0.713 . . . . 0.0 109.488 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.57 -45.65 70.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.059 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -62.49 -50.51 71.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.109 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 58.9 m-70 . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.343 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 118.976 -0.535 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.2 p -76.92 139.73 40.29 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 119.934 1.243 . . . . 0.0 110.35 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.688 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -50.78 -47.99 59.53 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.391 1.091 . . . . 0.0 110.653 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.449 ' OE2' ' OE2' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -38.21 -38.87 0.37 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.884 -179.007 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -68.35 -38.96 81.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.469 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.3 mt -59.76 -44.6 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 175.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.0 -49.17 63.86 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.094 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.449 ' OE2' ' OE2' ' A' ' 7' ' ' GLU . 98.4 mt-10 -60.46 -47.56 85.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 111.748 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -59.0 -42.12 89.32 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.866 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -50.42 -57.31 8.29 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.396 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -51.18 -44.72 61.58 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.847 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.72 -37.79 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.218 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.44 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 2.6 m-85 -58.44 -40.38 82.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.2 p -65.2 -15.56 62.59 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.456 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.7 -42.13 95.51 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -105.61 -13.99 15.42 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -71.92 93.91 1.39 Allowed 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.472 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -67.41 -49.64 62.89 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.833 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.1 p30 -103.62 14.88 30.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.16 44.79 0.82 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.164 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 31.0 p-10 -85.02 -3.17 58.69 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.729 0.299 . . . . 0.0 110.89 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 -0.83 78.87 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 t -140.48 154.9 46.77 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.15 0.5 . . . . 0.0 110.097 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 27' ' ' ILE . 3.8 mp -91.41 123.96 43.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.4 p -111.77 162.98 14.66 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.853 0.835 . . . . 0.0 112.064 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.7 p -59.93 -37.57 79.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.629 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -60.47 -57.01 14.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.472 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -64.31 -28.71 69.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.479 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.498 HD22 HD11 ' A' ' 52' ' ' ILE . 3.0 tp -60.8 -53.42 57.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.062 0.934 . . . . 0.0 109.765 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.3 -37.48 94.11 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.124 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -58.81 -52.8 64.15 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.777 1.288 . . . . 0.0 108.813 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.93 -45.03 87.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 119.404 1.002 . . . . 0.0 111.278 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.7 tpt -59.07 -38.73 80.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 120.028 1.285 . . . . 0.0 109.555 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -51.46 -38.36 53.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.65 0.738 . . . . 0.0 110.457 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.9 p -63.13 -20.94 65.84 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.439 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.45 ' O ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -73.81 0.79 12.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.77 179.426 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.5 27.05 40.55 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.23 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -130.54 170.04 14.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.415 0.607 . . . . 0.0 109.923 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -133.8 76.42 65.65 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.396 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.14 147.57 95.29 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.764 2.31 . . . . 0.0 111.995 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.2 t -76.0 164.51 26.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.256 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.18 -43.75 87.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.983 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.33 -24.24 42.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.545 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.65 -38.76 90.24 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.057 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.57 -40.86 75.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.298 0.571 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -70.89 -56.38 6.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.803 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -55.25 -50.45 69.44 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.1 mmm -65.02 -51.53 61.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.498 HD11 HD22 ' A' ' 32' ' ' LEU . 30.1 mm -59.54 -48.14 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.821 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -58.37 -33.51 69.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -65.68 -39.62 91.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.215 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.31 -19.43 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.276 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.2 t0 -78.01 86.59 4.19 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -174.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.35 90.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.234 -1.803 . . . . 0.0 113.988 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -86.33 -2.76 58.69 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.0 23.66 61.88 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 118.467 0.576 . . . . 0.0 112.988 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -87.91 3.14 49.62 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.257 0.528 . . . . 0.0 110.333 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.63 0.54 87.9 Favored Glycine 0 CA--C 1.52 0.361 0 O-C-N 121.586 -0.696 . . . . 0.0 114.569 175.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.2 p -147.66 169.22 20.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.8 mt -112.79 128.51 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 23.6 t0 -103.16 -177.19 3.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.639 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.553 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -56.71 -47.94 98.12 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.513 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.3 -49.54 14.83 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.215 1.277 . . . . 0.0 111.889 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.21 -19.63 64.69 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.476 0.655 . . . . 0.0 110.927 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -74.43 -59.63 2.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.752 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.47 -43.44 79.59 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.0 m -45.59 -48.47 14.53 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.607 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.8 mtm -67.09 -45.59 76.8 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.0 mmm -61.4 -39.2 89.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.02 79.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.644 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -93.6 -14.56 26.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.572 0.225 . . . . 0.0 111.304 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' O ' ' NZ ' ' B' 1105 ' ' LYS . 0.0 OUTLIER -83.1 64.64 7.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.218 0.532 . . . . 0.0 110.49 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.3 mmt -107.5 16.53 23.72 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.801 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -38.7 141.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.357 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.54 -70.43 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.831 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.5 m 58.99 77.27 0.31 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.8 m-20 -57.61 126.0 25.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.3 m -38.99 -18.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.835 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 80' ' ' ASP . 72.4 mm-40 -68.38 -36.38 79.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.936 0.398 . . . . 0.0 111.757 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -51.37 -39.25 56.73 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.418 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 12.3 pt-20 -86.12 -4.33 59.15 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.3 mm -69.56 -73.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.883 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -60.29 -51.96 67.31 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 88' ' ' ALA . 3.1 pp20? -55.35 -37.6 67.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.007 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -60.51 -22.31 63.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.932 0.396 . . . . 0.0 110.902 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -73.76 -48.61 30.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.304 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -55.29 -42.27 73.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.587 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.13 -44.75 97.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.421 ' CE2' HG21 ' A' ' 108' ' ' VAL . 8.3 m-85 -69.33 -39.07 78.4 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.456 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -88.29 83.49 6.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.17 -48.67 80.75 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -90.9 5.06 50.14 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.66 0.267 . . . . 0.0 111.631 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.76 48.42 50.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -91.43 4.61 52.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.567 0.223 . . . . 0.0 110.697 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.21 0.89 86.71 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -139.19 152.28 47.26 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.838 0.827 . . . . 0.0 111.622 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -94.12 115.57 33.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.3 t -88.46 150.52 23.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.555 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.33 -45.79 83.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 119.167 0.894 . . . . 0.0 110.741 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.89 -40.86 66.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.984 0.421 . . . . 0.0 110.588 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -65.3 -41.35 94.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.956 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.402 ' CD2' HD11 ' A' ' 125' ' ' ILE . 59.4 tp -63.71 -44.36 93.86 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.605 0.716 . . . . 0.0 111.207 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -45.7 -44.6 13.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.499 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -62.35 -29.0 70.15 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.605 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.421 HG21 ' CE2' ' A' ' 92' ' ' PHE . 84.6 t -58.32 -41.24 80.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.87 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.626 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.59 -46.54 63.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.179 0.99 . . . . 0.0 111.446 -177.214 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -56.97 -41.42 78.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.442 -1.708 . . . . 0.0 110.675 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -65.2 -40.8 94.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.768 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.535 ' O ' ' NH1' ' B' 1099 ' ' ARG . 76.6 mt -81.5 -14.5 56.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.788 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.11 30.33 57.4 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.566 -1.13 . . . . 0.0 110.366 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -86.49 -22.86 26.19 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.749 2.275 . . . . 0.0 110.75 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 43.43 60.83 2.44 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 122.31 1.052 . . . . 0.0 110.089 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.8 mt -79.06 148.22 32.53 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 113.417 -1.719 . . . . 0.0 112.637 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 121' ' ' VAL . 62.2 p -82.46 174.99 10.57 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.383 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -57.83 -44.53 86.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -57.84 -50.67 72.51 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.56 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -68.3 -30.79 69.87 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.826 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 117' ' ' THR . 47.5 t -64.18 -42.46 95.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.396 0.617 . . . . 0.0 109.342 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 67.8 t0 -67.03 -37.77 84.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.722 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.28 -48.01 83.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.449 ' SD ' ' CD1' ' B' 1093 ' ' TRP . 20.2 mmm -54.96 -45.69 74.97 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.808 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 105' ' ' LEU . 46.5 mm -59.62 -44.88 94.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.35 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -58.37 -40.11 81.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.371 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.69 -41.0 76.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.073 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.445 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -92.67 -16.99 24.86 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.5 t0 -73.41 87.97 1.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.457 0.646 . . . . 0.0 112.076 -177.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 tt -70.78 -14.79 18.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.531 1.158 . . . . 0.0 113.241 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.5 p-10 -142.9 144.6 32.5 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.31 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.53 52.49 1.16 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.709 -0.282 . . . . 0.0 113.175 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -91.14 -9.97 43.59 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.098 0.449 . . . . 0.0 110.119 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.66 2.09 74.31 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.162 -0.542 . . . . 0.0 114.293 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -134.57 154.27 51.56 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.413 0.607 . . . . 0.0 110.435 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.49 118.51 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.272 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.459 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 46.8 t30 -85.17 175.24 9.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.917 0.389 . . . . 0.0 110.962 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.459 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 74.2 t80 -61.59 -41.02 96.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.492 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 13.1 pt-20 -62.23 -44.45 96.53 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.839 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 139' ' ' GLU . 96.8 mt-10 -64.39 -37.66 88.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.892 0.377 . . . . 0.0 110.566 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -61.12 -45.63 93.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.594 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.65 -47.79 84.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.681 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -47.27 -50.04 22.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.115 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.445 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 91.7 mmm -70.04 -35.47 74.32 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -176.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.452 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 22.7 mmt -71.79 -43.21 66.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.861 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.628 -179.161 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B 1093 ' ' TRP . . . . . 0.449 ' CD1' ' SD ' ' A' ' 124' ' ' MET . 5.5 m95 -60.95 -57.5 12.36 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.587 0.708 . . . . 0.0 112.095 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B 1094 ' ' PHE . . . . . 0.452 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 17.5 m-85 -57.61 -43.99 85.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -40.05 -51.98 2.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.11 99.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.371 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.9 tp -57.23 -44.86 84.18 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.507 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -59.17 -47.32 85.74 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.691 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B 1099 ' ' ARG . . . . . 0.535 ' NH1' ' O ' ' A' ' 112' ' ' LEU . 79.5 mtp180 -65.16 -37.94 88.99 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 4.0 mm -60.58 -41.86 89.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.436 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B 1101 ' ' GLN . . . . . 0.462 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 81.8 mt-30 -52.0 -49.28 63.64 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.468 ' O ' ' N ' ' B' 1105 ' ' LYS . 21.3 m -64.98 -47.81 76.23 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.415 ' C ' ' O ' ' B' 1102 ' ' THR . 36.6 mm-40 -28.18 -59.86 0.12 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.758 1.266 . . . . 0.0 112.324 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.5 mt -83.94 -15.9 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 111.716 -2.493 . . . . 0.0 112.471 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 75' ' ' LYS . 66.1 tttm -59.39 -44.41 92.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.009 -1.477 . . . . 0.0 107.838 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 61.6 t -61.49 -48.98 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -66.36 -36.89 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.161 -177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.6 mttt -49.77 -38.11 32.68 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.661 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.03 62.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.27 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -63.35 -50.0 71.69 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 68.7 m-70 . . . . . 0 C--N 1.327 -0.399 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -178.264 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 119.003 -0.522 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -80.02 135.4 36.36 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.512 1.051 . . . . 0.0 110.055 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.8 tt0 -51.04 -60.2 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.029 0.918 . . . . 0.0 111.373 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 44.7 tp10 -34.55 -38.03 0.07 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.933 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -70.35 -31.63 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.647 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.2 mt -57.22 -44.09 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 121.922 2.146 . . . . 0.0 105.355 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -53.55 -51.61 62.37 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.286 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -62.29 -46.48 88.6 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.411 0.624 . . . . 0.0 112.312 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.42 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 10.0 m-85 -61.68 -40.67 95.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.9 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -52.19 -56.15 16.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.235 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -48.7 -42.69 35.73 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.102 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.36 -37.32 69.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.201 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.0 m-85 -56.42 -40.79 75.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -65.9 -15.61 63.1 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.428 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.34 -43.26 98.22 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.427 ' CZ ' ' HA ' ' A' ' 16' ' ' PHE . 0.9 OUTLIER -106.41 -14.51 15.06 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.871 -178.685 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -75.37 96.11 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.252 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -67.96 -48.13 66.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.229 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.2 p-10 -102.89 14.48 31.86 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.96 48.72 1.41 Allowed Glycine 0 N--CA 1.468 0.83 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.091 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 36.1 p-10 -86.49 -4.77 59.22 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.71 0.29 . . . . 0.0 111.237 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.51 -1.55 79.25 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.8 p -139.41 156.11 47.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.22 0.534 . . . . 0.0 109.732 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -93.02 124.34 45.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.522 HG23 ' H ' ' A' ' 30' ' ' LYS . 1.2 t -115.0 165.52 12.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.8 -177.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.0 p -58.04 -39.52 78.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.439 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.522 ' H ' HG23 ' A' ' 28' ' ' THR . 62.4 tttp -58.67 -59.93 4.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.724 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -63.11 -30.71 71.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 119.598 -0.239 . . . . 0.0 111.51 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.412 HD22 HD11 ' A' ' 52' ' ' ILE . 3.3 tp -59.73 -56.39 22.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.501 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.84 -38.96 94.79 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 113.757 -1.565 . . . . 0.0 112.037 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.5 m -58.52 -53.44 58.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.107 1.454 . . . . 0.0 108.656 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.86 -46.23 87.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 118.991 0.814 . . . . 0.0 111.457 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.0 tpt -59.45 -41.84 90.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 120.112 1.324 . . . . 0.0 109.839 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -54.21 -41.98 69.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.602 0.715 . . . . 0.0 110.27 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -64.35 -22.75 67.06 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.944 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 tp -73.04 -3.41 26.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.666 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.09 13.56 58.76 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.547 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -107.75 155.41 20.24 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.66 0.73 . . . . 0.0 109.789 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -117.17 65.19 3.87 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.357 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.05 145.49 85.15 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.172 1.915 . . . . 0.0 112.215 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.1 p -79.86 167.25 20.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.092 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -57.8 -44.26 86.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.014 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.19 -23.15 20.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.489 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -66.79 -38.81 87.26 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.254 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.8 mp -56.08 -40.59 73.86 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -72.08 -57.08 4.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.057 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -54.13 -49.49 69.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 41.7 mmm -66.19 -52.23 50.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 52' ' ' ILE . 25.9 mm -57.92 -48.21 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.476 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -56.71 -33.97 67.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -66.45 -40.05 89.19 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.668 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.25 -20.29 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.404 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 41.1 t0 -78.01 86.85 4.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -174.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.74 86.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.377 -1.738 . . . . 0.0 114.302 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 37.7 p-10 -87.62 -2.65 58.76 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.28 23.22 64.08 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 118.632 0.651 . . . . 0.0 112.721 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.42 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -88.04 2.02 52.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.393 0.597 . . . . 0.0 110.688 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.65 0.85 87.76 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 175.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.6 p -148.62 171.39 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.8 mt -115.21 129.2 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -104.33 -173.65 2.36 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -59.68 -48.58 94.98 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -177.287 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.66 -53.22 5.97 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.183 1.255 . . . . 0.0 111.66 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.62 -16.77 41.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.594 0.711 . . . . 0.0 110.312 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -76.08 -58.17 3.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.16 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' THR . 77.4 mt -56.99 -45.36 83.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.2 p -44.07 -49.76 8.69 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.459 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.4 mtm -67.55 -45.43 75.68 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.4 mmt -58.45 -38.78 78.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.95 76.62 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.683 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -94.87 -11.19 29.22 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.8 0.333 . . . . 0.0 111.453 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.45 67.44 8.49 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.278 0.561 . . . . 0.0 110.337 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 mmt -109.26 15.66 22.99 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.747 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -52.31 132.28 33.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.418 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -106.63 159.4 16.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.959 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.9 136.08 25.03 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 82' ' ' GLU . 41.8 t0 -61.55 116.16 4.5 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 174.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.6 m -36.94 -19.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 80' ' ' ASP . 94.8 mt-10 -69.02 -35.21 76.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -48.7 -38.37 21.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.487 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -86.49 -17.66 33.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.305 0.574 . . . . 0.0 111.761 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 mm -61.37 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.116 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -62.21 -40.8 97.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.98 -42.11 97.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.811 0.338 . . . . 0.0 111.679 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.98 -19.51 52.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -75.44 -49.05 20.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.985 0.421 . . . . 0.0 111.233 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -55.49 -42.52 74.51 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.607 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.7 -44.47 96.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.9 m-85 -69.19 -38.25 78.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.553 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -85.94 81.22 8.61 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -58.32 -48.99 78.77 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -176.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.2 p30 -90.99 5.53 48.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.471 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.39 48.33 48.55 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -92.16 6.81 45.2 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.597 0.237 . . . . 0.0 110.603 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.62 1.42 89.14 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -141.12 154.05 45.71 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.893 0.854 . . . . 0.0 111.725 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.7 mt -95.09 115.85 35.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 p -90.58 153.05 20.62 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.31 82.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.28 0.945 . . . . 0.0 110.946 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.41 -43.81 68.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.946 0.403 . . . . 0.0 110.711 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.31 -42.54 99.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.596 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 tt -63.93 -45.28 89.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.226 0.536 . . . . 0.0 111.608 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -41.99 -45.01 3.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.61 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -59.73 -26.88 66.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.714 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.582 HG21 ' CE2' ' A' ' 92' ' ' PHE . 86.6 t -57.95 -42.97 83.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.671 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.703 ' HG2' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -51.17 -49.22 61.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.15 0.976 . . . . 0.0 111.89 -177.833 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.8 p -52.65 -38.89 61.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.622 -1.627 . . . . 0.0 110.901 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -65.76 -39.08 90.69 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.495 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.2 mt -83.95 -12.96 54.57 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.76 38.24 50.29 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.353 -1.248 . . . . 0.0 110.196 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -89.45 -22.79 22.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.913 2.357 . . . . 0.0 111.118 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt 45.01 58.41 4.05 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.611 1.196 . . . . 0.0 110.065 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.853 HD23 ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -75.63 149.74 38.14 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 112.952 -1.931 . . . . 0.0 112.982 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 33.4 p -84.07 174.67 10.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 110.349 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.86 -44.73 74.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.3 -41.57 72.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.123 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.17 -28.64 65.48 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.519 -0.472 . . . . 0.0 112.037 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 49.2 t -64.03 -43.68 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.297 0.57 . . . . 0.0 109.63 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -74.62 -36.15 62.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.204 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -60.0 -54.11 49.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.8 mmm -51.27 -52.15 47.64 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.01 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -56.22 -42.58 73.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.582 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -60.02 -36.97 78.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.643 0.259 . . . . 0.0 111.428 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -57.62 -40.78 79.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.717 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.71 -15.01 25.67 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.6 t0 -77.57 82.73 3.99 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.642 0.734 . . . . 0.0 111.682 -177.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.7 pt -70.89 -7.56 9.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 122.622 1.201 . . . . 0.0 113.351 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.9 p-10 -144.45 143.32 30.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 112.458 -2.156 . . . . 0.0 109.171 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.13 51.46 1.67 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 122.202 -0.311 . . . . 0.0 113.41 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -90.72 -10.59 42.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.274 0.537 . . . . 0.0 109.835 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.6 -0.45 64.89 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.54 0.576 . . . . 0.0 114.54 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -132.73 153.17 51.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.339 0.57 . . . . 0.0 110.471 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.45 117.96 45.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.232 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.413 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 53.8 t30 -83.99 173.07 11.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.934 0.397 . . . . 0.0 110.949 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.413 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 80.5 t80 -61.16 -39.56 90.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.998 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.23 -44.51 96.39 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.854 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.98 -37.82 88.82 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.626 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -61.21 -44.87 96.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.706 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.7 t -65.1 -47.42 87.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.365 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -50.58 -42.74 56.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.736 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.2 mmt -74.64 -40.13 61.67 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.5 mmt -77.2 -44.57 29.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.884 -0.144 . . . . 0.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.466 0.335 0 CA-C-O 120.587 0.232 . . . . 0.0 111.335 -179.197 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 11.1 mt . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.68 -56.6 18.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.289 0.566 . . . . 0.0 112.357 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B 1094 ' ' PHE . . . . . 0.528 ' CE2' ' OD1' ' B' 1098 ' ' ASN . 11.8 t80 -59.83 -48.47 81.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -174.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -39.33 -51.92 2.04 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.0 -39.39 96.99 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.027 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.1 tp -57.15 -41.95 80.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 118.322 1.061 . . . . 0.0 109.559 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B 1098 ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' B' 1094 ' ' PHE . 6.2 m-20 -59.85 -51.58 69.11 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 76.0 mmt-85 -65.47 -39.81 92.41 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.21 -41.35 83.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.422 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -50.4 -45.36 55.53 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.534 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.3 m -63.69 -47.98 78.98 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.434 ' C ' ' O ' ' B' 1102 ' ' THR . 84.7 mt-30 -27.64 -57.54 0.1 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.61 1.195 . . . . 0.0 112.31 -176.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.8 mt -84.77 -13.81 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.437 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.534 ' N ' ' O ' ' B' 1102 ' ' THR . 38.3 ttmt -59.85 -45.66 91.71 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 118.181 -1.408 . . . . 0.0 108.069 176.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.6 t -60.52 -49.78 83.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.7 m -65.8 -36.0 76.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.967 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 86.6 mttt -50.12 -37.69 35.33 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.608 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.59 -45.62 63.21 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.202 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.99 -49.65 73.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 69.3 m-70 . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -178.351 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 119.462 -0.304 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 m -78.92 136.19 37.19 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.386 0.994 . . . . 0.0 110.138 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 9' ' ' ILE . 9.4 tm-20 -51.43 -55.47 18.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.893 0.854 . . . . 0.0 111.089 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -37.62 -36.89 0.19 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.648 -1.615 . . . . 0.0 110.576 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -70.25 -32.4 70.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 118.45 -0.785 . . . . 0.0 110.723 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.7 mt -59.54 -45.26 94.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 175.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.23 -49.4 64.05 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.617 -177.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.36 -46.56 88.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.359 0.599 . . . . 0.0 111.923 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.3 m-85 -62.83 -39.3 93.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.812 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -52.64 -53.2 50.26 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.56 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.26 -39.77 60.81 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.059 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.24 -37.67 70.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.084 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.441 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 3.8 m-85 -58.49 -40.85 83.92 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.5 m -65.29 -14.61 61.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.782 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.22 -41.64 94.25 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -105.64 -13.56 15.54 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -74.61 93.14 2.48 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.26 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -69.28 -47.24 65.14 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.96 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.5 p-10 -102.19 13.64 34.13 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.945 -0.472 . . . . 0.0 112.195 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.98 46.64 1.23 Allowed Glycine 0 CA--C 1.533 1.199 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.996 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -86.18 -4.19 59.12 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.637 -0.331 . . . . 0.0 110.957 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.12 84.51 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.9 p -137.3 152.13 49.42 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.105 0.479 . . . . 0.0 109.982 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.93 124.36 45.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.419 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 19.7 p -113.48 164.52 13.51 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.941 0.877 . . . . 0.0 112.194 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 p -59.2 -38.25 79.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.541 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -62.1 -56.63 16.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.556 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 28' ' ' THR . 16.0 pt-20 -64.24 -30.23 71.29 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.37 -52.25 65.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.264 1.031 . . . . 0.0 109.515 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.85 -35.61 87.26 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.865 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.22 -53.14 61.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.09 1.445 . . . . 0.0 108.661 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.44 -45.66 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 120.731 -1.23 . . . . 0.0 111.636 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.6 ttt -59.06 -40.91 86.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 120.064 1.302 . . . . 0.0 109.643 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -53.16 -37.02 61.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.556 0.693 . . . . 0.0 110.48 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.5 t -62.39 -20.25 64.25 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.735 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.4 mt -75.82 2.9 11.09 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.1 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.58 16.16 74.09 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.91 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -109.55 160.31 16.35 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.582 0.691 . . . . 0.0 109.872 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -112.82 69.2 1.1 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.085 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.7 141.84 67.81 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.845 1.697 . . . . 0.0 112.181 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -81.58 157.36 24.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.029 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.0 -42.13 68.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.762 0.315 . . . . 0.0 110.572 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.9 -25.64 43.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.346 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -65.63 -39.48 91.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.816 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.2 mp -56.06 -40.96 74.34 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.492 0.663 . . . . 0.0 109.847 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -69.12 -56.49 7.53 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.655 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -53.13 -48.69 67.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.412 ' SD ' ' NE2' ' B' 1111 ' ' HIS . 1.5 mtm -71.44 -44.51 64.68 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 52' ' ' ILE . 12.1 mm -58.57 -48.41 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -56.58 -34.34 67.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -66.11 -40.41 90.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.669 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.406 HG21 ' CE2' ' B' 1110 ' ' PHE . 50.1 t -85.52 -21.43 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.275 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.405 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.5 t0 -78.45 86.12 4.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -175.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.28 89.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.179 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 36.4 p-10 -85.58 -3.25 58.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.62 23.73 61.12 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 121.872 -0.518 . . . . 0.0 113.029 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.4 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.1 p-10 -87.51 4.65 42.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.046 0.423 . . . . 0.0 110.348 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.405 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.03 0.66 89.7 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.871 -0.681 . . . . 0.0 114.38 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.4 p -147.79 167.49 24.6 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.2 mt -112.62 128.4 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -103.82 -174.57 2.58 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.66 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.441 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.63 -47.28 99.03 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -176.655 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -56.61 -51.38 9.26 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.415 1.41 . . . . 0.0 111.354 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.95 -20.51 65.3 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.372 0.606 . . . . 0.0 111.097 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -71.24 -58.33 3.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.871 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.76 -44.3 86.06 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 m -40.5 -59.09 1.42 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.665 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -64.8 -41.6 95.68 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -176.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 98.2 mmm -59.44 -39.6 84.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.36 78.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.286 0.235 . . . . 0.0 111.499 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -96.65 -8.48 31.48 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.228 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 67.18 7.24 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.169 0.509 . . . . 0.0 110.24 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 19.8 mmt -108.54 16.41 23.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.782 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -52.67 130.99 34.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.674 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 54.3 p-10 -105.57 148.07 27.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.781 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.1 p -133.65 134.1 42.75 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 82' ' ' GLU . 22.7 t0 -62.05 117.17 5.62 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.9 m -37.45 -20.49 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.615 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 80' ' ' ASP . 71.3 mm-40 -69.36 -34.32 74.4 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 111.616 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -49.1 -37.88 22.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.596 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -86.87 -19.28 29.15 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.132 0.491 . . . . 0.0 111.671 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.36 -74.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.853 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -62.39 -40.58 96.93 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.98 -40.91 97.23 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.665 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.07 -21.19 63.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.104 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -71.44 -50.55 30.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.091 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -55.28 -43.03 74.37 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.79 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.37 -44.13 94.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.548 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.4 m-85 -68.22 -38.21 81.66 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.244 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -85.28 81.51 8.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -58.81 -48.76 80.17 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -91.29 4.56 52.03 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 122.236 -0.29 . . . . 0.0 111.274 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.13 46.22 56.56 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -90.08 6.75 41.11 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.679 0.276 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.26 2.0 89.33 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -140.14 152.52 46.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.747 0.784 . . . . 0.0 111.688 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -93.46 114.84 30.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -88.03 150.0 23.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.299 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.71 -45.39 85.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.17 0.896 . . . . 0.0 110.586 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.74 -40.66 72.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.912 0.386 . . . . 0.0 110.568 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.68 -42.54 91.17 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.261 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 108' ' ' VAL . 6.8 tt -63.4 -44.9 93.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.309 0.576 . . . . 0.0 111.052 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -41.25 -44.18 2.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.63 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.25 -25.8 65.95 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.616 0.246 . . . . 0.0 110.998 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.548 HG21 ' CE2' ' A' ' 92' ' ' PHE . 67.7 t -58.59 -43.14 86.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.551 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.646 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.26 -45.92 65.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.911 0.863 . . . . 0.0 111.554 -176.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.6 p -62.1 -36.22 81.07 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.178 -176.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.634 HD22 HG12 ' B' 1100 ' ' ILE . 0.1 OUTLIER -65.09 -41.05 95.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.66 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.838 ' O ' HD12 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -89.01 -8.6 53.73 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -178.678 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.87 40.41 36.3 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.532 -1.149 . . . . 0.0 111.08 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.579 ' HB2' HD11 ' A' ' 112' ' ' LEU . 36.8 tp10 -89.96 -25.87 20.69 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 121.036 2.418 . . . . 0.0 110.741 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 46.52 63.42 1.9 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.242 1.02 . . . . 0.0 110.494 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.509 HD12 ' CG ' ' A' ' 109' ' ' MET . 82.3 mt -81.99 147.63 29.09 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.255 -1.793 . . . . 0.0 113.568 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 121' ' ' VAL . 81.4 p -83.16 175.74 9.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -58.29 -46.07 86.77 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -57.54 -48.32 79.62 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -69.15 -30.81 69.13 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.891 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 117' ' ' THR . 42.3 t -63.75 -41.75 93.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.483 0.659 . . . . 0.0 109.297 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -67.72 -36.98 81.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.299 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -59.65 -51.48 69.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 91.6 mtp -57.1 -43.33 82.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.001 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.0 mm -59.56 -44.29 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.559 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.78 -35.65 78.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 111.463 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.21 -40.71 82.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.712 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.48 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -91.06 -20.61 21.87 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.679 0.276 . . . . 0.0 111.637 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 19.3 t0 -77.63 83.16 4.02 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.469 0.652 . . . . 0.0 112.195 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.6 pt -71.02 -9.66 13.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.496 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 54.7 p-10 -142.8 144.1 32.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 112.621 -2.082 . . . . 0.0 109.054 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.28 51.04 1.7 Allowed Glycine 0 CA--C 1.532 1.147 0 CA-C-N 116.741 -0.209 . . . . 0.0 113.533 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -90.48 -9.87 45.77 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.159 0.48 . . . . 0.0 110.135 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.95 0.13 68.32 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.873 -0.679 . . . . 0.0 114.376 176.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -133.78 154.18 51.18 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.206 0.503 . . . . 0.0 110.606 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.2 t -101.14 118.03 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -84.39 174.51 10.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.938 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.15 -40.52 94.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.292 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -62.35 -44.26 96.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.68 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.47 -37.2 86.7 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.532 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -61.26 -45.22 95.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.135 0.493 . . . . 0.0 110.69 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.45 -47.21 87.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.286 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -49.14 -46.5 45.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.085 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.48 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 1.4 mmt -71.97 -36.88 69.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -177.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.483 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 24.5 mmt -71.85 -44.21 64.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.785 -0.189 . . . . 0.0 110.606 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.7 m . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.503 -179.4 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 8.2 m95 -60.0 -58.86 6.72 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.792 0.806 . . . . 0.0 111.973 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B 1094 ' ' PHE . . . . . 0.483 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 29.3 m-85 -59.81 -46.66 88.53 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -174.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -42.2 -52.06 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.68 -40.97 99.49 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.779 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 56.8 tp -57.57 -45.28 85.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.196 0.998 . . . . 0.0 109.73 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 15.3 m120 -61.33 -51.75 67.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -65.66 -38.81 90.36 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B 1100 ' ' ILE . . . . . 0.634 HG12 HD22 ' A' ' 111' ' ' ASN . 88.6 mt -60.96 -42.35 92.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.765 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -52.11 -45.33 64.87 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.537 ' O ' ' N ' ' B' 1105 ' ' LYS . 90.9 m -63.1 -48.01 80.4 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.699 -0.626 . . . . 0.0 111.502 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.449 ' C ' ' O ' ' B' 1102 ' ' THR . 91.3 mt-30 -27.97 -55.91 0.11 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.541 1.163 . . . . 0.0 112.65 -176.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B 1104 ' ' ILE . . . . . 0.402 HG21 HD13 ' B' 1104 ' ' ILE . 2.0 mt -83.53 -15.04 11.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 112.165 -2.289 . . . . 0.0 112.602 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.537 ' N ' ' O ' ' B' 1102 ' ' THR . 64.0 tttp -59.53 -44.41 93.2 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 118.063 -1.455 . . . . 0.0 108.259 176.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.5 t -61.39 -48.85 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.78 -35.98 76.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.198 -178.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 92.8 mttt -49.92 -36.72 28.73 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.796 0.726 . . . . 0.0 109.756 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.76 -45.75 70.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.247 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B 1110 ' ' PHE . . . . . 0.406 ' CE2' HG21 ' A' ' 55' ' ' VAL . 51.7 m-85 -63.07 -48.91 76.64 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.229 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B 1111 ' ' HIS . . . . . 0.412 ' NE2' ' SD ' ' A' ' 51' ' ' MET . 83.3 m-70 . . . . . 0 C--N 1.328 -0.334 0 O-C-N 122.119 -0.363 . . . . 0.0 111.963 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.7 tp . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 119.158 -0.448 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -73.75 141.13 46.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.203 0.911 . . . . 0.0 109.653 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.0 tt0 -45.26 -61.68 1.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.064 0.935 . . . . 0.0 110.375 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -34.1 -36.14 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.627 -1.624 . . . . 0.0 111.18 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.621 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 1.2 tm0? -69.11 -38.75 79.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.414 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.1 mt -59.68 -44.39 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.431 ' O ' ' OE2' ' A' ' 14' ' ' GLU . . . -53.31 -52.16 60.03 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.238 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.53 -45.49 93.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.531 0.682 . . . . 0.0 112.596 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.621 ' CD1' ' NE2' ' A' ' 8' ' ' GLN . 5.2 m-85 -62.67 -38.55 90.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.705 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -53.03 -53.8 44.81 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.432 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 10' ' ' ALA . 1.9 mp0 -48.38 -41.31 28.51 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.199 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.53 -39.06 72.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.237 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -57.64 -42.0 82.56 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 m -64.88 -14.54 59.95 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.469 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.63 -43.15 97.67 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -105.96 -13.34 15.52 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -74.34 93.77 2.44 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.263 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -68.78 -48.0 64.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.791 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.0 p-10 -102.61 13.74 33.72 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.66 48.02 1.26 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.157 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -85.32 -4.33 59.12 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.749 0.309 . . . . 0.0 110.904 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.49 -2.3 82.75 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.7 p -137.37 152.52 49.76 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.8 mp -91.81 123.59 43.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.433 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 19.0 p -113.76 166.18 11.81 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.539 0.685 . . . . 0.0 112.418 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.3 p -58.99 -37.3 76.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.372 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -61.22 -60.62 3.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.263 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 28' ' ' THR . 15.5 pt-20 -61.1 -30.45 70.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.518 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.408 HD22 HD11 ' A' ' 52' ' ' ILE . 2.9 tp -60.76 -53.68 54.44 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.727 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.52 -37.97 94.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 113.786 -1.552 . . . . 0.0 112.242 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.68 -52.0 67.56 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.782 1.291 . . . . 0.0 108.919 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.17 -45.26 88.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 119.303 0.956 . . . . 0.0 111.275 -177.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 28.2 ttt -59.31 -39.33 82.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 119.805 1.184 . . . . 0.0 109.917 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -52.29 -39.88 61.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.738 0.78 . . . . 0.0 110.259 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.1 p -62.52 -20.64 64.83 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.21 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.95 -0.33 15.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.959 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.06 25.39 44.93 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.183 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -124.97 165.12 18.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.317 0.558 . . . . 0.0 109.772 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -125.62 77.09 69.68 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.278 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.37 147.87 72.52 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.99 1.794 . . . . 0.0 112.119 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.4 p -79.4 162.76 25.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.103 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -57.19 -43.15 82.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.996 -179.177 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.489 ' H ' ' CD ' ' A' ' 45' ' ' GLU . . . -57.19 -25.32 58.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.368 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -65.26 -40.72 94.33 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.088 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.3 mp -55.06 -38.63 68.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.565 0.698 . . . . 0.0 109.46 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -72.97 -55.42 6.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.187 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.41 -49.61 69.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.414 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 63.7 mtp -66.9 -48.98 67.03 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 52' ' ' ILE . 24.4 mm -58.54 -45.23 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.433 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -56.42 -35.42 67.8 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.57 -40.63 89.07 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.507 -0.477 . . . . 0.0 112.076 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.452 HG21 ' CE2' ' B' 1110 ' ' PHE . 75.4 t -85.53 -21.74 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.651 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.476 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.0 t0 -78.69 86.75 4.63 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -175.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.78 87.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.367 -1.742 . . . . 0.0 114.27 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.471 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 39.5 p-10 -86.14 -2.95 58.82 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.26 23.17 63.99 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.548 0.613 . . . . 0.0 112.795 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.471 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.2 p-10 -88.04 2.16 52.53 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.392 0.596 . . . . 0.0 110.66 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.476 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.6 1.75 89.05 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.701 -0.625 . . . . 0.0 114.586 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.4 p -145.78 166.56 25.55 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.1 mm -109.7 126.5 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.85 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -102.78 -176.98 3.25 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.907 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.93 -47.39 98.77 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.21 -51.39 9.53 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.1 1.2 . . . . 0.0 111.613 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.72 -18.33 53.77 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.648 0.737 . . . . 0.0 110.586 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -77.17 -56.75 4.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.441 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.4 mt -58.49 -46.16 87.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.7 p -46.24 -47.33 18.04 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.104 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.7 mtp -66.83 -45.45 78.23 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.6 mmt -59.78 -39.74 85.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.58 78.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.242 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 -94.76 -10.66 30.88 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.727 0.299 . . . . 0.0 111.561 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.31 68.22 8.64 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.13 0.49 . . . . 0.0 110.613 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.5 mmt -107.26 18.62 21.41 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.389 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -50.17 130.43 22.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.239 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -93.57 106.02 18.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.799 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.515 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 2.8 m -90.26 122.08 32.85 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 82' ' ' GLU . 90.3 m-20 -69.66 112.14 5.93 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.0 m -37.58 -21.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.694 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.4 mp0 -68.88 -37.24 78.91 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -47.69 -35.67 9.99 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.266 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -88.97 -17.45 29.45 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.307 0.575 . . . . 0.0 112.039 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 85' ' ' ILE . 27.7 mm -60.87 -74.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.959 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -62.61 -39.1 92.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -62.7 -40.88 98.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.371 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.59 -19.53 62.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -72.92 -50.77 21.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.955 0.407 . . . . 0.0 111.317 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -55.5 -42.48 74.51 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.42 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.23 -43.73 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.605 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.3 m-85 -68.29 -38.97 82.21 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.475 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -89.22 84.03 6.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.7 -46.19 91.33 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -92.15 4.41 53.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.294 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.43 50.35 48.01 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -92.24 5.72 49.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.637 0.256 . . . . 0.0 110.576 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.98 0.76 89.76 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -139.55 153.07 47.35 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.545 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.46 115.32 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.4 m -89.82 153.23 20.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.35 -47.79 80.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 119.039 0.836 . . . . 0.0 110.986 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.01 -40.17 60.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.994 0.426 . . . . 0.0 110.461 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -66.22 -41.43 90.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.383 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 tp -63.5 -46.33 86.61 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.37 0.605 . . . . 0.0 111.422 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -44.22 -36.89 2.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.753 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -69.33 -27.6 65.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.717 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.605 HG21 ' CE2' ' A' ' 92' ' ' PHE . 94.8 t -58.76 -43.08 87.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.03 -178.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.57 ' SD ' HD13 ' A' ' 116' ' ' LEU . 8.7 mmt -51.89 -49.69 62.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.219 1.009 . . . . 0.0 111.879 -176.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 65.9 p -52.78 -37.14 59.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.245 -1.798 . . . . 0.0 110.817 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -66.3 -39.6 89.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.949 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.0 mt -82.83 -13.81 55.5 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.49 37.6 53.06 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.26 -1.3 . . . . 0.0 110.058 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -85.12 -20.57 30.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 121.021 2.411 . . . . 0.0 110.976 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt 42.38 50.6 4.68 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.723 1.249 . . . . 0.0 110.367 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.57 HD13 ' SD ' ' A' ' 109' ' ' MET . 0.9 OUTLIER -74.23 153.47 39.42 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.957 -1.928 . . . . 0.0 112.701 -178.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 61.3 p -85.64 174.14 9.63 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -55.93 -43.97 77.88 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -55.59 -41.87 73.99 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.051 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.09 -29.95 68.15 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.979 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.408 HG22 HD11 ' A' ' 116' ' ' LEU . 43.8 t -62.75 -43.95 99.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.466 0.651 . . . . 0.0 109.593 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -72.83 -36.45 67.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.994 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -59.22 -54.89 41.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 83.9 mtp -56.74 -43.25 80.49 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.645 -1.162 . . . . 0.0 109.812 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.8 mt -59.28 -43.74 90.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.243 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -59.26 -39.44 82.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.828 0.347 . . . . 0.0 111.106 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.31 -41.28 84.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.187 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.65 -24.88 21.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.1 t0 -71.77 88.73 1.01 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.651 0.739 . . . . 0.0 111.933 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 72.3 mt -70.06 -15.88 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.703 1.24 . . . . 0.0 113.208 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 44.7 p-10 -141.53 144.4 34.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 112.295 -2.23 . . . . 0.0 109.522 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.59 52.28 1.17 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.604 -0.331 . . . . 0.0 112.947 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 32.1 p-10 -91.37 -9.91 43.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.187 0.494 . . . . 0.0 110.19 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.82 2.49 76.9 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.218 -0.515 . . . . 0.0 114.268 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -135.04 154.5 51.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 117.198 0.499 . . . . 0.0 110.445 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.5 t -100.9 118.94 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.357 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -84.55 174.44 10.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.85 0.357 . . . . 0.0 110.816 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -61.24 -40.3 93.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.24 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.1 -44.51 96.5 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.34 -38.49 90.28 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.763 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -61.16 -45.4 94.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.054 0.454 . . . . 0.0 110.849 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.9 t -65.23 -46.21 91.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.353 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -49.8 -45.02 49.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.611 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.6 mmt -72.7 -38.44 67.51 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.4 mmt -71.93 -46.89 55.95 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.341 -0.144 . . . . 0.0 110.909 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.467 0.393 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.725 -179.309 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.6 m95 -62.34 -54.57 38.56 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.57 0.7 . . . . 0.0 112.244 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 8.3 t80 -59.44 -46.6 88.3 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 18.6 mmm-85 -40.69 -51.3 3.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.28 -39.58 97.4 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.33 -44.03 83.9 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.697 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 39.7 t30 -59.46 -49.78 76.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.631 -1.168 . . . . 0.0 114.118 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -65.58 -37.83 87.78 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.7 -41.68 89.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.889 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -51.39 -46.02 62.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B 1102 ' ' THR . . . . . 0.527 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.5 m -63.89 -48.18 77.68 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.886 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B 1103 ' ' GLN . . . . . 0.436 ' C ' ' O ' ' B' 1102 ' ' THR . 83.8 mt-30 -27.47 -56.91 0.1 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.638 1.209 . . . . 0.0 112.569 -176.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.3 mt -85.84 -14.17 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.453 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B 1105 ' ' LYS . . . . . 0.527 ' N ' ' O ' ' B' 1102 ' ' THR . 78.5 tttt -60.32 -45.93 91.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.012 176.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 96.1 t -61.57 -49.06 85.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.7 m -66.04 -35.89 76.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.013 -177.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B 1108 ' ' LYS . . . . . 0.515 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 87.0 mttt -49.62 -38.65 32.89 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.571 0.7 . . . . 0.0 109.727 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.71 -45.92 67.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.355 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B 1110 ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 55' ' ' VAL . 49.7 m-85 -63.41 -49.4 73.91 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 68.1 m-70 . . . . . 0 C--N 1.33 -0.249 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.621 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.524 ' OD1' ' NE2' ' A' ' 3' ' ' GLN . 31.0 p-10 -91.32 3.43 54.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.746 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 2' ' ' ASP . 11.0 mp0 -102.04 104.02 14.65 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.98 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.4 mt -113.95 -15.34 12.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.563 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.5 p -80.03 136.98 36.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.324 0.965 . . . . 0.0 110.32 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 9' ' ' ILE . 46.3 tt0 -51.86 -53.65 38.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 122.072 0.939 . . . . 0.0 110.201 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 10.2 pt-20 -32.84 -36.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.108 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.52 ' OE1' ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -69.62 -37.77 76.96 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.286 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.3 mt -58.58 -44.9 90.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.67 -49.23 62.78 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.108 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.56 -46.37 90.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.339 0.59 . . . . 0.0 111.535 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.52 ' CD2' ' OE1' ' A' ' 8' ' ' GLN . 28.2 m-85 -58.41 -42.37 87.05 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.781 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -49.21 -58.1 5.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.378 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.48 -44.97 62.63 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.031 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.22 -38.16 70.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.222 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.16 -41.84 84.65 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 t -64.41 -15.78 61.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.421 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -64.08 -42.82 96.81 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -178.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -105.64 -14.52 15.24 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -75.45 94.94 3.18 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.137 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -68.25 -47.43 67.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.226 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.2 p-10 -102.38 14.18 32.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.46 46.17 1.03 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.035 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -85.35 -4.0 59.02 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.694 -0.298 . . . . 0.0 110.961 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.38 -2.0 82.71 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.5 p -137.51 152.24 49.29 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.103 0.478 . . . . 0.0 109.891 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.64 124.53 45.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.9 p -114.31 165.27 12.87 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.801 0.81 . . . . 0.0 112.393 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.4 p -58.85 -35.82 73.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.715 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.59 -61.4 2.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.565 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.92 -30.48 71.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.795 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.412 HD22 HD11 ' A' ' 52' ' ' ILE . 2.9 tp -60.16 -55.73 30.3 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.015 0.912 . . . . 0.0 109.667 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.65 -37.69 93.87 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.975 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 m -58.75 -53.03 63.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 119.047 1.423 . . . . 0.0 108.624 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.0 -46.47 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 121.228 -0.92 . . . . 0.0 111.523 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.6 ttt -59.0 -39.93 83.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 120.054 1.297 . . . . 0.0 109.461 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -51.56 -38.36 54.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.531 0.681 . . . . 0.0 110.183 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.1 p -63.54 -21.08 66.14 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.376 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.473 ' O ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -73.73 -1.72 20.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.536 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.34 13.77 67.57 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.127 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -107.14 158.01 17.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 117.611 0.705 . . . . 0.0 109.854 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -114.74 64.77 1.58 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.286 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.05 143.29 94.78 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.19 1.927 . . . . 0.0 112.156 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 t -80.58 166.74 20.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.438 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.15 -44.12 87.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.72 -24.2 33.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.558 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -65.63 -39.15 91.16 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.069 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.2 mp -56.42 -41.59 76.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.463 0.649 . . . . 0.0 109.759 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.25 -56.67 6.2 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.757 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.45 -48.81 71.29 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 41.2 mmm -65.85 -50.17 65.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.412 HD11 HD22 ' A' ' 32' ' ' LEU . 25.9 mm -59.44 -47.69 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.672 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -56.45 -34.97 67.35 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -66.18 -40.01 90.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.8 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.489 HG21 ' CD2' ' B' 1110 ' ' PHE . 71.4 t -86.35 -20.37 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.503 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.494 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.3 t0 -78.49 85.93 4.55 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.21 -38.0 87.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.326 -1.761 . . . . 0.0 114.066 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 36.8 p-10 -86.26 -2.89 58.79 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.98 23.55 63.82 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 118.476 0.58 . . . . 0.0 112.927 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.419 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.4 p-10 -87.36 2.38 50.51 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.234 0.517 . . . . 0.0 110.578 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.2 1.39 89.54 Favored Glycine 0 CA--C 1.521 0.442 0 O-C-N 121.585 -0.697 . . . . 0.0 114.448 175.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.0 p -145.85 165.33 29.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.9 mm -108.91 126.64 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -103.38 -176.33 3.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -57.3 -59.11 13.81 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.24 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -47.25 -49.62 12.6 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.37 1.38 . . . . 0.0 111.243 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.57 -19.77 62.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.348 0.594 . . . . 0.0 110.641 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 65' ' ' PHE . 22.7 t80 -74.55 -58.24 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.962 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.18 -45.21 83.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -44.24 -49.88 9.1 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.61 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 72.8 mtm -66.98 -44.5 80.28 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.656 -0.417 . . . . 0.0 112.026 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.8 mmt -57.62 -39.42 76.88 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.46 77.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.548 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -95.74 -9.05 32.82 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.434 ' C ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -85.98 63.84 8.25 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.154 0.502 . . . . 0.0 110.685 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.56 17.24 22.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.41 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -48.31 135.02 14.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.175 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -89.41 108.94 19.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.827 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -93.75 119.68 33.04 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 82' ' ' GLU . 36.8 t0 -67.02 112.89 4.61 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 174.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 m -37.68 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.522 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 80' ' ' ASP . 95.3 mt-10 -72.09 -31.51 66.15 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -50.38 -39.14 45.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.878 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.55 ' OE1' HD11 ' B' 1097 ' ' LEU . 9.2 pt-20 -89.53 -11.04 43.98 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.4 mm -62.43 -74.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.798 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -62.01 -40.75 96.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.91 -41.3 97.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.571 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.41 -21.26 63.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -73.81 -48.41 31.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -54.95 -40.55 70.09 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.815 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.3 t -65.54 -44.1 94.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.512 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.4 m-85 -69.02 -38.7 79.34 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.264 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -85.55 81.11 8.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.37 -49.4 77.36 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -176.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -91.32 4.83 51.38 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.175 -0.328 . . . . 0.0 111.168 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.61 48.13 50.39 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -90.22 6.25 43.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.674 0.273 . . . . 0.0 110.745 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.18 2.13 85.91 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -142.98 156.18 44.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.751 0.786 . . . . 0.0 111.593 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -94.08 115.37 32.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 t -89.05 151.1 22.45 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.23 -46.54 82.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.201 0.91 . . . . 0.0 110.723 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.42 -40.59 65.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.951 0.405 . . . . 0.0 110.554 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.22 -41.13 94.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.168 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.19 -44.64 94.82 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.614 0.721 . . . . 0.0 110.949 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -44.55 -44.01 8.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.548 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.92 -29.71 70.99 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 122.456 -0.152 . . . . 0.0 110.747 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.512 HG21 ' CE2' ' A' ' 92' ' ' PHE . 95.5 t -57.64 -41.32 79.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.837 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.604 ' CE ' HG22 ' A' ' 121' ' ' VAL . 8.5 mtt -50.84 -45.54 59.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.075 0.94 . . . . 0.0 111.526 -177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 m -56.68 -41.41 77.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.537 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -66.55 -41.55 88.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.132 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 74.8 mt -80.87 -16.36 53.86 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.24 30.52 58.67 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.51 -23.1 27.87 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.962 2.381 . . . . 0.0 110.481 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.9 tptp 45.02 60.37 3.01 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.067 0.937 . . . . 0.0 110.326 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.9 mt -79.95 147.2 31.71 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.566 -1.652 . . . . 0.0 112.463 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.57 ' O ' HG23 ' A' ' 121' ' ' VAL . 81.5 p -81.99 175.35 10.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.468 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -57.41 -44.79 84.86 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -56.49 -47.91 78.28 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.196 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 123' ' ' GLU . 64.3 mm-40 -71.35 -28.44 64.06 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.73 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.604 HG22 ' CE ' ' A' ' 109' ' ' MET . 54.4 t -63.91 -42.43 95.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.669 0.747 . . . . 0.0 109.288 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.53 -35.09 65.5 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.382 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 120' ' ' GLU . 82.5 tt0 -59.66 -51.28 70.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 93.0 mtp -56.08 -44.47 78.98 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.35 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.74 -43.66 88.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.189 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -58.63 -39.45 80.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.953 0.406 . . . . 0.0 111.212 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.37 -40.92 79.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.059 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.41 -20.15 22.1 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.9 t0 -72.88 87.69 1.32 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.301 0.572 . . . . 0.0 112.072 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 tt -70.5 -15.18 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.374 1.083 . . . . 0.0 113.242 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.7 p-10 -142.65 144.78 32.92 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 112.322 -2.217 . . . . 0.0 109.172 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.1 52.27 1.35 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-N 116.736 -0.211 . . . . 0.0 113.255 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -90.79 -9.21 47.37 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.973 0.387 . . . . 0.0 110.013 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.34 1.02 68.41 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.995 -0.621 . . . . 0.0 114.262 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -134.43 153.87 51.69 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.395 0.598 . . . . 0.0 110.422 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.68 118.38 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.366 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -84.44 174.55 9.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 0.0 111.149 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -61.05 -40.8 95.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.202 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.64 -44.6 96.68 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.701 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.94 -35.64 81.81 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.599 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -60.75 -44.75 96.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.076 0.465 . . . . 0.0 110.574 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.11 -47.01 89.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.365 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.708 ' O ' HG22 ' A' ' 146' ' ' THR . 52.6 tt0 -49.34 -40.73 36.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.78 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 mmt -74.9 -38.58 61.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.1 mmt -80.69 4.5 18.59 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.168 0.587 . . . . 0.0 111.18 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 143' ' ' GLN . 5.0 t -79.04 35.91 0.27 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.303 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' B' 1094 ' ' PHE . . . -47.16 -97.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.217 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.1 tttp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.441 -179.574 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 55.9 tp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -77.31 145.88 37.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.494 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.52 ' C ' ' H ' ' B' 1090 ' ' GLN . 55.0 ttp180 60.96 41.12 14.57 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -63.78 3.83 1.33 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.52 ' H ' ' C ' ' B' 1088 ' ' ARG . 1.3 mp0 -62.34 -44.05 97.38 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1091 ' ' ILE . . . . . 0.477 HD11 ' NE ' ' B' 1088 ' ' ARG . 54.1 mt -54.68 -55.41 15.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.975 0.417 . . . . 0.0 111.784 -177.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 9.5 mt -56.16 -54.74 41.59 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.481 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 4.6 m95 -60.77 -57.86 10.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.681 0.753 . . . . 0.0 112.127 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1094 ' ' PHE . . . . . 0.513 ' CE2' ' OD1' ' B' 1098 ' ' ASN . 26.1 t80 -58.88 -45.51 90.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.224 -1.353 . . . . 0.0 114.55 -173.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -38.53 -52.65 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.61 -39.55 98.02 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.052 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1097 ' ' LEU . . . . . 0.55 HD11 ' OE1' ' A' ' 84' ' ' GLU . 46.7 tp -56.26 -42.44 77.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.54 1.17 . . . . 0.0 109.798 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1098 ' ' ASN . . . . . 0.513 ' OD1' ' CE2' ' B' 1094 ' ' PHE . 8.4 m-20 -56.92 -43.08 81.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.378 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -64.07 -36.92 85.58 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.26 -42.03 91.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.853 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1101 ' ' GLN . . . . . 0.48 ' CG ' ' OE2' ' A' ' 84' ' ' GLU . 41.8 mt-30 -50.78 -46.21 59.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.51 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.7 m -63.56 -48.19 78.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.99 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.44 ' C ' ' O ' ' B' 1102 ' ' THR . 84.2 mt-30 -27.55 -57.81 0.1 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.556 1.169 . . . . 0.0 112.715 -176.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.2 mt -84.8 -15.14 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 112.161 -2.29 . . . . 0.0 112.691 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.51 ' N ' ' O ' ' B' 1102 ' ' THR . 64.3 tttp -60.23 -44.8 94.89 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.003 -1.479 . . . . 0.0 107.899 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 73.3 t -61.31 -49.05 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1107 ' ' VAL . . . . . 0.408 HG13 ' H ' ' B' 1107 ' ' VAL . 1.3 m -66.41 -36.25 76.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.429 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 90.4 mttt -49.65 -39.21 35.37 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.53 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.86 -45.52 67.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.914 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1110 ' ' PHE . . . . . 0.489 ' CD2' HG21 ' A' ' 55' ' ' VAL . 46.4 m-85 -63.65 -49.68 72.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -68.19 -42.16 80.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.4 m 68.77 58.67 0.39 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.48 1.044 0 CA-C-N 123.57 2.895 . . . . 0.0 111.929 179.476 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.651 ' O ' ' OE1' ' A' ' 8' ' ' GLN . 90.5 m-20 -40.08 -80.3 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.499 ' O ' ' CB ' ' A' ' 4' ' ' LEU . 83.0 mt-30 -78.15 126.8 31.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.105 0.479 . . . . 0.0 110.916 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.499 ' CB ' ' O ' ' A' ' 3' ' ' GLN . 1.0 OUTLIER 155.58 -32.42 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.155 -178.31 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.3 m -75.21 139.26 42.5 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.271 0.941 . . . . 0.0 109.492 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 9' ' ' ILE . 10.3 tm-20 -48.47 -56.8 7.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.969 0.89 . . . . 0.0 110.473 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -34.59 -37.88 0.06 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.971 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.651 ' OE1' ' O ' ' A' ' 2' ' ' ASP . 81.3 mt-30 -69.34 -37.15 77.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.613 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' GLU . 63.8 mt -57.25 -47.6 83.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.29 -49.88 60.41 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.124 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -61.72 -46.85 87.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.099 0.476 . . . . 0.0 112.276 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -59.8 -41.01 90.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.949 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -51.46 -56.55 12.67 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.055 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.43 -45.19 55.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.007 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.26 -38.68 66.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.434 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.77 -40.54 80.04 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.9 m -65.05 -15.37 62.27 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.651 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.2 -41.04 94.92 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -105.96 -14.36 15.21 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.91 94.42 2.8 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.325 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -67.85 -51.85 43.6 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.181 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.6 p30 -100.84 15.73 27.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 37.17 51.98 1.65 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.108 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 26' ' ' THR . 12.3 p30 -88.33 -5.43 58.33 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.925 0.362 . . . . 0.0 111.079 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.93 -0.72 76.74 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.436 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 1.9 t -141.22 157.63 44.99 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.151 0.5 . . . . 0.0 110.49 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 27' ' ' ILE . 3.5 mp -90.52 123.99 42.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.8 p -111.21 161.46 15.96 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.28 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.413 HG22 HG13 ' A' ' 52' ' ' ILE . 21.5 p -59.84 -38.07 81.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.212 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -61.38 -59.28 5.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.325 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.72 -28.3 69.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.762 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.501 HD22 HD11 ' A' ' 52' ' ' ILE . 3.5 tp -61.67 -55.39 30.93 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.977 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.49 92.04 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.186 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -57.98 -55.4 35.39 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.052 1.426 . . . . 0.0 108.198 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.63 -46.56 72.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 118.798 0.727 . . . . 0.0 111.29 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.1 tpt -58.0 -39.86 79.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 120.38 1.445 . . . . 0.0 109.85 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -51.1 -33.55 26.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.346 0.593 . . . . 0.0 110.999 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.9 p -64.9 -20.01 66.22 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.85 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 1.5 mm? -76.27 3.24 11.25 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.143 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.92 27.58 40.84 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.279 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 9.1 tt0 -131.51 170.41 14.75 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.65 0.725 . . . . 0.0 109.469 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.409 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 16.1 m-20 -131.33 78.23 72.53 Favored Pre-proline 0 N--CA 1.466 0.351 0 CA-C-O 120.739 0.304 . . . . 0.0 110.217 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.07 147.03 96.87 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.698 2.265 . . . . 0.0 111.876 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.2 p -77.78 163.39 26.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.401 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.03 -45.43 90.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.721 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.1 -24.68 26.89 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.626 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -65.63 -40.16 92.25 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.662 -0.415 . . . . 0.0 109.989 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.1 mp -56.14 -41.7 75.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.382 0.611 . . . . 0.0 109.939 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -72.57 -56.02 6.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.682 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -55.76 -50.2 71.06 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.4 mmm -64.05 -50.61 67.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.501 HD11 HD22 ' A' ' 32' ' ' LEU . 26.4 mm -57.72 -45.11 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.77 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -55.44 -34.43 64.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -67.0 -40.94 87.45 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.071 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.477 HG12 HD12 ' A' ' 63' ' ' ILE . 42.2 t -85.99 -21.54 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.155 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.5 t0 -79.42 83.71 5.4 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -174.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.53 79.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.816 -1.538 . . . . 0.0 114.442 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.8 p-10 -85.71 -2.47 58.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.331 -0.547 . . . . 0.0 112.463 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.8 23.02 60.6 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.867 -0.521 . . . . 0.0 112.507 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.435 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -86.61 3.83 42.8 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.335 0.568 . . . . 0.0 110.565 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.521 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.15 2.01 89.45 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 118.657 0.662 . . . . 0.0 114.664 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.2 p -148.19 167.79 24.16 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.477 HD12 HG12 ' A' ' 55' ' ' VAL . 10.0 mm -110.06 127.38 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.228 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -102.57 -177.39 3.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.54 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.413 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -58.19 -46.3 99.67 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.191 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 33.3 Cg_exo -56.6 -52.62 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.393 1.395 . . . . 0.0 111.297 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' O ' ' SD ' ' A' ' 71' ' ' MET . 97.4 mt-10 -61.16 -18.91 60.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.26 0.553 . . . . 0.0 110.941 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -76.77 -59.11 2.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.814 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.8 mt -56.05 -47.41 77.94 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.1 t -46.39 -43.58 16.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.071 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 67' ' ' GLU . 39.5 mtp -66.92 -47.76 70.74 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.0 mmm -62.07 -40.71 96.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.13 -33.92 76.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.573 0.225 . . . . 0.0 111.463 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -91.99 -20.76 21.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 111.178 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.58 67.84 5.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.15 0.5 . . . . 0.0 110.178 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.2 mmt -107.81 15.83 24.15 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.578 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -48.33 132.98 16.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.311 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -89.85 107.6 19.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.964 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.491 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 3.2 m -93.64 120.42 33.89 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.5 m-20 -69.63 111.97 5.8 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 m -36.89 -20.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.864 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.6 mm-40 -68.26 -37.49 80.8 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.794 0.33 . . . . 0.0 111.615 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -48.65 -36.41 15.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.144 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -88.09 -16.55 33.23 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 85' ' ' ILE . 26.5 mm -61.96 -74.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.563 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 74.4 mtt85 -62.02 -41.35 97.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.86 -41.5 97.91 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.848 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.07 -17.97 55.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.817 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -72.69 -50.7 23.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -54.95 -42.13 71.94 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.5 t -65.1 -44.38 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.421 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.1 m-85 -69.33 -37.81 77.9 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.159 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -86.25 80.75 8.64 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.81 -48.91 78.37 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -90.59 4.99 49.73 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.264 -0.273 . . . . 0.0 111.351 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.17 47.19 50.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -90.27 7.03 40.35 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.75 0.31 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.33 2.02 89.25 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -140.68 153.42 45.97 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.636 0.731 . . . . 0.0 111.835 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -93.34 116.4 34.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.3 m -89.65 149.31 22.85 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.93 79.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.166 0.894 . . . . 0.0 110.683 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.19 -40.79 64.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.815 0.341 . . . . 0.0 110.673 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.12 -41.4 94.9 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.204 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.74 -45.73 88.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.233 0.54 . . . . 0.0 110.843 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -43.24 -44.44 5.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.857 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -64.82 -28.83 69.83 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.662 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.503 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 85.0 t -58.11 -41.82 81.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.134 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.626 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.27 -46.73 65.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.953 0.882 . . . . 0.0 111.705 -177.08 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 71.9 p -53.43 -35.89 60.93 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 113.771 -1.559 . . . . 0.0 110.882 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -68.51 -39.88 81.07 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.473 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.86 -13.29 59.06 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.45 30.45 60.31 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -87.68 -24.67 23.81 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.681 2.241 . . . . 0.0 110.779 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 45.25 64.39 1.42 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.713 0.768 . . . . 0.0 110.155 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.3 mt -80.5 148.13 30.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.374 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 121' ' ' VAL . 30.5 p -82.07 174.61 11.07 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.693 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -57.2 -45.83 83.44 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.16 -47.81 77.51 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -71.96 -30.36 65.2 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.588 -0.445 . . . . 0.0 112.108 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 117' ' ' THR . 42.5 t -65.04 -42.69 95.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -70.61 -34.98 72.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.099 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -59.99 -49.12 78.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.041 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 29.8 mmm -52.46 -47.37 66.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.023 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 40.7 mm -57.44 -44.33 84.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.695 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -58.0 -40.23 80.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.89 0.376 . . . . 0.0 111.394 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -57.98 -40.82 81.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.056 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.89 -17.94 24.5 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.716 0.293 . . . . 0.0 111.645 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.2 t0 -73.83 89.56 1.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.436 0.636 . . . . 0.0 111.816 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 80.1 mt -70.73 -17.63 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.063 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.9 p-10 -141.59 145.55 35.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.743 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.45 52.27 1.48 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.76 -0.257 . . . . 0.0 113.117 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -90.66 -9.16 47.91 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.023 0.412 . . . . 0.0 110.219 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.0 1.89 75.43 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.961 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -134.75 154.33 51.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.234 0.517 . . . . 0.0 110.39 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.76 118.58 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.038 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -84.26 174.71 9.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.775 0.321 . . . . 0.0 110.924 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -61.62 -40.03 93.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.095 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.96 -44.66 95.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.54 -38.5 89.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.733 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -60.82 -44.38 96.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.139 0.495 . . . . 0.0 110.807 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.22 -46.42 87.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.233 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -48.43 -45.56 36.51 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.164 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 88.1 mmm -74.68 -38.3 62.45 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 18.6 mmt -72.8 -46.55 52.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 m -87.53 32.39 0.72 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.66 0.267 . . . . 0.0 111.441 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.14 96.65 10.44 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.683 0.278 . . . . 0.0 110.893 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.8 pttp . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.079 -0.963 . . . . 0.0 110.608 179.759 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B 1086 ' ' LEU . . . . . 0.481 ' C ' HD12 ' B' 1086 ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1087 ' ' ARG . . . . . 0.445 ' N ' HD12 ' B' 1086 ' ' LEU . 10.5 tpp85 -76.8 138.02 39.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.539 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.557 ' C ' ' H ' ' B' 1090 ' ' GLN . 2.5 mpp_? -82.08 97.1 8.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -53.2 -5.78 0.32 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.557 ' H ' ' C ' ' B' 1088 ' ' ARG . 73.0 mt-30 -63.84 -50.13 70.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.859 0.361 . . . . 0.0 111.484 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 58.8 mt -58.56 -50.94 77.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.204 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 14.4 mt -55.42 -61.95 2.0 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.349 -0.54 . . . . 0.0 112.021 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.72 -54.55 41.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.265 0.555 . . . . 0.0 112.029 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 37.9 t80 -57.97 -46.08 85.69 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -42.16 -52.01 4.47 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.49 -42.11 99.69 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.162 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.55 -46.1 80.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.391 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.21 -48.73 79.45 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.26 -38.17 90.1 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.96 -42.16 91.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.795 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -51.3 -46.42 62.51 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.517 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.8 m -63.38 -48.45 77.82 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.422 ' C ' ' O ' ' B' 1102 ' ' THR . 84.5 mt-30 -27.31 -60.2 0.1 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.603 1.192 . . . . 0.0 112.741 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -82.01 -14.59 12.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 112.67 -2.059 . . . . 0.0 112.344 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.517 ' N ' ' O ' ' B' 1102 ' ' THR . 65.8 tttm -57.69 -43.34 85.06 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 117.874 -1.53 . . . . 0.0 108.059 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.8 t -61.88 -47.04 95.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.55 0.69 . . . . 0.0 112.818 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 65.8 t -65.38 -41.18 90.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.097 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1108 ' ' LYS . . . . . 0.491 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 96.1 mttt -49.03 -38.14 22.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.396 0.617 . . . . 0.0 109.634 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -54.09 -46.91 72.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.343 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1110 ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 55' ' ' VAL . 54.8 m-85 -62.35 -49.81 74.07 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -68.84 -40.55 79.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.2 t 66.81 59.25 0.58 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 116.781 -1.581 . . . . 0.0 107.741 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 25.8 p . . . . . 0 N--CA 1.47 0.544 0 CA-C-N 124.194 3.179 . . . . 0.0 111.897 179.377 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.42 ' OD2' ' HB1' ' A' ' 73' ' ' ALA . 58.5 m-20 56.99 27.84 13.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.395 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 168.08 88.77 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.993 0.808 . . . . 0.0 109.325 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.17 -25.3 14.06 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.065 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.8 p -80.64 137.83 36.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.461 1.028 . . . . 0.0 110.454 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' A' ' 7' ' ' GLU . 18.0 pt-20 -52.65 -50.06 63.95 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.123 0.963 . . . . 0.0 110.893 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.507 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 43.4 tp10 -36.44 -38.13 0.15 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.033 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -70.63 -35.34 72.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.66 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.1 mt -58.92 -45.6 91.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 175.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.59 -49.02 62.95 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.08 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.26 -47.88 83.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.225 0.535 . . . . 0.0 112.083 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.426 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 10.0 m-85 -60.58 -41.96 95.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.988 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -49.52 -59.5 3.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.367 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -47.62 -42.5 24.4 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.414 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -55.6 -39.15 70.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.294 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -56.91 -41.52 78.29 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 m -65.09 -13.43 58.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.387 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.44 -43.47 97.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -106.73 -13.21 15.33 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -76.05 94.04 3.39 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.073 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -68.33 -46.7 69.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.41 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.7 p-10 -102.77 14.17 32.62 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.62 49.67 1.35 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.018 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -87.06 -5.01 59.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.944 0.372 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.02 -2.05 81.19 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.6 p -137.32 151.61 48.83 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.143 0.496 . . . . 0.0 110.307 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.8 mp -93.34 125.24 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -114.1 165.04 13.05 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.671 0.748 . . . . 0.0 112.575 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.426 HG22 HG13 ' A' ' 52' ' ' ILE . 21.6 p -58.85 -35.34 72.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.823 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -61.25 -61.89 2.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.158 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.12 -29.54 70.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.773 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.549 HD22 HD11 ' A' ' 52' ' ' ILE . 2.8 tp -60.57 -56.77 17.31 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.123 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.66 -39.18 93.12 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.107 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.9 m -58.26 -54.65 44.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.05 1.425 . . . . 0.0 108.517 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -55.63 -47.04 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.014 -0.675 . . . . 0.0 111.674 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -58.65 -41.04 85.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 120.143 1.338 . . . . 0.0 110.085 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -51.97 -40.06 60.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.434 0.635 . . . . 0.0 110.351 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 23.0 t -63.57 -20.74 65.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.041 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 tp -73.91 -2.16 22.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.744 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.17 13.44 63.98 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.308 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -106.67 156.44 18.62 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.537 0.669 . . . . 0.0 110.045 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -115.67 63.44 2.07 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.376 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.07 144.2 92.15 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.244 1.962 . . . . 0.0 112.192 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.8 p -80.46 166.63 21.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.393 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -57.37 -44.63 84.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.13 -23.71 22.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.636 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -65.9 -39.4 90.59 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.147 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.48 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.2 mp -56.84 -42.34 79.49 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.311 0.577 . . . . 0.0 109.779 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -70.97 -57.07 4.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.851 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -54.95 -48.76 72.78 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 42.7 mmm -65.68 -50.64 64.19 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.549 HD11 HD22 ' A' ' 32' ' ' LEU . 26.4 mm -58.32 -47.13 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.789 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -55.68 -34.53 65.12 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -66.28 -39.82 89.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.86 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.416 HG21 ' CE2' ' B' 1110 ' ' PHE . 39.3 t -87.22 -20.09 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.388 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.0 t0 -78.1 85.61 4.29 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.2 85.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.541 -1.663 . . . . 0.0 114.359 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.7 p-10 -86.65 -2.48 58.55 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.16 23.28 61.74 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 118.452 0.569 . . . . 0.0 112.597 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.438 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.1 p-10 -87.21 2.85 48.75 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.294 0.547 . . . . 0.0 110.568 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.44 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.6 1.92 89.0 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.3 p -148.14 168.55 22.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.4 mt -112.69 128.4 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 43.9 t0 -103.59 -175.51 2.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.647 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.515 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -56.31 -56.88 26.86 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -177.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 9.9 Cg_endo -50.26 -49.54 16.07 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 CA-C-N 120.522 1.222 . . . . 0.0 111.673 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -62.04 -18.85 61.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.262 0.553 . . . . 0.0 110.753 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -75.56 -58.81 3.06 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.748 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.9 mt -56.1 -45.24 79.52 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.8 m -44.05 -50.28 8.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.513 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 74.5 mtm -66.05 -43.93 86.04 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.48 ' O ' ' CE ' ' A' ' 76' ' ' MET . 15.2 mmt -57.52 -37.54 73.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.42 ' HB1' ' OD2' ' A' ' 2' ' ' ASP . . . -70.63 -35.23 72.83 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -93.76 -17.25 23.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 111.727 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.31 68.11 5.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.213 0.53 . . . . 0.0 110.456 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.48 ' CE ' ' O ' ' A' ' 72' ' ' MET . 24.3 mmt -108.81 15.47 23.54 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.608 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -52.89 131.62 35.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.637 0.732 . . . . 0.0 111.706 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -132.07 143.95 50.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.372 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.504 ' O ' ' CB ' ' A' ' 80' ' ' ASP . 35.8 p -127.14 -45.14 1.56 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 82' ' ' GLU . 99.8 m-20 126.15 134.84 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 125.357 1.66 . . . . 0.0 109.62 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.1 m -37.61 -17.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.212 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.9 mm-40 -68.51 -37.22 79.87 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.855 0.359 . . . . 0.0 111.653 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -47.67 -36.14 10.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.312 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -89.57 -16.73 29.97 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.064 0.459 . . . . 0.0 111.916 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 85' ' ' ILE . 26.3 mm -61.1 -74.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.541 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -61.58 -41.63 97.69 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.63 -41.01 94.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.587 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.36 -19.53 61.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.118 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -72.57 -51.26 20.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.841 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.95 -42.28 72.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.678 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.92 -43.88 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.0 m-85 -68.86 -38.04 79.47 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.916 -0.313 . . . . 0.0 111.471 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -90.71 83.39 5.76 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.85 -44.65 96.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -90.53 4.32 51.5 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 122.179 -0.326 . . . . 0.0 111.584 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.18 48.71 46.23 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -91.45 6.25 46.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.676 0.274 . . . . 0.0 110.402 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.11 0.14 90.08 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -137.94 151.91 48.43 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.611 0.72 . . . . 0.0 111.454 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.14 115.28 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 92.1 p -91.53 154.58 19.0 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.91 -48.24 78.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 119.024 0.829 . . . . 0.0 111.071 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.52 -41.44 61.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.998 0.428 . . . . 0.0 110.594 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.67 -41.2 92.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.894 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 108' ' ' VAL . 9.2 tp -63.56 -46.7 84.72 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.974 -0.454 . . . . 0.0 111.22 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -44.25 -35.99 2.53 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.943 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -66.8 -26.7 67.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.033 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.582 HG21 ' CE2' ' A' ' 92' ' ' PHE . 83.0 t -58.19 -43.13 85.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.798 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.9 mtp -50.13 -47.24 54.23 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.901 0.858 . . . . 0.0 111.781 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 m -58.1 -41.64 83.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.682 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 38' ' ' SER . 2.9 m-80 -66.13 -41.81 89.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.823 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.6 mt -81.46 -15.47 54.93 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.86 30.18 61.94 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -86.06 -24.26 26.41 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.957 2.379 . . . . 0.0 110.691 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 45.57 60.08 3.28 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.689 0.756 . . . . 0.0 110.457 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.2 148.38 32.28 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.938 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 121' ' ' VAL . 80.7 p -82.12 174.69 10.98 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.344 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -57.89 -45.47 86.37 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.92 -49.95 74.03 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.584 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -68.52 -29.58 68.2 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.955 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 117' ' ' THR . 39.7 t -63.84 -41.51 92.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -66.65 -36.99 83.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.102 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -59.43 -53.32 59.5 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -44.64 76.6 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.334 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.48 -44.32 92.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.027 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -60.05 -38.56 83.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.829 0.347 . . . . 0.0 111.292 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.12 -41.76 84.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.25 -22.11 21.78 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.811 0.338 . . . . 0.0 111.687 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.7 t0 -73.7 87.69 1.7 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.33 0.586 . . . . 0.0 112.014 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.6 tp -69.3 -15.77 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 122.611 1.196 . . . . 0.0 113.495 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.6 p-10 -142.44 145.43 33.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.111 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.58 52.59 1.54 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.576 -0.345 . . . . 0.0 113.12 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -90.88 -9.25 46.96 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.089 0.445 . . . . 0.0 110.076 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.88 1.7 73.92 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.984 -0.627 . . . . 0.0 114.133 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -134.54 154.48 51.43 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.372 0.586 . . . . 0.0 110.202 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.9 t -100.39 118.47 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.438 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -84.0 173.87 10.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.787 0.327 . . . . 0.0 110.844 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -61.76 -39.41 91.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.018 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.29 -44.75 94.13 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.878 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.83 -38.69 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.591 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.64 -44.66 96.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.859 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.19 -47.01 89.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.4 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -49.37 -44.54 44.97 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.25 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.1 mmm -75.44 -39.31 59.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.6 mmt -74.36 -48.04 30.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.605 -0.146 . . . . 0.0 110.605 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 p -89.27 33.47 0.81 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.686 0.279 . . . . 0.0 111.591 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.04 85.57 4.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.789 0.328 . . . . 0.0 111.156 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.351 179.732 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -75.72 153.28 37.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.733 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.574 ' C ' ' H ' ' B' 1090 ' ' GLN . 21.9 ttm180 65.43 40.84 4.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.868 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -60.14 3.86 0.27 Allowed Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.574 ' H ' ' C ' ' B' 1088 ' ' ARG . 84.8 mt-30 -60.5 -45.06 95.16 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.664 0.268 . . . . 0.0 111.602 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 59.6 mt -57.43 -51.9 63.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.025 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.2 mt -57.22 -62.22 1.92 Allowed 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.244 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.0 m95 -59.99 -57.63 12.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.402 0.62 . . . . 0.0 112.077 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 41.5 t80 -57.54 -44.96 85.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -40.82 -51.11 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.57 99.7 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.514 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 46.0 tp -56.11 -46.24 79.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.517 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 65.8 t30 -59.21 -49.28 78.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -65.22 -38.4 90.32 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 88.0 mt -60.79 -42.33 91.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.71 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -50.25 -44.73 53.67 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.519 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.0 m -63.6 -48.39 77.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.416 ' C ' ' O ' ' B' 1102 ' ' THR . 89.3 mt-30 -27.57 -60.18 0.1 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.738 1.256 . . . . 0.0 112.747 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.1 mt -82.43 -14.8 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 112.33 -2.214 . . . . 0.0 111.968 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.519 ' N ' ' O ' ' B' 1102 ' ' THR . 17.3 ttmm -59.1 -45.04 91.91 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 117.845 -1.542 . . . . 0.0 107.937 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.2 t -60.78 -49.26 85.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.97 -36.35 77.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.305 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.0 mttt -49.35 -38.15 27.2 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.641 -0.662 . . . . 0.0 109.659 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.19 -45.99 68.81 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.341 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1110 ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 55' ' ' VAL . 47.8 m-85 -62.87 -49.8 73.41 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -68.84 -40.96 79.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.2 t 67.48 59.26 0.5 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 116.906 -1.521 . . . . 0.0 107.743 -177.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 22.6 p . . . . . 0 N--CA 1.471 0.581 0 CA-C-N 124.105 3.138 . . . . 0.0 111.811 179.396 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -79.17 -5.0 53.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.995 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.453 ' NE2' ' CZ ' ' A' ' 12' ' ' PHE . 73.4 mt-30 -98.86 98.08 9.21 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.419 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.4 mt -113.44 -17.24 12.28 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.872 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.6 p -79.33 135.98 36.88 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.371 0.987 . . . . 0.0 110.36 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ILE . 48.6 tp10 -51.94 -55.43 20.33 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.97 0.891 . . . . 0.0 110.467 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -34.8 -36.33 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.773 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -70.1 -33.96 72.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.598 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.4 mm -59.2 -45.42 92.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.52 -51.36 59.96 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.383 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.92 -46.64 89.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.422 0.629 . . . . 0.0 112.221 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.453 ' CZ ' ' NE2' ' A' ' 3' ' ' GLN . 2.2 m-85 -62.81 -38.86 92.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.771 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -52.59 -53.67 43.57 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.177 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.85 -41.27 61.7 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.041 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -55.95 -37.88 69.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.355 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.61 -41.76 81.9 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 t -64.6 -14.85 59.77 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.476 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.97 -42.78 97.16 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -106.14 -13.82 15.33 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -76.4 95.09 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.422 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -68.35 -46.89 68.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.227 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 23' ' ' GLY . 35.4 p30 -101.89 14.17 32.71 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.02 46.47 0.94 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.031 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -85.77 -4.17 59.09 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.898 0.38 . . . . 0.0 111.044 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.69 80.79 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.9 p -137.64 152.09 48.98 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.078 0.466 . . . . 0.0 110.068 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.12 124.51 44.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.8 p -112.51 163.4 14.52 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.521 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.428 HG22 HG13 ' A' ' 52' ' ' ILE . 18.7 p -59.42 -36.62 76.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.052 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -61.73 -59.58 4.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.317 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.82 -28.92 70.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.558 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.521 HD22 HD11 ' A' ' 52' ' ' ILE . 3.1 tp -61.17 -54.41 44.73 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.461 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.53 -38.36 93.5 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.192 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.36 -53.92 52.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.835 1.318 . . . . 0.0 108.729 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.7 t -56.2 -45.92 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 O-C-N 121.341 -0.85 . . . . 0.0 111.223 -176.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 ttt -58.76 -38.98 79.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 120.157 1.344 . . . . 0.0 109.946 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -52.48 -40.41 62.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 110.725 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.2 p -63.08 -20.83 65.72 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.037 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.79 -1.43 19.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.805 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.0 23.97 39.44 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.389 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -125.76 166.81 16.12 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 117.369 0.585 . . . . 0.0 109.669 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 14.1 p30 -131.38 76.75 75.17 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.461 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -63.87 148.85 91.69 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.941 2.427 . . . . 0.0 112.175 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.4 p -79.03 165.2 23.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.115 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -58.71 -45.0 90.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.85 -24.73 53.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.876 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -64.53 -40.92 96.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.139 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.5 mp -54.18 -38.79 65.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.222 0.534 . . . . 0.0 109.707 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -72.74 -55.34 6.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.797 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -54.68 -50.44 68.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 73.2 mtp -66.87 -49.35 65.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.521 HD11 HD22 ' A' ' 32' ' ' LEU . 27.6 mm -59.01 -47.78 88.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.769 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -57.33 -32.85 67.13 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -67.35 -40.25 85.83 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.8 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.12 -21.03 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.171 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.47 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.5 t0 -78.27 86.06 4.39 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -174.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.1 81.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 113.427 -1.715 . . . . 0.0 114.184 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -86.47 -2.46 58.47 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.52 23.17 60.17 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 118.543 0.611 . . . . 0.0 112.707 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -87.47 4.72 42.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.205 0.503 . . . . 0.0 110.54 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.47 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.32 1.17 89.49 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.737 -0.602 . . . . 0.0 114.599 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.5 p -148.35 168.42 22.64 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.4 mt -112.91 128.67 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 45.7 t0 -104.03 -174.57 2.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.604 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.527 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -57.12 -57.21 26.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 10.4 Cg_endo -50.47 -49.86 15.32 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 CA-C-N 120.541 1.229 . . . . 0.0 111.569 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.89 -18.59 60.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.273 0.559 . . . . 0.0 110.72 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -73.47 -57.59 3.89 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.123 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' THR . 78.3 mt -57.74 -45.27 86.06 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 53.6 m -38.59 -64.57 0.42 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.749 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.487 ' SD ' ' N ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -63.17 -42.03 99.32 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.487 ' N ' ' SD ' ' A' ' 71' ' ' MET . 97.9 mmm -58.73 -40.69 84.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.02 -33.51 76.21 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 122.395 0.278 . . . . 0.0 111.022 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -95.21 -10.22 31.03 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.112 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.4 65.85 8.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.974 0.416 . . . . 0.0 110.375 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.5 mmt -108.24 16.22 23.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.569 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -49.1 133.34 18.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.394 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -90.75 106.86 18.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.968 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.454 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 15.7 m -91.8 120.18 32.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.6 m-20 -68.74 112.71 5.64 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.4 m -37.42 -20.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.768 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 80' ' ' ASP . 94.9 mt-10 -68.13 -39.8 82.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.733 0.302 . . . . 0.0 111.648 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -46.93 -35.32 6.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -87.71 -19.4 27.67 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.954 0.407 . . . . 0.0 111.78 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 85' ' ' ILE . 30.4 mm -61.04 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.735 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -61.47 -41.2 96.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.05 -40.54 94.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.5 -178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.05 -20.5 64.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -71.57 -51.6 22.58 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.03 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -54.8 -42.34 71.7 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.347 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.73 -43.74 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.526 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.5 m-85 -68.89 -39.07 79.95 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.326 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -85.3 81.09 8.93 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -57.63 -49.46 76.37 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -91.85 4.82 52.03 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 122.181 -0.324 . . . . 0.0 111.42 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.76 48.31 50.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -90.37 6.34 43.57 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.739 0.304 . . . . 0.0 110.715 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.19 2.1 88.1 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -142.34 155.99 45.21 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.487 0.66 . . . . 0.0 111.463 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.0 mt -93.57 114.93 31.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 t -88.98 150.98 22.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.47 78.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 119.085 0.857 . . . . 0.0 110.815 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.21 -40.08 61.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.942 0.401 . . . . 0.0 110.419 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.37 -42.11 88.47 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.69 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.8 tp -62.84 -47.16 84.6 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.249 0.547 . . . . 0.0 111.079 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -43.01 -43.31 4.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.652 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -64.23 -28.63 69.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.005 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.526 HG21 ' CE2' ' A' ' 92' ' ' PHE . 92.9 t -57.78 -42.38 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.602 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.624 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -50.96 -44.12 60.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.699 0.761 . . . . 0.0 111.253 -177.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 m -56.28 -40.91 75.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.781 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -65.51 -41.02 93.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.79 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.8 mt -81.82 -13.77 57.23 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.905 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.2 31.36 59.55 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -85.31 -22.63 28.45 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.55 2.175 . . . . 0.0 111.286 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 44.16 60.93 2.55 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.71 0.767 . . . . 0.0 109.675 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.432 HD12 ' CG ' ' A' ' 109' ' ' MET . 88.9 mt -80.7 148.23 30.24 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 113.527 -1.67 . . . . 0.0 112.462 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 121' ' ' VAL . 65.4 p -82.85 175.5 10.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.3 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 119' ' ' GLU . 18.9 p-10 -58.41 -43.99 88.87 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 176.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.491 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 67.5 mm-40 -57.85 -49.16 77.6 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -70.87 -30.3 66.64 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.627 -0.429 . . . . 0.0 112.039 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 117' ' ' THR . 40.7 t -63.97 -41.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.6 0.714 . . . . 0.0 109.1 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -70.78 -35.6 72.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.339 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.41 -51.33 69.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 37.9 mmm -55.98 -44.62 78.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.253 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.96 -43.49 88.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.404 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -60.73 -35.22 75.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.848 0.356 . . . . 0.0 111.153 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.453 ' OE1' ' NH2' ' B' 1087 ' ' ARG . 38.5 tp10 -59.45 -41.36 89.5 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.938 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.95 -20.51 22.09 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 21.4 t0 -73.09 89.05 1.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.528 0.68 . . . . 0.0 111.706 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 76.4 mt -70.08 -16.35 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.021 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 49.1 p-10 -140.48 144.82 36.25 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 112.644 -2.071 . . . . 0.0 108.805 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.27 52.17 1.41 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.899 -0.191 . . . . 0.0 113.154 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 22.0 p-10 -91.24 -8.84 47.29 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.966 0.383 . . . . 0.0 110.057 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.86 3.17 79.64 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.117 -0.564 . . . . 0.0 114.125 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -136.09 155.2 50.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.444 0.622 . . . . 0.0 110.383 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.9 t -101.56 119.01 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.207 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -84.79 175.64 9.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.597 0.237 . . . . 0.0 110.89 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -61.64 -41.12 97.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.306 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -61.61 -45.0 95.93 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.704 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.59 -38.0 88.25 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.668 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 90.9 t80 -58.57 -44.64 89.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.999 0.428 . . . . 0.0 110.796 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.03 -46.13 88.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.411 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -48.35 -44.58 34.49 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.03 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 77.3 mmm -75.73 -36.48 59.92 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.585 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.6 mmt -65.96 -50.98 62.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 147' ' ' ALA . 6.7 m -85.67 -124.65 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.08 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.428 ' N ' HG22 ' A' ' 146' ' ' THR . . . -94.04 139.1 31.38 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.673 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.9 tttm . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.748 -179.936 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B 1086 ' ' LEU . . . . . 0.53 HD12 ' N ' ' B' 1086 ' ' LEU . 10.4 mp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1087 ' ' ARG . . . . . 0.453 ' NH2' ' OE1' ' A' ' 127' ' ' GLU . 84.0 mtp180 -64.06 -40.42 96.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.364 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.533 ' C ' ' H ' ' B' 1090 ' ' GLN . 43.8 ttt-85 40.45 48.65 2.49 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -61.86 2.69 0.86 Allowed Glycine 0 CA--C 1.529 0.967 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.533 ' H ' ' C ' ' B' 1088 ' ' ARG . 77.7 mt-30 -61.43 -49.78 75.48 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1091 ' ' ILE . . . . . 0.667 HD12 ' H ' ' B' 1092 ' ' LEU . 0.6 OUTLIER -51.21 -56.94 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.064 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B 1092 ' ' LEU . . . . . 0.667 ' H ' HD12 ' B' 1091 ' ' ILE . 9.3 mt -49.53 -55.36 13.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -175.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.8 m95 -63.4 -47.29 82.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1094 ' ' PHE . . . . . 0.532 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 2.4 m-85 -58.02 -46.3 85.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -40.51 -53.46 2.67 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.85 -42.11 99.71 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.129 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 50.8 tp -56.85 -44.6 82.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.217 1.008 . . . . 0.0 109.592 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -58.8 -47.6 84.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -65.06 -37.46 87.63 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.12 -42.43 93.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.772 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -50.83 -45.88 59.74 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 118.863 -1.135 . . . . 0.0 108.039 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.527 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.8 m -63.64 -48.22 78.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.434 -0.506 . . . . 0.0 112.152 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.429 ' C ' ' O ' ' B' 1102 ' ' THR . 84.3 mt-30 -27.79 -57.78 0.11 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 122.457 1.122 . . . . 0.0 112.451 -176.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1104 ' ' ILE . . . . . 0.404 HG21 HD13 ' B' 1104 ' ' ILE . 1.5 mt -83.98 -14.45 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.365 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.527 ' N ' ' O ' ' B' 1102 ' ' THR . 65.7 tttm -59.72 -46.28 89.59 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 118.152 -1.419 . . . . 0.0 107.972 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 86.2 t -61.08 -49.31 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.64 -35.97 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.329 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1108 ' ' LYS . . . . . 0.454 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 88.8 mttt -49.31 -37.75 25.28 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.646 0.657 . . . . 0.0 109.641 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.59 -45.91 66.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.295 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -62.9 -50.23 71.7 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -67.81 -41.81 82.53 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.3 m 68.24 58.01 0.46 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 117.209 -1.377 . . . . 0.0 107.414 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 47.6 p . . . . . 0 N--CA 1.476 0.87 0 CA-C-N 123.78 2.991 . . . . 0.0 111.846 179.608 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 92.6 m-20 -62.62 -40.62 97.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.966 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.472 ' CD ' ' O ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER 157.68 99.97 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.37 -16.7 10.85 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.166 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.7 m -81.07 136.43 35.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.093 0.861 . . . . 0.0 110.366 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.1 tt0 -51.01 -58.84 5.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.795 0.807 . . . . 0.0 110.991 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -33.8 -38.64 0.05 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.855 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -68.86 -35.06 76.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.49 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.6 mt -58.32 -45.11 89.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.55 -51.28 63.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.097 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -59.82 -48.27 82.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.283 0.564 . . . . 0.0 112.384 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -61.37 -40.4 94.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.952 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -51.63 -56.9 10.93 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.734 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.35 -43.65 23.26 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.462 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.82 -39.04 65.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.987 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -56.92 -42.37 79.86 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -64.25 -15.49 60.2 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.056 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.96 -41.34 95.56 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -105.99 -13.65 15.42 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -74.4 95.84 2.77 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.565 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -68.86 -49.46 58.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.111 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.0 p-10 -101.84 15.76 28.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 33.87 47.82 0.51 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.035 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 33.9 p-10 -85.24 -5.18 59.34 Favored 'General case' 0 N--CA 1.461 0.106 0 O-C-N 122.69 -0.3 . . . . 0.0 111.038 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.72 -1.93 79.3 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.0 p -138.25 153.89 49.08 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.693 ' N ' HD12 ' A' ' 27' ' ' ILE . 2.0 mp -93.0 125.46 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.519 HG22 ' OE1' ' A' ' 31' ' ' GLU . 10.0 t -116.86 166.37 12.24 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.421 HG22 HG13 ' A' ' 52' ' ' ILE . 37.5 p -56.79 -32.45 65.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.407 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -59.78 -63.61 1.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.298 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' OE1' HG22 ' A' ' 28' ' ' THR . 4.7 pt-20 -62.54 -30.49 71.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 119.326 -0.369 . . . . 0.0 111.882 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.404 HD22 HD11 ' A' ' 52' ' ' ILE . 4.1 tp -58.25 -61.3 2.67 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 118.821 -1.151 . . . . 0.0 108.69 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.19 72.96 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.098 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.8 m -56.67 -53.64 55.4 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.782 1.791 . . . . 0.0 108.431 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.71 -45.64 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 119.196 0.907 . . . . 0.0 111.563 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.417 ' SD ' HD12 ' A' ' 39' ' ' LEU . 9.2 tpt -58.2 -41.69 84.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 120.355 1.434 . . . . 0.0 109.698 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -52.3 -39.85 61.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.506 0.67 . . . . 0.0 111.32 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 t -62.96 -20.52 65.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.706 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.417 HD12 ' SD ' ' A' ' 36' ' ' MET . 80.4 mt -74.98 2.21 11.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.167 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.1 26.81 47.29 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.978 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -125.8 166.65 16.45 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 117.41 0.605 . . . . 0.0 109.91 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -124.11 81.07 57.63 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.23 146.76 52.02 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.802 1.668 . . . . 0.0 112.204 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -80.29 163.19 24.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.84 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -58.02 -44.48 87.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.097 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.74 -24.49 35.42 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.771 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -65.25 -40.62 94.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.895 0.378 . . . . 0.0 110.657 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 6.8 mp -56.2 -41.05 74.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.638 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -70.01 -56.93 5.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.826 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -55.27 -49.69 71.43 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.5 mtp -66.21 -51.4 58.04 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.421 HG13 HG22 ' A' ' 29' ' ' THR . 25.7 mm -57.64 -49.18 81.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -56.15 -32.57 64.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -67.26 -40.39 86.22 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.868 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.7 t -86.27 -20.32 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.425 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.404 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 43.5 t0 -78.69 83.64 4.83 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -174.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.7 75.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 113.595 -1.639 . . . . 0.0 114.748 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.454 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 26.1 p30 -88.61 -1.66 58.18 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.17 23.84 60.22 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 118.664 0.666 . . . . 0.0 112.95 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.627 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -87.52 2.97 49.21 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 117.42 0.61 . . . . 0.0 110.368 179.316 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.18 1.73 86.2 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 114.831 0.692 . . . . 0.0 114.831 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.627 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 19.2 p -147.66 169.65 19.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -112.22 128.17 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.097 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -102.46 -178.99 3.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.761 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.96 99.78 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -54.13 -51.83 9.73 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.071 1.181 . . . . 0.0 111.978 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.24 -23.19 66.53 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.388 0.613 . . . . 0.0 111.269 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -71.18 -61.11 1.89 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.514 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.5 mt -56.69 -43.81 80.85 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.1 p -44.0 -51.72 7.56 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.605 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.0 mtm -64.9 -44.65 88.9 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.6 mmm -61.23 -41.06 96.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.91 79.31 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.415 0.286 . . . . 0.0 111.623 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -91.91 -16.25 26.91 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.722 0.296 . . . . 0.0 111.331 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 27.8 tptp -80.49 71.62 7.34 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.819 0.819 . . . . 0.0 110.631 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 20.6 mmt -109.5 15.35 23.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.255 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -47.77 131.27 14.88 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.237 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -89.28 109.62 20.49 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.927 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.518 HG21 ' NZ ' ' B' 1108 ' ' LYS . 17.2 p -97.98 114.79 27.02 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -64.99 115.5 5.46 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 62.6 m -37.44 -21.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.845 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 80' ' ' ASP . 42.5 tp10 -68.26 -35.86 78.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.028 0.442 . . . . 0.0 111.707 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 80.2 tt0 -49.6 -37.2 26.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.341 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -87.35 -16.3 35.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.128 0.49 . . . . 0.0 111.701 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 85' ' ' ILE . 29.5 mm -62.57 -73.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.735 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -60.39 -44.21 95.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 87' ' ' GLU . 7.1 mp0 -61.05 -41.29 96.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.364 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.5 -17.84 47.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.188 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -75.15 -49.67 18.79 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.476 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -55.4 -42.94 74.76 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.932 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.9 t -65.13 -44.12 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.488 ' CE2' HG21 ' A' ' 108' ' ' VAL . 8.0 m-85 -69.82 -38.16 76.47 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.635 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.561 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 31.4 t0 -88.32 82.59 7.01 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.12 -48.59 78.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 40.7 p-10 -91.65 5.47 49.56 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.1 50.13 40.56 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.741 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -92.62 5.11 52.17 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.416 0.287 . . . . 0.0 110.818 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.465 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 85.25 0.21 88.61 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.741 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 87.0 m-85 -138.74 152.12 47.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.944 0.878 . . . . 0.0 111.887 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 95.8 mt -94.79 117.37 38.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.1 m -89.46 148.12 23.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.529 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.29 -48.03 74.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 119.66 1.118 . . . . 0.0 110.17 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.38 -42.61 53.71 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.75 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.91 -41.05 97.78 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.34 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.33 -45.28 92.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.552 0.691 . . . . 0.0 111.203 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 74.5 ttp85 -44.28 -44.94 8.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.551 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -63.63 -31.33 72.47 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.331 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.488 HG21 ' CE2' ' A' ' 92' ' ' PHE . 84.5 t -56.05 -42.15 71.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.004 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.736 ' SD ' HD12 ' A' ' 116' ' ' LEU . 16.0 mmt -51.31 -44.38 61.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.795 0.807 . . . . 0.0 111.222 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 m -53.76 -42.03 67.81 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.952 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -66.4 -41.17 89.72 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.521 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.31 -16.03 53.65 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.08 30.39 59.15 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-O 118.258 -1.301 . . . . 0.0 110.546 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -85.66 -22.27 27.98 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.341 2.571 . . . . 0.0 110.982 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 43.76 60.42 2.69 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 122.18 0.99 . . . . 0.0 110.056 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.736 HD12 ' SD ' ' A' ' 109' ' ' MET . 40.4 mt -80.49 147.24 30.97 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.64 -1.618 . . . . 0.0 111.799 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 121' ' ' VAL . 28.5 p -82.14 174.89 10.78 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -56.55 -44.98 81.45 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -57.7 -47.25 82.89 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.594 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -73.22 -30.18 63.31 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.762 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 117' ' ' THR . 44.5 t -64.68 -41.71 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.463 0.649 . . . . 0.0 109.864 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 67.7 t0 -73.45 -34.8 65.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.291 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -59.5 -50.01 75.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.934 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.0 mtp -53.58 -46.6 70.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.285 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.8 mm -56.41 -43.54 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -60.1 -36.5 77.56 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.288 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -58.68 -41.18 85.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.846 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.91 -17.16 25.61 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.8 t0 -72.54 90.74 1.36 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.737 0.78 . . . . 0.0 112.213 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.405 ' O ' HG22 ' A' ' 130' ' ' ILE . 79.3 mt -71.74 -17.63 19.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.158 -1.383 . . . . 0.0 113.123 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 50.4 p-10 -142.72 144.28 32.62 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 112.65 -2.068 . . . . 0.0 108.813 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.41 53.82 1.53 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.129 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -90.85 -8.87 48.35 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.051 0.425 . . . . 0.0 110.14 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.52 1.64 71.73 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.997 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -134.76 155.33 50.78 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.159 0.479 . . . . 0.0 110.439 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.3 t -100.91 118.42 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.322 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.42 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 53.3 t30 -84.46 173.7 10.65 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 111.258 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.42 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 82.5 t80 -61.0 -40.6 94.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.96 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.06 -44.63 96.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.794 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.48 -37.24 86.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.549 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -61.12 -45.04 96.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.046 0.451 . . . . 0.0 111.046 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.69 -47.18 89.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.829 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -50.58 -41.93 55.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.145 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.6 mmt -74.67 -38.57 62.39 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 19.9 mmt -73.17 -46.12 52.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.0 p -87.93 29.94 0.88 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.576 0.227 . . . . 0.0 111.456 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.79 84.54 5.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.727 0.299 . . . . 0.0 110.819 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.0 tptp . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.24 179.746 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B 1086 ' ' LEU . . . . . 0.559 ' N ' HD22 ' B' 1086 ' ' LEU . 3.5 mm? . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 61.3 ttt85 -61.82 -41.74 98.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.395 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.531 ' C ' ' H ' ' B' 1090 ' ' GLN . 8.0 mpt_? -82.78 93.22 7.39 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.94 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -50.98 -9.4 0.3 Allowed Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.559 ' H ' ' CD ' ' B' 1090 ' ' GLN . 20.8 mp0 -63.51 -47.36 82.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.848 -0.176 . . . . 0.0 111.46 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.19 -51.79 66.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.689 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 15.0 mt -55.24 -60.09 3.88 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.417 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.7 m95 -61.33 -55.76 28.02 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.462 0.649 . . . . 0.0 112.172 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 50.3 t80 -57.94 -46.98 84.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1095 ' ' ARG . . . . . 0.684 HH21 ' NH2' ' B' 1099 ' ' ARG . 59.4 ttt85 -40.31 -52.75 2.65 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.4 -40.62 98.91 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 48.7 tp -56.0 -46.32 78.78 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.689 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -58.63 -49.88 75.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1099 ' ' ARG . . . . . 0.684 ' NH2' HH21 ' B' 1095 ' ' ARG . 91.2 mtt180 -63.87 -39.76 94.95 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.77 -42.61 89.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.14 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -52.29 -47.42 65.91 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 118.605 -1.238 . . . . 0.0 107.677 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.527 ' O ' ' N ' ' B' 1105 ' ' LYS . 18.8 m -61.58 -48.87 78.99 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 93.4 mt-30 -27.57 -57.95 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 122.709 1.242 . . . . 0.0 113.382 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.0 mt -81.68 -14.42 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 112.434 -2.166 . . . . 0.0 112.389 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.527 ' N ' ' O ' ' B' 1102 ' ' THR . 93.4 mttt -59.28 -41.87 89.9 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.27 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 90.8 t -60.39 -46.7 94.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.994 0.902 . . . . 0.0 112.24 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 55.5 t -65.59 -42.34 92.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.877 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1108 ' ' LYS . . . . . 0.518 ' NZ ' HG21 ' A' ' 79' ' ' THR . 94.0 mttt -49.25 -41.32 37.2 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.848 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.25 61.66 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.693 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -60.44 -65.65 0.65 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.848 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1111 ' ' HIS . . . . . 0.649 ' ND1' ' N ' ' B' 1112 ' ' SER . 35.4 p80 -89.78 -54.22 4.16 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1112 ' ' SER . . . . . 0.649 ' N ' ' ND1' ' B' 1111 ' ' HIS . 2.9 p 85.75 92.51 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 117.642 -1.171 . . . . 0.0 109.858 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1113 ' ' SER . . . . . 0.423 ' OG ' ' O ' ' B' 1112 ' ' SER . 17.9 p . . . . . 0 C--O 1.219 -0.515 0 CA-C-N 123.526 2.876 . . . . 0.0 110.724 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 3' ' ' GLN . 37.5 p-10 -63.88 -41.87 97.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.262 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.482 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 0.0 OUTLIER 156.18 92.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.86 0.725 . . . . 0.0 109.282 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.91 -25.37 13.07 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.306 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -80.92 140.21 35.43 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.15 0.886 . . . . 0.0 110.196 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.5 tt0 -50.39 -56.26 12.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 122.167 0.984 . . . . 0.0 110.642 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -34.83 -37.77 0.07 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.189 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -68.9 -38.59 79.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.72 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 6' ' ' GLU . 66.6 mt -56.85 -45.74 83.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.62 -51.27 63.61 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.455 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -61.43 -47.33 86.25 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.466 0.65 . . . . 0.0 112.246 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.0 m-85 -62.83 -37.7 87.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.897 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -54.59 -52.21 62.86 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.777 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -51.08 -39.99 57.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.082 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.84 -38.0 72.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.309 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -58.04 -42.31 85.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.1 t -65.03 -14.79 61.32 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.6 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.74 -43.05 99.81 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.39 -12.56 15.97 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.72 94.84 3.32 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.265 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -65.04 -47.89 75.78 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.521 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 8.9 p30 -109.69 14.5 23.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.31 59.78 1.47 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.303 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -87.54 -6.79 58.19 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.804 0.335 . . . . 0.0 110.237 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.91 -1.63 74.8 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.0 p -139.77 156.66 46.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.015 0.436 . . . . 0.0 109.998 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.639 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.8 mp -89.2 123.1 41.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -111.46 162.71 14.8 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.91 0.757 . . . . 0.0 112.41 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.425 HG22 HG13 ' A' ' 52' ' ' ILE . 18.8 p -60.33 -38.52 84.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.859 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -59.75 -62.21 2.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.821 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -62.0 -28.1 69.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.652 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.476 HD22 HD11 ' A' ' 52' ' ' ILE . 2.9 tp -60.43 -52.66 64.28 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.471 178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.91 91.81 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.891 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.67 -52.42 65.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.828 1.314 . . . . 0.0 108.632 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.8 t -58.65 -45.06 90.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 119.267 0.94 . . . . 0.0 111.231 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.484 ' SD ' ' O ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -59.54 -40.29 86.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 119.782 1.173 . . . . 0.0 109.789 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -52.58 -38.12 59.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.403 0.621 . . . . 0.0 110.041 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.2 p -62.27 -20.01 63.84 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.177 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -73.82 2.24 8.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.99 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.24 26.23 40.97 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.132 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -131.75 171.3 13.67 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.356 0.578 . . . . 0.0 109.817 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 16.9 p-10 -132.77 76.79 70.34 Favored Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.409 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.46 146.27 97.13 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.783 2.322 . . . . 0.0 111.93 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.2 p -76.28 163.85 26.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.173 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -58.59 -43.64 89.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.848 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.78 -24.25 49.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.378 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -65.38 -39.51 92.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.154 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.0 mp -56.71 -41.03 76.71 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.395 0.617 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -72.1 -56.12 6.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.008 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -55.99 -49.72 72.84 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 40.8 mmm -64.59 -50.86 65.57 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.476 HD11 HD22 ' A' ' 32' ' ' LEU . 25.8 mm -59.23 -45.37 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.346 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -56.97 -34.68 68.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.35 -40.68 85.85 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.872 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.437 HG21 ' CE2' ' B' 1110 ' ' PHE . 54.8 t -84.93 -21.95 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.471 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.496 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.6 t0 -78.6 87.15 4.55 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -175.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.68 -37.19 85.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.356 -1.747 . . . . 0.0 113.669 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 39.9 p-10 -86.05 -2.46 58.34 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.66 23.09 60.39 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.313 0.506 . . . . 0.0 112.942 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -88.26 4.13 47.01 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.3 0.55 . . . . 0.0 110.354 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.496 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.05 0.87 88.89 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 121.091 -0.576 . . . . 0.0 114.383 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.1 p -147.87 169.2 20.32 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.5 mt -111.93 128.11 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 23.7 t0 -102.29 -178.14 3.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.658 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.546 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -57.03 -48.31 97.64 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.387 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -55.79 -49.34 16.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.26 1.306 . . . . 0.0 111.824 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.01 -20.65 64.14 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.487 0.661 . . . . 0.0 110.662 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -74.8 -57.0 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.131 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 72.8 mt -58.08 -45.23 87.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -47.29 -46.59 25.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.321 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 81.4 mtp -66.62 -45.29 79.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.6 mmt -60.13 -40.68 90.63 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -34.8 78.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.531 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -92.3 -16.86 25.53 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.64 0.257 . . . . 0.0 111.461 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 67.31 7.11 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.197 0.522 . . . . 0.0 110.709 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.9 mmt -107.99 16.8 23.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.517 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -49.3 132.59 20.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.981 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.57 109.11 20.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.871 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -95.28 118.88 32.83 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -66.65 113.32 4.71 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 174.318 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.8 m -37.8 -20.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.751 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 80' ' ' ASP . 5.3 mp0 -66.87 -41.9 86.52 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -45.21 -35.64 3.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.319 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -87.52 -20.3 26.7 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.003 0.43 . . . . 0.0 111.865 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 30.4 mm -60.11 -74.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.669 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -63.09 -40.21 96.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.09 -40.76 94.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.434 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.8 -20.75 63.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.136 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -70.74 -50.43 36.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.075 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -55.38 -41.84 73.18 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.414 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.11 -45.05 97.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.559 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.5 m-85 -68.94 -39.67 79.42 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.423 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -85.52 81.29 8.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.81 -48.89 79.72 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -91.31 4.87 51.28 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.344 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.55 48.3 49.58 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -90.7 7.32 40.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.665 0.269 . . . . 0.0 110.51 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.64 1.93 88.95 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -142.39 155.77 45.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.716 0.77 . . . . 0.0 111.491 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.3 mt -93.33 114.26 29.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.3 m -88.83 151.52 22.32 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.54 -48.98 77.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.838 0.745 . . . . 0.0 110.895 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.77 -40.81 60.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.9 0.381 . . . . 0.0 110.726 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -64.98 -40.86 95.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.027 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 108' ' ' VAL . 7.4 tt -63.42 -45.02 92.87 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.337 0.589 . . . . 0.0 111.408 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.485 ' HE ' HG11 ' A' ' 121' ' ' VAL . 24.5 mmt85 -40.7 -37.87 0.81 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.71 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -69.31 -25.32 64.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.783 0.325 . . . . 0.0 111.46 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.559 HG21 ' CE2' ' A' ' 92' ' ' PHE . 90.1 t -59.01 -44.88 92.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.625 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.708 ' SD ' HD12 ' A' ' 116' ' ' LEU . 16.4 mmt -52.02 -44.95 64.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.12 0.962 . . . . 0.0 111.234 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.5 m -58.62 -42.73 88.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.706 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -65.73 -41.49 92.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.148 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.7 mt -81.52 -15.88 53.5 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.879 -0.329 . . . . 0.0 111.812 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.53 30.65 57.95 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.418 ' OE1' ' SD ' ' A' ' 109' ' ' MET . 96.9 mt-10 -85.66 -23.24 27.55 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.552 2.176 . . . . 0.0 110.578 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt 43.84 59.62 3.05 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.927 0.87 . . . . 0.0 110.366 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.708 HD12 ' SD ' ' A' ' 109' ' ' MET . 44.6 mt -79.69 148.83 31.42 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.519 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.6 p -82.91 174.78 10.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.197 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -57.99 -44.5 87.2 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.81 -48.81 78.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.484 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.0 -31.54 69.27 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.821 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.485 HG11 ' HE ' ' A' ' 106' ' ' ARG . 30.3 t -63.17 -43.29 98.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.487 0.66 . . . . 0.0 109.343 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.06 -37.74 84.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.582 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -59.77 -50.36 74.13 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 20.1 mmm -57.12 -44.08 82.94 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.342 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.9 mt -59.9 -43.41 92.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.044 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -58.94 -38.63 79.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.999 0.428 . . . . 0.0 111.199 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -58.73 -40.61 84.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.006 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.6 -21.44 21.72 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.0 t0 -74.23 88.55 2.0 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.486 0.66 . . . . 0.0 111.883 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 42.7 mm -71.93 -14.19 17.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 122.624 1.202 . . . . 0.0 113.13 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.6 p-10 -142.84 144.59 32.58 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 112.414 -2.176 . . . . 0.0 109.251 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.02 52.23 1.32 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.784 -0.246 . . . . 0.0 112.968 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -90.85 -10.07 44.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.061 0.431 . . . . 0.0 110.056 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.12 1.11 67.62 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.195 -0.526 . . . . 0.0 114.221 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -134.9 153.76 51.94 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.435 0.618 . . . . 0.0 110.433 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.21 118.61 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.243 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.1 174.86 9.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.733 0.301 . . . . 0.0 110.858 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -61.65 -40.16 93.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.965 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.54 -44.64 95.86 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.837 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.26 -37.85 88.47 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.505 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -60.26 -45.42 93.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 110.721 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.55 -46.59 89.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.458 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.753 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 51.9 tt0 -48.78 -47.12 42.2 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.893 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.7 mmm -72.33 -37.57 68.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.431 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 24.2 mmt -72.11 -45.23 61.4 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.857 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 147' ' ' ALA . 4.8 m -82.62 -30.98 29.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.066 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.753 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -35.46 100.12 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.195 0.521 . . . . 0.0 111.397 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.594 179.341 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -158.76 -157.47 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.558 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.543 ' C ' ' H ' ' B' 1090 ' ' GLN . 53.0 ttt85 61.3 41.2 13.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.573 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -64.31 5.47 1.01 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.543 ' H ' ' C ' ' B' 1088 ' ' ARG . 85.7 mt-30 -56.84 -41.09 77.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.871 0.367 . . . . 0.0 111.277 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 64.6 mt -44.19 -65.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.5 mt -55.71 -51.28 67.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.549 -0.46 . . . . 0.0 112.162 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.7 m95 -58.11 -65.01 0.72 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.752 0.787 . . . . 0.0 111.875 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1094 ' ' PHE . . . . . 0.431 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 38.0 m-85 -56.68 -43.35 80.36 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -174.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 12.3 tpp85 -39.73 -51.49 2.34 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.12 99.94 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.47 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.0 tp -56.35 -45.69 80.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.501 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -59.79 -49.09 79.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.878 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -65.77 -37.67 86.95 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.11 -42.04 91.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.903 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -51.47 -45.39 62.75 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.507 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.1 m -64.27 -47.99 77.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.825 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 84.0 mt-30 -27.98 -57.08 0.11 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.83 1.3 . . . . 0.0 112.597 -176.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.89 -13.94 11.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 CA-C-N 112.519 -2.128 . . . . 0.0 112.578 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.507 ' N ' ' O ' ' B' 1102 ' ' THR . 88.6 tttt -57.51 -41.65 81.25 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 118.316 -1.354 . . . . 0.0 107.95 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 77.5 t -62.74 -46.82 95.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.724 0.773 . . . . 0.0 112.814 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 37.1 t -65.83 -42.08 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.209 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 97.0 mttt -48.79 -38.07 20.96 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.833 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.87 -45.04 67.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.076 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1110 ' ' PHE . . . . . 0.437 ' CE2' HG21 ' A' ' 55' ' ' VAL . 48.7 m-85 -63.25 -50.0 71.9 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -68.17 -42.38 80.08 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.2 t 68.97 59.87 0.35 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 20.3 t . . . . . 0 N--CA 1.473 0.712 0 CA-C-N 123.228 2.74 . . . . 0.0 112.017 179.392 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 3' ' ' GLN . 24.7 p30 -64.53 -34.86 79.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.298 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 5.1 tp-100 159.54 103.08 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 O-C-N 124.136 0.897 . . . . 0.0 109.437 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.9 mt -119.32 -9.76 9.85 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.271 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.468 ' N ' ' OE1' ' A' ' 3' ' ' GLN . 61.3 p -79.81 133.22 36.28 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.643 1.111 . . . . 0.0 111.12 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.7 tt0 -54.66 -51.3 65.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.769 0.795 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -34.17 -36.01 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.129 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.521 ' NE2' ' OE1' ' A' ' 11' ' ' GLU . 39.5 tp60 -70.61 -32.87 70.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.475 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' A' ' 6' ' ' GLU . 93.7 mt -57.83 -45.73 87.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.89 -50.14 61.62 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.412 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.521 ' OE1' ' NE2' ' A' ' 8' ' ' GLN . 97.4 mt-10 -64.15 -44.76 91.15 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.439 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.1 m-85 -62.98 -40.79 98.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.753 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -52.14 -55.58 19.99 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.204 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -49.87 -41.84 46.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.116 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -54.83 -35.66 64.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.503 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.434 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 2.5 m-85 -57.73 -39.61 77.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.4 m -65.95 -16.06 63.54 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.255 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 2.7 mm? -64.23 -41.99 96.75 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.78 -15.25 14.78 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.897 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -74.99 94.72 2.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.145 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -67.15 -48.22 68.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.802 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.0 p30 -103.25 14.68 31.07 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 38.08 50.48 2.14 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.961 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -87.57 -5.17 58.88 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.925 0.362 . . . . 0.0 111.572 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.43 -0.59 78.01 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.7 p -140.07 157.9 44.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.981 0.42 . . . . 0.0 109.954 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mm -88.03 122.81 40.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 p -111.57 161.56 16.07 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.012 0.82 . . . . 0.0 112.276 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 p -59.26 -38.4 79.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.708 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -60.99 -60.05 4.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.06 -30.16 71.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.766 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 tp -60.54 -55.92 27.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.322 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.99 -37.56 91.66 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.806 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -58.5 -53.71 55.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 119.317 1.558 . . . . 0.0 108.434 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.7 t -56.97 -46.69 84.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.598 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.0 ttt -58.51 -42.26 87.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 120.27 1.395 . . . . 0.0 110.189 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -52.27 -37.62 55.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.481 0.658 . . . . 0.0 110.15 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.0 t -63.69 -21.22 66.28 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.517 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.52 0.4 17.4 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.756 -0.777 . . . . 0.0 109.935 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 18.21 62.59 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.173 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -109.81 157.91 18.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.72 0.76 . . . . 0.0 110.038 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -113.0 66.15 0.96 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.443 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.74 142.68 90.11 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.075 1.85 . . . . 0.0 112.302 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -82.36 166.78 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.447 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -58.29 -44.77 88.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.851 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.43 -23.59 25.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.635 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.65 -39.02 90.95 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.273 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 7.8 mp -56.45 -41.31 76.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.23 0.538 . . . . 0.0 109.662 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.425 ' OE1' ' ND2' ' A' ' 53' ' ' ASN . 8.9 tp-100 -68.78 -58.52 4.08 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.71 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -55.05 -49.37 71.78 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.9 mmm -63.81 -53.91 43.38 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 52' ' ' ILE . 26.4 mm -58.31 -47.63 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.83 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.425 ' ND2' ' OE1' ' A' ' 49' ' ' GLN . 34.3 m-80 -56.49 -33.64 66.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -66.41 -40.31 89.49 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.596 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.47 HG21 ' CD2' ' B' 1110 ' ' PHE . 76.3 t -86.65 -19.8 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.42 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 40.6 t0 -78.98 84.59 4.98 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -174.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.28 -37.39 83.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.626 -1.625 . . . . 0.0 114.238 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.454 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.7 p-10 -86.1 -2.35 58.25 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.5 23.34 62.55 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 118.383 0.538 . . . . 0.0 112.696 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.454 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.4 p-10 -87.5 1.96 52.02 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.27 0.535 . . . . 0.0 110.606 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.552 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 86.73 1.58 85.17 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.685 0.634 . . . . 0.0 114.685 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.3 p -148.84 170.9 17.22 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.416 HD12 HG12 ' A' ' 55' ' ' VAL . 15.9 mm -110.85 128.29 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -102.35 -178.27 3.64 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.434 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -58.06 -48.96 96.16 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.202 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -55.94 -51.86 8.67 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.536 1.491 . . . . 0.0 111.537 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.1 -19.99 62.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.607 0.717 . . . . 0.0 110.354 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -75.95 -58.99 2.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.2 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.87 -44.94 78.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.9 p -45.75 -44.29 13.66 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.561 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.5 mtp -71.89 -49.48 37.55 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.4 mmm -61.01 -40.72 94.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.16 -33.58 76.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.66 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -93.45 -14.82 26.27 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.627 0.251 . . . . 0.0 111.529 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 mmpp? -77.87 71.91 4.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.163 0.506 . . . . 0.0 111.311 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.7 mmt -107.03 18.33 21.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.858 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -51.73 129.87 27.25 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.197 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -90.69 105.18 17.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.135 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.495 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 3.1 m -88.45 123.18 32.74 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 82' ' ' GLU . 15.5 t0 -69.43 109.86 4.43 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 174.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.8 m -37.04 -21.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 80' ' ' ASP . 50.6 mp0 -70.33 -34.14 72.32 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 111.835 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.444 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 81.1 tt0 -50.32 -39.14 45.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.266 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 76.7 mt-10 -88.34 -5.57 58.24 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 85' ' ' ILE . 26.9 mm -70.79 -74.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.85 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -61.48 -50.39 72.95 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 83' ' ' GLU . 16.1 pt-20 -54.41 -38.77 66.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -60.79 -20.03 60.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.014 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -73.99 -48.1 32.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.771 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -54.59 -41.01 69.39 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.418 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.91 -43.29 92.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.553 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.6 m-85 -68.78 -39.03 80.38 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.248 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 30.1 t0 -87.36 82.8 7.46 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.88 -49.45 76.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 35.6 p-10 -90.91 5.28 49.27 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.629 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.07 48.49 46.15 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.71 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -90.31 6.48 42.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.678 0.275 . . . . 0.0 110.634 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.424 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 84.54 1.45 89.21 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.71 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 97.9 m-85 -140.72 153.91 46.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.671 0.748 . . . . 0.0 111.612 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.422 ' HB ' HG13 ' A' ' 136' ' ' VAL . 96.7 mt -97.07 117.28 41.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.3 m -90.46 152.67 20.86 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.1 80.03 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.974 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.97 -39.93 60.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.89 0.376 . . . . 0.0 110.463 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -66.01 -41.54 90.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.357 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.3 tp -63.07 -46.55 86.91 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.267 0.556 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -43.57 -44.35 6.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.65 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -63.54 -29.26 70.55 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 121.281 -0.168 . . . . 0.0 110.99 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.553 HG21 ' CE2' ' A' ' 92' ' ' PHE . 96.6 t -57.54 -41.81 79.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.842 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.623 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.54 -45.27 62.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.958 0.885 . . . . 0.0 111.543 -177.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.9 m -55.91 -40.73 73.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.853 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.33 -40.46 93.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.759 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.5 -13.0 58.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.739 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.65 29.09 60.07 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -85.34 -21.78 28.76 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.805 2.302 . . . . 0.0 111.111 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mttm 42.82 60.58 2.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.952 0.882 . . . . 0.0 110.013 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.446 HD12 ' HG3' ' A' ' 109' ' ' MET . 81.5 mt -80.04 148.38 31.1 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.48 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 121' ' ' VAL . 58.7 p -82.96 175.17 10.26 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.376 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -57.98 -45.12 87.25 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -57.21 -51.15 70.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.456 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.405 ' OE1' ' OE1' ' A' ' 123' ' ' GLU . 78.7 mm-40 -67.3 -30.55 70.43 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.484 -0.486 . . . . 0.0 112.001 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 117' ' ' THR . 39.6 t -63.72 -41.53 92.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -66.94 -38.22 85.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.407 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.405 ' OE1' ' OE1' ' A' ' 120' ' ' GLU . 94.6 mt-10 -59.21 -52.51 65.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.46 ' SD ' ' CD1' ' B' 1093 ' ' TRP . 17.6 mmm -54.72 -45.04 74.0 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.682 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 91.3 mt -59.05 -44.71 92.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.234 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -61.35 -36.4 80.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.685 0.279 . . . . 0.0 111.553 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.45 -41.3 84.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.88 -16.86 24.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.723 0.297 . . . . 0.0 111.746 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.8 t0 -71.09 91.76 0.93 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.491 0.662 . . . . 0.0 111.991 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.1 mt -70.48 -17.26 20.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 122.591 1.186 . . . . 0.0 113.317 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 51.4 p-10 -142.24 144.12 33.2 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 112.404 -2.18 . . . . 0.0 108.905 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.18 53.07 1.05 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.699 -0.286 . . . . 0.0 113.118 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -90.9 -8.13 50.27 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.002 0.401 . . . . 0.0 110.222 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.92 3.87 81.55 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.671 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -136.67 157.86 45.79 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.562 0.681 . . . . 0.0 110.439 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 136' ' ' VAL . 7.9 p -103.98 119.63 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.718 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -85.92 177.24 7.67 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.737 0.303 . . . . 0.0 111.079 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.98 -42.08 98.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.213 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.44 -45.33 94.74 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.902 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.94 -36.86 84.51 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.356 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -61.15 -45.39 94.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.2 t -65.7 -46.33 89.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.932 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -50.26 -44.14 53.55 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.994 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.2 mmt -72.92 -39.31 66.4 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 21.1 mmt -74.66 -47.04 34.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.877 -0.147 . . . . 0.0 110.823 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 p -89.97 32.17 0.93 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.689 0.28 . . . . 0.0 111.678 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.95 89.26 6.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.716 0.293 . . . . 0.0 111.363 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 35.5 tptt . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.416 179.653 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 61.8 mt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -79.43 40.5 0.43 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.556 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.573 ' C ' ' H ' ' B' 1090 ' ' GLN . 55.1 ttp180 56.46 43.07 26.6 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -60.81 3.86 0.36 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.573 ' H ' ' C ' ' B' 1088 ' ' ARG . 84.3 mt-30 -60.82 -45.29 95.05 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -177.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 73.8 mt -58.99 -49.05 84.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 17.6 mt -56.71 -62.26 1.86 Allowed 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.002 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1093 ' ' TRP . . . . . 0.46 ' CD1' ' SD ' ' A' ' 124' ' ' MET . 6.2 m95 -61.9 -53.51 54.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.366 0.603 . . . . 0.0 111.908 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 48.5 t80 -58.19 -46.34 85.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -40.38 -52.3 2.73 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.5 -41.08 99.48 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.106 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.7 tp -56.84 -45.36 82.44 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.484 -0.887 . . . . 0.0 109.562 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 40.9 t30 -58.65 -49.33 77.91 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -64.28 -38.14 90.0 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.3 mt -60.65 -41.91 89.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.68 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -50.37 -48.34 55.8 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.002 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.512 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.2 m -64.19 -47.9 78.0 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.42 ' C ' ' O ' ' B' 1102 ' ' THR . 85.3 mt-30 -27.61 -59.46 0.1 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 122.565 1.174 . . . . 0.0 112.612 -176.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.8 mt -83.02 -12.79 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 112.954 -1.93 . . . . 0.0 112.381 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.512 ' N ' ' O ' ' B' 1102 ' ' THR . 63.8 tttm -57.46 -43.28 83.87 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 118.001 -1.479 . . . . 0.0 108.024 176.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 57.5 t -61.92 -47.36 93.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 41.2 t -65.53 -41.52 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.074 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1108 ' ' LYS . . . . . 0.495 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 95.4 mttt -47.56 -37.11 11.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.659 0.742 . . . . 0.0 109.782 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -55.29 -46.63 76.19 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.63 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1110 ' ' PHE . . . . . 0.47 ' CD2' HG21 ' A' ' 55' ' ' VAL . 56.1 m-85 -63.77 -48.91 75.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -68.78 20.46 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1112 ' ' SER . . . . . 0.411 ' H ' ' C ' ' B' 1110 ' ' PHE . 1.1 m 60.86 84.58 0.13 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.805 -0.559 . . . . 0.0 109.831 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1113 ' ' SER . . . . . 0.41 ' OG ' ' O ' ' B' 1112 ' ' SER . 5.3 p . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.818 -1.087 . . . . 0.0 109.852 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -63.28 -40.33 97.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.179 0.514 . . . . 0.0 111.219 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -94.39 179.79 5.17 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.1 tp 166.88 -26.33 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.773 0.671 . . . . 0.0 109.452 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.407 ' H ' ' HG1' ' A' ' 5' ' ' THR . 33.6 p -77.79 141.01 39.49 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.03 0.832 . . . . 0.0 110.628 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.1 tt0 -50.4 -55.95 13.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.166 0.984 . . . . 0.0 110.46 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -35.21 -38.45 0.09 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.886 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -68.27 -38.74 82.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.208 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.0 mt -58.7 -44.92 90.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 176.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.26 -50.38 67.37 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.797 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -60.23 -48.55 81.25 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.174 0.512 . . . . 0.0 112.228 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -61.72 -39.4 91.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.612 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -52.19 -56.19 16.19 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.999 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -50.42 -42.81 54.46 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.295 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.64 -36.83 64.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.125 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.56 -40.74 79.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -63.56 -16.31 60.46 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.205 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.445 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.9 mm? -64.7 -41.14 96.22 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -106.1 -15.08 14.97 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.49 92.99 1.93 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.192 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -67.81 -49.83 60.15 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.884 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.8 p-10 -101.89 15.74 28.07 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.7 45.37 0.52 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.2 p30 -85.35 -4.51 59.18 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 122.676 -0.308 . . . . 0.0 110.802 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.96 -2.2 81.54 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 p -137.91 152.73 49.29 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.975 0.417 . . . . 0.0 109.95 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 27' ' ' ILE . 4.6 mp -91.47 124.47 44.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -113.21 164.91 12.94 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.992 0.807 . . . . 0.0 112.37 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.3 p -59.73 -34.7 73.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.872 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -62.38 -61.58 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.757 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -60.4 -31.42 70.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.845 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 52' ' ' ILE . 3.7 tp -60.56 -55.53 32.24 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.991 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.32 -39.41 92.63 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.988 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.2 m -57.71 -53.91 52.9 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.921 1.361 . . . . 0.0 108.704 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.92 -46.87 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 118.694 0.679 . . . . 0.0 111.527 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.5 ttt -59.24 -40.85 87.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 120.082 1.31 . . . . 0.0 109.868 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -52.15 -39.2 59.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.63 0.729 . . . . 0.0 110.358 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.0 t -63.32 -21.35 66.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.086 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.466 ' O ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -73.45 -2.18 21.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.54 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.35 14.63 65.81 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.097 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -106.38 156.45 18.51 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 117.356 0.578 . . . . 0.0 110.095 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -116.43 63.06 2.6 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.355 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.08 144.95 93.63 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.229 1.952 . . . . 0.0 112.169 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.6 p -80.23 166.73 21.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.522 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -57.7 -43.68 85.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.604 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.73 -24.26 33.93 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.398 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -65.97 -39.33 90.29 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.174 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.6 mp -57.23 -42.75 82.0 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.657 0.741 . . . . 0.0 109.867 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -68.81 -56.09 9.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.494 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.05 -49.21 74.38 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.7 mmm -63.91 -50.72 67.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.505 HD11 HD22 ' A' ' 32' ' ' LEU . 26.9 mm -59.3 -48.06 88.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.619 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -55.9 -34.62 65.73 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.95 -39.83 90.77 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.728 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.411 HG21 ' CE2' ' B' 1110 ' ' PHE . 41.7 t -87.1 -20.18 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.299 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 44.6 t0 -79.38 84.3 5.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.45 82.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.619 -1.628 . . . . 0.0 114.263 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -86.41 -2.36 58.37 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.047 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.9 23.97 59.76 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.407 0.548 . . . . 0.0 112.463 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -87.91 3.74 47.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.421 0.61 . . . . 0.0 110.199 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.44 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.06 1.43 88.66 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 118.578 0.626 . . . . 0.0 114.573 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.9 p -148.9 170.97 17.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.2 mt -114.82 129.05 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -103.27 -175.32 2.77 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.604 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.438 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -59.27 -45.79 99.15 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.035 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 41.9 Cg_exo -55.49 -53.72 5.31 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.298 1.332 . . . . 0.0 111.513 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.88 -20.9 64.23 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.492 0.663 . . . . 0.0 110.763 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -72.87 -57.94 3.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.579 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.07 -44.81 87.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.405 HG23 HH12 ' A' ' 74' ' ' ARG . 8.6 m -40.53 -57.96 1.7 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.015 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.6 ptp -63.78 -39.29 93.89 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.811 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.1 mmt -59.06 -41.14 87.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.11 -35.49 78.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.429 0.291 . . . . 0.0 111.663 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.405 HH12 HG23 ' A' ' 70' ' ' THR . 84.8 mtt85 -94.05 -12.45 28.53 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -81.61 72.91 8.66 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.704 0.764 . . . . 0.0 110.376 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 21.6 mmt -110.33 17.77 20.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.056 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -53.08 129.72 31.79 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.487 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -107.45 143.96 35.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.674 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.0 p -130.55 135.71 48.19 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.4 m-20 -61.2 116.07 4.29 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 175.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.2 m -36.91 -20.08 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 80' ' ' ASP . 45.1 tp10 -69.44 -31.55 69.94 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -51.86 -40.38 60.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.745 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -86.91 -9.17 56.33 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.1 mm -67.88 -73.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.915 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -61.97 -40.99 97.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.94 -41.67 98.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.379 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.56 -21.35 60.16 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.966 0.412 . . . . 0.0 111.425 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -74.71 -47.29 32.26 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.744 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -55.61 -43.08 75.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.923 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.54 -45.73 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.546 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.463 ' CE2' HG21 ' A' ' 108' ' ' VAL . 11.5 m-85 -70.01 -39.05 76.06 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.595 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.405 ' OD1' ' OD1' ' A' ' 97' ' ' ASN . 32.3 t0 -89.56 84.83 6.38 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.01 -48.63 79.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.4 p-10 -92.24 5.03 51.98 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.99 50.4 51.31 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.405 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 27.0 p30 -95.02 6.28 49.52 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 122.416 0.286 . . . . 0.0 110.798 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.56 -0.19 89.7 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.422 ' CZ ' ' CG ' ' A' ' 137' ' ' ASN . 4.4 m-85 -136.86 149.66 47.81 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.984 0.897 . . . . 0.0 111.299 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 80.7 mt -97.17 119.38 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t -89.88 151.08 21.92 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.66 78.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.112 0.869 . . . . 0.0 110.159 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.09 -41.73 62.65 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.698 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -65.28 -42.04 93.54 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.697 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.2 -45.65 90.74 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.51 0.671 . . . . 0.0 111.072 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -44.07 -42.76 6.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.366 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -65.47 -30.48 71.27 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.671 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' A' ' 92' ' ' PHE . 93.2 t -57.62 -42.38 81.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.943 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.13 -46.9 65.54 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.971 0.891 . . . . 0.0 111.284 -177.126 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.3 p -55.33 -39.19 69.68 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.567 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -66.38 -41.23 89.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.763 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.0 mt -81.77 -14.51 56.33 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.01 31.05 60.31 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -87.33 -25.71 23.75 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.77 2.285 . . . . 0.0 110.463 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.0 mttp 45.96 63.16 1.93 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.102 0.953 . . . . 0.0 110.377 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.74 148.31 31.55 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.923 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 121' ' ' VAL . 32.4 p -82.67 174.2 11.22 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -57.57 -45.56 85.05 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.71 -46.72 84.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.172 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -70.66 -30.67 67.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.919 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 117' ' ' THR . 43.3 t -64.03 -41.99 94.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.471 0.653 . . . . 0.0 109.436 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.64 -35.69 75.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.349 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -59.56 -52.59 64.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.815 0.817 . . . . 0.0 112.837 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.2 mtp -55.64 -44.09 76.85 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.291 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.5 mt -59.11 -43.85 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.43 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -59.72 -38.32 81.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.95 0.405 . . . . 0.0 111.253 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -58.4 -41.61 85.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.168 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.55 -21.42 22.89 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.7 t0 -78.44 84.64 4.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.283 0.563 . . . . 0.0 112.051 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.9 pt -70.66 -11.52 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 122.674 1.226 . . . . 0.0 113.515 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 53.8 p-10 -142.08 145.01 33.84 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.157 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.45 52.35 2.27 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.656 -0.307 . . . . 0.0 113.357 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -90.9 -9.28 46.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 117.188 0.494 . . . . 0.0 110.1 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.8 -0.57 65.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 114.409 0.524 . . . . 0.0 114.409 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -132.95 150.85 52.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.304 0.552 . . . . 0.0 109.881 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 t -98.21 118.46 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.825 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.422 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 16.5 t-20 -85.14 174.51 9.63 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.721 0.296 . . . . 0.0 110.965 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -60.96 -42.15 97.72 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.456 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.13 -44.12 95.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.699 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.67 -38.03 89.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.462 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -60.94 -45.28 95.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.096 0.474 . . . . 0.0 111.019 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.17 -46.88 89.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.039 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.667 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 68.8 tp60 -51.05 -44.51 61.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.025 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmt -72.02 -36.99 69.83 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 25.5 mmt -71.91 -45.88 59.63 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.489 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 p -81.33 -28.86 34.34 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.033 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -41.83 109.24 0.12 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.627 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.404 ' O ' ' OE1' ' B' 1090 ' ' GLN . 63.5 tttp . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.206 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 81.8 mt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -80.0 133.03 36.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.79 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.522 ' C ' ' H ' ' B' 1090 ' ' GLN . 73.5 mtt180 -90.13 92.39 8.94 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.537 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -51.91 -8.78 0.44 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.522 ' H ' ' C ' ' B' 1088 ' ' ARG . 71.3 mt-30 -65.69 -52.06 54.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 111.377 -178.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 60.9 mt -59.13 -50.58 79.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.848 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.9 mt -55.61 -59.13 5.28 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.606 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.3 m95 -63.23 -56.11 19.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.625 0.726 . . . . 0.0 112.346 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.1 t80 -58.4 -46.18 86.91 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 46.9 ttt85 -41.97 -52.04 4.26 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.71 -40.41 98.74 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.679 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.41 -44.72 80.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.977 0.888 . . . . 0.0 109.829 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 38.8 t30 -58.03 -47.72 82.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -176.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -65.01 -38.25 90.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.392 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.9 mt -60.36 -42.37 90.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.718 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -51.37 -45.42 62.4 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.586 -1.245 . . . . 0.0 107.67 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.508 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.7 m -62.16 -48.79 78.5 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.417 ' C ' ' O ' ' B' 1102 ' ' THR . 84.5 mt-30 -27.75 -59.61 0.11 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.913 1.339 . . . . 0.0 113.101 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -83.08 -13.72 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 112.514 -2.13 . . . . 0.0 111.643 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.508 ' N ' ' O ' ' B' 1102 ' ' THR . 66.3 tttm -59.93 -47.8 84.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 118.358 -1.337 . . . . 0.0 107.906 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.6 t -60.71 -48.85 86.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.9 m -65.76 -35.72 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.986 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 83.2 mttt -49.67 -39.08 35.18 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.72 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -50.56 -44.41 56.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.315 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1110 ' ' PHE . . . . . 0.411 ' CE2' HG21 ' A' ' 55' ' ' VAL . 41.8 m-85 -63.55 -49.46 73.35 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.725 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -67.85 -42.54 81.22 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1112 ' ' SER . . . . . 0.412 ' O ' ' C ' ' B' 1113 ' ' SER . 1.6 t 68.51 59.48 0.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 117.014 -1.47 . . . . 0.0 107.319 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1113 ' ' SER . . . . . 0.412 ' C ' ' O ' ' B' 1112 ' ' SER . 26.6 p . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 124.011 3.096 . . . . 0.0 111.513 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.471 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 55.3 t0 56.74 25.34 10.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.129 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 2' ' ' ASP . 52.7 tt0 94.42 118.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 124.329 1.018 . . . . 0.0 110.35 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 173.22 -34.81 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.23 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.02 144.28 43.15 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.002 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.672 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -51.29 -43.82 61.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 122.574 1.178 . . . . 0.0 110.574 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 81.2 tt0 -43.35 -41.23 4.0 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 112.718 -2.037 . . . . 0.0 110.662 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -69.36 -38.06 77.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.504 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.1 -44.81 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.44 -50.27 62.92 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.667 -178.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -62.61 -45.57 92.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.387 0.613 . . . . 0.0 112.039 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 8.7 m-85 -62.27 -40.9 97.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.817 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -52.89 -55.23 24.73 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.275 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -50.31 -42.39 52.59 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.957 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -55.3 -36.3 66.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.409 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.79 -38.76 79.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.3 p -65.33 -15.95 63.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.22 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 18' ' ' LEU . 6.7 mp -65.42 -40.72 93.68 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -106.05 -14.75 15.08 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -73.04 93.2 1.74 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.486 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -67.72 -49.41 62.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.934 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.0 p-10 -103.11 14.9 30.72 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.16 46.27 0.96 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.131 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -86.57 -4.55 59.19 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 122.673 -0.31 . . . . 0.0 110.934 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 -1.83 80.74 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.4 p -138.21 153.56 49.14 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.189 0.519 . . . . 0.0 110.02 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 27' ' ' ILE . 4.2 mp -91.12 123.6 43.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.8 p -113.79 164.22 14.02 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.926 0.87 . . . . 0.0 112.455 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 p -58.34 -37.88 76.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.827 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.19 -61.83 2.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.732 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -60.63 -29.48 69.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.448 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.537 HD22 HD13 ' A' ' 52' ' ' ILE . 3.0 tp -61.37 -53.61 54.35 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.571 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.07 97.9 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.545 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 m -58.66 -54.33 48.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.912 1.356 . . . . 0.0 108.605 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.4 t -56.72 -46.01 82.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 118.979 0.808 . . . . 0.0 111.297 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.5 ttt -59.18 -40.22 85.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 120.111 1.323 . . . . 0.0 109.822 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -53.43 -41.53 66.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.42 0.629 . . . . 0.0 110.46 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.8 p -63.73 -21.49 66.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.941 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 tp -73.86 -3.54 29.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.748 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.74 20.7 46.23 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.332 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -117.77 158.65 24.37 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.662 0.731 . . . . 0.0 109.671 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -119.65 74.85 18.28 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.87 145.79 57.54 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.064 1.843 . . . . 0.0 112.405 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -80.16 165.83 22.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.309 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.4 pt-20 -58.83 -45.07 90.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.417 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -56.55 -24.36 46.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.501 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -65.65 -40.25 92.27 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.218 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.25 -39.67 70.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.223 0.535 . . . . 0.0 109.793 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -73.98 -55.17 6.48 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.238 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -54.84 -48.56 72.7 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 60.6 mtp -65.76 -52.06 54.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.537 HD13 HD22 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -56.02 -44.07 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -56.33 -35.16 67.29 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -67.3 -40.71 86.05 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.963 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.0 t -86.07 -21.34 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.383 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.493 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.1 t0 -78.2 86.16 4.33 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -174.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.3 82.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.342 -1.754 . . . . 0.0 114.081 -175.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 40.1 p-10 -86.82 -2.41 58.55 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.1 23.47 61.86 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 118.526 0.603 . . . . 0.0 112.839 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -87.87 3.57 47.91 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.273 0.536 . . . . 0.0 110.517 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.493 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.1 1.36 88.61 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 121.556 -0.715 . . . . 0.0 114.495 175.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.0 p -148.26 169.0 21.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -113.06 128.61 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.026 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -103.94 -174.83 2.63 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.801 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -58.09 19.55 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.51 -49.39 15.83 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.2 1.267 . . . . 0.0 111.661 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.79 -19.64 62.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.498 0.666 . . . . 0.0 110.628 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -75.71 -59.55 2.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.235 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.58 -44.15 80.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 m -44.92 -49.93 10.77 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.803 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 58.8 mtm -66.91 -45.6 77.43 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.4 mmm -61.08 -41.02 95.88 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.88 -34.16 77.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.567 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -93.42 -13.69 27.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.637 0.256 . . . . 0.0 111.343 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.452 ' C ' ' SD ' ' A' ' 76' ' ' MET . 2.4 mmmt -80.74 69.82 7.36 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.415 0.626 . . . . 0.0 110.765 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -105.88 18.72 21.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.851 179.158 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -49.94 131.44 22.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.418 0.627 . . . . 0.0 111.403 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 46.3 p-10 -91.99 109.05 20.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.875 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.518 HG21 ' NZ ' ' B' 1108 ' ' LYS . 8.5 p -97.81 114.21 26.19 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 82' ' ' GLU . 37.2 t0 -63.16 117.44 6.53 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 175.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.3 m -37.39 -20.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.772 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.7 mm-40 -69.8 -34.8 74.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.809 0.337 . . . . 0.0 111.718 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -49.34 -37.48 24.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.427 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.532 ' OE1' HD11 ' B' 1097 ' ' LEU . 9.3 pt-20 -89.11 -13.97 37.32 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 85' ' ' ILE . 24.2 mm -62.29 -74.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.176 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -62.04 -39.67 93.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -64.03 -40.68 96.87 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.515 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.1 -19.25 62.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.091 0.472 . . . . 0.0 111.127 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -71.97 -50.25 30.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.949 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -54.9 -40.71 70.09 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.757 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.22 -44.67 97.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.524 -0.471 . . . . 0.0 109.779 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.55 ' CE2' HG21 ' A' ' 108' ' ' VAL . 8.4 m-85 -69.44 -39.1 78.02 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.463 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -89.74 83.12 6.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.55 -45.06 95.74 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.9 p30 -91.42 4.02 53.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.623 0.249 . . . . 0.0 111.459 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.71 50.23 43.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -92.23 6.37 46.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.64 0.257 . . . . 0.0 110.516 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.14 0.76 89.64 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -140.38 154.16 46.61 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.695 0.76 . . . . 0.0 111.533 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.6 mt -96.92 115.82 37.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.2 p -91.7 156.13 17.8 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.34 -47.99 80.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 118.726 0.694 . . . . 0.0 111.14 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.8 -40.59 60.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 110.448 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.89 -41.29 91.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.511 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.23 -46.29 87.6 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.505 0.669 . . . . 0.0 111.358 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -44.38 -44.22 8.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.698 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -63.24 -28.82 70.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.784 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.55 HG21 ' CE2' ' A' ' 92' ' ' PHE . 98.7 t -57.99 -41.85 81.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.837 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.629 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.48 -46.22 63.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.074 0.94 . . . . 0.0 111.212 -177.209 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.8 m -57.68 -41.36 81.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.76 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.46 -40.75 93.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.975 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.3 mt -81.73 -14.06 57.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.699 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.05 29.82 58.27 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -85.68 -22.51 27.84 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.721 2.26 . . . . 0.0 110.878 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 43.14 60.48 2.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.116 0.96 . . . . 0.0 109.912 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.5 mt -79.74 148.76 31.38 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.511 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.4 p -82.99 174.61 10.73 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.405 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -58.06 -45.17 87.49 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.3 mp0 -58.15 -49.84 75.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.706 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -67.3 -31.23 71.4 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.937 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.13 -41.98 94.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.29 -39.15 89.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.62 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -59.44 -51.12 71.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.9 mmm -55.81 -45.05 78.37 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.274 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.99 -43.89 93.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.405 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -61.66 -36.77 81.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.031 0.443 . . . . 0.0 111.186 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.54 -40.19 86.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.833 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.758 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -89.52 -27.97 19.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.2 t0 -68.88 89.33 0.4 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.631 0.729 . . . . 0.0 111.811 -176.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.3 mm -71.4 -15.84 18.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.994 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 47.0 p-10 -141.44 144.42 34.42 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 112.465 -2.152 . . . . 0.0 108.967 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.32 51.47 1.05 Allowed Glycine 0 CA--C 1.531 1.042 0 CA-C-O 120.313 -0.159 . . . . 0.0 113.018 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -90.67 -12.23 37.39 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.035 0.418 . . . . 0.0 110.011 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.0 1.66 74.44 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.998 -0.62 . . . . 0.0 114.276 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -134.06 153.16 51.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.376 0.588 . . . . 0.0 110.481 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.6 t -100.46 118.4 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -83.65 173.85 11.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.988 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -61.41 -40.06 93.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.024 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.94 -44.29 97.08 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.805 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -65.48 -39.37 91.87 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.571 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.433 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 90.0 t80 -60.66 -44.17 96.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.035 0.445 . . . . 0.0 111.219 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.15 -45.0 95.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.018 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.24 -40.16 46.88 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.176 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.758 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 78.1 mtm -79.05 -46.11 18.78 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.433 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -73.39 -47.03 45.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.081 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.3 m -90.07 33.31 0.88 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.793 0.33 . . . . 0.0 111.332 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.48 84.42 5.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.672 0.272 . . . . 0.0 110.976 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.5 tttp . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.408 179.824 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B 1086 ' ' LEU . . . . . 0.567 HD12 ' N ' ' B' 1086 ' ' LEU . 10.5 mp . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -78.29 142.35 37.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.552 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.579 ' C ' ' H ' ' B' 1090 ' ' GLN . 0.8 OUTLIER -102.92 96.75 7.03 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.421 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -54.96 -2.89 0.23 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.579 ' H ' ' C ' ' B' 1088 ' ' ARG . 70.0 mt-30 -68.72 -56.87 6.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.956 0.408 . . . . 0.0 111.947 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.98 -49.4 84.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.36 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.35 -62.11 1.89 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.966 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1093 ' ' TRP . . . . . 0.59 ' CE2' ' SD ' ' A' ' 144' ' ' MET . 6.6 m95 -61.88 -53.42 56.06 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.675 0.75 . . . . 0.0 111.817 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 47.5 t80 -57.79 -46.5 84.53 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1095 ' ' ARG . . . . . 0.47 ' HE ' ' NH1' ' B' 1099 ' ' ARG . 77.4 ttt180 -39.93 -52.43 2.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.39 -40.43 99.05 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.272 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1097 ' ' LEU . . . . . 0.532 HD11 ' OE1' ' A' ' 84' ' ' GLU . 50.8 tp -56.35 -44.45 80.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 118.196 0.998 . . . . 0.0 109.214 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -57.74 -47.64 81.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1099 ' ' ARG . . . . . 0.47 ' NH1' ' HE ' ' B' 1095 ' ' ARG . 76.7 mtt85 -65.14 -37.43 87.4 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 82.4 mt -60.75 -42.36 91.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.666 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1101 ' ' GLN . . . . . 0.405 ' CD ' ' OE2' ' A' ' 84' ' ' GLU . 41.8 mt-30 -50.1 -45.12 52.43 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 118.744 -1.182 . . . . 0.0 108.025 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.518 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.9 m -63.56 -48.2 78.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.426 ' C ' ' O ' ' B' 1102 ' ' THR . 83.7 mt-30 -27.61 -58.97 0.11 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.647 1.213 . . . . 0.0 112.578 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -83.62 -14.89 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 112.198 -2.274 . . . . 0.0 112.314 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' 1102 ' ' THR . 65.0 tttm -59.59 -45.22 92.53 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 117.96 -1.496 . . . . 0.0 108.135 176.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.7 t -60.67 -48.99 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1107 ' ' VAL . . . . . 0.402 HG13 ' H ' ' B' 1107 ' ' VAL . 1.3 m -66.28 -36.53 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.346 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1108 ' ' LYS . . . . . 0.518 ' NZ ' HG21 ' A' ' 79' ' ' THR . 89.3 mttt -49.52 -38.82 32.06 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.606 -0.684 . . . . 0.0 109.562 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.95 -45.19 64.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.95 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -63.42 -50.2 70.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -67.79 -41.99 82.32 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1112 ' ' SER . . . . . 0.402 ' O ' ' OG ' ' B' 1113 ' ' SER . 1.2 m 68.53 58.82 0.41 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 117.173 -1.394 . . . . 0.0 107.347 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1113 ' ' SER . . . . . 0.402 ' OG ' ' O ' ' B' 1112 ' ' SER . 56.1 p . . . . . 0 N--CA 1.471 0.588 0 CA-C-N 123.719 2.963 . . . . 0.0 111.809 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 1' ' ' ALA . 98.0 m-20 -36.25 -78.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.323 0.582 . . . . 0.0 111.385 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -93.15 179.49 5.41 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.6 tp 167.38 -27.64 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 123.663 0.602 . . . . 0.0 109.442 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p -76.25 139.43 41.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.482 1.037 . . . . 0.0 110.744 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.65 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -50.83 -47.81 60.02 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.993 0.902 . . . . 0.0 110.684 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -38.5 -38.32 0.37 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.474 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.462 ' NE2' ' CE1' ' A' ' 12' ' ' PHE . 45.0 tp60 -68.74 -39.14 80.48 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 118.31 -0.853 . . . . 0.0 110.298 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.8 mt -58.97 -46.0 91.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 175.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.55 -50.65 62.48 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.114 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.02 -48.34 82.12 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.158 0.504 . . . . 0.0 112.282 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.0 m-85 -62.45 -40.63 97.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.835 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -50.86 -56.53 11.78 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.151 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -50.92 -41.88 59.02 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.95 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -54.21 -36.96 64.04 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.42 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.457 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 2.9 m-85 -58.42 -38.94 78.44 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -65.36 -15.52 62.65 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.458 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.8 mm? -65.59 -40.81 93.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -106.29 -14.6 15.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -72.13 93.21 1.4 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.642 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -68.17 -49.49 60.55 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.715 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.1 p-10 -102.32 15.68 28.46 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.53 44.0 0.41 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.451 -0.404 . . . . 0.0 112.171 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -85.35 -3.82 58.96 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.952 0.406 . . . . 0.0 110.978 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.76 -1.68 81.38 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.3 p -137.8 152.69 49.4 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.079 0.466 . . . . 0.0 110.035 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.26 124.74 44.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -113.95 163.91 14.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.427 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.412 HG22 HG13 ' A' ' 52' ' ' ILE . 20.9 p -58.14 -35.5 71.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.052 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -60.71 -60.39 3.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.209 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -62.39 -30.07 70.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.63 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 52' ' ' ILE . 3.2 tp -61.05 -55.53 31.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.255 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.75 -39.76 94.08 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.267 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -58.32 -54.99 40.71 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.954 1.377 . . . . 0.0 108.569 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -55.98 -46.75 80.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 118.859 0.754 . . . . 0.0 111.29 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.9 ttt -58.71 -40.05 82.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 120.413 1.46 . . . . 0.0 110.276 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -51.7 -38.38 54.89 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.344 0.592 . . . . 0.0 110.583 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.0 t -62.52 -19.89 64.07 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.047 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 tp -73.87 1.1 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.859 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.1 25.99 38.58 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.226 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -130.5 169.64 15.28 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.275 0.537 . . . . 0.0 109.887 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -133.28 77.29 66.79 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.295 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.74 148.08 93.86 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.823 2.349 . . . . 0.0 111.985 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.2 p -77.11 165.29 24.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.328 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 21.3 pt-20 -58.76 -44.99 90.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.66 -24.12 32.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.761 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -65.74 -39.8 91.49 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.174 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.2 mp -56.17 -41.5 75.59 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.175 0.512 . . . . 0.0 110.03 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -71.7 -56.42 5.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.48 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -55.65 -50.34 70.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.7 mmm -63.52 -52.08 62.75 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 32' ' ' LEU . 29.5 mm -58.29 -46.97 88.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.105 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -55.91 -34.22 65.39 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -66.72 -40.07 88.27 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.669 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.417 HG21 ' CE2' ' B' 1110 ' ' PHE . 40.0 t -86.75 -20.06 7.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.178 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.2 t0 -78.61 84.74 4.7 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -174.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.81 83.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.323 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.0 p-10 -86.17 -2.44 58.36 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.55 23.1 60.15 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.323 0.51 . . . . 0.0 112.686 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -86.71 3.84 43.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 117.189 0.494 . . . . 0.0 110.504 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.447 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.4 1.44 89.34 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 118.637 0.653 . . . . 0.0 114.702 175.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.8 p -148.14 167.92 23.77 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.25 128.35 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -103.03 -176.41 3.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.743 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.457 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -57.07 -46.75 99.83 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -176.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 31.4 Cg_exo -57.66 -51.9 7.27 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 121.462 1.442 . . . . 0.0 111.852 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.21 -20.97 64.75 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.43 0.633 . . . . 0.0 110.727 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -74.88 -59.87 2.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.687 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -54.98 -45.16 74.96 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 m -44.9 -50.51 10.39 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.912 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.6 mtm -65.42 -44.33 87.75 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 35.3 mmm -60.82 -41.46 95.78 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.16 77.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.337 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -92.43 -19.25 22.24 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.39 67.4 5.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.128 0.489 . . . . 0.0 110.297 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.5 mmt -107.76 15.3 24.71 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.356 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -48.29 133.89 15.27 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.37 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -89.68 107.89 19.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.943 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 m -93.83 120.57 34.28 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 82' ' ' GLU . 90.7 m-20 -70.28 112.28 6.49 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m -37.06 -20.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.828 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.579 ' N ' ' O ' ' A' ' 80' ' ' ASP . 96.2 mt-10 -69.15 -36.64 77.63 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.756 0.312 . . . . 0.0 111.585 -178.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -48.63 -35.86 14.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.25 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -89.07 -18.72 26.7 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.103 0.477 . . . . 0.0 111.794 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 85' ' ' ILE . 25.9 mm -58.92 -75.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.827 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -61.51 -37.53 84.05 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -63.66 -40.75 97.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.466 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.58 -20.84 63.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.001 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -72.22 -51.59 20.35 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.779 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -54.88 -41.77 71.25 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.67 -44.26 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.7 m-85 -69.28 -38.55 78.41 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.211 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.519 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 29.3 t0 -88.51 83.5 6.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.42 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 88.4 tttt -57.78 -49.41 76.69 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.2 p-10 -91.89 5.02 51.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.703 0.287 . . . . 0.0 111.59 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.28 49.55 50.31 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.694 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -91.33 5.27 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.488 0.315 . . . . 0.0 110.713 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.454 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 84.87 0.72 89.09 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.694 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 79.9 m-85 -138.38 151.26 47.35 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.72 0.771 . . . . 0.0 111.783 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.2 mt -93.83 117.21 36.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 t -89.99 150.08 22.29 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.76 -46.34 77.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.109 0.868 . . . . 0.0 110.788 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.31 62.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.836 0.35 . . . . 0.0 110.636 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.42 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.2 mt-10 -66.2 -41.46 90.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.557 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.0 -46.9 85.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.264 0.554 . . . . 0.0 110.822 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -42.89 -43.09 3.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.683 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -65.19 -29.24 70.04 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.005 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' A' ' 92' ' ' PHE . 96.7 t -58.08 -42.67 83.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.73 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.63 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.15 -45.96 61.85 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.784 0.802 . . . . 0.0 111.668 -177.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.6 p -55.84 -38.49 70.12 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.825 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -66.58 -40.89 89.17 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.892 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 73.4 mt -82.15 -13.14 57.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.79 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.21 30.83 62.25 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -86.17 -23.19 26.63 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 121.0 2.4 . . . . 0.0 110.856 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.9 mtmt 45.2 61.77 2.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.571 0.7 . . . . 0.0 110.497 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.1 mt -80.2 148.36 30.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.266 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.529 HG23 ' H ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -82.67 176.78 9.08 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.403 179.002 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.458 ' N ' ' OG1' ' A' ' 117' ' ' THR . 45.4 m-20 -59.7 -45.48 91.98 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.79 -46.95 81.23 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.529 ' H ' HG23 ' A' ' 117' ' ' THR . 76.4 mm-40 -70.38 -30.59 67.54 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.08 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.73 -42.18 95.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.34 -35.98 73.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.209 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -60.07 -53.2 60.61 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 81.9 mtp -54.96 -44.47 74.41 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.269 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.6 mt -58.18 -43.88 86.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.598 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -60.13 -36.38 77.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.836 0.35 . . . . 0.0 111.486 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -59.53 -41.06 89.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.055 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.6 -18.42 24.07 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.6 t0 -74.87 87.88 2.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.108 0.48 . . . . 0.0 111.868 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.406 HG22 ' OE2' ' A' ' 140' ' ' GLU . 10.8 tt -69.87 -15.1 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 122.523 1.154 . . . . 0.0 113.524 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.2 p-10 -143.07 145.71 33.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.159 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.79 52.35 1.6 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.883 -0.199 . . . . 0.0 113.213 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -90.74 -8.9 48.54 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 117.054 0.427 . . . . 0.0 110.219 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.85 1.36 72.38 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.986 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -134.67 154.43 51.54 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.227 0.514 . . . . 0.0 110.399 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.86 118.27 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.186 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.417 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 51.9 t30 -84.11 174.17 10.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.352 . . . . 0.0 111.065 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.417 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 84.0 t80 -61.15 -40.66 94.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.041 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.28 -44.62 96.11 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.946 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.406 ' OE2' HG22 ' A' ' 130' ' ' ILE . 96.8 mt-10 -64.87 -38.53 91.29 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.707 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -61.3 -44.7 96.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.907 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.22 -46.95 89.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.055 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -50.05 -43.05 50.81 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.891 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.7 mmt -74.93 -39.62 61.29 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.2 mmt -72.9 -47.42 45.94 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.9 p -88.71 32.32 0.8 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.802 0.334 . . . . 0.0 111.601 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -42.21 -33.36 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.237 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 82.4 tttt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.98 -179.548 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 53.5 tp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -147.44 78.25 1.46 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.181 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.604 ' C ' ' H ' ' B' 1090 ' ' GLN . 50.7 mtm180 46.43 47.87 13.91 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -56.79 1.61 0.11 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.604 ' H ' ' C ' ' B' 1088 ' ' ARG . 74.7 mt-30 -62.45 -47.55 83.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.918 0.389 . . . . 0.0 111.445 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 61.6 mt -58.72 -50.34 79.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.7 mt -56.32 -63.03 1.32 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 8.8 m95 -62.65 -55.69 24.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.257 0.551 . . . . 0.0 112.419 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.4 t80 -59.46 -46.55 88.45 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -43.05 -51.3 5.82 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.52 -41.89 99.65 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.1 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1097 ' ' LEU . . . . . 0.43 ' O ' ' NE2' ' B' 1101 ' ' GLN . 56.7 tp -56.91 -45.78 82.41 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.595 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 39.6 t30 -57.93 -47.47 82.77 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -64.69 -37.32 87.18 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.2 mt -61.33 -42.61 94.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.824 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1101 ' ' GLN . . . . . 0.43 ' NE2' ' O ' ' B' 1097 ' ' LEU . 2.8 mp0 -50.27 -46.47 55.1 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.524 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.7 m -63.19 -48.45 78.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.43 ' C ' ' O ' ' B' 1102 ' ' THR . 90.2 mt-30 -27.31 -59.64 0.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 122.745 1.26 . . . . 0.0 112.642 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -83.31 -14.72 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 112.475 -2.148 . . . . 0.0 112.198 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.524 ' N ' ' O ' ' B' 1102 ' ' THR . 66.3 tttm -59.93 -46.51 89.14 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 117.829 -1.548 . . . . 0.0 107.895 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.7 t -61.32 -49.31 85.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.6 m -65.54 -36.14 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.406 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 87.8 mttt -49.01 -38.15 22.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.642 0.656 . . . . 0.0 109.82 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.58 -45.5 66.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.289 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1110 ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 55' ' ' VAL . 45.0 m-85 -62.59 -50.02 72.92 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -68.17 -41.12 82.0 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.3 m 67.73 58.37 0.5 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 116.709 -1.615 . . . . 0.0 107.583 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 25.3 p . . . . . 0 C--N 1.348 0.539 0 CA-C-N 124.385 3.266 . . . . 0.0 112.036 179.512 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -63.94 -37.7 88.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.017 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.482 ' OE1' ' CD1' ' A' ' 12' ' ' PHE . 38.0 mt-30 -98.08 95.96 7.8 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.526 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.7 tp -108.88 -25.14 10.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.648 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.3 p -77.95 139.96 39.21 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.321 0.964 . . . . 0.0 110.317 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ILE . 45.8 tp10 -49.7 -57.23 7.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 122.281 1.039 . . . . 0.0 110.449 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 83.5 tt0 -34.7 -38.33 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.218 -1.81 . . . . 0.0 111.066 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -68.9 -37.05 78.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 118.07 -0.966 . . . . 0.0 110.65 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.3 mt -59.0 -44.75 91.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 175.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -53.92 -52.66 59.87 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.356 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.42 -47.77 84.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.441 0.639 . . . . 0.0 112.004 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.482 ' CD1' ' OE1' ' A' ' 3' ' ' GLN . 10.1 m-85 -62.36 -38.68 90.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.677 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -52.61 -54.84 27.67 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.467 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.31 -40.76 49.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.966 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.45 -37.65 70.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.095 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.406 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 3.4 m-85 -58.37 -41.12 84.07 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 t -64.04 -15.54 59.7 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.505 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.53 -42.25 95.87 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -106.01 -14.0 15.31 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -72.29 93.28 1.47 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.482 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -67.41 -49.49 63.58 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.983 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 23' ' ' GLY . 37.0 p30 -102.31 14.73 31.19 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.88 43.78 0.66 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.105 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -84.87 -3.47 58.7 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.764 0.316 . . . . 0.0 110.972 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.42 -1.72 82.3 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.7 p -137.87 153.04 49.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.225 0.536 . . . . 0.0 109.801 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 27' ' ' ILE . 4.4 mp -91.59 123.8 43.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.5 p -114.53 165.25 12.96 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 124.124 0.89 . . . . 0.0 112.335 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.415 HG22 HG13 ' A' ' 52' ' ' ILE . 23.7 p -58.62 -36.84 74.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.578 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.86 -60.65 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.496 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -62.06 -30.26 70.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.426 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tp -60.73 -53.78 53.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.219 1.009 . . . . 0.0 109.804 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.16 -37.68 94.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 113.593 -1.639 . . . . 0.0 111.825 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.6 m -58.69 -53.88 53.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 119.005 1.402 . . . . 0.0 108.537 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.88 -46.12 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 121.254 -0.904 . . . . 0.0 111.561 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.9 ttt -58.87 -41.57 87.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 119.99 1.268 . . . . 0.0 109.628 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -51.77 -34.81 41.3 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.648 0.737 . . . . 0.0 110.165 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.1 t -63.07 -20.34 65.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.589 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -75.82 2.81 11.31 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.163 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.52 17.0 74.48 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.956 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -109.26 160.99 15.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.462 0.631 . . . . 0.0 110.013 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -116.05 68.71 3.46 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.165 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.07 143.88 91.46 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.041 1.827 . . . . 0.0 112.291 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.7 p -81.01 165.28 21.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.42 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -58.69 -43.76 90.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.029 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.53 -23.64 27.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.536 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -66.0 -38.48 88.58 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.242 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.6 mp -56.57 -41.31 76.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.404 0.621 . . . . 0.0 109.733 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -71.09 -56.48 6.03 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.722 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -55.03 -49.55 71.29 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.9 mmm -66.0 -50.91 62.59 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 52' ' ' ILE . 26.9 mm -59.43 -48.18 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.618 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -57.79 -34.01 69.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -66.49 -40.43 89.26 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.547 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.409 HG21 ' CE2' ' B' 1110 ' ' PHE . 56.6 t -85.73 -20.88 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.544 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.16 86.56 4.29 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.81 87.46 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 113.308 -1.769 . . . . 0.0 113.906 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 37.8 p-10 -86.44 -2.46 58.46 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.35 23.05 61.86 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 118.451 0.568 . . . . 0.0 112.89 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -87.99 2.43 51.78 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.229 0.515 . . . . 0.0 110.335 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.483 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 86.0 0.97 87.07 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 121.714 -0.616 . . . . 0.0 114.572 175.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.8 p -148.51 170.42 18.09 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.79 129.48 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -103.67 -175.54 2.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.854 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.7 -46.99 99.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.725 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -55.49 -51.95 8.77 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.282 1.321 . . . . 0.0 111.76 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.74 -18.53 55.18 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.446 0.641 . . . . 0.0 110.617 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -76.36 -57.82 3.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.553 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.84 -46.08 85.27 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.3 m -45.31 -49.37 12.78 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.369 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 72.5 mtm -66.16 -44.53 83.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.2 mmt -58.75 -41.65 87.03 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.77 -34.02 77.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.551 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -94.9 -9.29 34.62 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.527 0.203 . . . . 0.0 111.304 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.691 ' HZ2' ' N ' ' B' 1109 ' ' ALA . 0.3 OUTLIER -82.01 69.36 8.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.55 0.69 . . . . 0.0 111.047 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.26 18.29 21.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.126 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -51.19 130.2 25.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.034 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -89.62 108.74 19.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.055 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.7 m -93.59 119.38 32.55 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.2 m-20 -69.32 111.66 5.37 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 173.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.9 m -37.48 -21.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.642 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.5 mp0 -69.42 -35.33 75.62 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -48.83 -37.21 18.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.393 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' OE2' ' NE2' ' B' 1101 ' ' GLN . 10.6 pt-20 -89.28 -13.24 38.5 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 85' ' ' ILE . 24.5 mm -63.14 -74.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.993 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -63.02 -39.41 94.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -63.05 -40.95 99.25 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.436 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.54 -18.4 59.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.937 0.398 . . . . 0.0 111.062 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -74.45 -48.74 25.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.012 0.434 . . . . 0.0 111.327 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -55.16 -41.77 72.28 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.64 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -64.84 -43.9 96.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.4 m-85 -69.02 -38.54 79.28 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.518 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -85.48 81.22 8.8 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -58.24 -49.32 77.51 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -91.23 5.23 49.93 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.365 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.84 48.35 51.24 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -91.37 6.79 43.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.752 0.31 . . . . 0.0 110.673 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.73 1.95 89.9 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.696 -0.561 . . . . 0.0 111.696 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -140.51 153.95 46.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.686 0.755 . . . . 0.0 111.521 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.6 mt -93.97 114.61 30.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.1 t -89.07 151.61 22.14 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.82 -47.03 83.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 119.067 0.849 . . . . 0.0 110.638 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.02 -35.35 61.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.894 0.378 . . . . 0.0 110.278 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.56 -39.52 73.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.076 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.45 -47.36 76.43 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.231 0.539 . . . . 0.0 112.187 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.4 -33.71 2.71 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.235 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -72.49 -28.91 63.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.567 HG21 ' CE2' ' A' ' 92' ' ' PHE . 75.0 t -58.08 -41.42 80.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.734 -178.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.536 ' HG3' HD13 ' A' ' 116' ' ' LEU . 4.6 mmt -53.22 -47.24 69.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.301 1.048 . . . . 0.0 111.789 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.1 p -55.56 -35.52 65.81 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 113.115 -1.857 . . . . 0.0 110.925 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -36.45 82.59 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.043 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.0 mt -84.5 -11.25 56.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.94 36.71 51.66 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.46 -22.8 23.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.827 2.314 . . . . 0.0 111.18 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.7 tptt 44.78 59.78 3.23 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.549 1.166 . . . . 0.0 109.993 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.536 HD13 ' HG3' ' A' ' 109' ' ' MET . 0.8 OUTLIER -76.57 150.96 36.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.602 -2.09 . . . . 0.0 113.386 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.3 p -84.35 175.43 9.37 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.973 0.416 . . . . 0.0 109.927 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -56.36 -45.13 80.61 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.77 -40.81 69.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.027 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.77 -30.13 68.66 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.619 -0.432 . . . . 0.0 112.105 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.34 -43.57 98.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.501 0.667 . . . . 0.0 109.504 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -74.13 -35.82 64.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.816 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -60.77 -55.27 35.08 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 97.7 mmm -48.83 -60.39 2.79 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.472 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.3 pt -50.57 -40.74 19.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.719 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -61.98 -35.36 78.25 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.704 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -57.21 -40.68 77.96 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.219 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.24 -12.91 25.44 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.3 t0 -73.51 87.34 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.425 0.631 . . . . 0.0 111.789 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.0 pt -71.49 -11.86 15.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 122.484 1.135 . . . . 0.0 113.561 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 52.5 p-10 -143.21 142.59 31.46 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 112.265 -2.243 . . . . 0.0 109.035 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.67 52.46 0.9 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.692 -0.29 . . . . 0.0 113.436 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -91.29 -11.19 38.79 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.172 0.486 . . . . 0.0 110.111 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.69 2.79 70.92 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.195 -0.526 . . . . 0.0 114.385 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -134.13 152.94 52.07 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.134 0.467 . . . . 0.0 110.318 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.48 118.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.455 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -84.58 173.79 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 0.0 110.877 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -61.05 -40.08 92.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.026 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.5 -44.81 95.47 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.914 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.39 -37.96 89.31 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.419 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.17 -45.69 93.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.3 t -65.69 -48.58 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.767 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -49.02 -45.96 43.34 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.972 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.475 ' O ' ' CE1' ' B' 1094 ' ' PHE . 13.2 mmt -72.73 -38.99 67.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 18.1 mmt -75.56 -45.09 39.9 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 m -91.12 30.43 1.24 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.98 89.43 6.4 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.091 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.7 tttm . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.518 179.828 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 49.3 tp . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B 1087 ' ' ARG . . . . . 0.431 ' C ' ' H ' ' B' 1089 ' ' GLY . 99.9 mtt180 44.67 68.09 0.6 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.345 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.624 ' C ' ' H ' ' B' 1090 ' ' GLN . 68.8 ttt-85 -70.66 6.75 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B 1089 ' ' GLY . . . . . 0.431 ' H ' ' C ' ' B' 1087 ' ' ARG . . . -61.66 9.42 0.1 Allowed Glycine 0 CA--C 1.534 1.228 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.624 ' H ' ' C ' ' B' 1088 ' ' ARG . 76.0 mt-30 -58.67 -44.21 90.12 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B 1091 ' ' ILE . . . . . 0.453 HD11 ' NH1' ' B' 1088 ' ' ARG . 56.2 mt -54.88 -53.48 32.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 10.0 mt -57.16 -58.22 9.16 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.222 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 5.5 m95 -60.55 -62.51 1.81 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.238 0.542 . . . . 0.0 112.415 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B 1094 ' ' PHE . . . . . 0.475 ' CE1' ' O ' ' A' ' 144' ' ' MET . 48.8 m-85 -57.78 -44.69 86.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -39.37 -52.04 2.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.52 -41.66 99.77 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.178 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B 1097 ' ' LEU . . . . . 0.429 HD11 ' OE1' ' A' ' 84' ' ' GLU . 50.8 tp -56.35 -45.22 80.55 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.454 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -59.07 -47.32 85.68 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.651 -175.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -65.38 -37.48 87.13 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.22 -42.01 91.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.868 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B 1101 ' ' GLN . . . . . 0.458 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 68.7 mt-30 -51.34 -45.95 62.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.528 ' O ' ' N ' ' B' 1105 ' ' LYS . 93.9 m -63.47 -47.95 79.67 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.912 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 84.3 mt-30 -28.06 -57.62 0.11 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.741 1.258 . . . . 0.0 112.572 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.7 mt -84.27 -14.81 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 112.085 -2.325 . . . . 0.0 112.313 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.538 ' O ' ' NZ ' ' A' ' 75' ' ' LYS . 88.8 tttt -59.54 -44.72 93.13 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.954 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 67.5 t -61.49 -49.11 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B 1107 ' ' VAL . . . . . 0.402 HG13 ' H ' ' B' 1107 ' ' VAL . 1.4 m -65.83 -36.09 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.322 -177.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 89.7 mttt -49.88 -37.55 31.7 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.682 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B 1109 ' ' ALA . . . . . 0.691 ' N ' ' HZ2' ' A' ' 75' ' ' LYS . . . -51.41 -45.06 62.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.784 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B 1110 ' ' PHE . . . . . 0.409 ' CE2' HG21 ' A' ' 55' ' ' VAL . 46.8 m-85 -63.88 -49.73 71.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -67.72 -42.47 81.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.2 m 68.82 59.21 0.37 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.476 0.833 0 CA-C-N 123.769 2.986 . . . . 0.0 111.885 179.346 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.9 p30 -87.75 -0.39 56.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.474 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.535 ' C ' HD22 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -106.41 110.14 22.27 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.776 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.535 HD22 ' C ' ' A' ' 3' ' ' GLN . 4.1 mm? -111.4 -17.63 13.07 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.554 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -79.14 137.26 37.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.365 0.984 . . . . 0.0 110.306 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 9' ' ' ILE . 21.3 mt-10 -54.42 -49.98 68.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.132 0.968 . . . . 0.0 110.43 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 42.8 tp10 -34.32 -36.39 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.569 -1.65 . . . . 0.0 111.102 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -69.12 -36.04 77.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.265 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 6' ' ' GLU . 88.4 mt -58.82 -43.95 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -53.81 -50.53 65.94 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.893 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -63.49 -45.79 89.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.325 0.583 . . . . 0.0 112.05 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.5 m-85 -62.51 -40.42 96.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.888 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -49.95 -57.19 8.02 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.472 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -49.66 -40.43 39.69 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.04 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.7 -37.58 71.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.203 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.518 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 3.0 m-85 -57.79 -41.62 82.47 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.1 t -64.37 -15.7 60.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.65 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.87 -42.59 97.47 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -106.07 -13.97 15.3 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -74.08 95.65 2.58 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.203 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -68.74 -52.83 26.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.44 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.5 p-10 -98.77 13.97 30.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.72 45.22 1.01 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.024 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 32.7 p-10 -85.28 -3.82 58.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.665 0.269 . . . . 0.0 110.875 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.5 -0.79 78.11 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -139.99 153.99 47.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.11 0.481 . . . . 0.0 110.025 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 27' ' ' ILE . 5.1 mp -93.2 124.56 45.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -112.79 165.29 12.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.513 0.673 . . . . 0.0 112.405 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.7 p -59.5 -35.83 74.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.322 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -61.6 -61.73 2.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.77 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.53 -30.12 70.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.715 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.457 HD22 HD11 ' A' ' 52' ' ' ILE . 2.7 tp -60.42 -53.63 55.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.875 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.55 93.54 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.927 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.63 -51.47 69.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.816 1.308 . . . . 0.0 108.936 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.0 t -59.33 -46.01 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 118.739 0.699 . . . . 0.0 111.042 -176.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.0 ttt -59.01 -41.48 87.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.552 1.069 . . . . 0.0 109.654 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -52.1 -37.08 52.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.733 0.778 . . . . 0.0 110.247 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 p -62.71 -20.6 65.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.702 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.7 mt -75.53 1.6 13.82 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.104 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.1 17.44 67.17 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.154 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -109.11 158.7 17.53 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 117.498 0.649 . . . . 0.0 109.955 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -114.2 65.47 1.43 Allowed Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.13 142.4 91.92 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.03 1.82 . . . . 0.0 112.081 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -80.94 165.27 21.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.246 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -58.17 -43.88 87.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.74 -24.57 50.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.484 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -64.85 -40.19 94.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.209 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.7 mp -55.41 -38.5 69.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.404 0.621 . . . . 0.0 109.354 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -71.66 -56.01 6.64 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.095 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -54.06 -49.23 69.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.5 mtp -68.4 -48.61 64.22 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.457 HD11 HD22 ' A' ' 32' ' ' LEU . 24.3 mm -59.46 -47.58 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.7 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -58.49 -33.8 70.21 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.93 -39.85 90.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.539 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.2 t -86.69 -20.27 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 121.154 -0.218 . . . . 0.0 111.33 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.53 87.44 4.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -175.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.98 -37.33 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 113.535 -1.666 . . . . 0.0 113.987 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.4 p-10 -86.35 -2.69 58.64 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.2 23.27 61.81 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 118.338 0.517 . . . . 0.0 112.709 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.4 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 51.5 p-10 -88.15 3.63 48.49 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.422 0.611 . . . . 0.0 110.423 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.46 0.72 89.39 Favored Glycine 0 CA--C 1.522 0.525 0 O-C-N 121.74 -0.6 . . . . 0.0 114.423 175.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.7 p -147.74 169.78 18.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.8 mt -114.66 128.77 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -103.88 -173.94 2.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.705 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.518 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -58.84 -46.62 99.54 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.34 -51.72 7.93 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 121.245 1.297 . . . . 0.0 111.85 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.55 -18.36 61.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.485 0.659 . . . . 0.0 110.687 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -75.19 -58.76 3.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.907 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.8 mt -57.49 -42.6 83.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -46.04 -49.35 16.37 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.566 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.21 -45.23 77.44 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.5 mmm -61.06 -40.34 93.3 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.4 78.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.229 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -94.34 -10.05 33.93 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.831 0.348 . . . . 0.0 111.467 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.19 67.45 8.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.249 0.547 . . . . 0.0 110.487 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 mmt -108.63 15.19 23.94 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.696 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -49.46 133.45 20.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.061 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 45.2 p-10 -92.66 105.2 17.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.932 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.7 m -88.24 123.04 32.46 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 82' ' ' GLU . 96.6 m-20 -69.87 112.05 6.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.0 m -37.6 -21.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.726 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 80' ' ' ASP . 54.2 mp0 -69.14 -36.32 77.32 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -48.67 -36.45 16.09 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.252 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.514 ' OE2' ' NE2' ' B' 1101 ' ' GLN . 11.1 pt-20 -89.11 -13.86 37.56 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 85' ' ' ILE . 24.9 mm -62.84 -74.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.279 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -62.41 -41.12 98.44 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -62.98 -40.39 97.59 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.488 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.83 -17.02 54.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.003 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -73.79 -49.3 25.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.021 0.438 . . . . 0.0 111.35 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -55.09 -41.74 71.99 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.604 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.54 -43.96 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -68.52 -39.41 81.22 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.486 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -85.28 81.84 8.62 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.13 -50.18 74.41 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -90.88 5.4 48.68 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.216 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.15 48.49 46.59 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -89.93 6.23 42.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.756 0.312 . . . . 0.0 110.609 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.54 2.76 84.63 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -144.23 157.7 44.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.742 0.782 . . . . 0.0 111.553 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -94.63 114.32 30.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -87.49 151.75 22.77 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.89 78.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 119.036 0.834 . . . . 0.0 110.842 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.01 -40.89 64.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.993 0.425 . . . . 0.0 110.238 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.91 -44.09 86.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.734 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.501 ' O ' HG12 ' A' ' 108' ' ' VAL . 7.1 tt -62.84 -47.56 82.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.83 0.348 . . . . 0.0 111.764 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -41.16 -45.02 2.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.101 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -57.14 -26.99 61.44 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.529 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 105' ' ' LEU . 2.0 p -56.45 -41.34 71.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.22 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -50.32 59.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 122.248 1.023 . . . . 0.0 111.245 -177.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.8 m -51.44 -40.85 60.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.483 -1.689 . . . . 0.0 110.775 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.99 -41.25 95.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.06 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.9 mt -82.91 -14.41 54.23 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.79 55.77 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.553 -1.137 . . . . 0.0 110.42 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -86.72 -22.42 26.03 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.385 2.092 . . . . 0.0 110.866 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 43.49 60.34 2.66 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.281 1.039 . . . . 0.0 110.172 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.1 mt -80.87 148.69 29.81 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.599 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 76.5 p -83.0 175.36 10.1 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -57.63 -44.67 85.74 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.31 -48.58 80.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.324 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -70.49 -31.07 68.03 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.916 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.19 -42.29 95.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -68.04 -36.56 80.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.792 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.22 -50.53 73.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.706 0.765 . . . . 0.0 112.916 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 19.3 mmm -57.85 -42.75 85.09 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.89 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.3 mt -60.08 -43.65 93.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.048 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -59.67 -38.67 82.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.743 0.306 . . . . 0.0 111.168 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.75 -41.62 86.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.16 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.46 -25.49 21.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.0 t0 -71.58 88.47 0.95 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.451 0.643 . . . . 0.0 111.842 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.5 tp -70.11 -14.58 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 122.844 1.307 . . . . 0.0 113.147 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 37.2 p-10 -141.04 144.15 34.81 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 112.402 -2.181 . . . . 0.0 109.486 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.34 52.22 1.08 Allowed Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.403 -0.427 . . . . 0.0 113.0 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.408 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 37.5 p-10 -91.63 -9.85 42.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.259 0.529 . . . . 0.0 110.167 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.55 3.41 78.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 114.168 0.427 . . . . 0.0 114.168 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -135.14 154.56 51.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 117.243 0.522 . . . . 0.0 110.422 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.6 t -101.19 118.64 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.462 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.414 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 51.9 t30 -84.21 173.18 11.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.922 0.392 . . . . 0.0 110.981 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.414 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 80.4 t80 -60.82 -40.98 94.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.222 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.11 -44.55 97.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.152 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.92 -38.37 90.74 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.654 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -61.33 -45.68 93.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.952 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.404 ' O ' ' OG1' ' A' ' 146' ' ' THR . 73.2 t -64.76 -46.39 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.5 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -51.0 -43.22 60.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.805 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.4 mmt -75.15 -39.88 60.04 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.7 mmt -71.43 -47.76 53.81 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.837 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 3.1 p -87.8 35.02 0.72 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.904 0.383 . . . . 0.0 110.945 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -45.96 -51.8 12.77 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.871 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.4 mttm . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.302 179.874 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B 1087 ' ' ARG . . . . . 0.476 ' C ' ' H ' ' B' 1089 ' ' GLY . 41.7 ttm180 -60.5 -43.37 97.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.466 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.646 ' C ' ' H ' ' B' 1090 ' ' GLN . 56.7 ttt180 -67.15 6.66 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B 1089 ' ' GLY . . . . . 0.476 ' H ' ' C ' ' B' 1087 ' ' ARG . . . -61.07 11.02 0.06 OUTLIER Glycine 0 CA--C 1.534 1.25 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.171 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.646 ' H ' ' C ' ' B' 1088 ' ' ARG . 76.1 mt-30 -60.82 -45.72 93.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.018 0.437 . . . . 0.0 111.304 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 56.1 mt -60.5 -47.98 90.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.338 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 18.8 mt -57.71 -66.83 0.4 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.9 m95 -62.04 -55.6 27.47 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.541 0.686 . . . . 0.0 112.626 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.6 t80 -60.51 -47.41 86.28 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -173.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -39.65 -50.78 2.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.69 -40.15 98.82 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.269 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.5 tp -56.44 -45.02 81.0 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.993 0.896 . . . . 0.0 109.702 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 42.1 t30 -59.23 -46.91 87.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.515 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -65.42 -38.41 89.81 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.7 mt -60.88 -41.94 90.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.271 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B 1101 ' ' GLN . . . . . 0.514 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 66.5 mt-30 -52.48 -46.58 66.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.505 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.0 m -63.71 -48.28 77.72 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.835 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.447 ' C ' ' O ' ' B' 1102 ' ' THR . 90.6 mt-30 -28.0 -55.5 0.11 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 123.11 1.433 . . . . 0.0 112.758 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.1 mt -84.75 -14.88 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 112.193 -2.276 . . . . 0.0 112.641 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.505 ' N ' ' O ' ' B' 1102 ' ' THR . 87.6 mttt -59.74 -42.7 93.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 117.97 -1.492 . . . . 0.0 108.86 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 81.7 t -61.42 -48.91 86.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.2 m -66.97 -36.64 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.906 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.5 mttt -49.79 -38.34 33.9 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.623 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.02 -44.42 64.15 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.217 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -63.95 -50.64 67.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -67.68 -42.87 81.39 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 69.5 57.88 0.33 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 117.362 -1.304 . . . . 0.0 107.731 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 84.7 p . . . . . 0 C--O 1.218 -0.583 0 CA-C-N 123.099 2.682 . . . . 0.0 111.853 179.721 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.556 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 82.3 m-20 -92.16 6.27 47.25 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.202 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.556 ' HB2' ' O ' ' A' ' 2' ' ' ASP . 43.7 mt-30 100.86 18.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.783 1.302 . . . . 0.0 110.907 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 50.7 tp -107.4 -29.17 9.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.501 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.1 p -77.08 140.02 40.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.332 0.969 . . . . 0.0 109.863 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ILE . 47.9 tp10 -47.28 -63.48 1.03 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 122.149 0.976 . . . . 0.0 110.319 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 84.2 tt0 -34.16 -37.4 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.087 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -70.18 -36.14 74.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.577 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 6' ' ' GLU . 93.1 mt -59.57 -44.29 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 175.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.39 -49.42 64.47 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.401 -177.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -63.49 -45.14 92.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.51 0.671 . . . . 0.0 112.379 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.453 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.6 m-85 -63.15 -41.28 99.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.987 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -52.62 -57.04 11.3 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.442 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -46.8 -41.8 16.04 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.597 . . . . 0.0 110.363 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -55.38 -35.88 65.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.27 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.81 -39.73 81.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -64.77 -15.88 62.24 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.083 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 18' ' ' LEU . 7.3 mp -65.01 -40.81 95.46 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -106.13 -14.39 15.16 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -72.56 92.79 1.53 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.211 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -67.63 -49.84 61.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.76 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.0 p-10 -102.41 15.42 29.26 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.26 44.24 0.55 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.171 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.8 p30 -85.3 -4.24 59.09 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.282 . . . . 0.0 110.932 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.95 -2.26 81.65 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.2 p -137.33 152.12 49.38 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.106 0.479 . . . . 0.0 109.767 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.5 mp -91.61 123.98 43.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.3 p -113.07 163.88 14.17 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.492 0.663 . . . . 0.0 112.425 -177.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -58.59 -36.32 73.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.487 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -62.04 -61.51 2.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.43 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -61.03 -30.69 70.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.576 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 tp -60.62 -54.5 44.67 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.243 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.14 95.32 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.17 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 m -58.22 -53.59 56.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.759 1.279 . . . . 0.0 108.794 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -57.36 -46.47 85.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 121.414 -0.804 . . . . 0.0 111.405 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.0 ttt -59.38 -40.15 85.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 119.888 1.222 . . . . 0.0 109.727 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -53.72 -41.77 67.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.529 0.681 . . . . 0.0 110.229 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 p -63.4 -21.6 66.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.125 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.91 -2.7 24.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.835 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.24 14.81 59.8 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.495 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -107.88 155.29 20.45 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.541 0.671 . . . . 0.0 109.825 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.93 63.95 1.57 Allowed Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.339 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -62.85 144.24 93.11 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.214 1.943 . . . . 0.0 112.251 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 44' ' ' THR . 1.7 t -80.31 167.69 19.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.111 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 15.6 pt-20 -58.85 -44.75 91.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.001 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.436 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -56.08 -23.52 34.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.43 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -65.82 -39.45 90.86 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.584 -0.446 . . . . 0.0 109.964 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -56.53 -41.41 76.72 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.525 0.678 . . . . 0.0 109.468 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -70.39 -57.1 5.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.863 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -53.69 -48.69 69.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.338 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 31.7 mmm -66.74 -50.19 63.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.9 mm -58.71 -48.33 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.622 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -56.53 -34.83 67.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -66.07 -39.68 90.26 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.852 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.454 HG21 ' CE2' ' B' 1110 ' ' PHE . 73.5 t -86.07 -20.46 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.577 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.479 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.3 t0 -79.22 85.33 5.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -175.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.37 84.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.391 -1.731 . . . . 0.0 114.187 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 39.7 p-10 -86.47 -2.72 58.69 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.27 23.06 63.88 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 118.398 0.544 . . . . 0.0 112.752 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.429 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -87.89 2.06 52.47 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 117.418 0.609 . . . . 0.0 110.664 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.479 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.53 1.82 87.49 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 118.603 0.638 . . . . 0.0 114.552 175.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.3 p -146.36 166.63 25.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.35 126.7 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -102.93 -177.09 3.27 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -47.01 99.55 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -176.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.45 -51.51 9.09 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 120.995 1.13 . . . . 0.0 111.66 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.63 -18.77 60.84 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.416 0.627 . . . . 0.0 110.521 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -75.8 -59.28 2.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.063 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.02 -44.45 82.87 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.7 m -45.92 -48.06 16.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.399 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.1 mtm -66.88 -45.02 79.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.0 mmm -61.3 -41.31 96.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.12 -35.16 79.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.41 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -92.12 -16.36 26.45 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.813 0.339 . . . . 0.0 111.414 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.493 ' HZ1' ' HG3' ' B' 1105 ' ' LYS . 28.4 tptp -80.18 72.09 6.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.612 0.72 . . . . 0.0 110.562 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.9 19.39 20.12 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.983 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -49.87 129.99 20.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.146 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.52 109.35 20.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.861 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.2 p -99.3 111.75 24.06 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.582 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -60.4 117.85 5.75 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.013 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 m -37.37 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.711 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 80' ' ' ASP . 80.5 tt0 -68.67 -35.57 77.41 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -49.98 -38.8 38.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.259 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -87.21 -19.44 28.38 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.092 0.473 . . . . 0.0 111.671 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.8 mm -60.41 -74.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.679 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.6 mtm180 -62.77 -41.55 99.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.7 -40.57 92.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.408 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.53 -17.48 46.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.007 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -74.17 -49.59 22.95 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.223 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -55.68 -43.18 76.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.435 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.82 -43.56 93.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.7 m-85 -68.68 -38.8 80.62 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.393 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -86.23 82.36 8.06 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -57.64 -50.21 73.91 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -91.04 5.83 47.3 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.277 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.21 47.81 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -90.32 7.47 38.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.667 0.27 . . . . 0.0 110.616 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.18 2.16 89.37 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -141.48 153.62 45.05 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.809 0.814 . . . . 0.0 111.756 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -96.05 117.04 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.3 p -91.34 153.69 19.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.73 83.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 119.227 0.921 . . . . 0.0 110.906 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.64 -41.9 64.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.891 0.377 . . . . 0.0 110.617 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -64.35 -43.26 95.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.54 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 108' ' ' VAL . 11.5 mt -62.76 -44.95 94.85 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.324 0.583 . . . . 0.0 111.391 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -42.5 -43.17 3.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.651 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -63.28 -27.33 69.26 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.035 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.567 HG21 ' CE2' ' A' ' 92' ' ' PHE . 94.0 t -58.07 -42.83 83.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.651 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.649 ' HG3' HD13 ' A' ' 116' ' ' LEU . 15.1 mmt -51.35 -44.46 62.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.204 1.002 . . . . 0.0 111.458 -177.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.6 m -55.36 -41.1 72.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.885 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -64.73 -39.84 94.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.538 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.3 mt -83.44 -13.56 54.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.63 35.89 50.09 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.396 -1.224 . . . . 0.0 110.482 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.5 ' OE1' ' SD ' ' A' ' 109' ' ' MET . 80.7 tt0 -89.78 -24.57 21.45 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.729 2.265 . . . . 0.0 110.879 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.0 tptp 45.89 63.0 1.99 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.551 1.167 . . . . 0.0 110.096 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.872 HD23 ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -76.31 150.92 36.85 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.955 -1.929 . . . . 0.0 112.854 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.2 p -86.3 174.16 9.25 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.367 0.603 . . . . 0.0 109.952 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -54.42 -44.02 72.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -55.83 -41.63 74.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.219 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -68.4 -28.98 67.57 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.721 -178.724 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.477 ' CG2' HD11 ' A' ' 116' ' ' LEU . 52.6 t -63.8 -44.07 98.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.33 0.586 . . . . 0.0 109.773 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.66 -37.33 65.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.292 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -58.73 -54.95 41.29 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.422 ' CE ' HD12 ' B' 1092 ' ' LEU . 95.1 mtp -57.17 -43.19 82.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.746 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.6 mm -58.7 -44.0 88.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.132 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -60.65 -35.68 76.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.348 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.98 -42.23 89.49 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.69 -20.15 21.88 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.6 t0 -70.45 90.29 0.72 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.539 0.685 . . . . 0.0 112.069 -177.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.0 -16.12 19.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 122.711 1.243 . . . . 0.0 113.219 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.6 p-10 -143.82 144.99 32.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 112.334 -2.212 . . . . 0.0 109.443 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.05 52.74 1.36 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.961 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -91.17 -9.29 45.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.087 0.443 . . . . 0.0 110.145 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.64 2.14 74.38 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.401 -0.428 . . . . 0.0 114.115 176.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -133.75 153.05 52.0 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 117.36 0.58 . . . . 0.0 110.477 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.1 t -99.15 118.23 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.145 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.416 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 52.2 t30 -84.0 173.61 11.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.977 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.416 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 82.9 t80 -61.37 -39.33 90.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.929 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.72 -44.66 92.95 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.015 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.17 -38.67 91.29 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.567 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -61.04 -44.74 96.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.799 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 82.8 t -65.86 -46.27 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.471 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -49.23 -44.87 43.83 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.008 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.3 mmm -75.66 -39.98 56.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.2 mmt -76.21 -46.86 26.28 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.341 -0.144 . . . . 0.0 111.069 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.2 m -91.52 34.14 0.98 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 111.446 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -45.83 -39.23 8.2 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.882 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.7 tttp . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.203 -179.919 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 51.5 tp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B 1087 ' ' ARG . . . . . 0.545 ' C ' ' H ' ' B' 1089 ' ' GLY . 10.3 ptp85 -146.81 166.9 25.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.536 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.622 ' C ' ' H ' ' B' 1090 ' ' GLN . 28.1 ttm180 -64.57 7.87 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B 1089 ' ' GLY . . . . . 0.545 ' H ' ' C ' ' B' 1087 ' ' ARG . . . -61.83 9.49 0.11 Allowed Glycine 0 CA--C 1.534 1.22 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.622 ' H ' ' C ' ' B' 1088 ' ' ARG . 17.4 mt-30 -60.4 -46.11 91.18 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.009 0.433 . . . . 0.0 111.619 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 71.4 mt -55.22 -53.66 32.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B 1092 ' ' LEU . . . . . 0.511 ' O ' HD13 ' B' 1092 ' ' LEU . 0.3 OUTLIER -57.26 -60.82 3.04 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.754 -176.363 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 4.7 m95 -58.6 -60.65 3.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.574 0.702 . . . . 0.0 112.095 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -46.64 82.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -174.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B 1095 ' ' ARG . . . . . 0.646 HH11 ' NH2' ' B' 1099 ' ' ARG . 63.7 ttm-85 -36.51 -51.97 0.84 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.79 -40.1 98.35 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.179 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.65 -44.18 81.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 118.031 0.916 . . . . 0.0 109.628 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -59.63 -49.52 77.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.767 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B 1099 ' ' ARG . . . . . 0.646 ' NH2' HH11 ' B' 1095 ' ' ARG . 3.2 mpt_? -65.72 -39.22 90.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.302 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.74 -43.33 94.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.509 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -55.49 -45.15 77.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.513 ' O ' ' C ' ' B' 1103 ' ' GLN . 90.4 m -60.9 -48.56 81.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.955 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.513 ' C ' ' O ' ' B' 1102 ' ' THR . 86.1 mt-30 -28.29 -97.54 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 123.238 1.494 . . . . 0.0 112.137 -175.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -39.47 -14.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 111.806 -2.452 . . . . 0.0 111.752 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.493 ' HG3' ' HZ1' ' A' ' 75' ' ' LYS . 52.5 tttp -60.4 -44.63 95.5 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 118.01 -1.476 . . . . 0.0 107.476 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.5 t -61.45 -48.97 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B 1107 ' ' VAL . . . . . 0.407 ' H ' HG13 ' B' 1107 ' ' VAL . 1.2 m -66.83 -37.88 80.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.96 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 63.4 mttt -49.87 -39.41 39.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.205 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -50.86 -44.91 59.63 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.035 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B 1110 ' ' PHE . . . . . 0.454 ' CE2' HG21 ' A' ' 55' ' ' VAL . 45.2 m-85 -63.46 -48.53 77.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -68.74 -41.98 78.23 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.74 57.33 0.42 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 117.421 -1.276 . . . . 0.0 107.753 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.218 -0.58 0 CA-C-N 123.823 3.01 . . . . 0.0 110.907 179.962 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.28 -18.37 63.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.77 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -100.47 99.7 10.35 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.0 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.69 -19.52 12.84 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.697 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.2 p -80.45 139.31 36.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.256 0.935 . . . . 0.0 110.384 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 9' ' ' ILE . 48.4 tp10 -50.98 -54.65 22.59 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.798 0.808 . . . . 0.0 110.519 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -35.77 -37.57 0.1 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.096 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -68.99 -37.54 78.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.605 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.8 mt -58.64 -45.64 90.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 175.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.39 -51.58 62.1 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.393 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -61.6 -47.06 87.15 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.468 0.651 . . . . 0.0 112.622 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -62.9 -36.86 84.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.556 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -55.16 -51.51 66.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.373 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.77 -41.82 61.93 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.31 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.47 -39.14 67.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.212 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -56.29 -41.51 76.04 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -65.28 -14.69 61.32 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.441 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.2 tp -63.25 -43.45 97.96 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -107.06 -13.73 15.11 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.99 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -76.27 95.43 3.74 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.098 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -68.34 -46.99 68.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.297 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.5 p-10 -101.63 14.84 30.76 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.65 46.85 0.6 Allowed Glycine 0 CA--C 1.533 1.195 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -84.15 -3.44 58.13 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.43 -1.58 82.13 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.425 ' C ' HD12 ' A' ' 27' ' ' ILE . 57.7 p -137.39 151.88 49.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.918 0.389 . . . . 0.0 110.168 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.7 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -93.49 125.73 46.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.509 HG23 ' H ' ' A' ' 30' ' ' LYS . 1.9 t -115.29 164.27 14.48 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.176 -0.92 . . . . 0.0 113.182 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.4 HG22 HG13 ' A' ' 52' ' ' ILE . 20.0 p -57.66 -36.08 71.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.83 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.509 ' H ' HG23 ' A' ' 28' ' ' THR . 34.5 ttpt -60.97 -58.5 8.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.85 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -64.36 -28.68 69.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.448 HD22 HD11 ' A' ' 52' ' ' ILE . 3.2 tp -61.41 -56.1 24.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.78 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.22 -37.64 87.43 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.365 -1.288 . . . . 0.0 112.11 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.7 m -57.85 -54.57 45.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.911 1.356 . . . . 0.0 107.619 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.9 t -55.96 -46.05 80.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 118.852 0.751 . . . . 0.0 111.515 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.1 mmm -58.35 -42.34 86.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 119.963 1.256 . . . . 0.0 110.229 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -54.48 -41.77 69.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.441 0.639 . . . . 0.0 110.786 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -63.6 -21.32 66.29 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.83 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 tp -73.95 -2.54 24.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.851 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.78 14.51 62.98 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.164 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -109.31 156.79 19.55 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.537 0.669 . . . . 0.0 109.518 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -119.67 65.67 9.42 Favored Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.53 145.45 76.56 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.163 1.909 . . . . 0.0 112.03 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 m -78.22 159.29 28.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.268 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -52.49 -41.84 63.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.696 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.79 -25.21 26.61 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -65.61 -39.73 91.85 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.065 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.52 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.7 mp -56.19 -41.45 75.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.327 0.585 . . . . 0.0 109.909 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -67.31 -57.35 6.81 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.071 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -54.98 -49.53 71.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.5 mmm -64.17 -51.63 62.88 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.448 HD11 HD22 ' A' ' 32' ' ' LEU . 28.5 mm -59.23 -49.58 82.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.092 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -56.66 -33.96 66.89 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -66.28 -40.35 90.02 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.786 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.479 HG21 ' CD2' ' B' 1110 ' ' PHE . 69.0 t -86.6 -20.03 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.335 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.523 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 44.0 t0 -78.68 84.61 4.76 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -175.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.62 79.6 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.842 -1.526 . . . . 0.0 114.36 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.414 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 36.1 p-10 -85.11 -2.79 58.4 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.342 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.06 22.75 60.85 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.901 -0.499 . . . . 0.0 112.316 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.414 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -86.24 3.51 42.78 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.313 0.556 . . . . 0.0 110.441 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 83.12 2.33 90.53 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 114.8 0.68 . . . . 0.0 114.8 175.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 69.0 p -147.06 165.94 28.39 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.7 mm -109.42 126.81 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -102.99 -177.25 3.32 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.838 0.352 . . . . 0.0 110.731 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.412 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -57.02 -57.71 22.72 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 9.7 Cg_endo -49.08 -50.59 12.44 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.158 1.238 . . . . 0.0 111.336 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.3 -20.78 60.58 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.279 0.562 . . . . 0.0 110.708 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -75.64 -58.31 3.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.962 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -55.74 -47.9 76.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.3 p -44.22 -48.21 9.32 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.309 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.5 mtp -65.52 -45.57 82.98 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 31.4 mmt -59.92 -40.78 90.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.6 -34.1 77.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.332 0.253 . . . . 0.0 111.538 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.8 mtp85 -95.24 -12.35 26.39 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.569 0.223 . . . . 0.0 111.355 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.84 68.54 7.14 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 110.481 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 21.5 mmt -108.69 15.47 23.64 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.684 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -52.82 129.78 31.03 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.535 0.683 . . . . 0.0 111.6 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 79' ' ' THR . 61.6 t0 -105.57 146.35 29.76 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.694 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.521 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 75.3 p -132.81 133.97 44.07 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 82' ' ' GLU . 1.1 p30 -61.12 115.95 4.17 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 175.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 m -36.44 -19.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 80' ' ' ASP . 46.0 tp10 -70.54 -32.09 69.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.941 0.401 . . . . 0.0 111.513 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -51.16 -41.12 59.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.668 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 37.0 tp10 -83.96 -17.45 40.58 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 111.872 -178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.6 mm -59.21 -73.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.46 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -58.57 -55.87 29.44 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.47 ' CD ' ' N ' ' A' ' 88' ' ' ALA . 3.1 pp20? -52.83 -36.36 58.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.297 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -60.71 -23.49 64.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.812 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -72.37 -48.84 38.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.24 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -54.79 -41.55 70.71 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.896 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.25 -45.06 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.745 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.525 ' CE2' HG21 ' A' ' 108' ' ' VAL . 9.5 m-85 -70.02 -38.55 75.94 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.349 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.517 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 31.6 t0 -88.69 82.48 6.84 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 176.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.503 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 65.2 tttm -58.46 -48.42 80.8 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 40.2 p-10 -90.65 4.88 50.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.664 0.269 . . . . 0.0 111.652 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.2 47.52 49.53 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.716 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -90.61 5.98 45.68 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 122.35 0.26 . . . . 0.0 110.742 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.459 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 85.11 0.96 88.76 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.716 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 74.1 m-85 -139.22 152.29 47.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.611 0.72 . . . . 0.0 111.708 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.6 mt -94.51 117.72 38.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 t -91.06 150.12 21.55 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.49 -45.96 76.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 119.159 0.891 . . . . 0.0 110.481 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.44 62.67 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.892 0.377 . . . . 0.0 110.745 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.503 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.1 mt-10 -65.84 -40.59 91.88 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.227 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.3 tp -62.93 -46.14 89.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.216 0.531 . . . . 0.0 110.543 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -43.54 -43.11 5.36 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.573 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -64.96 -30.81 71.82 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.646 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.525 HG21 ' CE2' ' A' ' 92' ' ' PHE . 93.6 t -56.99 -41.8 77.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.643 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.628 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -50.6 -44.43 57.02 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.786 0.803 . . . . 0.0 111.276 -178.046 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 m -57.2 -41.29 79.12 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 114.046 -1.434 . . . . 0.0 111.013 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -65.96 -41.31 91.38 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.564 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.1 mt -81.52 -13.81 57.67 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.8 31.98 57.61 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.556 -1.136 . . . . 0.0 110.401 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -85.44 -21.51 28.72 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.628 2.214 . . . . 0.0 111.744 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt 43.27 61.05 2.32 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.892 0.854 . . . . 0.0 109.948 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.453 HD12 ' CG ' ' A' ' 109' ' ' MET . 87.7 mt -81.51 147.72 29.54 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.404 -1.726 . . . . 0.0 112.317 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 121' ' ' VAL . 65.3 p -82.48 175.74 9.97 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.839 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -57.75 -46.44 84.5 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -55.98 -48.58 75.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.983 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -71.66 -30.85 66.17 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.288 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 117' ' ' THR . 39.0 t -63.51 -41.4 92.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.522 0.677 . . . . 0.0 109.408 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -72.64 -33.26 66.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.78 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.42 -50.98 71.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.684 ' CE ' HD21 ' B' 1092 ' ' LEU . 76.3 mtp -52.85 -48.07 67.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.641 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.8 mm -57.76 -43.48 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.882 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -62.17 -35.3 78.39 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.808 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -57.06 -41.02 77.98 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.42 -11.66 29.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.791 0.329 . . . . 0.0 111.358 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.2 t0 -75.12 89.1 2.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.507 0.67 . . . . 0.0 111.855 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.77 -18.36 20.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.596 -1.184 . . . . 0.0 113.105 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.461 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.3 p-10 -140.32 145.73 37.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 112.781 -2.009 . . . . 0.0 108.678 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.96 52.2 1.65 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.696 -0.288 . . . . 0.0 113.031 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -90.72 -9.48 46.56 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.978 0.389 . . . . 0.0 110.089 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.74 1.49 72.3 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.957 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -135.5 154.19 51.49 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.127 0.463 . . . . 0.0 110.471 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.44 118.37 47.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.175 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -83.84 173.26 11.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 0.0 111.093 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -61.35 -40.85 95.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.046 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -61.76 -44.41 96.95 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.744 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.81 -39.71 94.02 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.58 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.565 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 92.1 t80 -61.3 -46.44 90.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.976 0.417 . . . . 0.0 111.175 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.48 -46.65 92.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.383 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.846 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 52.0 tt0 -49.54 -47.62 48.92 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.714 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 88.2 mmm -71.22 -35.2 71.42 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.565 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.7 mtt -79.56 -46.97 16.32 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p -89.28 -40.23 12.95 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.846 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -78.2 41.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.706 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 pttm . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.526 -179.819 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B 1086 ' ' LEU . . . . . 0.533 HD12 ' N ' ' B' 1086 ' ' LEU . 10.7 mp . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B 1087 ' ' ARG . . . . . 0.497 ' C ' ' H ' ' B' 1089 ' ' GLY . 11.6 ptp85 -62.97 -33.69 75.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.807 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.564 ' C ' ' H ' ' B' 1090 ' ' GLN . 66.0 ttt180 -67.51 10.55 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B 1089 ' ' GLY . . . . . 0.497 ' H ' ' C ' ' B' 1087 ' ' ARG . . . -64.37 8.5 0.46 Allowed Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.564 ' H ' ' C ' ' B' 1088 ' ' ARG . 43.0 mt-30 -63.19 -50.68 69.37 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B 1091 ' ' ILE . . . . . 0.421 ' C ' ' O ' ' B' 1090 ' ' GLN . 80.1 mt -28.75 -77.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.017 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B 1092 ' ' LEU . . . . . 0.75 HD23 ' N ' ' B' 1093 ' ' TRP . 0.9 OUTLIER -50.56 -43.13 56.2 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.516 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B 1093 ' ' TRP . . . . . 0.75 ' N ' HD23 ' B' 1092 ' ' LEU . 2.3 m95 -55.31 -62.25 1.8 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.358 0.599 . . . . 0.0 110.864 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 51.6 t80 -56.51 -44.24 80.54 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 61.9 ttt85 -39.94 -53.47 2.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -60.27 -39.95 96.74 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 48.0 tp -56.6 -44.12 80.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 118.494 1.147 . . . . 0.0 109.73 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 46.4 t30 -57.66 -47.61 81.8 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -63.96 -38.15 90.03 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.04 -42.27 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.638 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -51.41 -46.27 62.85 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.628 -1.229 . . . . 0.0 107.874 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.518 ' O ' ' N ' ' B' 1105 ' ' LYS . 96.1 m -62.37 -48.38 80.01 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.59 -0.444 . . . . 0.0 112.047 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.432 ' C ' ' O ' ' B' 1102 ' ' THR . 84.8 mt-30 -27.98 -59.22 0.11 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.591 1.186 . . . . 0.0 112.66 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B 1104 ' ' ILE . . . . . 0.402 HG21 HD13 ' B' 1104 ' ' ILE . 2.0 mt -81.52 -14.34 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 112.711 -2.041 . . . . 0.0 112.089 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' 1102 ' ' THR . 64.0 tttp -58.92 -45.95 89.13 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 118.087 -1.445 . . . . 0.0 108.179 176.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.3 t -60.57 -49.73 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.06 -36.56 78.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.116 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 88.9 mttt -49.09 -37.08 20.37 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.739 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.44 63.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.287 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B 1110 ' ' PHE . . . . . 0.479 ' CD2' HG21 ' A' ' 55' ' ' VAL . 44.3 m-85 -62.92 -49.45 74.73 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -68.2 -41.06 81.94 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.4 t 67.15 59.38 0.53 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 116.555 -1.688 . . . . 0.0 107.476 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.471 0.577 0 CA-C-N 124.488 3.313 . . . . 0.0 111.878 179.384 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.506 ' O ' HD22 ' A' ' 4' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.426 ' O ' ' OE1' ' A' ' 8' ' ' GLN . 25.6 t70 -65.84 -39.18 90.55 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -97.49 124.42 41.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.724 0.297 . . . . 0.0 110.342 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 4' ' ' LEU . 1.9 pt? 174.81 -34.71 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.037 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.7 p -77.2 140.14 40.07 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.865 0.757 . . . . 0.0 110.827 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.1 tt0 -48.73 -60.98 2.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 122.108 0.956 . . . . 0.0 110.497 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 81.1 tt0 -34.61 -37.01 0.05 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.998 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 2' ' ' ASP . 38.9 tt0 -69.86 -35.78 74.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.403 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.8 mm -59.71 -44.6 94.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 175.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.51 -49.96 63.76 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.282 -177.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -63.1 -44.84 94.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.507 0.67 . . . . 0.0 112.332 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.8 m-85 -63.28 -39.28 94.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.887 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -52.51 -54.02 38.14 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.357 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -50.78 -41.63 57.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.162 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -54.79 -39.13 68.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.137 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.445 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 3.0 m-85 -57.7 -41.29 81.4 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.3 p -64.55 -15.91 61.73 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.402 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.586 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -64.65 -42.3 95.51 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.79 -178.614 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -105.95 -14.14 15.28 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -72.72 94.0 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.344 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -67.71 -49.65 61.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.722 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 23' ' ' GLY . 48.2 p-10 -102.72 15.78 28.35 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.88 45.19 0.54 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.132 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -86.01 -4.24 59.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.83 0.347 . . . . 0.0 111.062 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.05 -1.58 80.5 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.3 p -138.01 152.95 49.38 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.17 0.509 . . . . 0.0 110.043 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.69 124.08 44.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.0 p -113.19 163.51 14.68 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.941 0.776 . . . . 0.0 112.559 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.1 p -58.24 -37.11 74.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.884 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.57 -62.09 2.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.185 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -60.58 -29.89 69.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.668 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.461 HD22 HD11 ' A' ' 52' ' ' ILE . 3.1 tp -61.07 -55.02 37.47 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.026 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.87 -40.32 95.06 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.401 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.11 -54.65 44.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 118.884 1.342 . . . . 0.0 108.423 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.9 t -56.76 -46.78 83.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 118.889 0.768 . . . . 0.0 111.841 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.2 ttt -58.63 -41.5 86.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 120.065 1.302 . . . . 0.0 109.964 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -51.78 -38.28 54.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.512 0.673 . . . . 0.0 110.296 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 t -62.59 -20.58 64.86 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.949 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -74.08 -0.4 16.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.897 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.44 14.56 70.77 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.116 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -107.47 158.5 17.15 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 117.484 0.642 . . . . 0.0 109.992 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -116.1 65.83 2.88 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.272 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.75 144.03 87.96 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.182 1.921 . . . . 0.0 112.111 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.5 t -80.42 165.45 22.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.555 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -57.9 -44.94 87.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.68 -23.96 31.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.586 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -65.61 -39.99 92.14 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.146 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.8 mp -55.64 -40.8 72.68 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.495 0.664 . . . . 0.0 109.799 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -71.45 -56.22 6.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.815 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -54.52 -49.23 70.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.0 mtp -67.08 -48.65 67.56 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.461 HD11 HD22 ' A' ' 32' ' ' LEU . 26.0 mm -58.47 -46.71 89.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.607 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -55.59 -35.54 65.93 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -66.62 -40.3 88.72 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.146 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' B' 1110 ' ' PHE . 59.4 t -85.58 -20.97 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.39 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.446 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.3 t0 -79.63 84.3 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -175.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.81 -37.1 80.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.64 -1.618 . . . . 0.0 114.319 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -86.57 -2.04 58.16 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.53 23.04 60.03 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 118.44 0.563 . . . . 0.0 112.473 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -87.65 3.81 46.36 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.44 0.62 . . . . 0.0 110.515 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.72 1.41 89.05 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 175.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.0 p -148.42 168.86 21.55 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.8 mt -113.48 128.79 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 5.9 p30 -103.61 -175.97 2.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.867 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.445 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.16 -47.63 98.49 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.738 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -55.72 -52.06 8.36 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.287 1.325 . . . . 0.0 111.84 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.22 -19.59 61.82 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.506 0.669 . . . . 0.0 110.533 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -75.52 -59.33 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.352 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.5 mt -56.46 -45.16 81.02 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.8 p -45.24 -47.49 12.77 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.404 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 33.6 mtp -67.68 -46.81 71.23 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.6 mmm -61.75 -39.89 93.17 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.64 -34.21 77.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.373 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -94.95 -12.44 26.76 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' C ' ' SD ' ' A' ' 76' ' ' MET . 3.9 tptt -81.9 67.02 7.72 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.016 0.436 . . . . 0.0 110.237 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.524 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -106.98 17.52 22.97 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.34 179.496 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -49.79 132.39 22.15 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.508 0.67 . . . . 0.0 111.41 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -92.51 108.12 19.73 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.107 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.0 m -93.5 121.29 34.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 82' ' ' GLU . 30.4 m-20 -69.42 113.19 6.51 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.4 m -37.78 -19.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.796 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 80' ' ' ASP . 83.2 tt0 -67.01 -41.05 87.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.863 0.363 . . . . 0.0 111.217 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -56.95 -40.75 77.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.724 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.56 ' O ' ' N ' ' A' ' 87' ' ' GLU . 51.0 tp10 -72.3 -80.52 0.06 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.655 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.614 HD12 ' N ' ' A' ' 86' ' ' ARG . 1.9 pp -20.56 -60.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 123.684 0.615 . . . . 0.0 111.319 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.614 ' N ' HD12 ' A' ' 85' ' ' ILE . 9.1 ptm180 -60.76 -42.21 96.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.581 ' CD ' HH21 ' A' ' 90' ' ' ARG . 40.3 mm-40 -61.84 -40.07 94.01 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.939 0.399 . . . . 0.0 111.092 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -17.58 62.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.856 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -71.43 -52.79 16.59 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.735 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.581 HH21 ' CD ' ' A' ' 87' ' ' GLU . 78.9 mtm-85 -55.53 -40.63 72.08 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.874 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.62 -42.92 90.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.527 ' CE2' HG21 ' A' ' 108' ' ' VAL . 4.8 m-85 -68.01 -37.91 81.97 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.417 -178.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -89.34 83.7 6.43 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.43 -46.39 90.2 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -91.5 4.55 52.27 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.386 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.39 49.9 37.07 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.19 6.7 41.59 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.77 0.55 89.85 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.669 -0.573 . . . . 0.0 111.669 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -139.5 151.92 46.55 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.615 0.722 . . . . 0.0 111.736 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.3 mt -95.9 117.5 40.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 m -91.32 152.81 20.31 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.19 80.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.412 1.005 . . . . 0.0 110.848 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.56 -40.52 62.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 110.676 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -65.33 -42.64 92.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.222 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 108' ' ' VAL . 21.2 mt -63.03 -45.15 93.68 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.29 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -41.53 -45.45 3.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.746 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -59.78 -26.11 65.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.798 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.527 HG21 ' CE2' ' A' ' 92' ' ' PHE . 63.4 t -58.33 -43.1 85.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.895 -178.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.44 ' SD ' HD12 ' A' ' 116' ' ' LEU . 8.3 mmt -51.15 -45.54 61.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.065 0.936 . . . . 0.0 111.098 -177.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.0 p -57.92 -38.61 76.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.085 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -40.55 81.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.493 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 70.3 mt -81.32 -13.68 58.14 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.29 29.59 59.98 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.393 -1.226 . . . . 0.0 110.15 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -85.87 -22.62 27.45 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.779 2.29 . . . . 0.0 111.005 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm 44.77 61.81 2.33 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.222 1.01 . . . . 0.0 109.862 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.44 HD12 ' SD ' ' A' ' 109' ' ' MET . 78.1 mt -80.65 147.0 30.86 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.472 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 121' ' ' VAL . 30.8 p -81.95 175.54 10.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.614 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -57.15 -44.87 83.83 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.28 -48.26 79.34 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -72.75 -30.65 64.33 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.103 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 117' ' ' THR . 42.7 t -64.99 -43.22 96.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -69.15 -35.02 75.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.214 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -59.72 -47.57 85.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.059 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 15.8 mmm -55.18 -45.12 75.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.62 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 40.1 mm -58.14 -44.1 86.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.446 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -58.91 -39.57 81.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.746 0.308 . . . . 0.0 111.132 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.99 -41.68 83.52 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.52 -23.1 21.02 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.7 t0 -72.42 87.97 1.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.485 0.66 . . . . 0.0 112.098 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.69 -15.26 19.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.945 1.355 . . . . 0.0 113.265 -178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 37.6 p-10 -141.68 145.0 34.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.214 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.06 52.31 1.7 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.551 -0.357 . . . . 0.0 113.385 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -91.32 -8.76 47.26 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.182 0.491 . . . . 0.0 110.108 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.04 2.54 78.39 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.118 -0.563 . . . . 0.0 114.21 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -134.99 153.87 51.93 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 117.19 0.495 . . . . 0.0 110.551 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.7 118.57 47.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.321 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -83.65 173.0 11.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.06 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -61.8 -39.74 92.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.022 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -61.57 -44.68 96.58 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.621 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.11 -37.76 88.61 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.436 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -61.07 -44.94 96.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.701 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.05 -47.77 86.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.371 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -50.24 -44.35 53.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.171 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.4 mmt -73.33 -38.94 65.61 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 22.4 mmt -75.66 -46.92 28.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.911 -0.131 . . . . 0.0 111.021 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 p -89.24 31.51 0.89 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.564 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.86 87.1 5.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.746 0.308 . . . . 0.0 111.133 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.3 tptp . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.372 179.702 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B 1086 ' ' LEU . . . . . 0.539 HD12 ' N ' ' B' 1086 ' ' LEU . 10.6 mp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -77.2 142.19 39.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.586 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.764 ' NE ' ' H ' ' B' 1088 ' ' ARG . 0.0 OUTLIER -107.84 95.43 5.68 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.162 0.506 . . . . 0.0 110.684 179.68 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -54.33 -3.62 0.26 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.556 ' H ' ' C ' ' B' 1088 ' ' ARG . 4.6 mt-30 -65.07 -51.9 58.78 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 68.4 mt -58.78 -50.12 80.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.6 mt -55.56 -62.39 1.72 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.659 -0.416 . . . . 0.0 112.026 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.51 -53.69 53.1 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.451 0.643 . . . . 0.0 112.111 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 53.8 t80 -58.02 -46.06 85.89 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -174.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -40.69 -52.33 2.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.23 -41.83 99.72 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.084 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.2 tp -55.93 -46.3 78.51 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.446 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 41.2 t30 -58.01 -48.31 80.42 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -64.96 -38.11 89.89 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 87.5 mt -60.91 -42.6 93.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.802 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -50.96 -44.99 60.68 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.514 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.4 m -63.0 -48.28 79.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.92 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.424 ' C ' ' O ' ' B' 1102 ' ' THR . 84.4 mt-30 -28.01 -58.64 0.11 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.805 1.288 . . . . 0.0 112.929 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -82.74 -15.4 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 112.25 -2.25 . . . . 0.0 111.985 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.514 ' N ' ' O ' ' B' 1102 ' ' THR . 88.8 tttt -58.8 -45.92 88.79 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 117.989 -1.484 . . . . 0.0 107.89 176.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.5 t -60.85 -49.06 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.57 -36.84 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.091 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 90.5 mttt -49.74 -37.16 28.25 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.512 0.672 . . . . 0.0 109.661 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.03 -45.53 64.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.285 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1110 ' ' PHE . . . . . 0.46 ' CE2' HG21 ' A' ' 55' ' ' VAL . 49.3 m-85 -63.13 -50.44 70.44 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -68.01 -41.8 81.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.2 t 67.82 60.33 0.45 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 116.749 -1.596 . . . . 0.0 107.619 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 38.7 p . . . . . 0 C--O 1.218 -0.582 0 CA-C-N 124.214 3.188 . . . . 0.0 111.771 179.309 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -64.55 -35.35 80.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.56 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.444 ' CG ' ' NE2' ' A' ' 8' ' ' GLN . 3.4 mp0 -101.32 101.77 12.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.117 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.2 mt -112.09 -21.13 11.67 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.695 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.7 p -79.97 138.62 37.11 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.997 0.817 . . . . 0.0 110.523 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 9' ' ' ILE . 27.1 mm-40 -49.17 -58.1 5.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 122.099 0.952 . . . . 0.0 110.788 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -35.64 -37.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 113.352 -1.749 . . . . 0.0 110.611 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.444 ' NE2' ' CG ' ' A' ' 3' ' ' GLN . 23.3 tt0 -70.19 -37.18 75.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.468 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.1 mt -59.76 -46.04 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.41 -48.63 62.58 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.51 -177.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.04 -44.36 92.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.551 0.691 . . . . 0.0 112.299 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.456 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.5 m-85 -63.19 -39.99 96.22 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.862 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -50.22 -53.67 26.45 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.572 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -51.85 -39.2 58.5 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.174 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.35 -39.91 73.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.379 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -55.55 -42.05 74.12 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.9 t -64.05 -16.54 61.92 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.381 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.613 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -63.67 -43.44 96.68 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.487 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -104.67 -15.13 15.36 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.602 -178.856 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -77.7 93.13 4.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.361 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -66.75 -46.83 74.15 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.706 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -101.7 15.15 29.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.24 50.48 3.65 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.732 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -89.43 -5.55 57.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.171 0.486 . . . . 0.0 111.898 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.12 0.69 73.69 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.849 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.469 HG22 ' OD1' ' A' ' 64' ' ' ASP . 31.7 p -141.25 159.76 41.54 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.971 0.415 . . . . 0.0 110.07 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.2 mt -92.32 126.19 44.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.419 ' OG1' ' OE1' ' A' ' 31' ' ' GLU . 19.1 p -111.78 162.65 15.03 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.044 0.84 . . . . 0.0 112.256 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 p -60.36 -37.97 82.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.87 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.43 -58.88 6.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.464 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.419 ' OE1' ' OG1' ' A' ' 28' ' ' THR . 10.1 pt-20 -63.38 -29.52 70.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.625 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.48 HD22 HD11 ' A' ' 52' ' ' ILE . 3.5 tp -61.08 -52.5 64.64 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.3 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.99 -38.09 94.93 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.938 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.2 m -58.76 -54.15 50.36 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.731 1.265 . . . . 0.0 108.593 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.79 -46.06 87.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 121.058 -1.026 . . . . 0.0 111.513 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.3 tpt -59.31 -40.33 85.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 119.914 1.234 . . . . 0.0 109.531 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -53.35 -41.56 65.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.307 0.575 . . . . 0.0 110.251 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.6 p -63.71 -21.47 66.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.157 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.42 -4.09 31.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.61 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.01 60.74 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.032 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -106.68 155.12 20.0 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.642 0.721 . . . . 0.0 110.094 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.581 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 4.6 t30 -116.46 62.85 2.58 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.37 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.25 145.7 93.37 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.265 1.977 . . . . 0.0 112.204 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.7 p -80.36 167.73 19.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.565 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -58.24 -44.06 88.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.805 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.7 -24.09 32.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.502 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -65.49 -38.6 90.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.016 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.8 mp -57.25 -42.26 81.17 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.311 0.577 . . . . 0.0 109.882 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -69.16 -56.48 7.53 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.383 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -55.32 -48.98 73.33 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.9 mmm -65.39 -51.68 58.71 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.48 HD11 HD22 ' A' ' 32' ' ' LEU . 28.6 mm -59.63 -48.9 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.777 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -57.82 -33.47 68.64 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.85 -39.84 94.2 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.53 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.21 -17.73 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.265 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.45 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.37 85.55 4.48 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -174.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.02 88.39 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 113.427 -1.715 . . . . 0.0 113.728 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.1 p-10 -85.6 -3.06 58.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.82 23.82 61.68 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.886 -0.509 . . . . 0.0 112.937 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.433 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.6 p-10 -87.56 3.76 46.26 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.174 0.487 . . . . 0.0 110.26 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.45 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.09 0.54 88.84 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.893 -0.67 . . . . 0.0 114.214 175.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.6 p -149.13 170.38 18.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.0 mt -112.59 128.77 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.469 ' OD1' HG22 ' A' ' 26' ' ' THR . 92.1 m-20 -104.41 -173.7 2.37 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.433 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.419 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -58.7 -46.11 99.59 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.412 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 35.3 Cg_exo -56.06 -53.39 5.51 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.465 1.443 . . . . 0.0 111.21 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.41 -22.08 66.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.15 0.5 . . . . 0.0 111.161 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.61 -61.41 1.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.9 mt -57.78 -43.83 85.84 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.3 m -40.74 -58.3 1.68 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.943 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -65.66 -41.42 92.55 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.983 -176.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 97.2 mmm -58.94 -41.24 86.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.26 77.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.352 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -93.93 -13.99 26.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.657 0.265 . . . . 0.0 111.239 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.42 ' C ' ' SD ' ' A' ' 76' ' ' MET . 0.1 OUTLIER -80.84 66.65 6.44 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.206 0.527 . . . . 0.0 110.591 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -108.37 15.61 23.83 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.441 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -49.62 134.59 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.245 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.84 108.62 19.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.156 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.9 m -93.33 121.32 34.59 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 82' ' ' GLU . 97.7 m-20 -68.63 112.3 5.32 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.9 m -37.49 -22.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.528 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.9 mp0 -69.43 -35.78 76.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.77 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -48.25 -35.84 12.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.257 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 84' ' ' GLU . 2.4 mp0 -90.95 -16.54 27.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 85' ' ' ILE . 26.0 mm -59.99 -74.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.566 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -61.83 -41.2 97.51 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -62.53 -38.92 91.86 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.249 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.63 -20.74 65.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.998 0.427 . . . . 0.0 111.078 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -70.61 -49.93 42.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.053 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -54.85 -41.62 70.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.535 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.57 -43.82 94.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.3 m-85 -68.38 -39.68 81.68 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.188 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.492 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 27.1 t0 -87.15 83.54 7.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.511 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 88.6 tttt -58.04 -49.61 76.27 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 35.1 p-10 -91.88 4.51 52.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.696 0.284 . . . . 0.0 111.608 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.56 49.29 53.19 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.727 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -90.61 5.24 48.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.793 0.33 . . . . 0.0 110.83 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.481 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 84.98 2.0 88.56 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.727 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 88.1 m-85 -140.01 152.88 46.62 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.611 0.719 . . . . 0.0 111.506 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.3 mt -94.04 115.31 32.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 t -89.07 150.93 22.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.634 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.32 83.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.981 0.81 . . . . 0.0 110.646 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.74 -39.59 65.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.862 0.363 . . . . 0.0 110.443 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.511 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.2 mt-10 -66.64 -41.18 88.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.338 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.09 -45.71 90.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.456 0.646 . . . . 0.0 110.997 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -44.23 -43.18 7.06 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.422 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -65.49 -28.62 69.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.51 0.195 . . . . 0.0 111.236 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.524 HG21 ' CE2' ' A' ' 92' ' ' PHE . 96.1 t -58.21 -42.46 83.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.573 -177.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.709 ' SD ' HD12 ' A' ' 116' ' ' LEU . 36.8 mmt -51.34 -43.22 61.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.82 0.819 . . . . 0.0 111.107 -177.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 m -57.93 -41.68 83.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.763 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -42.32 82.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.681 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.58 -15.85 56.93 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.475 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.1 28.7 59.91 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -84.43 -22.49 30.36 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.625 2.213 . . . . 0.0 110.59 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 43.07 58.68 3.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.804 0.811 . . . . 0.0 110.301 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.709 HD12 ' SD ' ' A' ' 109' ' ' MET . 50.9 mt -79.52 149.15 31.55 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.679 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 121' ' ' VAL . 70.2 p -82.71 175.29 10.25 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.5 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -58.14 -44.17 87.69 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.47 -49.44 76.28 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.61 -30.68 67.41 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.88 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 117' ' ' THR . 39.5 t -63.51 -42.41 96.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.29 -35.66 73.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.335 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -59.74 -50.89 72.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 90.5 mtp -57.12 -43.52 82.41 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.137 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.38 -44.18 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.286 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -59.57 -38.82 82.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.033 0.444 . . . . 0.0 111.208 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -57.23 -40.45 77.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.848 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.58 -20.09 22.04 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.1 t0 -75.36 86.1 2.52 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.389 0.614 . . . . 0.0 111.916 -177.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 130' ' ' ILE . 25.6 pt -71.87 -12.08 15.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.275 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 40.6 p-10 -140.67 142.09 34.95 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 112.504 -2.135 . . . . 0.0 108.771 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.69 52.09 1.55 Allowed Glycine 0 CA--C 1.53 1.012 0 CA-C-O 120.269 -0.184 . . . . 0.0 113.472 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -91.17 -7.92 50.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.281 0.54 . . . . 0.0 110.139 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.68 1.3 66.04 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.131 -0.557 . . . . 0.0 114.296 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -135.01 153.66 52.0 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.426 0.613 . . . . 0.0 110.478 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 51.3 t -100.74 118.54 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.451 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -84.2 174.87 9.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -61.84 -40.85 96.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.133 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.39 -44.82 95.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.891 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -63.91 -38.49 91.29 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.461 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -60.22 -45.54 92.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.594 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.57 -47.95 84.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.269 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.71 -46.7 59.07 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.316 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.404 ' O ' ' CE1' ' B' 1094 ' ' PHE . 11.8 mmt -72.08 -39.44 68.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.8 mmt -77.03 -46.58 23.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.391 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.8 p -93.12 34.39 1.12 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -46.67 -40.5 13.27 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.227 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.237 -179.881 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B 1086 ' ' LEU . . . . . 0.541 ' N ' HD22 ' B' 1086 ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1087 ' ' ARG . . . . . 0.481 ' C ' ' H ' ' B' 1089 ' ' GLY . 91.5 mtm-85 -78.28 -12.44 60.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.742 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.594 ' C ' ' H ' ' B' 1090 ' ' GLN . 25.2 ttm180 -67.7 8.2 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B 1089 ' ' GLY . . . . . 0.481 ' H ' ' C ' ' B' 1087 ' ' ARG . . . -62.94 9.2 0.17 Allowed Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.594 ' H ' ' C ' ' B' 1088 ' ' ARG . 75.4 mt-30 -59.38 -43.8 92.85 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.927 0.394 . . . . 0.0 111.769 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 61.8 mt -47.78 -62.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.781 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.0 mt -55.7 -52.98 62.04 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.151 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.1 m95 -59.44 -62.67 1.71 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.333 0.587 . . . . 0.0 112.199 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1094 ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 144' ' ' MET . 40.1 m-85 -57.71 -42.6 84.1 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -174.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -40.6 -51.51 2.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.602 0.715 . . . . 0.0 112.664 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.36 -41.83 99.74 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.79 -46.32 81.62 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.563 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -59.61 -48.15 82.78 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 24.0 mtp-105 -65.49 -38.08 88.69 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.605 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.98 -42.18 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.884 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -51.12 -46.53 61.95 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.51 ' O ' ' N ' ' B' 1105 ' ' LYS . 99.1 m -63.83 -47.88 79.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.609 -0.436 . . . . 0.0 112.002 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.427 ' C ' ' O ' ' B' 1102 ' ' THR . 84.0 mt-30 -28.24 -57.53 0.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.538 1.161 . . . . 0.0 112.435 -176.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -84.58 -15.5 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 112.202 -2.272 . . . . 0.0 112.449 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.51 ' N ' ' O ' ' B' 1102 ' ' THR . 88.6 tttt -60.24 -46.55 89.4 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 118.077 -1.449 . . . . 0.0 107.951 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 57.7 t -61.89 -48.72 87.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.61 -36.27 77.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.774 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 87.4 mttt -49.54 -36.04 22.24 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 119.919 -0.713 . . . . 0.0 109.488 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.57 -45.65 70.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.059 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -62.49 -50.51 71.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.109 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -68.48 -41.42 80.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.2 t 67.92 58.44 0.48 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.482 1.127 0 CA-C-N 123.33 2.786 . . . . 0.0 112.383 179.301 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -64.56 -36.85 85.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.457 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -94.38 -175.32 3.61 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 162.23 -24.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 118.976 -0.535 . . . . 0.0 109.569 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.2 p -76.92 139.73 40.29 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 119.934 1.243 . . . . 0.0 110.35 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.688 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -50.78 -47.99 59.53 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.391 1.091 . . . . 0.0 110.653 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.449 ' OE2' ' OE2' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -38.21 -38.87 0.37 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.884 -179.007 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -68.35 -38.96 81.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.469 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.3 mt -59.76 -44.6 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 175.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.0 -49.17 63.86 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.094 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.449 ' OE2' ' OE2' ' A' ' 7' ' ' GLU . 98.4 mt-10 -60.46 -47.56 85.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 111.748 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -59.0 -42.12 89.32 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.866 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -50.42 -57.31 8.29 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.396 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -51.18 -44.72 61.58 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.847 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.72 -37.79 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.218 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.44 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 2.6 m-85 -58.44 -40.38 82.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.2 p -65.2 -15.56 62.59 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.456 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.7 -42.13 95.51 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -105.61 -13.99 15.42 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -71.92 93.91 1.39 Allowed 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.472 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -67.41 -49.64 62.89 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.833 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.1 p30 -103.62 14.88 30.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.16 44.79 0.82 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.164 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 31.0 p-10 -85.02 -3.17 58.69 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.729 0.299 . . . . 0.0 110.89 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 -0.83 78.87 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 t -140.48 154.9 46.77 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.15 0.5 . . . . 0.0 110.097 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 27' ' ' ILE . 3.8 mp -91.41 123.96 43.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.4 p -111.77 162.98 14.66 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.853 0.835 . . . . 0.0 112.064 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.7 p -59.93 -37.57 79.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.629 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -60.47 -57.01 14.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.472 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -64.31 -28.71 69.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.479 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.498 HD22 HD11 ' A' ' 52' ' ' ILE . 3.0 tp -60.8 -53.42 57.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.062 0.934 . . . . 0.0 109.765 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.3 -37.48 94.11 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.124 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -58.81 -52.8 64.15 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.777 1.288 . . . . 0.0 108.813 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.93 -45.03 87.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 119.404 1.002 . . . . 0.0 111.278 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.7 tpt -59.07 -38.73 80.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 120.028 1.285 . . . . 0.0 109.555 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -51.46 -38.36 53.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.65 0.738 . . . . 0.0 110.457 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.9 p -63.13 -20.94 65.84 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.439 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.45 ' O ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -73.81 0.79 12.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.77 179.426 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.5 27.05 40.55 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.23 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -130.54 170.04 14.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.415 0.607 . . . . 0.0 109.923 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -133.8 76.42 65.65 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.396 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.14 147.57 95.29 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.764 2.31 . . . . 0.0 111.995 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.2 t -76.0 164.51 26.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.256 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.18 -43.75 87.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.983 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.33 -24.24 42.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.545 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.65 -38.76 90.24 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.057 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.57 -40.86 75.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.298 0.571 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -70.89 -56.38 6.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.803 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -55.25 -50.45 69.44 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.1 mmm -65.02 -51.53 61.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.498 HD11 HD22 ' A' ' 32' ' ' LEU . 30.1 mm -59.54 -48.14 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.821 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -58.37 -33.51 69.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -65.68 -39.62 91.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.215 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.31 -19.43 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.276 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.2 t0 -78.01 86.59 4.19 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -174.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.35 90.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.234 -1.803 . . . . 0.0 113.988 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -86.33 -2.76 58.69 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.0 23.66 61.88 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 118.467 0.576 . . . . 0.0 112.988 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -87.91 3.14 49.62 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.257 0.528 . . . . 0.0 110.333 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.63 0.54 87.9 Favored Glycine 0 CA--C 1.52 0.361 0 O-C-N 121.586 -0.696 . . . . 0.0 114.569 175.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.2 p -147.66 169.22 20.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.8 mt -112.79 128.51 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 23.6 t0 -103.16 -177.19 3.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.639 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.553 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -56.71 -47.94 98.12 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.513 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.3 -49.54 14.83 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.215 1.277 . . . . 0.0 111.889 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.21 -19.63 64.69 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.476 0.655 . . . . 0.0 110.927 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -74.43 -59.63 2.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.752 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.47 -43.44 79.59 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.0 m -45.59 -48.47 14.53 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.607 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.8 mtm -67.09 -45.59 76.8 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.0 mmm -61.4 -39.2 89.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.02 79.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.644 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -93.6 -14.56 26.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.572 0.225 . . . . 0.0 111.304 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' O ' ' NZ ' ' B' 1105 ' ' LYS . 0.0 OUTLIER -83.1 64.64 7.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.218 0.532 . . . . 0.0 110.49 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.3 mmt -107.5 16.53 23.72 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.801 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -38.7 141.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.357 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.54 -70.43 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.831 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.5 m 58.99 77.27 0.31 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.8 m-20 -57.61 126.0 25.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.3 m -38.99 -18.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.835 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 80' ' ' ASP . 72.4 mm-40 -68.38 -36.38 79.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.936 0.398 . . . . 0.0 111.757 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -51.37 -39.25 56.73 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.418 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 12.3 pt-20 -86.12 -4.33 59.15 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.3 mm -69.56 -73.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.883 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -60.29 -51.96 67.31 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 88' ' ' ALA . 3.1 pp20? -55.35 -37.6 67.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.007 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -60.51 -22.31 63.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.932 0.396 . . . . 0.0 110.902 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -73.76 -48.61 30.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.304 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -55.29 -42.27 73.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.587 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.13 -44.75 97.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.421 ' CE2' HG21 ' A' ' 108' ' ' VAL . 8.3 m-85 -69.33 -39.07 78.4 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.456 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.523 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 27.9 t0 -88.29 83.49 6.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.17 -48.67 80.75 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -90.9 5.06 50.14 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.66 0.267 . . . . 0.0 111.631 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.76 48.42 50.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.733 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -91.43 4.61 52.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.567 0.223 . . . . 0.0 110.697 179.755 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.471 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 86.21 0.89 86.71 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.733 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 90.5 m-85 -139.19 152.28 47.26 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.838 0.827 . . . . 0.0 111.622 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -94.12 115.57 33.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.3 t -88.46 150.52 23.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.555 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.33 -45.79 83.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 119.167 0.894 . . . . 0.0 110.741 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.89 -40.86 66.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.984 0.421 . . . . 0.0 110.588 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -65.3 -41.35 94.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.956 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.402 ' CD2' HD11 ' A' ' 125' ' ' ILE . 59.4 tp -63.71 -44.36 93.86 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.605 0.716 . . . . 0.0 111.207 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -45.7 -44.6 13.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.499 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -62.35 -29.0 70.15 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.605 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.421 HG21 ' CE2' ' A' ' 92' ' ' PHE . 84.6 t -58.32 -41.24 80.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.87 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.626 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.59 -46.54 63.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.179 0.99 . . . . 0.0 111.446 -177.214 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -56.97 -41.42 78.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.442 -1.708 . . . . 0.0 110.675 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -65.2 -40.8 94.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.768 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.535 ' O ' ' NH1' ' B' 1099 ' ' ARG . 76.6 mt -81.5 -14.5 56.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.788 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.11 30.33 57.4 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.566 -1.13 . . . . 0.0 110.366 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -86.49 -22.86 26.19 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.749 2.275 . . . . 0.0 110.75 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 43.43 60.83 2.44 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 122.31 1.052 . . . . 0.0 110.089 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.8 mt -79.06 148.22 32.53 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 113.417 -1.719 . . . . 0.0 112.637 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 121' ' ' VAL . 62.2 p -82.46 174.99 10.57 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.383 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -57.83 -44.53 86.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -57.84 -50.67 72.51 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.56 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -68.3 -30.79 69.87 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.826 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 117' ' ' THR . 47.5 t -64.18 -42.46 95.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.396 0.617 . . . . 0.0 109.342 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 67.8 t0 -67.03 -37.77 84.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.722 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.28 -48.01 83.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.449 ' SD ' ' CD1' ' B' 1093 ' ' TRP . 20.2 mmm -54.96 -45.69 74.97 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.808 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 105' ' ' LEU . 46.5 mm -59.62 -44.88 94.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.35 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -58.37 -40.11 81.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.371 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.69 -41.0 76.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.073 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.445 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -92.67 -16.99 24.86 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.5 t0 -73.41 87.97 1.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.457 0.646 . . . . 0.0 112.076 -177.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 tt -70.78 -14.79 18.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.531 1.158 . . . . 0.0 113.241 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.5 p-10 -142.9 144.6 32.5 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.31 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.53 52.49 1.16 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.709 -0.282 . . . . 0.0 113.175 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -91.14 -9.97 43.59 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.098 0.449 . . . . 0.0 110.119 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.66 2.09 74.31 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.162 -0.542 . . . . 0.0 114.293 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -134.57 154.27 51.56 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.413 0.607 . . . . 0.0 110.435 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.49 118.51 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.272 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.459 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 46.8 t30 -85.17 175.24 9.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.917 0.389 . . . . 0.0 110.962 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.459 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 74.2 t80 -61.59 -41.02 96.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.492 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 13.1 pt-20 -62.23 -44.45 96.53 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.839 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 139' ' ' GLU . 96.8 mt-10 -64.39 -37.66 88.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.892 0.377 . . . . 0.0 110.566 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -61.12 -45.63 93.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.594 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.65 -47.79 84.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.681 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 11.5 tp-100 -47.27 -50.04 22.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.115 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.445 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 91.7 mmm -70.04 -35.47 74.32 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -176.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.452 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 22.7 mmt -71.79 -43.21 66.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.861 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.7 m -85.11 -32.84 22.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.628 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -53.54 133.37 41.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.181 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.39 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B 1086 ' ' LEU . . . . . 0.518 ' N ' HD22 ' B' 1086 ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -134.52 139.04 45.15 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.545 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.556 ' NE ' HD11 ' B' 1091 ' ' ILE . 55.2 ttp180 57.56 42.52 24.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.622 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -61.96 2.15 1.07 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.537 ' H ' ' C ' ' B' 1088 ' ' ARG . 84.4 mt-30 -61.2 -44.65 96.94 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B 1091 ' ' ILE . . . . . 0.556 HD11 ' NE ' ' B' 1088 ' ' ARG . 57.8 mt -48.7 -58.76 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 10.3 mt -55.4 -52.21 64.31 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.722 -176.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B 1093 ' ' TRP . . . . . 0.449 ' CD1' ' SD ' ' A' ' 124' ' ' MET . 5.5 m95 -60.95 -57.5 12.36 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.587 0.708 . . . . 0.0 112.095 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B 1094 ' ' PHE . . . . . 0.452 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 17.5 m-85 -57.61 -43.99 85.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -40.05 -51.98 2.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.11 99.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.371 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.9 tp -57.23 -44.86 84.18 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.507 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -59.17 -47.32 85.74 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.691 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B 1099 ' ' ARG . . . . . 0.535 ' NH1' ' O ' ' A' ' 112' ' ' LEU . 79.5 mtp180 -65.16 -37.94 88.99 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 4.0 mm -60.58 -41.86 89.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.436 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B 1101 ' ' GLN . . . . . 0.462 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 81.8 mt-30 -52.0 -49.28 63.64 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.468 ' O ' ' N ' ' B' 1105 ' ' LYS . 21.3 m -64.98 -47.81 76.23 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.415 ' C ' ' O ' ' B' 1102 ' ' THR . 36.6 mm-40 -28.18 -59.86 0.12 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.758 1.266 . . . . 0.0 112.324 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.5 mt -83.94 -15.9 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 111.716 -2.493 . . . . 0.0 112.471 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 75' ' ' LYS . 66.1 tttm -59.39 -44.41 92.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.009 -1.477 . . . . 0.0 107.838 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 61.6 t -61.49 -48.98 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -66.36 -36.89 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.161 -177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.6 mttt -49.77 -38.11 32.68 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.661 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.03 62.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.27 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -63.35 -50.0 71.69 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -67.92 -42.06 81.67 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.9 58.83 0.37 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.47 0.57 0 CA-C-N 123.728 2.967 . . . . 0.0 112.264 179.408 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 3' ' ' GLN . 33.4 p-10 -90.87 6.03 46.1 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.692 ' NE2' ' CE2' ' A' ' 12' ' ' PHE . 7.1 tt0 51.65 103.44 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.393 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.79 -14.34 8.55 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.041 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -80.02 135.4 36.36 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.512 1.051 . . . . 0.0 110.055 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.8 tt0 -51.04 -60.2 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.029 0.918 . . . . 0.0 111.373 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 44.7 tp10 -34.55 -38.03 0.07 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.933 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -70.35 -31.63 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.647 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.2 mt -57.22 -44.09 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 121.922 2.146 . . . . 0.0 105.355 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -53.55 -51.61 62.37 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.286 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -62.29 -46.48 88.6 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.411 0.624 . . . . 0.0 112.312 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.692 ' CE2' ' NE2' ' A' ' 3' ' ' GLN . 10.0 m-85 -61.68 -40.67 95.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.9 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -52.19 -56.15 16.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.235 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -48.7 -42.69 35.73 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.102 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.36 -37.32 69.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.201 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.0 m-85 -56.42 -40.79 75.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -65.9 -15.61 63.1 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.428 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.34 -43.26 98.22 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.427 ' CZ ' ' HA ' ' A' ' 16' ' ' PHE . 0.9 OUTLIER -106.41 -14.51 15.06 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.871 -178.685 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -75.37 96.11 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.252 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -67.96 -48.13 66.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.229 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.2 p-10 -102.89 14.48 31.86 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.96 48.72 1.41 Allowed Glycine 0 N--CA 1.468 0.83 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.091 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 36.1 p-10 -86.49 -4.77 59.22 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.71 0.29 . . . . 0.0 111.237 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.51 -1.55 79.25 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.8 p -139.41 156.11 47.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.22 0.534 . . . . 0.0 109.732 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -93.02 124.34 45.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.522 HG23 ' H ' ' A' ' 30' ' ' LYS . 1.2 t -115.0 165.52 12.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.8 -177.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.0 p -58.04 -39.52 78.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.439 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.522 ' H ' HG23 ' A' ' 28' ' ' THR . 62.4 tttp -58.67 -59.93 4.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.724 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -63.11 -30.71 71.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 119.598 -0.239 . . . . 0.0 111.51 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.412 HD22 HD11 ' A' ' 52' ' ' ILE . 3.3 tp -59.73 -56.39 22.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.501 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.84 -38.96 94.79 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 113.757 -1.565 . . . . 0.0 112.037 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.5 m -58.52 -53.44 58.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.107 1.454 . . . . 0.0 108.656 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.86 -46.23 87.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 118.991 0.814 . . . . 0.0 111.457 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.0 tpt -59.45 -41.84 90.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 120.112 1.324 . . . . 0.0 109.839 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -54.21 -41.98 69.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.602 0.715 . . . . 0.0 110.27 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -64.35 -22.75 67.06 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.944 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 tp -73.04 -3.41 26.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.666 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.09 13.56 58.76 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.547 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -107.75 155.41 20.24 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.66 0.73 . . . . 0.0 109.789 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -117.17 65.19 3.87 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.357 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.05 145.49 85.15 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.172 1.915 . . . . 0.0 112.215 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.1 p -79.86 167.25 20.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.092 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -57.8 -44.26 86.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.014 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.19 -23.15 20.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.489 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -66.79 -38.81 87.26 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.254 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.8 mp -56.08 -40.59 73.86 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -72.08 -57.08 4.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.057 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -54.13 -49.49 69.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 41.7 mmm -66.19 -52.23 50.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 52' ' ' ILE . 25.9 mm -57.92 -48.21 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.476 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -56.71 -33.97 67.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -66.45 -40.05 89.19 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.668 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.25 -20.29 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.404 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 41.1 t0 -78.01 86.85 4.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -174.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.74 86.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.377 -1.738 . . . . 0.0 114.302 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 37.7 p-10 -87.62 -2.65 58.76 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.28 23.22 64.08 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 118.632 0.651 . . . . 0.0 112.721 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.42 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -88.04 2.02 52.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.393 0.597 . . . . 0.0 110.688 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.65 0.85 87.76 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 175.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.6 p -148.62 171.39 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.8 mt -115.21 129.2 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -104.33 -173.65 2.36 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -59.68 -48.58 94.98 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -177.287 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.66 -53.22 5.97 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.183 1.255 . . . . 0.0 111.66 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.62 -16.77 41.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.594 0.711 . . . . 0.0 110.312 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -76.08 -58.17 3.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.16 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' THR . 77.4 mt -56.99 -45.36 83.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.2 p -44.07 -49.76 8.69 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.459 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.4 mtm -67.55 -45.43 75.68 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.4 mmt -58.45 -38.78 78.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.95 76.62 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.683 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -94.87 -11.19 29.22 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.8 0.333 . . . . 0.0 111.453 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.45 67.44 8.49 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.278 0.561 . . . . 0.0 110.337 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 mmt -109.26 15.66 22.99 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.747 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -52.31 132.28 33.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.418 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -106.63 159.4 16.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.959 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.9 136.08 25.03 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 82' ' ' GLU . 41.8 t0 -61.55 116.16 4.5 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 174.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.6 m -36.94 -19.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 80' ' ' ASP . 94.8 mt-10 -69.02 -35.21 76.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -48.7 -38.37 21.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.487 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -86.49 -17.66 33.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.305 0.574 . . . . 0.0 111.761 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 mm -61.37 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.116 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -62.21 -40.8 97.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.98 -42.11 97.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.811 0.338 . . . . 0.0 111.679 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.98 -19.51 52.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -75.44 -49.05 20.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.985 0.421 . . . . 0.0 111.233 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -55.49 -42.52 74.51 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.607 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.7 -44.47 96.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.9 m-85 -69.19 -38.25 78.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.553 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -85.94 81.22 8.61 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -58.32 -48.99 78.77 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -176.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.2 p30 -90.99 5.53 48.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.471 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.39 48.33 48.55 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -92.16 6.81 45.2 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.597 0.237 . . . . 0.0 110.603 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.62 1.42 89.14 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -141.12 154.05 45.71 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.893 0.854 . . . . 0.0 111.725 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.7 mt -95.09 115.85 35.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 p -90.58 153.05 20.62 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.31 82.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.28 0.945 . . . . 0.0 110.946 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.41 -43.81 68.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.946 0.403 . . . . 0.0 110.711 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.31 -42.54 99.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.596 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 tt -63.93 -45.28 89.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.226 0.536 . . . . 0.0 111.608 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -41.99 -45.01 3.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.61 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -59.73 -26.88 66.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.714 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.582 HG21 ' CE2' ' A' ' 92' ' ' PHE . 86.6 t -57.95 -42.97 83.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.671 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.703 ' HG2' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -51.17 -49.22 61.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.15 0.976 . . . . 0.0 111.89 -177.833 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.8 p -52.65 -38.89 61.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.622 -1.627 . . . . 0.0 110.901 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -65.76 -39.08 90.69 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.495 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.2 mt -83.95 -12.96 54.57 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.76 38.24 50.29 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.353 -1.248 . . . . 0.0 110.196 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -89.45 -22.79 22.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.913 2.357 . . . . 0.0 111.118 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt 45.01 58.41 4.05 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.611 1.196 . . . . 0.0 110.065 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.853 HD23 ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -75.63 149.74 38.14 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 112.952 -1.931 . . . . 0.0 112.982 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 33.4 p -84.07 174.67 10.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 110.349 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.86 -44.73 74.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.3 -41.57 72.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.123 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.17 -28.64 65.48 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.519 -0.472 . . . . 0.0 112.037 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 49.2 t -64.03 -43.68 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.297 0.57 . . . . 0.0 109.63 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -74.62 -36.15 62.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.204 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.62 ' CG ' HH22 ' B' 1087 ' ' ARG . 82.5 tt0 -60.0 -54.11 49.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.8 mmm -51.27 -52.15 47.64 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.01 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -56.22 -42.58 73.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.582 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -60.02 -36.97 78.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.643 0.259 . . . . 0.0 111.428 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -57.62 -40.78 79.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.717 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.71 -15.01 25.67 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.6 t0 -77.57 82.73 3.99 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.642 0.734 . . . . 0.0 111.682 -177.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.7 pt -70.89 -7.56 9.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 122.622 1.201 . . . . 0.0 113.351 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.9 p-10 -144.45 143.32 30.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 112.458 -2.156 . . . . 0.0 109.171 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.13 51.46 1.67 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 122.202 -0.311 . . . . 0.0 113.41 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -90.72 -10.59 42.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.274 0.537 . . . . 0.0 109.835 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.6 -0.45 64.89 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.54 0.576 . . . . 0.0 114.54 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -132.73 153.17 51.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.339 0.57 . . . . 0.0 110.471 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.45 117.96 45.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.232 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.413 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 53.8 t30 -83.99 173.07 11.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.934 0.397 . . . . 0.0 110.949 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.413 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 80.5 t80 -61.16 -39.56 90.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.998 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.23 -44.51 96.39 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.854 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.98 -37.82 88.82 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.626 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -61.21 -44.87 96.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.706 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.7 t -65.1 -47.42 87.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.365 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -50.58 -42.74 56.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.736 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.2 mmt -74.64 -40.13 61.67 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.5 mmt -77.2 -44.57 29.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.884 -0.144 . . . . 0.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 m -88.74 31.8 0.83 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.587 0.232 . . . . 0.0 111.335 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -44.76 -45.48 9.98 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.825 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.8 tttm . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.372 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B 1086 ' ' LEU . . . . . 0.538 ' N ' HD22 ' B' 1086 ' ' LEU . 3.8 mm? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1087 ' ' ARG . . . . . 0.62 HH22 ' CG ' ' A' ' 123' ' ' GLU . 34.2 ptt180 -161.48 46.02 0.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.459 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.528 ' C ' ' H ' ' B' 1090 ' ' GLN . 35.9 ttm180 48.2 45.79 19.85 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -59.2 1.74 0.35 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.528 ' H ' ' C ' ' B' 1088 ' ' ARG . 0.9 OUTLIER -59.16 -42.9 91.85 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.559 0.219 . . . . 0.0 111.374 -178.605 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 57.0 mt -57.29 -51.49 68.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 11.1 mt -56.42 -62.08 1.97 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.68 -56.6 18.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.289 0.566 . . . . 0.0 112.357 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1094 ' ' PHE . . . . . 0.528 ' CE2' ' OD1' ' B' 1098 ' ' ASN . 11.8 t80 -59.83 -48.47 81.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -174.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -39.33 -51.92 2.04 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.0 -39.39 96.99 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.027 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.1 tp -57.15 -41.95 80.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 118.322 1.061 . . . . 0.0 109.559 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1098 ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' B' 1094 ' ' PHE . 6.2 m-20 -59.85 -51.58 69.11 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 76.0 mmt-85 -65.47 -39.81 92.41 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.21 -41.35 83.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.422 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -50.4 -45.36 55.53 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.534 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.3 m -63.69 -47.98 78.98 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.434 ' C ' ' O ' ' B' 1102 ' ' THR . 84.7 mt-30 -27.64 -57.54 0.1 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.61 1.195 . . . . 0.0 112.31 -176.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.8 mt -84.77 -13.81 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.437 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.534 ' N ' ' O ' ' B' 1102 ' ' THR . 38.3 ttmt -59.85 -45.66 91.71 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 118.181 -1.408 . . . . 0.0 108.069 176.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.6 t -60.52 -49.78 83.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.7 m -65.8 -36.0 76.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.967 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 86.6 mttt -50.12 -37.69 35.33 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.608 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.59 -45.62 63.21 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.202 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.99 -49.65 73.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -68.45 -41.69 79.89 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B 1112 ' ' SER . . . . . 0.464 ' OG ' ' O ' ' B' 1112 ' ' SER . 5.6 p 68.32 59.44 0.42 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 117.358 -1.306 . . . . 0.0 107.48 -177.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B 1113 ' ' SER . . . . . 0.4 ' C ' ' O ' ' B' 1112 ' ' SER . 17.9 t . . . . . 0 C--O 1.22 -0.499 0 CA-C-N 123.75 2.977 . . . . 0.0 111.709 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.587 ' O ' ' NE2' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 3' ' ' GLN . 46.5 t0 -104.74 15.27 28.23 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.587 ' NE2' ' O ' ' A' ' 1' ' ' ALA . 7.7 mp0 51.67 104.29 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.219 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.4 mt -109.5 -22.27 12.08 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.62 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 m -78.92 136.19 37.19 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.386 0.994 . . . . 0.0 110.138 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 9' ' ' ILE . 9.4 tm-20 -51.43 -55.47 18.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.893 0.854 . . . . 0.0 111.089 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -37.62 -36.89 0.19 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.648 -1.615 . . . . 0.0 110.576 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -70.25 -32.4 70.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 118.45 -0.785 . . . . 0.0 110.723 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.7 mt -59.54 -45.26 94.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 175.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.23 -49.4 64.05 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.617 -177.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.36 -46.56 88.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.359 0.599 . . . . 0.0 111.923 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.3 m-85 -62.83 -39.3 93.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.812 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -52.64 -53.2 50.26 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.56 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.26 -39.77 60.81 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.059 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.24 -37.67 70.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.084 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.441 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 3.8 m-85 -58.49 -40.85 83.92 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.5 m -65.29 -14.61 61.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.782 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.22 -41.64 94.25 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -105.64 -13.56 15.54 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -74.61 93.14 2.48 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.26 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -69.28 -47.24 65.14 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.96 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.5 p-10 -102.19 13.64 34.13 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.945 -0.472 . . . . 0.0 112.195 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.98 46.64 1.23 Allowed Glycine 0 CA--C 1.533 1.199 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.996 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -86.18 -4.19 59.12 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.637 -0.331 . . . . 0.0 110.957 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.12 84.51 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.9 p -137.3 152.13 49.42 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.105 0.479 . . . . 0.0 109.982 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.93 124.36 45.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.419 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 19.7 p -113.48 164.52 13.51 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.941 0.877 . . . . 0.0 112.194 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 p -59.2 -38.25 79.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.541 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -62.1 -56.63 16.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.556 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 28' ' ' THR . 16.0 pt-20 -64.24 -30.23 71.29 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.37 -52.25 65.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.264 1.031 . . . . 0.0 109.515 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.85 -35.61 87.26 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.865 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.22 -53.14 61.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.09 1.445 . . . . 0.0 108.661 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.44 -45.66 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 120.731 -1.23 . . . . 0.0 111.636 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.6 ttt -59.06 -40.91 86.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 120.064 1.302 . . . . 0.0 109.643 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -53.16 -37.02 61.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.556 0.693 . . . . 0.0 110.48 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.5 t -62.39 -20.25 64.25 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.735 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.4 mt -75.82 2.9 11.09 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.1 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.58 16.16 74.09 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.91 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -109.55 160.31 16.35 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.582 0.691 . . . . 0.0 109.872 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -112.82 69.2 1.1 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.085 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.7 141.84 67.81 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.845 1.697 . . . . 0.0 112.181 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -81.58 157.36 24.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.029 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.0 -42.13 68.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.762 0.315 . . . . 0.0 110.572 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.9 -25.64 43.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.346 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -65.63 -39.48 91.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.816 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.2 mp -56.06 -40.96 74.34 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.492 0.663 . . . . 0.0 109.847 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -69.12 -56.49 7.53 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.655 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -53.13 -48.69 67.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.412 ' SD ' ' NE2' ' B' 1111 ' ' HIS . 1.5 mtm -71.44 -44.51 64.68 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 52' ' ' ILE . 12.1 mm -58.57 -48.41 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -56.58 -34.34 67.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -66.11 -40.41 90.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.669 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.406 HG21 ' CE2' ' B' 1110 ' ' PHE . 50.1 t -85.52 -21.43 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.275 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.405 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.5 t0 -78.45 86.12 4.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -175.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.28 89.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.179 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 36.4 p-10 -85.58 -3.25 58.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.62 23.73 61.12 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 121.872 -0.518 . . . . 0.0 113.029 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.4 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.1 p-10 -87.51 4.65 42.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.046 0.423 . . . . 0.0 110.348 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.405 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.03 0.66 89.7 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.871 -0.681 . . . . 0.0 114.38 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.4 p -147.79 167.49 24.6 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.2 mt -112.62 128.4 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -103.82 -174.57 2.58 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.66 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.441 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.63 -47.28 99.03 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -176.655 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -56.61 -51.38 9.26 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.415 1.41 . . . . 0.0 111.354 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.95 -20.51 65.3 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.372 0.606 . . . . 0.0 111.097 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -71.24 -58.33 3.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.871 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.76 -44.3 86.06 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 m -40.5 -59.09 1.42 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.665 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -64.8 -41.6 95.68 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -176.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 98.2 mmm -59.44 -39.6 84.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.36 78.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.286 0.235 . . . . 0.0 111.499 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -96.65 -8.48 31.48 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.228 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 67.18 7.24 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.169 0.509 . . . . 0.0 110.24 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 19.8 mmt -108.54 16.41 23.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.782 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -52.67 130.99 34.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.674 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 54.3 p-10 -105.57 148.07 27.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.781 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.1 p -133.65 134.1 42.75 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 82' ' ' GLU . 22.7 t0 -62.05 117.17 5.62 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.9 m -37.45 -20.49 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.615 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 80' ' ' ASP . 71.3 mm-40 -69.36 -34.32 74.4 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 111.616 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -49.1 -37.88 22.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.596 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -86.87 -19.28 29.15 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.132 0.491 . . . . 0.0 111.671 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.36 -74.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.853 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -62.39 -40.58 96.93 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.98 -40.91 97.23 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.665 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.07 -21.19 63.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.104 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -71.44 -50.55 30.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.091 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -55.28 -43.03 74.37 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.79 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.37 -44.13 94.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.548 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.4 m-85 -68.22 -38.21 81.66 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.244 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -85.28 81.51 8.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -58.81 -48.76 80.17 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -91.29 4.56 52.03 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 122.236 -0.29 . . . . 0.0 111.274 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.13 46.22 56.56 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -90.08 6.75 41.11 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.679 0.276 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.26 2.0 89.33 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -140.14 152.52 46.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.747 0.784 . . . . 0.0 111.688 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -93.46 114.84 30.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -88.03 150.0 23.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.299 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.71 -45.39 85.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.17 0.896 . . . . 0.0 110.586 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.74 -40.66 72.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.912 0.386 . . . . 0.0 110.568 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.68 -42.54 91.17 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.261 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 108' ' ' VAL . 6.8 tt -63.4 -44.9 93.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.309 0.576 . . . . 0.0 111.052 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -41.25 -44.18 2.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.63 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.25 -25.8 65.95 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.616 0.246 . . . . 0.0 110.998 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.548 HG21 ' CE2' ' A' ' 92' ' ' PHE . 67.7 t -58.59 -43.14 86.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.551 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.646 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.26 -45.92 65.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.911 0.863 . . . . 0.0 111.554 -176.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.6 p -62.1 -36.22 81.07 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.178 -176.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.634 HD22 HG12 ' B' 1100 ' ' ILE . 0.1 OUTLIER -65.09 -41.05 95.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.66 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.838 ' O ' HD12 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -89.01 -8.6 53.73 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -178.678 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.87 40.41 36.3 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.532 -1.149 . . . . 0.0 111.08 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.579 ' HB2' HD11 ' A' ' 112' ' ' LEU . 36.8 tp10 -89.96 -25.87 20.69 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 121.036 2.418 . . . . 0.0 110.741 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 46.52 63.42 1.9 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.242 1.02 . . . . 0.0 110.494 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.509 HD12 ' CG ' ' A' ' 109' ' ' MET . 82.3 mt -81.99 147.63 29.09 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.255 -1.793 . . . . 0.0 113.568 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 121' ' ' VAL . 81.4 p -83.16 175.74 9.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -58.29 -46.07 86.77 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -57.54 -48.32 79.62 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -69.15 -30.81 69.13 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.891 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 117' ' ' THR . 42.3 t -63.75 -41.75 93.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.483 0.659 . . . . 0.0 109.297 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -67.72 -36.98 81.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.299 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -59.65 -51.48 69.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 91.6 mtp -57.1 -43.33 82.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.001 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.0 mm -59.56 -44.29 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.559 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.78 -35.65 78.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 111.463 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.21 -40.71 82.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.712 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.48 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -91.06 -20.61 21.87 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.679 0.276 . . . . 0.0 111.637 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 19.3 t0 -77.63 83.16 4.02 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.469 0.652 . . . . 0.0 112.195 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.6 pt -71.02 -9.66 13.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.496 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 54.7 p-10 -142.8 144.1 32.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 112.621 -2.082 . . . . 0.0 109.054 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.28 51.04 1.7 Allowed Glycine 0 CA--C 1.532 1.147 0 CA-C-N 116.741 -0.209 . . . . 0.0 113.533 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -90.48 -9.87 45.77 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.159 0.48 . . . . 0.0 110.135 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.95 0.13 68.32 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.873 -0.679 . . . . 0.0 114.376 176.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -133.78 154.18 51.18 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.206 0.503 . . . . 0.0 110.606 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.2 t -101.14 118.03 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -84.39 174.51 10.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.938 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.15 -40.52 94.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.292 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -62.35 -44.26 96.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.68 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.47 -37.2 86.7 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.532 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -61.26 -45.22 95.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.135 0.493 . . . . 0.0 110.69 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.45 -47.21 87.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.286 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.69 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 52.0 tt0 -49.14 -46.5 45.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.085 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.48 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 1.4 mmt -71.97 -36.88 69.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -177.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.483 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 24.5 mmt -71.85 -44.21 64.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.785 -0.189 . . . . 0.0 110.606 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 147' ' ' ALA . 88.7 m -83.71 -30.63 26.59 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.503 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -39.45 108.4 0.08 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.979 0.418 . . . . 0.0 111.398 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 54.6 tttp . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.284 179.765 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.34 -38.57 91.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.377 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.506 ' C ' ' H ' ' B' 1090 ' ' GLN . 68.1 ttt180 58.8 41.46 21.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -64.33 4.15 1.48 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.536 ' N ' ' OE1' ' B' 1090 ' ' GLN . 0.9 OUTLIER -59.45 -41.9 90.73 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -177.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 77.5 mt -38.79 -67.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.017 0.437 . . . . 0.0 111.449 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.5 mt -53.61 -47.89 69.8 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.461 -0.495 . . . . 0.0 112.161 -175.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 8.2 m95 -60.0 -58.86 6.72 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.792 0.806 . . . . 0.0 111.973 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B 1094 ' ' PHE . . . . . 0.483 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 29.3 m-85 -59.81 -46.66 88.53 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -174.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -42.2 -52.06 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.68 -40.97 99.49 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.779 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 56.8 tp -57.57 -45.28 85.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.196 0.998 . . . . 0.0 109.73 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 15.3 m120 -61.33 -51.75 67.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -65.66 -38.81 90.36 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B 1100 ' ' ILE . . . . . 0.634 HG12 HD22 ' A' ' 111' ' ' ASN . 88.6 mt -60.96 -42.35 92.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.765 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -52.11 -45.33 64.87 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.537 ' O ' ' N ' ' B' 1105 ' ' LYS . 90.9 m -63.1 -48.01 80.4 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.699 -0.626 . . . . 0.0 111.502 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.449 ' C ' ' O ' ' B' 1102 ' ' THR . 91.3 mt-30 -27.97 -55.91 0.11 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.541 1.163 . . . . 0.0 112.65 -176.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B 1104 ' ' ILE . . . . . 0.402 HG21 HD13 ' B' 1104 ' ' ILE . 2.0 mt -83.53 -15.04 11.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 112.165 -2.289 . . . . 0.0 112.602 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.537 ' N ' ' O ' ' B' 1102 ' ' THR . 64.0 tttp -59.53 -44.41 93.2 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 118.063 -1.455 . . . . 0.0 108.259 176.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.5 t -61.39 -48.85 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.78 -35.98 76.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.198 -178.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 92.8 mttt -49.92 -36.72 28.73 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.796 0.726 . . . . 0.0 109.756 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.76 -45.75 70.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.247 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B 1110 ' ' PHE . . . . . 0.406 ' CE2' HG21 ' A' ' 55' ' ' VAL . 51.7 m-85 -63.07 -48.91 76.64 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.229 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B 1111 ' ' HIS . . . . . 0.412 ' NE2' ' SD ' ' A' ' 51' ' ' MET . 83.3 m-70 -71.53 17.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.119 -0.363 . . . . 0.0 111.963 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 73.29 73.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.716 0.689 . . . . 0.0 109.884 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 87.0 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.524 -179.594 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.01 -44.99 95.54 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -110.0 122.23 47.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.055 0.389 . . . . 0.0 110.426 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.7 tp 172.35 -36.93 0.0 OUTLIER 'General case' 0 C--N 1.341 0.224 0 O-C-N 124.033 0.833 . . . . 0.0 109.836 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -73.75 141.13 46.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.203 0.911 . . . . 0.0 109.653 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.0 tt0 -45.26 -61.68 1.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.064 0.935 . . . . 0.0 110.375 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -34.1 -36.14 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.627 -1.624 . . . . 0.0 111.18 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.621 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 1.2 tm0? -69.11 -38.75 79.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.414 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.1 mt -59.68 -44.39 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.431 ' O ' ' OE2' ' A' ' 14' ' ' GLU . . . -53.31 -52.16 60.03 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.238 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.53 -45.49 93.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.531 0.682 . . . . 0.0 112.596 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.621 ' CD1' ' NE2' ' A' ' 8' ' ' GLN . 5.2 m-85 -62.67 -38.55 90.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.705 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -53.03 -53.8 44.81 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.432 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 10' ' ' ALA . 1.9 mp0 -48.38 -41.31 28.51 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.199 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.53 -39.06 72.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.237 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -57.64 -42.0 82.56 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 m -64.88 -14.54 59.95 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.469 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.63 -43.15 97.67 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -105.96 -13.34 15.52 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -74.34 93.77 2.44 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.263 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -68.78 -48.0 64.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.791 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.0 p-10 -102.61 13.74 33.72 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.66 48.02 1.26 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.157 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -85.32 -4.33 59.12 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.749 0.309 . . . . 0.0 110.904 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.49 -2.3 82.75 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.7 p -137.37 152.52 49.76 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.8 mp -91.81 123.59 43.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.433 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 19.0 p -113.76 166.18 11.81 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.539 0.685 . . . . 0.0 112.418 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.3 p -58.99 -37.3 76.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.372 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -61.22 -60.62 3.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.263 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 28' ' ' THR . 15.5 pt-20 -61.1 -30.45 70.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.518 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.408 HD22 HD11 ' A' ' 52' ' ' ILE . 2.9 tp -60.76 -53.68 54.44 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.727 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.52 -37.97 94.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 113.786 -1.552 . . . . 0.0 112.242 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.68 -52.0 67.56 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.782 1.291 . . . . 0.0 108.919 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.17 -45.26 88.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 119.303 0.956 . . . . 0.0 111.275 -177.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 28.2 ttt -59.31 -39.33 82.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 119.805 1.184 . . . . 0.0 109.917 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -52.29 -39.88 61.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.738 0.78 . . . . 0.0 110.259 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.1 p -62.52 -20.64 64.83 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.21 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.95 -0.33 15.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.959 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.06 25.39 44.93 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.183 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -124.97 165.12 18.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.317 0.558 . . . . 0.0 109.772 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -125.62 77.09 69.68 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.278 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.37 147.87 72.52 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.99 1.794 . . . . 0.0 112.119 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.4 p -79.4 162.76 25.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.103 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -57.19 -43.15 82.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.996 -179.177 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.489 ' H ' ' CD ' ' A' ' 45' ' ' GLU . . . -57.19 -25.32 58.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.368 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -65.26 -40.72 94.33 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.088 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.3 mp -55.06 -38.63 68.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.565 0.698 . . . . 0.0 109.46 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -72.97 -55.42 6.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.187 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.41 -49.61 69.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.414 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 63.7 mtp -66.9 -48.98 67.03 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 52' ' ' ILE . 24.4 mm -58.54 -45.23 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.433 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -56.42 -35.42 67.8 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.57 -40.63 89.07 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.507 -0.477 . . . . 0.0 112.076 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.452 HG21 ' CE2' ' B' 1110 ' ' PHE . 75.4 t -85.53 -21.74 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.651 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.476 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.0 t0 -78.69 86.75 4.63 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -175.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.78 87.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.367 -1.742 . . . . 0.0 114.27 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.471 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 39.5 p-10 -86.14 -2.95 58.82 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.26 23.17 63.99 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.548 0.613 . . . . 0.0 112.795 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.471 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.2 p-10 -88.04 2.16 52.53 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.392 0.596 . . . . 0.0 110.66 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.476 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.6 1.75 89.05 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.701 -0.625 . . . . 0.0 114.586 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.4 p -145.78 166.56 25.55 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.1 mm -109.7 126.5 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.85 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -102.78 -176.98 3.25 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.907 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.93 -47.39 98.77 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.21 -51.39 9.53 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.1 1.2 . . . . 0.0 111.613 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.72 -18.33 53.77 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.648 0.737 . . . . 0.0 110.586 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -77.17 -56.75 4.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.441 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.4 mt -58.49 -46.16 87.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.7 p -46.24 -47.33 18.04 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.104 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.7 mtp -66.83 -45.45 78.23 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.6 mmt -59.78 -39.74 85.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.58 78.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.242 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 -94.76 -10.66 30.88 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.727 0.299 . . . . 0.0 111.561 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.31 68.22 8.64 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.13 0.49 . . . . 0.0 110.613 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.5 mmt -107.26 18.62 21.41 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.389 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -50.17 130.43 22.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.239 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -93.57 106.02 18.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.799 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.515 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 2.8 m -90.26 122.08 32.85 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 82' ' ' GLU . 90.3 m-20 -69.66 112.14 5.93 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.0 m -37.58 -21.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.694 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.4 mp0 -68.88 -37.24 78.91 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -47.69 -35.67 9.99 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.266 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -88.97 -17.45 29.45 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.307 0.575 . . . . 0.0 112.039 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 85' ' ' ILE . 27.7 mm -60.87 -74.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.959 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -62.61 -39.1 92.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -62.7 -40.88 98.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.371 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.59 -19.53 62.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -72.92 -50.77 21.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.955 0.407 . . . . 0.0 111.317 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -55.5 -42.48 74.51 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.42 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.23 -43.73 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.605 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.3 m-85 -68.29 -38.97 82.21 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.475 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -89.22 84.03 6.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.7 -46.19 91.33 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -92.15 4.41 53.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.294 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.43 50.35 48.01 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -92.24 5.72 49.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.637 0.256 . . . . 0.0 110.576 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.98 0.76 89.76 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -139.55 153.07 47.35 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.545 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.46 115.32 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.4 m -89.82 153.23 20.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.35 -47.79 80.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 119.039 0.836 . . . . 0.0 110.986 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.01 -40.17 60.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.994 0.426 . . . . 0.0 110.461 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -66.22 -41.43 90.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.383 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 tp -63.5 -46.33 86.61 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.37 0.605 . . . . 0.0 111.422 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -44.22 -36.89 2.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.753 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -69.33 -27.6 65.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.717 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.605 HG21 ' CE2' ' A' ' 92' ' ' PHE . 94.8 t -58.76 -43.08 87.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.03 -178.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.57 ' SD ' HD13 ' A' ' 116' ' ' LEU . 8.7 mmt -51.89 -49.69 62.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.219 1.009 . . . . 0.0 111.879 -176.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 65.9 p -52.78 -37.14 59.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.245 -1.798 . . . . 0.0 110.817 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -66.3 -39.6 89.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.949 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.0 mt -82.83 -13.81 55.5 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.49 37.6 53.06 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.26 -1.3 . . . . 0.0 110.058 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -85.12 -20.57 30.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 121.021 2.411 . . . . 0.0 110.976 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt 42.38 50.6 4.68 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.723 1.249 . . . . 0.0 110.367 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.57 HD13 ' SD ' ' A' ' 109' ' ' MET . 0.9 OUTLIER -74.23 153.47 39.42 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.957 -1.928 . . . . 0.0 112.701 -178.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 61.3 p -85.64 174.14 9.63 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -55.93 -43.97 77.88 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -55.59 -41.87 73.99 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.051 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.09 -29.95 68.15 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.979 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.408 HG22 HD11 ' A' ' 116' ' ' LEU . 43.8 t -62.75 -43.95 99.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.466 0.651 . . . . 0.0 109.593 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -72.83 -36.45 67.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.994 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -59.22 -54.89 41.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 83.9 mtp -56.74 -43.25 80.49 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.645 -1.162 . . . . 0.0 109.812 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.8 mt -59.28 -43.74 90.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.243 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -59.26 -39.44 82.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.828 0.347 . . . . 0.0 111.106 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.31 -41.28 84.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.187 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.65 -24.88 21.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.1 t0 -71.77 88.73 1.01 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.651 0.739 . . . . 0.0 111.933 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 72.3 mt -70.06 -15.88 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.703 1.24 . . . . 0.0 113.208 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 44.7 p-10 -141.53 144.4 34.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 112.295 -2.23 . . . . 0.0 109.522 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.59 52.28 1.17 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.604 -0.331 . . . . 0.0 112.947 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 32.1 p-10 -91.37 -9.91 43.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.187 0.494 . . . . 0.0 110.19 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.82 2.49 76.9 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.218 -0.515 . . . . 0.0 114.268 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -135.04 154.5 51.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 117.198 0.499 . . . . 0.0 110.445 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.5 t -100.9 118.94 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.357 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -84.55 174.44 10.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.85 0.357 . . . . 0.0 110.816 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -61.24 -40.3 93.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.24 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.1 -44.51 96.5 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.34 -38.49 90.28 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.763 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -61.16 -45.4 94.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.054 0.454 . . . . 0.0 110.849 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.9 t -65.23 -46.21 91.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.353 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.734 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 51.6 tt0 -49.8 -45.02 49.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.611 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.6 mmt -72.7 -38.44 67.51 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.4 mmt -71.93 -46.89 55.95 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.341 -0.144 . . . . 0.0 110.909 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 147' ' ' ALA . 22.0 m -80.28 -29.65 38.28 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.725 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -40.81 110.58 0.16 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.022 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.198 179.726 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 71.0 mt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -148.34 173.15 13.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.433 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1088 ' ' ARG . . . . . 0.592 ' C ' ' H ' ' B' 1090 ' ' GLN . 0.0 OUTLIER -131.18 106.66 8.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.6 -179.576 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -58.85 2.85 0.18 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.15 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1090 ' ' GLN . . . . . 0.592 ' H ' ' C ' ' B' 1088 ' ' ARG . 70.9 mt-30 -61.96 -46.2 90.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.787 0.327 . . . . 0.0 111.483 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 56.3 mt -58.04 -49.89 79.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.8 mt -56.72 -62.04 2.01 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.6 m95 -62.34 -54.57 38.56 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.57 0.7 . . . . 0.0 112.244 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 8.3 t80 -59.44 -46.6 88.3 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 18.6 mmm-85 -40.69 -51.3 3.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.28 -39.58 97.4 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.33 -44.03 83.9 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.697 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 39.7 t30 -59.46 -49.78 76.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.631 -1.168 . . . . 0.0 114.118 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -65.58 -37.83 87.78 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.7 -41.68 89.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.889 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -51.39 -46.02 62.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1102 ' ' THR . . . . . 0.527 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.5 m -63.89 -48.18 77.68 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.886 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B 1103 ' ' GLN . . . . . 0.436 ' C ' ' O ' ' B' 1102 ' ' THR . 83.8 mt-30 -27.47 -56.91 0.1 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.638 1.209 . . . . 0.0 112.569 -176.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.3 mt -85.84 -14.17 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.453 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1105 ' ' LYS . . . . . 0.527 ' N ' ' O ' ' B' 1102 ' ' THR . 78.5 tttt -60.32 -45.93 91.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.012 176.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 96.1 t -61.57 -49.06 85.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.7 m -66.04 -35.89 76.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.013 -177.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1108 ' ' LYS . . . . . 0.515 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 87.0 mttt -49.62 -38.65 32.89 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.571 0.7 . . . . 0.0 109.727 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.71 -45.92 67.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.355 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B 1110 ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 55' ' ' VAL . 49.7 m-85 -63.41 -49.4 73.91 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B 1111 ' ' HIS . . . . . 0.459 ' O ' ' OG ' ' B' 1112 ' ' SER . 68.1 m-70 -70.36 20.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B 1112 ' ' SER . . . . . 0.506 ' OG ' ' O ' ' B' 1112 ' ' SER . 5.1 p 68.12 77.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.001 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.751 -179.269 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.5 p -80.03 136.98 36.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.324 0.965 . . . . 0.0 110.32 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 9' ' ' ILE . 46.3 tt0 -51.86 -53.65 38.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 122.072 0.939 . . . . 0.0 110.201 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 10.2 pt-20 -32.84 -36.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.108 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.52 ' OE1' ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -69.62 -37.77 76.96 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.286 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.3 mt -58.58 -44.9 90.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.67 -49.23 62.78 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.108 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.56 -46.37 90.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.339 0.59 . . . . 0.0 111.535 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.52 ' CD2' ' OE1' ' A' ' 8' ' ' GLN . 28.2 m-85 -58.41 -42.37 87.05 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.781 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -49.21 -58.1 5.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.378 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.48 -44.97 62.63 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.031 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.22 -38.16 70.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.222 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.16 -41.84 84.65 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 t -64.41 -15.78 61.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.421 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -64.08 -42.82 96.81 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -178.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -105.64 -14.52 15.24 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -75.45 94.94 3.18 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.137 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -68.25 -47.43 67.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.226 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.2 p-10 -102.38 14.18 32.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.46 46.17 1.03 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.035 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -85.35 -4.0 59.02 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.694 -0.298 . . . . 0.0 110.961 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.38 -2.0 82.71 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.5 p -137.51 152.24 49.29 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.103 0.478 . . . . 0.0 109.891 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.64 124.53 45.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.9 p -114.31 165.27 12.87 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.801 0.81 . . . . 0.0 112.393 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.4 p -58.85 -35.82 73.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.715 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.59 -61.4 2.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.565 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.92 -30.48 71.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.795 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.412 HD22 HD11 ' A' ' 52' ' ' ILE . 2.9 tp -60.16 -55.73 30.3 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.015 0.912 . . . . 0.0 109.667 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.65 -37.69 93.87 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.975 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 m -58.75 -53.03 63.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 119.047 1.423 . . . . 0.0 108.624 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.0 -46.47 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 121.228 -0.92 . . . . 0.0 111.523 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.6 ttt -59.0 -39.93 83.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 120.054 1.297 . . . . 0.0 109.461 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -51.56 -38.36 54.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.531 0.681 . . . . 0.0 110.183 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.1 p -63.54 -21.08 66.14 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.376 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.473 ' O ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -73.73 -1.72 20.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.536 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.34 13.77 67.57 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.127 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -107.14 158.01 17.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 117.611 0.705 . . . . 0.0 109.854 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -114.74 64.77 1.58 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.286 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.05 143.29 94.78 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.19 1.927 . . . . 0.0 112.156 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 t -80.58 166.74 20.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.438 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.15 -44.12 87.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.72 -24.2 33.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.558 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -65.63 -39.15 91.16 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.069 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.2 mp -56.42 -41.59 76.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.463 0.649 . . . . 0.0 109.759 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.25 -56.67 6.2 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.757 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.45 -48.81 71.29 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 41.2 mmm -65.85 -50.17 65.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.412 HD11 HD22 ' A' ' 32' ' ' LEU . 25.9 mm -59.44 -47.69 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.672 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -56.45 -34.97 67.35 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -66.18 -40.01 90.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.8 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.489 HG21 ' CD2' ' B' 1110 ' ' PHE . 71.4 t -86.35 -20.37 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.503 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.494 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.3 t0 -78.49 85.93 4.55 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.21 -38.0 87.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.326 -1.761 . . . . 0.0 114.066 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 36.8 p-10 -86.26 -2.89 58.79 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.98 23.55 63.82 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 118.476 0.58 . . . . 0.0 112.927 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.419 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.4 p-10 -87.36 2.38 50.51 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.234 0.517 . . . . 0.0 110.578 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.2 1.39 89.54 Favored Glycine 0 CA--C 1.521 0.442 0 O-C-N 121.585 -0.697 . . . . 0.0 114.448 175.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.0 p -145.85 165.33 29.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.9 mm -108.91 126.64 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -103.38 -176.33 3.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -57.3 -59.11 13.81 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -47.25 -49.62 12.6 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.37 1.38 . . . . 0.0 111.243 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.57 -19.77 62.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.348 0.594 . . . . 0.0 110.641 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 65' ' ' PHE . 22.7 t80 -74.55 -58.24 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.962 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.18 -45.21 83.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -44.24 -49.88 9.1 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.61 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 72.8 mtm -66.98 -44.5 80.28 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.656 -0.417 . . . . 0.0 112.026 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.8 mmt -57.62 -39.42 76.88 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.46 77.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.548 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -95.74 -9.05 32.82 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.434 ' C ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -85.98 63.84 8.25 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.154 0.502 . . . . 0.0 110.685 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.56 17.24 22.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.41 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -48.31 135.02 14.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.175 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -89.41 108.94 19.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.827 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -93.75 119.68 33.04 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 82' ' ' GLU . 36.8 t0 -67.02 112.89 4.61 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 174.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 m -37.68 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.522 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 80' ' ' ASP . 95.3 mt-10 -72.09 -31.51 66.15 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -50.38 -39.14 45.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.878 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.55 ' OE1' HD11 ' B' 1097 ' ' LEU . 9.2 pt-20 -89.53 -11.04 43.98 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.4 mm -62.43 -74.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.798 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -62.01 -40.75 96.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.91 -41.3 97.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.571 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.41 -21.26 63.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -73.81 -48.41 31.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -54.95 -40.55 70.09 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.815 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.3 t -65.54 -44.1 94.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.512 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.4 m-85 -69.02 -38.7 79.34 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.264 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -85.55 81.11 8.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.37 -49.4 77.36 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -176.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -91.32 4.83 51.38 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.175 -0.328 . . . . 0.0 111.168 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.61 48.13 50.39 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -90.22 6.25 43.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.674 0.273 . . . . 0.0 110.745 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.18 2.13 85.91 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -142.98 156.18 44.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.751 0.786 . . . . 0.0 111.593 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -94.08 115.37 32.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 t -89.05 151.1 22.45 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.23 -46.54 82.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.201 0.91 . . . . 0.0 110.723 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.42 -40.59 65.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.951 0.405 . . . . 0.0 110.554 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.22 -41.13 94.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.168 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.19 -44.64 94.82 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.614 0.721 . . . . 0.0 110.949 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -44.55 -44.01 8.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.548 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.92 -29.71 70.99 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 122.456 -0.152 . . . . 0.0 110.747 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.512 HG21 ' CE2' ' A' ' 92' ' ' PHE . 95.5 t -57.64 -41.32 79.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.837 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.604 ' CE ' HG22 ' A' ' 121' ' ' VAL . 8.5 mtt -50.84 -45.54 59.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.075 0.94 . . . . 0.0 111.526 -177.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 m -56.68 -41.41 77.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.537 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -66.55 -41.55 88.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.132 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 74.8 mt -80.87 -16.36 53.86 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.24 30.52 58.67 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.51 -23.1 27.87 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.962 2.381 . . . . 0.0 110.481 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.9 tptp 45.02 60.37 3.01 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.067 0.937 . . . . 0.0 110.326 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.9 mt -79.95 147.2 31.71 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.566 -1.652 . . . . 0.0 112.463 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.57 ' O ' HG23 ' A' ' 121' ' ' VAL . 81.5 p -81.99 175.35 10.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.468 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -57.41 -44.79 84.86 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -56.49 -47.91 78.28 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.196 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 123' ' ' GLU . 64.3 mm-40 -71.35 -28.44 64.06 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.73 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.604 HG22 ' CE ' ' A' ' 109' ' ' MET . 54.4 t -63.91 -42.43 95.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.669 0.747 . . . . 0.0 109.288 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.53 -35.09 65.5 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.382 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 120' ' ' GLU . 82.5 tt0 -59.66 -51.28 70.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 93.0 mtp -56.08 -44.47 78.98 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.35 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.74 -43.66 88.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.189 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -58.63 -39.45 80.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.953 0.406 . . . . 0.0 111.212 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.37 -40.92 79.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.059 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.41 -20.15 22.1 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.9 t0 -72.88 87.69 1.32 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.301 0.572 . . . . 0.0 112.072 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 tt -70.5 -15.18 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.374 1.083 . . . . 0.0 113.242 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.7 p-10 -142.65 144.78 32.92 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 112.322 -2.217 . . . . 0.0 109.172 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.1 52.27 1.35 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-N 116.736 -0.211 . . . . 0.0 113.255 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -90.79 -9.21 47.37 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.973 0.387 . . . . 0.0 110.013 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.34 1.02 68.41 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.995 -0.621 . . . . 0.0 114.262 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -134.43 153.87 51.69 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.395 0.598 . . . . 0.0 110.422 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.68 118.38 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.366 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -84.44 174.55 9.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 0.0 111.149 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -61.05 -40.8 95.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.202 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.64 -44.6 96.68 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.701 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.94 -35.64 81.81 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.599 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -60.75 -44.75 96.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.076 0.465 . . . . 0.0 110.574 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.11 -47.01 89.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.365 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.708 ' O ' HG22 ' A' ' 146' ' ' THR . 52.6 tt0 -49.34 -40.73 36.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.78 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 mmt -74.9 -38.58 61.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.1 mmt -80.69 4.5 18.59 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.168 0.587 . . . . 0.0 111.18 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 143' ' ' GLN . 5.0 t . . . . . 0 N--CA 1.468 0.473 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.303 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 111.481 0.178 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 4.6 m95 -60.77 -57.86 10.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.681 0.753 . . . . 0.0 112.127 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . 0.513 ' CE2' ' OD1' ' B' 1098 ' ' ASN . 26.1 t80 -58.88 -45.51 90.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.224 -1.353 . . . . 0.0 114.55 -173.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -38.53 -52.65 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.61 -39.55 98.02 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.052 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . 0.55 HD11 ' OE1' ' A' ' 84' ' ' GLU . 46.7 tp -56.26 -42.44 77.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.54 1.17 . . . . 0.0 109.798 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . 0.513 ' OD1' ' CE2' ' B' 1094 ' ' PHE . 8.4 m-20 -56.92 -43.08 81.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.378 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -64.07 -36.92 85.58 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.26 -42.03 91.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.853 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . 0.48 ' CG ' ' OE2' ' A' ' 84' ' ' GLU . 41.8 mt-30 -50.78 -46.21 59.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.51 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.7 m -63.56 -48.19 78.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.99 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.44 ' C ' ' O ' ' B' 1102 ' ' THR . 84.2 mt-30 -27.55 -57.81 0.1 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.556 1.169 . . . . 0.0 112.715 -176.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.2 mt -84.8 -15.14 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 112.161 -2.29 . . . . 0.0 112.691 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.51 ' N ' ' O ' ' B' 1102 ' ' THR . 64.3 tttp -60.23 -44.8 94.89 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.003 -1.479 . . . . 0.0 107.899 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 73.3 t -61.31 -49.05 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . 0.408 HG13 ' H ' ' B' 1107 ' ' VAL . 1.3 m -66.41 -36.25 76.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.429 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 90.4 mttt -49.65 -39.21 35.37 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.53 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.86 -45.52 67.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.914 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . 0.489 ' CD2' HG21 ' A' ' 55' ' ' VAL . 46.4 m-85 -63.65 -49.68 72.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.378 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.622 0 CA-C-O 119.417 -0.325 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.3 m -75.21 139.26 42.5 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.271 0.941 . . . . 0.0 109.492 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 9' ' ' ILE . 10.3 tm-20 -48.47 -56.8 7.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.969 0.89 . . . . 0.0 110.473 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -34.59 -37.88 0.06 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.971 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -69.34 -37.15 77.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.613 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' GLU . 63.8 mt -57.25 -47.6 83.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.29 -49.88 60.41 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.124 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -61.72 -46.85 87.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.099 0.476 . . . . 0.0 112.276 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -59.8 -41.01 90.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.949 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -51.46 -56.55 12.67 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.055 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.43 -45.19 55.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.007 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.26 -38.68 66.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.434 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.77 -40.54 80.04 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.9 m -65.05 -15.37 62.27 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.651 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.2 -41.04 94.92 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -105.96 -14.36 15.21 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.91 94.42 2.8 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.325 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -67.85 -51.85 43.6 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.181 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.6 p30 -100.84 15.73 27.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 37.17 51.98 1.65 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.108 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 26' ' ' THR . 12.3 p30 -88.33 -5.43 58.33 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.925 0.362 . . . . 0.0 111.079 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.93 -0.72 76.74 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.436 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 1.9 t -141.22 157.63 44.99 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.151 0.5 . . . . 0.0 110.49 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 27' ' ' ILE . 3.5 mp -90.52 123.99 42.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.8 p -111.21 161.46 15.96 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.28 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.413 HG22 HG13 ' A' ' 52' ' ' ILE . 21.5 p -59.84 -38.07 81.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.212 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -61.38 -59.28 5.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.325 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.72 -28.3 69.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.762 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.501 HD22 HD11 ' A' ' 52' ' ' ILE . 3.5 tp -61.67 -55.39 30.93 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.977 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.49 92.04 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.186 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -57.98 -55.4 35.39 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.052 1.426 . . . . 0.0 108.198 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.63 -46.56 72.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 118.798 0.727 . . . . 0.0 111.29 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.1 tpt -58.0 -39.86 79.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 120.38 1.445 . . . . 0.0 109.85 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -51.1 -33.55 26.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.346 0.593 . . . . 0.0 110.999 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.9 p -64.9 -20.01 66.22 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.85 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 1.5 mm? -76.27 3.24 11.25 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.143 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.92 27.58 40.84 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.279 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 9.1 tt0 -131.51 170.41 14.75 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.65 0.725 . . . . 0.0 109.469 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.409 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 16.1 m-20 -131.33 78.23 72.53 Favored Pre-proline 0 N--CA 1.466 0.351 0 CA-C-O 120.739 0.304 . . . . 0.0 110.217 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.07 147.03 96.87 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.698 2.265 . . . . 0.0 111.876 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.2 p -77.78 163.39 26.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.401 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.03 -45.43 90.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.721 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.1 -24.68 26.89 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.626 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -65.63 -40.16 92.25 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.662 -0.415 . . . . 0.0 109.989 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.1 mp -56.14 -41.7 75.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.382 0.611 . . . . 0.0 109.939 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -72.57 -56.02 6.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.682 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -55.76 -50.2 71.06 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.4 mmm -64.05 -50.61 67.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.501 HD11 HD22 ' A' ' 32' ' ' LEU . 26.4 mm -57.72 -45.11 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.77 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -55.44 -34.43 64.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -67.0 -40.94 87.45 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.071 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.477 HG12 HD12 ' A' ' 63' ' ' ILE . 42.2 t -85.99 -21.54 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.155 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.5 t0 -79.42 83.71 5.4 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -174.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.53 79.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.816 -1.538 . . . . 0.0 114.442 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.8 p-10 -85.71 -2.47 58.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.331 -0.547 . . . . 0.0 112.463 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.8 23.02 60.6 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.867 -0.521 . . . . 0.0 112.507 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.435 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -86.61 3.83 42.8 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.335 0.568 . . . . 0.0 110.565 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.521 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.15 2.01 89.45 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 118.657 0.662 . . . . 0.0 114.664 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.2 p -148.19 167.79 24.16 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.477 HD12 HG12 ' A' ' 55' ' ' VAL . 10.0 mm -110.06 127.38 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.228 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -102.57 -177.39 3.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.54 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.413 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -58.19 -46.3 99.67 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.191 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 33.3 Cg_exo -56.6 -52.62 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.393 1.395 . . . . 0.0 111.297 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' O ' ' SD ' ' A' ' 71' ' ' MET . 97.4 mt-10 -61.16 -18.91 60.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.26 0.553 . . . . 0.0 110.941 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -76.77 -59.11 2.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.814 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.8 mt -56.05 -47.41 77.94 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.1 t -46.39 -43.58 16.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.071 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 67' ' ' GLU . 39.5 mtp -66.92 -47.76 70.74 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.0 mmm -62.07 -40.71 96.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.13 -33.92 76.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.573 0.225 . . . . 0.0 111.463 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -91.99 -20.76 21.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 111.178 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.58 67.84 5.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.15 0.5 . . . . 0.0 110.178 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.2 mmt -107.81 15.83 24.15 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.578 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -48.33 132.98 16.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.311 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -89.85 107.6 19.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.964 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.491 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 3.2 m -93.64 120.42 33.89 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.5 m-20 -69.63 111.97 5.8 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 m -36.89 -20.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.864 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.6 mm-40 -68.26 -37.49 80.8 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.794 0.33 . . . . 0.0 111.615 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -48.65 -36.41 15.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.144 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -88.09 -16.55 33.23 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 85' ' ' ILE . 26.5 mm -61.96 -74.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.563 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 74.4 mtt85 -62.02 -41.35 97.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.86 -41.5 97.91 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.848 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.07 -17.97 55.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.817 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -72.69 -50.7 23.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -54.95 -42.13 71.94 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.5 t -65.1 -44.38 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.421 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.1 m-85 -69.33 -37.81 77.9 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.159 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -86.25 80.75 8.64 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.81 -48.91 78.37 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -90.59 4.99 49.73 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.264 -0.273 . . . . 0.0 111.351 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.17 47.19 50.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -90.27 7.03 40.35 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.75 0.31 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.33 2.02 89.25 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -140.68 153.42 45.97 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.636 0.731 . . . . 0.0 111.835 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -93.34 116.4 34.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.3 m -89.65 149.31 22.85 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.93 79.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.166 0.894 . . . . 0.0 110.683 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.19 -40.79 64.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.815 0.341 . . . . 0.0 110.673 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.12 -41.4 94.9 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.204 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.74 -45.73 88.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.233 0.54 . . . . 0.0 110.843 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -43.24 -44.44 5.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.857 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -64.82 -28.83 69.83 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.662 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.503 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 85.0 t -58.11 -41.82 81.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.134 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.626 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.27 -46.73 65.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.953 0.882 . . . . 0.0 111.705 -177.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 71.9 p -53.43 -35.89 60.93 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 113.771 -1.559 . . . . 0.0 110.882 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -68.51 -39.88 81.07 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.473 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.86 -13.29 59.06 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.45 30.45 60.31 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -87.68 -24.67 23.81 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.681 2.241 . . . . 0.0 110.779 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 45.25 64.39 1.42 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.713 0.768 . . . . 0.0 110.155 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.3 mt -80.5 148.13 30.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.374 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 121' ' ' VAL . 30.5 p -82.07 174.61 11.07 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.693 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -57.2 -45.83 83.44 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.16 -47.81 77.51 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -71.96 -30.36 65.2 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.588 -0.445 . . . . 0.0 112.108 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 117' ' ' THR . 42.5 t -65.04 -42.69 95.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -70.61 -34.98 72.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.099 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -59.99 -49.12 78.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.041 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 29.8 mmm -52.46 -47.37 66.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.023 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 40.7 mm -57.44 -44.33 84.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.695 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -58.0 -40.23 80.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.89 0.376 . . . . 0.0 111.394 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -57.98 -40.82 81.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.056 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.89 -17.94 24.5 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.716 0.293 . . . . 0.0 111.645 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.2 t0 -73.83 89.56 1.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.436 0.636 . . . . 0.0 111.816 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 80.1 mt -70.73 -17.63 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.063 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.9 p-10 -141.59 145.55 35.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.743 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.45 52.27 1.48 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.76 -0.257 . . . . 0.0 113.117 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -90.66 -9.16 47.91 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.023 0.412 . . . . 0.0 110.219 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.0 1.89 75.43 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.961 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -134.75 154.33 51.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.234 0.517 . . . . 0.0 110.39 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.76 118.58 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.038 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -84.26 174.71 9.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.775 0.321 . . . . 0.0 110.924 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -61.62 -40.03 93.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.095 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.96 -44.66 95.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.54 -38.5 89.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.733 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -60.82 -44.38 96.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.139 0.495 . . . . 0.0 110.807 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.22 -46.42 87.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.233 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -48.43 -45.56 36.51 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.164 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 88.1 mmm -74.68 -38.3 62.45 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 18.6 mmt -72.8 -46.55 52.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 120.66 0.267 . . . . 0.0 111.441 -179.288 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.72 -54.55 41.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.265 0.555 . . . . 0.0 112.029 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 37.9 t80 -57.97 -46.08 85.69 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -42.16 -52.01 4.47 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.49 -42.11 99.69 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.162 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.55 -46.1 80.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.391 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.21 -48.73 79.45 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.26 -38.17 90.1 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.96 -42.16 91.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.795 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -51.3 -46.42 62.51 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.517 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.8 m -63.38 -48.45 77.82 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.422 ' C ' ' O ' ' B' 1102 ' ' THR . 84.5 mt-30 -27.31 -60.2 0.1 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.603 1.192 . . . . 0.0 112.741 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -82.01 -14.59 12.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 112.67 -2.059 . . . . 0.0 112.344 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.517 ' N ' ' O ' ' B' 1102 ' ' THR . 65.8 tttm -57.69 -43.34 85.06 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 117.874 -1.53 . . . . 0.0 108.059 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.8 t -61.88 -47.04 95.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.55 0.69 . . . . 0.0 112.818 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 65.8 t -65.38 -41.18 90.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.097 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . 0.491 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 96.1 mttt -49.03 -38.14 22.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.396 0.617 . . . . 0.0 109.634 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -54.09 -46.91 72.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.343 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 55' ' ' VAL . 54.8 m-85 -62.35 -49.81 74.07 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 23.4 m-70 . . . . . 0 C--N 1.326 -0.45 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.037 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.3 mt . . . . . 0 CA--C 1.532 0.273 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.8 p -80.64 137.83 36.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.461 1.028 . . . . 0.0 110.454 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' A' ' 7' ' ' GLU . 18.0 pt-20 -52.65 -50.06 63.95 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.123 0.963 . . . . 0.0 110.893 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.507 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 43.4 tp10 -36.44 -38.13 0.15 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.033 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -70.63 -35.34 72.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.66 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.1 mt -58.92 -45.6 91.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 175.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.59 -49.02 62.95 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.08 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.26 -47.88 83.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.225 0.535 . . . . 0.0 112.083 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.426 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 10.0 m-85 -60.58 -41.96 95.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.988 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -49.52 -59.5 3.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.367 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -47.62 -42.5 24.4 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.414 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -55.6 -39.15 70.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.294 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -56.91 -41.52 78.29 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 m -65.09 -13.43 58.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.387 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.44 -43.47 97.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -106.73 -13.21 15.33 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -76.05 94.04 3.39 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.073 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -68.33 -46.7 69.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.41 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.7 p-10 -102.77 14.17 32.62 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.62 49.67 1.35 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.018 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -87.06 -5.01 59.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.944 0.372 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.02 -2.05 81.19 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.6 p -137.32 151.61 48.83 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.143 0.496 . . . . 0.0 110.307 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.8 mp -93.34 125.24 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -114.1 165.04 13.05 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.671 0.748 . . . . 0.0 112.575 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.426 HG22 HG13 ' A' ' 52' ' ' ILE . 21.6 p -58.85 -35.34 72.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.823 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -61.25 -61.89 2.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.158 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.12 -29.54 70.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.773 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.549 HD22 HD11 ' A' ' 52' ' ' ILE . 2.8 tp -60.57 -56.77 17.31 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.123 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.66 -39.18 93.12 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.107 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.9 m -58.26 -54.65 44.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.05 1.425 . . . . 0.0 108.517 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -55.63 -47.04 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.014 -0.675 . . . . 0.0 111.674 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -58.65 -41.04 85.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 120.143 1.338 . . . . 0.0 110.085 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -51.97 -40.06 60.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.434 0.635 . . . . 0.0 110.351 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 23.0 t -63.57 -20.74 65.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.041 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 tp -73.91 -2.16 22.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.744 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.17 13.44 63.98 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.308 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -106.67 156.44 18.62 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.537 0.669 . . . . 0.0 110.045 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -115.67 63.44 2.07 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.376 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.07 144.2 92.15 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.244 1.962 . . . . 0.0 112.192 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.8 p -80.46 166.63 21.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.393 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -57.37 -44.63 84.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.13 -23.71 22.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.636 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -65.9 -39.4 90.59 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.147 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.48 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.2 mp -56.84 -42.34 79.49 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.311 0.577 . . . . 0.0 109.779 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -70.97 -57.07 4.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.851 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -54.95 -48.76 72.78 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 42.7 mmm -65.68 -50.64 64.19 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.549 HD11 HD22 ' A' ' 32' ' ' LEU . 26.4 mm -58.32 -47.13 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.789 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -55.68 -34.53 65.12 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -66.28 -39.82 89.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.86 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.416 HG21 ' CE2' ' B' 1110 ' ' PHE . 39.3 t -87.22 -20.09 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.388 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.0 t0 -78.1 85.61 4.29 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.2 85.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.541 -1.663 . . . . 0.0 114.359 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.7 p-10 -86.65 -2.48 58.55 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.16 23.28 61.74 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 118.452 0.569 . . . . 0.0 112.597 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.438 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.1 p-10 -87.21 2.85 48.75 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.294 0.547 . . . . 0.0 110.568 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.44 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.6 1.92 89.0 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.3 p -148.14 168.55 22.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.4 mt -112.69 128.4 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 43.9 t0 -103.59 -175.51 2.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.647 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.515 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -56.31 -56.88 26.86 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -177.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 9.9 Cg_endo -50.26 -49.54 16.07 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 CA-C-N 120.522 1.222 . . . . 0.0 111.673 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -62.04 -18.85 61.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.262 0.553 . . . . 0.0 110.753 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -75.56 -58.81 3.06 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.748 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.9 mt -56.1 -45.24 79.52 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.8 m -44.05 -50.28 8.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.513 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 74.5 mtm -66.05 -43.93 86.04 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.48 ' O ' ' CE ' ' A' ' 76' ' ' MET . 15.2 mmt -57.52 -37.54 73.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.63 -35.23 72.83 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -93.76 -17.25 23.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 111.727 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.31 68.11 5.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.213 0.53 . . . . 0.0 110.456 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.48 ' CE ' ' O ' ' A' ' 72' ' ' MET . 24.3 mmt -108.81 15.47 23.54 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.608 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -52.89 131.62 35.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.637 0.732 . . . . 0.0 111.706 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -132.07 143.95 50.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.372 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.504 ' O ' ' CB ' ' A' ' 80' ' ' ASP . 35.8 p -127.14 -45.14 1.56 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 82' ' ' GLU . 99.8 m-20 126.15 134.84 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 125.357 1.66 . . . . 0.0 109.62 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.1 m -37.61 -17.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.212 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.9 mm-40 -68.51 -37.22 79.87 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.855 0.359 . . . . 0.0 111.653 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -47.67 -36.14 10.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.312 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -89.57 -16.73 29.97 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.064 0.459 . . . . 0.0 111.916 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 85' ' ' ILE . 26.3 mm -61.1 -74.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.541 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -61.58 -41.63 97.69 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.63 -41.01 94.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.587 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.36 -19.53 61.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.118 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -72.57 -51.26 20.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.841 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.95 -42.28 72.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.678 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.92 -43.88 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.0 m-85 -68.86 -38.04 79.47 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.916 -0.313 . . . . 0.0 111.471 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -90.71 83.39 5.76 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.85 -44.65 96.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -90.53 4.32 51.5 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 122.179 -0.326 . . . . 0.0 111.584 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.18 48.71 46.23 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -91.45 6.25 46.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.676 0.274 . . . . 0.0 110.402 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.11 0.14 90.08 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -137.94 151.91 48.43 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.611 0.72 . . . . 0.0 111.454 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.14 115.28 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 92.1 p -91.53 154.58 19.0 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.91 -48.24 78.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 119.024 0.829 . . . . 0.0 111.071 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.52 -41.44 61.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.998 0.428 . . . . 0.0 110.594 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.67 -41.2 92.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.894 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 108' ' ' VAL . 9.2 tp -63.56 -46.7 84.72 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.974 -0.454 . . . . 0.0 111.22 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -44.25 -35.99 2.53 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.943 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -66.8 -26.7 67.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.033 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.582 HG21 ' CE2' ' A' ' 92' ' ' PHE . 83.0 t -58.19 -43.13 85.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.798 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.9 mtp -50.13 -47.24 54.23 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.901 0.858 . . . . 0.0 111.781 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 m -58.1 -41.64 83.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.682 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 38' ' ' SER . 2.9 m-80 -66.13 -41.81 89.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.823 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.6 mt -81.46 -15.47 54.93 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.86 30.18 61.94 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -86.06 -24.26 26.41 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.957 2.379 . . . . 0.0 110.691 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 45.57 60.08 3.28 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.689 0.756 . . . . 0.0 110.457 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.2 148.38 32.28 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.938 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 121' ' ' VAL . 80.7 p -82.12 174.69 10.98 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.344 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -57.89 -45.47 86.37 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.92 -49.95 74.03 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.584 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -68.52 -29.58 68.2 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.955 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 117' ' ' THR . 39.7 t -63.84 -41.51 92.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -66.65 -36.99 83.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.102 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -59.43 -53.32 59.5 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -44.64 76.6 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.334 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.48 -44.32 92.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.027 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -60.05 -38.56 83.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.829 0.347 . . . . 0.0 111.292 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.12 -41.76 84.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.25 -22.11 21.78 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.811 0.338 . . . . 0.0 111.687 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.7 t0 -73.7 87.69 1.7 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.33 0.586 . . . . 0.0 112.014 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.6 tp -69.3 -15.77 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 122.611 1.196 . . . . 0.0 113.495 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.6 p-10 -142.44 145.43 33.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.111 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.58 52.59 1.54 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.576 -0.345 . . . . 0.0 113.12 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -90.88 -9.25 46.96 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.089 0.445 . . . . 0.0 110.076 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.88 1.7 73.92 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.984 -0.627 . . . . 0.0 114.133 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -134.54 154.48 51.43 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.372 0.586 . . . . 0.0 110.202 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.9 t -100.39 118.47 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.438 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -84.0 173.87 10.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.787 0.327 . . . . 0.0 110.844 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -61.76 -39.41 91.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.018 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.29 -44.75 94.13 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.878 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.83 -38.69 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.591 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.64 -44.66 96.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.859 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.19 -47.01 89.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.4 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -49.37 -44.54 44.97 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.25 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.1 mmm -75.44 -39.31 59.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.6 mmt -74.36 -48.04 30.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.605 -0.146 . . . . 0.0 110.605 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.686 0.279 . . . . 0.0 111.591 -179.39 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.0 m95 -59.99 -57.63 12.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.402 0.62 . . . . 0.0 112.077 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 41.5 t80 -57.54 -44.96 85.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -40.82 -51.11 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.57 99.7 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.514 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 46.0 tp -56.11 -46.24 79.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.517 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 65.8 t30 -59.21 -49.28 78.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -65.22 -38.4 90.32 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 88.0 mt -60.79 -42.33 91.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.71 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -50.25 -44.73 53.67 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.519 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.0 m -63.6 -48.39 77.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.416 ' C ' ' O ' ' B' 1102 ' ' THR . 23.8 mt-30 -27.57 -60.18 0.1 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.738 1.256 . . . . 0.0 112.747 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.1 mt -82.43 -14.8 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 112.33 -2.214 . . . . 0.0 111.968 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.519 ' N ' ' O ' ' B' 1102 ' ' THR . 17.3 ttmm -59.1 -45.04 91.91 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 117.845 -1.542 . . . . 0.0 107.937 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.2 t -60.78 -49.26 85.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.97 -36.35 77.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.305 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.0 mttt -49.35 -38.15 27.2 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.641 -0.662 . . . . 0.0 109.659 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.19 -45.99 68.81 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.341 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 55' ' ' VAL . 47.8 m-85 -62.87 -49.8 73.41 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 25.1 m-70 . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.945 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 119.366 -0.349 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.6 p -79.33 135.98 36.88 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.371 0.987 . . . . 0.0 110.36 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ILE . 48.6 tp10 -51.94 -55.43 20.33 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.97 0.891 . . . . 0.0 110.467 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -34.8 -36.33 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.773 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -70.1 -33.96 72.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.598 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.4 mm -59.2 -45.42 92.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.52 -51.36 59.96 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.383 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.92 -46.64 89.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.422 0.629 . . . . 0.0 112.221 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.2 m-85 -62.81 -38.86 92.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.771 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -52.59 -53.67 43.57 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.177 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.85 -41.27 61.7 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.041 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -55.95 -37.88 69.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.355 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.61 -41.76 81.9 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 t -64.6 -14.85 59.77 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.476 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.97 -42.78 97.16 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -106.14 -13.82 15.33 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -76.4 95.09 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.422 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -68.35 -46.89 68.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.227 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 23' ' ' GLY . 35.4 p30 -101.89 14.17 32.71 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.02 46.47 0.94 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.031 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -85.77 -4.17 59.09 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.898 0.38 . . . . 0.0 111.044 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.69 80.79 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.9 p -137.64 152.09 48.98 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.078 0.466 . . . . 0.0 110.068 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.12 124.51 44.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.8 p -112.51 163.4 14.52 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.521 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.428 HG22 HG13 ' A' ' 52' ' ' ILE . 18.7 p -59.42 -36.62 76.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.052 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -61.73 -59.58 4.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.317 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.82 -28.92 70.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.558 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.521 HD22 HD11 ' A' ' 52' ' ' ILE . 3.1 tp -61.17 -54.41 44.73 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.461 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.53 -38.36 93.5 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.192 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.36 -53.92 52.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.835 1.318 . . . . 0.0 108.729 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.7 t -56.2 -45.92 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 O-C-N 121.341 -0.85 . . . . 0.0 111.223 -176.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 ttt -58.76 -38.98 79.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 120.157 1.344 . . . . 0.0 109.946 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -52.48 -40.41 62.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 110.725 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.2 p -63.08 -20.83 65.72 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.037 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.79 -1.43 19.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.805 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.0 23.97 39.44 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.389 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -125.76 166.81 16.12 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 117.369 0.585 . . . . 0.0 109.669 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 14.1 p30 -131.38 76.75 75.17 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.461 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -63.87 148.85 91.69 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.941 2.427 . . . . 0.0 112.175 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.4 p -79.03 165.2 23.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.115 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -58.71 -45.0 90.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.85 -24.73 53.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.876 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -64.53 -40.92 96.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.139 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.5 mp -54.18 -38.79 65.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.222 0.534 . . . . 0.0 109.707 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -72.74 -55.34 6.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.797 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -54.68 -50.44 68.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 73.2 mtp -66.87 -49.35 65.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.521 HD11 HD22 ' A' ' 32' ' ' LEU . 27.6 mm -59.01 -47.78 88.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.769 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -57.33 -32.85 67.13 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -67.35 -40.25 85.83 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.8 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.12 -21.03 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.171 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.47 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.5 t0 -78.27 86.06 4.39 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -174.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.1 81.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 113.427 -1.715 . . . . 0.0 114.184 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -86.47 -2.46 58.47 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.52 23.17 60.17 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 118.543 0.611 . . . . 0.0 112.707 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -87.47 4.72 42.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.205 0.503 . . . . 0.0 110.54 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.47 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.32 1.17 89.49 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.737 -0.602 . . . . 0.0 114.599 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.5 p -148.35 168.42 22.64 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.4 mt -112.91 128.67 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 45.7 t0 -104.03 -174.57 2.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.604 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.527 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -57.12 -57.21 26.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 10.4 Cg_endo -50.47 -49.86 15.32 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 CA-C-N 120.541 1.229 . . . . 0.0 111.569 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.89 -18.59 60.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.273 0.559 . . . . 0.0 110.72 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -73.47 -57.59 3.89 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.123 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' THR . 78.3 mt -57.74 -45.27 86.06 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 53.6 m -38.59 -64.57 0.42 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.749 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.487 ' SD ' ' N ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -63.17 -42.03 99.32 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.487 ' N ' ' SD ' ' A' ' 71' ' ' MET . 97.9 mmm -58.73 -40.69 84.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.02 -33.51 76.21 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 122.395 0.278 . . . . 0.0 111.022 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -95.21 -10.22 31.03 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.112 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.4 65.85 8.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.974 0.416 . . . . 0.0 110.375 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.5 mmt -108.24 16.22 23.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.569 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -49.1 133.34 18.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.394 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -90.75 106.86 18.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.968 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.454 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 15.7 m -91.8 120.18 32.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.6 m-20 -68.74 112.71 5.64 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.4 m -37.42 -20.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.768 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 80' ' ' ASP . 94.9 mt-10 -68.13 -39.8 82.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.733 0.302 . . . . 0.0 111.648 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -46.93 -35.32 6.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -87.71 -19.4 27.67 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.954 0.407 . . . . 0.0 111.78 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 85' ' ' ILE . 30.4 mm -61.04 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.735 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -61.47 -41.2 96.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.05 -40.54 94.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.5 -178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.05 -20.5 64.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -71.57 -51.6 22.58 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.03 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -54.8 -42.34 71.7 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.347 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.73 -43.74 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.526 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.5 m-85 -68.89 -39.07 79.95 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.326 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -85.3 81.09 8.93 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -57.63 -49.46 76.37 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -91.85 4.82 52.03 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 122.181 -0.324 . . . . 0.0 111.42 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.76 48.31 50.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -90.37 6.34 43.57 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.739 0.304 . . . . 0.0 110.715 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.19 2.1 88.1 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -142.34 155.99 45.21 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.487 0.66 . . . . 0.0 111.463 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.0 mt -93.57 114.93 31.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 t -88.98 150.98 22.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.47 78.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 119.085 0.857 . . . . 0.0 110.815 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.21 -40.08 61.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.942 0.401 . . . . 0.0 110.419 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.37 -42.11 88.47 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.69 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.8 tp -62.84 -47.16 84.6 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.249 0.547 . . . . 0.0 111.079 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -43.01 -43.31 4.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.652 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -64.23 -28.63 69.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.005 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.526 HG21 ' CE2' ' A' ' 92' ' ' PHE . 92.9 t -57.78 -42.38 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.602 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.624 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -50.96 -44.12 60.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.699 0.761 . . . . 0.0 111.253 -177.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 m -56.28 -40.91 75.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.781 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -65.51 -41.02 93.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.79 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.8 mt -81.82 -13.77 57.23 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.905 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.2 31.36 59.55 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -85.31 -22.63 28.45 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.55 2.175 . . . . 0.0 111.286 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 44.16 60.93 2.55 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.71 0.767 . . . . 0.0 109.675 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.432 HD12 ' CG ' ' A' ' 109' ' ' MET . 88.9 mt -80.7 148.23 30.24 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 113.527 -1.67 . . . . 0.0 112.462 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 121' ' ' VAL . 65.4 p -82.85 175.5 10.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.3 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 119' ' ' GLU . 18.9 p-10 -58.41 -43.99 88.87 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 176.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.491 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 67.5 mm-40 -57.85 -49.16 77.6 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -70.87 -30.3 66.64 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.627 -0.429 . . . . 0.0 112.039 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 117' ' ' THR . 40.7 t -63.97 -41.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.6 0.714 . . . . 0.0 109.1 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -70.78 -35.6 72.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.339 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.41 -51.33 69.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 37.9 mmm -55.98 -44.62 78.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.253 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.96 -43.49 88.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.404 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -60.73 -35.22 75.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.848 0.356 . . . . 0.0 111.153 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -59.45 -41.36 89.5 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.938 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.95 -20.51 22.09 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 21.4 t0 -73.09 89.05 1.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.528 0.68 . . . . 0.0 111.706 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 76.4 mt -70.08 -16.35 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.021 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 49.1 p-10 -140.48 144.82 36.25 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 112.644 -2.071 . . . . 0.0 108.805 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.27 52.17 1.41 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.899 -0.191 . . . . 0.0 113.154 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 22.0 p-10 -91.24 -8.84 47.29 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.966 0.383 . . . . 0.0 110.057 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.86 3.17 79.64 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.117 -0.564 . . . . 0.0 114.125 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -136.09 155.2 50.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.444 0.622 . . . . 0.0 110.383 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.9 t -101.56 119.01 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.207 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -84.79 175.64 9.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.597 0.237 . . . . 0.0 110.89 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -61.64 -41.12 97.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.306 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -61.61 -45.0 95.93 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.704 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.59 -38.0 88.25 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.668 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 90.9 t80 -58.57 -44.64 89.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.999 0.428 . . . . 0.0 110.796 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.03 -46.13 88.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.411 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -48.35 -44.58 34.49 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.03 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 77.3 mmm -75.73 -36.48 59.92 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.585 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.6 mmt -65.96 -50.98 62.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 m . . . . . 0 C--N 1.326 -0.441 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.08 -179.612 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 9.3 mt . . . . . 0 C--O 1.24 0.562 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.8 m95 -63.4 -47.29 82.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . 0.532 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 2.4 m-85 -58.02 -46.3 85.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -40.51 -53.46 2.67 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.85 -42.11 99.71 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.129 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 50.8 tp -56.85 -44.6 82.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.217 1.008 . . . . 0.0 109.592 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 12.4 m120 -58.8 -47.6 84.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -65.06 -37.46 87.63 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.12 -42.43 93.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.772 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -50.83 -45.88 59.74 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 118.863 -1.135 . . . . 0.0 108.039 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.527 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.8 m -63.64 -48.22 78.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.434 -0.506 . . . . 0.0 112.152 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.429 ' C ' ' O ' ' B' 1102 ' ' THR . 84.3 mt-30 -27.79 -57.78 0.11 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 122.457 1.122 . . . . 0.0 112.451 -176.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . 0.404 HG21 HD13 ' B' 1104 ' ' ILE . 1.5 mt -83.98 -14.45 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.365 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.527 ' N ' ' O ' ' B' 1102 ' ' THR . 65.7 tttm -59.72 -46.28 89.59 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 118.152 -1.419 . . . . 0.0 107.972 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 86.2 t -61.08 -49.31 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.64 -35.97 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.329 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . 0.454 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 88.8 mttt -49.31 -37.75 25.28 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.646 0.657 . . . . 0.0 109.641 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.59 -45.91 66.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.295 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -62.9 -50.23 71.7 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 78.5 m-70 . . . . . 0 C--N 1.325 -0.467 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.198 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 CA--C 1.534 0.338 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.7 m -81.07 136.43 35.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.093 0.861 . . . . 0.0 110.366 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.1 tt0 -51.01 -58.84 5.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.795 0.807 . . . . 0.0 110.991 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -33.8 -38.64 0.05 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.855 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -68.86 -35.06 76.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.49 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.6 mt -58.32 -45.11 89.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.55 -51.28 63.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.097 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -59.82 -48.27 82.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.283 0.564 . . . . 0.0 112.384 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -61.37 -40.4 94.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.952 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -51.63 -56.9 10.93 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.734 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.35 -43.65 23.26 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.462 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.82 -39.04 65.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.987 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -56.92 -42.37 79.86 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -64.25 -15.49 60.2 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.056 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.96 -41.34 95.56 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -105.99 -13.65 15.42 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -74.4 95.84 2.77 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.565 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -68.86 -49.46 58.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.111 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.0 p-10 -101.84 15.76 28.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 33.87 47.82 0.51 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.035 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 33.9 p-10 -85.24 -5.18 59.34 Favored 'General case' 0 N--CA 1.461 0.106 0 O-C-N 122.69 -0.3 . . . . 0.0 111.038 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.72 -1.93 79.3 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.0 p -138.25 153.89 49.08 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.693 ' N ' HD12 ' A' ' 27' ' ' ILE . 2.0 mp -93.0 125.46 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.519 HG22 ' OE1' ' A' ' 31' ' ' GLU . 10.0 t -116.86 166.37 12.24 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.421 HG22 HG13 ' A' ' 52' ' ' ILE . 37.5 p -56.79 -32.45 65.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.407 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -59.78 -63.61 1.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.298 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' OE1' HG22 ' A' ' 28' ' ' THR . 4.7 pt-20 -62.54 -30.49 71.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 119.326 -0.369 . . . . 0.0 111.882 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.404 HD22 HD11 ' A' ' 52' ' ' ILE . 4.1 tp -58.25 -61.3 2.67 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 118.821 -1.151 . . . . 0.0 108.69 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.19 72.96 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.098 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.8 m -56.67 -53.64 55.4 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.782 1.791 . . . . 0.0 108.431 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.71 -45.64 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 119.196 0.907 . . . . 0.0 111.563 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.417 ' SD ' HD12 ' A' ' 39' ' ' LEU . 9.2 tpt -58.2 -41.69 84.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 120.355 1.434 . . . . 0.0 109.698 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -52.3 -39.85 61.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.506 0.67 . . . . 0.0 111.32 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 t -62.96 -20.52 65.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.706 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.417 HD12 ' SD ' ' A' ' 36' ' ' MET . 80.4 mt -74.98 2.21 11.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.167 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.1 26.81 47.29 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.978 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -125.8 166.65 16.45 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 117.41 0.605 . . . . 0.0 109.91 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -124.11 81.07 57.63 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.23 146.76 52.02 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.802 1.668 . . . . 0.0 112.204 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -80.29 163.19 24.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.84 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -58.02 -44.48 87.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.097 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.74 -24.49 35.42 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.771 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -65.25 -40.62 94.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.895 0.378 . . . . 0.0 110.657 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 6.8 mp -56.2 -41.05 74.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.638 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -70.01 -56.93 5.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.826 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -55.27 -49.69 71.43 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.5 mtp -66.21 -51.4 58.04 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.421 HG13 HG22 ' A' ' 29' ' ' THR . 25.7 mm -57.64 -49.18 81.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -56.15 -32.57 64.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -67.26 -40.39 86.22 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.868 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.7 t -86.27 -20.32 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.425 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.404 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 43.5 t0 -78.69 83.64 4.83 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -174.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.7 75.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 113.595 -1.639 . . . . 0.0 114.748 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.454 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 26.1 p30 -88.61 -1.66 58.18 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.17 23.84 60.22 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 118.664 0.666 . . . . 0.0 112.95 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.627 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -87.52 2.97 49.21 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 117.42 0.61 . . . . 0.0 110.368 179.316 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.18 1.73 86.2 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 114.831 0.692 . . . . 0.0 114.831 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.627 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 19.2 p -147.66 169.65 19.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -112.22 128.17 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.097 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -102.46 -178.99 3.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.761 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.96 99.78 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -54.13 -51.83 9.73 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.071 1.181 . . . . 0.0 111.978 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.24 -23.19 66.53 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.388 0.613 . . . . 0.0 111.269 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -71.18 -61.11 1.89 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.514 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.5 mt -56.69 -43.81 80.85 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.1 p -44.0 -51.72 7.56 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.605 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.0 mtm -64.9 -44.65 88.9 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.6 mmm -61.23 -41.06 96.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.91 79.31 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.415 0.286 . . . . 0.0 111.623 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -91.91 -16.25 26.91 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.722 0.296 . . . . 0.0 111.331 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 27.8 tptp -80.49 71.62 7.34 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.819 0.819 . . . . 0.0 110.631 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 20.6 mmt -109.5 15.35 23.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.255 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -47.77 131.27 14.88 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.237 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -89.28 109.62 20.49 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.927 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.518 HG21 ' NZ ' ' B' 1108 ' ' LYS . 17.2 p -97.98 114.79 27.02 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -64.99 115.5 5.46 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 62.6 m -37.44 -21.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.845 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 80' ' ' ASP . 42.5 tp10 -68.26 -35.86 78.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.028 0.442 . . . . 0.0 111.707 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 80.2 tt0 -49.6 -37.2 26.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.341 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -87.35 -16.3 35.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.128 0.49 . . . . 0.0 111.701 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 85' ' ' ILE . 29.5 mm -62.57 -73.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.735 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -60.39 -44.21 95.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 87' ' ' GLU . 7.1 mp0 -61.05 -41.29 96.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.364 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.5 -17.84 47.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.188 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -75.15 -49.67 18.79 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.476 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -55.4 -42.94 74.76 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.932 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.9 t -65.13 -44.12 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.488 ' CE2' HG21 ' A' ' 108' ' ' VAL . 8.0 m-85 -69.82 -38.16 76.47 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.635 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.561 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 31.4 t0 -88.32 82.59 7.01 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.12 -48.59 78.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 40.7 p-10 -91.65 5.47 49.56 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.1 50.13 40.56 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.741 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -92.62 5.11 52.17 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.416 0.287 . . . . 0.0 110.818 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.465 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 85.25 0.21 88.61 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.741 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 87.0 m-85 -138.74 152.12 47.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.944 0.878 . . . . 0.0 111.887 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 95.8 mt -94.79 117.37 38.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.1 m -89.46 148.12 23.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.529 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.29 -48.03 74.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 119.66 1.118 . . . . 0.0 110.17 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.38 -42.61 53.71 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.75 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.91 -41.05 97.78 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.34 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.33 -45.28 92.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.552 0.691 . . . . 0.0 111.203 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 74.5 ttp85 -44.28 -44.94 8.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.551 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -63.63 -31.33 72.47 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.331 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.488 HG21 ' CE2' ' A' ' 92' ' ' PHE . 84.5 t -56.05 -42.15 71.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.004 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.736 ' SD ' HD12 ' A' ' 116' ' ' LEU . 16.0 mmt -51.31 -44.38 61.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.795 0.807 . . . . 0.0 111.222 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 m -53.76 -42.03 67.81 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.952 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -66.4 -41.17 89.72 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.521 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.31 -16.03 53.65 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.08 30.39 59.15 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-O 118.258 -1.301 . . . . 0.0 110.546 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -85.66 -22.27 27.98 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.341 2.571 . . . . 0.0 110.982 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 43.76 60.42 2.69 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 122.18 0.99 . . . . 0.0 110.056 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.736 HD12 ' SD ' ' A' ' 109' ' ' MET . 40.4 mt -80.49 147.24 30.97 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.64 -1.618 . . . . 0.0 111.799 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 121' ' ' VAL . 28.5 p -82.14 174.89 10.78 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -56.55 -44.98 81.45 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -57.7 -47.25 82.89 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.594 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -73.22 -30.18 63.31 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.762 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 117' ' ' THR . 44.5 t -64.68 -41.71 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.463 0.649 . . . . 0.0 109.864 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 67.7 t0 -73.45 -34.8 65.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.291 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -59.5 -50.01 75.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.934 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.0 mtp -53.58 -46.6 70.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.285 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.8 mm -56.41 -43.54 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -60.1 -36.5 77.56 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.288 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -58.68 -41.18 85.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.846 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.91 -17.16 25.61 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.8 t0 -72.54 90.74 1.36 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.737 0.78 . . . . 0.0 112.213 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.405 ' O ' HG22 ' A' ' 130' ' ' ILE . 79.3 mt -71.74 -17.63 19.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.158 -1.383 . . . . 0.0 113.123 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 50.4 p-10 -142.72 144.28 32.62 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 112.65 -2.068 . . . . 0.0 108.813 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.41 53.82 1.53 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.129 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -90.85 -8.87 48.35 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.051 0.425 . . . . 0.0 110.14 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.52 1.64 71.73 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.997 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -134.76 155.33 50.78 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.159 0.479 . . . . 0.0 110.439 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.3 t -100.91 118.42 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.322 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.42 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 53.3 t30 -84.46 173.7 10.65 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 111.258 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.42 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 82.5 t80 -61.0 -40.6 94.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.96 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.06 -44.63 96.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.794 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.48 -37.24 86.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.549 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -61.12 -45.04 96.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.046 0.451 . . . . 0.0 111.046 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.69 -47.18 89.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.829 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -50.58 -41.93 55.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.145 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.6 mmt -74.67 -38.57 62.39 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 19.9 mmt -73.17 -46.12 52.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 120.576 0.227 . . . . 0.0 111.456 -179.764 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 111.417 0.154 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.7 m95 -61.33 -55.76 28.02 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.462 0.649 . . . . 0.0 112.172 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 50.3 t80 -57.94 -46.98 84.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . 0.684 HH21 ' NH2' ' B' 1099 ' ' ARG . 59.4 ttt85 -40.31 -52.75 2.65 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.4 -40.62 98.91 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 48.7 tp -56.0 -46.32 78.78 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.689 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -58.63 -49.88 75.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . 0.684 ' NH2' HH21 ' B' 1095 ' ' ARG . 91.2 mtt180 -63.87 -39.76 94.95 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.77 -42.61 89.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.14 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -52.29 -47.42 65.91 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 118.605 -1.238 . . . . 0.0 107.677 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.527 ' O ' ' N ' ' B' 1105 ' ' LYS . 18.8 m -61.58 -48.87 78.99 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 25.2 mt-30 -27.57 -57.95 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 122.709 1.242 . . . . 0.0 113.382 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.0 mt -81.68 -14.42 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 112.434 -2.166 . . . . 0.0 112.389 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.527 ' N ' ' O ' ' B' 1102 ' ' THR . 93.4 mttt -59.28 -41.87 89.9 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.27 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 90.8 t -60.39 -46.7 94.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.994 0.902 . . . . 0.0 112.24 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 55.5 t -65.59 -42.34 92.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.877 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . 0.518 ' NZ ' HG21 ' A' ' 79' ' ' THR . 94.0 mttt -49.25 -41.32 37.2 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.848 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.25 61.66 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.693 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -60.44 -65.65 0.65 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.848 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 35.4 p80 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.929 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 119.346 -0.359 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -80.92 140.21 35.43 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.15 0.886 . . . . 0.0 110.196 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.5 tt0 -50.39 -56.26 12.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 122.167 0.984 . . . . 0.0 110.642 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -34.83 -37.77 0.07 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.189 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -68.9 -38.59 79.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.72 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 6' ' ' GLU . 66.6 mt -56.85 -45.74 83.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.62 -51.27 63.61 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.455 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -61.43 -47.33 86.25 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.466 0.65 . . . . 0.0 112.246 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.0 m-85 -62.83 -37.7 87.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.897 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -54.59 -52.21 62.86 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.777 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -51.08 -39.99 57.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.082 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.84 -38.0 72.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.309 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -58.04 -42.31 85.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.1 t -65.03 -14.79 61.32 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.6 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.74 -43.05 99.81 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.39 -12.56 15.97 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.72 94.84 3.32 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.265 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -65.04 -47.89 75.78 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.521 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 8.9 p30 -109.69 14.5 23.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.31 59.78 1.47 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.303 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -87.54 -6.79 58.19 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.804 0.335 . . . . 0.0 110.237 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.91 -1.63 74.8 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.0 p -139.77 156.66 46.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.015 0.436 . . . . 0.0 109.998 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.639 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.8 mp -89.2 123.1 41.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -111.46 162.71 14.8 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.91 0.757 . . . . 0.0 112.41 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.425 HG22 HG13 ' A' ' 52' ' ' ILE . 18.8 p -60.33 -38.52 84.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.859 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -59.75 -62.21 2.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.821 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -62.0 -28.1 69.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.652 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.476 HD22 HD11 ' A' ' 52' ' ' ILE . 2.9 tp -60.43 -52.66 64.28 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.471 178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.91 91.81 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.891 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.67 -52.42 65.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.828 1.314 . . . . 0.0 108.632 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.8 t -58.65 -45.06 90.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 119.267 0.94 . . . . 0.0 111.231 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.484 ' SD ' ' O ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -59.54 -40.29 86.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 119.782 1.173 . . . . 0.0 109.789 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -52.58 -38.12 59.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.403 0.621 . . . . 0.0 110.041 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.2 p -62.27 -20.01 63.84 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.177 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -73.82 2.24 8.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.99 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.24 26.23 40.97 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.132 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -131.75 171.3 13.67 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.356 0.578 . . . . 0.0 109.817 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 16.9 p-10 -132.77 76.79 70.34 Favored Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.409 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.46 146.27 97.13 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.783 2.322 . . . . 0.0 111.93 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.2 p -76.28 163.85 26.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.173 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -58.59 -43.64 89.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.848 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.78 -24.25 49.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.378 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -65.38 -39.51 92.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.154 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.0 mp -56.71 -41.03 76.71 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.395 0.617 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -72.1 -56.12 6.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.008 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -55.99 -49.72 72.84 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 40.8 mmm -64.59 -50.86 65.57 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.476 HD11 HD22 ' A' ' 32' ' ' LEU . 25.8 mm -59.23 -45.37 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.346 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -56.97 -34.68 68.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.35 -40.68 85.85 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.872 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.437 HG21 ' CE2' ' B' 1110 ' ' PHE . 54.8 t -84.93 -21.95 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.471 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.496 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.6 t0 -78.6 87.15 4.55 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -175.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.68 -37.19 85.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.356 -1.747 . . . . 0.0 113.669 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.416 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 39.9 p-10 -86.05 -2.46 58.34 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.66 23.09 60.39 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.313 0.506 . . . . 0.0 112.942 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -88.26 4.13 47.01 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.3 0.55 . . . . 0.0 110.354 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.496 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.05 0.87 88.89 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 121.091 -0.576 . . . . 0.0 114.383 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.1 p -147.87 169.2 20.32 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.5 mt -111.93 128.11 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 23.7 t0 -102.29 -178.14 3.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.658 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.546 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -57.03 -48.31 97.64 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -55.79 -49.34 16.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.26 1.306 . . . . 0.0 111.824 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.01 -20.65 64.14 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.487 0.661 . . . . 0.0 110.662 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -74.8 -57.0 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.131 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 72.8 mt -58.08 -45.23 87.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -47.29 -46.59 25.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.321 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 81.4 mtp -66.62 -45.29 79.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.6 mmt -60.13 -40.68 90.63 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -34.8 78.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.531 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -92.3 -16.86 25.53 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.64 0.257 . . . . 0.0 111.461 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 67.31 7.11 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.197 0.522 . . . . 0.0 110.709 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.9 mmt -107.99 16.8 23.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.517 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -49.3 132.59 20.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.981 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.57 109.11 20.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.871 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -95.28 118.88 32.83 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -66.65 113.32 4.71 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 174.318 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.8 m -37.8 -20.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.751 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 80' ' ' ASP . 5.3 mp0 -66.87 -41.9 86.52 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -45.21 -35.64 3.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.319 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -87.52 -20.3 26.7 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.003 0.43 . . . . 0.0 111.865 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 30.4 mm -60.11 -74.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.669 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -63.09 -40.21 96.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.09 -40.76 94.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.434 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.8 -20.75 63.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.136 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -70.74 -50.43 36.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.075 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -55.38 -41.84 73.18 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.414 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.11 -45.05 97.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.559 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.5 m-85 -68.94 -39.67 79.42 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.423 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -85.52 81.29 8.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.81 -48.89 79.72 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -91.31 4.87 51.28 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.344 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.55 48.3 49.58 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -90.7 7.32 40.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.665 0.269 . . . . 0.0 110.51 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.64 1.93 88.95 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -142.39 155.77 45.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.716 0.77 . . . . 0.0 111.491 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.3 mt -93.33 114.26 29.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.3 m -88.83 151.52 22.32 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.54 -48.98 77.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.838 0.745 . . . . 0.0 110.895 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.77 -40.81 60.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.9 0.381 . . . . 0.0 110.726 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -64.98 -40.86 95.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.027 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 108' ' ' VAL . 7.4 tt -63.42 -45.02 92.87 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.337 0.589 . . . . 0.0 111.408 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.485 ' HE ' HG11 ' A' ' 121' ' ' VAL . 24.5 mmt85 -40.7 -37.87 0.81 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.71 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.61 ' CE1' HD21 ' A' ' 111' ' ' ASN . 56.8 t-80 -69.31 -25.32 64.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.783 0.325 . . . . 0.0 111.46 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.559 HG21 ' CE2' ' A' ' 92' ' ' PHE . 90.1 t -59.01 -44.88 92.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.625 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.708 ' SD ' HD12 ' A' ' 116' ' ' LEU . 16.4 mmt -52.02 -44.95 64.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.12 0.962 . . . . 0.0 111.234 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.5 m -58.62 -42.73 88.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.706 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.61 HD21 ' CE1' ' A' ' 107' ' ' HIS . 1.1 m-80 -65.73 -41.49 92.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.148 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.7 mt -81.52 -15.88 53.5 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.879 -0.329 . . . . 0.0 111.812 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.53 30.65 57.95 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.418 ' OE1' ' SD ' ' A' ' 109' ' ' MET . 96.9 mt-10 -85.66 -23.24 27.55 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.552 2.176 . . . . 0.0 110.578 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt 43.84 59.62 3.05 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.927 0.87 . . . . 0.0 110.366 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.708 HD12 ' SD ' ' A' ' 109' ' ' MET . 44.6 mt -79.69 148.83 31.42 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.519 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.6 p -82.91 174.78 10.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.197 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -57.99 -44.5 87.2 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.81 -48.81 78.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.484 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.0 -31.54 69.27 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.821 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.485 HG11 ' HE ' ' A' ' 106' ' ' ARG . 30.3 t -63.17 -43.29 98.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.487 0.66 . . . . 0.0 109.343 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.06 -37.74 84.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.582 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -59.77 -50.36 74.13 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 20.1 mmm -57.12 -44.08 82.94 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.342 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.9 mt -59.9 -43.41 92.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.044 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -58.94 -38.63 79.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.999 0.428 . . . . 0.0 111.199 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -58.73 -40.61 84.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.006 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.6 -21.44 21.72 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.0 t0 -74.23 88.55 2.0 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.486 0.66 . . . . 0.0 111.883 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 42.7 mm -71.93 -14.19 17.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 122.624 1.202 . . . . 0.0 113.13 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.6 p-10 -142.84 144.59 32.58 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 112.414 -2.176 . . . . 0.0 109.251 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.02 52.23 1.32 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.784 -0.246 . . . . 0.0 112.968 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -90.85 -10.07 44.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.061 0.431 . . . . 0.0 110.056 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.12 1.11 67.62 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.195 -0.526 . . . . 0.0 114.221 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -134.9 153.76 51.94 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.435 0.618 . . . . 0.0 110.433 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.21 118.61 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.243 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.1 174.86 9.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.733 0.301 . . . . 0.0 110.858 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -61.65 -40.16 93.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.965 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.54 -44.64 95.86 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.837 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.26 -37.85 88.47 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.505 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -60.26 -45.42 93.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 110.721 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.55 -46.59 89.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.458 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -48.78 -47.12 42.2 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.893 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.7 mmm -72.33 -37.57 68.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.431 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 24.2 mmt -72.11 -45.23 61.4 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.857 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.066 -179.357 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.7 m95 -58.11 -65.01 0.72 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.752 0.787 . . . . 0.0 111.875 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . 0.431 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 38.0 m-85 -56.68 -43.35 80.36 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -174.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 12.3 tpp85 -39.73 -51.49 2.34 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.12 99.94 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.47 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.0 tp -56.35 -45.69 80.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.501 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -59.79 -49.09 79.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.878 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -65.77 -37.67 86.95 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.11 -42.04 91.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.903 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -51.47 -45.39 62.75 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.507 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.1 m -64.27 -47.99 77.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.825 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 84.0 mt-30 -27.98 -57.08 0.11 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.83 1.3 . . . . 0.0 112.597 -176.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.89 -13.94 11.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 CA-C-N 112.519 -2.128 . . . . 0.0 112.578 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.507 ' N ' ' O ' ' B' 1102 ' ' THR . 88.6 tttt -57.51 -41.65 81.25 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 118.316 -1.354 . . . . 0.0 107.95 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 77.5 t -62.74 -46.82 95.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.724 0.773 . . . . 0.0 112.814 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 37.1 t -65.83 -42.08 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.209 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 97.0 mttt -48.79 -38.07 20.96 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.833 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.87 -45.04 67.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.076 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . 0.437 ' CE2' HG21 ' A' ' 55' ' ' VAL . 48.7 m-85 -63.25 -50.0 71.9 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 69.8 m-70 . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.285 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.3 p -79.81 133.22 36.28 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.643 1.111 . . . . 0.0 111.12 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.7 tt0 -54.66 -51.3 65.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.769 0.795 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -34.17 -36.01 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.129 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.61 -32.87 70.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.475 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' A' ' 6' ' ' GLU . 93.7 mt -57.83 -45.73 87.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.89 -50.14 61.62 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.412 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.15 -44.76 91.15 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.439 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.1 m-85 -62.98 -40.79 98.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.753 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -52.14 -55.58 19.99 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.204 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -49.87 -41.84 46.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.116 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -54.83 -35.66 64.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.503 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.434 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 2.5 m-85 -57.73 -39.61 77.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.4 m -65.95 -16.06 63.54 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.255 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 2.7 mm? -64.23 -41.99 96.75 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.78 -15.25 14.78 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.897 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -74.99 94.72 2.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.145 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -67.15 -48.22 68.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.802 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.0 p30 -103.25 14.68 31.07 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 38.08 50.48 2.14 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.961 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -87.57 -5.17 58.88 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.925 0.362 . . . . 0.0 111.572 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.43 -0.59 78.01 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.7 p -140.07 157.9 44.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.981 0.42 . . . . 0.0 109.954 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mm -88.03 122.81 40.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 p -111.57 161.56 16.07 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.012 0.82 . . . . 0.0 112.276 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 p -59.26 -38.4 79.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.708 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -60.99 -60.05 4.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.06 -30.16 71.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.766 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 tp -60.54 -55.92 27.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.322 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.99 -37.56 91.66 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.806 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -58.5 -53.71 55.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 119.317 1.558 . . . . 0.0 108.434 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.7 t -56.97 -46.69 84.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.598 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.0 ttt -58.51 -42.26 87.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 120.27 1.395 . . . . 0.0 110.189 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -52.27 -37.62 55.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.481 0.658 . . . . 0.0 110.15 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.0 t -63.69 -21.22 66.28 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.517 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.52 0.4 17.4 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.756 -0.777 . . . . 0.0 109.935 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 18.21 62.59 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.173 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -109.81 157.91 18.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.72 0.76 . . . . 0.0 110.038 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -113.0 66.15 0.96 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.443 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.74 142.68 90.11 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.075 1.85 . . . . 0.0 112.302 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -82.36 166.78 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.447 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -58.29 -44.77 88.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.851 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.43 -23.59 25.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.635 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.65 -39.02 90.95 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.273 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 7.8 mp -56.45 -41.31 76.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.23 0.538 . . . . 0.0 109.662 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.425 ' OE1' ' ND2' ' A' ' 53' ' ' ASN . 8.9 tp-100 -68.78 -58.52 4.08 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.71 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -55.05 -49.37 71.78 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.9 mmm -63.81 -53.91 43.38 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 52' ' ' ILE . 26.4 mm -58.31 -47.63 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.83 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.425 ' ND2' ' OE1' ' A' ' 49' ' ' GLN . 34.3 m-80 -56.49 -33.64 66.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -66.41 -40.31 89.49 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.596 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.47 HG21 ' CD2' ' B' 1110 ' ' PHE . 76.3 t -86.65 -19.8 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.42 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 40.6 t0 -78.98 84.59 4.98 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -174.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.28 -37.39 83.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.626 -1.625 . . . . 0.0 114.238 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.454 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.7 p-10 -86.1 -2.35 58.25 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.5 23.34 62.55 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 118.383 0.538 . . . . 0.0 112.696 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.454 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.4 p-10 -87.5 1.96 52.02 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.27 0.535 . . . . 0.0 110.606 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.552 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 86.73 1.58 85.17 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.685 0.634 . . . . 0.0 114.685 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.3 p -148.84 170.9 17.22 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.416 HD12 HG12 ' A' ' 55' ' ' VAL . 15.9 mm -110.85 128.29 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -102.35 -178.27 3.64 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.434 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -58.06 -48.96 96.16 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -55.94 -51.86 8.67 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.536 1.491 . . . . 0.0 111.537 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.1 -19.99 62.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.607 0.717 . . . . 0.0 110.354 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -75.95 -58.99 2.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.2 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.87 -44.94 78.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.9 p -45.75 -44.29 13.66 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.561 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.5 mtp -71.89 -49.48 37.55 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.4 mmm -61.01 -40.72 94.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.16 -33.58 76.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.66 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -93.45 -14.82 26.27 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.627 0.251 . . . . 0.0 111.529 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 mmpp? -77.87 71.91 4.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.163 0.506 . . . . 0.0 111.311 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.7 mmt -107.03 18.33 21.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.858 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -51.73 129.87 27.25 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.197 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -90.69 105.18 17.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.135 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.495 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 3.1 m -88.45 123.18 32.74 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 82' ' ' GLU . 15.5 t0 -69.43 109.86 4.43 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 174.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.8 m -37.04 -21.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 80' ' ' ASP . 50.6 mp0 -70.33 -34.14 72.32 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 111.835 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.444 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 81.1 tt0 -50.32 -39.14 45.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.266 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 76.7 mt-10 -88.34 -5.57 58.24 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 85' ' ' ILE . 26.9 mm -70.79 -74.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.85 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -61.48 -50.39 72.95 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 83' ' ' GLU . 16.1 pt-20 -54.41 -38.77 66.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -60.79 -20.03 60.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.014 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -73.99 -48.1 32.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.771 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -54.59 -41.01 69.39 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.418 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.91 -43.29 92.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.553 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.6 m-85 -68.78 -39.03 80.38 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.248 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 30.1 t0 -87.36 82.8 7.46 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.88 -49.45 76.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 35.6 p-10 -90.91 5.28 49.27 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.629 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.07 48.49 46.15 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.71 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -90.31 6.48 42.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.678 0.275 . . . . 0.0 110.634 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.424 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 84.54 1.45 89.21 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.71 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 97.9 m-85 -140.72 153.91 46.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.671 0.748 . . . . 0.0 111.612 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.422 ' HB ' HG13 ' A' ' 136' ' ' VAL . 96.7 mt -97.07 117.28 41.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.3 m -90.46 152.67 20.86 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.1 80.03 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.974 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.97 -39.93 60.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.89 0.376 . . . . 0.0 110.463 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -66.01 -41.54 90.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.357 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.3 tp -63.07 -46.55 86.91 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.267 0.556 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -43.57 -44.35 6.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.65 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -63.54 -29.26 70.55 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 121.281 -0.168 . . . . 0.0 110.99 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.553 HG21 ' CE2' ' A' ' 92' ' ' PHE . 96.6 t -57.54 -41.81 79.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.842 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.623 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.54 -45.27 62.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.958 0.885 . . . . 0.0 111.543 -177.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.9 m -55.91 -40.73 73.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.853 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.33 -40.46 93.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.759 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.5 -13.0 58.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.739 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.65 29.09 60.07 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -85.34 -21.78 28.76 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.805 2.302 . . . . 0.0 111.111 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mttm 42.82 60.58 2.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.952 0.882 . . . . 0.0 110.013 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.446 HD12 ' HG3' ' A' ' 109' ' ' MET . 81.5 mt -80.04 148.38 31.1 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.48 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 121' ' ' VAL . 58.7 p -82.96 175.17 10.26 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.376 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -57.98 -45.12 87.25 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -57.21 -51.15 70.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.456 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.405 ' OE1' ' OE1' ' A' ' 123' ' ' GLU . 78.7 mm-40 -67.3 -30.55 70.43 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.484 -0.486 . . . . 0.0 112.001 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 117' ' ' THR . 39.6 t -63.72 -41.53 92.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -66.94 -38.22 85.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.407 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.405 ' OE1' ' OE1' ' A' ' 120' ' ' GLU . 94.6 mt-10 -59.21 -52.51 65.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.46 ' SD ' ' CD1' ' B' 1093 ' ' TRP . 17.6 mmm -54.72 -45.04 74.0 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.682 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 91.3 mt -59.05 -44.71 92.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.234 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -61.35 -36.4 80.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.685 0.279 . . . . 0.0 111.553 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.45 -41.3 84.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.88 -16.86 24.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.723 0.297 . . . . 0.0 111.746 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.8 t0 -71.09 91.76 0.93 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.491 0.662 . . . . 0.0 111.991 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.1 mt -70.48 -17.26 20.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 122.591 1.186 . . . . 0.0 113.317 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 51.4 p-10 -142.24 144.12 33.2 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 112.404 -2.18 . . . . 0.0 108.905 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.18 53.07 1.05 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.699 -0.286 . . . . 0.0 113.118 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -90.9 -8.13 50.27 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.002 0.401 . . . . 0.0 110.222 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.92 3.87 81.55 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.671 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -136.67 157.86 45.79 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.562 0.681 . . . . 0.0 110.439 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 136' ' ' VAL . 7.9 p -103.98 119.63 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.718 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -85.92 177.24 7.67 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.737 0.303 . . . . 0.0 111.079 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.98 -42.08 98.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.213 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.44 -45.33 94.74 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.902 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.94 -36.86 84.51 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.356 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -61.15 -45.39 94.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.2 t -65.7 -46.33 89.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.932 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -50.26 -44.14 53.55 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.994 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.2 mmt -72.92 -39.31 66.4 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 21.1 mmt -74.66 -47.04 34.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.877 -0.147 . . . . 0.0 110.823 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 120.689 0.28 . . . . 0.0 111.678 -179.282 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 CA--C 1.537 0.481 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . 0.46 ' CD1' ' SD ' ' A' ' 124' ' ' MET . 6.2 m95 -61.9 -53.51 54.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.366 0.603 . . . . 0.0 111.908 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 48.5 t80 -58.19 -46.34 85.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -40.38 -52.3 2.73 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.5 -41.08 99.48 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.106 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.7 tp -56.84 -45.36 82.44 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.484 -0.887 . . . . 0.0 109.562 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 40.9 t30 -58.65 -49.33 77.91 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -64.28 -38.14 90.0 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.3 mt -60.65 -41.91 89.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.68 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -50.37 -48.34 55.8 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.002 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.512 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.2 m -64.19 -47.9 78.0 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.42 ' C ' ' O ' ' B' 1102 ' ' THR . 25.5 mt-30 -27.61 -59.46 0.1 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 122.565 1.174 . . . . 0.0 112.612 -176.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.8 mt -83.02 -12.79 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 112.954 -1.93 . . . . 0.0 112.381 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.512 ' N ' ' O ' ' B' 1102 ' ' THR . 63.8 tttm -57.46 -43.28 83.87 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 118.001 -1.479 . . . . 0.0 108.024 176.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 57.5 t -61.92 -47.36 93.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 41.2 t -65.53 -41.52 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.074 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . 0.495 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 95.4 mttt -47.56 -37.11 11.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.659 0.742 . . . . 0.0 109.782 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -55.29 -46.63 76.19 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.63 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . 0.47 ' CD2' HG21 ' A' ' 55' ' ' VAL . 56.1 m-85 -63.77 -48.91 75.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 27.5 m-70 . . . . . 0 C--N 1.327 -0.4 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.539 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.1 tp . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.407 ' H ' ' HG1' ' A' ' 5' ' ' THR . 33.6 p -77.79 141.01 39.49 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.03 0.832 . . . . 0.0 110.628 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.1 tt0 -50.4 -55.95 13.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.166 0.984 . . . . 0.0 110.46 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -35.21 -38.45 0.09 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.886 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -68.27 -38.74 82.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.208 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.0 mt -58.7 -44.92 90.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 176.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.26 -50.38 67.37 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.797 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -60.23 -48.55 81.25 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.174 0.512 . . . . 0.0 112.228 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -61.72 -39.4 91.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.612 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -52.19 -56.19 16.19 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.999 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -50.42 -42.81 54.46 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.295 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.64 -36.83 64.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.125 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.56 -40.74 79.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -63.56 -16.31 60.46 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.205 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.445 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.9 mm? -64.7 -41.14 96.22 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -106.1 -15.08 14.97 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.49 92.99 1.93 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.192 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -67.81 -49.83 60.15 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.884 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.8 p-10 -101.89 15.74 28.07 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.7 45.37 0.52 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.2 p30 -85.35 -4.51 59.18 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 122.676 -0.308 . . . . 0.0 110.802 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.96 -2.2 81.54 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 p -137.91 152.73 49.29 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.975 0.417 . . . . 0.0 109.95 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 27' ' ' ILE . 4.6 mp -91.47 124.47 44.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -113.21 164.91 12.94 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.992 0.807 . . . . 0.0 112.37 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.3 p -59.73 -34.7 73.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.872 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -62.38 -61.58 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.757 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -60.4 -31.42 70.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.845 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 52' ' ' ILE . 3.7 tp -60.56 -55.53 32.24 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.991 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.32 -39.41 92.63 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.988 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.2 m -57.71 -53.91 52.9 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.921 1.361 . . . . 0.0 108.704 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.92 -46.87 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 118.694 0.679 . . . . 0.0 111.527 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.5 ttt -59.24 -40.85 87.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 120.082 1.31 . . . . 0.0 109.868 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -52.15 -39.2 59.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.63 0.729 . . . . 0.0 110.358 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.0 t -63.32 -21.35 66.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.086 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.466 ' O ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -73.45 -2.18 21.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.54 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.35 14.63 65.81 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.097 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -106.38 156.45 18.51 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 117.356 0.578 . . . . 0.0 110.095 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -116.43 63.06 2.6 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.355 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.08 144.95 93.63 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.229 1.952 . . . . 0.0 112.169 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.6 p -80.23 166.73 21.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.522 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -57.7 -43.68 85.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.604 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.73 -24.26 33.93 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.398 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -65.97 -39.33 90.29 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.174 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.6 mp -57.23 -42.75 82.0 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.657 0.741 . . . . 0.0 109.867 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -68.81 -56.09 9.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.494 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.05 -49.21 74.38 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.7 mmm -63.91 -50.72 67.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.505 HD11 HD22 ' A' ' 32' ' ' LEU . 26.9 mm -59.3 -48.06 88.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.619 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -55.9 -34.62 65.73 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.95 -39.83 90.77 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.728 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.411 HG21 ' CE2' ' B' 1110 ' ' PHE . 41.7 t -87.1 -20.18 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.299 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 44.6 t0 -79.38 84.3 5.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.45 82.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.619 -1.628 . . . . 0.0 114.263 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -86.41 -2.36 58.37 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.047 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.9 23.97 59.76 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.407 0.548 . . . . 0.0 112.463 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -87.91 3.74 47.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.421 0.61 . . . . 0.0 110.199 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.44 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.06 1.43 88.66 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 118.578 0.626 . . . . 0.0 114.573 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.9 p -148.9 170.97 17.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.2 mt -114.82 129.05 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -103.27 -175.32 2.77 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.604 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.438 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -59.27 -45.79 99.15 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 41.9 Cg_exo -55.49 -53.72 5.31 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.298 1.332 . . . . 0.0 111.513 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.88 -20.9 64.23 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.492 0.663 . . . . 0.0 110.763 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -72.87 -57.94 3.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.579 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.07 -44.81 87.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.405 HG23 HH12 ' A' ' 74' ' ' ARG . 8.6 m -40.53 -57.96 1.7 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.015 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.6 ptp -63.78 -39.29 93.89 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.811 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.1 mmt -59.06 -41.14 87.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.11 -35.49 78.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.429 0.291 . . . . 0.0 111.663 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.405 HH12 HG23 ' A' ' 70' ' ' THR . 84.8 mtt85 -94.05 -12.45 28.53 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -81.61 72.91 8.66 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.704 0.764 . . . . 0.0 110.376 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 21.6 mmt -110.33 17.77 20.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.056 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -53.08 129.72 31.79 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.487 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -107.45 143.96 35.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.674 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.0 p -130.55 135.71 48.19 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.4 m-20 -61.2 116.07 4.29 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 175.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.2 m -36.91 -20.08 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 80' ' ' ASP . 45.1 tp10 -69.44 -31.55 69.94 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -51.86 -40.38 60.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.745 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -86.91 -9.17 56.33 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.1 mm -67.88 -73.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.915 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -61.97 -40.99 97.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.94 -41.67 98.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.379 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.56 -21.35 60.16 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.966 0.412 . . . . 0.0 111.425 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -74.71 -47.29 32.26 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.744 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -55.61 -43.08 75.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.923 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.54 -45.73 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.546 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.463 ' CE2' HG21 ' A' ' 108' ' ' VAL . 11.5 m-85 -70.01 -39.05 76.06 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.595 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.56 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 32.3 t0 -89.56 84.83 6.38 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.01 -48.63 79.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.4 p-10 -92.24 5.03 51.98 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.99 50.4 51.31 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.687 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -95.02 6.28 49.52 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 122.416 0.286 . . . . 0.0 110.798 179.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.423 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 83.56 -0.19 89.7 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.687 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 4.4 m-85 -136.86 149.66 47.81 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.984 0.897 . . . . 0.0 111.299 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 80.7 mt -97.17 119.38 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t -89.88 151.08 21.92 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.66 78.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.112 0.869 . . . . 0.0 110.159 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.09 -41.73 62.65 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.698 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -65.28 -42.04 93.54 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.697 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.2 -45.65 90.74 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.51 0.671 . . . . 0.0 111.072 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -44.07 -42.76 6.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.366 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -65.47 -30.48 71.27 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.671 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' A' ' 92' ' ' PHE . 93.2 t -57.62 -42.38 81.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.943 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.13 -46.9 65.54 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.971 0.891 . . . . 0.0 111.284 -177.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.3 p -55.33 -39.19 69.68 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.567 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -66.38 -41.23 89.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.763 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.0 mt -81.77 -14.51 56.33 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.01 31.05 60.31 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -87.33 -25.71 23.75 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.77 2.285 . . . . 0.0 110.463 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.0 mttp 45.96 63.16 1.93 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.102 0.953 . . . . 0.0 110.377 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.74 148.31 31.55 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.923 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 121' ' ' VAL . 32.4 p -82.67 174.2 11.22 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -57.57 -45.56 85.05 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.71 -46.72 84.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.172 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -70.66 -30.67 67.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.919 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 117' ' ' THR . 43.3 t -64.03 -41.99 94.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.471 0.653 . . . . 0.0 109.436 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.64 -35.69 75.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.349 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -59.56 -52.59 64.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.815 0.817 . . . . 0.0 112.837 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.2 mtp -55.64 -44.09 76.85 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.291 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.5 mt -59.11 -43.85 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.43 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -59.72 -38.32 81.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.95 0.405 . . . . 0.0 111.253 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -58.4 -41.61 85.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.168 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.55 -21.42 22.89 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.7 t0 -78.44 84.64 4.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.283 0.563 . . . . 0.0 112.051 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.9 pt -70.66 -11.52 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 122.674 1.226 . . . . 0.0 113.515 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 53.8 p-10 -142.08 145.01 33.84 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.157 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.45 52.35 2.27 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.656 -0.307 . . . . 0.0 113.357 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -90.9 -9.28 46.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 117.188 0.494 . . . . 0.0 110.1 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.8 -0.57 65.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 114.409 0.524 . . . . 0.0 114.409 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -132.95 150.85 52.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.304 0.552 . . . . 0.0 109.881 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 t -98.21 118.46 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.825 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.422 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 16.5 t-20 -85.14 174.51 9.63 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.721 0.296 . . . . 0.0 110.965 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -60.96 -42.15 97.72 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.456 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.13 -44.12 95.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.699 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.67 -38.03 89.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.462 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -60.94 -45.28 95.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.096 0.474 . . . . 0.0 111.019 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.17 -46.88 89.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.039 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -51.05 -44.51 61.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.025 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmt -72.02 -36.99 69.83 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 25.5 mmt -71.91 -45.88 59.63 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.489 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 p . . . . . 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.033 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.9 mt . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.3 m95 -63.23 -56.11 19.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.625 0.726 . . . . 0.0 112.346 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.1 t80 -58.4 -46.18 86.91 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 46.9 ttt85 -41.97 -52.04 4.26 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.71 -40.41 98.74 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.679 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.41 -44.72 80.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.977 0.888 . . . . 0.0 109.829 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 38.8 t30 -58.03 -47.72 82.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -176.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -65.01 -38.25 90.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.392 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.9 mt -60.36 -42.37 90.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.718 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -51.37 -45.42 62.4 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.586 -1.245 . . . . 0.0 107.67 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.508 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.7 m -62.16 -48.79 78.5 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.417 ' C ' ' O ' ' B' 1102 ' ' THR . 84.5 mt-30 -27.75 -59.61 0.11 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.913 1.339 . . . . 0.0 113.101 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -83.08 -13.72 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 112.514 -2.13 . . . . 0.0 111.643 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.508 ' N ' ' O ' ' B' 1102 ' ' THR . 66.3 tttm -59.93 -47.8 84.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 118.358 -1.337 . . . . 0.0 107.906 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.6 t -60.71 -48.85 86.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.9 m -65.76 -35.72 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.986 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 83.2 mttt -49.67 -39.08 35.18 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.72 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -50.56 -44.41 56.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.315 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . 0.411 ' CE2' HG21 ' A' ' 55' ' ' VAL . 41.8 m-85 -63.55 -49.46 73.35 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.725 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 78.2 m-70 . . . . . 0 C--N 1.328 -0.356 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.544 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.02 144.28 43.15 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.002 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.672 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -51.29 -43.82 61.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 122.574 1.178 . . . . 0.0 110.574 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 81.2 tt0 -43.35 -41.23 4.0 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 112.718 -2.037 . . . . 0.0 110.662 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -69.36 -38.06 77.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.504 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.1 -44.81 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.44 -50.27 62.92 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.667 -178.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -62.61 -45.57 92.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.387 0.613 . . . . 0.0 112.039 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 8.7 m-85 -62.27 -40.9 97.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.817 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -52.89 -55.23 24.73 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.275 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -50.31 -42.39 52.59 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.957 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -55.3 -36.3 66.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.409 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.79 -38.76 79.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.3 p -65.33 -15.95 63.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.22 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 18' ' ' LEU . 6.7 mp -65.42 -40.72 93.68 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -106.05 -14.75 15.08 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -73.04 93.2 1.74 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.486 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -67.72 -49.41 62.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.934 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.0 p-10 -103.11 14.9 30.72 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.16 46.27 0.96 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.131 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -86.57 -4.55 59.19 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 122.673 -0.31 . . . . 0.0 110.934 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 -1.83 80.74 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.4 p -138.21 153.56 49.14 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.189 0.519 . . . . 0.0 110.02 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 27' ' ' ILE . 4.2 mp -91.12 123.6 43.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.8 p -113.79 164.22 14.02 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.926 0.87 . . . . 0.0 112.455 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 p -58.34 -37.88 76.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.827 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.19 -61.83 2.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.732 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -60.63 -29.48 69.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.448 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.537 HD22 HD13 ' A' ' 52' ' ' ILE . 3.0 tp -61.37 -53.61 54.35 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.571 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.07 97.9 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.545 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 m -58.66 -54.33 48.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.912 1.356 . . . . 0.0 108.605 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.4 t -56.72 -46.01 82.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 118.979 0.808 . . . . 0.0 111.297 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.5 ttt -59.18 -40.22 85.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 120.111 1.323 . . . . 0.0 109.822 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -53.43 -41.53 66.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.42 0.629 . . . . 0.0 110.46 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.8 p -63.73 -21.49 66.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.941 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 tp -73.86 -3.54 29.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.748 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.74 20.7 46.23 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.332 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -117.77 158.65 24.37 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.662 0.731 . . . . 0.0 109.671 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -119.65 74.85 18.28 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.87 145.79 57.54 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.064 1.843 . . . . 0.0 112.405 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -80.16 165.83 22.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.309 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.4 pt-20 -58.83 -45.07 90.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.417 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -56.55 -24.36 46.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.501 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -65.65 -40.25 92.27 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.218 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.25 -39.67 70.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.223 0.535 . . . . 0.0 109.793 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -73.98 -55.17 6.48 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.238 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -54.84 -48.56 72.7 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 60.6 mtp -65.76 -52.06 54.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.537 HD13 HD22 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -56.02 -44.07 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -56.33 -35.16 67.29 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -67.3 -40.71 86.05 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.963 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.0 t -86.07 -21.34 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.383 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.493 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.1 t0 -78.2 86.16 4.33 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -174.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.3 82.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.342 -1.754 . . . . 0.0 114.081 -175.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 40.1 p-10 -86.82 -2.41 58.55 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.1 23.47 61.86 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 118.526 0.603 . . . . 0.0 112.839 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -87.87 3.57 47.91 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.273 0.536 . . . . 0.0 110.517 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.493 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.1 1.36 88.61 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 121.556 -0.715 . . . . 0.0 114.495 175.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.0 p -148.26 169.0 21.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -113.06 128.61 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.026 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -103.94 -174.83 2.63 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.801 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -58.09 19.55 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.51 -49.39 15.83 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.2 1.267 . . . . 0.0 111.661 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.79 -19.64 62.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.498 0.666 . . . . 0.0 110.628 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -75.71 -59.55 2.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.235 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.58 -44.15 80.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 m -44.92 -49.93 10.77 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.803 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 58.8 mtm -66.91 -45.6 77.43 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.4 mmm -61.08 -41.02 95.88 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.88 -34.16 77.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.567 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -93.42 -13.69 27.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.637 0.256 . . . . 0.0 111.343 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.452 ' C ' ' SD ' ' A' ' 76' ' ' MET . 2.4 mmmt -80.74 69.82 7.36 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.415 0.626 . . . . 0.0 110.765 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -105.88 18.72 21.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.851 179.158 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -49.94 131.44 22.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.418 0.627 . . . . 0.0 111.403 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 46.3 p-10 -91.99 109.05 20.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.875 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.518 HG21 ' NZ ' ' B' 1108 ' ' LYS . 8.5 p -97.81 114.21 26.19 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 82' ' ' GLU . 37.2 t0 -63.16 117.44 6.53 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 175.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.3 m -37.39 -20.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.772 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.7 mm-40 -69.8 -34.8 74.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.809 0.337 . . . . 0.0 111.718 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -49.34 -37.48 24.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.427 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.532 ' OE1' HD11 ' B' 1097 ' ' LEU . 9.3 pt-20 -89.11 -13.97 37.32 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 85' ' ' ILE . 24.2 mm -62.29 -74.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.176 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -62.04 -39.67 93.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -64.03 -40.68 96.87 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.515 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.1 -19.25 62.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.091 0.472 . . . . 0.0 111.127 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -71.97 -50.25 30.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.949 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -54.9 -40.71 70.09 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.757 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.22 -44.67 97.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.524 -0.471 . . . . 0.0 109.779 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.55 ' CE2' HG21 ' A' ' 108' ' ' VAL . 8.4 m-85 -69.44 -39.1 78.02 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.463 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -89.74 83.12 6.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.55 -45.06 95.74 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.9 p30 -91.42 4.02 53.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.623 0.249 . . . . 0.0 111.459 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.71 50.23 43.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -92.23 6.37 46.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.64 0.257 . . . . 0.0 110.516 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.14 0.76 89.64 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -140.38 154.16 46.61 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.695 0.76 . . . . 0.0 111.533 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.6 mt -96.92 115.82 37.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.2 p -91.7 156.13 17.8 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.34 -47.99 80.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 118.726 0.694 . . . . 0.0 111.14 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.8 -40.59 60.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 110.448 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.89 -41.29 91.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.511 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.23 -46.29 87.6 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.505 0.669 . . . . 0.0 111.358 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -44.38 -44.22 8.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.698 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -63.24 -28.82 70.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.784 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.55 HG21 ' CE2' ' A' ' 92' ' ' PHE . 98.7 t -57.99 -41.85 81.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.837 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.629 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.48 -46.22 63.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.074 0.94 . . . . 0.0 111.212 -177.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.8 m -57.68 -41.36 81.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.76 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.46 -40.75 93.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.975 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.3 mt -81.73 -14.06 57.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.699 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.05 29.82 58.27 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -85.68 -22.51 27.84 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.721 2.26 . . . . 0.0 110.878 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 43.14 60.48 2.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.116 0.96 . . . . 0.0 109.912 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.5 mt -79.74 148.76 31.38 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.511 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.4 p -82.99 174.61 10.73 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.405 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -58.06 -45.17 87.49 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.3 mp0 -58.15 -49.84 75.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.706 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -67.3 -31.23 71.4 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.937 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.13 -41.98 94.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.29 -39.15 89.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.62 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -59.44 -51.12 71.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.9 mmm -55.81 -45.05 78.37 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.274 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.99 -43.89 93.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.405 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -61.66 -36.77 81.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.031 0.443 . . . . 0.0 111.186 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.54 -40.19 86.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.833 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.758 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -89.52 -27.97 19.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.2 t0 -68.88 89.33 0.4 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.631 0.729 . . . . 0.0 111.811 -176.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.3 mm -71.4 -15.84 18.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.994 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 47.0 p-10 -141.44 144.42 34.42 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 112.465 -2.152 . . . . 0.0 108.967 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.32 51.47 1.05 Allowed Glycine 0 CA--C 1.531 1.042 0 CA-C-O 120.313 -0.159 . . . . 0.0 113.018 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -90.67 -12.23 37.39 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.035 0.418 . . . . 0.0 110.011 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.0 1.66 74.44 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.998 -0.62 . . . . 0.0 114.276 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -134.06 153.16 51.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.376 0.588 . . . . 0.0 110.481 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.6 t -100.46 118.4 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -83.65 173.85 11.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.988 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -61.41 -40.06 93.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.024 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.94 -44.29 97.08 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.805 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -65.48 -39.37 91.87 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.571 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.433 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 90.0 t80 -60.66 -44.17 96.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.035 0.445 . . . . 0.0 111.219 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.15 -45.0 95.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.018 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.24 -40.16 46.88 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.176 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.758 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 78.1 mtm -79.05 -46.11 18.78 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.433 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -73.39 -47.03 45.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.081 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.469 0.514 0 CA-C-O 120.793 0.33 . . . . 0.0 111.332 -179.03 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . 0.59 ' CE2' ' SD ' ' A' ' 144' ' ' MET . 6.6 m95 -61.88 -53.42 56.06 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.675 0.75 . . . . 0.0 111.817 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 47.5 t80 -57.79 -46.5 84.53 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . 0.47 ' HE ' ' NH1' ' B' 1099 ' ' ARG . 77.4 ttt180 -39.93 -52.43 2.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.39 -40.43 99.05 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.272 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . 0.532 HD11 ' OE1' ' A' ' 84' ' ' GLU . 50.8 tp -56.35 -44.45 80.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 118.196 0.998 . . . . 0.0 109.214 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -57.74 -47.64 81.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . 0.47 ' NH1' ' HE ' ' B' 1095 ' ' ARG . 76.7 mtt85 -65.14 -37.43 87.4 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 82.4 mt -60.75 -42.36 91.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.666 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . 0.405 ' CD ' ' OE2' ' A' ' 84' ' ' GLU . 41.8 mt-30 -50.1 -45.12 52.43 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 118.744 -1.182 . . . . 0.0 108.025 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.518 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.9 m -63.56 -48.2 78.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.426 ' C ' ' O ' ' B' 1102 ' ' THR . 83.7 mt-30 -27.61 -58.97 0.11 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.647 1.213 . . . . 0.0 112.578 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -83.62 -14.89 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 112.198 -2.274 . . . . 0.0 112.314 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' 1102 ' ' THR . 65.0 tttm -59.59 -45.22 92.53 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 117.96 -1.496 . . . . 0.0 108.135 176.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.7 t -60.67 -48.99 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . 0.402 HG13 ' H ' ' B' 1107 ' ' VAL . 1.3 m -66.28 -36.53 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.346 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . 0.518 ' NZ ' HG21 ' A' ' 79' ' ' THR . 89.3 mttt -49.52 -38.82 32.06 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.606 -0.684 . . . . 0.0 109.562 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.95 -45.19 64.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.95 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -63.42 -50.2 70.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 77.8 m-70 . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.019 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.6 tp . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p -76.25 139.43 41.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.482 1.037 . . . . 0.0 110.744 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.65 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -50.83 -47.81 60.02 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.993 0.902 . . . . 0.0 110.684 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -38.5 -38.32 0.37 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.474 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.462 ' NE2' ' CE1' ' A' ' 12' ' ' PHE . 45.0 tp60 -68.74 -39.14 80.48 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 118.31 -0.853 . . . . 0.0 110.298 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.8 mt -58.97 -46.0 91.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 175.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.55 -50.65 62.48 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.114 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.02 -48.34 82.12 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.158 0.504 . . . . 0.0 112.282 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.0 m-85 -62.45 -40.63 97.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.835 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -50.86 -56.53 11.78 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.151 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -50.92 -41.88 59.02 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.95 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -54.21 -36.96 64.04 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.42 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.457 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 2.9 m-85 -58.42 -38.94 78.44 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -65.36 -15.52 62.65 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.458 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.8 mm? -65.59 -40.81 93.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -106.29 -14.6 15.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -72.13 93.21 1.4 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.642 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -68.17 -49.49 60.55 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.715 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.1 p-10 -102.32 15.68 28.46 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.53 44.0 0.41 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.451 -0.404 . . . . 0.0 112.171 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -85.35 -3.82 58.96 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.952 0.406 . . . . 0.0 110.978 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.76 -1.68 81.38 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.3 p -137.8 152.69 49.4 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.079 0.466 . . . . 0.0 110.035 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.26 124.74 44.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -113.95 163.91 14.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.427 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.412 HG22 HG13 ' A' ' 52' ' ' ILE . 20.9 p -58.14 -35.5 71.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.052 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -60.71 -60.39 3.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.209 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -62.39 -30.07 70.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.63 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 52' ' ' ILE . 3.2 tp -61.05 -55.53 31.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.255 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.75 -39.76 94.08 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.267 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -58.32 -54.99 40.71 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.954 1.377 . . . . 0.0 108.569 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -55.98 -46.75 80.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 118.859 0.754 . . . . 0.0 111.29 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.9 ttt -58.71 -40.05 82.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 120.413 1.46 . . . . 0.0 110.276 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -51.7 -38.38 54.89 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.344 0.592 . . . . 0.0 110.583 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.0 t -62.52 -19.89 64.07 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.047 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 tp -73.87 1.1 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.859 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.1 25.99 38.58 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.226 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -130.5 169.64 15.28 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.275 0.537 . . . . 0.0 109.887 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -133.28 77.29 66.79 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.295 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.74 148.08 93.86 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.823 2.349 . . . . 0.0 111.985 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.2 p -77.11 165.29 24.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.328 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 21.3 pt-20 -58.76 -44.99 90.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.66 -24.12 32.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.761 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -65.74 -39.8 91.49 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.174 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.2 mp -56.17 -41.5 75.59 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.175 0.512 . . . . 0.0 110.03 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -71.7 -56.42 5.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.48 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -55.65 -50.34 70.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.7 mmm -63.52 -52.08 62.75 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 32' ' ' LEU . 29.5 mm -58.29 -46.97 88.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.105 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -55.91 -34.22 65.39 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -66.72 -40.07 88.27 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.669 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.417 HG21 ' CE2' ' B' 1110 ' ' PHE . 40.0 t -86.75 -20.06 7.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.178 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.2 t0 -78.61 84.74 4.7 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -174.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.81 83.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.323 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.0 p-10 -86.17 -2.44 58.36 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.55 23.1 60.15 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.323 0.51 . . . . 0.0 112.686 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -86.71 3.84 43.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 117.189 0.494 . . . . 0.0 110.504 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.447 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.4 1.44 89.34 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 118.637 0.653 . . . . 0.0 114.702 175.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.8 p -148.14 167.92 23.77 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.25 128.35 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -103.03 -176.41 3.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.743 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.457 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -57.07 -46.75 99.83 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -176.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 31.4 Cg_exo -57.66 -51.9 7.27 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 121.462 1.442 . . . . 0.0 111.852 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.21 -20.97 64.75 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.43 0.633 . . . . 0.0 110.727 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -74.88 -59.87 2.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.687 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -54.98 -45.16 74.96 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 m -44.9 -50.51 10.39 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.912 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.6 mtm -65.42 -44.33 87.75 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 35.3 mmm -60.82 -41.46 95.78 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.16 77.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.337 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -92.43 -19.25 22.24 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.39 67.4 5.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.128 0.489 . . . . 0.0 110.297 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.5 mmt -107.76 15.3 24.71 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.356 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -48.29 133.89 15.27 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.37 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -89.68 107.89 19.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.943 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 m -93.83 120.57 34.28 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 82' ' ' GLU . 90.7 m-20 -70.28 112.28 6.49 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m -37.06 -20.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.828 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.579 ' N ' ' O ' ' A' ' 80' ' ' ASP . 96.2 mt-10 -69.15 -36.64 77.63 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.756 0.312 . . . . 0.0 111.585 -178.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -48.63 -35.86 14.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.25 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -89.07 -18.72 26.7 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.103 0.477 . . . . 0.0 111.794 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 85' ' ' ILE . 25.9 mm -58.92 -75.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.827 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -61.51 -37.53 84.05 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -63.66 -40.75 97.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.466 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.58 -20.84 63.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.001 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -72.22 -51.59 20.35 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.779 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -54.88 -41.77 71.25 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.67 -44.26 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.7 m-85 -69.28 -38.55 78.41 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.211 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.519 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 29.3 t0 -88.51 83.5 6.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.42 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 88.4 tttt -57.78 -49.41 76.69 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.2 p-10 -91.89 5.02 51.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.703 0.287 . . . . 0.0 111.59 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.28 49.55 50.31 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.694 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -91.33 5.27 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.488 0.315 . . . . 0.0 110.713 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.454 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 84.87 0.72 89.09 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.694 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 79.9 m-85 -138.38 151.26 47.35 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.72 0.771 . . . . 0.0 111.783 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.2 mt -93.83 117.21 36.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 t -89.99 150.08 22.29 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.76 -46.34 77.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.109 0.868 . . . . 0.0 110.788 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.31 62.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.836 0.35 . . . . 0.0 110.636 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.42 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.2 mt-10 -66.2 -41.46 90.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.557 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.0 -46.9 85.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.264 0.554 . . . . 0.0 110.822 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -42.89 -43.09 3.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.683 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -65.19 -29.24 70.04 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.005 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' A' ' 92' ' ' PHE . 96.7 t -58.08 -42.67 83.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.73 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.63 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.15 -45.96 61.85 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.784 0.802 . . . . 0.0 111.668 -177.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.6 p -55.84 -38.49 70.12 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.825 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -66.58 -40.89 89.17 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.892 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 73.4 mt -82.15 -13.14 57.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.79 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.21 30.83 62.25 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -86.17 -23.19 26.63 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 121.0 2.4 . . . . 0.0 110.856 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.9 mtmt 45.2 61.77 2.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.571 0.7 . . . . 0.0 110.497 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.1 mt -80.2 148.36 30.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.266 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.529 HG23 ' H ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -82.67 176.78 9.08 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.403 179.002 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.458 ' N ' ' OG1' ' A' ' 117' ' ' THR . 45.4 m-20 -59.7 -45.48 91.98 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.79 -46.95 81.23 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.529 ' H ' HG23 ' A' ' 117' ' ' THR . 76.4 mm-40 -70.38 -30.59 67.54 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.08 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.73 -42.18 95.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.34 -35.98 73.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.209 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -60.07 -53.2 60.61 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 81.9 mtp -54.96 -44.47 74.41 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.269 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.6 mt -58.18 -43.88 86.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.598 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -60.13 -36.38 77.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.836 0.35 . . . . 0.0 111.486 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -59.53 -41.06 89.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.055 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.6 -18.42 24.07 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.6 t0 -74.87 87.88 2.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.108 0.48 . . . . 0.0 111.868 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.406 HG22 ' OE2' ' A' ' 140' ' ' GLU . 10.8 tt -69.87 -15.1 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 122.523 1.154 . . . . 0.0 113.524 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.2 p-10 -143.07 145.71 33.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.159 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.79 52.35 1.6 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.883 -0.199 . . . . 0.0 113.213 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -90.74 -8.9 48.54 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 117.054 0.427 . . . . 0.0 110.219 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.85 1.36 72.38 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.986 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -134.67 154.43 51.54 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.227 0.514 . . . . 0.0 110.399 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.86 118.27 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.186 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.417 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 51.9 t30 -84.11 174.17 10.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.352 . . . . 0.0 111.065 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.417 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 84.0 t80 -61.15 -40.66 94.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.041 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.28 -44.62 96.11 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.946 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.406 ' OE2' HG22 ' A' ' 130' ' ' ILE . 96.8 mt-10 -64.87 -38.53 91.29 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.707 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -61.3 -44.7 96.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.907 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.22 -46.95 89.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.055 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -50.05 -43.05 50.81 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.891 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.7 mmt -74.93 -39.62 61.29 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.2 mmt -72.9 -47.42 45.94 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.802 0.334 . . . . 0.0 111.601 -179.377 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 8.8 m95 -62.65 -55.69 24.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.257 0.551 . . . . 0.0 112.419 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.4 t80 -59.46 -46.55 88.45 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -43.05 -51.3 5.82 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.52 -41.89 99.65 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.1 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . 0.43 ' O ' ' NE2' ' B' 1101 ' ' GLN . 56.7 tp -56.91 -45.78 82.41 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.595 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 39.6 t30 -57.93 -47.47 82.77 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -64.69 -37.32 87.18 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.2 mt -61.33 -42.61 94.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.824 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . 0.43 ' NE2' ' O ' ' B' 1097 ' ' LEU . 2.8 mp0 -50.27 -46.47 55.1 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.524 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.7 m -63.19 -48.45 78.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.43 ' C ' ' O ' ' B' 1102 ' ' THR . 24.8 mt-30 -27.31 -59.64 0.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 122.745 1.26 . . . . 0.0 112.642 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -83.31 -14.72 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 112.475 -2.148 . . . . 0.0 112.198 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.524 ' N ' ' O ' ' B' 1102 ' ' THR . 66.3 tttm -59.93 -46.51 89.14 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 117.829 -1.548 . . . . 0.0 107.895 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.7 t -61.32 -49.31 85.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.6 m -65.54 -36.14 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.406 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 87.8 mttt -49.01 -38.15 22.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.642 0.656 . . . . 0.0 109.82 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.58 -45.5 66.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.289 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 55' ' ' VAL . 45.0 m-85 -62.59 -50.02 72.92 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 69.7 m-70 . . . . . 0 C--N 1.329 -0.322 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.375 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.7 tp . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 119.351 -0.356 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.3 p -77.95 139.96 39.21 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.321 0.964 . . . . 0.0 110.317 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ILE . 45.8 tp10 -49.7 -57.23 7.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 122.281 1.039 . . . . 0.0 110.449 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 83.5 tt0 -34.7 -38.33 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.218 -1.81 . . . . 0.0 111.066 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -68.9 -37.05 78.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 118.07 -0.966 . . . . 0.0 110.65 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.3 mt -59.0 -44.75 91.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 175.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -53.92 -52.66 59.87 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.356 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.42 -47.77 84.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.441 0.639 . . . . 0.0 112.004 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 10.1 m-85 -62.36 -38.68 90.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.677 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -52.61 -54.84 27.67 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.467 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.31 -40.76 49.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.966 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.45 -37.65 70.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.095 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.406 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 3.4 m-85 -58.37 -41.12 84.07 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 t -64.04 -15.54 59.7 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.505 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.53 -42.25 95.87 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -106.01 -14.0 15.31 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -72.29 93.28 1.47 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.482 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -67.41 -49.49 63.58 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.983 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 23' ' ' GLY . 37.0 p30 -102.31 14.73 31.19 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.88 43.78 0.66 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.105 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -84.87 -3.47 58.7 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.764 0.316 . . . . 0.0 110.972 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.42 -1.72 82.3 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.7 p -137.87 153.04 49.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.225 0.536 . . . . 0.0 109.801 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 27' ' ' ILE . 4.4 mp -91.59 123.8 43.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.5 p -114.53 165.25 12.96 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 124.124 0.89 . . . . 0.0 112.335 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.415 HG22 HG13 ' A' ' 52' ' ' ILE . 23.7 p -58.62 -36.84 74.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.578 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.86 -60.65 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.496 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -62.06 -30.26 70.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.426 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tp -60.73 -53.78 53.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.219 1.009 . . . . 0.0 109.804 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.16 -37.68 94.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 113.593 -1.639 . . . . 0.0 111.825 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.6 m -58.69 -53.88 53.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 119.005 1.402 . . . . 0.0 108.537 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.88 -46.12 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 121.254 -0.904 . . . . 0.0 111.561 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.9 ttt -58.87 -41.57 87.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 119.99 1.268 . . . . 0.0 109.628 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -51.77 -34.81 41.3 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.648 0.737 . . . . 0.0 110.165 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.1 t -63.07 -20.34 65.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.589 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -75.82 2.81 11.31 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.163 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.52 17.0 74.48 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.956 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -109.26 160.99 15.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.462 0.631 . . . . 0.0 110.013 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -116.05 68.71 3.46 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.165 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.07 143.88 91.46 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.041 1.827 . . . . 0.0 112.291 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.7 p -81.01 165.28 21.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.42 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -58.69 -43.76 90.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.029 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.53 -23.64 27.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.536 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -66.0 -38.48 88.58 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.242 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.6 mp -56.57 -41.31 76.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.404 0.621 . . . . 0.0 109.733 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -71.09 -56.48 6.03 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.722 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -55.03 -49.55 71.29 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.9 mmm -66.0 -50.91 62.59 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 52' ' ' ILE . 26.9 mm -59.43 -48.18 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.618 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -57.79 -34.01 69.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -66.49 -40.43 89.26 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.547 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.409 HG21 ' CE2' ' B' 1110 ' ' PHE . 56.6 t -85.73 -20.88 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.544 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.16 86.56 4.29 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.81 87.46 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 113.308 -1.769 . . . . 0.0 113.906 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 37.8 p-10 -86.44 -2.46 58.46 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.35 23.05 61.86 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 118.451 0.568 . . . . 0.0 112.89 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -87.99 2.43 51.78 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.229 0.515 . . . . 0.0 110.335 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.483 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 86.0 0.97 87.07 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 121.714 -0.616 . . . . 0.0 114.572 175.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.8 p -148.51 170.42 18.09 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.79 129.48 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -103.67 -175.54 2.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.854 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.7 -46.99 99.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -55.49 -51.95 8.77 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.282 1.321 . . . . 0.0 111.76 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.74 -18.53 55.18 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.446 0.641 . . . . 0.0 110.617 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -76.36 -57.82 3.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.553 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.84 -46.08 85.27 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.3 m -45.31 -49.37 12.78 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.369 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 72.5 mtm -66.16 -44.53 83.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.2 mmt -58.75 -41.65 87.03 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.77 -34.02 77.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.551 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -94.9 -9.29 34.62 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.527 0.203 . . . . 0.0 111.304 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.691 ' HZ2' ' N ' ' B' 1109 ' ' ALA . 0.3 OUTLIER -82.01 69.36 8.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.55 0.69 . . . . 0.0 111.047 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.26 18.29 21.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.126 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -51.19 130.2 25.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.034 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -89.62 108.74 19.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.055 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.7 m -93.59 119.38 32.55 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.2 m-20 -69.32 111.66 5.37 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 173.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.9 m -37.48 -21.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.642 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.5 mp0 -69.42 -35.33 75.62 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -48.83 -37.21 18.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.393 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' OE2' ' NE2' ' B' 1101 ' ' GLN . 10.6 pt-20 -89.28 -13.24 38.5 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 85' ' ' ILE . 24.5 mm -63.14 -74.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.993 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -63.02 -39.41 94.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -63.05 -40.95 99.25 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.436 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.54 -18.4 59.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.937 0.398 . . . . 0.0 111.062 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -74.45 -48.74 25.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.012 0.434 . . . . 0.0 111.327 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -55.16 -41.77 72.28 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.64 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -64.84 -43.9 96.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.4 m-85 -69.02 -38.54 79.28 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.518 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -85.48 81.22 8.8 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -58.24 -49.32 77.51 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -91.23 5.23 49.93 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.365 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.84 48.35 51.24 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -91.37 6.79 43.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.752 0.31 . . . . 0.0 110.673 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.73 1.95 89.9 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.696 -0.561 . . . . 0.0 111.696 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -140.51 153.95 46.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.686 0.755 . . . . 0.0 111.521 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.6 mt -93.97 114.61 30.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.1 t -89.07 151.61 22.14 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.82 -47.03 83.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 119.067 0.849 . . . . 0.0 110.638 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.02 -35.35 61.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.894 0.378 . . . . 0.0 110.278 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.56 -39.52 73.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.076 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.45 -47.36 76.43 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.231 0.539 . . . . 0.0 112.187 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.4 -33.71 2.71 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.235 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -72.49 -28.91 63.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.567 HG21 ' CE2' ' A' ' 92' ' ' PHE . 75.0 t -58.08 -41.42 80.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.734 -178.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.536 ' HG3' HD13 ' A' ' 116' ' ' LEU . 4.6 mmt -53.22 -47.24 69.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.301 1.048 . . . . 0.0 111.789 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.1 p -55.56 -35.52 65.81 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 113.115 -1.857 . . . . 0.0 110.925 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -36.45 82.59 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.043 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.0 mt -84.5 -11.25 56.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.94 36.71 51.66 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.46 -22.8 23.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.827 2.314 . . . . 0.0 111.18 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.7 tptt 44.78 59.78 3.23 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.549 1.166 . . . . 0.0 109.993 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.536 HD13 ' HG3' ' A' ' 109' ' ' MET . 0.8 OUTLIER -76.57 150.96 36.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.602 -2.09 . . . . 0.0 113.386 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.3 p -84.35 175.43 9.37 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.973 0.416 . . . . 0.0 109.927 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -56.36 -45.13 80.61 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.77 -40.81 69.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.027 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.77 -30.13 68.66 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.619 -0.432 . . . . 0.0 112.105 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.34 -43.57 98.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.501 0.667 . . . . 0.0 109.504 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -74.13 -35.82 64.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.816 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -60.77 -55.27 35.08 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 97.7 mmm -48.83 -60.39 2.79 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.472 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.3 pt -50.57 -40.74 19.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.719 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -61.98 -35.36 78.25 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.704 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -57.21 -40.68 77.96 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.219 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.24 -12.91 25.44 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.3 t0 -73.51 87.34 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.425 0.631 . . . . 0.0 111.789 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.0 pt -71.49 -11.86 15.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 122.484 1.135 . . . . 0.0 113.561 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 52.5 p-10 -143.21 142.59 31.46 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 112.265 -2.243 . . . . 0.0 109.035 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.67 52.46 0.9 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.692 -0.29 . . . . 0.0 113.436 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -91.29 -11.19 38.79 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.172 0.486 . . . . 0.0 110.111 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.69 2.79 70.92 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.195 -0.526 . . . . 0.0 114.385 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -134.13 152.94 52.07 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.134 0.467 . . . . 0.0 110.318 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.48 118.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.455 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -84.58 173.79 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 0.0 110.877 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -61.05 -40.08 92.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.026 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.5 -44.81 95.47 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.914 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.39 -37.96 89.31 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.419 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.17 -45.69 93.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.3 t -65.69 -48.58 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.767 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -49.02 -45.96 43.34 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.972 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.475 ' O ' ' CE1' ' B' 1094 ' ' PHE . 13.2 mmt -72.73 -38.99 67.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 18.1 mmt -75.56 -45.09 39.9 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.795 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 5.5 m95 -60.55 -62.51 1.81 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.238 0.542 . . . . 0.0 112.415 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . 0.475 ' CE1' ' O ' ' A' ' 144' ' ' MET . 48.8 m-85 -57.78 -44.69 86.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -39.37 -52.04 2.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.52 -41.66 99.77 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.178 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . 0.429 HD11 ' OE1' ' A' ' 84' ' ' GLU . 50.8 tp -56.35 -45.22 80.55 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.454 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 12.2 m120 -59.07 -47.32 85.68 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.651 -175.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -65.38 -37.48 87.13 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.22 -42.01 91.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.868 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . 0.458 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 68.7 mt-30 -51.34 -45.95 62.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.528 ' O ' ' N ' ' B' 1105 ' ' LYS . 93.9 m -63.47 -47.95 79.67 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.912 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 84.3 mt-30 -28.06 -57.62 0.11 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.741 1.258 . . . . 0.0 112.572 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.7 mt -84.27 -14.81 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 112.085 -2.325 . . . . 0.0 112.313 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.538 ' O ' ' NZ ' ' A' ' 75' ' ' LYS . 88.8 tttt -59.54 -44.72 93.13 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.954 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 67.5 t -61.49 -49.11 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . 0.402 HG13 ' H ' ' B' 1107 ' ' VAL . 1.4 m -65.83 -36.09 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.322 -177.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 89.7 mttt -49.88 -37.55 31.7 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.682 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . 0.691 ' N ' ' HZ2' ' A' ' 75' ' ' LYS . . . -51.41 -45.06 62.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.784 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . 0.409 ' CE2' HG21 ' A' ' 55' ' ' VAL . 46.8 m-85 -63.88 -49.73 71.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 71.5 m-70 . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.223 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -79.14 137.26 37.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.365 0.984 . . . . 0.0 110.306 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 9' ' ' ILE . 21.3 mt-10 -54.42 -49.98 68.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.132 0.968 . . . . 0.0 110.43 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 42.8 tp10 -34.32 -36.39 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.569 -1.65 . . . . 0.0 111.102 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -69.12 -36.04 77.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.265 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 6' ' ' GLU . 88.4 mt -58.82 -43.95 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -53.81 -50.53 65.94 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.893 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -63.49 -45.79 89.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.325 0.583 . . . . 0.0 112.05 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.5 m-85 -62.51 -40.42 96.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.888 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -49.95 -57.19 8.02 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.472 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -49.66 -40.43 39.69 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.04 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.7 -37.58 71.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.203 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.518 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 3.0 m-85 -57.79 -41.62 82.47 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.1 t -64.37 -15.7 60.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.65 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.87 -42.59 97.47 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -106.07 -13.97 15.3 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -74.08 95.65 2.58 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.203 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -68.74 -52.83 26.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.44 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.5 p-10 -98.77 13.97 30.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.72 45.22 1.01 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.024 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 32.7 p-10 -85.28 -3.82 58.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.665 0.269 . . . . 0.0 110.875 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.5 -0.79 78.11 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -139.99 153.99 47.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.11 0.481 . . . . 0.0 110.025 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 27' ' ' ILE . 5.1 mp -93.2 124.56 45.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -112.79 165.29 12.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.513 0.673 . . . . 0.0 112.405 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.7 p -59.5 -35.83 74.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.322 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -61.6 -61.73 2.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.77 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.53 -30.12 70.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.715 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.457 HD22 HD11 ' A' ' 52' ' ' ILE . 2.7 tp -60.42 -53.63 55.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.875 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.55 93.54 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.927 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.63 -51.47 69.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.816 1.308 . . . . 0.0 108.936 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.0 t -59.33 -46.01 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 118.739 0.699 . . . . 0.0 111.042 -176.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.0 ttt -59.01 -41.48 87.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.552 1.069 . . . . 0.0 109.654 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -52.1 -37.08 52.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.733 0.778 . . . . 0.0 110.247 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 p -62.71 -20.6 65.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.702 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.7 mt -75.53 1.6 13.82 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.104 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.1 17.44 67.17 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.154 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -109.11 158.7 17.53 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 117.498 0.649 . . . . 0.0 109.955 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -114.2 65.47 1.43 Allowed Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.13 142.4 91.92 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.03 1.82 . . . . 0.0 112.081 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -80.94 165.27 21.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.246 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -58.17 -43.88 87.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.74 -24.57 50.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.484 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -64.85 -40.19 94.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.209 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.7 mp -55.41 -38.5 69.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.404 0.621 . . . . 0.0 109.354 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -71.66 -56.01 6.64 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.095 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -54.06 -49.23 69.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.5 mtp -68.4 -48.61 64.22 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.457 HD11 HD22 ' A' ' 32' ' ' LEU . 24.3 mm -59.46 -47.58 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.7 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -58.49 -33.8 70.21 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.93 -39.85 90.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.539 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.2 t -86.69 -20.27 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 121.154 -0.218 . . . . 0.0 111.33 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.53 87.44 4.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -175.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.98 -37.33 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 113.535 -1.666 . . . . 0.0 113.987 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.4 p-10 -86.35 -2.69 58.64 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.2 23.27 61.81 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 118.338 0.517 . . . . 0.0 112.709 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.4 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 51.5 p-10 -88.15 3.63 48.49 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.422 0.611 . . . . 0.0 110.423 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.46 0.72 89.39 Favored Glycine 0 CA--C 1.522 0.525 0 O-C-N 121.74 -0.6 . . . . 0.0 114.423 175.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.7 p -147.74 169.78 18.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.8 mt -114.66 128.77 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -103.88 -173.94 2.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.705 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.518 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -58.84 -46.62 99.54 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.34 -51.72 7.93 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 121.245 1.297 . . . . 0.0 111.85 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.55 -18.36 61.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.485 0.659 . . . . 0.0 110.687 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -75.19 -58.76 3.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.907 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.8 mt -57.49 -42.6 83.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -46.04 -49.35 16.37 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.566 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.21 -45.23 77.44 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.5 mmm -61.06 -40.34 93.3 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.4 78.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.229 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -94.34 -10.05 33.93 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.831 0.348 . . . . 0.0 111.467 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.19 67.45 8.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.249 0.547 . . . . 0.0 110.487 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 mmt -108.63 15.19 23.94 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.696 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -49.46 133.45 20.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.061 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 45.2 p-10 -92.66 105.2 17.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.932 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.7 m -88.24 123.04 32.46 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 82' ' ' GLU . 96.6 m-20 -69.87 112.05 6.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.0 m -37.6 -21.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.726 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 80' ' ' ASP . 54.2 mp0 -69.14 -36.32 77.32 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -48.67 -36.45 16.09 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.252 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.514 ' OE2' ' NE2' ' B' 1101 ' ' GLN . 11.1 pt-20 -89.11 -13.86 37.56 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 85' ' ' ILE . 24.9 mm -62.84 -74.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.279 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -62.41 -41.12 98.44 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -62.98 -40.39 97.59 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.488 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.83 -17.02 54.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.003 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -73.79 -49.3 25.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.021 0.438 . . . . 0.0 111.35 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -55.09 -41.74 71.99 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.604 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.54 -43.96 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -68.52 -39.41 81.22 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.486 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -85.28 81.84 8.62 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.13 -50.18 74.41 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -90.88 5.4 48.68 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.216 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.15 48.49 46.59 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -89.93 6.23 42.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.756 0.312 . . . . 0.0 110.609 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.54 2.76 84.63 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -144.23 157.7 44.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.742 0.782 . . . . 0.0 111.553 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -94.63 114.32 30.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -87.49 151.75 22.77 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.89 78.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 119.036 0.834 . . . . 0.0 110.842 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.01 -40.89 64.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.993 0.425 . . . . 0.0 110.238 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.91 -44.09 86.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.734 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.501 ' O ' HG12 ' A' ' 108' ' ' VAL . 7.1 tt -62.84 -47.56 82.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.83 0.348 . . . . 0.0 111.764 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -41.16 -45.02 2.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.101 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -57.14 -26.99 61.44 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.529 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 105' ' ' LEU . 2.0 p -56.45 -41.34 71.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.22 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -50.32 59.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 122.248 1.023 . . . . 0.0 111.245 -177.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.8 m -51.44 -40.85 60.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.483 -1.689 . . . . 0.0 110.775 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.99 -41.25 95.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.06 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.9 mt -82.91 -14.41 54.23 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.79 55.77 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.553 -1.137 . . . . 0.0 110.42 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -86.72 -22.42 26.03 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.385 2.092 . . . . 0.0 110.866 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 43.49 60.34 2.66 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.281 1.039 . . . . 0.0 110.172 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.1 mt -80.87 148.69 29.81 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.599 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 76.5 p -83.0 175.36 10.1 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -57.63 -44.67 85.74 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.31 -48.58 80.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.324 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -70.49 -31.07 68.03 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.916 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.19 -42.29 95.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -68.04 -36.56 80.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.792 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.22 -50.53 73.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.706 0.765 . . . . 0.0 112.916 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 19.3 mmm -57.85 -42.75 85.09 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.89 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.3 mt -60.08 -43.65 93.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.048 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -59.67 -38.67 82.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.743 0.306 . . . . 0.0 111.168 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.75 -41.62 86.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.16 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.46 -25.49 21.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.0 t0 -71.58 88.47 0.95 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.451 0.643 . . . . 0.0 111.842 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.5 tp -70.11 -14.58 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 122.844 1.307 . . . . 0.0 113.147 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 37.2 p-10 -141.04 144.15 34.81 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 112.402 -2.181 . . . . 0.0 109.486 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.34 52.22 1.08 Allowed Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.403 -0.427 . . . . 0.0 113.0 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.408 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 37.5 p-10 -91.63 -9.85 42.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.259 0.529 . . . . 0.0 110.167 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.55 3.41 78.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 114.168 0.427 . . . . 0.0 114.168 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -135.14 154.56 51.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 117.243 0.522 . . . . 0.0 110.422 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.6 t -101.19 118.64 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.462 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.414 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 51.9 t30 -84.21 173.18 11.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.922 0.392 . . . . 0.0 110.981 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.414 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 80.4 t80 -60.82 -40.98 94.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.222 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.11 -44.55 97.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.152 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.92 -38.37 90.74 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.654 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -61.33 -45.68 93.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.952 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.404 ' O ' ' OG1' ' A' ' 146' ' ' THR . 73.2 t -64.76 -46.39 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.5 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -51.0 -43.22 60.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.805 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.4 mmt -75.15 -39.88 60.04 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.7 mmt -71.43 -47.76 53.81 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.837 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 3.1 p . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.904 0.383 . . . . 0.0 110.945 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.9 m95 -62.04 -55.6 27.47 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.541 0.686 . . . . 0.0 112.626 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.6 t80 -60.51 -47.41 86.28 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -173.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -39.65 -50.78 2.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.69 -40.15 98.82 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.269 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.5 tp -56.44 -45.02 81.0 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.993 0.896 . . . . 0.0 109.702 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 42.1 t30 -59.23 -46.91 87.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.515 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -65.42 -38.41 89.81 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.7 mt -60.88 -41.94 90.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.271 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . 0.514 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 66.5 mt-30 -52.48 -46.58 66.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.505 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.0 m -63.71 -48.28 77.72 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.835 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.447 ' C ' ' O ' ' B' 1102 ' ' THR . 25.3 mt-30 -28.0 -55.5 0.11 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 123.11 1.433 . . . . 0.0 112.758 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.1 mt -84.75 -14.88 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 112.193 -2.276 . . . . 0.0 112.641 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.505 ' N ' ' O ' ' B' 1102 ' ' THR . 87.6 mttt -59.74 -42.7 93.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 117.97 -1.492 . . . . 0.0 108.86 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 81.7 t -61.42 -48.91 86.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.2 m -66.97 -36.64 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.906 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.5 mttt -49.79 -38.34 33.9 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.623 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.02 -44.42 64.15 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.217 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -63.95 -50.64 67.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 21.7 t-80 . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.188 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 50.7 tp . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 119.217 -0.42 . . . . 0.0 110.501 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.1 p -77.08 140.02 40.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.332 0.969 . . . . 0.0 109.863 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ILE . 47.9 tp10 -47.28 -63.48 1.03 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 122.149 0.976 . . . . 0.0 110.319 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 84.2 tt0 -34.16 -37.4 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.087 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -70.18 -36.14 74.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.577 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 6' ' ' GLU . 93.1 mt -59.57 -44.29 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 175.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.39 -49.42 64.47 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.401 -177.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -63.49 -45.14 92.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.51 0.671 . . . . 0.0 112.379 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.453 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.6 m-85 -63.15 -41.28 99.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.987 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -52.62 -57.04 11.3 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.442 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -46.8 -41.8 16.04 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.597 . . . . 0.0 110.363 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -55.38 -35.88 65.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.27 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.81 -39.73 81.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -64.77 -15.88 62.24 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.083 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 18' ' ' LEU . 7.3 mp -65.01 -40.81 95.46 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -106.13 -14.39 15.16 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -72.56 92.79 1.53 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.211 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -67.63 -49.84 61.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.76 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.0 p-10 -102.41 15.42 29.26 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.26 44.24 0.55 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.171 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.8 p30 -85.3 -4.24 59.09 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.282 . . . . 0.0 110.932 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.95 -2.26 81.65 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.2 p -137.33 152.12 49.38 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.106 0.479 . . . . 0.0 109.767 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.5 mp -91.61 123.98 43.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.3 p -113.07 163.88 14.17 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.492 0.663 . . . . 0.0 112.425 -177.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -58.59 -36.32 73.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.487 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -62.04 -61.51 2.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.43 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -61.03 -30.69 70.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.576 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 tp -60.62 -54.5 44.67 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.243 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.14 95.32 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.17 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 m -58.22 -53.59 56.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.759 1.279 . . . . 0.0 108.794 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -57.36 -46.47 85.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 121.414 -0.804 . . . . 0.0 111.405 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.0 ttt -59.38 -40.15 85.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 119.888 1.222 . . . . 0.0 109.727 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -53.72 -41.77 67.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.529 0.681 . . . . 0.0 110.229 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 p -63.4 -21.6 66.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.125 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.91 -2.7 24.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.835 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.24 14.81 59.8 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.495 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -107.88 155.29 20.45 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.541 0.671 . . . . 0.0 109.825 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -114.93 63.95 1.57 Allowed Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.339 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -62.85 144.24 93.11 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.214 1.943 . . . . 0.0 112.251 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 44' ' ' THR . 1.7 t -80.31 167.69 19.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.111 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 15.6 pt-20 -58.85 -44.75 91.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.001 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.436 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -56.08 -23.52 34.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.43 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -65.82 -39.45 90.86 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.584 -0.446 . . . . 0.0 109.964 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -56.53 -41.41 76.72 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.525 0.678 . . . . 0.0 109.468 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -70.39 -57.1 5.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.863 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -53.69 -48.69 69.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.338 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 31.7 mmm -66.74 -50.19 63.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.9 mm -58.71 -48.33 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.622 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -56.53 -34.83 67.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -66.07 -39.68 90.26 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.852 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.454 HG21 ' CE2' ' B' 1110 ' ' PHE . 73.5 t -86.07 -20.46 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.577 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.479 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.3 t0 -79.22 85.33 5.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -175.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.37 84.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.391 -1.731 . . . . 0.0 114.187 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 39.7 p-10 -86.47 -2.72 58.69 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.27 23.06 63.88 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 118.398 0.544 . . . . 0.0 112.752 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.429 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -87.89 2.06 52.47 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 117.418 0.609 . . . . 0.0 110.664 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.479 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.53 1.82 87.49 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 118.603 0.638 . . . . 0.0 114.552 175.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.3 p -146.36 166.63 25.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.35 126.7 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -102.93 -177.09 3.27 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -47.01 99.55 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -176.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.45 -51.51 9.09 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 120.995 1.13 . . . . 0.0 111.66 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.63 -18.77 60.84 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.416 0.627 . . . . 0.0 110.521 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -75.8 -59.28 2.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.063 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.02 -44.45 82.87 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.7 m -45.92 -48.06 16.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.399 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.1 mtm -66.88 -45.02 79.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.0 mmm -61.3 -41.31 96.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.12 -35.16 79.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.41 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -92.12 -16.36 26.45 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.813 0.339 . . . . 0.0 111.414 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.493 ' HZ1' ' HG3' ' B' 1105 ' ' LYS . 28.4 tptp -80.18 72.09 6.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.612 0.72 . . . . 0.0 110.562 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.9 19.39 20.12 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.983 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -49.87 129.99 20.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.146 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.52 109.35 20.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.861 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.2 p -99.3 111.75 24.06 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.582 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -60.4 117.85 5.75 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.013 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 m -37.37 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.711 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 80' ' ' ASP . 80.5 tt0 -68.67 -35.57 77.41 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -49.98 -38.8 38.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.259 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -87.21 -19.44 28.38 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.092 0.473 . . . . 0.0 111.671 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.8 mm -60.41 -74.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.679 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.6 mtm180 -62.77 -41.55 99.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.7 -40.57 92.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.408 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.53 -17.48 46.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.007 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -74.17 -49.59 22.95 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.223 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -55.68 -43.18 76.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.435 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.82 -43.56 93.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.7 m-85 -68.68 -38.8 80.62 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.393 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -86.23 82.36 8.06 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -57.64 -50.21 73.91 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -91.04 5.83 47.3 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.277 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.21 47.81 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -90.32 7.47 38.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.667 0.27 . . . . 0.0 110.616 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.18 2.16 89.37 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -141.48 153.62 45.05 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.809 0.814 . . . . 0.0 111.756 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -96.05 117.04 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.3 p -91.34 153.69 19.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.73 83.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 119.227 0.921 . . . . 0.0 110.906 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.64 -41.9 64.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.891 0.377 . . . . 0.0 110.617 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -64.35 -43.26 95.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.54 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 108' ' ' VAL . 11.5 mt -62.76 -44.95 94.85 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.324 0.583 . . . . 0.0 111.391 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -42.5 -43.17 3.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.651 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -63.28 -27.33 69.26 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.035 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.567 HG21 ' CE2' ' A' ' 92' ' ' PHE . 94.0 t -58.07 -42.83 83.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.651 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.649 ' HG3' HD13 ' A' ' 116' ' ' LEU . 15.1 mmt -51.35 -44.46 62.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.204 1.002 . . . . 0.0 111.458 -177.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.6 m -55.36 -41.1 72.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.885 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -64.73 -39.84 94.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.538 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.3 mt -83.44 -13.56 54.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.63 35.89 50.09 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.396 -1.224 . . . . 0.0 110.482 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.5 ' OE1' ' SD ' ' A' ' 109' ' ' MET . 80.7 tt0 -89.78 -24.57 21.45 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.729 2.265 . . . . 0.0 110.879 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.0 tptp 45.89 63.0 1.99 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.551 1.167 . . . . 0.0 110.096 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.872 HD23 ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -76.31 150.92 36.85 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.955 -1.929 . . . . 0.0 112.854 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.2 p -86.3 174.16 9.25 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.367 0.603 . . . . 0.0 109.952 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -54.42 -44.02 72.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -55.83 -41.63 74.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.219 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -68.4 -28.98 67.57 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.721 -178.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.477 ' CG2' HD11 ' A' ' 116' ' ' LEU . 52.6 t -63.8 -44.07 98.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.33 0.586 . . . . 0.0 109.773 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.66 -37.33 65.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.292 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -58.73 -54.95 41.29 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.422 ' CE ' HD12 ' B' 1092 ' ' LEU . 95.1 mtp -57.17 -43.19 82.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.746 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.6 mm -58.7 -44.0 88.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.132 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -60.65 -35.68 76.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.348 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.98 -42.23 89.49 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.69 -20.15 21.88 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.6 t0 -70.45 90.29 0.72 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.539 0.685 . . . . 0.0 112.069 -177.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.0 -16.12 19.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 122.711 1.243 . . . . 0.0 113.219 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.6 p-10 -143.82 144.99 32.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 112.334 -2.212 . . . . 0.0 109.443 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.05 52.74 1.36 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.961 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -91.17 -9.29 45.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.087 0.443 . . . . 0.0 110.145 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.64 2.14 74.38 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.401 -0.428 . . . . 0.0 114.115 176.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -133.75 153.05 52.0 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 117.36 0.58 . . . . 0.0 110.477 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.1 t -99.15 118.23 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.145 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.416 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 52.2 t30 -84.0 173.61 11.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.977 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.416 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 82.9 t80 -61.37 -39.33 90.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.929 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.72 -44.66 92.95 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.015 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.17 -38.67 91.29 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.567 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -61.04 -44.74 96.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.799 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 82.8 t -65.86 -46.27 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.471 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -49.23 -44.87 43.83 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.008 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.3 mmm -75.66 -39.98 56.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.2 mmt -76.21 -46.86 26.28 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.341 -0.144 . . . . 0.0 111.069 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 111.446 -178.945 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . 0.511 ' O ' HD13 ' B' 1092 ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 4.7 m95 -58.6 -60.65 3.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.574 0.702 . . . . 0.0 112.095 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -46.64 82.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -174.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . 0.646 HH11 ' NH2' ' B' 1099 ' ' ARG . 63.7 ttm-85 -36.51 -51.97 0.84 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.79 -40.1 98.35 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.179 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.65 -44.18 81.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 118.031 0.916 . . . . 0.0 109.628 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -59.63 -49.52 77.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.767 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . 0.646 ' NH2' HH11 ' B' 1095 ' ' ARG . 3.2 mpt_? -65.72 -39.22 90.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.302 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.74 -43.33 94.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.509 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -55.49 -45.15 77.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.513 ' O ' ' C ' ' B' 1103 ' ' GLN . 90.4 m -60.9 -48.56 81.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.955 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.513 ' C ' ' O ' ' B' 1102 ' ' THR . 86.1 mt-30 -28.29 -97.54 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 123.238 1.494 . . . . 0.0 112.137 -175.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -39.47 -14.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 111.806 -2.452 . . . . 0.0 111.752 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.493 ' HG3' ' HZ1' ' A' ' 75' ' ' LYS . 52.5 tttp -60.4 -44.63 95.5 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 118.01 -1.476 . . . . 0.0 107.476 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.5 t -61.45 -48.97 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . 0.407 ' H ' HG13 ' B' 1107 ' ' VAL . 1.2 m -66.83 -37.88 80.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.96 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 63.4 mttt -49.87 -39.41 39.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.205 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -50.86 -44.91 59.63 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.035 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . 0.454 ' CE2' HG21 ' A' ' 55' ' ' VAL . 45.2 m-85 -63.46 -48.53 77.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 19.4 t-80 . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.428 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.467 0.396 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.2 p -80.45 139.31 36.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.256 0.935 . . . . 0.0 110.384 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 9' ' ' ILE . 48.4 tp10 -50.98 -54.65 22.59 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.798 0.808 . . . . 0.0 110.519 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -35.77 -37.57 0.1 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.096 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -68.99 -37.54 78.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.605 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.8 mt -58.64 -45.64 90.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 175.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.39 -51.58 62.1 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.393 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -61.6 -47.06 87.15 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.468 0.651 . . . . 0.0 112.622 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -62.9 -36.86 84.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.556 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -55.16 -51.51 66.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.373 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.77 -41.82 61.93 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.31 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.47 -39.14 67.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.212 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -56.29 -41.51 76.04 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -65.28 -14.69 61.32 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.441 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.2 tp -63.25 -43.45 97.96 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -107.06 -13.73 15.11 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.99 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -76.27 95.43 3.74 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.098 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -68.34 -46.99 68.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.297 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.5 p-10 -101.63 14.84 30.76 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.65 46.85 0.6 Allowed Glycine 0 CA--C 1.533 1.195 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -84.15 -3.44 58.13 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.43 -1.58 82.13 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.425 ' C ' HD12 ' A' ' 27' ' ' ILE . 57.7 p -137.39 151.88 49.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.918 0.389 . . . . 0.0 110.168 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.7 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -93.49 125.73 46.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.509 HG23 ' H ' ' A' ' 30' ' ' LYS . 1.9 t -115.29 164.27 14.48 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.176 -0.92 . . . . 0.0 113.182 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.4 HG22 HG13 ' A' ' 52' ' ' ILE . 20.0 p -57.66 -36.08 71.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.83 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.509 ' H ' HG23 ' A' ' 28' ' ' THR . 34.5 ttpt -60.97 -58.5 8.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.85 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -64.36 -28.68 69.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.448 HD22 HD11 ' A' ' 52' ' ' ILE . 3.2 tp -61.41 -56.1 24.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.78 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.22 -37.64 87.43 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.365 -1.288 . . . . 0.0 112.11 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.7 m -57.85 -54.57 45.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.911 1.356 . . . . 0.0 107.619 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.9 t -55.96 -46.05 80.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 118.852 0.751 . . . . 0.0 111.515 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.1 mmm -58.35 -42.34 86.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 119.963 1.256 . . . . 0.0 110.229 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -54.48 -41.77 69.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.441 0.639 . . . . 0.0 110.786 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -63.6 -21.32 66.29 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.83 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 tp -73.95 -2.54 24.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.851 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.78 14.51 62.98 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.164 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -109.31 156.79 19.55 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.537 0.669 . . . . 0.0 109.518 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -119.67 65.67 9.42 Favored Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.53 145.45 76.56 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.163 1.909 . . . . 0.0 112.03 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 m -78.22 159.29 28.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.268 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -52.49 -41.84 63.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.696 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.79 -25.21 26.61 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -65.61 -39.73 91.85 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.065 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.52 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.7 mp -56.19 -41.45 75.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.327 0.585 . . . . 0.0 109.909 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -67.31 -57.35 6.81 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.071 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -54.98 -49.53 71.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.5 mmm -64.17 -51.63 62.88 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.448 HD11 HD22 ' A' ' 32' ' ' LEU . 28.5 mm -59.23 -49.58 82.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.092 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -56.66 -33.96 66.89 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -66.28 -40.35 90.02 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.786 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.479 HG21 ' CD2' ' B' 1110 ' ' PHE . 69.0 t -86.6 -20.03 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.335 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.523 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 44.0 t0 -78.68 84.61 4.76 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -175.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.62 79.6 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.842 -1.526 . . . . 0.0 114.36 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.414 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 36.1 p-10 -85.11 -2.79 58.4 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.342 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.06 22.75 60.85 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.901 -0.499 . . . . 0.0 112.316 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.414 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -86.24 3.51 42.78 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.313 0.556 . . . . 0.0 110.441 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 83.12 2.33 90.53 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 114.8 0.68 . . . . 0.0 114.8 175.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 69.0 p -147.06 165.94 28.39 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.7 mm -109.42 126.81 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -102.99 -177.25 3.32 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.838 0.352 . . . . 0.0 110.731 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.412 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -57.02 -57.71 22.72 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 9.7 Cg_endo -49.08 -50.59 12.44 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.158 1.238 . . . . 0.0 111.336 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.3 -20.78 60.58 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.279 0.562 . . . . 0.0 110.708 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -75.64 -58.31 3.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.962 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -55.74 -47.9 76.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.3 p -44.22 -48.21 9.32 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.309 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.5 mtp -65.52 -45.57 82.98 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 31.4 mmt -59.92 -40.78 90.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.6 -34.1 77.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.332 0.253 . . . . 0.0 111.538 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.8 mtp85 -95.24 -12.35 26.39 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.569 0.223 . . . . 0.0 111.355 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.84 68.54 7.14 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 110.481 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 21.5 mmt -108.69 15.47 23.64 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.684 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -52.82 129.78 31.03 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.535 0.683 . . . . 0.0 111.6 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 79' ' ' THR . 61.6 t0 -105.57 146.35 29.76 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.694 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.521 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 75.3 p -132.81 133.97 44.07 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 82' ' ' GLU . 1.1 p30 -61.12 115.95 4.17 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 175.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 m -36.44 -19.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 80' ' ' ASP . 46.0 tp10 -70.54 -32.09 69.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.941 0.401 . . . . 0.0 111.513 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -51.16 -41.12 59.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.668 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 37.0 tp10 -83.96 -17.45 40.58 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 111.872 -178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.6 mm -59.21 -73.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.46 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -58.57 -55.87 29.44 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.47 ' CD ' ' N ' ' A' ' 88' ' ' ALA . 3.1 pp20? -52.83 -36.36 58.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.297 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -60.71 -23.49 64.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.812 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -72.37 -48.84 38.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.24 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -54.79 -41.55 70.71 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.896 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.25 -45.06 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.745 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.525 ' CE2' HG21 ' A' ' 108' ' ' VAL . 9.5 m-85 -70.02 -38.55 75.94 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.349 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.517 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 31.6 t0 -88.69 82.48 6.84 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 176.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.503 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 65.2 tttm -58.46 -48.42 80.8 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 40.2 p-10 -90.65 4.88 50.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.664 0.269 . . . . 0.0 111.652 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.2 47.52 49.53 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.716 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -90.61 5.98 45.68 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 122.35 0.26 . . . . 0.0 110.742 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.459 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 85.11 0.96 88.76 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.716 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 74.1 m-85 -139.22 152.29 47.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.611 0.72 . . . . 0.0 111.708 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.6 mt -94.51 117.72 38.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 t -91.06 150.12 21.55 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.49 -45.96 76.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 119.159 0.891 . . . . 0.0 110.481 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.44 62.67 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.892 0.377 . . . . 0.0 110.745 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.503 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.1 mt-10 -65.84 -40.59 91.88 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.227 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.3 tp -62.93 -46.14 89.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.216 0.531 . . . . 0.0 110.543 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -43.54 -43.11 5.36 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.573 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -64.96 -30.81 71.82 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.646 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.525 HG21 ' CE2' ' A' ' 92' ' ' PHE . 93.6 t -56.99 -41.8 77.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.643 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.628 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -50.6 -44.43 57.02 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.786 0.803 . . . . 0.0 111.276 -178.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 m -57.2 -41.29 79.12 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 114.046 -1.434 . . . . 0.0 111.013 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -65.96 -41.31 91.38 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.564 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.1 mt -81.52 -13.81 57.67 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.8 31.98 57.61 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.556 -1.136 . . . . 0.0 110.401 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -85.44 -21.51 28.72 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.628 2.214 . . . . 0.0 111.744 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt 43.27 61.05 2.32 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.892 0.854 . . . . 0.0 109.948 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.453 HD12 ' CG ' ' A' ' 109' ' ' MET . 87.7 mt -81.51 147.72 29.54 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.404 -1.726 . . . . 0.0 112.317 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 121' ' ' VAL . 65.3 p -82.48 175.74 9.97 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.839 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -57.75 -46.44 84.5 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -55.98 -48.58 75.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.983 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -71.66 -30.85 66.17 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.288 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 117' ' ' THR . 39.0 t -63.51 -41.4 92.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.522 0.677 . . . . 0.0 109.408 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -72.64 -33.26 66.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.78 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.42 -50.98 71.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.684 ' CE ' HD21 ' B' 1092 ' ' LEU . 76.3 mtp -52.85 -48.07 67.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.641 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.8 mm -57.76 -43.48 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.882 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -62.17 -35.3 78.39 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.808 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -57.06 -41.02 77.98 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.42 -11.66 29.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.791 0.329 . . . . 0.0 111.358 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.2 t0 -75.12 89.1 2.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.507 0.67 . . . . 0.0 111.855 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.77 -18.36 20.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.596 -1.184 . . . . 0.0 113.105 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.461 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.3 p-10 -140.32 145.73 37.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 112.781 -2.009 . . . . 0.0 108.678 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.96 52.2 1.65 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.696 -0.288 . . . . 0.0 113.031 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -90.72 -9.48 46.56 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.978 0.389 . . . . 0.0 110.089 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.74 1.49 72.3 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.957 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -135.5 154.19 51.49 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.127 0.463 . . . . 0.0 110.471 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.44 118.37 47.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.175 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -83.84 173.26 11.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 0.0 111.093 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -61.35 -40.85 95.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.046 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -61.76 -44.41 96.95 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.744 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.81 -39.71 94.02 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.58 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.565 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 92.1 t80 -61.3 -46.44 90.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.976 0.417 . . . . 0.0 111.175 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.48 -46.65 92.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.383 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -49.54 -47.62 48.92 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.714 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 88.2 mmm -71.22 -35.2 71.42 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.565 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.7 mtt -79.56 -46.97 16.32 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.737 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . 0.75 HD23 ' N ' ' B' 1093 ' ' TRP . 0.9 OUTLIER . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . 0.75 ' N ' HD23 ' B' 1092 ' ' LEU . 2.3 m95 -55.31 -62.25 1.8 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.358 0.599 . . . . 0.0 110.864 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 51.6 t80 -56.51 -44.24 80.54 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 61.9 ttt85 -39.94 -53.47 2.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -60.27 -39.95 96.74 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 48.0 tp -56.6 -44.12 80.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 118.494 1.147 . . . . 0.0 109.73 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 46.4 t30 -57.66 -47.61 81.8 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -63.96 -38.15 90.03 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.04 -42.27 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.638 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -51.41 -46.27 62.85 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.628 -1.229 . . . . 0.0 107.874 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.518 ' O ' ' N ' ' B' 1105 ' ' LYS . 96.1 m -62.37 -48.38 80.01 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.59 -0.444 . . . . 0.0 112.047 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.432 ' C ' ' O ' ' B' 1102 ' ' THR . 84.8 mt-30 -27.98 -59.22 0.11 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.591 1.186 . . . . 0.0 112.66 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . 0.402 HG21 HD13 ' B' 1104 ' ' ILE . 2.0 mt -81.52 -14.34 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 112.711 -2.041 . . . . 0.0 112.089 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' 1102 ' ' THR . 64.0 tttp -58.92 -45.95 89.13 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 118.087 -1.445 . . . . 0.0 108.179 176.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.3 t -60.57 -49.73 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.06 -36.56 78.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.116 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 88.9 mttt -49.09 -37.08 20.37 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.739 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.44 63.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.287 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . 0.479 ' CD2' HG21 ' A' ' 55' ' ' VAL . 44.3 m-85 -62.92 -49.45 74.73 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 70.0 m-70 . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.454 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 4' ' ' LEU . 1.9 pt? . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.7 p -77.2 140.14 40.07 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.865 0.757 . . . . 0.0 110.827 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.1 tt0 -48.73 -60.98 2.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 122.108 0.956 . . . . 0.0 110.497 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 81.1 tt0 -34.61 -37.01 0.05 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.998 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -69.86 -35.78 74.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.403 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.8 mm -59.71 -44.6 94.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 175.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.51 -49.96 63.76 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.282 -177.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -63.1 -44.84 94.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.507 0.67 . . . . 0.0 112.332 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.8 m-85 -63.28 -39.28 94.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.887 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -52.51 -54.02 38.14 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.357 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -50.78 -41.63 57.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.162 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -54.79 -39.13 68.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.137 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.445 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 3.0 m-85 -57.7 -41.29 81.4 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.3 p -64.55 -15.91 61.73 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.402 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.586 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -64.65 -42.3 95.51 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.79 -178.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -105.95 -14.14 15.28 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -72.72 94.0 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.344 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -67.71 -49.65 61.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.722 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 23' ' ' GLY . 48.2 p-10 -102.72 15.78 28.35 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.88 45.19 0.54 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.132 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -86.01 -4.24 59.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.83 0.347 . . . . 0.0 111.062 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.05 -1.58 80.5 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.3 p -138.01 152.95 49.38 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.17 0.509 . . . . 0.0 110.043 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.69 124.08 44.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.0 p -113.19 163.51 14.68 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.941 0.776 . . . . 0.0 112.559 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.1 p -58.24 -37.11 74.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.884 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.57 -62.09 2.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.185 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -60.58 -29.89 69.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.668 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.461 HD22 HD11 ' A' ' 52' ' ' ILE . 3.1 tp -61.07 -55.02 37.47 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.026 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.87 -40.32 95.06 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.401 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.11 -54.65 44.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 118.884 1.342 . . . . 0.0 108.423 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.9 t -56.76 -46.78 83.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 118.889 0.768 . . . . 0.0 111.841 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.2 ttt -58.63 -41.5 86.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 120.065 1.302 . . . . 0.0 109.964 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -51.78 -38.28 54.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.512 0.673 . . . . 0.0 110.296 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 t -62.59 -20.58 64.86 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.949 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -74.08 -0.4 16.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.897 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.44 14.56 70.77 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.116 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -107.47 158.5 17.15 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 117.484 0.642 . . . . 0.0 109.992 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -116.1 65.83 2.88 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.272 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.75 144.03 87.96 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.182 1.921 . . . . 0.0 112.111 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.5 t -80.42 165.45 22.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.555 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -57.9 -44.94 87.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.68 -23.96 31.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.586 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -65.61 -39.99 92.14 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.146 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.8 mp -55.64 -40.8 72.68 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.495 0.664 . . . . 0.0 109.799 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -71.45 -56.22 6.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.815 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -54.52 -49.23 70.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.0 mtp -67.08 -48.65 67.56 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.461 HD11 HD22 ' A' ' 32' ' ' LEU . 26.0 mm -58.47 -46.71 89.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.607 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -55.59 -35.54 65.93 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -66.62 -40.3 88.72 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.146 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' B' 1110 ' ' PHE . 59.4 t -85.58 -20.97 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.39 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.446 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.3 t0 -79.63 84.3 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -175.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.81 -37.1 80.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.64 -1.618 . . . . 0.0 114.319 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -86.57 -2.04 58.16 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.53 23.04 60.03 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 118.44 0.563 . . . . 0.0 112.473 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -87.65 3.81 46.36 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.44 0.62 . . . . 0.0 110.515 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.446 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.72 1.41 89.05 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 175.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.0 p -148.42 168.86 21.55 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.8 mt -113.48 128.79 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 5.9 p30 -103.61 -175.97 2.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.867 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.445 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.16 -47.63 98.49 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.738 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -55.72 -52.06 8.36 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.287 1.325 . . . . 0.0 111.84 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.22 -19.59 61.82 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.506 0.669 . . . . 0.0 110.533 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -75.52 -59.33 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.352 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.5 mt -56.46 -45.16 81.02 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.8 p -45.24 -47.49 12.77 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.404 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 33.6 mtp -67.68 -46.81 71.23 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.6 mmm -61.75 -39.89 93.17 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.64 -34.21 77.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.373 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -94.95 -12.44 26.76 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.441 ' C ' ' SD ' ' A' ' 76' ' ' MET . 3.9 tptt -81.9 67.02 7.72 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.016 0.436 . . . . 0.0 110.237 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.524 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -106.98 17.52 22.97 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.34 179.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -49.79 132.39 22.15 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.508 0.67 . . . . 0.0 111.41 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -92.51 108.12 19.73 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.107 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.0 m -93.5 121.29 34.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 82' ' ' GLU . 30.4 m-20 -69.42 113.19 6.51 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.4 m -37.78 -19.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.796 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 80' ' ' ASP . 83.2 tt0 -67.01 -41.05 87.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.863 0.363 . . . . 0.0 111.217 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -56.95 -40.75 77.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.724 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.56 ' O ' ' N ' ' A' ' 87' ' ' GLU . 51.0 tp10 -72.3 -80.52 0.06 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.655 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.614 HD12 ' N ' ' A' ' 86' ' ' ARG . 1.9 pp -20.56 -60.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 123.684 0.615 . . . . 0.0 111.319 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.614 ' N ' HD12 ' A' ' 85' ' ' ILE . 9.1 ptm180 -60.76 -42.21 96.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.581 ' CD ' HH21 ' A' ' 90' ' ' ARG . 40.3 mm-40 -61.84 -40.07 94.01 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.939 0.399 . . . . 0.0 111.092 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -17.58 62.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.856 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -71.43 -52.79 16.59 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.735 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.581 HH21 ' CD ' ' A' ' 87' ' ' GLU . 78.9 mtm-85 -55.53 -40.63 72.08 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.874 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.62 -42.92 90.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.527 ' CE2' HG21 ' A' ' 108' ' ' VAL . 4.8 m-85 -68.01 -37.91 81.97 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.417 -178.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -89.34 83.7 6.43 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.43 -46.39 90.2 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -91.5 4.55 52.27 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.386 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.39 49.9 37.07 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.19 6.7 41.59 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.77 0.55 89.85 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.669 -0.573 . . . . 0.0 111.669 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -139.5 151.92 46.55 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.615 0.722 . . . . 0.0 111.736 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.3 mt -95.9 117.5 40.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 m -91.32 152.81 20.31 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.19 80.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.412 1.005 . . . . 0.0 110.848 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.56 -40.52 62.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 110.676 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -65.33 -42.64 92.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.222 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 108' ' ' VAL . 21.2 mt -63.03 -45.15 93.68 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.29 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -41.53 -45.45 3.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.746 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -59.78 -26.11 65.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.798 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.527 HG21 ' CE2' ' A' ' 92' ' ' PHE . 63.4 t -58.33 -43.1 85.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.895 -178.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.44 ' SD ' HD12 ' A' ' 116' ' ' LEU . 8.3 mmt -51.15 -45.54 61.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.065 0.936 . . . . 0.0 111.098 -177.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.0 p -57.92 -38.61 76.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.085 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -40.55 81.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.493 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 70.3 mt -81.32 -13.68 58.14 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.29 29.59 59.98 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.393 -1.226 . . . . 0.0 110.15 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -85.87 -22.62 27.45 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.779 2.29 . . . . 0.0 111.005 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm 44.77 61.81 2.33 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.222 1.01 . . . . 0.0 109.862 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.44 HD12 ' SD ' ' A' ' 109' ' ' MET . 78.1 mt -80.65 147.0 30.86 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.472 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 121' ' ' VAL . 30.8 p -81.95 175.54 10.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.614 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -57.15 -44.87 83.83 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.28 -48.26 79.34 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -72.75 -30.65 64.33 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.103 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 117' ' ' THR . 42.7 t -64.99 -43.22 96.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -69.15 -35.02 75.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.214 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -59.72 -47.57 85.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.059 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 15.8 mmm -55.18 -45.12 75.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.62 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 40.1 mm -58.14 -44.1 86.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.446 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -58.91 -39.57 81.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.746 0.308 . . . . 0.0 111.132 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.99 -41.68 83.52 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.52 -23.1 21.02 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.7 t0 -72.42 87.97 1.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.485 0.66 . . . . 0.0 112.098 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.69 -15.26 19.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.945 1.355 . . . . 0.0 113.265 -178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 37.6 p-10 -141.68 145.0 34.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.214 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.06 52.31 1.7 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.551 -0.357 . . . . 0.0 113.385 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -91.32 -8.76 47.26 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.182 0.491 . . . . 0.0 110.108 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.04 2.54 78.39 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.118 -0.563 . . . . 0.0 114.21 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -134.99 153.87 51.93 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 117.19 0.495 . . . . 0.0 110.551 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.7 118.57 47.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.321 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -83.65 173.0 11.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.06 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -61.8 -39.74 92.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.022 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -61.57 -44.68 96.58 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.621 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.11 -37.76 88.61 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.436 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -61.07 -44.94 96.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.701 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.05 -47.77 86.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.371 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -50.24 -44.35 53.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.171 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.4 mmt -73.33 -38.94 65.61 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 22.4 mmt -75.66 -46.92 28.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.911 -0.131 . . . . 0.0 111.021 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.47 0.538 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.564 -179.299 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.51 -53.69 53.1 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.451 0.643 . . . . 0.0 112.111 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 53.8 t80 -58.02 -46.06 85.89 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -174.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -40.69 -52.33 2.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.23 -41.83 99.72 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.084 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.2 tp -55.93 -46.3 78.51 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.446 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 41.2 t30 -58.01 -48.31 80.42 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -64.96 -38.11 89.89 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 87.5 mt -60.91 -42.6 93.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.802 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -50.96 -44.99 60.68 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.514 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.4 m -63.0 -48.28 79.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.92 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.424 ' C ' ' O ' ' B' 1102 ' ' THR . 84.4 mt-30 -28.01 -58.64 0.11 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.805 1.288 . . . . 0.0 112.929 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -82.74 -15.4 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 112.25 -2.25 . . . . 0.0 111.985 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.514 ' N ' ' O ' ' B' 1102 ' ' THR . 88.8 tttt -58.8 -45.92 88.79 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 117.989 -1.484 . . . . 0.0 107.89 176.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.5 t -60.85 -49.06 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.57 -36.84 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.091 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 90.5 mttt -49.74 -37.16 28.25 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.512 0.672 . . . . 0.0 109.661 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.03 -45.53 64.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.285 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . 0.46 ' CE2' HG21 ' A' ' 55' ' ' VAL . 49.3 m-85 -63.13 -50.44 70.44 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 83.9 m-70 . . . . . 0 C--N 1.329 -0.293 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.141 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 119.573 -0.251 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.7 p -79.97 138.62 37.11 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.997 0.817 . . . . 0.0 110.523 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 9' ' ' ILE . 27.1 mm-40 -49.17 -58.1 5.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 122.099 0.952 . . . . 0.0 110.788 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -35.64 -37.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 113.352 -1.749 . . . . 0.0 110.611 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -70.19 -37.18 75.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.468 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.1 mt -59.76 -46.04 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.41 -48.63 62.58 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.51 -177.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.04 -44.36 92.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.551 0.691 . . . . 0.0 112.299 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.456 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.5 m-85 -63.19 -39.99 96.22 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.862 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -50.22 -53.67 26.45 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.572 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -51.85 -39.2 58.5 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.174 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.35 -39.91 73.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.379 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -55.55 -42.05 74.12 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.9 t -64.05 -16.54 61.92 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.381 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.613 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -63.67 -43.44 96.68 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -104.67 -15.13 15.36 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.602 -178.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -77.7 93.13 4.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.361 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -66.75 -46.83 74.15 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.706 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -101.7 15.15 29.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.24 50.48 3.65 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.732 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -89.43 -5.55 57.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.171 0.486 . . . . 0.0 111.898 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.12 0.69 73.69 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.849 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.469 HG22 ' OD1' ' A' ' 64' ' ' ASP . 31.7 p -141.25 159.76 41.54 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.971 0.415 . . . . 0.0 110.07 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.2 mt -92.32 126.19 44.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.419 ' OG1' ' OE1' ' A' ' 31' ' ' GLU . 19.1 p -111.78 162.65 15.03 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.044 0.84 . . . . 0.0 112.256 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 p -60.36 -37.97 82.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.87 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.43 -58.88 6.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.464 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.419 ' OE1' ' OG1' ' A' ' 28' ' ' THR . 10.1 pt-20 -63.38 -29.52 70.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.625 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.48 HD22 HD11 ' A' ' 52' ' ' ILE . 3.5 tp -61.08 -52.5 64.64 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.3 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.99 -38.09 94.93 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.938 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.2 m -58.76 -54.15 50.36 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.731 1.265 . . . . 0.0 108.593 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.79 -46.06 87.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 121.058 -1.026 . . . . 0.0 111.513 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.3 tpt -59.31 -40.33 85.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 119.914 1.234 . . . . 0.0 109.531 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -53.35 -41.56 65.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.307 0.575 . . . . 0.0 110.251 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.6 p -63.71 -21.47 66.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.157 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.42 -4.09 31.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.61 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.01 60.74 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.032 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -106.68 155.12 20.0 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.642 0.721 . . . . 0.0 110.094 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 26.1 t-20 -116.46 62.85 2.58 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.37 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.25 145.7 93.37 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.265 1.977 . . . . 0.0 112.204 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.7 p -80.36 167.73 19.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.565 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -58.24 -44.06 88.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.805 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.7 -24.09 32.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.502 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -65.49 -38.6 90.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.016 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.8 mp -57.25 -42.26 81.17 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.311 0.577 . . . . 0.0 109.882 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -69.16 -56.48 7.53 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.383 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -55.32 -48.98 73.33 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.9 mmm -65.39 -51.68 58.71 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.48 HD11 HD22 ' A' ' 32' ' ' LEU . 28.6 mm -59.63 -48.9 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.777 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -57.82 -33.47 68.64 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.85 -39.84 94.2 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.53 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.21 -17.73 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.265 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.45 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.37 85.55 4.48 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -174.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.02 88.39 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 113.427 -1.715 . . . . 0.0 113.728 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.1 p-10 -85.6 -3.06 58.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.82 23.82 61.68 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.886 -0.509 . . . . 0.0 112.937 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.433 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.6 p-10 -87.56 3.76 46.26 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.174 0.487 . . . . 0.0 110.26 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.45 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.09 0.54 88.84 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.893 -0.67 . . . . 0.0 114.214 175.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.6 p -149.13 170.38 18.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.0 mt -112.59 128.77 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.469 ' OD1' HG22 ' A' ' 26' ' ' THR . 92.1 m-20 -104.41 -173.7 2.37 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.433 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.419 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -58.7 -46.11 99.59 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.412 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 35.3 Cg_exo -56.06 -53.39 5.51 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.465 1.443 . . . . 0.0 111.21 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.41 -22.08 66.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.15 0.5 . . . . 0.0 111.161 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.61 -61.41 1.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.9 mt -57.78 -43.83 85.84 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.3 m -40.74 -58.3 1.68 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.943 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -65.66 -41.42 92.55 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.983 -176.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 97.2 mmm -58.94 -41.24 86.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.26 77.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.352 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -93.93 -13.99 26.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.657 0.265 . . . . 0.0 111.239 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.42 ' C ' ' SD ' ' A' ' 76' ' ' MET . 0.1 OUTLIER -80.84 66.65 6.44 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.206 0.527 . . . . 0.0 110.591 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -108.37 15.61 23.83 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.441 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -49.62 134.59 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.245 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.84 108.62 19.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.156 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.9 m -93.33 121.32 34.59 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 82' ' ' GLU . 97.7 m-20 -68.63 112.3 5.32 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.9 m -37.49 -22.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.528 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.9 mp0 -69.43 -35.78 76.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.77 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -48.25 -35.84 12.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.257 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 84' ' ' GLU . 2.4 mp0 -90.95 -16.54 27.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 85' ' ' ILE . 26.0 mm -59.99 -74.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.566 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -61.83 -41.2 97.51 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -62.53 -38.92 91.86 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.249 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.63 -20.74 65.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.998 0.427 . . . . 0.0 111.078 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -70.61 -49.93 42.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.053 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -54.85 -41.62 70.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.535 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.57 -43.82 94.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.3 m-85 -68.38 -39.68 81.68 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.188 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.492 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 27.1 t0 -87.15 83.54 7.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.511 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 88.6 tttt -58.04 -49.61 76.27 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 35.1 p-10 -91.88 4.51 52.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.696 0.284 . . . . 0.0 111.608 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.56 49.29 53.19 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.727 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -90.61 5.24 48.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.793 0.33 . . . . 0.0 110.83 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.481 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 84.98 2.0 88.56 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.727 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 88.1 m-85 -140.01 152.88 46.62 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.611 0.719 . . . . 0.0 111.506 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.3 mt -94.04 115.31 32.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 t -89.07 150.93 22.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.634 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.32 83.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.981 0.81 . . . . 0.0 110.646 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.74 -39.59 65.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.862 0.363 . . . . 0.0 110.443 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.511 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.2 mt-10 -66.64 -41.18 88.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.338 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.09 -45.71 90.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.456 0.646 . . . . 0.0 110.997 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -44.23 -43.18 7.06 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.422 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -65.49 -28.62 69.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.51 0.195 . . . . 0.0 111.236 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.524 HG21 ' CE2' ' A' ' 92' ' ' PHE . 96.1 t -58.21 -42.46 83.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.573 -177.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.709 ' SD ' HD12 ' A' ' 116' ' ' LEU . 36.8 mmt -51.34 -43.22 61.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.82 0.819 . . . . 0.0 111.107 -177.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 m -57.93 -41.68 83.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.763 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -42.32 82.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.681 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.58 -15.85 56.93 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.475 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.1 28.7 59.91 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -84.43 -22.49 30.36 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.625 2.213 . . . . 0.0 110.59 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 43.07 58.68 3.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.804 0.811 . . . . 0.0 110.301 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.709 HD12 ' SD ' ' A' ' 109' ' ' MET . 50.9 mt -79.52 149.15 31.55 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.679 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 121' ' ' VAL . 70.2 p -82.71 175.29 10.25 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.5 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -58.14 -44.17 87.69 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.47 -49.44 76.28 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.61 -30.68 67.41 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.88 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 117' ' ' THR . 39.5 t -63.51 -42.41 96.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.29 -35.66 73.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.335 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -59.74 -50.89 72.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 90.5 mtp -57.12 -43.52 82.41 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.137 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.38 -44.18 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.286 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -59.57 -38.82 82.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.033 0.444 . . . . 0.0 111.208 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -57.23 -40.45 77.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.848 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.58 -20.09 22.04 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.1 t0 -75.36 86.1 2.52 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.389 0.614 . . . . 0.0 111.916 -177.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 130' ' ' ILE . 25.6 pt -71.87 -12.08 15.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.275 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 40.6 p-10 -140.67 142.09 34.95 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 112.504 -2.135 . . . . 0.0 108.771 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.69 52.09 1.55 Allowed Glycine 0 CA--C 1.53 1.012 0 CA-C-O 120.269 -0.184 . . . . 0.0 113.472 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -91.17 -7.92 50.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.281 0.54 . . . . 0.0 110.139 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.68 1.3 66.04 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.131 -0.557 . . . . 0.0 114.296 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -135.01 153.66 52.0 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.426 0.613 . . . . 0.0 110.478 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 51.3 t -100.74 118.54 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.451 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -84.2 174.87 9.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -61.84 -40.85 96.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.133 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.39 -44.82 95.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.891 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -63.91 -38.49 91.29 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.461 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -60.22 -45.54 92.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.594 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.57 -47.95 84.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.269 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.71 -46.7 59.07 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.316 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.404 ' O ' ' CE1' ' B' 1094 ' ' PHE . 11.8 mmt -72.08 -39.44 68.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.8 mmt -77.03 -46.58 23.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.391 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.47 0.539 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.94 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.1 m95 -59.44 -62.67 1.71 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.333 0.587 . . . . 0.0 112.199 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 144' ' ' MET . 40.1 m-85 -57.71 -42.6 84.1 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -174.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -40.6 -51.51 2.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.602 0.715 . . . . 0.0 112.664 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.36 -41.83 99.74 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.79 -46.32 81.62 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.563 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -59.61 -48.15 82.78 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 24.0 mtp-105 -65.49 -38.08 88.69 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.605 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.98 -42.18 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.884 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -51.12 -46.53 61.95 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.51 ' O ' ' N ' ' B' 1105 ' ' LYS . 99.1 m -63.83 -47.88 79.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.609 -0.436 . . . . 0.0 112.002 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.427 ' C ' ' O ' ' B' 1102 ' ' THR . 84.0 mt-30 -28.24 -57.53 0.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.538 1.161 . . . . 0.0 112.435 -176.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -84.58 -15.5 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 112.202 -2.272 . . . . 0.0 112.449 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.51 ' N ' ' O ' ' B' 1102 ' ' THR . 88.6 tttt -60.24 -46.55 89.4 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 118.077 -1.449 . . . . 0.0 107.951 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 57.7 t -61.89 -48.72 87.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.61 -36.27 77.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.774 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 87.4 mttt -49.54 -36.04 22.24 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 119.919 -0.713 . . . . 0.0 109.488 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.57 -45.65 70.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.059 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -62.49 -50.51 71.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.109 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 58.9 m-70 . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.343 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 118.976 -0.535 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.2 p -76.92 139.73 40.29 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 119.934 1.243 . . . . 0.0 110.35 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.688 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -50.78 -47.99 59.53 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.391 1.091 . . . . 0.0 110.653 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.449 ' OE2' ' OE2' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -38.21 -38.87 0.37 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.884 -179.007 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -68.35 -38.96 81.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.469 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.3 mt -59.76 -44.6 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 175.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.0 -49.17 63.86 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.094 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.449 ' OE2' ' OE2' ' A' ' 7' ' ' GLU . 98.4 mt-10 -60.46 -47.56 85.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 111.748 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -59.0 -42.12 89.32 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.866 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -50.42 -57.31 8.29 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.396 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -51.18 -44.72 61.58 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.847 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.72 -37.79 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.218 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.44 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 2.6 m-85 -58.44 -40.38 82.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.2 p -65.2 -15.56 62.59 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.456 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.7 -42.13 95.51 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -105.61 -13.99 15.42 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -71.92 93.91 1.39 Allowed 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.472 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -67.41 -49.64 62.89 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.833 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.1 p30 -103.62 14.88 30.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.16 44.79 0.82 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.164 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 31.0 p-10 -85.02 -3.17 58.69 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.729 0.299 . . . . 0.0 110.89 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 -0.83 78.87 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 t -140.48 154.9 46.77 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.15 0.5 . . . . 0.0 110.097 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 27' ' ' ILE . 3.8 mp -91.41 123.96 43.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.4 p -111.77 162.98 14.66 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.853 0.835 . . . . 0.0 112.064 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.7 p -59.93 -37.57 79.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.629 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -60.47 -57.01 14.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.472 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -64.31 -28.71 69.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.479 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.498 HD22 HD11 ' A' ' 52' ' ' ILE . 3.0 tp -60.8 -53.42 57.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.062 0.934 . . . . 0.0 109.765 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.3 -37.48 94.11 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.124 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -58.81 -52.8 64.15 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.777 1.288 . . . . 0.0 108.813 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.93 -45.03 87.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 119.404 1.002 . . . . 0.0 111.278 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.7 tpt -59.07 -38.73 80.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 120.028 1.285 . . . . 0.0 109.555 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -51.46 -38.36 53.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.65 0.738 . . . . 0.0 110.457 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.9 p -63.13 -20.94 65.84 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.439 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.45 ' O ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -73.81 0.79 12.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.77 179.426 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.5 27.05 40.55 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.23 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -130.54 170.04 14.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.415 0.607 . . . . 0.0 109.923 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -133.8 76.42 65.65 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.396 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.14 147.57 95.29 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.764 2.31 . . . . 0.0 111.995 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.2 t -76.0 164.51 26.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.256 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.18 -43.75 87.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.983 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.33 -24.24 42.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.545 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.65 -38.76 90.24 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.057 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.57 -40.86 75.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.298 0.571 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -70.89 -56.38 6.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.803 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -55.25 -50.45 69.44 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.1 mmm -65.02 -51.53 61.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.498 HD11 HD22 ' A' ' 32' ' ' LEU . 30.1 mm -59.54 -48.14 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.821 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -58.37 -33.51 69.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -65.68 -39.62 91.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.215 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.31 -19.43 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.276 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.2 t0 -78.01 86.59 4.19 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -174.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.35 90.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.234 -1.803 . . . . 0.0 113.988 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -86.33 -2.76 58.69 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.0 23.66 61.88 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 118.467 0.576 . . . . 0.0 112.988 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -87.91 3.14 49.62 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.257 0.528 . . . . 0.0 110.333 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.63 0.54 87.9 Favored Glycine 0 CA--C 1.52 0.361 0 O-C-N 121.586 -0.696 . . . . 0.0 114.569 175.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.2 p -147.66 169.22 20.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.8 mt -112.79 128.51 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 23.6 t0 -103.16 -177.19 3.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.639 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.553 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -56.71 -47.94 98.12 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.3 -49.54 14.83 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.215 1.277 . . . . 0.0 111.889 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.21 -19.63 64.69 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.476 0.655 . . . . 0.0 110.927 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -74.43 -59.63 2.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.752 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.47 -43.44 79.59 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.0 m -45.59 -48.47 14.53 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.607 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.8 mtm -67.09 -45.59 76.8 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.0 mmm -61.4 -39.2 89.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.02 79.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.644 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -93.6 -14.56 26.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.572 0.225 . . . . 0.0 111.304 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' O ' ' NZ ' ' B' 1105 ' ' LYS . 0.0 OUTLIER -83.1 64.64 7.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.218 0.532 . . . . 0.0 110.49 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.3 mmt -107.5 16.53 23.72 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.801 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -38.7 141.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.357 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.54 -70.43 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.831 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.5 m 58.99 77.27 0.31 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.8 m-20 -57.61 126.0 25.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.3 m -38.99 -18.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.835 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 80' ' ' ASP . 72.4 mm-40 -68.38 -36.38 79.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.936 0.398 . . . . 0.0 111.757 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -51.37 -39.25 56.73 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.418 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 12.3 pt-20 -86.12 -4.33 59.15 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.3 mm -69.56 -73.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.883 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -60.29 -51.96 67.31 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 88' ' ' ALA . 3.1 pp20? -55.35 -37.6 67.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.007 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -60.51 -22.31 63.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.932 0.396 . . . . 0.0 110.902 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -73.76 -48.61 30.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.304 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -55.29 -42.27 73.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.587 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.13 -44.75 97.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.421 ' CE2' HG21 ' A' ' 108' ' ' VAL . 8.3 m-85 -69.33 -39.07 78.4 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.456 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.523 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 27.9 t0 -88.29 83.49 6.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.17 -48.67 80.75 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -90.9 5.06 50.14 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.66 0.267 . . . . 0.0 111.631 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.76 48.42 50.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.733 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -91.43 4.61 52.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.567 0.223 . . . . 0.0 110.697 179.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.471 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 86.21 0.89 86.71 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.733 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 90.5 m-85 -139.19 152.28 47.26 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.838 0.827 . . . . 0.0 111.622 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -94.12 115.57 33.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.3 t -88.46 150.52 23.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.555 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.33 -45.79 83.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 119.167 0.894 . . . . 0.0 110.741 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.89 -40.86 66.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.984 0.421 . . . . 0.0 110.588 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -65.3 -41.35 94.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.956 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.402 ' CD2' HD11 ' A' ' 125' ' ' ILE . 59.4 tp -63.71 -44.36 93.86 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.605 0.716 . . . . 0.0 111.207 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -45.7 -44.6 13.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.499 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -62.35 -29.0 70.15 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.605 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.421 HG21 ' CE2' ' A' ' 92' ' ' PHE . 84.6 t -58.32 -41.24 80.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.87 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.626 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.59 -46.54 63.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.179 0.99 . . . . 0.0 111.446 -177.214 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -56.97 -41.42 78.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.442 -1.708 . . . . 0.0 110.675 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -65.2 -40.8 94.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.768 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.535 ' O ' ' NH1' ' B' 1099 ' ' ARG . 76.6 mt -81.5 -14.5 56.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.788 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.11 30.33 57.4 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.566 -1.13 . . . . 0.0 110.366 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -86.49 -22.86 26.19 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.749 2.275 . . . . 0.0 110.75 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 43.43 60.83 2.44 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 122.31 1.052 . . . . 0.0 110.089 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.8 mt -79.06 148.22 32.53 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 113.417 -1.719 . . . . 0.0 112.637 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 121' ' ' VAL . 62.2 p -82.46 174.99 10.57 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.383 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -57.83 -44.53 86.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -57.84 -50.67 72.51 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.56 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -68.3 -30.79 69.87 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.826 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 117' ' ' THR . 47.5 t -64.18 -42.46 95.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.396 0.617 . . . . 0.0 109.342 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 67.8 t0 -67.03 -37.77 84.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.722 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.28 -48.01 83.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.449 ' SD ' ' CD1' ' B' 1093 ' ' TRP . 20.2 mmm -54.96 -45.69 74.97 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.808 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 105' ' ' LEU . 46.5 mm -59.62 -44.88 94.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.35 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -58.37 -40.11 81.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.371 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.69 -41.0 76.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.073 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.445 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -92.67 -16.99 24.86 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.5 t0 -73.41 87.97 1.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.457 0.646 . . . . 0.0 112.076 -177.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 tt -70.78 -14.79 18.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.531 1.158 . . . . 0.0 113.241 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.5 p-10 -142.9 144.6 32.5 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.31 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.53 52.49 1.16 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.709 -0.282 . . . . 0.0 113.175 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -91.14 -9.97 43.59 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.098 0.449 . . . . 0.0 110.119 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.66 2.09 74.31 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.162 -0.542 . . . . 0.0 114.293 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -134.57 154.27 51.56 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.413 0.607 . . . . 0.0 110.435 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.49 118.51 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.272 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.459 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 46.8 t30 -85.17 175.24 9.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.917 0.389 . . . . 0.0 110.962 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.459 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 74.2 t80 -61.59 -41.02 96.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.492 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 13.1 pt-20 -62.23 -44.45 96.53 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.839 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 139' ' ' GLU . 96.8 mt-10 -64.39 -37.66 88.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.892 0.377 . . . . 0.0 110.566 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -61.12 -45.63 93.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.594 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.65 -47.79 84.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.681 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -47.27 -50.04 22.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.115 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.445 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 91.7 mmm -70.04 -35.47 74.32 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -176.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.452 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 22.7 mmt -71.79 -43.21 66.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.861 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.628 -179.161 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . 0.449 ' CD1' ' SD ' ' A' ' 124' ' ' MET . 5.5 m95 -60.95 -57.5 12.36 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.587 0.708 . . . . 0.0 112.095 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . 0.452 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 17.5 m-85 -57.61 -43.99 85.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -40.05 -51.98 2.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.11 99.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.371 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.9 tp -57.23 -44.86 84.18 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.507 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 16.1 m120 -59.17 -47.32 85.74 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.691 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . 0.535 ' NH1' ' O ' ' A' ' 112' ' ' LEU . 79.5 mtp180 -65.16 -37.94 88.99 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 4.0 mm -60.58 -41.86 89.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.436 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . 0.462 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 81.8 mt-30 -52.0 -49.28 63.64 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.468 ' O ' ' N ' ' B' 1105 ' ' LYS . 21.3 m -64.98 -47.81 76.23 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.415 ' C ' ' O ' ' B' 1102 ' ' THR . 36.6 mm-40 -28.18 -59.86 0.12 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.758 1.266 . . . . 0.0 112.324 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.5 mt -83.94 -15.9 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 111.716 -2.493 . . . . 0.0 112.471 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 75' ' ' LYS . 66.1 tttm -59.39 -44.41 92.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.009 -1.477 . . . . 0.0 107.838 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 61.6 t -61.49 -48.98 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -66.36 -36.89 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.161 -177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.6 mttt -49.77 -38.11 32.68 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.661 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.03 62.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.27 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -63.35 -50.0 71.69 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 68.7 m-70 . . . . . 0 C--N 1.327 -0.399 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -178.264 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 119.003 -0.522 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -80.02 135.4 36.36 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.512 1.051 . . . . 0.0 110.055 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.8 tt0 -51.04 -60.2 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.029 0.918 . . . . 0.0 111.373 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 44.7 tp10 -34.55 -38.03 0.07 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.933 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -70.35 -31.63 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.647 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.2 mt -57.22 -44.09 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 121.922 2.146 . . . . 0.0 105.355 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -53.55 -51.61 62.37 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.286 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -62.29 -46.48 88.6 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.411 0.624 . . . . 0.0 112.312 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.42 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 10.0 m-85 -61.68 -40.67 95.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.9 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -52.19 -56.15 16.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.235 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -48.7 -42.69 35.73 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.102 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.36 -37.32 69.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.201 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.0 m-85 -56.42 -40.79 75.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -65.9 -15.61 63.1 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.428 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.34 -43.26 98.22 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.427 ' CZ ' ' HA ' ' A' ' 16' ' ' PHE . 0.9 OUTLIER -106.41 -14.51 15.06 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.871 -178.685 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -75.37 96.11 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.252 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -67.96 -48.13 66.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.229 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.2 p-10 -102.89 14.48 31.86 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.96 48.72 1.41 Allowed Glycine 0 N--CA 1.468 0.83 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.091 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 36.1 p-10 -86.49 -4.77 59.22 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.71 0.29 . . . . 0.0 111.237 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.51 -1.55 79.25 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.8 p -139.41 156.11 47.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.22 0.534 . . . . 0.0 109.732 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -93.02 124.34 45.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.522 HG23 ' H ' ' A' ' 30' ' ' LYS . 1.2 t -115.0 165.52 12.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.8 -177.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.0 p -58.04 -39.52 78.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.439 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.522 ' H ' HG23 ' A' ' 28' ' ' THR . 62.4 tttp -58.67 -59.93 4.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.724 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -63.11 -30.71 71.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 119.598 -0.239 . . . . 0.0 111.51 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.412 HD22 HD11 ' A' ' 52' ' ' ILE . 3.3 tp -59.73 -56.39 22.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.501 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.84 -38.96 94.79 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 113.757 -1.565 . . . . 0.0 112.037 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.5 m -58.52 -53.44 58.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.107 1.454 . . . . 0.0 108.656 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.86 -46.23 87.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 118.991 0.814 . . . . 0.0 111.457 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.0 tpt -59.45 -41.84 90.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 120.112 1.324 . . . . 0.0 109.839 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -54.21 -41.98 69.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.602 0.715 . . . . 0.0 110.27 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -64.35 -22.75 67.06 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.944 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 tp -73.04 -3.41 26.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.666 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.09 13.56 58.76 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.547 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -107.75 155.41 20.24 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.66 0.73 . . . . 0.0 109.789 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.542 HD22 ' C ' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -117.17 65.19 3.87 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.357 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.05 145.49 85.15 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.172 1.915 . . . . 0.0 112.215 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.1 p -79.86 167.25 20.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.092 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -57.8 -44.26 86.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.014 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.19 -23.15 20.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.489 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -66.79 -38.81 87.26 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.254 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.8 mp -56.08 -40.59 73.86 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -72.08 -57.08 4.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.057 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -54.13 -49.49 69.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 41.7 mmm -66.19 -52.23 50.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 52' ' ' ILE . 25.9 mm -57.92 -48.21 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.476 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -56.71 -33.97 67.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -66.45 -40.05 89.19 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.668 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.25 -20.29 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.404 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 41.1 t0 -78.01 86.85 4.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -174.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.74 86.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.377 -1.738 . . . . 0.0 114.302 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 37.7 p-10 -87.62 -2.65 58.76 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.28 23.22 64.08 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 118.632 0.651 . . . . 0.0 112.721 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.42 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -88.04 2.02 52.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.393 0.597 . . . . 0.0 110.688 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.65 0.85 87.76 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 175.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.6 p -148.62 171.39 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.8 mt -115.21 129.2 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -104.33 -173.65 2.36 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -59.68 -48.58 94.98 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -177.287 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.66 -53.22 5.97 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.183 1.255 . . . . 0.0 111.66 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.62 -16.77 41.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.594 0.711 . . . . 0.0 110.312 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -76.08 -58.17 3.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.16 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' THR . 77.4 mt -56.99 -45.36 83.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.2 p -44.07 -49.76 8.69 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.459 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.4 mtm -67.55 -45.43 75.68 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.4 mmt -58.45 -38.78 78.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.95 76.62 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.683 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -94.87 -11.19 29.22 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.8 0.333 . . . . 0.0 111.453 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.45 67.44 8.49 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.278 0.561 . . . . 0.0 110.337 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 mmt -109.26 15.66 22.99 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.747 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -52.31 132.28 33.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.418 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -106.63 159.4 16.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.959 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.9 136.08 25.03 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 82' ' ' GLU . 41.8 t0 -61.55 116.16 4.5 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 174.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.6 m -36.94 -19.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 80' ' ' ASP . 94.8 mt-10 -69.02 -35.21 76.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -48.7 -38.37 21.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.487 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -86.49 -17.66 33.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.305 0.574 . . . . 0.0 111.761 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 mm -61.37 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.116 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -62.21 -40.8 97.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.98 -42.11 97.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.811 0.338 . . . . 0.0 111.679 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.98 -19.51 52.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -75.44 -49.05 20.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.985 0.421 . . . . 0.0 111.233 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -55.49 -42.52 74.51 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.607 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.7 -44.47 96.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.9 m-85 -69.19 -38.25 78.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.553 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -85.94 81.22 8.61 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -58.32 -48.99 78.77 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -176.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.2 p30 -90.99 5.53 48.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.471 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.39 48.33 48.55 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -92.16 6.81 45.2 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.597 0.237 . . . . 0.0 110.603 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.62 1.42 89.14 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -141.12 154.05 45.71 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.893 0.854 . . . . 0.0 111.725 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.7 mt -95.09 115.85 35.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 p -90.58 153.05 20.62 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.31 82.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.28 0.945 . . . . 0.0 110.946 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.41 -43.81 68.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.946 0.403 . . . . 0.0 110.711 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.31 -42.54 99.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.596 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 tt -63.93 -45.28 89.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.226 0.536 . . . . 0.0 111.608 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -41.99 -45.01 3.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.61 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.44 ' CE1' HD21 ' A' ' 111' ' ' ASN . 56.9 t-80 -59.73 -26.88 66.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.714 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.582 HG21 ' CE2' ' A' ' 92' ' ' PHE . 86.6 t -57.95 -42.97 83.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.671 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.703 ' HG2' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -51.17 -49.22 61.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.15 0.976 . . . . 0.0 111.89 -177.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.8 p -52.65 -38.89 61.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.622 -1.627 . . . . 0.0 110.901 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.44 HD21 ' CE1' ' A' ' 107' ' ' HIS . 1.8 m120 -65.76 -39.08 90.69 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.495 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.2 mt -83.95 -12.96 54.57 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.76 38.24 50.29 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.353 -1.248 . . . . 0.0 110.196 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -89.45 -22.79 22.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.913 2.357 . . . . 0.0 111.118 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt 45.01 58.41 4.05 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.611 1.196 . . . . 0.0 110.065 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.853 HD23 ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -75.63 149.74 38.14 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 112.952 -1.931 . . . . 0.0 112.982 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 33.4 p -84.07 174.67 10.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 110.349 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.86 -44.73 74.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.3 -41.57 72.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.123 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.17 -28.64 65.48 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.519 -0.472 . . . . 0.0 112.037 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 49.2 t -64.03 -43.68 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.297 0.57 . . . . 0.0 109.63 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -74.62 -36.15 62.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.204 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -60.0 -54.11 49.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.8 mmm -51.27 -52.15 47.64 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.01 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -56.22 -42.58 73.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.582 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -60.02 -36.97 78.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.643 0.259 . . . . 0.0 111.428 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -57.62 -40.78 79.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.717 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.71 -15.01 25.67 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.6 t0 -77.57 82.73 3.99 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.642 0.734 . . . . 0.0 111.682 -177.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.7 pt -70.89 -7.56 9.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 122.622 1.201 . . . . 0.0 113.351 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.9 p-10 -144.45 143.32 30.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 112.458 -2.156 . . . . 0.0 109.171 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.13 51.46 1.67 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 122.202 -0.311 . . . . 0.0 113.41 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -90.72 -10.59 42.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.274 0.537 . . . . 0.0 109.835 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.6 -0.45 64.89 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.54 0.576 . . . . 0.0 114.54 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -132.73 153.17 51.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.339 0.57 . . . . 0.0 110.471 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.45 117.96 45.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.232 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.413 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 53.8 t30 -83.99 173.07 11.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.934 0.397 . . . . 0.0 110.949 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.413 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 80.5 t80 -61.16 -39.56 90.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.998 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.23 -44.51 96.39 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.854 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.98 -37.82 88.82 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.626 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -61.21 -44.87 96.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.706 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.7 t -65.1 -47.42 87.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.365 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -50.58 -42.74 56.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.736 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.2 mmt -74.64 -40.13 61.67 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.5 mmt -77.2 -44.57 29.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.884 -0.144 . . . . 0.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.466 0.335 0 CA-C-O 120.587 0.232 . . . . 0.0 111.335 -179.197 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 11.1 mt . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.68 -56.6 18.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.289 0.566 . . . . 0.0 112.357 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . 0.528 ' CE2' ' OD1' ' B' 1098 ' ' ASN . 11.8 t80 -59.83 -48.47 81.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -174.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -39.33 -51.92 2.04 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.0 -39.39 96.99 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.027 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.1 tp -57.15 -41.95 80.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 118.322 1.061 . . . . 0.0 109.559 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' B' 1094 ' ' PHE . 6.2 m-20 -59.85 -51.58 69.11 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 76.0 mmt-85 -65.47 -39.81 92.41 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.21 -41.35 83.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.422 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -50.4 -45.36 55.53 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.534 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.3 m -63.69 -47.98 78.98 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.434 ' C ' ' O ' ' B' 1102 ' ' THR . 23.9 mt-30 -27.64 -57.54 0.1 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.61 1.195 . . . . 0.0 112.31 -176.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.8 mt -84.77 -13.81 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.437 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.534 ' N ' ' O ' ' B' 1102 ' ' THR . 38.3 ttmt -59.85 -45.66 91.71 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 118.181 -1.408 . . . . 0.0 108.069 176.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.6 t -60.52 -49.78 83.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.7 m -65.8 -36.0 76.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.967 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 86.6 mttt -50.12 -37.69 35.33 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.608 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.59 -45.62 63.21 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.202 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.99 -49.65 73.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 69.3 m-70 . . . . . 0 N--CA 1.465 0.297 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -178.351 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 119.462 -0.304 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 m -78.92 136.19 37.19 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.386 0.994 . . . . 0.0 110.138 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 9' ' ' ILE . 9.4 tm-20 -51.43 -55.47 18.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.893 0.854 . . . . 0.0 111.089 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -37.62 -36.89 0.19 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.648 -1.615 . . . . 0.0 110.576 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -70.25 -32.4 70.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 118.45 -0.785 . . . . 0.0 110.723 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.7 mt -59.54 -45.26 94.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 175.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.23 -49.4 64.05 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.617 -177.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.36 -46.56 88.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.359 0.599 . . . . 0.0 111.923 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.3 m-85 -62.83 -39.3 93.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.812 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -52.64 -53.2 50.26 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.56 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.26 -39.77 60.81 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.059 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.24 -37.67 70.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.084 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.441 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 3.8 m-85 -58.49 -40.85 83.92 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.5 m -65.29 -14.61 61.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.782 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.22 -41.64 94.25 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -105.64 -13.56 15.54 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -74.61 93.14 2.48 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.26 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -69.28 -47.24 65.14 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.96 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.5 p-10 -102.19 13.64 34.13 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.945 -0.472 . . . . 0.0 112.195 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.98 46.64 1.23 Allowed Glycine 0 CA--C 1.533 1.199 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.996 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -86.18 -4.19 59.12 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.637 -0.331 . . . . 0.0 110.957 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.12 84.51 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.9 p -137.3 152.13 49.42 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.105 0.479 . . . . 0.0 109.982 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.93 124.36 45.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.419 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 19.7 p -113.48 164.52 13.51 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.941 0.877 . . . . 0.0 112.194 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 p -59.2 -38.25 79.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.541 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -62.1 -56.63 16.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.556 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 28' ' ' THR . 16.0 pt-20 -64.24 -30.23 71.29 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.37 -52.25 65.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.264 1.031 . . . . 0.0 109.515 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.85 -35.61 87.26 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.865 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.22 -53.14 61.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.09 1.445 . . . . 0.0 108.661 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.44 -45.66 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 120.731 -1.23 . . . . 0.0 111.636 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.6 ttt -59.06 -40.91 86.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 120.064 1.302 . . . . 0.0 109.643 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -53.16 -37.02 61.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.556 0.693 . . . . 0.0 110.48 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.5 t -62.39 -20.25 64.25 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.735 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.4 mt -75.82 2.9 11.09 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.1 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.58 16.16 74.09 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.91 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -109.55 160.31 16.35 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.582 0.691 . . . . 0.0 109.872 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -112.82 69.2 1.1 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.085 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.7 141.84 67.81 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.845 1.697 . . . . 0.0 112.181 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -81.58 157.36 24.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.029 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.0 -42.13 68.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.762 0.315 . . . . 0.0 110.572 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.9 -25.64 43.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.346 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -65.63 -39.48 91.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.816 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.2 mp -56.06 -40.96 74.34 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.492 0.663 . . . . 0.0 109.847 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -69.12 -56.49 7.53 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.655 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -53.13 -48.69 67.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.412 ' SD ' ' NE2' ' B' 1111 ' ' HIS . 1.5 mtm -71.44 -44.51 64.68 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 52' ' ' ILE . 12.1 mm -58.57 -48.41 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -56.58 -34.34 67.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -66.11 -40.41 90.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.669 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.406 HG21 ' CE2' ' B' 1110 ' ' PHE . 50.1 t -85.52 -21.43 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.275 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.405 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.5 t0 -78.45 86.12 4.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -175.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.28 89.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.179 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 36.4 p-10 -85.58 -3.25 58.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.62 23.73 61.12 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 121.872 -0.518 . . . . 0.0 113.029 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.4 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.1 p-10 -87.51 4.65 42.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.046 0.423 . . . . 0.0 110.348 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.405 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.03 0.66 89.7 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.871 -0.681 . . . . 0.0 114.38 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.4 p -147.79 167.49 24.6 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.2 mt -112.62 128.4 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -103.82 -174.57 2.58 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.66 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.441 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.63 -47.28 99.03 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -176.655 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -56.61 -51.38 9.26 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.415 1.41 . . . . 0.0 111.354 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.95 -20.51 65.3 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.372 0.606 . . . . 0.0 111.097 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -71.24 -58.33 3.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.871 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.76 -44.3 86.06 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 m -40.5 -59.09 1.42 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.665 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -64.8 -41.6 95.68 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -176.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 98.2 mmm -59.44 -39.6 84.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.36 78.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.286 0.235 . . . . 0.0 111.499 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -96.65 -8.48 31.48 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.228 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 67.18 7.24 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.169 0.509 . . . . 0.0 110.24 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 19.8 mmt -108.54 16.41 23.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.782 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -52.67 130.99 34.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.674 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 54.3 p-10 -105.57 148.07 27.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.781 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.1 p -133.65 134.1 42.75 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 82' ' ' GLU . 22.7 t0 -62.05 117.17 5.62 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.9 m -37.45 -20.49 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.615 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 80' ' ' ASP . 71.3 mm-40 -69.36 -34.32 74.4 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 111.616 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -49.1 -37.88 22.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.596 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -86.87 -19.28 29.15 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.132 0.491 . . . . 0.0 111.671 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.36 -74.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.853 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -62.39 -40.58 96.93 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.98 -40.91 97.23 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.665 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.07 -21.19 63.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.104 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -71.44 -50.55 30.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.091 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -55.28 -43.03 74.37 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.79 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.37 -44.13 94.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.548 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.4 m-85 -68.22 -38.21 81.66 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.244 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -85.28 81.51 8.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -58.81 -48.76 80.17 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -91.29 4.56 52.03 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 122.236 -0.29 . . . . 0.0 111.274 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.13 46.22 56.56 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -90.08 6.75 41.11 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.679 0.276 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.26 2.0 89.33 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -140.14 152.52 46.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.747 0.784 . . . . 0.0 111.688 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -93.46 114.84 30.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -88.03 150.0 23.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.299 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.71 -45.39 85.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.17 0.896 . . . . 0.0 110.586 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.74 -40.66 72.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.912 0.386 . . . . 0.0 110.568 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.68 -42.54 91.17 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.261 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 108' ' ' VAL . 6.8 tt -63.4 -44.9 93.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.309 0.576 . . . . 0.0 111.052 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -41.25 -44.18 2.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.63 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.25 -25.8 65.95 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.616 0.246 . . . . 0.0 110.998 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.548 HG21 ' CE2' ' A' ' 92' ' ' PHE . 67.7 t -58.59 -43.14 86.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.551 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.646 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.26 -45.92 65.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.911 0.863 . . . . 0.0 111.554 -176.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.6 p -62.1 -36.22 81.07 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.178 -176.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.554 ' ND2' ' N ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -65.09 -41.05 95.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.66 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.838 ' O ' HD12 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -89.01 -8.6 53.73 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -178.678 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.87 40.41 36.3 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.532 -1.149 . . . . 0.0 111.08 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.579 ' HB2' HD11 ' A' ' 112' ' ' LEU . 36.8 tp10 -89.96 -25.87 20.69 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 121.036 2.418 . . . . 0.0 110.741 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 46.52 63.42 1.9 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.242 1.02 . . . . 0.0 110.494 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.509 HD12 ' CG ' ' A' ' 109' ' ' MET . 82.3 mt -81.99 147.63 29.09 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.255 -1.793 . . . . 0.0 113.568 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 121' ' ' VAL . 81.4 p -83.16 175.74 9.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -58.29 -46.07 86.77 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -57.54 -48.32 79.62 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -69.15 -30.81 69.13 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.891 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 117' ' ' THR . 42.3 t -63.75 -41.75 93.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.483 0.659 . . . . 0.0 109.297 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -67.72 -36.98 81.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.299 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -59.65 -51.48 69.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 91.6 mtp -57.1 -43.33 82.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.001 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.0 mm -59.56 -44.29 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.559 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.78 -35.65 78.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 111.463 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.21 -40.71 82.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.712 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.48 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -91.06 -20.61 21.87 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.679 0.276 . . . . 0.0 111.637 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 19.3 t0 -77.63 83.16 4.02 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.469 0.652 . . . . 0.0 112.195 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.6 pt -71.02 -9.66 13.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.496 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 54.7 p-10 -142.8 144.1 32.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 112.621 -2.082 . . . . 0.0 109.054 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.28 51.04 1.7 Allowed Glycine 0 CA--C 1.532 1.147 0 CA-C-N 116.741 -0.209 . . . . 0.0 113.533 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -90.48 -9.87 45.77 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.159 0.48 . . . . 0.0 110.135 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.95 0.13 68.32 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.873 -0.679 . . . . 0.0 114.376 176.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -133.78 154.18 51.18 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.206 0.503 . . . . 0.0 110.606 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.2 t -101.14 118.03 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -84.39 174.51 10.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.938 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.15 -40.52 94.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.292 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -62.35 -44.26 96.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.68 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.47 -37.2 86.7 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.532 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -61.26 -45.22 95.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.135 0.493 . . . . 0.0 110.69 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.45 -47.21 87.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.286 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -49.14 -46.5 45.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.085 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.48 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 1.4 mmt -71.97 -36.88 69.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -177.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.483 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 24.5 mmt -71.85 -44.21 64.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.785 -0.189 . . . . 0.0 110.606 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 88.7 m . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.503 -179.4 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 8.2 m95 -60.0 -58.86 6.72 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.792 0.806 . . . . 0.0 111.973 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . 0.483 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 29.3 m-85 -59.81 -46.66 88.53 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -174.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -42.2 -52.06 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.68 -40.97 99.49 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.779 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 56.8 tp -57.57 -45.28 85.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.196 0.998 . . . . 0.0 109.73 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 15.3 m120 -61.33 -51.75 67.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -65.66 -38.81 90.36 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 88.6 mt -60.96 -42.35 92.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.765 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -52.11 -45.33 64.87 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.537 ' O ' ' N ' ' B' 1105 ' ' LYS . 90.9 m -63.1 -48.01 80.4 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.699 -0.626 . . . . 0.0 111.502 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.449 ' C ' ' O ' ' B' 1102 ' ' THR . 24.8 mt-30 -27.97 -55.91 0.11 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.541 1.163 . . . . 0.0 112.65 -176.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . 0.402 HG21 HD13 ' B' 1104 ' ' ILE . 2.0 mt -83.53 -15.04 11.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 112.165 -2.289 . . . . 0.0 112.602 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.537 ' N ' ' O ' ' B' 1102 ' ' THR . 64.0 tttp -59.53 -44.41 93.2 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 118.063 -1.455 . . . . 0.0 108.259 176.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.5 t -61.39 -48.85 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.78 -35.98 76.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.198 -178.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 92.8 mttt -49.92 -36.72 28.73 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.796 0.726 . . . . 0.0 109.756 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.76 -45.75 70.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.247 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . 0.406 ' CE2' HG21 ' A' ' 55' ' ' VAL . 51.7 m-85 -63.07 -48.91 76.64 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.229 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . 0.412 ' NE2' ' SD ' ' A' ' 51' ' ' MET . 83.3 m-70 . . . . . 0 C--N 1.328 -0.334 0 O-C-N 122.119 -0.363 . . . . 0.0 111.963 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.7 tp . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 119.158 -0.448 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -73.75 141.13 46.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.203 0.911 . . . . 0.0 109.653 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.0 tt0 -45.26 -61.68 1.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.064 0.935 . . . . 0.0 110.375 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -34.1 -36.14 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.627 -1.624 . . . . 0.0 111.18 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.621 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 1.2 tm0? -69.11 -38.75 79.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.414 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.1 mt -59.68 -44.39 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.431 ' O ' ' OE2' ' A' ' 14' ' ' GLU . . . -53.31 -52.16 60.03 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.238 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.53 -45.49 93.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.531 0.682 . . . . 0.0 112.596 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.621 ' CD1' ' NE2' ' A' ' 8' ' ' GLN . 5.2 m-85 -62.67 -38.55 90.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.705 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -53.03 -53.8 44.81 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.432 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 10' ' ' ALA . 1.9 mp0 -48.38 -41.31 28.51 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.199 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.53 -39.06 72.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.237 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -57.64 -42.0 82.56 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 m -64.88 -14.54 59.95 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.469 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.63 -43.15 97.67 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -105.96 -13.34 15.52 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -74.34 93.77 2.44 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.263 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -68.78 -48.0 64.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.791 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.0 p-10 -102.61 13.74 33.72 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.66 48.02 1.26 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.157 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -85.32 -4.33 59.12 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.749 0.309 . . . . 0.0 110.904 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.49 -2.3 82.75 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.7 p -137.37 152.52 49.76 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.8 mp -91.81 123.59 43.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.433 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 19.0 p -113.76 166.18 11.81 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.539 0.685 . . . . 0.0 112.418 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.3 p -58.99 -37.3 76.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.372 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -61.22 -60.62 3.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.263 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 28' ' ' THR . 15.5 pt-20 -61.1 -30.45 70.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.518 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.408 HD22 HD11 ' A' ' 52' ' ' ILE . 2.9 tp -60.76 -53.68 54.44 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.727 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.52 -37.97 94.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 113.786 -1.552 . . . . 0.0 112.242 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.68 -52.0 67.56 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.782 1.291 . . . . 0.0 108.919 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.17 -45.26 88.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 119.303 0.956 . . . . 0.0 111.275 -177.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 28.2 ttt -59.31 -39.33 82.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 119.805 1.184 . . . . 0.0 109.917 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -52.29 -39.88 61.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.738 0.78 . . . . 0.0 110.259 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.1 p -62.52 -20.64 64.83 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.21 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.95 -0.33 15.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.959 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.06 25.39 44.93 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.183 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -124.97 165.12 18.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.317 0.558 . . . . 0.0 109.772 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -125.62 77.09 69.68 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.278 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.37 147.87 72.52 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.99 1.794 . . . . 0.0 112.119 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.4 p -79.4 162.76 25.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.103 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -57.19 -43.15 82.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.996 -179.177 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.489 ' H ' ' CD ' ' A' ' 45' ' ' GLU . . . -57.19 -25.32 58.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.368 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -65.26 -40.72 94.33 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.088 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.3 mp -55.06 -38.63 68.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.565 0.698 . . . . 0.0 109.46 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -72.97 -55.42 6.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.187 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.41 -49.61 69.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.414 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 63.7 mtp -66.9 -48.98 67.03 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 52' ' ' ILE . 24.4 mm -58.54 -45.23 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.433 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -56.42 -35.42 67.8 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.57 -40.63 89.07 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.507 -0.477 . . . . 0.0 112.076 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.452 HG21 ' CE2' ' B' 1110 ' ' PHE . 75.4 t -85.53 -21.74 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.651 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.476 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.0 t0 -78.69 86.75 4.63 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -175.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.78 87.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.367 -1.742 . . . . 0.0 114.27 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.471 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 39.5 p-10 -86.14 -2.95 58.82 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.26 23.17 63.99 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.548 0.613 . . . . 0.0 112.795 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.471 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.2 p-10 -88.04 2.16 52.53 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.392 0.596 . . . . 0.0 110.66 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.476 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.6 1.75 89.05 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.701 -0.625 . . . . 0.0 114.586 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.4 p -145.78 166.56 25.55 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.1 mm -109.7 126.5 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.85 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -102.78 -176.98 3.25 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.907 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.93 -47.39 98.77 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.21 -51.39 9.53 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.1 1.2 . . . . 0.0 111.613 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.72 -18.33 53.77 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.648 0.737 . . . . 0.0 110.586 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -77.17 -56.75 4.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.441 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.4 mt -58.49 -46.16 87.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.7 p -46.24 -47.33 18.04 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.104 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.7 mtp -66.83 -45.45 78.23 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.6 mmt -59.78 -39.74 85.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.58 78.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.242 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 -94.76 -10.66 30.88 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.727 0.299 . . . . 0.0 111.561 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.31 68.22 8.64 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.13 0.49 . . . . 0.0 110.613 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.5 mmt -107.26 18.62 21.41 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.389 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -50.17 130.43 22.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.239 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -93.57 106.02 18.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.799 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.515 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 2.8 m -90.26 122.08 32.85 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 82' ' ' GLU . 90.3 m-20 -69.66 112.14 5.93 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.0 m -37.58 -21.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.694 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.4 mp0 -68.88 -37.24 78.91 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -47.69 -35.67 9.99 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.266 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -88.97 -17.45 29.45 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.307 0.575 . . . . 0.0 112.039 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 85' ' ' ILE . 27.7 mm -60.87 -74.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.959 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -62.61 -39.1 92.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -62.7 -40.88 98.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.371 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.59 -19.53 62.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -72.92 -50.77 21.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.955 0.407 . . . . 0.0 111.317 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -55.5 -42.48 74.51 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.42 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.23 -43.73 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.605 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.3 m-85 -68.29 -38.97 82.21 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.475 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -89.22 84.03 6.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.7 -46.19 91.33 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -92.15 4.41 53.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.294 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.43 50.35 48.01 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -92.24 5.72 49.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.637 0.256 . . . . 0.0 110.576 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.98 0.76 89.76 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -139.55 153.07 47.35 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.545 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.46 115.32 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.4 m -89.82 153.23 20.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.35 -47.79 80.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 119.039 0.836 . . . . 0.0 110.986 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.01 -40.17 60.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.994 0.426 . . . . 0.0 110.461 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -66.22 -41.43 90.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.383 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 tp -63.5 -46.33 86.61 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.37 0.605 . . . . 0.0 111.422 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -44.22 -36.89 2.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.753 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -69.33 -27.6 65.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.717 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.605 HG21 ' CE2' ' A' ' 92' ' ' PHE . 94.8 t -58.76 -43.08 87.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.03 -178.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.57 ' SD ' HD13 ' A' ' 116' ' ' LEU . 8.7 mmt -51.89 -49.69 62.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.219 1.009 . . . . 0.0 111.879 -176.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 65.9 p -52.78 -37.14 59.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.245 -1.798 . . . . 0.0 110.817 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -66.3 -39.6 89.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.949 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.0 mt -82.83 -13.81 55.5 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.49 37.6 53.06 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.26 -1.3 . . . . 0.0 110.058 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -85.12 -20.57 30.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 121.021 2.411 . . . . 0.0 110.976 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt 42.38 50.6 4.68 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.723 1.249 . . . . 0.0 110.367 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.57 HD13 ' SD ' ' A' ' 109' ' ' MET . 0.9 OUTLIER -74.23 153.47 39.42 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.957 -1.928 . . . . 0.0 112.701 -178.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 61.3 p -85.64 174.14 9.63 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -55.93 -43.97 77.88 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -55.59 -41.87 73.99 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.051 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.09 -29.95 68.15 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.979 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.408 HG22 HD11 ' A' ' 116' ' ' LEU . 43.8 t -62.75 -43.95 99.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.466 0.651 . . . . 0.0 109.593 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -72.83 -36.45 67.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.994 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -59.22 -54.89 41.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 83.9 mtp -56.74 -43.25 80.49 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.645 -1.162 . . . . 0.0 109.812 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.8 mt -59.28 -43.74 90.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.243 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -59.26 -39.44 82.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.828 0.347 . . . . 0.0 111.106 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.31 -41.28 84.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.187 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.65 -24.88 21.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.1 t0 -71.77 88.73 1.01 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.651 0.739 . . . . 0.0 111.933 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 72.3 mt -70.06 -15.88 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.703 1.24 . . . . 0.0 113.208 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 44.7 p-10 -141.53 144.4 34.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 112.295 -2.23 . . . . 0.0 109.522 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.59 52.28 1.17 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.604 -0.331 . . . . 0.0 112.947 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 32.1 p-10 -91.37 -9.91 43.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.187 0.494 . . . . 0.0 110.19 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.82 2.49 76.9 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.218 -0.515 . . . . 0.0 114.268 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -135.04 154.5 51.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 117.198 0.499 . . . . 0.0 110.445 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.5 t -100.9 118.94 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.357 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -84.55 174.44 10.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.85 0.357 . . . . 0.0 110.816 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -61.24 -40.3 93.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.24 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.1 -44.51 96.5 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.34 -38.49 90.28 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.763 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -61.16 -45.4 94.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.054 0.454 . . . . 0.0 110.849 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.9 t -65.23 -46.21 91.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.353 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -49.8 -45.02 49.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.611 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.6 mmt -72.7 -38.44 67.51 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.4 mmt -71.93 -46.89 55.95 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.341 -0.144 . . . . 0.0 110.909 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.467 0.393 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.725 -179.309 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.6 m95 -62.34 -54.57 38.56 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.57 0.7 . . . . 0.0 112.244 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 8.3 t80 -59.44 -46.6 88.3 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 18.6 mmm-85 -40.69 -51.3 3.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.28 -39.58 97.4 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.33 -44.03 83.9 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.697 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 39.7 t30 -59.46 -49.78 76.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.631 -1.168 . . . . 0.0 114.118 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -65.58 -37.83 87.78 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.7 -41.68 89.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.889 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -51.39 -46.02 62.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B 1102 ' ' THR . . . . . 0.527 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.5 m -63.89 -48.18 77.68 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.886 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B 1103 ' ' GLN . . . . . 0.436 ' C ' ' O ' ' B' 1102 ' ' THR . 83.8 mt-30 -27.47 -56.91 0.1 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.638 1.209 . . . . 0.0 112.569 -176.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.3 mt -85.84 -14.17 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.453 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B 1105 ' ' LYS . . . . . 0.527 ' N ' ' O ' ' B' 1102 ' ' THR . 78.5 tttt -60.32 -45.93 91.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.012 176.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 96.1 t -61.57 -49.06 85.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.7 m -66.04 -35.89 76.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.013 -177.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B 1108 ' ' LYS . . . . . 0.515 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 87.0 mttt -49.62 -38.65 32.89 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.571 0.7 . . . . 0.0 109.727 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.71 -45.92 67.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.355 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B 1110 ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 55' ' ' VAL . 49.7 m-85 -63.41 -49.4 73.91 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 68.1 m-70 . . . . . 0 C--N 1.33 -0.249 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.621 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.524 ' OD1' ' NE2' ' A' ' 3' ' ' GLN . 31.0 p-10 -91.32 3.43 54.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.746 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 2' ' ' ASP . 11.0 mp0 -102.04 104.02 14.65 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.98 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.4 mt -113.95 -15.34 12.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.563 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.5 p -80.03 136.98 36.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.324 0.965 . . . . 0.0 110.32 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 9' ' ' ILE . 46.3 tt0 -51.86 -53.65 38.17 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 122.072 0.939 . . . . 0.0 110.201 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 10.2 pt-20 -32.84 -36.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.108 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.52 ' OE1' ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -69.62 -37.77 76.96 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.286 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.3 mt -58.58 -44.9 90.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 175.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.67 -49.23 62.78 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.108 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.56 -46.37 90.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.339 0.59 . . . . 0.0 111.535 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.52 ' CD2' ' OE1' ' A' ' 8' ' ' GLN . 28.2 m-85 -58.41 -42.37 87.05 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.781 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -49.21 -58.1 5.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.378 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.48 -44.97 62.63 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.031 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.22 -38.16 70.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.222 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.16 -41.84 84.65 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 t -64.41 -15.78 61.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.421 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -64.08 -42.82 96.81 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -178.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -105.64 -14.52 15.24 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -75.45 94.94 3.18 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.137 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -68.25 -47.43 67.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.226 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.2 p-10 -102.38 14.18 32.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.46 46.17 1.03 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.035 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -85.35 -4.0 59.02 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.694 -0.298 . . . . 0.0 110.961 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.38 -2.0 82.71 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.5 p -137.51 152.24 49.29 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.103 0.478 . . . . 0.0 109.891 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.64 124.53 45.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.9 p -114.31 165.27 12.87 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.801 0.81 . . . . 0.0 112.393 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.4 p -58.85 -35.82 73.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.715 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.59 -61.4 2.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.565 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.92 -30.48 71.58 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.795 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.412 HD22 HD11 ' A' ' 52' ' ' ILE . 2.9 tp -60.16 -55.73 30.3 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.015 0.912 . . . . 0.0 109.667 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.65 -37.69 93.87 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 113.648 -1.615 . . . . 0.0 111.975 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 m -58.75 -53.03 63.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 119.047 1.423 . . . . 0.0 108.624 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.0 -46.47 84.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 121.228 -0.92 . . . . 0.0 111.523 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.6 ttt -59.0 -39.93 83.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 120.054 1.297 . . . . 0.0 109.461 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -51.56 -38.36 54.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.531 0.681 . . . . 0.0 110.183 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.1 p -63.54 -21.08 66.14 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.376 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.473 ' O ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -73.73 -1.72 20.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.536 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.34 13.77 67.57 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.127 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -107.14 158.01 17.42 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 117.611 0.705 . . . . 0.0 109.854 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -114.74 64.77 1.58 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.286 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.05 143.29 94.78 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.19 1.927 . . . . 0.0 112.156 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 t -80.58 166.74 20.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.438 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.15 -44.12 87.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.72 -24.2 33.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.558 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -65.63 -39.15 91.16 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.069 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.2 mp -56.42 -41.59 76.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.463 0.649 . . . . 0.0 109.759 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.25 -56.67 6.2 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.757 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.45 -48.81 71.29 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 41.2 mmm -65.85 -50.17 65.52 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.412 HD11 HD22 ' A' ' 32' ' ' LEU . 25.9 mm -59.44 -47.69 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.672 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -56.45 -34.97 67.35 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -66.18 -40.01 90.16 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.8 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.489 HG21 ' CD2' ' B' 1110 ' ' PHE . 71.4 t -86.35 -20.37 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.503 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.494 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.3 t0 -78.49 85.93 4.55 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.21 -38.0 87.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.326 -1.761 . . . . 0.0 114.066 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 36.8 p-10 -86.26 -2.89 58.79 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.98 23.55 63.82 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 118.476 0.58 . . . . 0.0 112.927 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.419 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.4 p-10 -87.36 2.38 50.51 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.234 0.517 . . . . 0.0 110.578 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.2 1.39 89.54 Favored Glycine 0 CA--C 1.521 0.442 0 O-C-N 121.585 -0.697 . . . . 0.0 114.448 175.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.0 p -145.85 165.33 29.21 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 26.9 mm -108.91 126.64 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -103.38 -176.33 3.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -57.3 -59.11 13.81 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -47.25 -49.62 12.6 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.37 1.38 . . . . 0.0 111.243 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.57 -19.77 62.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.348 0.594 . . . . 0.0 110.641 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 65' ' ' PHE . 22.7 t80 -74.55 -58.24 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.962 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.18 -45.21 83.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -44.24 -49.88 9.1 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.61 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 72.8 mtm -66.98 -44.5 80.28 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.656 -0.417 . . . . 0.0 112.026 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.8 mmt -57.62 -39.42 76.88 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.6 -34.46 77.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.548 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -95.74 -9.05 32.82 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.434 ' C ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -85.98 63.84 8.25 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.154 0.502 . . . . 0.0 110.685 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.56 17.24 22.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.41 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -48.31 135.02 14.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.175 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -89.41 108.94 19.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.827 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -93.75 119.68 33.04 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 82' ' ' GLU . 36.8 t0 -67.02 112.89 4.61 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 174.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 m -37.68 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.522 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 80' ' ' ASP . 95.3 mt-10 -72.09 -31.51 66.15 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -50.38 -39.14 45.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.878 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.55 ' OE1' HD11 ' B' 1097 ' ' LEU . 9.2 pt-20 -89.53 -11.04 43.98 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.4 mm -62.43 -74.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.798 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -62.01 -40.75 96.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.91 -41.3 97.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.571 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.41 -21.26 63.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -73.81 -48.41 31.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -54.95 -40.55 70.09 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.815 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.3 t -65.54 -44.1 94.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.512 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.4 m-85 -69.02 -38.7 79.34 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.264 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -85.55 81.11 8.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.37 -49.4 77.36 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -176.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.5 p30 -91.32 4.83 51.38 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.175 -0.328 . . . . 0.0 111.168 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.61 48.13 50.39 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -90.22 6.25 43.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.674 0.273 . . . . 0.0 110.745 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.18 2.13 85.91 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -142.98 156.18 44.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.751 0.786 . . . . 0.0 111.593 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -94.08 115.37 32.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 t -89.05 151.1 22.45 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.23 -46.54 82.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.201 0.91 . . . . 0.0 110.723 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.42 -40.59 65.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.951 0.405 . . . . 0.0 110.554 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -65.22 -41.13 94.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.168 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.19 -44.64 94.82 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.614 0.721 . . . . 0.0 110.949 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -44.55 -44.01 8.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.548 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.92 -29.71 70.99 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 122.456 -0.152 . . . . 0.0 110.747 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.512 HG21 ' CE2' ' A' ' 92' ' ' PHE . 95.5 t -57.64 -41.32 79.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.837 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.604 ' CE ' HG22 ' A' ' 121' ' ' VAL . 8.5 mtt -50.84 -45.54 59.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.075 0.94 . . . . 0.0 111.526 -177.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 m -56.68 -41.41 77.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.537 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -66.55 -41.55 88.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.132 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 74.8 mt -80.87 -16.36 53.86 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.24 30.52 58.67 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.51 -23.1 27.87 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.962 2.381 . . . . 0.0 110.481 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.9 tptp 45.02 60.37 3.01 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.067 0.937 . . . . 0.0 110.326 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 44.9 mt -79.95 147.2 31.71 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.566 -1.652 . . . . 0.0 112.463 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.57 ' O ' HG23 ' A' ' 121' ' ' VAL . 81.5 p -81.99 175.35 10.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.468 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -57.41 -44.79 84.86 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -56.49 -47.91 78.28 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.196 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 123' ' ' GLU . 64.3 mm-40 -71.35 -28.44 64.06 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.73 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.604 HG22 ' CE ' ' A' ' 109' ' ' MET . 54.4 t -63.91 -42.43 95.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.669 0.747 . . . . 0.0 109.288 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.53 -35.09 65.5 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.382 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 120' ' ' GLU . 82.5 tt0 -59.66 -51.28 70.47 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 93.0 mtp -56.08 -44.47 78.98 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.35 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.74 -43.66 88.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.189 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -58.63 -39.45 80.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.953 0.406 . . . . 0.0 111.212 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.37 -40.92 79.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.059 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.41 -20.15 22.1 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.9 t0 -72.88 87.69 1.32 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.301 0.572 . . . . 0.0 112.072 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.3 tt -70.5 -15.18 18.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.374 1.083 . . . . 0.0 113.242 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.7 p-10 -142.65 144.78 32.92 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 112.322 -2.217 . . . . 0.0 109.172 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.1 52.27 1.35 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-N 116.736 -0.211 . . . . 0.0 113.255 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -90.79 -9.21 47.37 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.973 0.387 . . . . 0.0 110.013 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.34 1.02 68.41 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.995 -0.621 . . . . 0.0 114.262 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -134.43 153.87 51.69 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.395 0.598 . . . . 0.0 110.422 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.1 t -99.68 118.38 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.366 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -84.44 174.55 9.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 0.0 111.149 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -61.05 -40.8 95.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.202 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -61.64 -44.6 96.68 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.701 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.94 -35.64 81.81 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.599 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -60.75 -44.75 96.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.076 0.465 . . . . 0.0 110.574 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.11 -47.01 89.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.365 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.708 ' O ' HG22 ' A' ' 146' ' ' THR . 52.6 tt0 -49.34 -40.73 36.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.78 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 mmt -74.9 -38.58 61.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.1 mmt -80.69 4.5 18.59 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.168 0.587 . . . . 0.0 111.18 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 143' ' ' GLN . 5.0 t -79.04 35.91 0.27 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.303 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' B' 1094 ' ' PHE . . . -47.16 -97.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.217 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.1 tttp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.441 -179.574 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 55.9 tp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -77.31 145.88 37.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.494 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.52 ' C ' ' H ' ' B' 1090 ' ' GLN . 55.0 ttp180 60.96 41.12 14.57 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -63.78 3.83 1.33 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.52 ' H ' ' C ' ' B' 1088 ' ' ARG . 1.3 mp0 -62.34 -44.05 97.38 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . 0.477 HD11 ' NE ' ' B' 1088 ' ' ARG . 54.1 mt -54.68 -55.41 15.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.975 0.417 . . . . 0.0 111.784 -177.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 9.5 mt -56.16 -54.74 41.59 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.481 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 4.6 m95 -60.77 -57.86 10.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.681 0.753 . . . . 0.0 112.127 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . 0.513 ' CE2' ' OD1' ' B' 1098 ' ' ASN . 26.1 t80 -58.88 -45.51 90.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.224 -1.353 . . . . 0.0 114.55 -173.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -38.53 -52.65 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.61 -39.55 98.02 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.052 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . 0.55 HD11 ' OE1' ' A' ' 84' ' ' GLU . 46.7 tp -56.26 -42.44 77.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.54 1.17 . . . . 0.0 109.798 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . 0.513 ' OD1' ' CE2' ' B' 1094 ' ' PHE . 8.4 m-20 -56.92 -43.08 81.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.468 -1.242 . . . . 0.0 113.378 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -64.07 -36.92 85.58 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 83.8 mt -61.26 -42.03 91.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.853 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . 0.48 ' CG ' ' OE2' ' A' ' 84' ' ' GLU . 41.8 mt-30 -50.78 -46.21 59.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.51 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.7 m -63.56 -48.19 78.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.99 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.44 ' C ' ' O ' ' B' 1102 ' ' THR . 84.2 mt-30 -27.55 -57.81 0.1 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 122.556 1.169 . . . . 0.0 112.715 -176.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.2 mt -84.8 -15.14 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 112.161 -2.29 . . . . 0.0 112.691 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.51 ' N ' ' O ' ' B' 1102 ' ' THR . 64.3 tttp -60.23 -44.8 94.89 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.003 -1.479 . . . . 0.0 107.899 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 73.3 t -61.31 -49.05 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . 0.408 HG13 ' H ' ' B' 1107 ' ' VAL . 1.3 m -66.41 -36.25 76.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.429 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 90.4 mttt -49.65 -39.21 35.37 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.53 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.86 -45.52 67.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.914 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . 0.489 ' CD2' HG21 ' A' ' 55' ' ' VAL . 46.4 m-85 -63.65 -49.68 72.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -68.19 -42.16 80.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.4 m 68.77 58.67 0.39 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.48 1.044 0 CA-C-N 123.57 2.895 . . . . 0.0 111.929 179.476 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.651 ' O ' ' OE1' ' A' ' 8' ' ' GLN . 90.5 m-20 -40.08 -80.3 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.499 ' O ' ' CB ' ' A' ' 4' ' ' LEU . 83.0 mt-30 -78.15 126.8 31.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.105 0.479 . . . . 0.0 110.916 -177.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.499 ' CB ' ' O ' ' A' ' 3' ' ' GLN . 1.0 OUTLIER 155.58 -32.42 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.155 -178.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.3 m -75.21 139.26 42.5 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.271 0.941 . . . . 0.0 109.492 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 9' ' ' ILE . 10.3 tm-20 -48.47 -56.8 7.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.969 0.89 . . . . 0.0 110.473 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -34.59 -37.88 0.06 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 113.554 -1.657 . . . . 0.0 110.971 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.651 ' OE1' ' O ' ' A' ' 2' ' ' ASP . 81.3 mt-30 -69.34 -37.15 77.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.613 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' GLU . 63.8 mt -57.25 -47.6 83.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.29 -49.88 60.41 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.124 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -61.72 -46.85 87.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.099 0.476 . . . . 0.0 112.276 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -59.8 -41.01 90.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.949 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -51.46 -56.55 12.67 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.055 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.43 -45.19 55.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.007 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.26 -38.68 66.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.434 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -57.77 -40.54 80.04 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.9 m -65.05 -15.37 62.27 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.651 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.1 mt -65.2 -41.04 94.92 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -105.96 -14.36 15.21 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -74.91 94.42 2.8 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.325 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -67.85 -51.85 43.6 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.181 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.6 p30 -100.84 15.73 27.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 37.17 51.98 1.65 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.108 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 26' ' ' THR . 12.3 p30 -88.33 -5.43 58.33 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.925 0.362 . . . . 0.0 111.079 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.93 -0.72 76.74 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.436 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 1.9 t -141.22 157.63 44.99 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.151 0.5 . . . . 0.0 110.49 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 27' ' ' ILE . 3.5 mp -90.52 123.99 42.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.8 p -111.21 161.46 15.96 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.28 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.413 HG22 HG13 ' A' ' 52' ' ' ILE . 21.5 p -59.84 -38.07 81.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.212 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -61.38 -59.28 5.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.325 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.72 -28.3 69.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.762 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.501 HD22 HD11 ' A' ' 52' ' ' ILE . 3.5 tp -61.67 -55.39 30.93 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.977 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.49 92.04 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 114.205 -1.361 . . . . 0.0 112.186 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -57.98 -55.4 35.39 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.052 1.426 . . . . 0.0 108.198 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.5 t -54.63 -46.56 72.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 118.798 0.727 . . . . 0.0 111.29 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.1 tpt -58.0 -39.86 79.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 120.38 1.445 . . . . 0.0 109.85 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -51.1 -33.55 26.67 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.346 0.593 . . . . 0.0 110.999 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.9 p -64.9 -20.01 66.22 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.85 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 1.5 mm? -76.27 3.24 11.25 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.143 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.92 27.58 40.84 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.279 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 42' ' ' ASN . 9.1 tt0 -131.51 170.41 14.75 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.65 0.725 . . . . 0.0 109.469 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.409 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 16.1 m-20 -131.33 78.23 72.53 Favored Pre-proline 0 N--CA 1.466 0.351 0 CA-C-O 120.739 0.304 . . . . 0.0 110.217 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.07 147.03 96.87 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.698 2.265 . . . . 0.0 111.876 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.2 p -77.78 163.39 26.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.401 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.03 -45.43 90.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.721 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.1 -24.68 26.89 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.626 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -65.63 -40.16 92.25 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.662 -0.415 . . . . 0.0 109.989 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.1 mp -56.14 -41.7 75.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.382 0.611 . . . . 0.0 109.939 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -72.57 -56.02 6.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.682 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -55.76 -50.2 71.06 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.4 mmm -64.05 -50.61 67.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.501 HD11 HD22 ' A' ' 32' ' ' LEU . 26.4 mm -57.72 -45.11 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.77 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -55.44 -34.43 64.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -67.0 -40.94 87.45 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.071 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.477 HG12 HD12 ' A' ' 63' ' ' ILE . 42.2 t -85.99 -21.54 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.155 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.5 t0 -79.42 83.71 5.4 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -174.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.53 79.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.816 -1.538 . . . . 0.0 114.442 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.8 p-10 -85.71 -2.47 58.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.331 -0.547 . . . . 0.0 112.463 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.8 23.02 60.6 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 121.867 -0.521 . . . . 0.0 112.507 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.435 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -86.61 3.83 42.8 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.335 0.568 . . . . 0.0 110.565 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.521 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.15 2.01 89.45 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 118.657 0.662 . . . . 0.0 114.664 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.2 p -148.19 167.79 24.16 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.477 HD12 HG12 ' A' ' 55' ' ' VAL . 10.0 mm -110.06 127.38 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.228 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -102.57 -177.39 3.38 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.54 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.413 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -58.19 -46.3 99.67 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.191 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 33.3 Cg_exo -56.6 -52.62 6.57 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.393 1.395 . . . . 0.0 111.297 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' O ' ' SD ' ' A' ' 71' ' ' MET . 97.4 mt-10 -61.16 -18.91 60.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.26 0.553 . . . . 0.0 110.941 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -76.77 -59.11 2.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.814 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.8 mt -56.05 -47.41 77.94 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.1 t -46.39 -43.58 16.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.071 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.432 ' SD ' ' O ' ' A' ' 67' ' ' GLU . 39.5 mtp -66.92 -47.76 70.74 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.0 mmm -62.07 -40.71 96.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.13 -33.92 76.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.573 0.225 . . . . 0.0 111.463 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -91.99 -20.76 21.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 111.178 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.58 67.84 5.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.15 0.5 . . . . 0.0 110.178 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.2 mmt -107.81 15.83 24.15 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.578 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -48.33 132.98 16.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.311 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -89.85 107.6 19.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.964 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.491 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 3.2 m -93.64 120.42 33.89 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.5 m-20 -69.63 111.97 5.8 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 m -36.89 -20.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.864 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.6 mm-40 -68.26 -37.49 80.8 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.794 0.33 . . . . 0.0 111.615 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -48.65 -36.41 15.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.144 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -88.09 -16.55 33.23 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 85' ' ' ILE . 26.5 mm -61.96 -74.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.563 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 74.4 mtt85 -62.02 -41.35 97.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.86 -41.5 97.91 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.848 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.07 -17.97 55.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.817 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -72.69 -50.7 23.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -54.95 -42.13 71.94 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.5 t -65.1 -44.38 95.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.421 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.1 m-85 -69.33 -37.81 77.9 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.159 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -86.25 80.75 8.64 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.81 -48.91 78.37 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -90.59 4.99 49.73 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.264 -0.273 . . . . 0.0 111.351 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.17 47.19 50.28 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -90.27 7.03 40.35 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.75 0.31 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.33 2.02 89.25 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -140.68 153.42 45.97 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.636 0.731 . . . . 0.0 111.835 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.9 mt -93.34 116.4 34.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.3 m -89.65 149.31 22.85 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.93 79.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 119.166 0.894 . . . . 0.0 110.683 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.19 -40.79 64.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.815 0.341 . . . . 0.0 110.673 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.12 -41.4 94.9 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.204 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.74 -45.73 88.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.233 0.54 . . . . 0.0 110.843 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -43.24 -44.44 5.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.857 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -64.82 -28.83 69.83 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.662 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.503 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 85.0 t -58.11 -41.82 81.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.134 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.626 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.27 -46.73 65.97 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.953 0.882 . . . . 0.0 111.705 -177.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 71.9 p -53.43 -35.89 60.93 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 113.771 -1.559 . . . . 0.0 110.882 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -68.51 -39.88 81.07 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.473 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.86 -13.29 59.06 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.45 30.45 60.31 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -87.68 -24.67 23.81 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.681 2.241 . . . . 0.0 110.779 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 45.25 64.39 1.42 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.713 0.768 . . . . 0.0 110.155 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.3 mt -80.5 148.13 30.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.374 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 121' ' ' VAL . 30.5 p -82.07 174.61 11.07 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.693 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -57.2 -45.83 83.44 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.16 -47.81 77.51 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -71.96 -30.36 65.2 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.588 -0.445 . . . . 0.0 112.108 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 117' ' ' THR . 42.5 t -65.04 -42.69 95.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -70.61 -34.98 72.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.099 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -59.99 -49.12 78.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.041 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 29.8 mmm -52.46 -47.37 66.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.023 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 40.7 mm -57.44 -44.33 84.38 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.432 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.695 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -58.0 -40.23 80.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.89 0.376 . . . . 0.0 111.394 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -57.98 -40.82 81.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.056 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.89 -17.94 24.5 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.716 0.293 . . . . 0.0 111.645 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.2 t0 -73.83 89.56 1.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.436 0.636 . . . . 0.0 111.816 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 80.1 mt -70.73 -17.63 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.063 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.9 p-10 -141.59 145.55 35.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 112.745 -2.025 . . . . 0.0 108.743 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.45 52.27 1.48 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.76 -0.257 . . . . 0.0 113.117 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -90.66 -9.16 47.91 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.023 0.412 . . . . 0.0 110.219 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.0 1.89 75.43 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.961 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -134.75 154.33 51.63 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.234 0.517 . . . . 0.0 110.39 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.0 t -100.76 118.58 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.038 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -84.26 174.71 9.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.775 0.321 . . . . 0.0 110.924 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -61.62 -40.03 93.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.095 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.96 -44.66 95.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.54 -38.5 89.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.733 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -60.82 -44.38 96.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.139 0.495 . . . . 0.0 110.807 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.22 -46.42 87.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.233 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -48.43 -45.56 36.51 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.164 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 88.1 mmm -74.68 -38.3 62.45 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 18.6 mmt -72.8 -46.55 52.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 m -87.53 32.39 0.72 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.66 0.267 . . . . 0.0 111.441 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.14 96.65 10.44 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.683 0.278 . . . . 0.0 110.893 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.8 pttp . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.079 -0.963 . . . . 0.0 110.608 179.759 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . 0.481 ' C ' HD12 ' B' 1086 ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . 0.445 ' N ' HD12 ' B' 1086 ' ' LEU . 10.5 tpp85 -76.8 138.02 39.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.539 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.557 ' C ' ' H ' ' B' 1090 ' ' GLN . 2.5 mpp_? -82.08 97.1 8.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -53.2 -5.78 0.32 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.557 ' H ' ' C ' ' B' 1088 ' ' ARG . 73.0 mt-30 -63.84 -50.13 70.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.859 0.361 . . . . 0.0 111.484 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 58.8 mt -58.56 -50.94 77.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.204 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 14.4 mt -55.42 -61.95 2.0 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.349 -0.54 . . . . 0.0 112.021 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.72 -54.55 41.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.265 0.555 . . . . 0.0 112.029 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 37.9 t80 -57.97 -46.08 85.69 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -42.16 -52.01 4.47 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.49 -42.11 99.69 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.162 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.55 -46.1 80.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.391 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.21 -48.73 79.45 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.26 -38.17 90.1 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.4 mt -60.96 -42.16 91.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.795 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -51.3 -46.42 62.51 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.517 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.8 m -63.38 -48.45 77.82 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.422 ' C ' ' O ' ' B' 1102 ' ' THR . 84.5 mt-30 -27.31 -60.2 0.1 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 122.603 1.192 . . . . 0.0 112.741 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -82.01 -14.59 12.27 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.355 0 CA-C-N 112.67 -2.059 . . . . 0.0 112.344 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.517 ' N ' ' O ' ' B' 1102 ' ' THR . 65.8 tttm -57.69 -43.34 85.06 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 117.874 -1.53 . . . . 0.0 108.059 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.8 t -61.88 -47.04 95.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.55 0.69 . . . . 0.0 112.818 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 65.8 t -65.38 -41.18 90.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.097 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . 0.491 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 96.1 mttt -49.03 -38.14 22.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.396 0.617 . . . . 0.0 109.634 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -54.09 -46.91 72.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.343 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . 0.426 ' CE2' HG21 ' A' ' 55' ' ' VAL . 54.8 m-85 -62.35 -49.81 74.07 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -68.84 -40.55 79.36 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.2 t 66.81 59.25 0.58 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 116.781 -1.581 . . . . 0.0 107.741 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 25.8 p . . . . . 0 N--CA 1.47 0.544 0 CA-C-N 124.194 3.179 . . . . 0.0 111.897 179.377 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.42 ' OD2' ' HB1' ' A' ' 73' ' ' ALA . 58.5 m-20 56.99 27.84 13.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.395 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 168.08 88.77 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.993 0.808 . . . . 0.0 109.325 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.17 -25.3 14.06 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.065 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.8 p -80.64 137.83 36.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.461 1.028 . . . . 0.0 110.454 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' A' ' 7' ' ' GLU . 18.0 pt-20 -52.65 -50.06 63.95 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.123 0.963 . . . . 0.0 110.893 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.507 ' N ' ' CG ' ' A' ' 6' ' ' GLU . 43.4 tp10 -36.44 -38.13 0.15 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.033 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -70.63 -35.34 72.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.66 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.1 mt -58.92 -45.6 91.8 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 175.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.59 -49.02 62.95 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.08 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.26 -47.88 83.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.225 0.535 . . . . 0.0 112.083 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.426 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 10.0 m-85 -60.58 -41.96 95.71 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.988 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -49.52 -59.5 3.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.367 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -47.62 -42.5 24.4 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.414 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -55.6 -39.15 70.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.294 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -56.91 -41.52 78.29 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 m -65.09 -13.43 58.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.387 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.44 -43.47 97.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -106.73 -13.21 15.33 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -76.05 94.04 3.39 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.073 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -68.33 -46.7 69.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.41 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.7 p-10 -102.77 14.17 32.62 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.62 49.67 1.35 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.018 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -87.06 -5.01 59.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.944 0.372 . . . . 0.0 111.028 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.02 -2.05 81.19 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.6 p -137.32 151.61 48.83 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.143 0.496 . . . . 0.0 110.307 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.8 mp -93.34 125.24 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.7 p -114.1 165.04 13.05 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.671 0.748 . . . . 0.0 112.575 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.426 HG22 HG13 ' A' ' 52' ' ' ILE . 21.6 p -58.85 -35.34 72.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.823 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -61.25 -61.89 2.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.158 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.12 -29.54 70.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.773 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.549 HD22 HD11 ' A' ' 52' ' ' ILE . 2.8 tp -60.57 -56.77 17.31 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.123 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.66 -39.18 93.12 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.168 -1.378 . . . . 0.0 112.107 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.9 m -58.26 -54.65 44.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.05 1.425 . . . . 0.0 108.517 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -55.63 -47.04 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.014 -0.675 . . . . 0.0 111.674 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -58.65 -41.04 85.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 120.143 1.338 . . . . 0.0 110.085 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -51.97 -40.06 60.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.434 0.635 . . . . 0.0 110.351 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 23.0 t -63.57 -20.74 65.89 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.041 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 tp -73.91 -2.16 22.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.744 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.17 13.44 63.98 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.308 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -106.67 156.44 18.62 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 117.537 0.669 . . . . 0.0 110.045 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -115.67 63.44 2.07 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.376 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.07 144.2 92.15 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.244 1.962 . . . . 0.0 112.192 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.8 p -80.46 166.63 21.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.393 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -57.37 -44.63 84.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.13 -23.71 22.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.636 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -65.9 -39.4 90.59 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.147 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.48 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.2 mp -56.84 -42.34 79.49 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.311 0.577 . . . . 0.0 109.779 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -70.97 -57.07 4.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.851 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -54.95 -48.76 72.78 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 42.7 mmm -65.68 -50.64 64.19 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.549 HD11 HD22 ' A' ' 32' ' ' LEU . 26.4 mm -58.32 -47.13 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.789 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -55.68 -34.53 65.12 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -66.28 -39.82 89.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.86 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.416 HG21 ' CE2' ' B' 1110 ' ' PHE . 39.3 t -87.22 -20.09 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.388 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.0 t0 -78.1 85.61 4.29 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.22 -38.2 85.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 113.541 -1.663 . . . . 0.0 114.359 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.7 p-10 -86.65 -2.48 58.55 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.16 23.28 61.74 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 118.452 0.569 . . . . 0.0 112.597 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.438 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.1 p-10 -87.21 2.85 48.75 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.294 0.547 . . . . 0.0 110.568 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.44 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.6 1.92 89.0 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.3 p -148.14 168.55 22.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.4 mt -112.69 128.4 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 43.9 t0 -103.59 -175.51 2.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.647 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.515 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -56.31 -56.88 26.86 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -177.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 9.9 Cg_endo -50.26 -49.54 16.07 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 CA-C-N 120.522 1.222 . . . . 0.0 111.673 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -62.04 -18.85 61.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.262 0.553 . . . . 0.0 110.753 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -75.56 -58.81 3.06 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.748 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.9 mt -56.1 -45.24 79.52 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.8 m -44.05 -50.28 8.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.513 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 74.5 mtm -66.05 -43.93 86.04 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.48 ' O ' ' CE ' ' A' ' 76' ' ' MET . 15.2 mmt -57.52 -37.54 73.2 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.42 ' HB1' ' OD2' ' A' ' 2' ' ' ASP . . . -70.63 -35.23 72.83 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -93.76 -17.25 23.35 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 111.727 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.31 68.11 5.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.213 0.53 . . . . 0.0 110.456 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.48 ' CE ' ' O ' ' A' ' 72' ' ' MET . 24.3 mmt -108.81 15.47 23.54 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.608 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -52.89 131.62 35.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.637 0.732 . . . . 0.0 111.706 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -132.07 143.95 50.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.372 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.504 ' O ' ' CB ' ' A' ' 80' ' ' ASP . 35.8 p -127.14 -45.14 1.56 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 82' ' ' GLU . 99.8 m-20 126.15 134.84 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 125.357 1.66 . . . . 0.0 109.62 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 74.1 m -37.61 -17.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.212 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.9 mm-40 -68.51 -37.22 79.87 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.855 0.359 . . . . 0.0 111.653 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -47.67 -36.14 10.64 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.312 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -89.57 -16.73 29.97 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.064 0.459 . . . . 0.0 111.916 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 85' ' ' ILE . 26.3 mm -61.1 -74.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.541 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -61.58 -41.63 97.69 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.63 -41.01 94.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.587 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.36 -19.53 61.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.118 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -72.57 -51.26 20.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.841 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -54.95 -42.28 72.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.678 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.92 -43.88 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.0 m-85 -68.86 -38.04 79.47 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.916 -0.313 . . . . 0.0 111.471 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -90.71 83.39 5.76 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.85 -44.65 96.4 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -90.53 4.32 51.5 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 122.179 -0.326 . . . . 0.0 111.584 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.18 48.71 46.23 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -91.45 6.25 46.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.676 0.274 . . . . 0.0 110.402 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.11 0.14 90.08 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -137.94 151.91 48.43 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.611 0.72 . . . . 0.0 111.454 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.0 mt -95.14 115.28 33.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 92.1 p -91.53 154.58 19.0 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.91 -48.24 78.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 119.024 0.829 . . . . 0.0 111.071 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.52 -41.44 61.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.998 0.428 . . . . 0.0 110.594 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.67 -41.2 92.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.894 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 108' ' ' VAL . 9.2 tp -63.56 -46.7 84.72 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.974 -0.454 . . . . 0.0 111.22 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -44.25 -35.99 2.53 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.943 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -66.8 -26.7 67.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.033 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.582 HG21 ' CE2' ' A' ' 92' ' ' PHE . 83.0 t -58.19 -43.13 85.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.798 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.9 mtp -50.13 -47.24 54.23 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.901 0.858 . . . . 0.0 111.781 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 m -58.1 -41.64 83.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.682 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 38' ' ' SER . 2.9 m-80 -66.13 -41.81 89.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.823 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.6 mt -81.46 -15.47 54.93 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.86 30.18 61.94 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -86.06 -24.26 26.41 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.957 2.379 . . . . 0.0 110.691 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 45.57 60.08 3.28 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.689 0.756 . . . . 0.0 110.457 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.2 148.38 32.28 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.938 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 121' ' ' VAL . 80.7 p -82.12 174.69 10.98 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.344 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -57.89 -45.47 86.37 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.92 -49.95 74.03 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.584 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -68.52 -29.58 68.2 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.955 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 117' ' ' THR . 39.7 t -63.84 -41.51 92.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -66.65 -36.99 83.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.102 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -59.43 -53.32 59.5 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -44.64 76.6 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.334 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.48 -44.32 92.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.027 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -60.05 -38.56 83.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.829 0.347 . . . . 0.0 111.292 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.12 -41.76 84.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.25 -22.11 21.78 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.811 0.338 . . . . 0.0 111.687 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.7 t0 -73.7 87.69 1.7 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.33 0.586 . . . . 0.0 112.014 -177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.6 tp -69.3 -15.77 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 122.611 1.196 . . . . 0.0 113.495 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.6 p-10 -142.44 145.43 33.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.111 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.58 52.59 1.54 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.576 -0.345 . . . . 0.0 113.12 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -90.88 -9.25 46.96 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.089 0.445 . . . . 0.0 110.076 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.88 1.7 73.92 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.984 -0.627 . . . . 0.0 114.133 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -134.54 154.48 51.43 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.372 0.586 . . . . 0.0 110.202 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.9 t -100.39 118.47 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.438 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -84.0 173.87 10.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.787 0.327 . . . . 0.0 110.844 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -61.76 -39.41 91.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.018 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.29 -44.75 94.13 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.878 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.83 -38.69 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.591 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.64 -44.66 96.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.859 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.19 -47.01 89.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.4 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -49.37 -44.54 44.97 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.25 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.1 mmm -75.44 -39.31 59.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.6 mmt -74.36 -48.04 30.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.605 -0.146 . . . . 0.0 110.605 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 p -89.27 33.47 0.81 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.686 0.279 . . . . 0.0 111.591 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.04 85.57 4.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.789 0.328 . . . . 0.0 111.156 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.351 179.732 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -75.72 153.28 37.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.733 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.574 ' C ' ' H ' ' B' 1090 ' ' GLN . 21.9 ttm180 65.43 40.84 4.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.868 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -60.14 3.86 0.27 Allowed Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.574 ' H ' ' C ' ' B' 1088 ' ' ARG . 84.8 mt-30 -60.5 -45.06 95.16 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.664 0.268 . . . . 0.0 111.602 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 59.6 mt -57.43 -51.9 63.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.025 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.2 mt -57.22 -62.22 1.92 Allowed 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.244 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.0 m95 -59.99 -57.63 12.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.402 0.62 . . . . 0.0 112.077 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 41.5 t80 -57.54 -44.96 85.56 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -40.82 -51.11 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.42 -42.57 99.7 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.514 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 46.0 tp -56.11 -46.24 79.2 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.517 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 65.8 t30 -59.21 -49.28 78.46 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -65.22 -38.4 90.32 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 88.0 mt -60.79 -42.33 91.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.71 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -50.25 -44.73 53.67 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.519 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.0 m -63.6 -48.39 77.54 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.416 ' C ' ' O ' ' B' 1102 ' ' THR . 23.8 mt-30 -27.57 -60.18 0.1 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.738 1.256 . . . . 0.0 112.747 -177.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.1 mt -82.43 -14.8 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 112.33 -2.214 . . . . 0.0 111.968 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.519 ' N ' ' O ' ' B' 1102 ' ' THR . 17.3 ttmm -59.1 -45.04 91.91 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 117.845 -1.542 . . . . 0.0 107.937 176.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.2 t -60.78 -49.26 85.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.97 -36.35 77.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.305 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.0 mttt -49.35 -38.15 27.2 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.641 -0.662 . . . . 0.0 109.659 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.19 -45.99 68.81 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.341 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 55' ' ' VAL . 47.8 m-85 -62.87 -49.8 73.41 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -68.84 -40.96 79.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.2 t 67.48 59.26 0.5 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 116.906 -1.521 . . . . 0.0 107.743 -177.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 22.6 p . . . . . 0 N--CA 1.471 0.581 0 CA-C-N 124.105 3.138 . . . . 0.0 111.811 179.396 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -79.17 -5.0 53.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.995 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.453 ' NE2' ' CZ ' ' A' ' 12' ' ' PHE . 73.4 mt-30 -98.86 98.08 9.21 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.419 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.4 mt -113.44 -17.24 12.28 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.872 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.6 p -79.33 135.98 36.88 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.371 0.987 . . . . 0.0 110.36 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ILE . 48.6 tp10 -51.94 -55.43 20.33 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.97 0.891 . . . . 0.0 110.467 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -34.8 -36.33 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.773 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -70.1 -33.96 72.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.598 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.4 mm -59.2 -45.42 92.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.52 -51.36 59.96 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.383 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.92 -46.64 89.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.422 0.629 . . . . 0.0 112.221 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.453 ' CZ ' ' NE2' ' A' ' 3' ' ' GLN . 2.2 m-85 -62.81 -38.86 92.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.771 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -52.59 -53.67 43.57 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.177 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.85 -41.27 61.7 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.041 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -55.95 -37.88 69.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.355 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.61 -41.76 81.9 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 t -64.6 -14.85 59.77 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.476 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -63.97 -42.78 97.16 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -106.14 -13.82 15.33 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -76.4 95.09 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.422 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -68.35 -46.89 68.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.227 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 23' ' ' GLY . 35.4 p30 -101.89 14.17 32.71 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.02 46.47 0.94 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.031 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -85.77 -4.17 59.09 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.898 0.38 . . . . 0.0 111.044 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.69 80.79 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.9 p -137.64 152.09 48.98 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.078 0.466 . . . . 0.0 110.068 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.12 124.51 44.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.8 p -112.51 163.4 14.52 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.521 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.428 HG22 HG13 ' A' ' 52' ' ' ILE . 18.7 p -59.42 -36.62 76.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.052 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -61.73 -59.58 4.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.317 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.82 -28.92 70.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.558 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.521 HD22 HD11 ' A' ' 52' ' ' ILE . 3.1 tp -61.17 -54.41 44.73 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.461 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.53 -38.36 93.5 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.192 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.36 -53.92 52.82 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.835 1.318 . . . . 0.0 108.729 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.7 t -56.2 -45.92 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 O-C-N 121.341 -0.85 . . . . 0.0 111.223 -176.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.2 ttt -58.76 -38.98 79.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 120.157 1.344 . . . . 0.0 109.946 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -52.48 -40.41 62.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 110.725 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.2 p -63.08 -20.83 65.72 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.037 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.79 -1.43 19.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.805 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.0 23.97 39.44 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.389 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -125.76 166.81 16.12 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 117.369 0.585 . . . . 0.0 109.669 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 14.1 p30 -131.38 76.75 75.17 Favored Pre-proline 0 N--CA 1.466 0.342 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.461 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -63.87 148.85 91.69 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.941 2.427 . . . . 0.0 112.175 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.4 p -79.03 165.2 23.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.115 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -58.71 -45.0 90.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.85 -24.73 53.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.876 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -64.53 -40.92 96.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.139 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.5 mp -54.18 -38.79 65.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.222 0.534 . . . . 0.0 109.707 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -72.74 -55.34 6.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.797 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -54.68 -50.44 68.24 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 73.2 mtp -66.87 -49.35 65.97 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.521 HD11 HD22 ' A' ' 32' ' ' LEU . 27.6 mm -59.01 -47.78 88.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.769 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -57.33 -32.85 67.13 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -67.35 -40.25 85.83 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.8 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.12 -21.03 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.171 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.47 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.5 t0 -78.27 86.06 4.39 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -174.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.07 -37.1 81.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 113.427 -1.715 . . . . 0.0 114.184 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -86.47 -2.46 58.47 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.52 23.17 60.17 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 118.543 0.611 . . . . 0.0 112.707 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -87.47 4.72 42.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.205 0.503 . . . . 0.0 110.54 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.47 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.32 1.17 89.49 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.737 -0.602 . . . . 0.0 114.599 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.5 p -148.35 168.42 22.64 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.4 mt -112.91 128.67 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 45.7 t0 -104.03 -174.57 2.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.604 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.527 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -57.12 -57.21 26.28 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 10.4 Cg_endo -50.47 -49.86 15.32 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 CA-C-N 120.541 1.229 . . . . 0.0 111.569 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.89 -18.59 60.71 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.273 0.559 . . . . 0.0 110.72 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -73.47 -57.59 3.89 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.123 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' THR . 78.3 mt -57.74 -45.27 86.06 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 53.6 m -38.59 -64.57 0.42 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.749 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.487 ' SD ' ' N ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -63.17 -42.03 99.32 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -176.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.487 ' N ' ' SD ' ' A' ' 71' ' ' MET . 97.9 mmm -58.73 -40.69 84.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.02 -33.51 76.21 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 122.395 0.278 . . . . 0.0 111.022 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -95.21 -10.22 31.03 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.112 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.4 65.85 8.56 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.974 0.416 . . . . 0.0 110.375 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.5 mmt -108.24 16.22 23.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.569 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -49.1 133.34 18.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.394 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -90.75 106.86 18.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.968 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.454 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 15.7 m -91.8 120.18 32.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.6 m-20 -68.74 112.71 5.64 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.4 m -37.42 -20.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.768 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 80' ' ' ASP . 94.9 mt-10 -68.13 -39.8 82.61 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.733 0.302 . . . . 0.0 111.648 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -46.93 -35.32 6.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 -178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 -87.71 -19.4 27.67 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.954 0.407 . . . . 0.0 111.78 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 85' ' ' ILE . 30.4 mm -61.04 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.735 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -61.47 -41.2 96.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.05 -40.54 94.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.5 -178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.05 -20.5 64.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -71.57 -51.6 22.58 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.03 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -54.8 -42.34 71.7 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.347 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.73 -43.74 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.526 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.5 m-85 -68.89 -39.07 79.95 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.326 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -85.3 81.09 8.93 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -57.63 -49.46 76.37 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -91.85 4.82 52.03 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 122.181 -0.324 . . . . 0.0 111.42 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.76 48.31 50.87 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -90.37 6.34 43.57 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.739 0.304 . . . . 0.0 110.715 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.19 2.1 88.1 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -142.34 155.99 45.21 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.487 0.66 . . . . 0.0 111.463 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.0 mt -93.57 114.93 31.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 t -88.98 150.98 22.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.47 78.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 119.085 0.857 . . . . 0.0 110.815 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.21 -40.08 61.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.942 0.401 . . . . 0.0 110.419 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.37 -42.11 88.47 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.69 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.8 tp -62.84 -47.16 84.6 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.249 0.547 . . . . 0.0 111.079 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -43.01 -43.31 4.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.652 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -64.23 -28.63 69.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.005 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.526 HG21 ' CE2' ' A' ' 92' ' ' PHE . 92.9 t -57.78 -42.38 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.602 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.624 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -50.96 -44.12 60.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.699 0.761 . . . . 0.0 111.253 -177.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 m -56.28 -40.91 75.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.781 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -65.51 -41.02 93.63 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.79 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.8 mt -81.82 -13.77 57.23 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.905 -177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.2 31.36 59.55 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -85.31 -22.63 28.45 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 120.55 2.175 . . . . 0.0 111.286 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 44.16 60.93 2.55 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.71 0.767 . . . . 0.0 109.675 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.432 HD12 ' CG ' ' A' ' 109' ' ' MET . 88.9 mt -80.7 148.23 30.24 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 113.527 -1.67 . . . . 0.0 112.462 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 121' ' ' VAL . 65.4 p -82.85 175.5 10.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.3 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 119' ' ' GLU . 18.9 p-10 -58.41 -43.99 88.87 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 176.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.491 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 67.5 mm-40 -57.85 -49.16 77.6 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -70.87 -30.3 66.64 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.627 -0.429 . . . . 0.0 112.039 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 117' ' ' THR . 40.7 t -63.97 -41.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.6 0.714 . . . . 0.0 109.1 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -70.78 -35.6 72.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.339 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.41 -51.33 69.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 37.9 mmm -55.98 -44.62 78.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.253 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.8 mt -58.96 -43.49 88.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.404 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -60.73 -35.22 75.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.848 0.356 . . . . 0.0 111.153 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.453 ' OE1' ' NH2' ' B' 1087 ' ' ARG . 38.5 tp10 -59.45 -41.36 89.5 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.938 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.95 -20.51 22.09 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.43 ' OD1' ' OD1' ' A' ' 133' ' ' ASP . 21.4 t0 -73.09 89.05 1.45 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.528 0.68 . . . . 0.0 111.706 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 76.4 mt -70.08 -16.35 20.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.021 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 49.1 p-10 -140.48 144.82 36.25 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 112.644 -2.071 . . . . 0.0 108.805 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.27 52.17 1.41 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.899 -0.191 . . . . 0.0 113.154 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 22.0 p-10 -91.24 -8.84 47.29 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.966 0.383 . . . . 0.0 110.057 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.86 3.17 79.64 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.117 -0.564 . . . . 0.0 114.125 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -136.09 155.2 50.54 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.444 0.622 . . . . 0.0 110.383 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.9 t -101.56 119.01 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.207 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -84.79 175.64 9.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.597 0.237 . . . . 0.0 110.89 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -61.64 -41.12 97.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.306 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -61.61 -45.0 95.93 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.704 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.59 -38.0 88.25 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.668 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 90.9 t80 -58.57 -44.64 89.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.999 0.428 . . . . 0.0 110.796 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.03 -46.13 88.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.411 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -48.35 -44.58 34.49 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.03 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 77.3 mmm -75.73 -36.48 59.92 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.585 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.6 mmt -65.96 -50.98 62.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 147' ' ' ALA . 6.7 m -85.67 -124.65 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.08 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.428 ' N ' HG22 ' A' ' 146' ' ' THR . . . -94.04 139.1 31.38 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.673 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.9 tttm . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.748 -179.936 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . 0.53 HD12 ' N ' ' B' 1086 ' ' LEU . 10.4 mp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . 0.453 ' NH2' ' OE1' ' A' ' 127' ' ' GLU . 84.0 mtp180 -64.06 -40.42 96.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.364 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.533 ' C ' ' H ' ' B' 1090 ' ' GLN . 43.8 ttt-85 40.45 48.65 2.49 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -61.86 2.69 0.86 Allowed Glycine 0 CA--C 1.529 0.967 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.533 ' H ' ' C ' ' B' 1088 ' ' ARG . 77.7 mt-30 -61.43 -49.78 75.48 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . 0.667 HD12 ' H ' ' B' 1092 ' ' LEU . 0.6 OUTLIER -51.21 -56.94 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . 0.667 ' H ' HD12 ' B' 1091 ' ' ILE . 9.3 mt -49.53 -55.36 13.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -175.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.8 m95 -63.4 -47.29 82.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . 0.532 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 2.4 m-85 -58.02 -46.3 85.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -40.51 -53.46 2.67 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.85 -42.11 99.71 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.129 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 50.8 tp -56.85 -44.6 82.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.217 1.008 . . . . 0.0 109.592 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 12.4 m120 -58.8 -47.6 84.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -65.06 -37.46 87.63 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.12 -42.43 93.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.772 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -50.83 -45.88 59.74 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 118.863 -1.135 . . . . 0.0 108.039 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.527 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.8 m -63.64 -48.22 78.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.434 -0.506 . . . . 0.0 112.152 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.429 ' C ' ' O ' ' B' 1102 ' ' THR . 84.3 mt-30 -27.79 -57.78 0.11 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 122.457 1.122 . . . . 0.0 112.451 -176.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . 0.404 HG21 HD13 ' B' 1104 ' ' ILE . 1.5 mt -83.98 -14.45 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 112.587 -2.097 . . . . 0.0 112.365 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.527 ' N ' ' O ' ' B' 1102 ' ' THR . 65.7 tttm -59.72 -46.28 89.59 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 118.152 -1.419 . . . . 0.0 107.972 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 86.2 t -61.08 -49.31 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.64 -35.97 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.329 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . 0.454 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 88.8 mttt -49.31 -37.75 25.28 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.646 0.657 . . . . 0.0 109.641 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.59 -45.91 66.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.295 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -62.9 -50.23 71.7 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -67.81 -41.81 82.53 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.3 m 68.24 58.01 0.46 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 117.209 -1.377 . . . . 0.0 107.414 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 47.6 p . . . . . 0 N--CA 1.476 0.87 0 CA-C-N 123.78 2.991 . . . . 0.0 111.846 179.608 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.416 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 92.6 m-20 -62.62 -40.62 97.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.966 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.472 ' CD ' ' O ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER 157.68 99.97 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.37 -16.7 10.85 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.166 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.7 m -81.07 136.43 35.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.093 0.861 . . . . 0.0 110.366 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.1 tt0 -51.01 -58.84 5.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.795 0.807 . . . . 0.0 110.991 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -33.8 -38.64 0.05 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.855 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -68.86 -35.06 76.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.49 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.561 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.6 mt -58.32 -45.11 89.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.55 -51.28 63.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.201 -1.0 . . . . 0.0 111.097 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -59.82 -48.27 82.34 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.283 0.564 . . . . 0.0 112.384 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -61.37 -40.4 94.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.952 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -51.63 -56.9 10.93 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.734 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -47.35 -43.65 23.26 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.462 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.82 -39.04 65.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.987 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -56.92 -42.37 79.86 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -64.25 -15.49 60.2 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.056 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.8 mt -64.96 -41.34 95.56 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -105.99 -13.65 15.42 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -74.4 95.84 2.77 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.565 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -68.86 -49.46 58.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.111 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.0 p-10 -101.84 15.76 28.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 33.87 47.82 0.51 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.035 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 33.9 p-10 -85.24 -5.18 59.34 Favored 'General case' 0 N--CA 1.461 0.106 0 O-C-N 122.69 -0.3 . . . . 0.0 111.038 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.72 -1.93 79.3 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.85 -0.5 . . . . 0.0 111.85 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.0 p -138.25 153.89 49.08 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.693 ' N ' HD12 ' A' ' 27' ' ' ILE . 2.0 mp -93.0 125.46 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.519 HG22 ' OE1' ' A' ' 31' ' ' GLU . 10.0 t -116.86 166.37 12.24 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.421 HG22 HG13 ' A' ' 52' ' ' ILE . 37.5 p -56.79 -32.45 65.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.662 -1.153 . . . . 0.0 111.407 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -59.78 -63.61 1.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.298 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' OE1' HG22 ' A' ' 28' ' ' THR . 4.7 pt-20 -62.54 -30.49 71.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 119.326 -0.369 . . . . 0.0 111.882 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.404 HD22 HD11 ' A' ' 52' ' ' ILE . 4.1 tp -58.25 -61.3 2.67 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 118.821 -1.151 . . . . 0.0 108.69 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.19 72.96 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.323 -1.308 . . . . 0.0 112.098 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.8 m -56.67 -53.64 55.4 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.782 1.791 . . . . 0.0 108.431 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.71 -45.64 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 119.196 0.907 . . . . 0.0 111.563 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.417 ' SD ' HD12 ' A' ' 39' ' ' LEU . 9.2 tpt -58.2 -41.69 84.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 120.355 1.434 . . . . 0.0 109.698 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -52.3 -39.85 61.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.506 0.67 . . . . 0.0 111.32 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 t -62.96 -20.52 65.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.706 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.417 HD12 ' SD ' ' A' ' 36' ' ' MET . 80.4 mt -74.98 2.21 11.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.167 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.1 26.81 47.29 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.978 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -125.8 166.65 16.45 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 117.41 0.605 . . . . 0.0 109.91 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -124.11 81.07 57.63 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.23 146.76 52.02 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.802 1.668 . . . . 0.0 112.204 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -80.29 163.19 24.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.84 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -58.02 -44.48 87.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.097 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.74 -24.49 35.42 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.771 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -65.25 -40.62 94.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.895 0.378 . . . . 0.0 110.657 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 6.8 mp -56.2 -41.05 74.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.638 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -70.01 -56.93 5.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.826 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -55.27 -49.69 71.43 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.5 mtp -66.21 -51.4 58.04 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.421 HG13 HG22 ' A' ' 29' ' ' THR . 25.7 mm -57.64 -49.18 81.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -56.15 -32.57 64.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -67.26 -40.39 86.22 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.868 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.7 t -86.27 -20.32 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.425 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.404 ' OD1' ' OD1' ' A' ' 58' ' ' ASP . 43.5 t0 -78.69 83.64 4.83 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -174.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.7 75.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 113.595 -1.639 . . . . 0.0 114.748 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.454 ' OD2' ' OD1' ' A' ' 60' ' ' ASN . 26.1 p30 -88.61 -1.66 58.18 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.17 23.84 60.22 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 118.664 0.666 . . . . 0.0 112.95 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.627 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -87.52 2.97 49.21 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 117.42 0.61 . . . . 0.0 110.368 179.316 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.18 1.73 86.2 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 114.831 0.692 . . . . 0.0 114.831 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.627 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 19.2 p -147.66 169.65 19.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.3 mt -112.22 128.17 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.097 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -102.46 -178.99 3.85 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.761 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.96 99.78 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -54.13 -51.83 9.73 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.071 1.181 . . . . 0.0 111.978 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.24 -23.19 66.53 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.388 0.613 . . . . 0.0 111.269 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -71.18 -61.11 1.89 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.514 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.5 mt -56.69 -43.81 80.85 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.1 p -44.0 -51.72 7.56 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.605 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.0 mtm -64.9 -44.65 88.9 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.6 mmm -61.23 -41.06 96.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.69 -34.91 79.31 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.415 0.286 . . . . 0.0 111.623 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -91.91 -16.25 26.91 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.722 0.296 . . . . 0.0 111.331 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 27.8 tptp -80.49 71.62 7.34 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.819 0.819 . . . . 0.0 110.631 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 20.6 mmt -109.5 15.35 23.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.255 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -47.77 131.27 14.88 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.237 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -89.28 109.62 20.49 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.927 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.518 HG21 ' NZ ' ' B' 1108 ' ' LYS . 17.2 p -97.98 114.79 27.02 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.5 OUTLIER -64.99 115.5 5.46 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 62.6 m -37.44 -21.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.845 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 80' ' ' ASP . 42.5 tp10 -68.26 -35.86 78.54 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.028 0.442 . . . . 0.0 111.707 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 80.2 tt0 -49.6 -37.2 26.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.341 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -87.35 -16.3 35.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.128 0.49 . . . . 0.0 111.701 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 85' ' ' ILE . 29.5 mm -62.57 -73.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.735 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 -60.39 -44.21 95.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 87' ' ' GLU . 7.1 mp0 -61.05 -41.29 96.32 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.364 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.5 -17.84 47.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.188 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -75.15 -49.67 18.79 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.476 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -55.4 -42.94 74.76 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.932 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.9 t -65.13 -44.12 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.488 ' CE2' HG21 ' A' ' 108' ' ' VAL . 8.0 m-85 -69.82 -38.16 76.47 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.635 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.561 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 31.4 t0 -88.32 82.59 7.01 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.12 -48.59 78.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 40.7 p-10 -91.65 5.47 49.56 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.1 50.13 40.56 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.741 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -92.62 5.11 52.17 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.416 0.287 . . . . 0.0 110.818 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.465 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 85.25 0.21 88.61 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.741 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 87.0 m-85 -138.74 152.12 47.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.944 0.878 . . . . 0.0 111.887 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 95.8 mt -94.79 117.37 38.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.1 m -89.46 148.12 23.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.529 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.29 -48.03 74.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 119.66 1.118 . . . . 0.0 110.17 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -50.38 -42.61 53.71 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.75 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.91 -41.05 97.78 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.34 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.33 -45.28 92.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.552 0.691 . . . . 0.0 111.203 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 74.5 ttp85 -44.28 -44.94 8.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.551 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -63.63 -31.33 72.47 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.331 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.488 HG21 ' CE2' ' A' ' 92' ' ' PHE . 84.5 t -56.05 -42.15 71.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.004 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.736 ' SD ' HD12 ' A' ' 116' ' ' LEU . 16.0 mmt -51.31 -44.38 61.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.795 0.807 . . . . 0.0 111.222 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 m -53.76 -42.03 67.81 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.952 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -66.4 -41.17 89.72 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.521 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.6 mt -81.31 -16.03 53.65 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.08 30.39 59.15 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-O 118.258 -1.301 . . . . 0.0 110.546 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -85.66 -22.27 27.98 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 121.341 2.571 . . . . 0.0 110.982 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 43.76 60.42 2.69 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 122.18 0.99 . . . . 0.0 110.056 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.736 HD12 ' SD ' ' A' ' 109' ' ' MET . 40.4 mt -80.49 147.24 30.97 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 113.64 -1.618 . . . . 0.0 111.799 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 121' ' ' VAL . 28.5 p -82.14 174.89 10.78 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -56.55 -44.98 81.45 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -57.7 -47.25 82.89 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.594 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -73.22 -30.18 63.31 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.762 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 117' ' ' THR . 44.5 t -64.68 -41.71 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.463 0.649 . . . . 0.0 109.864 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 67.7 t0 -73.45 -34.8 65.58 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.291 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -59.5 -50.01 75.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.934 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.0 mtp -53.58 -46.6 70.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.285 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.8 mm -56.41 -43.54 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -60.1 -36.5 77.56 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.288 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -58.68 -41.18 85.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.846 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.91 -17.16 25.61 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.8 t0 -72.54 90.74 1.36 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.737 0.78 . . . . 0.0 112.213 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.405 ' O ' HG22 ' A' ' 130' ' ' ILE . 79.3 mt -71.74 -17.63 19.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.158 -1.383 . . . . 0.0 113.123 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 50.4 p-10 -142.72 144.28 32.62 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 112.65 -2.068 . . . . 0.0 108.813 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.41 53.82 1.53 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.129 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -90.85 -8.87 48.35 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.051 0.425 . . . . 0.0 110.14 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.52 1.64 71.73 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.997 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -134.76 155.33 50.78 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.159 0.479 . . . . 0.0 110.439 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.3 t -100.91 118.42 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.322 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.42 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 53.3 t30 -84.46 173.7 10.65 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.774 0.321 . . . . 0.0 111.258 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.42 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 82.5 t80 -61.0 -40.6 94.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.96 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.06 -44.63 96.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.794 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.48 -37.24 86.25 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.549 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -61.12 -45.04 96.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.046 0.451 . . . . 0.0 111.046 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.69 -47.18 89.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.829 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -50.58 -41.93 55.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.145 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.6 mmt -74.67 -38.57 62.39 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 19.9 mmt -73.17 -46.12 52.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.0 p -87.93 29.94 0.88 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.576 0.227 . . . . 0.0 111.456 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.79 84.54 5.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.727 0.299 . . . . 0.0 110.819 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.0 tptp . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.24 179.746 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . 0.559 ' N ' HD22 ' B' 1086 ' ' LEU . 3.5 mm? . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 61.3 ttt85 -61.82 -41.74 98.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.395 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.531 ' C ' ' H ' ' B' 1090 ' ' GLN . 8.0 mpt_? -82.78 93.22 7.39 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.94 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -50.98 -9.4 0.3 Allowed Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.559 ' H ' ' CD ' ' B' 1090 ' ' GLN . 20.8 mp0 -63.51 -47.36 82.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.848 -0.176 . . . . 0.0 111.46 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.19 -51.79 66.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.689 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 15.0 mt -55.24 -60.09 3.88 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.417 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.7 m95 -61.33 -55.76 28.02 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.462 0.649 . . . . 0.0 112.172 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 50.3 t80 -57.94 -46.98 84.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 115.921 1.823 . . . . 0.0 115.921 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . 0.684 HH21 ' NH2' ' B' 1099 ' ' ARG . 59.4 ttt85 -40.31 -52.75 2.65 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.4 -40.62 98.91 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 48.7 tp -56.0 -46.32 78.78 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.689 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -58.63 -49.88 75.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . 0.684 ' NH2' HH21 ' B' 1095 ' ' ARG . 91.2 mtt180 -63.87 -39.76 94.95 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.77 -42.61 89.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.14 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -52.29 -47.42 65.91 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 118.605 -1.238 . . . . 0.0 107.677 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.527 ' O ' ' N ' ' B' 1105 ' ' LYS . 18.8 m -61.58 -48.87 78.99 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 25.2 mt-30 -27.57 -57.95 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 122.709 1.242 . . . . 0.0 113.382 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.0 mt -81.68 -14.42 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 112.434 -2.166 . . . . 0.0 112.389 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.527 ' N ' ' O ' ' B' 1102 ' ' THR . 93.4 mttt -59.28 -41.87 89.9 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.27 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 90.8 t -60.39 -46.7 94.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.994 0.902 . . . . 0.0 112.24 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 55.5 t -65.59 -42.34 92.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.877 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . 0.518 ' NZ ' HG21 ' A' ' 79' ' ' THR . 94.0 mttt -49.25 -41.32 37.2 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.848 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.25 61.66 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.693 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -60.44 -65.65 0.65 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.848 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . 0.649 ' ND1' ' N ' ' B' 1112 ' ' SER . 35.4 p80 -89.78 -54.22 4.16 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . 0.649 ' N ' ' ND1' ' B' 1111 ' ' HIS . 2.9 p 85.75 92.51 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 117.642 -1.171 . . . . 0.0 109.858 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . 0.423 ' OG ' ' O ' ' B' 1112 ' ' SER . 17.9 p . . . . . 0 C--O 1.219 -0.515 0 CA-C-N 123.526 2.876 . . . . 0.0 110.724 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 3' ' ' GLN . 37.5 p-10 -63.88 -41.87 97.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.262 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.482 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 0.0 OUTLIER 156.18 92.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.86 0.725 . . . . 0.0 109.282 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.91 -25.37 13.07 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.306 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -80.92 140.21 35.43 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.15 0.886 . . . . 0.0 110.196 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.5 tt0 -50.39 -56.26 12.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 122.167 0.984 . . . . 0.0 110.642 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -34.83 -37.77 0.07 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.189 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -68.9 -38.59 79.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.72 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.493 ' N ' ' O ' ' A' ' 6' ' ' GLU . 66.6 mt -56.85 -45.74 83.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.62 -51.27 63.61 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.455 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -61.43 -47.33 86.25 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.466 0.65 . . . . 0.0 112.246 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 11.0 m-85 -62.83 -37.7 87.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.897 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -54.59 -52.21 62.86 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.777 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -51.08 -39.99 57.34 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.082 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.84 -38.0 72.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.309 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -58.04 -42.31 85.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.1 t -65.03 -14.79 61.32 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.6 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.74 -43.05 99.81 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.39 -12.56 15.97 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.72 94.84 3.32 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.265 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -65.04 -47.89 75.78 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.521 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 8.9 p30 -109.69 14.5 23.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.31 59.78 1.47 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.193 -0.527 . . . . 0.0 112.303 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -87.54 -6.79 58.19 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.804 0.335 . . . . 0.0 110.237 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.91 -1.63 74.8 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.0 p -139.77 156.66 46.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.015 0.436 . . . . 0.0 109.998 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.639 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.8 mp -89.2 123.1 41.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -111.46 162.71 14.8 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.91 0.757 . . . . 0.0 112.41 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.425 HG22 HG13 ' A' ' 52' ' ' ILE . 18.8 p -60.33 -38.52 84.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.859 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -59.75 -62.21 2.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.821 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -62.0 -28.1 69.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.652 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.476 HD22 HD11 ' A' ' 52' ' ' ILE . 2.9 tp -60.43 -52.66 64.28 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.471 178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.54 -35.91 91.81 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.891 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.67 -52.42 65.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.828 1.314 . . . . 0.0 108.632 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.8 t -58.65 -45.06 90.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 119.267 0.94 . . . . 0.0 111.231 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.484 ' SD ' ' O ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -59.54 -40.29 86.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 119.782 1.173 . . . . 0.0 109.789 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -52.58 -38.12 59.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.403 0.621 . . . . 0.0 110.041 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.2 p -62.27 -20.01 63.84 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.177 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -73.82 2.24 8.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.99 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.24 26.23 40.97 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.132 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -131.75 171.3 13.67 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.356 0.578 . . . . 0.0 109.817 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 42' ' ' ASN . 16.9 p-10 -132.77 76.79 70.34 Favored Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.409 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.46 146.27 97.13 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.783 2.322 . . . . 0.0 111.93 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.2 p -76.28 163.85 26.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.173 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -58.59 -43.64 89.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.848 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.78 -24.25 49.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.378 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -65.38 -39.51 92.34 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.154 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.0 mp -56.71 -41.03 76.71 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.395 0.617 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -72.1 -56.12 6.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.008 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -55.99 -49.72 72.84 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 40.8 mmm -64.59 -50.86 65.57 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.476 HD11 HD22 ' A' ' 32' ' ' LEU . 25.8 mm -59.23 -45.37 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.346 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -56.97 -34.68 68.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.35 -40.68 85.85 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.872 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.437 HG21 ' CE2' ' B' 1110 ' ' PHE . 54.8 t -84.93 -21.95 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.471 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.496 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.6 t0 -78.6 87.15 4.55 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -175.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.68 -37.19 85.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 113.356 -1.747 . . . . 0.0 113.669 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 39.9 p-10 -86.05 -2.46 58.34 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.66 23.09 60.39 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.313 0.506 . . . . 0.0 112.942 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -88.26 4.13 47.01 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.3 0.55 . . . . 0.0 110.354 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.496 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.05 0.87 88.89 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 121.091 -0.576 . . . . 0.0 114.383 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.1 p -147.87 169.2 20.32 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.5 mt -111.93 128.11 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 23.7 t0 -102.29 -178.14 3.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.658 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.546 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -57.03 -48.31 97.64 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -55.79 -49.34 16.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.26 1.306 . . . . 0.0 111.824 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.01 -20.65 64.14 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.487 0.661 . . . . 0.0 110.662 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -74.8 -57.0 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.131 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 72.8 mt -58.08 -45.23 87.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -47.29 -46.59 25.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.321 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 81.4 mtp -66.62 -45.29 79.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.6 mmt -60.13 -40.68 90.63 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.1 -34.8 78.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.531 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -92.3 -16.86 25.53 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.64 0.257 . . . . 0.0 111.461 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 67.31 7.11 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.197 0.522 . . . . 0.0 110.709 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 22.9 mmt -107.99 16.8 23.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.517 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -49.3 132.59 20.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.981 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -89.57 109.11 20.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.871 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -95.28 118.88 32.83 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -66.65 113.32 4.71 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 174.318 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.8 m -37.8 -20.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.751 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.556 ' N ' ' O ' ' A' ' 80' ' ' ASP . 5.3 mp0 -66.87 -41.9 86.52 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -45.21 -35.64 3.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.319 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -87.52 -20.3 26.7 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.003 0.43 . . . . 0.0 111.865 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 30.4 mm -60.11 -74.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.669 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -63.09 -40.21 96.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.09 -40.76 94.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.434 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.8 -20.75 63.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.136 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -70.74 -50.43 36.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.075 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -55.38 -41.84 73.18 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.414 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.11 -45.05 97.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.559 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.5 m-85 -68.94 -39.67 79.42 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.423 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -85.52 81.29 8.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -58.81 -48.89 79.72 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -91.31 4.87 51.28 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.344 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.55 48.3 49.58 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -90.7 7.32 40.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.665 0.269 . . . . 0.0 110.51 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.64 1.93 88.95 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -142.39 155.77 45.16 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.716 0.77 . . . . 0.0 111.491 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.3 mt -93.33 114.26 29.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.3 m -88.83 151.52 22.32 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.54 -48.98 77.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 118.838 0.745 . . . . 0.0 110.895 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.77 -40.81 60.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.9 0.381 . . . . 0.0 110.726 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -64.98 -40.86 95.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.027 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 108' ' ' VAL . 7.4 tt -63.42 -45.02 92.87 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.337 0.589 . . . . 0.0 111.408 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.485 ' HE ' HG11 ' A' ' 121' ' ' VAL . 24.5 mmt85 -40.7 -37.87 0.81 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.71 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.61 ' CE1' HD21 ' A' ' 111' ' ' ASN . 56.8 t-80 -69.31 -25.32 64.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.783 0.325 . . . . 0.0 111.46 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.559 HG21 ' CE2' ' A' ' 92' ' ' PHE . 90.1 t -59.01 -44.88 92.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.625 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.708 ' SD ' HD12 ' A' ' 116' ' ' LEU . 16.4 mmt -52.02 -44.95 64.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.12 0.962 . . . . 0.0 111.234 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.5 m -58.62 -42.73 88.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 113.531 -1.668 . . . . 0.0 110.706 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.61 HD21 ' CE1' ' A' ' 107' ' ' HIS . 1.1 m-80 -65.73 -41.49 92.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.148 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.7 mt -81.52 -15.88 53.5 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.879 -0.329 . . . . 0.0 111.812 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.53 30.65 57.95 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.418 ' OE1' ' SD ' ' A' ' 109' ' ' MET . 96.9 mt-10 -85.66 -23.24 27.55 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.552 2.176 . . . . 0.0 110.578 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt 43.84 59.62 3.05 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.927 0.87 . . . . 0.0 110.366 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.708 HD12 ' SD ' ' A' ' 109' ' ' MET . 44.6 mt -79.69 148.83 31.42 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.519 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 72.6 p -82.91 174.78 10.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.197 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -57.99 -44.5 87.2 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.81 -48.81 78.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.484 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.0 -31.54 69.27 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.821 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.485 HG11 ' HE ' ' A' ' 106' ' ' ARG . 30.3 t -63.17 -43.29 98.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.487 0.66 . . . . 0.0 109.343 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -67.06 -37.74 84.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.582 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -59.77 -50.36 74.13 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 20.1 mmm -57.12 -44.08 82.94 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.342 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.9 mt -59.9 -43.41 92.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.044 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -58.94 -38.63 79.44 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.999 0.428 . . . . 0.0 111.199 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -58.73 -40.61 84.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.006 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.6 -21.44 21.72 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.0 t0 -74.23 88.55 2.0 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.486 0.66 . . . . 0.0 111.883 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 42.7 mm -71.93 -14.19 17.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 122.624 1.202 . . . . 0.0 113.13 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.6 p-10 -142.84 144.59 32.58 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 112.414 -2.176 . . . . 0.0 109.251 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.02 52.23 1.32 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.784 -0.246 . . . . 0.0 112.968 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -90.85 -10.07 44.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.061 0.431 . . . . 0.0 110.056 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.12 1.11 67.62 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.195 -0.526 . . . . 0.0 114.221 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -134.9 153.76 51.94 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.435 0.618 . . . . 0.0 110.433 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.21 118.61 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.243 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.1 174.86 9.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.733 0.301 . . . . 0.0 110.858 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -61.65 -40.16 93.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.965 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.54 -44.64 95.86 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.837 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.26 -37.85 88.47 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.505 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -60.26 -45.42 93.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.076 0.465 . . . . 0.0 110.721 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.55 -46.59 89.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.458 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.753 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 51.9 tt0 -48.78 -47.12 42.2 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.893 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.7 mmm -72.33 -37.57 68.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.431 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 24.2 mmt -72.11 -45.23 61.4 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.857 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 147' ' ' ALA . 4.8 m -82.62 -30.98 29.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.066 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.753 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -35.46 100.12 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.195 0.521 . . . . 0.0 111.397 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.594 179.341 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -158.76 -157.47 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.558 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.543 ' C ' ' H ' ' B' 1090 ' ' GLN . 53.0 ttt85 61.3 41.2 13.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.573 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -64.31 5.47 1.01 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.543 ' H ' ' C ' ' B' 1088 ' ' ARG . 85.7 mt-30 -56.84 -41.09 77.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.871 0.367 . . . . 0.0 111.277 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 64.6 mt -44.19 -65.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.5 mt -55.71 -51.28 67.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.549 -0.46 . . . . 0.0 112.162 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.7 m95 -58.11 -65.01 0.72 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.752 0.787 . . . . 0.0 111.875 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . 0.431 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 38.0 m-85 -56.68 -43.35 80.36 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -174.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 12.3 tpp85 -39.73 -51.49 2.34 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.12 99.94 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.47 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.0 tp -56.35 -45.69 80.32 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.501 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -59.79 -49.09 79.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.878 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -65.77 -37.67 86.95 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.11 -42.04 91.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.903 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -51.47 -45.39 62.75 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.507 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.1 m -64.27 -47.99 77.44 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.825 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 84.0 mt-30 -27.98 -57.08 0.11 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.83 1.3 . . . . 0.0 112.597 -176.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.89 -13.94 11.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 CA-C-N 112.519 -2.128 . . . . 0.0 112.578 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.507 ' N ' ' O ' ' B' 1102 ' ' THR . 88.6 tttt -57.51 -41.65 81.25 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 118.316 -1.354 . . . . 0.0 107.95 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 77.5 t -62.74 -46.82 95.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.724 0.773 . . . . 0.0 112.814 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 37.1 t -65.83 -42.08 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.209 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 97.0 mttt -48.79 -38.07 20.96 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.833 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.87 -45.04 67.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.076 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . 0.437 ' CE2' HG21 ' A' ' 55' ' ' VAL . 48.7 m-85 -63.25 -50.0 71.9 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -68.17 -42.38 80.08 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.2 t 68.97 59.87 0.35 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 20.3 t . . . . . 0 N--CA 1.473 0.712 0 CA-C-N 123.228 2.74 . . . . 0.0 112.017 179.392 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 3' ' ' GLN . 24.7 p30 -64.53 -34.86 79.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.298 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.618 ' NE2' ' N ' ' A' ' 5' ' ' THR . 27.4 tp60 159.54 103.08 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 O-C-N 124.136 0.897 . . . . 0.0 109.437 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.9 mt -119.32 -9.76 9.85 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.271 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.618 ' N ' ' NE2' ' A' ' 3' ' ' GLN . 61.3 p -79.81 133.22 36.28 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.643 1.111 . . . . 0.0 111.12 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 9' ' ' ILE . 84.7 tt0 -54.66 -51.3 65.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.769 0.795 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -34.17 -36.01 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 113.988 -1.46 . . . . 0.0 111.129 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.61 -32.87 70.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.475 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' A' ' 6' ' ' GLU . 93.7 mt -57.83 -45.73 87.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.89 -50.14 61.62 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.412 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.15 -44.76 91.15 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.439 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.1 m-85 -62.98 -40.79 98.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.753 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -52.14 -55.58 19.99 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.204 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -49.87 -41.84 46.34 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.116 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -54.83 -35.66 64.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.503 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.434 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 2.5 m-85 -57.73 -39.61 77.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.4 m -65.95 -16.06 63.54 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.255 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 2.7 mm? -64.23 -41.99 96.75 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.78 -15.25 14.78 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.897 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -74.99 94.72 2.89 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.145 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -67.15 -48.22 68.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.802 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.0 p30 -103.25 14.68 31.07 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 38.08 50.48 2.14 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.0 -0.619 . . . . 0.0 111.961 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -87.57 -5.17 58.88 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.925 0.362 . . . . 0.0 111.572 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.43 -0.59 78.01 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.7 p -140.07 157.9 44.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.981 0.42 . . . . 0.0 109.954 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 mm -88.03 122.81 40.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 p -111.57 161.56 16.07 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.012 0.82 . . . . 0.0 112.276 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 p -59.26 -38.4 79.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.708 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -60.99 -60.05 4.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.06 -30.16 71.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.766 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 tp -60.54 -55.92 27.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.322 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.99 -37.56 91.66 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.806 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -58.5 -53.71 55.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 119.317 1.558 . . . . 0.0 108.434 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.7 t -56.97 -46.69 84.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.598 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.0 ttt -58.51 -42.26 87.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 120.27 1.395 . . . . 0.0 110.189 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -52.27 -37.62 55.95 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.481 0.658 . . . . 0.0 110.15 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.0 t -63.69 -21.22 66.28 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.517 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.52 0.4 17.4 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.756 -0.777 . . . . 0.0 109.935 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 18.21 62.59 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.173 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -109.81 157.91 18.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.72 0.76 . . . . 0.0 110.038 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -113.0 66.15 0.96 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.443 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.74 142.68 90.11 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.075 1.85 . . . . 0.0 112.302 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -82.36 166.78 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.447 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -58.29 -44.77 88.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.851 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.43 -23.59 25.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.635 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.65 -39.02 90.95 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.273 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 7.8 mp -56.45 -41.31 76.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.23 0.538 . . . . 0.0 109.662 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.425 ' OE1' ' ND2' ' A' ' 53' ' ' ASN . 8.9 tp-100 -68.78 -58.52 4.08 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.71 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -55.05 -49.37 71.78 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.9 mmm -63.81 -53.91 43.38 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 52' ' ' ILE . 26.4 mm -58.31 -47.63 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.83 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.425 ' ND2' ' OE1' ' A' ' 49' ' ' GLN . 34.3 m-80 -56.49 -33.64 66.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -66.41 -40.31 89.49 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.596 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.47 HG21 ' CD2' ' B' 1110 ' ' PHE . 76.3 t -86.65 -19.8 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.42 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 40.6 t0 -78.98 84.59 4.98 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -174.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.28 -37.39 83.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.626 -1.625 . . . . 0.0 114.238 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.454 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.7 p-10 -86.1 -2.35 58.25 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.5 23.34 62.55 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 118.383 0.538 . . . . 0.0 112.696 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.454 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.4 p-10 -87.5 1.96 52.02 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.27 0.535 . . . . 0.0 110.606 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.552 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 86.73 1.58 85.17 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.685 0.634 . . . . 0.0 114.685 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.3 p -148.84 170.9 17.22 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.416 HD12 HG12 ' A' ' 55' ' ' VAL . 15.9 mm -110.85 128.29 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -102.35 -178.27 3.64 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.434 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -58.06 -48.96 96.16 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -55.94 -51.86 8.67 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.536 1.491 . . . . 0.0 111.537 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.1 -19.99 62.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.607 0.717 . . . . 0.0 110.354 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -75.95 -58.99 2.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.2 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.87 -44.94 78.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.9 p -45.75 -44.29 13.66 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.561 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.5 mtp -71.89 -49.48 37.55 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.4 mmm -61.01 -40.72 94.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -177.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.16 -33.58 76.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.66 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -93.45 -14.82 26.27 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.627 0.251 . . . . 0.0 111.529 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 mmpp? -77.87 71.91 4.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.163 0.506 . . . . 0.0 111.311 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.7 mmt -107.03 18.33 21.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.858 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -51.73 129.87 27.25 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.197 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -90.69 105.18 17.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.135 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.495 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 3.1 m -88.45 123.18 32.74 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 82' ' ' GLU . 15.5 t0 -69.43 109.86 4.43 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 174.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.8 m -37.04 -21.1 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 80' ' ' ASP . 50.6 mp0 -70.33 -34.14 72.32 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 111.835 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.444 ' O ' ' OE1' ' A' ' 87' ' ' GLU . 81.1 tt0 -50.32 -39.14 45.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.266 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 76.7 mt-10 -88.34 -5.57 58.24 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 85' ' ' ILE . 26.9 mm -70.79 -74.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.85 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -61.48 -50.39 72.95 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 83' ' ' GLU . 16.1 pt-20 -54.41 -38.77 66.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -60.79 -20.03 60.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.014 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -73.99 -48.1 32.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.771 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -54.59 -41.01 69.39 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.418 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.91 -43.29 92.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.553 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.6 m-85 -68.78 -39.03 80.38 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.248 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 30.1 t0 -87.36 82.8 7.46 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.88 -49.45 76.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 35.6 p-10 -90.91 5.28 49.27 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.629 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.07 48.49 46.15 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.71 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -90.31 6.48 42.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.678 0.275 . . . . 0.0 110.634 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.424 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 84.54 1.45 89.21 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.71 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 97.9 m-85 -140.72 153.91 46.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.671 0.748 . . . . 0.0 111.612 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.422 ' HB ' HG13 ' A' ' 136' ' ' VAL . 96.7 mt -97.07 117.28 41.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.3 m -90.46 152.67 20.86 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.1 80.03 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.974 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.97 -39.93 60.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.89 0.376 . . . . 0.0 110.463 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -66.01 -41.54 90.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.357 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.3 tp -63.07 -46.55 86.91 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.267 0.556 . . . . 0.0 111.131 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -43.57 -44.35 6.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.65 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -63.54 -29.26 70.55 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 121.281 -0.168 . . . . 0.0 110.99 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.553 HG21 ' CE2' ' A' ' 92' ' ' PHE . 96.6 t -57.54 -41.81 79.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.842 -178.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.623 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.54 -45.27 62.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.958 0.885 . . . . 0.0 111.543 -177.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.9 m -55.91 -40.73 73.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.853 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.33 -40.46 93.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.759 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.5 -13.0 58.65 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.739 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.65 29.09 60.07 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -85.34 -21.78 28.76 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.805 2.302 . . . . 0.0 111.111 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mttm 42.82 60.58 2.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.952 0.882 . . . . 0.0 110.013 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.446 HD12 ' HG3' ' A' ' 109' ' ' MET . 81.5 mt -80.04 148.38 31.1 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.48 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 121' ' ' VAL . 58.7 p -82.96 175.17 10.26 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.376 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -57.98 -45.12 87.25 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -57.21 -51.15 70.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.456 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.405 ' OE1' ' OE1' ' A' ' 123' ' ' GLU . 78.7 mm-40 -67.3 -30.55 70.43 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.484 -0.486 . . . . 0.0 112.001 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 117' ' ' THR . 39.6 t -63.72 -41.53 92.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -66.94 -38.22 85.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.407 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.405 ' OE1' ' OE1' ' A' ' 120' ' ' GLU . 94.6 mt-10 -59.21 -52.51 65.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.46 ' SD ' ' CD1' ' B' 1093 ' ' TRP . 17.6 mmm -54.72 -45.04 74.0 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.682 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 91.3 mt -59.05 -44.71 92.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.234 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -61.35 -36.4 80.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.685 0.279 . . . . 0.0 111.553 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.45 -41.3 84.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.88 -16.86 24.74 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.723 0.297 . . . . 0.0 111.746 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.8 t0 -71.09 91.76 0.93 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.491 0.662 . . . . 0.0 111.991 -176.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.1 mt -70.48 -17.26 20.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 122.591 1.186 . . . . 0.0 113.317 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 51.4 p-10 -142.24 144.12 33.2 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 112.404 -2.18 . . . . 0.0 108.905 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.18 53.07 1.05 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.699 -0.286 . . . . 0.0 113.118 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -90.9 -8.13 50.27 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.002 0.401 . . . . 0.0 110.222 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.92 3.87 81.55 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.671 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -136.67 157.86 45.79 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.562 0.681 . . . . 0.0 110.439 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 136' ' ' VAL . 7.9 p -103.98 119.63 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.718 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -85.92 177.24 7.67 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.737 0.303 . . . . 0.0 111.079 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -61.98 -42.08 98.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.213 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.44 -45.33 94.74 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.902 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.94 -36.86 84.51 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.356 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -61.15 -45.39 94.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.2 t -65.7 -46.33 89.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.932 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -50.26 -44.14 53.55 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.994 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.2 mmt -72.92 -39.31 66.4 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 21.1 mmt -74.66 -47.04 34.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.877 -0.147 . . . . 0.0 110.823 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 p -89.97 32.17 0.93 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.689 0.28 . . . . 0.0 111.678 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.95 89.26 6.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.716 0.293 . . . . 0.0 111.363 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 35.5 tptt . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.416 179.653 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 61.8 mt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -79.43 40.5 0.43 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.556 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.573 ' C ' ' H ' ' B' 1090 ' ' GLN . 55.1 ttp180 56.46 43.07 26.6 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -60.81 3.86 0.36 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.573 ' H ' ' C ' ' B' 1088 ' ' ARG . 84.3 mt-30 -60.82 -45.29 95.05 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -177.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 73.8 mt -58.99 -49.05 84.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 17.6 mt -56.71 -62.26 1.86 Allowed 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.002 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . 0.46 ' CD1' ' SD ' ' A' ' 124' ' ' MET . 6.2 m95 -61.9 -53.51 54.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.366 0.603 . . . . 0.0 111.908 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 48.5 t80 -58.19 -46.34 85.97 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -174.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -40.38 -52.3 2.73 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.5 -41.08 99.48 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.106 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.7 tp -56.84 -45.36 82.44 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.484 -0.887 . . . . 0.0 109.562 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 40.9 t30 -58.65 -49.33 77.91 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -64.28 -38.14 90.0 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.3 mt -60.65 -41.91 89.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.68 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -50.37 -48.34 55.8 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.002 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.512 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.2 m -64.19 -47.9 78.0 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.42 ' C ' ' O ' ' B' 1102 ' ' THR . 25.5 mt-30 -27.61 -59.46 0.1 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 122.565 1.174 . . . . 0.0 112.612 -176.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.8 mt -83.02 -12.79 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 112.954 -1.93 . . . . 0.0 112.381 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.512 ' N ' ' O ' ' B' 1102 ' ' THR . 63.8 tttm -57.46 -43.28 83.87 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 118.001 -1.479 . . . . 0.0 108.024 176.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 57.5 t -61.92 -47.36 93.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 41.2 t -65.53 -41.52 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.074 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . 0.495 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 95.4 mttt -47.56 -37.11 11.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.659 0.742 . . . . 0.0 109.782 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -55.29 -46.63 76.19 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.63 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . 0.47 ' CD2' HG21 ' A' ' 55' ' ' VAL . 56.1 m-85 -63.77 -48.91 75.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -68.78 20.46 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . 0.411 ' H ' ' C ' ' B' 1110 ' ' PHE . 1.1 m 60.86 84.58 0.13 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.805 -0.559 . . . . 0.0 109.831 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . 0.41 ' OG ' ' O ' ' B' 1112 ' ' SER . 5.3 p . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.818 -1.087 . . . . 0.0 109.852 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -63.28 -40.33 97.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.179 0.514 . . . . 0.0 111.219 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -94.39 179.79 5.17 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.1 tp 166.88 -26.33 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.773 0.671 . . . . 0.0 109.452 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.407 ' H ' ' HG1' ' A' ' 5' ' ' THR . 33.6 p -77.79 141.01 39.49 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.03 0.832 . . . . 0.0 110.628 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.1 tt0 -50.4 -55.95 13.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.166 0.984 . . . . 0.0 110.46 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -35.21 -38.45 0.09 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.886 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -68.27 -38.74 82.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.208 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.0 mt -58.7 -44.92 90.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 176.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.26 -50.38 67.37 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.797 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -60.23 -48.55 81.25 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.174 0.512 . . . . 0.0 112.228 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -61.72 -39.4 91.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.612 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -52.19 -56.19 16.19 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.999 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -50.42 -42.81 54.46 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.295 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.64 -36.83 64.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.125 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -57.56 -40.74 79.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -63.56 -16.31 60.46 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.205 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.445 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.9 mm? -64.7 -41.14 96.22 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -106.1 -15.08 14.97 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.49 92.99 1.93 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.192 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -67.81 -49.83 60.15 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.884 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.8 p-10 -101.89 15.74 28.07 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.7 45.37 0.52 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.2 p30 -85.35 -4.51 59.18 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 122.676 -0.308 . . . . 0.0 110.802 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.96 -2.2 81.54 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.1 p -137.91 152.73 49.29 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.975 0.417 . . . . 0.0 109.95 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 27' ' ' ILE . 4.6 mp -91.47 124.47 44.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -113.21 164.91 12.94 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.992 0.807 . . . . 0.0 112.37 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.3 p -59.73 -34.7 73.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.872 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -62.38 -61.58 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.757 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -60.4 -31.42 70.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.845 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 52' ' ' ILE . 3.7 tp -60.56 -55.53 32.24 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.991 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.32 -39.41 92.63 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.988 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.2 m -57.71 -53.91 52.9 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.921 1.361 . . . . 0.0 108.704 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.92 -46.87 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 118.694 0.679 . . . . 0.0 111.527 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.5 ttt -59.24 -40.85 87.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 120.082 1.31 . . . . 0.0 109.868 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -52.15 -39.2 59.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.63 0.729 . . . . 0.0 110.358 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.0 t -63.32 -21.35 66.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.086 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.466 ' O ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -73.45 -2.18 21.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.54 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.35 14.63 65.81 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.097 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -106.38 156.45 18.51 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 117.356 0.578 . . . . 0.0 110.095 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -116.43 63.06 2.6 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.355 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.08 144.95 93.63 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.229 1.952 . . . . 0.0 112.169 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.6 p -80.23 166.73 21.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.522 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -57.7 -43.68 85.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.604 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.73 -24.26 33.93 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.398 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -65.97 -39.33 90.29 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.689 -0.405 . . . . 0.0 110.174 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.6 mp -57.23 -42.75 82.0 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.657 0.741 . . . . 0.0 109.867 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 -68.81 -56.09 9.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.494 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -56.05 -49.21 74.38 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.7 mmm -63.91 -50.72 67.61 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.505 HD11 HD22 ' A' ' 32' ' ' LEU . 26.9 mm -59.3 -48.06 88.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.619 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -55.9 -34.62 65.73 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -65.95 -39.83 90.77 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.728 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.411 HG21 ' CE2' ' B' 1110 ' ' PHE . 41.7 t -87.1 -20.18 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.299 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 44.6 t0 -79.38 84.3 5.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -174.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.45 82.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.619 -1.628 . . . . 0.0 114.263 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -86.41 -2.36 58.37 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.047 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.9 23.97 59.76 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.407 0.548 . . . . 0.0 112.463 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -87.91 3.74 47.38 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.421 0.61 . . . . 0.0 110.199 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.44 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.06 1.43 88.66 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 118.578 0.626 . . . . 0.0 114.573 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.9 p -148.9 170.97 17.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.2 mt -114.82 129.05 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -103.27 -175.32 2.77 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.604 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.438 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -59.27 -45.79 99.15 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 41.9 Cg_exo -55.49 -53.72 5.31 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.298 1.332 . . . . 0.0 111.513 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.88 -20.9 64.23 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.492 0.663 . . . . 0.0 110.763 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -72.87 -57.94 3.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.579 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.07 -44.81 87.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.405 HG23 HH12 ' A' ' 74' ' ' ARG . 8.6 m -40.53 -57.96 1.7 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.015 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 8.6 ptp -63.78 -39.29 93.89 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.811 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.1 mmt -59.06 -41.14 87.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.11 -35.49 78.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.429 0.291 . . . . 0.0 111.663 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.405 HH12 HG23 ' A' ' 70' ' ' THR . 84.8 mtt85 -94.05 -12.45 28.53 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -81.61 72.91 8.66 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.704 0.764 . . . . 0.0 110.376 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 21.6 mmt -110.33 17.77 20.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.056 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -53.08 129.72 31.79 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.487 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -107.45 143.96 35.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.674 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.0 p -130.55 135.71 48.19 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.4 m-20 -61.2 116.07 4.29 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 175.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.2 m -36.91 -20.08 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 80' ' ' ASP . 45.1 tp10 -69.44 -31.55 69.94 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -51.86 -40.38 60.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.745 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -86.91 -9.17 56.33 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.1 mm -67.88 -73.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.915 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -61.97 -40.99 97.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.94 -41.67 98.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.379 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.56 -21.35 60.16 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.966 0.412 . . . . 0.0 111.425 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -74.71 -47.29 32.26 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.744 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -55.61 -43.08 75.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.923 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.54 -45.73 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.546 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.463 ' CE2' HG21 ' A' ' 108' ' ' VAL . 11.5 m-85 -70.01 -39.05 76.06 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.595 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.56 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 32.3 t0 -89.56 84.83 6.38 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.01 -48.63 79.46 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.4 p-10 -92.24 5.03 51.98 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.99 50.4 51.31 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.687 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -95.02 6.28 49.52 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 122.416 0.286 . . . . 0.0 110.798 179.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.423 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 83.56 -0.19 89.7 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.687 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 4.4 m-85 -136.86 149.66 47.81 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.984 0.897 . . . . 0.0 111.299 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 80.7 mt -97.17 119.38 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t -89.88 151.08 21.92 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.66 78.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.112 0.869 . . . . 0.0 110.159 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.09 -41.73 62.65 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.698 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -65.28 -42.04 93.54 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.697 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.2 -45.65 90.74 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.51 0.671 . . . . 0.0 111.072 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -44.07 -42.76 6.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.366 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -65.47 -30.48 71.27 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.671 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' A' ' 92' ' ' PHE . 93.2 t -57.62 -42.38 81.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.943 -177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.612 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.13 -46.9 65.54 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.971 0.891 . . . . 0.0 111.284 -177.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.3 p -55.33 -39.19 69.68 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.567 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -66.38 -41.23 89.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.763 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.0 mt -81.77 -14.51 56.33 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.01 31.05 60.31 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -87.33 -25.71 23.75 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.77 2.285 . . . . 0.0 110.463 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 65.0 mttp 45.96 63.16 1.93 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.102 0.953 . . . . 0.0 110.377 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.1 mt -79.74 148.31 31.55 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.923 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 121' ' ' VAL . 32.4 p -82.67 174.2 11.22 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -57.57 -45.56 85.05 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.71 -46.72 84.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.172 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -70.66 -30.67 67.34 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.919 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 117' ' ' THR . 43.3 t -64.03 -41.99 94.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.471 0.653 . . . . 0.0 109.436 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.64 -35.69 75.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.349 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -59.56 -52.59 64.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.815 0.817 . . . . 0.0 112.837 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.2 mtp -55.64 -44.09 76.85 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.291 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.5 mt -59.11 -43.85 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.43 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -59.72 -38.32 81.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.95 0.405 . . . . 0.0 111.253 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -58.4 -41.61 85.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.168 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.55 -21.42 22.89 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.7 t0 -78.44 84.64 4.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.283 0.563 . . . . 0.0 112.051 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.9 pt -70.66 -11.52 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 122.674 1.226 . . . . 0.0 113.515 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 53.8 p-10 -142.08 145.01 33.84 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.157 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.45 52.35 2.27 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.656 -0.307 . . . . 0.0 113.357 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -90.9 -9.28 46.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 117.188 0.494 . . . . 0.0 110.1 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.8 -0.57 65.3 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 114.409 0.524 . . . . 0.0 114.409 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -132.95 150.85 52.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.304 0.552 . . . . 0.0 109.881 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 t -98.21 118.46 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.825 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.422 ' CG ' ' CZ ' ' A' ' 99' ' ' TYR . 16.5 t-20 -85.14 174.51 9.63 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.721 0.296 . . . . 0.0 110.965 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -60.96 -42.15 97.72 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.456 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.13 -44.12 95.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.699 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.67 -38.03 89.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.462 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -60.94 -45.28 95.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.096 0.474 . . . . 0.0 111.019 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.17 -46.88 89.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.039 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.667 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 68.8 tp60 -51.05 -44.51 61.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.025 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmt -72.02 -36.99 69.83 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 25.5 mmt -71.91 -45.88 59.63 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.489 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 p -81.33 -28.86 34.34 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.033 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -41.83 109.24 0.12 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.627 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.404 ' O ' ' OE1' ' B' 1090 ' ' GLN . 63.5 tttp . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.206 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 81.8 mt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -80.0 133.03 36.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.79 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.522 ' C ' ' H ' ' B' 1090 ' ' GLN . 73.5 mtt180 -90.13 92.39 8.94 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.537 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -51.91 -8.78 0.44 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.522 ' H ' ' C ' ' B' 1088 ' ' ARG . 71.3 mt-30 -65.69 -52.06 54.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 111.377 -178.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 60.9 mt -59.13 -50.58 79.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.848 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.9 mt -55.61 -59.13 5.28 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.606 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.3 m95 -63.23 -56.11 19.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.625 0.726 . . . . 0.0 112.346 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.1 t80 -58.4 -46.18 86.91 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 46.9 ttt85 -41.97 -52.04 4.26 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.71 -40.41 98.74 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.679 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.41 -44.72 80.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.977 0.888 . . . . 0.0 109.829 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 38.8 t30 -58.03 -47.72 82.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -176.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -65.01 -38.25 90.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.392 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.9 mt -60.36 -42.37 90.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.718 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -51.37 -45.42 62.4 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.586 -1.245 . . . . 0.0 107.67 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.508 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.7 m -62.16 -48.79 78.5 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.417 ' C ' ' O ' ' B' 1102 ' ' THR . 84.5 mt-30 -27.75 -59.61 0.11 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.913 1.339 . . . . 0.0 113.101 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -83.08 -13.72 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 112.514 -2.13 . . . . 0.0 111.643 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.508 ' N ' ' O ' ' B' 1102 ' ' THR . 66.3 tttm -59.93 -47.8 84.32 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 118.358 -1.337 . . . . 0.0 107.906 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.6 t -60.71 -48.85 86.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.9 m -65.76 -35.72 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.986 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 83.2 mttt -49.67 -39.08 35.18 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.72 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -50.56 -44.41 56.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.315 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . 0.411 ' CE2' HG21 ' A' ' 55' ' ' VAL . 41.8 m-85 -63.55 -49.46 73.35 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.725 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -67.85 -42.54 81.22 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . 0.412 ' O ' ' C ' ' B' 1113 ' ' SER . 1.6 t 68.51 59.48 0.4 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 117.014 -1.47 . . . . 0.0 107.319 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . 0.412 ' C ' ' O ' ' B' 1112 ' ' SER . 26.6 p . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 124.011 3.096 . . . . 0.0 111.513 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.471 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 55.3 t0 56.74 25.34 10.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.129 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.471 ' CB ' ' O ' ' A' ' 2' ' ' ASP . 52.7 tt0 94.42 118.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 124.329 1.018 . . . . 0.0 110.35 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 173.22 -34.81 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.23 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.02 144.28 43.15 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.002 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.672 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -51.29 -43.82 61.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 122.574 1.178 . . . . 0.0 110.574 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 81.2 tt0 -43.35 -41.23 4.0 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 112.718 -2.037 . . . . 0.0 110.662 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -69.36 -38.06 77.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.504 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.1 -44.81 92.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.44 -50.27 62.92 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.667 -178.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -62.61 -45.57 92.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.387 0.613 . . . . 0.0 112.039 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 8.7 m-85 -62.27 -40.9 97.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.817 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -52.89 -55.23 24.73 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.275 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -50.31 -42.39 52.59 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.957 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -55.3 -36.3 66.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.409 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.79 -38.76 79.26 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.3 p -65.33 -15.95 63.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.22 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 18' ' ' LEU . 6.7 mp -65.42 -40.72 93.68 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -106.05 -14.75 15.08 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -73.04 93.2 1.74 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.486 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -67.72 -49.41 62.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.934 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.0 p-10 -103.11 14.9 30.72 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.16 46.27 0.96 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.131 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -86.57 -4.55 59.19 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 122.673 -0.31 . . . . 0.0 110.934 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 -1.83 80.74 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.4 p -138.21 153.56 49.14 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.189 0.519 . . . . 0.0 110.02 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 27' ' ' ILE . 4.2 mp -91.12 123.6 43.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.8 p -113.79 164.22 14.02 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.926 0.87 . . . . 0.0 112.455 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 p -58.34 -37.88 76.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.827 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.19 -61.83 2.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.732 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -60.63 -29.48 69.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.448 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.537 HD22 HD13 ' A' ' 52' ' ' ILE . 3.0 tp -61.37 -53.61 54.35 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.571 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.07 97.9 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 113.684 -1.598 . . . . 0.0 112.545 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 m -58.66 -54.33 48.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.912 1.356 . . . . 0.0 108.605 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.4 t -56.72 -46.01 82.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 118.979 0.808 . . . . 0.0 111.297 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.5 ttt -59.18 -40.22 85.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 120.111 1.323 . . . . 0.0 109.822 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -53.43 -41.53 66.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.42 0.629 . . . . 0.0 110.46 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.8 p -63.73 -21.49 66.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.941 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 tp -73.86 -3.54 29.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.748 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.74 20.7 46.23 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.332 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -117.77 158.65 24.37 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.662 0.731 . . . . 0.0 109.671 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -119.65 74.85 18.28 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.25 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.87 145.79 57.54 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.064 1.843 . . . . 0.0 112.405 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -80.16 165.83 22.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.309 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.4 pt-20 -58.83 -45.07 90.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.417 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -56.55 -24.36 46.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.501 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -65.65 -40.25 92.27 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.218 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.25 -39.67 70.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.223 0.535 . . . . 0.0 109.793 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -73.98 -55.17 6.48 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.238 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -54.84 -48.56 72.7 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 60.6 mtp -65.76 -52.06 54.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.537 HD13 HD22 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -56.02 -44.07 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -56.33 -35.16 67.29 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -67.3 -40.71 86.05 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.963 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.0 t -86.07 -21.34 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.383 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.493 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.1 t0 -78.2 86.16 4.33 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -174.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.3 82.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.342 -1.754 . . . . 0.0 114.081 -175.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 40.1 p-10 -86.82 -2.41 58.55 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.1 23.47 61.86 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 118.526 0.603 . . . . 0.0 112.839 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -87.87 3.57 47.91 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.273 0.536 . . . . 0.0 110.517 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.493 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.1 1.36 88.61 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 121.556 -0.715 . . . . 0.0 114.495 175.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.0 p -148.26 169.0 21.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -113.06 128.61 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.026 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -103.94 -174.83 2.63 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.801 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -58.09 19.55 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.51 -49.39 15.83 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.2 1.267 . . . . 0.0 111.661 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.79 -19.64 62.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.498 0.666 . . . . 0.0 110.628 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -75.71 -59.55 2.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.235 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.58 -44.15 80.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 m -44.92 -49.93 10.77 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.229 -0.988 . . . . 0.0 109.803 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 58.8 mtm -66.91 -45.6 77.43 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.4 mmm -61.08 -41.02 95.88 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.88 -34.16 77.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.567 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -93.42 -13.69 27.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.637 0.256 . . . . 0.0 111.343 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.452 ' C ' ' SD ' ' A' ' 76' ' ' MET . 2.4 mmmt -80.74 69.82 7.36 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.415 0.626 . . . . 0.0 110.765 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -105.88 18.72 21.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.851 179.158 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -49.94 131.44 22.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.418 0.627 . . . . 0.0 111.403 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 46.3 p-10 -91.99 109.05 20.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.875 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.518 HG21 ' NZ ' ' B' 1108 ' ' LYS . 8.5 p -97.81 114.21 26.19 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 82' ' ' GLU . 37.2 t0 -63.16 117.44 6.53 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 175.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.3 m -37.39 -20.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.772 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 80' ' ' ASP . 79.7 mm-40 -69.8 -34.8 74.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.809 0.337 . . . . 0.0 111.718 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -49.34 -37.48 24.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.427 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.532 ' OE1' HD11 ' B' 1097 ' ' LEU . 9.3 pt-20 -89.11 -13.97 37.32 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 85' ' ' ILE . 24.2 mm -62.29 -74.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.176 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -62.04 -39.67 93.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -64.03 -40.68 96.87 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.515 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.1 -19.25 62.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.091 0.472 . . . . 0.0 111.127 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -71.97 -50.25 30.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.949 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -54.9 -40.71 70.09 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.757 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.22 -44.67 97.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.524 -0.471 . . . . 0.0 109.779 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.55 ' CE2' HG21 ' A' ' 108' ' ' VAL . 8.4 m-85 -69.44 -39.1 78.02 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.463 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -89.74 83.12 6.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.55 -45.06 95.74 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.9 p30 -91.42 4.02 53.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.623 0.249 . . . . 0.0 111.459 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.71 50.23 43.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -92.23 6.37 46.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.64 0.257 . . . . 0.0 110.516 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.14 0.76 89.64 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -140.38 154.16 46.61 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.695 0.76 . . . . 0.0 111.533 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.6 mt -96.92 115.82 37.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.2 p -91.7 156.13 17.8 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.34 -47.99 80.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 118.726 0.694 . . . . 0.0 111.14 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -51.8 -40.59 60.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 110.448 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.89 -41.29 91.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.511 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.23 -46.29 87.6 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.505 0.669 . . . . 0.0 111.358 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -44.38 -44.22 8.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.698 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -63.24 -28.82 70.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.784 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.55 HG21 ' CE2' ' A' ' 92' ' ' PHE . 98.7 t -57.99 -41.85 81.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.837 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.629 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.48 -46.22 63.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.074 0.94 . . . . 0.0 111.212 -177.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.8 m -57.68 -41.36 81.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 113.578 -1.647 . . . . 0.0 110.76 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.46 -40.75 93.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.975 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.3 mt -81.73 -14.06 57.0 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.941 -0.303 . . . . 0.0 111.699 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.05 29.82 58.27 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -85.68 -22.51 27.84 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.721 2.26 . . . . 0.0 110.878 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 43.14 60.48 2.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.116 0.96 . . . . 0.0 109.912 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.5 mt -79.74 148.76 31.38 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.482 -1.69 . . . . 0.0 112.511 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.4 p -82.99 174.61 10.73 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.405 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -58.06 -45.17 87.49 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.3 mp0 -58.15 -49.84 75.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.706 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -67.3 -31.23 71.4 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.937 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.13 -41.98 94.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.29 -39.15 89.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.62 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -59.44 -51.12 71.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 8.9 mmm -55.81 -45.05 78.37 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.274 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.99 -43.89 93.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.405 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -61.66 -36.77 81.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.031 0.443 . . . . 0.0 111.186 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.54 -40.19 86.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.833 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.758 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -89.52 -27.97 19.94 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.2 t0 -68.88 89.33 0.4 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.631 0.729 . . . . 0.0 111.811 -176.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.3 mm -71.4 -15.84 18.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.994 -177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 47.0 p-10 -141.44 144.42 34.42 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 112.465 -2.152 . . . . 0.0 108.967 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.32 51.47 1.05 Allowed Glycine 0 CA--C 1.531 1.042 0 CA-C-O 120.313 -0.159 . . . . 0.0 113.018 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -90.67 -12.23 37.39 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.035 0.418 . . . . 0.0 110.011 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.0 1.66 74.44 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.998 -0.62 . . . . 0.0 114.276 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -134.06 153.16 51.98 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.376 0.588 . . . . 0.0 110.481 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.6 t -100.46 118.4 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -83.65 173.85 11.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.988 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -61.41 -40.06 93.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.024 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.94 -44.29 97.08 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.805 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -65.48 -39.37 91.87 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.571 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.433 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 90.0 t80 -60.66 -44.17 96.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.035 0.445 . . . . 0.0 111.219 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.15 -45.0 95.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.018 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.24 -40.16 46.88 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.176 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.758 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 78.1 mtm -79.05 -46.11 18.78 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.433 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -73.39 -47.03 45.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.081 -179.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.3 m -90.07 33.31 0.88 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.793 0.33 . . . . 0.0 111.332 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.48 84.42 5.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.672 0.272 . . . . 0.0 110.976 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.5 tttp . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.408 179.824 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . 0.567 HD12 ' N ' ' B' 1086 ' ' LEU . 10.5 mp . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -78.29 142.35 37.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.552 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.579 ' C ' ' H ' ' B' 1090 ' ' GLN . 0.8 OUTLIER -102.92 96.75 7.03 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.421 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -54.96 -2.89 0.23 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.579 ' H ' ' C ' ' B' 1088 ' ' ARG . 70.0 mt-30 -68.72 -56.87 6.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.956 0.408 . . . . 0.0 111.947 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.98 -49.4 84.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.36 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.35 -62.11 1.89 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.966 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . 0.59 ' CE2' ' SD ' ' A' ' 144' ' ' MET . 6.6 m95 -61.88 -53.42 56.06 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.675 0.75 . . . . 0.0 111.817 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 47.5 t80 -57.79 -46.5 84.53 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . 0.47 ' HE ' ' NH1' ' B' 1099 ' ' ARG . 77.4 ttt180 -39.93 -52.43 2.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.39 -40.43 99.05 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.272 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . 0.532 HD11 ' OE1' ' A' ' 84' ' ' GLU . 50.8 tp -56.35 -44.45 80.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 118.196 0.998 . . . . 0.0 109.214 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -57.74 -47.64 81.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . 0.47 ' NH1' ' HE ' ' B' 1095 ' ' ARG . 76.7 mtt85 -65.14 -37.43 87.4 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 82.4 mt -60.75 -42.36 91.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 119.715 -0.794 . . . . 0.0 109.666 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . 0.405 ' CD ' ' OE2' ' A' ' 84' ' ' GLU . 41.8 mt-30 -50.1 -45.12 52.43 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 118.744 -1.182 . . . . 0.0 108.025 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.518 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.9 m -63.56 -48.2 78.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.426 ' C ' ' O ' ' B' 1102 ' ' THR . 83.7 mt-30 -27.61 -58.97 0.11 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.647 1.213 . . . . 0.0 112.578 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -83.62 -14.89 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 112.198 -2.274 . . . . 0.0 112.314 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' 1102 ' ' THR . 65.0 tttm -59.59 -45.22 92.53 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 117.96 -1.496 . . . . 0.0 108.135 176.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.7 t -60.67 -48.99 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . 0.402 HG13 ' H ' ' B' 1107 ' ' VAL . 1.3 m -66.28 -36.53 77.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.346 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . 0.518 ' NZ ' HG21 ' A' ' 79' ' ' THR . 89.3 mttt -49.52 -38.82 32.06 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.606 -0.684 . . . . 0.0 109.562 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.95 -45.19 64.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.95 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -63.42 -50.2 70.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -67.79 -41.99 82.32 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . 0.402 ' O ' ' OG ' ' B' 1113 ' ' SER . 1.2 m 68.53 58.82 0.41 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 117.173 -1.394 . . . . 0.0 107.347 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . 0.402 ' OG ' ' O ' ' B' 1112 ' ' SER . 56.1 p . . . . . 0 N--CA 1.471 0.588 0 CA-C-N 123.719 2.963 . . . . 0.0 111.809 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 2' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 1' ' ' ALA . 98.0 m-20 -36.25 -78.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.323 0.582 . . . . 0.0 111.385 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -93.15 179.49 5.41 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.6 tp 167.38 -27.64 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 O-C-N 123.663 0.602 . . . . 0.0 109.442 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p -76.25 139.43 41.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.482 1.037 . . . . 0.0 110.744 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.65 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -50.83 -47.81 60.02 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.993 0.902 . . . . 0.0 110.684 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -38.5 -38.32 0.37 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.474 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.462 ' NE2' ' CE1' ' A' ' 12' ' ' PHE . 45.0 tp60 -68.74 -39.14 80.48 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 118.31 -0.853 . . . . 0.0 110.298 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.8 mt -58.97 -46.0 91.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 175.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.55 -50.65 62.48 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.114 -178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.02 -48.34 82.12 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.158 0.504 . . . . 0.0 112.282 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.0 m-85 -62.45 -40.63 97.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.835 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -50.86 -56.53 11.78 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.151 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -50.92 -41.88 59.02 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.95 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -54.21 -36.96 64.04 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.42 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.457 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 2.9 m-85 -58.42 -38.94 78.44 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -65.36 -15.52 62.65 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.458 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.8 mm? -65.59 -40.81 93.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -106.29 -14.6 15.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -72.13 93.21 1.4 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.642 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -68.17 -49.49 60.55 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.715 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.1 p-10 -102.32 15.68 28.46 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.53 44.0 0.41 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.451 -0.404 . . . . 0.0 112.171 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -85.35 -3.82 58.96 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.952 0.406 . . . . 0.0 110.978 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.76 -1.68 81.38 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.3 p -137.8 152.69 49.4 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.079 0.466 . . . . 0.0 110.035 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.0 mp -92.26 124.74 44.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -113.95 163.91 14.49 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.427 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.412 HG22 HG13 ' A' ' 52' ' ' ILE . 20.9 p -58.14 -35.5 71.61 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.052 -178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -60.71 -60.39 3.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.209 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -62.39 -30.07 70.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.63 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 52' ' ' ILE . 3.2 tp -61.05 -55.53 31.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.255 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.75 -39.76 94.08 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.267 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -58.32 -54.99 40.71 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.954 1.377 . . . . 0.0 108.569 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.0 t -55.98 -46.75 80.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 118.859 0.754 . . . . 0.0 111.29 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.9 ttt -58.71 -40.05 82.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 120.413 1.46 . . . . 0.0 110.276 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -51.7 -38.38 54.89 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.344 0.592 . . . . 0.0 110.583 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.0 t -62.52 -19.89 64.07 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.047 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 tp -73.87 1.1 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.859 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.1 25.99 38.58 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.226 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -130.5 169.64 15.28 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.275 0.537 . . . . 0.0 109.887 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -133.28 77.29 66.79 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.295 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.74 148.08 93.86 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.823 2.349 . . . . 0.0 111.985 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.2 p -77.11 165.29 24.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.328 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 21.3 pt-20 -58.76 -44.99 90.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.66 -24.12 32.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.761 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -65.74 -39.8 91.49 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.174 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 8.2 mp -56.17 -41.5 75.59 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.175 0.512 . . . . 0.0 110.03 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -71.7 -56.42 5.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.48 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -55.65 -50.34 70.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 48.7 mmm -63.52 -52.08 62.75 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 32' ' ' LEU . 29.5 mm -58.29 -46.97 88.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.105 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -55.91 -34.22 65.39 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -66.72 -40.07 88.27 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.669 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.417 HG21 ' CE2' ' B' 1110 ' ' PHE . 40.0 t -86.75 -20.06 7.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.178 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.2 t0 -78.61 84.74 4.7 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -174.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.81 83.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.323 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.434 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.0 p-10 -86.17 -2.44 58.36 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.55 23.1 60.15 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.323 0.51 . . . . 0.0 112.686 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -86.71 3.84 43.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 117.189 0.494 . . . . 0.0 110.504 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.447 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.4 1.44 89.34 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 118.637 0.653 . . . . 0.0 114.702 175.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.8 p -148.14 167.92 23.77 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.25 128.35 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -103.03 -176.41 3.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.743 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.457 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -57.07 -46.75 99.83 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -176.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 31.4 Cg_exo -57.66 -51.9 7.27 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 121.462 1.442 . . . . 0.0 111.852 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.21 -20.97 64.75 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.43 0.633 . . . . 0.0 110.727 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -74.88 -59.87 2.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.687 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -54.98 -45.16 74.96 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 m -44.9 -50.51 10.39 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.912 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.6 mtm -65.42 -44.33 87.75 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 35.3 mmm -60.82 -41.46 95.78 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.16 77.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.337 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -92.43 -19.25 22.24 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.39 67.4 5.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.128 0.489 . . . . 0.0 110.297 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.5 mmt -107.76 15.3 24.71 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.356 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -48.29 133.89 15.27 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.37 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -89.68 107.89 19.36 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.943 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 m -93.83 120.57 34.28 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 82' ' ' GLU . 90.7 m-20 -70.28 112.28 6.49 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.1 m -37.06 -20.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.828 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.579 ' N ' ' O ' ' A' ' 80' ' ' ASP . 96.2 mt-10 -69.15 -36.64 77.63 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.756 0.312 . . . . 0.0 111.585 -178.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -48.63 -35.86 14.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.25 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -89.07 -18.72 26.7 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.103 0.477 . . . . 0.0 111.794 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 85' ' ' ILE . 25.9 mm -58.92 -75.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.827 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -61.51 -37.53 84.05 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -63.66 -40.75 97.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.466 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.58 -20.84 63.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.001 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -72.22 -51.59 20.35 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.779 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -54.88 -41.77 71.25 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.67 -44.26 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.529 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.7 m-85 -69.28 -38.55 78.41 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.211 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.519 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 29.3 t0 -88.51 83.5 6.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.42 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 88.4 tttt -57.78 -49.41 76.69 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 31.2 p-10 -91.89 5.02 51.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.703 0.287 . . . . 0.0 111.59 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.28 49.55 50.31 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.694 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -91.33 5.27 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.488 0.315 . . . . 0.0 110.713 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.454 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 84.87 0.72 89.09 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.694 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 79.9 m-85 -138.38 151.26 47.35 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.72 0.771 . . . . 0.0 111.783 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.2 mt -93.83 117.21 36.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 t -89.99 150.08 22.29 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.76 -46.34 77.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.109 0.868 . . . . 0.0 110.788 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.31 62.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.836 0.35 . . . . 0.0 110.636 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.42 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.2 mt-10 -66.2 -41.46 90.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.557 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.0 -46.9 85.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.264 0.554 . . . . 0.0 110.822 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -42.89 -43.09 3.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.683 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -65.19 -29.24 70.04 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.005 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' A' ' 92' ' ' PHE . 96.7 t -58.08 -42.67 83.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.73 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.63 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.15 -45.96 61.85 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.784 0.802 . . . . 0.0 111.668 -177.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.6 p -55.84 -38.49 70.12 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.825 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -66.58 -40.89 89.17 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.892 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 73.4 mt -82.15 -13.14 57.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.79 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.21 30.83 62.25 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -86.17 -23.19 26.63 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 121.0 2.4 . . . . 0.0 110.856 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.9 mtmt 45.2 61.77 2.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.571 0.7 . . . . 0.0 110.497 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.1 mt -80.2 148.36 30.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.266 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.529 HG23 ' H ' ' A' ' 120' ' ' GLU . 0.5 OUTLIER -82.67 176.78 9.08 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.403 179.002 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.458 ' N ' ' OG1' ' A' ' 117' ' ' THR . 45.4 m-20 -59.7 -45.48 91.98 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.79 -46.95 81.23 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.529 ' H ' HG23 ' A' ' 117' ' ' THR . 76.4 mm-40 -70.38 -30.59 67.54 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.08 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.73 -42.18 95.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.34 -35.98 73.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.209 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -60.07 -53.2 60.61 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 81.9 mtp -54.96 -44.47 74.41 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.269 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.6 mt -58.18 -43.88 86.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.598 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -60.13 -36.38 77.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.836 0.35 . . . . 0.0 111.486 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -59.53 -41.06 89.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.055 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.6 -18.42 24.07 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.6 t0 -74.87 87.88 2.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.108 0.48 . . . . 0.0 111.868 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.406 HG22 ' OE2' ' A' ' 140' ' ' GLU . 10.8 tt -69.87 -15.1 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 122.523 1.154 . . . . 0.0 113.524 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.2 p-10 -143.07 145.71 33.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 112.475 -2.148 . . . . 0.0 109.159 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.79 52.35 1.6 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.883 -0.199 . . . . 0.0 113.213 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -90.74 -8.9 48.54 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 117.054 0.427 . . . . 0.0 110.219 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.85 1.36 72.38 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.986 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -134.67 154.43 51.54 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.227 0.514 . . . . 0.0 110.399 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.86 118.27 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.186 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.417 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 51.9 t30 -84.11 174.17 10.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.352 . . . . 0.0 111.065 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.417 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 84.0 t80 -61.15 -40.66 94.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.041 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.28 -44.62 96.11 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.946 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.406 ' OE2' HG22 ' A' ' 130' ' ' ILE . 96.8 mt-10 -64.87 -38.53 91.29 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.707 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -61.3 -44.7 96.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.118 0.485 . . . . 0.0 110.907 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.22 -46.95 89.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.055 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -50.05 -43.05 50.81 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.891 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.7 mmt -74.93 -39.62 61.29 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.2 mmt -72.9 -47.42 45.94 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.9 p -88.71 32.32 0.8 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.802 0.334 . . . . 0.0 111.601 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -42.21 -33.36 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.237 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 82.4 tttt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.98 -179.548 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 53.5 tp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 -147.44 78.25 1.46 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.181 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.604 ' C ' ' H ' ' B' 1090 ' ' GLN . 50.7 mtm180 46.43 47.87 13.91 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -56.79 1.61 0.11 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.604 ' H ' ' C ' ' B' 1088 ' ' ARG . 74.7 mt-30 -62.45 -47.55 83.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.918 0.389 . . . . 0.0 111.445 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 61.6 mt -58.72 -50.34 79.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.7 mt -56.32 -63.03 1.32 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 8.8 m95 -62.65 -55.69 24.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.257 0.551 . . . . 0.0 112.419 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.4 t80 -59.46 -46.55 88.45 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -43.05 -51.3 5.82 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.52 -41.89 99.65 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.1 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . 0.43 ' O ' ' NE2' ' B' 1101 ' ' GLN . 56.7 tp -56.91 -45.78 82.41 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.595 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 39.6 t30 -57.93 -47.47 82.77 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -64.69 -37.32 87.18 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.2 mt -61.33 -42.61 94.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.824 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . 0.43 ' NE2' ' O ' ' B' 1097 ' ' LEU . 2.8 mp0 -50.27 -46.47 55.1 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.524 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.7 m -63.19 -48.45 78.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.43 ' C ' ' O ' ' B' 1102 ' ' THR . 24.8 mt-30 -27.31 -59.64 0.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 122.745 1.26 . . . . 0.0 112.642 -177.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -83.31 -14.72 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 112.475 -2.148 . . . . 0.0 112.198 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.524 ' N ' ' O ' ' B' 1102 ' ' THR . 66.3 tttm -59.93 -46.51 89.14 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 117.829 -1.548 . . . . 0.0 107.895 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.7 t -61.32 -49.31 85.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.6 m -65.54 -36.14 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.406 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 87.8 mttt -49.01 -38.15 22.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.642 0.656 . . . . 0.0 109.82 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.58 -45.5 66.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.289 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 55' ' ' VAL . 45.0 m-85 -62.59 -50.02 72.92 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -68.17 -41.12 82.0 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.3 m 67.73 58.37 0.5 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 116.709 -1.615 . . . . 0.0 107.583 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 25.3 p . . . . . 0 C--N 1.348 0.539 0 CA-C-N 124.385 3.266 . . . . 0.0 112.036 179.512 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -63.94 -37.7 88.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.017 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.632 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 22.5 mt-30 -98.08 95.96 7.8 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.526 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.7 tp -108.88 -25.14 10.92 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.648 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.3 p -77.95 139.96 39.21 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.321 0.964 . . . . 0.0 110.317 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 9' ' ' ILE . 45.8 tp10 -49.7 -57.23 7.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 122.281 1.039 . . . . 0.0 110.449 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 83.5 tt0 -34.7 -38.33 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.218 -1.81 . . . . 0.0 111.066 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -68.9 -37.05 78.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 118.07 -0.966 . . . . 0.0 110.65 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.3 mt -59.0 -44.75 91.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 175.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -53.92 -52.66 59.87 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.791 -0.764 . . . . 0.0 111.356 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.42 -47.77 84.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.441 0.639 . . . . 0.0 112.004 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.632 ' CD1' ' NE2' ' A' ' 3' ' ' GLN . 10.1 m-85 -62.36 -38.68 90.47 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.677 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -52.61 -54.84 27.67 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.467 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.31 -40.76 49.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.966 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.45 -37.65 70.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.095 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.406 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 3.4 m-85 -58.37 -41.12 84.07 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 t -64.04 -15.54 59.7 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.505 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.53 -42.25 95.87 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -106.01 -14.0 15.31 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -72.29 93.28 1.47 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.482 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -67.41 -49.49 63.58 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.983 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 23' ' ' GLY . 37.0 p30 -102.31 14.73 31.19 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.88 43.78 0.66 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.105 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -84.87 -3.47 58.7 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.764 0.316 . . . . 0.0 110.972 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.42 -1.72 82.3 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.7 p -137.87 153.04 49.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.225 0.536 . . . . 0.0 109.801 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 27' ' ' ILE . 4.4 mp -91.59 123.8 43.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.5 p -114.53 165.25 12.96 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 124.124 0.89 . . . . 0.0 112.335 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.415 HG22 HG13 ' A' ' 52' ' ' ILE . 23.7 p -58.62 -36.84 74.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.578 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -60.86 -60.65 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.496 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -62.06 -30.26 70.86 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.426 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tp -60.73 -53.78 53.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.219 1.009 . . . . 0.0 109.804 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.16 -37.68 94.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 113.593 -1.639 . . . . 0.0 111.825 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.6 m -58.69 -53.88 53.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 119.005 1.402 . . . . 0.0 108.537 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.9 t -57.88 -46.12 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 121.254 -0.904 . . . . 0.0 111.561 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.9 ttt -58.87 -41.57 87.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 119.99 1.268 . . . . 0.0 109.628 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -51.77 -34.81 41.3 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.648 0.737 . . . . 0.0 110.165 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.1 t -63.07 -20.34 65.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.589 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.8 mt -75.82 2.81 11.31 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.163 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.52 17.0 74.48 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.956 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -109.26 160.99 15.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.462 0.631 . . . . 0.0 110.013 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -116.05 68.71 3.46 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.165 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.07 143.88 91.46 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.041 1.827 . . . . 0.0 112.291 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.7 p -81.01 165.28 21.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.42 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -58.69 -43.76 90.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.029 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.53 -23.64 27.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.536 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -66.0 -38.48 88.58 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.242 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.6 mp -56.57 -41.31 76.71 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.404 0.621 . . . . 0.0 109.733 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -71.09 -56.48 6.03 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.722 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -55.03 -49.55 71.29 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.9 mmm -66.0 -50.91 62.59 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 52' ' ' ILE . 26.9 mm -59.43 -48.18 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.618 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -57.79 -34.01 69.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -66.49 -40.43 89.26 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.547 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.409 HG21 ' CE2' ' B' 1110 ' ' PHE . 56.6 t -85.73 -20.88 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.544 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.16 86.56 4.29 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.5 -37.81 87.46 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 113.308 -1.769 . . . . 0.0 113.906 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' OD1' ' OD1' ' A' ' 56' ' ' ASP . 37.8 p-10 -86.44 -2.46 58.46 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.35 23.05 61.86 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 118.451 0.568 . . . . 0.0 112.89 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -87.99 2.43 51.78 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.229 0.515 . . . . 0.0 110.335 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.483 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 86.0 0.97 87.07 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 121.714 -0.616 . . . . 0.0 114.572 175.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.8 p -148.51 170.42 18.09 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.79 129.48 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -103.67 -175.54 2.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.854 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.7 -46.99 99.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -176.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -55.49 -51.95 8.77 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.282 1.321 . . . . 0.0 111.76 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.74 -18.53 55.18 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.446 0.641 . . . . 0.0 110.617 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -76.36 -57.82 3.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.553 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.84 -46.08 85.27 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.3 m -45.31 -49.37 12.78 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.369 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 72.5 mtm -66.16 -44.53 83.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.2 mmt -58.75 -41.65 87.03 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.77 -34.02 77.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.551 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -94.9 -9.29 34.62 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.527 0.203 . . . . 0.0 111.304 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.691 ' HZ2' ' N ' ' B' 1109 ' ' ALA . 0.3 OUTLIER -82.01 69.36 8.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.55 0.69 . . . . 0.0 111.047 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.26 18.29 21.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.126 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -51.19 130.2 25.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.034 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -89.62 108.74 19.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.055 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.7 m -93.59 119.38 32.55 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.2 m-20 -69.32 111.66 5.37 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 173.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.9 m -37.48 -21.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.642 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.5 mp0 -69.42 -35.33 75.62 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -48.83 -37.21 18.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.393 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' OE2' ' NE2' ' B' 1101 ' ' GLN . 10.6 pt-20 -89.28 -13.24 38.5 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 85' ' ' ILE . 24.5 mm -63.14 -74.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.993 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -63.02 -39.41 94.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -63.05 -40.95 99.25 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.436 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.54 -18.4 59.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.937 0.398 . . . . 0.0 111.062 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -74.45 -48.74 25.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.012 0.434 . . . . 0.0 111.327 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -55.16 -41.77 72.28 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.64 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -64.84 -43.9 96.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.4 m-85 -69.02 -38.54 79.28 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.518 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -85.48 81.22 8.8 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -58.24 -49.32 77.51 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.2 p30 -91.23 5.23 49.93 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.365 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.84 48.35 51.24 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -91.37 6.79 43.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.752 0.31 . . . . 0.0 110.673 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.73 1.95 89.9 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.696 -0.561 . . . . 0.0 111.696 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -140.51 153.95 46.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.686 0.755 . . . . 0.0 111.521 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.6 mt -93.97 114.61 30.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.1 t -89.07 151.61 22.14 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.82 -47.03 83.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 119.067 0.849 . . . . 0.0 110.638 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.02 -35.35 61.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.894 0.378 . . . . 0.0 110.278 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.56 -39.52 73.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.076 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.45 -47.36 76.43 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.231 0.539 . . . . 0.0 112.187 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.4 -33.71 2.71 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.235 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -72.49 -28.91 63.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.567 HG21 ' CE2' ' A' ' 92' ' ' PHE . 75.0 t -58.08 -41.42 80.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.734 -178.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.536 ' HG3' HD13 ' A' ' 116' ' ' LEU . 4.6 mmt -53.22 -47.24 69.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.301 1.048 . . . . 0.0 111.789 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 72.1 p -55.56 -35.52 65.81 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 113.115 -1.857 . . . . 0.0 110.925 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -36.45 82.59 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.043 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.0 mt -84.5 -11.25 56.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.94 36.71 51.66 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -88.46 -22.8 23.48 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.827 2.314 . . . . 0.0 111.18 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.7 tptt 44.78 59.78 3.23 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.549 1.166 . . . . 0.0 109.993 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.536 HD13 ' HG3' ' A' ' 109' ' ' MET . 0.8 OUTLIER -76.57 150.96 36.46 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.602 -2.09 . . . . 0.0 113.386 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 60.3 p -84.35 175.43 9.37 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.973 0.416 . . . . 0.0 109.927 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -56.36 -45.13 80.61 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -54.77 -40.81 69.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.027 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.77 -30.13 68.66 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.619 -0.432 . . . . 0.0 112.105 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.34 -43.57 98.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.501 0.667 . . . . 0.0 109.504 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -74.13 -35.82 64.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.816 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -60.77 -55.27 35.08 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 97.7 mmm -48.83 -60.39 2.79 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.472 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.3 pt -50.57 -40.74 19.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.719 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -61.98 -35.36 78.25 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.704 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -57.21 -40.68 77.96 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.219 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.24 -12.91 25.44 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.3 t0 -73.51 87.34 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.425 0.631 . . . . 0.0 111.789 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.0 pt -71.49 -11.86 15.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 122.484 1.135 . . . . 0.0 113.561 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 52.5 p-10 -143.21 142.59 31.46 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 112.265 -2.243 . . . . 0.0 109.035 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.67 52.46 0.9 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.692 -0.29 . . . . 0.0 113.436 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -91.29 -11.19 38.79 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.172 0.486 . . . . 0.0 110.111 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.69 2.79 70.92 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.195 -0.526 . . . . 0.0 114.385 176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -134.13 152.94 52.07 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.134 0.467 . . . . 0.0 110.318 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.48 118.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.455 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -84.58 173.79 10.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 0.0 110.877 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -61.05 -40.08 92.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.026 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.5 -44.81 95.47 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.914 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -63.39 -37.96 89.31 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.419 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -61.17 -45.69 93.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.819 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 86.3 t -65.69 -48.58 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.767 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -49.02 -45.96 43.34 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.972 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.475 ' O ' ' CE1' ' B' 1094 ' ' PHE . 13.2 mmt -72.73 -38.99 67.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 18.1 mmt -75.56 -45.09 39.9 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 m -91.12 30.43 1.24 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.98 89.43 6.4 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.091 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.7 tttm . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.518 179.828 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 49.3 tp . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . 0.431 ' C ' ' H ' ' B' 1089 ' ' GLY . 99.9 mtt180 44.67 68.09 0.6 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.345 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.624 ' C ' ' H ' ' B' 1090 ' ' GLN . 68.8 ttt-85 -70.66 6.75 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . 0.431 ' H ' ' C ' ' B' 1087 ' ' ARG . . . -61.66 9.42 0.1 Allowed Glycine 0 CA--C 1.534 1.228 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.624 ' H ' ' C ' ' B' 1088 ' ' ARG . 76.0 mt-30 -58.67 -44.21 90.12 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . 0.453 HD11 ' NH1' ' B' 1088 ' ' ARG . 56.2 mt -54.88 -53.48 32.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 10.0 mt -57.16 -58.22 9.16 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.222 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 5.5 m95 -60.55 -62.51 1.81 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.238 0.542 . . . . 0.0 112.415 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . 0.475 ' CE1' ' O ' ' A' ' 144' ' ' MET . 48.8 m-85 -57.78 -44.69 86.4 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -39.37 -52.04 2.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.52 -41.66 99.77 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.178 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . 0.429 HD11 ' OE1' ' A' ' 84' ' ' GLU . 50.8 tp -56.35 -45.22 80.55 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.454 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 12.2 m120 -59.07 -47.32 85.68 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.651 -175.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -65.38 -37.48 87.13 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.3 mt -61.22 -42.01 91.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.868 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . 0.458 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 68.7 mt-30 -51.34 -45.95 62.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.528 ' O ' ' N ' ' B' 1105 ' ' LYS . 93.9 m -63.47 -47.95 79.67 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.912 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.433 ' C ' ' O ' ' B' 1102 ' ' THR . 84.3 mt-30 -28.06 -57.62 0.11 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.741 1.258 . . . . 0.0 112.572 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.7 mt -84.27 -14.81 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 112.085 -2.325 . . . . 0.0 112.313 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.538 ' O ' ' NZ ' ' A' ' 75' ' ' LYS . 88.8 tttt -59.54 -44.72 93.13 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.954 176.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 67.5 t -61.49 -49.11 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . 0.402 HG13 ' H ' ' B' 1107 ' ' VAL . 1.4 m -65.83 -36.09 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.322 -177.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 89.7 mttt -49.88 -37.55 31.7 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.682 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . 0.691 ' N ' ' HZ2' ' A' ' 75' ' ' LYS . . . -51.41 -45.06 62.42 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.784 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . 0.409 ' CE2' HG21 ' A' ' 55' ' ' VAL . 46.8 m-85 -63.88 -49.73 71.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -67.72 -42.47 81.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.2 m 68.82 59.21 0.37 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.476 0.833 0 CA-C-N 123.769 2.986 . . . . 0.0 111.885 179.346 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.9 p30 -87.75 -0.39 56.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.474 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.535 ' C ' HD22 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -106.41 110.14 22.27 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.535 HD22 ' C ' ' A' ' 3' ' ' GLN . 4.1 mm? -111.4 -17.63 13.07 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.554 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -79.14 137.26 37.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.365 0.984 . . . . 0.0 110.306 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 9' ' ' ILE . 21.3 mt-10 -54.42 -49.98 68.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.132 0.968 . . . . 0.0 110.43 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 42.8 tp10 -34.32 -36.39 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.569 -1.65 . . . . 0.0 111.102 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -69.12 -36.04 77.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.265 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 6' ' ' GLU . 88.4 mt -58.82 -43.95 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -53.81 -50.53 65.94 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.893 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -63.49 -45.79 89.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.325 0.583 . . . . 0.0 112.05 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.475 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.5 m-85 -62.51 -40.42 96.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.888 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -49.95 -57.19 8.02 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.472 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -49.66 -40.43 39.69 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.04 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.7 -37.58 71.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.203 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.518 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 3.0 m-85 -57.79 -41.62 82.47 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.1 t -64.37 -15.7 60.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.65 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.87 -42.59 97.47 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -106.07 -13.97 15.3 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -74.08 95.65 2.58 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.203 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -68.74 -52.83 26.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.44 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.5 p-10 -98.77 13.97 30.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.72 45.22 1.01 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.024 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 32.7 p-10 -85.28 -3.82 58.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.665 0.269 . . . . 0.0 110.875 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.5 -0.79 78.11 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -139.99 153.99 47.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.11 0.481 . . . . 0.0 110.025 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 27' ' ' ILE . 5.1 mp -93.2 124.56 45.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -112.79 165.29 12.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.513 0.673 . . . . 0.0 112.405 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.7 p -59.5 -35.83 74.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.322 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -61.6 -61.73 2.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.77 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.53 -30.12 70.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.715 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.457 HD22 HD11 ' A' ' 52' ' ' ILE . 2.7 tp -60.42 -53.63 55.32 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.875 178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.55 93.54 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.927 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.63 -51.47 69.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.816 1.308 . . . . 0.0 108.936 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.0 t -59.33 -46.01 92.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 118.739 0.699 . . . . 0.0 111.042 -176.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.0 ttt -59.01 -41.48 87.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.552 1.069 . . . . 0.0 109.654 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -52.1 -37.08 52.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.733 0.778 . . . . 0.0 110.247 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 p -62.71 -20.6 65.05 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.702 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.7 mt -75.53 1.6 13.82 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.104 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.1 17.44 67.17 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.154 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -109.11 158.7 17.53 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 117.498 0.649 . . . . 0.0 109.955 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -114.2 65.47 1.43 Allowed Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.13 142.4 91.92 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.03 1.82 . . . . 0.0 112.081 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 t -80.94 165.27 21.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.246 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -58.17 -43.88 87.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.74 -24.57 50.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.484 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -64.85 -40.19 94.76 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.209 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.7 mp -55.41 -38.5 69.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.404 0.621 . . . . 0.0 109.354 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -71.66 -56.01 6.64 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.095 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -54.06 -49.23 69.47 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 55.5 mtp -68.4 -48.61 64.22 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.457 HD11 HD22 ' A' ' 32' ' ' LEU . 24.3 mm -59.46 -47.58 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.7 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -58.49 -33.8 70.21 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.93 -39.85 90.86 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.539 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.2 t -86.69 -20.27 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 121.154 -0.218 . . . . 0.0 111.33 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.53 87.44 4.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -175.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.98 -37.33 86.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 113.535 -1.666 . . . . 0.0 113.987 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.4 p-10 -86.35 -2.69 58.64 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.2 23.27 61.81 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 118.338 0.517 . . . . 0.0 112.709 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.4 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 51.5 p-10 -88.15 3.63 48.49 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.422 0.611 . . . . 0.0 110.423 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.46 0.72 89.39 Favored Glycine 0 CA--C 1.522 0.525 0 O-C-N 121.74 -0.6 . . . . 0.0 114.423 175.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 42.7 p -147.74 169.78 18.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.8 mt -114.66 128.77 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -103.88 -173.94 2.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.705 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.518 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -58.84 -46.62 99.54 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.34 -51.72 7.93 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 121.245 1.297 . . . . 0.0 111.85 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.55 -18.36 61.89 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.485 0.659 . . . . 0.0 110.687 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -75.19 -58.76 3.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.907 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.8 mt -57.49 -42.6 83.01 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -176.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -46.04 -49.35 16.37 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.566 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 57.8 mtm -67.21 -45.23 77.44 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.5 mmm -61.06 -40.34 93.3 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.4 78.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.229 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -94.34 -10.05 33.93 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.831 0.348 . . . . 0.0 111.467 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.19 67.45 8.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.249 0.547 . . . . 0.0 110.487 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 mmt -108.63 15.19 23.94 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.696 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -49.46 133.45 20.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.061 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 45.2 p-10 -92.66 105.2 17.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.932 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.7 m -88.24 123.04 32.46 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 82' ' ' GLU . 96.6 m-20 -69.87 112.05 6.03 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.0 m -37.6 -21.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.726 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 80' ' ' ASP . 54.2 mp0 -69.14 -36.32 77.32 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -48.67 -36.45 16.09 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.252 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.514 ' OE2' ' NE2' ' B' 1101 ' ' GLN . 11.1 pt-20 -89.11 -13.86 37.56 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 85' ' ' ILE . 24.9 mm -62.84 -74.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.279 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -62.41 -41.12 98.44 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -62.98 -40.39 97.59 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.488 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.83 -17.02 54.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.003 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -73.79 -49.3 25.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.021 0.438 . . . . 0.0 111.35 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -55.09 -41.74 71.99 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.604 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.54 -43.96 94.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -68.52 -39.41 81.22 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.486 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -85.28 81.84 8.62 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.13 -50.18 74.41 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -90.88 5.4 48.68 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.216 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.15 48.49 46.59 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -89.93 6.23 42.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.756 0.312 . . . . 0.0 110.609 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.54 2.76 84.63 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -144.23 157.7 44.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.742 0.782 . . . . 0.0 111.553 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -94.63 114.32 30.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 m -87.49 151.75 22.77 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.56 -48.89 78.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 119.036 0.834 . . . . 0.0 110.842 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.01 -40.89 64.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.993 0.425 . . . . 0.0 110.238 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -65.91 -44.09 86.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.734 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.501 ' O ' HG12 ' A' ' 108' ' ' VAL . 7.1 tt -62.84 -47.56 82.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.83 0.348 . . . . 0.0 111.764 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -41.16 -45.02 2.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.101 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -57.14 -26.99 61.44 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.529 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 105' ' ' LEU . 2.0 p -56.45 -41.34 71.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.22 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -50.32 59.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 122.248 1.023 . . . . 0.0 111.245 -177.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.8 m -51.44 -40.85 60.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.483 -1.689 . . . . 0.0 110.775 -177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.99 -41.25 95.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.06 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.9 mt -82.91 -14.41 54.23 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.79 55.77 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.553 -1.137 . . . . 0.0 110.42 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -86.72 -22.42 26.03 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.385 2.092 . . . . 0.0 110.866 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 43.49 60.34 2.66 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.281 1.039 . . . . 0.0 110.172 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.1 mt -80.87 148.69 29.81 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.599 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 76.5 p -83.0 175.36 10.1 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -57.63 -44.67 85.74 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.31 -48.58 80.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.324 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -70.49 -31.07 68.03 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.916 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.19 -42.29 95.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -68.04 -36.56 80.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.792 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.22 -50.53 73.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.706 0.765 . . . . 0.0 112.916 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 19.3 mmm -57.85 -42.75 85.09 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.89 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 92.3 mt -60.08 -43.65 93.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.048 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -59.67 -38.67 82.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.743 0.306 . . . . 0.0 111.168 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.75 -41.62 86.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.16 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.46 -25.49 21.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.0 t0 -71.58 88.47 0.95 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.451 0.643 . . . . 0.0 111.842 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.5 tp -70.11 -14.58 18.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 122.844 1.307 . . . . 0.0 113.147 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 37.2 p-10 -141.04 144.15 34.81 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 112.402 -2.181 . . . . 0.0 109.486 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.34 52.22 1.08 Allowed Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.403 -0.427 . . . . 0.0 113.0 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.408 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 37.5 p-10 -91.63 -9.85 42.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.259 0.529 . . . . 0.0 110.167 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.55 3.41 78.21 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 114.168 0.427 . . . . 0.0 114.168 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -135.14 154.56 51.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 117.243 0.522 . . . . 0.0 110.422 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.6 t -101.19 118.64 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.462 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.414 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 51.9 t30 -84.21 173.18 11.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.922 0.392 . . . . 0.0 110.981 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.414 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 80.4 t80 -60.82 -40.98 94.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.222 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.11 -44.55 97.18 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.152 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.92 -38.37 90.74 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.654 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -61.33 -45.68 93.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.952 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.404 ' O ' ' OG1' ' A' ' 146' ' ' THR . 73.2 t -64.76 -46.39 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.5 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -51.0 -43.22 60.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.805 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.4 mmt -75.15 -39.88 60.04 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.7 mmt -71.43 -47.76 53.81 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.837 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 3.1 p -87.8 35.02 0.72 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.904 0.383 . . . . 0.0 110.945 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -45.96 -51.8 12.77 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.871 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.4 mttm . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.302 179.874 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . 0.476 ' C ' ' H ' ' B' 1089 ' ' GLY . 41.7 ttm180 -60.5 -43.37 97.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.466 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.646 ' C ' ' H ' ' B' 1090 ' ' GLN . 56.7 ttt180 -67.15 6.66 0.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . 0.476 ' H ' ' C ' ' B' 1087 ' ' ARG . . . -61.07 11.02 0.06 OUTLIER Glycine 0 CA--C 1.534 1.25 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.171 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.646 ' H ' ' C ' ' B' 1088 ' ' ARG . 76.1 mt-30 -60.82 -45.72 93.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.018 0.437 . . . . 0.0 111.304 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 56.1 mt -60.5 -47.98 90.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.338 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 18.8 mt -57.71 -66.83 0.4 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.9 m95 -62.04 -55.6 27.47 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.541 0.686 . . . . 0.0 112.626 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 5.6 t80 -60.51 -47.41 86.28 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -173.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -39.65 -50.78 2.29 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.69 -40.15 98.82 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.269 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.5 tp -56.44 -45.02 81.0 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.993 0.896 . . . . 0.0 109.702 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 42.1 t30 -59.23 -46.91 87.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.515 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -65.42 -38.41 89.81 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.7 mt -60.88 -41.94 90.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.271 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . 0.514 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 66.5 mt-30 -52.48 -46.58 66.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.505 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.0 m -63.71 -48.28 77.72 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.835 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.447 ' C ' ' O ' ' B' 1102 ' ' THR . 25.3 mt-30 -28.0 -55.5 0.11 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 123.11 1.433 . . . . 0.0 112.758 -177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 2.1 mt -84.75 -14.88 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 112.193 -2.276 . . . . 0.0 112.641 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.505 ' N ' ' O ' ' B' 1102 ' ' THR . 87.6 mttt -59.74 -42.7 93.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 117.97 -1.492 . . . . 0.0 108.86 176.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 81.7 t -61.42 -48.91 86.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.2 m -66.97 -36.64 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.906 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.5 mttt -49.79 -38.34 33.9 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.623 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.02 -44.42 64.15 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.217 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -63.95 -50.64 67.86 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -67.68 -42.87 81.39 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 69.5 57.88 0.33 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 117.362 -1.304 . . . . 0.0 107.731 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 84.7 p . . . . . 0 C--O 1.218 -0.583 0 CA-C-N 123.099 2.682 . . . . 0.0 111.853 179.721 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.556 ' O ' ' HB2' ' A' ' 3' ' ' GLN . 82.3 m-20 -92.16 6.27 47.25 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.202 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.556 ' HB2' ' O ' ' A' ' 2' ' ' ASP . 43.7 mt-30 100.86 18.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 124.783 1.302 . . . . 0.0 110.907 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 50.7 tp -107.4 -29.17 9.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.501 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.1 p -77.08 140.02 40.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.332 0.969 . . . . 0.0 109.863 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ILE . 47.9 tp10 -47.28 -63.48 1.03 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 122.149 0.976 . . . . 0.0 110.319 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 84.2 tt0 -34.16 -37.4 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 113.448 -1.705 . . . . 0.0 111.087 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -70.18 -36.14 74.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.577 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 6' ' ' GLU . 93.1 mt -59.57 -44.29 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 175.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.39 -49.42 64.47 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.401 -177.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -63.49 -45.14 92.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.51 0.671 . . . . 0.0 112.379 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.453 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 3.6 m-85 -63.15 -41.28 99.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.987 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -52.62 -57.04 11.3 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.442 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -46.8 -41.8 16.04 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.597 . . . . 0.0 110.363 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -55.38 -35.88 65.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.27 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.81 -39.73 81.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -64.77 -15.88 62.24 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.083 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 18' ' ' LEU . 7.3 mp -65.01 -40.81 95.46 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -106.13 -14.39 15.16 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -72.56 92.79 1.53 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.211 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -67.63 -49.84 61.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.76 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.0 p-10 -102.41 15.42 29.26 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 35.26 44.24 0.55 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.171 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.8 p30 -85.3 -4.24 59.09 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.282 . . . . 0.0 110.932 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.95 -2.26 81.65 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.2 p -137.33 152.12 49.38 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.106 0.479 . . . . 0.0 109.767 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.5 mp -91.61 123.98 43.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.3 p -113.07 163.88 14.17 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.492 0.663 . . . . 0.0 112.425 -177.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -58.59 -36.32 73.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.487 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -62.04 -61.51 2.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.43 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -61.03 -30.69 70.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.576 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 tp -60.62 -54.5 44.67 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.243 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.04 -39.14 95.32 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.17 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 m -58.22 -53.59 56.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.759 1.279 . . . . 0.0 108.794 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -57.36 -46.47 85.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 121.414 -0.804 . . . . 0.0 111.405 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.0 ttt -59.38 -40.15 85.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 119.888 1.222 . . . . 0.0 109.727 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -53.72 -41.77 67.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.529 0.681 . . . . 0.0 110.229 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.6 p -63.4 -21.6 66.38 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.125 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.91 -2.7 24.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.835 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.24 14.81 59.8 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.495 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -107.88 155.29 20.45 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 117.541 0.671 . . . . 0.0 109.825 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -114.93 63.95 1.57 Allowed Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.339 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -62.85 144.24 93.11 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.214 1.943 . . . . 0.0 112.251 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 44' ' ' THR . 1.7 t -80.31 167.69 19.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.111 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 15.6 pt-20 -58.85 -44.75 91.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.001 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.436 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -56.08 -23.52 34.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.43 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -65.82 -39.45 90.86 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.584 -0.446 . . . . 0.0 109.964 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -56.53 -41.41 76.72 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.525 0.678 . . . . 0.0 109.468 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -70.39 -57.1 5.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.863 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -53.69 -48.69 69.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.338 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 31.7 mmm -66.74 -50.19 63.55 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.9 mm -58.71 -48.33 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.622 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -56.53 -34.83 67.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -66.07 -39.68 90.26 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.852 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.454 HG21 ' CE2' ' B' 1110 ' ' PHE . 73.5 t -86.07 -20.46 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.577 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.479 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.3 t0 -79.22 85.33 5.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -175.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.37 84.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.391 -1.731 . . . . 0.0 114.187 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 39.7 p-10 -86.47 -2.72 58.69 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.27 23.06 63.88 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 118.398 0.544 . . . . 0.0 112.752 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.429 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -87.89 2.06 52.47 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 117.418 0.609 . . . . 0.0 110.664 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.479 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.53 1.82 87.49 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 118.603 0.638 . . . . 0.0 114.552 175.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.3 p -146.36 166.63 25.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.6 mm -109.35 126.7 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -102.93 -177.09 3.27 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -47.01 99.55 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -176.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -56.45 -51.51 9.09 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 120.995 1.13 . . . . 0.0 111.66 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.63 -18.77 60.84 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.416 0.627 . . . . 0.0 110.521 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -75.8 -59.28 2.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.063 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.02 -44.45 82.87 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.7 m -45.92 -48.06 16.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.399 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 60.1 mtm -66.88 -45.02 79.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 32.0 mmm -61.3 -41.31 96.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.12 -35.16 79.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.41 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -92.12 -16.36 26.45 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.813 0.339 . . . . 0.0 111.414 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.493 ' HZ1' ' HG3' ' B' 1105 ' ' LYS . 28.4 tptp -80.18 72.09 6.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.612 0.72 . . . . 0.0 110.562 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -107.9 19.39 20.12 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.983 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -49.87 129.99 20.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.146 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.52 109.35 20.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.861 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.2 p -99.3 111.75 24.06 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.582 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER -60.4 117.85 5.75 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.013 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 m -37.37 -19.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.711 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 80' ' ' ASP . 80.5 tt0 -68.67 -35.57 77.41 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -49.98 -38.8 38.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.259 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -87.21 -19.44 28.38 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.092 0.473 . . . . 0.0 111.671 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.8 mm -60.41 -74.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.679 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.6 mtm180 -62.77 -41.55 99.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.7 -40.57 92.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.408 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.53 -17.48 46.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.007 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -74.17 -49.59 22.95 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.223 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -55.68 -43.18 76.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.435 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.82 -43.56 93.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.7 m-85 -68.68 -38.8 80.62 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.393 -178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -86.23 82.36 8.06 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -57.64 -50.21 73.91 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -91.04 5.83 47.3 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.277 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.21 47.81 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -90.32 7.47 38.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.667 0.27 . . . . 0.0 110.616 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.18 2.16 89.37 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -141.48 153.62 45.05 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.809 0.814 . . . . 0.0 111.756 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -96.05 117.04 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.3 p -91.34 153.69 19.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.54 -46.73 83.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 119.227 0.921 . . . . 0.0 110.906 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.64 -41.9 64.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.891 0.377 . . . . 0.0 110.617 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -64.35 -43.26 95.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.54 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 108' ' ' VAL . 11.5 mt -62.76 -44.95 94.85 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.324 0.583 . . . . 0.0 111.391 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.2 ttt85 -42.5 -43.17 3.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.651 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -63.28 -27.33 69.26 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.035 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.567 HG21 ' CE2' ' A' ' 92' ' ' PHE . 94.0 t -58.07 -42.83 83.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.651 -178.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.649 ' HG3' HD13 ' A' ' 116' ' ' LEU . 15.1 mmt -51.35 -44.46 62.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.204 1.002 . . . . 0.0 111.458 -177.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.6 m -55.36 -41.1 72.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 113.345 -1.752 . . . . 0.0 110.885 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -64.73 -39.84 94.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.538 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.3 mt -83.44 -13.56 54.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.63 35.89 50.09 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.396 -1.224 . . . . 0.0 110.482 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.5 ' OE1' ' SD ' ' A' ' 109' ' ' MET . 80.7 tt0 -89.78 -24.57 21.45 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.729 2.265 . . . . 0.0 110.879 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.0 tptp 45.89 63.0 1.99 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.551 1.167 . . . . 0.0 110.096 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.872 HD23 ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -76.31 150.92 36.85 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.955 -1.929 . . . . 0.0 112.854 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 71.2 p -86.3 174.16 9.25 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.367 0.603 . . . . 0.0 109.952 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -54.42 -44.02 72.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -55.83 -41.63 74.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.219 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -68.4 -28.98 67.57 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.721 -178.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.477 ' CG2' HD11 ' A' ' 116' ' ' LEU . 52.6 t -63.8 -44.07 98.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.33 0.586 . . . . 0.0 109.773 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.66 -37.33 65.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.292 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -58.73 -54.95 41.29 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.422 ' CE ' HD12 ' B' 1092 ' ' LEU . 95.1 mtp -57.17 -43.19 82.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.746 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.6 mm -58.7 -44.0 88.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.132 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -60.65 -35.68 76.81 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.348 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.98 -42.23 89.49 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.69 -20.15 21.88 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.6 t0 -70.45 90.29 0.72 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.539 0.685 . . . . 0.0 112.069 -177.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.0 -16.12 19.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 122.711 1.243 . . . . 0.0 113.219 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.6 p-10 -143.82 144.99 32.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 112.334 -2.212 . . . . 0.0 109.443 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.05 52.74 1.36 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.961 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -91.17 -9.29 45.98 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.087 0.443 . . . . 0.0 110.145 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.64 2.14 74.38 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.401 -0.428 . . . . 0.0 114.115 176.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -133.75 153.05 52.0 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 117.36 0.58 . . . . 0.0 110.477 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.1 t -99.15 118.23 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.145 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.416 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 52.2 t30 -84.0 173.61 11.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.977 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.416 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 82.9 t80 -61.37 -39.33 90.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.929 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -63.72 -44.66 92.95 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.015 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.17 -38.67 91.29 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.567 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -61.04 -44.74 96.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.799 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 82.8 t -65.86 -46.27 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.471 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -49.23 -44.87 43.83 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.008 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.3 mmm -75.66 -39.98 56.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.2 mmt -76.21 -46.86 26.28 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.341 -0.144 . . . . 0.0 111.069 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.2 m -91.52 34.14 0.98 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 111.446 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -45.83 -39.23 8.2 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.882 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.7 tttp . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.203 -179.919 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 51.5 tp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . 0.545 ' C ' ' H ' ' B' 1089 ' ' GLY . 10.3 ptp85 -146.81 166.9 25.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.536 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.622 ' C ' ' H ' ' B' 1090 ' ' GLN . 28.1 ttm180 -64.57 7.87 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . 0.545 ' H ' ' C ' ' B' 1087 ' ' ARG . . . -61.83 9.49 0.11 Allowed Glycine 0 CA--C 1.534 1.22 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.622 ' H ' ' C ' ' B' 1088 ' ' ARG . 17.4 mt-30 -60.4 -46.11 91.18 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.009 0.433 . . . . 0.0 111.619 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 71.4 mt -55.22 -53.66 32.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . 0.511 ' O ' HD13 ' B' 1092 ' ' LEU . 0.3 OUTLIER -57.26 -60.82 3.04 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.754 -176.363 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 4.7 m95 -58.6 -60.65 3.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.574 0.702 . . . . 0.0 112.095 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.99 -46.64 82.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -174.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . 0.646 HH11 ' NH2' ' B' 1099 ' ' ARG . 63.7 ttm-85 -36.51 -51.97 0.84 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.79 -40.1 98.35 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.179 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 51.8 tp -56.65 -44.18 81.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 118.031 0.916 . . . . 0.0 109.628 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -59.63 -49.52 77.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.692 -1.14 . . . . 0.0 113.767 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . 0.646 ' NH2' HH11 ' B' 1095 ' ' ARG . 3.2 mpt_? -65.72 -39.22 90.96 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.302 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.0 mt -60.74 -43.33 94.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.509 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -55.49 -45.15 77.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.513 ' O ' ' C ' ' B' 1103 ' ' GLN . 90.4 m -60.9 -48.56 81.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.955 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.513 ' C ' ' O ' ' B' 1102 ' ' THR . 86.1 mt-30 -28.29 -97.54 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 123.238 1.494 . . . . 0.0 112.137 -175.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -39.47 -14.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 111.806 -2.452 . . . . 0.0 111.752 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.493 ' HG3' ' HZ1' ' A' ' 75' ' ' LYS . 52.5 tttp -60.4 -44.63 95.5 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 118.01 -1.476 . . . . 0.0 107.476 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 72.5 t -61.45 -48.97 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . 0.407 ' H ' HG13 ' B' 1107 ' ' VAL . 1.2 m -66.83 -37.88 80.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.96 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 63.4 mttt -49.87 -39.41 39.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 119.959 -0.697 . . . . 0.0 109.205 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -50.86 -44.91 59.63 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.035 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . 0.454 ' CE2' HG21 ' A' ' 55' ' ' VAL . 45.2 m-85 -63.46 -48.53 77.3 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -68.74 -41.98 78.23 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.74 57.33 0.42 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 117.421 -1.276 . . . . 0.0 107.753 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.218 -0.58 0 CA-C-N 123.823 3.01 . . . . 0.0 110.907 179.962 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -69.28 -18.37 63.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.77 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -100.47 99.7 10.35 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.0 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.69 -19.52 12.84 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.697 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.2 p -80.45 139.31 36.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.256 0.935 . . . . 0.0 110.384 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 9' ' ' ILE . 48.4 tp10 -50.98 -54.65 22.59 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.798 0.808 . . . . 0.0 110.519 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -35.77 -37.57 0.1 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.096 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -68.99 -37.54 78.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.605 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.8 mt -58.64 -45.64 90.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 175.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.39 -51.58 62.1 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.393 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -61.6 -47.06 87.15 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.468 0.651 . . . . 0.0 112.622 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -62.9 -36.86 84.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.556 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -55.16 -51.51 66.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.373 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.77 -41.82 61.93 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.31 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.47 -39.14 67.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.212 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -56.29 -41.51 76.04 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -65.28 -14.69 61.32 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.441 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.2 tp -63.25 -43.45 97.96 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -107.06 -13.73 15.11 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.99 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -76.27 95.43 3.74 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.098 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -68.34 -46.99 68.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.297 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 23' ' ' GLY . 40.5 p-10 -101.63 14.84 30.76 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.65 46.85 0.6 Allowed Glycine 0 CA--C 1.533 1.195 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -84.15 -3.44 58.13 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.43 -1.58 82.13 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.425 ' C ' HD12 ' A' ' 27' ' ' ILE . 57.7 p -137.39 151.88 49.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.918 0.389 . . . . 0.0 110.168 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.7 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.6 mp -93.49 125.73 46.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.509 HG23 ' H ' ' A' ' 30' ' ' LYS . 1.9 t -115.29 164.27 14.48 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.176 -0.92 . . . . 0.0 113.182 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.4 HG22 HG13 ' A' ' 52' ' ' ILE . 20.0 p -57.66 -36.08 71.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.83 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.509 ' H ' HG23 ' A' ' 28' ' ' THR . 34.5 ttpt -60.97 -58.5 8.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.85 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -64.36 -28.68 69.86 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.448 HD22 HD11 ' A' ' 52' ' ' ILE . 3.2 tp -61.41 -56.1 24.01 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.78 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.22 -37.64 87.43 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.365 -1.288 . . . . 0.0 112.11 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.7 m -57.85 -54.57 45.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.911 1.356 . . . . 0.0 107.619 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.9 t -55.96 -46.05 80.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 118.852 0.751 . . . . 0.0 111.515 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.1 mmm -58.35 -42.34 86.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 119.963 1.256 . . . . 0.0 110.229 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.2 ttt-85 -54.48 -41.77 69.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.441 0.639 . . . . 0.0 110.786 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.1 t -63.6 -21.32 66.29 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.83 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 tp -73.95 -2.54 24.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.851 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.78 14.51 62.98 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.164 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -109.31 156.79 19.55 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 117.537 0.669 . . . . 0.0 109.518 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -119.67 65.67 9.42 Favored Pre-proline 0 N--CA 1.465 0.29 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.53 145.45 76.56 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.163 1.909 . . . . 0.0 112.03 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 m -78.22 159.29 28.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.268 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -52.49 -41.84 63.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.696 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.79 -25.21 26.61 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -65.61 -39.73 91.85 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.065 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.52 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.7 mp -56.19 -41.45 75.58 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.327 0.585 . . . . 0.0 109.909 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -67.31 -57.35 6.81 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.071 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -54.98 -49.53 71.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.5 mmm -64.17 -51.63 62.88 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.448 HD11 HD22 ' A' ' 32' ' ' LEU . 28.5 mm -59.23 -49.58 82.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.092 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -56.66 -33.96 66.89 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -66.28 -40.35 90.02 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.786 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.479 HG21 ' CD2' ' B' 1110 ' ' PHE . 69.0 t -86.6 -20.03 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.335 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.523 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 44.0 t0 -78.68 84.61 4.76 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 -175.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.62 79.6 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.842 -1.526 . . . . 0.0 114.36 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.414 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 36.1 p-10 -85.11 -2.79 58.4 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.342 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.06 22.75 60.85 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.901 -0.499 . . . . 0.0 112.316 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.414 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.9 p-10 -86.24 3.51 42.78 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.313 0.556 . . . . 0.0 110.441 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 83.12 2.33 90.53 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 114.8 0.68 . . . . 0.0 114.8 175.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 69.0 p -147.06 165.94 28.39 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.7 mm -109.42 126.81 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -102.99 -177.25 3.32 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.838 0.352 . . . . 0.0 110.731 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.412 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -57.02 -57.71 22.72 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 9.7 Cg_endo -49.08 -50.59 12.44 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.158 1.238 . . . . 0.0 111.336 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.3 -20.78 60.58 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.279 0.562 . . . . 0.0 110.708 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -75.64 -58.31 3.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.962 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -55.74 -47.9 76.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.3 p -44.22 -48.21 9.32 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.309 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 77.5 mtp -65.52 -45.57 82.98 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 31.4 mmt -59.92 -40.78 90.04 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.6 -34.1 77.44 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.332 0.253 . . . . 0.0 111.538 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.8 mtp85 -95.24 -12.35 26.39 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.569 0.223 . . . . 0.0 111.355 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.84 68.54 7.14 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.181 0.515 . . . . 0.0 110.481 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 21.5 mmt -108.69 15.47 23.64 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.684 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -52.82 129.78 31.03 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.535 0.683 . . . . 0.0 111.6 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 79' ' ' THR . 61.6 t0 -105.57 146.35 29.76 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.694 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.521 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 75.3 p -132.81 133.97 44.07 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 82' ' ' GLU . 1.1 p30 -61.12 115.95 4.17 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 175.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 m -36.44 -19.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 80' ' ' ASP . 46.0 tp10 -70.54 -32.09 69.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.941 0.401 . . . . 0.0 111.513 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -51.16 -41.12 59.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.668 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 37.0 tp10 -83.96 -17.45 40.58 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 111.872 -178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.6 mm -59.21 -73.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.46 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -58.57 -55.87 29.44 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.47 ' CD ' ' N ' ' A' ' 88' ' ' ALA . 3.1 pp20? -52.83 -36.36 58.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.297 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -60.71 -23.49 64.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.812 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -72.37 -48.84 38.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.24 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -54.79 -41.55 70.71 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.896 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.25 -45.06 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.745 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.525 ' CE2' HG21 ' A' ' 108' ' ' VAL . 9.5 m-85 -70.02 -38.55 75.94 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.349 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.517 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 31.6 t0 -88.69 82.48 6.84 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 176.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.503 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 65.2 tttm -58.46 -48.42 80.8 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 40.2 p-10 -90.65 4.88 50.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.664 0.269 . . . . 0.0 111.652 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.2 47.52 49.53 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.716 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -90.61 5.98 45.68 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 122.35 0.26 . . . . 0.0 110.742 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.459 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 85.11 0.96 88.76 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.716 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 74.1 m-85 -139.22 152.29 47.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.611 0.72 . . . . 0.0 111.708 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.6 mt -94.51 117.72 38.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 t -91.06 150.12 21.55 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.49 -45.96 76.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 119.159 0.891 . . . . 0.0 110.481 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.6 -40.44 62.67 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.892 0.377 . . . . 0.0 110.745 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.503 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.1 mt-10 -65.84 -40.59 91.88 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.227 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.3 tp -62.93 -46.14 89.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.216 0.531 . . . . 0.0 110.543 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -43.54 -43.11 5.36 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.573 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -64.96 -30.81 71.82 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 121.222 -0.191 . . . . 0.0 110.646 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.525 HG21 ' CE2' ' A' ' 92' ' ' PHE . 93.6 t -56.99 -41.8 77.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.643 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.628 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -50.6 -44.43 57.02 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.786 0.803 . . . . 0.0 111.276 -178.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 m -57.2 -41.29 79.12 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 114.046 -1.434 . . . . 0.0 111.013 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -65.96 -41.31 91.38 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.564 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.1 mt -81.52 -13.81 57.67 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.8 31.98 57.61 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.556 -1.136 . . . . 0.0 110.401 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -85.44 -21.51 28.72 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.628 2.214 . . . . 0.0 111.744 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt 43.27 61.05 2.32 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.892 0.854 . . . . 0.0 109.948 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.453 HD12 ' CG ' ' A' ' 109' ' ' MET . 87.7 mt -81.51 147.72 29.54 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.404 -1.726 . . . . 0.0 112.317 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 121' ' ' VAL . 65.3 p -82.48 175.74 9.97 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.839 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -57.75 -46.44 84.5 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -55.98 -48.58 75.58 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.983 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -71.66 -30.85 66.17 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.461 -0.496 . . . . 0.0 112.288 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 117' ' ' THR . 39.0 t -63.51 -41.4 92.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.522 0.677 . . . . 0.0 109.408 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -72.64 -33.26 66.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.78 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.42 -50.98 71.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.684 ' CE ' HD21 ' B' 1092 ' ' LEU . 76.3 mtp -52.85 -48.07 67.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.641 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.8 mm -57.76 -43.48 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.882 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -62.17 -35.3 78.39 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.808 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -57.06 -41.02 77.98 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.42 -11.66 29.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.791 0.329 . . . . 0.0 111.358 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.2 t0 -75.12 89.1 2.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.507 0.67 . . . . 0.0 111.855 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -70.77 -18.36 20.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.596 -1.184 . . . . 0.0 113.105 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.461 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.3 p-10 -140.32 145.73 37.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 112.781 -2.009 . . . . 0.0 108.678 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.96 52.2 1.65 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.696 -0.288 . . . . 0.0 113.031 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -90.72 -9.48 46.56 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.978 0.389 . . . . 0.0 110.089 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.74 1.49 72.3 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.957 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -135.5 154.19 51.49 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.127 0.463 . . . . 0.0 110.471 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.44 118.37 47.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.175 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -83.84 173.26 11.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 0.0 111.093 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -61.35 -40.85 95.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.046 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -61.76 -44.41 96.95 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.744 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.81 -39.71 94.02 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.58 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.565 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 92.1 t80 -61.3 -46.44 90.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.976 0.417 . . . . 0.0 111.175 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.48 -46.65 92.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.383 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.846 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 52.0 tt0 -49.54 -47.62 48.92 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.714 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 88.2 mmm -71.22 -35.2 71.42 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.565 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.7 mtt -79.56 -46.97 16.32 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p -89.28 -40.23 12.95 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.846 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -78.2 41.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.706 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.509 ' C ' ' NE2' ' B' 1090 ' ' GLN . 21.6 pttm . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.526 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . 0.533 HD12 ' N ' ' B' 1086 ' ' LEU . 10.7 mp . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . 0.497 ' C ' ' H ' ' B' 1089 ' ' GLY . 11.6 ptp85 -62.97 -33.69 75.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.807 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.564 ' C ' ' H ' ' B' 1090 ' ' GLN . 66.0 ttt180 -67.51 10.55 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . 0.497 ' H ' ' C ' ' B' 1087 ' ' ARG . . . -64.37 8.5 0.46 Allowed Glycine 0 CA--C 1.531 1.082 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.564 ' H ' ' C ' ' B' 1088 ' ' ARG . 14.2 mt-30 -63.19 -50.68 69.37 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . 0.421 ' C ' ' O ' ' B' 1090 ' ' GLN . 80.1 mt -28.75 -77.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.017 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . 0.75 HD23 ' N ' ' B' 1093 ' ' TRP . 0.9 OUTLIER -50.56 -43.13 56.2 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . 0.75 ' N ' HD23 ' B' 1092 ' ' LEU . 2.3 m95 -55.31 -62.25 1.8 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.358 0.599 . . . . 0.0 110.864 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 51.6 t80 -56.51 -44.24 80.54 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 61.9 ttt85 -39.94 -53.47 2.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -60.27 -39.95 96.74 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 48.0 tp -56.6 -44.12 80.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 118.494 1.147 . . . . 0.0 109.73 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 46.4 t30 -57.66 -47.61 81.8 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -63.96 -38.15 90.03 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.04 -42.27 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.638 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -51.41 -46.27 62.85 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.628 -1.229 . . . . 0.0 107.874 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.518 ' O ' ' N ' ' B' 1105 ' ' LYS . 96.1 m -62.37 -48.38 80.01 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.59 -0.444 . . . . 0.0 112.047 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.432 ' C ' ' O ' ' B' 1102 ' ' THR . 84.8 mt-30 -27.98 -59.22 0.11 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.591 1.186 . . . . 0.0 112.66 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . 0.402 HG21 HD13 ' B' 1104 ' ' ILE . 2.0 mt -81.52 -14.34 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 112.711 -2.041 . . . . 0.0 112.089 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' 1102 ' ' THR . 64.0 tttp -58.92 -45.95 89.13 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 118.087 -1.445 . . . . 0.0 108.179 176.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.3 t -60.57 -49.73 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.06 -36.56 78.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.116 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 88.9 mttt -49.09 -37.08 20.37 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.739 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.44 63.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.287 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . 0.479 ' CD2' HG21 ' A' ' 55' ' ' VAL . 44.3 m-85 -62.92 -49.45 74.73 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -68.2 -41.06 81.94 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.4 t 67.15 59.38 0.53 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 116.555 -1.688 . . . . 0.0 107.476 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.471 0.577 0 CA-C-N 124.488 3.313 . . . . 0.0 111.878 179.384 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.506 ' O ' HD22 ' A' ' 4' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.426 ' O ' ' OE1' ' A' ' 8' ' ' GLN . 25.6 t70 -65.84 -39.18 90.55 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -97.49 124.42 41.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.724 0.297 . . . . 0.0 110.342 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 4' ' ' LEU . 1.9 pt? 174.81 -34.71 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.037 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.7 p -77.2 140.14 40.07 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.865 0.757 . . . . 0.0 110.827 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.1 tt0 -48.73 -60.98 2.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 122.108 0.956 . . . . 0.0 110.497 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 81.1 tt0 -34.61 -37.01 0.05 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.998 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.426 ' OE1' ' O ' ' A' ' 2' ' ' ASP . 38.9 tt0 -69.86 -35.78 74.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.403 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.8 mm -59.71 -44.6 94.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 175.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.51 -49.96 63.76 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.282 -177.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -63.1 -44.84 94.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.507 0.67 . . . . 0.0 112.332 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.8 m-85 -63.28 -39.28 94.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.887 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -52.51 -54.02 38.14 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.357 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -50.78 -41.63 57.11 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.162 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -54.79 -39.13 68.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.137 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.445 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 3.0 m-85 -57.7 -41.29 81.4 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.3 p -64.55 -15.91 61.73 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.402 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.586 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -64.65 -42.3 95.51 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.79 -178.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -105.95 -14.14 15.28 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -72.72 94.0 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.344 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -67.71 -49.65 61.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.722 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 23' ' ' GLY . 48.2 p-10 -102.72 15.78 28.35 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 34.88 45.19 0.54 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.132 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -86.01 -4.24 59.12 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.83 0.347 . . . . 0.0 111.062 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.05 -1.58 80.5 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.3 p -138.01 152.95 49.38 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.17 0.509 . . . . 0.0 110.043 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.69 124.08 44.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.0 p -113.19 163.51 14.68 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.941 0.776 . . . . 0.0 112.559 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.1 p -58.24 -37.11 74.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.884 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.57 -62.09 2.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.185 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -60.58 -29.89 69.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.668 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.461 HD22 HD11 ' A' ' 52' ' ' ILE . 3.1 tp -61.07 -55.02 37.47 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.026 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.87 -40.32 95.06 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.401 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.11 -54.65 44.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 118.884 1.342 . . . . 0.0 108.423 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.9 t -56.76 -46.78 83.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 118.889 0.768 . . . . 0.0 111.841 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 27.2 ttt -58.63 -41.5 86.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 120.065 1.302 . . . . 0.0 109.964 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -51.78 -38.28 54.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.512 0.673 . . . . 0.0 110.296 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.1 t -62.59 -20.58 64.86 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.949 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -74.08 -0.4 16.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.897 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.44 14.56 70.77 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.116 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -107.47 158.5 17.15 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 117.484 0.642 . . . . 0.0 109.992 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -116.1 65.83 2.88 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.272 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.75 144.03 87.96 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.182 1.921 . . . . 0.0 112.111 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.5 t -80.42 165.45 22.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.555 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -57.9 -44.94 87.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.68 -23.96 31.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.586 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -65.61 -39.99 92.14 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.146 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.8 mp -55.64 -40.8 72.68 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.495 0.664 . . . . 0.0 109.799 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -71.45 -56.22 6.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.815 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -54.52 -49.23 70.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 66.0 mtp -67.08 -48.65 67.56 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.461 HD11 HD22 ' A' ' 32' ' ' LEU . 26.0 mm -58.47 -46.71 89.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.607 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -55.59 -35.54 65.93 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -66.62 -40.3 88.72 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.146 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' B' 1110 ' ' PHE . 59.4 t -85.58 -20.97 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.39 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.446 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 43.3 t0 -79.63 84.3 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -175.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.81 -37.1 80.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.64 -1.618 . . . . 0.0 114.319 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -86.57 -2.04 58.16 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.53 23.04 60.03 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 118.44 0.563 . . . . 0.0 112.473 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -87.65 3.81 46.36 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.44 0.62 . . . . 0.0 110.515 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.72 1.41 89.05 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 114.789 0.676 . . . . 0.0 114.789 175.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.0 p -148.42 168.86 21.55 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.8 mt -113.48 128.79 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 5.9 p30 -103.61 -175.97 2.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.867 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.445 ' CD2' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.16 -47.63 98.49 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.738 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -55.72 -52.06 8.36 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.287 1.325 . . . . 0.0 111.84 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.22 -19.59 61.82 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.506 0.669 . . . . 0.0 110.533 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -75.52 -59.33 2.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.352 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.5 mt -56.46 -45.16 81.02 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.8 p -45.24 -47.49 12.77 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.404 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 33.6 mtp -67.68 -46.81 71.23 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.6 mmm -61.75 -39.89 93.17 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.64 -34.21 77.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.373 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -94.95 -12.44 26.76 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' C ' ' SD ' ' A' ' 76' ' ' MET . 3.9 tptt -81.9 67.02 7.72 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.016 0.436 . . . . 0.0 110.237 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.524 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -106.98 17.52 22.97 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.34 179.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -49.79 132.39 22.15 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.508 0.67 . . . . 0.0 111.41 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -92.51 108.12 19.73 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.107 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.0 m -93.5 121.29 34.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 82' ' ' GLU . 30.4 m-20 -69.42 113.19 6.51 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.4 m -37.78 -19.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.796 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 80' ' ' ASP . 83.2 tt0 -67.01 -41.05 87.34 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.863 0.363 . . . . 0.0 111.217 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -56.95 -40.75 77.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.724 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.56 ' O ' ' N ' ' A' ' 87' ' ' GLU . 51.0 tp10 -72.3 -80.52 0.06 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.655 -178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.614 HD12 ' N ' ' A' ' 86' ' ' ARG . 1.9 pp -20.56 -60.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 123.684 0.615 . . . . 0.0 111.319 -177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.614 ' N ' HD12 ' A' ' 85' ' ' ILE . 9.1 ptm180 -60.76 -42.21 96.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.581 ' CD ' HH21 ' A' ' 90' ' ' ARG . 40.3 mm-40 -61.84 -40.07 94.01 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.939 0.399 . . . . 0.0 111.092 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -17.58 62.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.856 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -71.43 -52.79 16.59 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.735 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.581 HH21 ' CD ' ' A' ' 87' ' ' GLU . 78.9 mtm-85 -55.53 -40.63 72.08 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.874 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.62 -42.92 90.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.527 ' CE2' HG21 ' A' ' 108' ' ' VAL . 4.8 m-85 -68.01 -37.91 81.97 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.417 -178.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -89.34 83.7 6.43 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.43 -46.39 90.2 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -91.5 4.55 52.27 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.386 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.39 49.9 37.07 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.19 6.7 41.59 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.77 0.55 89.85 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.669 -0.573 . . . . 0.0 111.669 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -139.5 151.92 46.55 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.615 0.722 . . . . 0.0 111.736 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.3 mt -95.9 117.5 40.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 m -91.32 152.81 20.31 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.19 80.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 119.412 1.005 . . . . 0.0 110.848 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.56 -40.52 62.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 110.676 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -65.33 -42.64 92.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.222 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 108' ' ' VAL . 21.2 mt -63.03 -45.15 93.68 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.29 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -41.53 -45.45 3.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.746 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -59.78 -26.11 65.45 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.798 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.527 HG21 ' CE2' ' A' ' 92' ' ' PHE . 63.4 t -58.33 -43.1 85.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.895 -178.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.44 ' SD ' HD12 ' A' ' 116' ' ' LEU . 8.3 mmt -51.15 -45.54 61.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.065 0.936 . . . . 0.0 111.098 -177.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.0 p -57.92 -38.61 76.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 113.656 -1.611 . . . . 0.0 111.085 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -40.55 81.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.493 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 70.3 mt -81.32 -13.68 58.14 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.29 29.59 59.98 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.393 -1.226 . . . . 0.0 110.15 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -85.87 -22.62 27.45 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.779 2.29 . . . . 0.0 111.005 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm 44.77 61.81 2.33 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.222 1.01 . . . . 0.0 109.862 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.44 HD12 ' SD ' ' A' ' 109' ' ' MET . 78.1 mt -80.65 147.0 30.86 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.472 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 121' ' ' VAL . 30.8 p -81.95 175.54 10.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.614 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -57.15 -44.87 83.83 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.28 -48.26 79.34 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -72.75 -30.65 64.33 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.103 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 117' ' ' THR . 42.7 t -64.99 -43.22 96.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -69.15 -35.02 75.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.214 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -59.72 -47.57 85.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.059 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 15.8 mmm -55.18 -45.12 75.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.62 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 40.1 mm -58.14 -44.1 86.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.446 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -58.91 -39.57 81.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.746 0.308 . . . . 0.0 111.132 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.99 -41.68 83.52 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.52 -23.1 21.02 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 22.7 t0 -72.42 87.97 1.19 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.485 0.66 . . . . 0.0 112.098 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.69 -15.26 19.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.945 1.355 . . . . 0.0 113.265 -178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 37.6 p-10 -141.68 145.0 34.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.214 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.06 52.31 1.7 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.551 -0.357 . . . . 0.0 113.385 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -91.32 -8.76 47.26 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.182 0.491 . . . . 0.0 110.108 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.04 2.54 78.39 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.118 -0.563 . . . . 0.0 114.21 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -134.99 153.87 51.93 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 117.19 0.495 . . . . 0.0 110.551 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.7 118.57 47.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.321 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -83.65 173.0 11.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.893 0.378 . . . . 0.0 111.06 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -61.8 -39.74 92.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.022 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -61.57 -44.68 96.58 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.621 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.11 -37.76 88.61 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.436 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -61.07 -44.94 96.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.701 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.05 -47.77 86.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.371 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -50.24 -44.35 53.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.171 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.4 mmt -73.33 -38.94 65.61 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 22.4 mmt -75.66 -46.92 28.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.911 -0.131 . . . . 0.0 111.021 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 p -89.24 31.51 0.89 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.564 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.86 87.1 5.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.746 0.308 . . . . 0.0 111.133 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.3 tptp . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.372 179.702 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . 0.539 HD12 ' N ' ' B' 1086 ' ' LEU . 10.6 mp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -77.2 142.19 39.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.586 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.764 ' NE ' ' H ' ' B' 1088 ' ' ARG . 0.0 OUTLIER -107.84 95.43 5.68 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.162 0.506 . . . . 0.0 110.684 179.68 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -54.33 -3.62 0.26 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.556 ' H ' ' C ' ' B' 1088 ' ' ARG . 4.6 mt-30 -65.07 -51.9 58.78 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 68.4 mt -58.78 -50.12 80.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.6 mt -55.56 -62.39 1.72 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.659 -0.416 . . . . 0.0 112.026 -177.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.51 -53.69 53.1 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.451 0.643 . . . . 0.0 112.111 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 53.8 t80 -58.02 -46.06 85.89 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -174.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -40.69 -52.33 2.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.23 -41.83 99.72 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.084 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.2 tp -55.93 -46.3 78.51 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.446 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 41.2 t30 -58.01 -48.31 80.42 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -64.96 -38.11 89.89 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 87.5 mt -60.91 -42.6 93.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.802 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -50.96 -44.99 60.68 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.514 ' O ' ' N ' ' B' 1105 ' ' LYS . 19.4 m -63.0 -48.28 79.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.92 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.424 ' C ' ' O ' ' B' 1102 ' ' THR . 84.4 mt-30 -28.01 -58.64 0.11 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.805 1.288 . . . . 0.0 112.929 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.9 mt -82.74 -15.4 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 112.25 -2.25 . . . . 0.0 111.985 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.514 ' N ' ' O ' ' B' 1102 ' ' THR . 88.8 tttt -58.8 -45.92 88.79 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 117.989 -1.484 . . . . 0.0 107.89 176.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.5 t -60.85 -49.06 86.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.57 -36.84 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.091 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 90.5 mttt -49.74 -37.16 28.25 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.512 0.672 . . . . 0.0 109.661 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.03 -45.53 64.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.285 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . 0.46 ' CE2' HG21 ' A' ' 55' ' ' VAL . 49.3 m-85 -63.13 -50.44 70.44 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -68.01 -41.8 81.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.2 t 67.82 60.33 0.45 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 116.749 -1.596 . . . . 0.0 107.619 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 38.7 p . . . . . 0 C--O 1.218 -0.582 0 CA-C-N 124.214 3.188 . . . . 0.0 111.771 179.309 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -64.55 -35.35 80.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.56 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.797 ' H ' HE21 ' A' ' 3' ' ' GLN . 0.0 OUTLIER -101.32 101.77 12.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.117 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.2 mt -112.09 -21.13 11.67 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.695 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.7 p -79.97 138.62 37.11 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.997 0.817 . . . . 0.0 110.523 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 9' ' ' ILE . 27.1 mm-40 -49.17 -58.1 5.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 122.099 0.952 . . . . 0.0 110.788 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -35.64 -37.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 113.352 -1.749 . . . . 0.0 110.611 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.444 ' NE2' ' CG ' ' A' ' 3' ' ' GLN . 23.3 tt0 -70.19 -37.18 75.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 118.572 -0.727 . . . . 0.0 110.468 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' GLU . 97.1 mt -59.76 -46.04 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.41 -48.63 62.58 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.51 -177.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.04 -44.36 92.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.551 0.691 . . . . 0.0 112.299 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.456 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.5 m-85 -63.19 -39.99 96.22 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.862 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -50.22 -53.67 26.45 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.572 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -51.85 -39.2 58.5 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.174 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.35 -39.91 73.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.379 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -55.55 -42.05 74.12 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.9 t -64.05 -16.54 61.92 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.381 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.613 HD13 ' O ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -63.67 -43.44 96.68 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -178.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -104.67 -15.13 15.36 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.602 -178.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -77.7 93.13 4.22 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.361 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -66.75 -46.83 74.15 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.706 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -101.7 15.15 29.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.24 50.48 3.65 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.732 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 p30 -89.43 -5.55 57.29 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.171 0.486 . . . . 0.0 111.898 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.12 0.69 73.69 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.849 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.469 HG22 ' OD1' ' A' ' 64' ' ' ASP . 31.7 p -141.25 159.76 41.54 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.971 0.415 . . . . 0.0 110.07 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.2 mt -92.32 126.19 44.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.419 ' OG1' ' OE1' ' A' ' 31' ' ' GLU . 19.1 p -111.78 162.65 15.03 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.044 0.84 . . . . 0.0 112.256 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 p -60.36 -37.97 82.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.87 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -62.43 -58.88 6.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.464 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.419 ' OE1' ' OG1' ' A' ' 28' ' ' THR . 10.1 pt-20 -63.38 -29.52 70.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.625 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.48 HD22 HD11 ' A' ' 52' ' ' ILE . 3.5 tp -61.08 -52.5 64.64 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.3 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.99 -38.09 94.93 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.938 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.2 m -58.76 -54.15 50.36 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.731 1.265 . . . . 0.0 108.593 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.5 t -57.79 -46.06 87.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 121.058 -1.026 . . . . 0.0 111.513 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.3 tpt -59.31 -40.33 85.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 119.914 1.234 . . . . 0.0 109.531 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -53.35 -41.56 65.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.307 0.575 . . . . 0.0 110.251 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.6 p -63.71 -21.47 66.41 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.157 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.42 -4.09 31.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.61 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.3 13.01 60.74 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.032 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -106.68 155.12 20.0 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.642 0.721 . . . . 0.0 110.094 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 26.1 t-20 -116.46 62.85 2.58 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.37 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.25 145.7 93.37 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.265 1.977 . . . . 0.0 112.204 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.7 p -80.36 167.73 19.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.565 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -58.24 -44.06 88.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.805 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.7 -24.09 32.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.502 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -65.49 -38.6 90.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.016 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.8 mp -57.25 -42.26 81.17 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.311 0.577 . . . . 0.0 109.882 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -69.16 -56.48 7.53 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.383 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -55.32 -48.98 73.33 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.9 mmm -65.39 -51.68 58.71 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.48 HD11 HD22 ' A' ' 32' ' ' LEU . 28.6 mm -59.63 -48.9 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.777 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -57.82 -33.47 68.64 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.85 -39.84 94.2 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.53 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.8 t -88.21 -17.73 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.265 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.45 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.7 t0 -78.37 85.55 4.48 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -174.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.02 88.39 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 113.427 -1.715 . . . . 0.0 113.728 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 38.1 p-10 -85.6 -3.06 58.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.82 23.82 61.68 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.886 -0.509 . . . . 0.0 112.937 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.433 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.6 p-10 -87.56 3.76 46.26 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.174 0.487 . . . . 0.0 110.26 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.45 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.09 0.54 88.84 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.893 -0.67 . . . . 0.0 114.214 175.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.6 p -149.13 170.38 18.56 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.0 mt -112.59 128.77 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.469 ' OD1' HG22 ' A' ' 26' ' ' THR . 92.1 m-20 -104.41 -173.7 2.37 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.433 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.419 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -58.7 -46.11 99.59 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.412 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' PHE . 35.3 Cg_exo -56.06 -53.39 5.51 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.465 1.443 . . . . 0.0 111.21 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.41 -22.08 66.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.15 0.5 . . . . 0.0 111.161 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.61 -61.41 1.83 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.9 mt -57.78 -43.83 85.84 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -176.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.3 m -40.74 -58.3 1.68 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.943 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -65.66 -41.42 92.55 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.983 -176.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 97.2 mmm -58.94 -41.24 86.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.73 -34.26 77.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.352 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -93.93 -13.99 26.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.657 0.265 . . . . 0.0 111.239 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.42 ' C ' ' SD ' ' A' ' 76' ' ' MET . 0.1 OUTLIER -80.84 66.65 6.44 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.206 0.527 . . . . 0.0 110.591 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 76' ' ' MET . 0.0 OUTLIER -108.37 15.61 23.83 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.441 -179.75 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -49.62 134.59 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.245 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.84 108.62 19.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.156 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.9 m -93.33 121.32 34.59 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 82' ' ' GLU . 97.7 m-20 -68.63 112.3 5.32 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.9 m -37.49 -22.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.528 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.9 mp0 -69.43 -35.78 76.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.77 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -48.25 -35.84 12.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.257 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 84' ' ' GLU . 2.4 mp0 -90.95 -16.54 27.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 85' ' ' ILE . 26.0 mm -59.99 -74.93 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.566 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -61.83 -41.2 97.51 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -62.53 -38.92 91.86 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.249 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.63 -20.74 65.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.998 0.427 . . . . 0.0 111.078 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -70.61 -49.93 42.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.053 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -54.85 -41.62 70.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.535 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.57 -43.82 94.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.3 m-85 -68.38 -39.68 81.68 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.991 -0.283 . . . . 0.0 111.188 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.492 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 27.1 t0 -87.15 83.54 7.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.511 ' N ' ' OE2' ' A' ' 104' ' ' GLU . 88.6 tttt -58.04 -49.61 76.27 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 35.1 p-10 -91.88 4.51 52.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.696 0.284 . . . . 0.0 111.608 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.56 49.29 53.19 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.727 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -90.61 5.24 48.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.793 0.33 . . . . 0.0 110.83 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.481 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 84.98 2.0 88.56 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.727 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 88.1 m-85 -140.01 152.88 46.62 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.611 0.719 . . . . 0.0 111.506 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.3 mt -94.04 115.31 32.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 t -89.07 150.93 22.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.634 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.32 83.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 118.981 0.81 . . . . 0.0 110.646 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.74 -39.59 65.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.862 0.363 . . . . 0.0 110.443 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.511 ' OE2' ' N ' ' A' ' 94' ' ' LYS . 76.2 mt-10 -66.64 -41.18 88.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.338 179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.09 -45.71 90.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.456 0.646 . . . . 0.0 110.997 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -44.23 -43.18 7.06 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.422 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -65.49 -28.62 69.33 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.51 0.195 . . . . 0.0 111.236 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.524 HG21 ' CE2' ' A' ' 92' ' ' PHE . 96.1 t -58.21 -42.46 83.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.573 -177.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.709 ' SD ' HD12 ' A' ' 116' ' ' LEU . 36.8 mmt -51.34 -43.22 61.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.82 0.819 . . . . 0.0 111.107 -177.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 m -57.93 -41.68 83.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.763 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -42.32 82.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.681 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.58 -15.85 56.93 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.475 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.1 28.7 59.91 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -84.43 -22.49 30.36 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.625 2.213 . . . . 0.0 110.59 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 43.07 58.68 3.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.804 0.811 . . . . 0.0 110.301 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.709 HD12 ' SD ' ' A' ' 109' ' ' MET . 50.9 mt -79.52 149.15 31.55 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.604 -1.635 . . . . 0.0 112.679 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 121' ' ' VAL . 70.2 p -82.71 175.29 10.25 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.5 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -58.14 -44.17 87.69 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.47 -49.44 76.28 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -70.61 -30.68 67.41 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.88 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 117' ' ' THR . 39.5 t -63.51 -42.41 96.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.29 -35.66 73.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.335 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -59.74 -50.89 72.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 90.5 mtp -57.12 -43.52 82.41 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.137 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.38 -44.18 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.286 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -59.57 -38.82 82.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.033 0.444 . . . . 0.0 111.208 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -57.23 -40.45 77.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.848 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.58 -20.09 22.04 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.1 t0 -75.36 86.1 2.52 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.389 0.614 . . . . 0.0 111.916 -177.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 130' ' ' ILE . 25.6 pt -71.87 -12.08 15.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.275 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 40.6 p-10 -140.67 142.09 34.95 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 112.504 -2.135 . . . . 0.0 108.771 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.69 52.09 1.55 Allowed Glycine 0 CA--C 1.53 1.012 0 CA-C-O 120.269 -0.184 . . . . 0.0 113.472 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -91.17 -7.92 50.09 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 117.281 0.54 . . . . 0.0 110.139 178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.68 1.3 66.04 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.131 -0.557 . . . . 0.0 114.296 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -135.01 153.66 52.0 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.426 0.613 . . . . 0.0 110.478 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 51.3 t -100.74 118.54 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.451 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -84.2 174.87 9.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -61.84 -40.85 96.76 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.133 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.39 -44.82 95.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.891 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -63.91 -38.49 91.29 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.461 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -60.22 -45.54 92.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.594 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.9 t -65.57 -47.95 84.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.269 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.71 -46.7 59.07 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.316 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.404 ' O ' ' CE1' ' B' 1094 ' ' PHE . 11.8 mmt -72.08 -39.44 68.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.8 mmt -77.03 -46.58 23.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.778 -0.192 . . . . 0.0 111.391 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.8 p -93.12 34.39 1.12 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -46.67 -40.5 13.27 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.227 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.237 -179.881 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . 0.541 ' N ' HD22 ' B' 1086 ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . 0.481 ' C ' ' H ' ' B' 1089 ' ' GLY . 91.5 mtm-85 -78.28 -12.44 60.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.742 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.594 ' C ' ' H ' ' B' 1090 ' ' GLN . 25.2 ttm180 -67.7 8.2 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . 0.481 ' H ' ' C ' ' B' 1087 ' ' ARG . . . -62.94 9.2 0.17 Allowed Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.594 ' H ' ' C ' ' B' 1088 ' ' ARG . 75.4 mt-30 -59.38 -43.8 92.85 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.927 0.394 . . . . 0.0 111.769 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 61.8 mt -47.78 -62.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.781 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.0 mt -55.7 -52.98 62.04 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.151 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.1 m95 -59.44 -62.67 1.71 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.333 0.587 . . . . 0.0 112.199 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 144' ' ' MET . 40.1 m-85 -57.71 -42.6 84.1 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -174.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -40.6 -51.51 2.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.602 0.715 . . . . 0.0 112.664 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.36 -41.83 99.74 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.79 -46.32 81.62 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.563 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -59.61 -48.15 82.78 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 24.0 mtp-105 -65.49 -38.08 88.69 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.605 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.98 -42.18 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.884 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -51.12 -46.53 61.95 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.51 ' O ' ' N ' ' B' 1105 ' ' LYS . 99.1 m -63.83 -47.88 79.03 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.609 -0.436 . . . . 0.0 112.002 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.427 ' C ' ' O ' ' B' 1102 ' ' THR . 84.0 mt-30 -28.24 -57.53 0.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 122.538 1.161 . . . . 0.0 112.435 -176.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.4 mt -84.58 -15.5 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 112.202 -2.272 . . . . 0.0 112.449 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.51 ' N ' ' O ' ' B' 1102 ' ' THR . 88.6 tttt -60.24 -46.55 89.4 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 118.077 -1.449 . . . . 0.0 107.951 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 57.7 t -61.89 -48.72 87.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -65.61 -36.27 77.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.774 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 87.4 mttt -49.54 -36.04 22.24 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 119.919 -0.713 . . . . 0.0 109.488 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.57 -45.65 70.0 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.059 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -62.49 -50.51 71.1 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.109 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -68.48 -41.42 80.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.2 t 67.92 58.44 0.48 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.482 1.127 0 CA-C-N 123.33 2.786 . . . . 0.0 112.383 179.301 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -64.56 -36.85 85.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.457 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -94.38 -175.32 3.61 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 162.23 -24.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 118.976 -0.535 . . . . 0.0 109.569 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.2 p -76.92 139.73 40.29 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 119.934 1.243 . . . . 0.0 110.35 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.688 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -50.78 -47.99 59.53 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.391 1.091 . . . . 0.0 110.653 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.449 ' OE2' ' OE2' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -38.21 -38.87 0.37 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.884 -179.007 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -68.35 -38.96 81.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.469 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.3 mt -59.76 -44.6 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 175.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -52.0 -49.17 63.86 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.094 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.449 ' OE2' ' OE2' ' A' ' 7' ' ' GLU . 98.4 mt-10 -60.46 -47.56 85.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 111.748 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -59.0 -42.12 89.32 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.866 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -50.42 -57.31 8.29 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.396 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -51.18 -44.72 61.58 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.847 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.72 -37.79 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.218 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.44 ' CE2' ' CD2' ' A' ' 65' ' ' PHE . 2.6 m-85 -58.44 -40.38 82.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.2 p -65.2 -15.56 62.59 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.456 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.7 -42.13 95.51 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -105.61 -13.99 15.42 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -71.92 93.91 1.39 Allowed 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.472 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -67.41 -49.64 62.89 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.833 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.1 p30 -103.62 14.88 30.21 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.16 44.79 0.82 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.164 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 31.0 p-10 -85.02 -3.17 58.69 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.729 0.299 . . . . 0.0 110.89 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.26 -0.83 78.87 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.1 t -140.48 154.9 46.77 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.15 0.5 . . . . 0.0 110.097 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 27' ' ' ILE . 3.8 mp -91.41 123.96 43.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.4 p -111.77 162.98 14.66 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.853 0.835 . . . . 0.0 112.064 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.7 p -59.93 -37.57 79.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.629 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -60.47 -57.01 14.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.472 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -64.31 -28.71 69.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.479 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.498 HD22 HD11 ' A' ' 52' ' ' ILE . 3.0 tp -60.8 -53.42 57.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.062 0.934 . . . . 0.0 109.765 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.3 -37.48 94.11 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.124 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -58.81 -52.8 64.15 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.777 1.288 . . . . 0.0 108.813 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.93 -45.03 87.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 119.404 1.002 . . . . 0.0 111.278 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.7 tpt -59.07 -38.73 80.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 120.028 1.285 . . . . 0.0 109.555 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -51.46 -38.36 53.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.65 0.738 . . . . 0.0 110.457 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.9 p -63.13 -20.94 65.84 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.439 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.45 ' O ' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -73.81 0.79 12.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.77 179.426 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.5 27.05 40.55 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.23 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -130.54 170.04 14.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.415 0.607 . . . . 0.0 109.923 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -133.8 76.42 65.65 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.396 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.14 147.57 95.29 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.764 2.31 . . . . 0.0 111.995 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.2 t -76.0 164.51 26.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.256 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.18 -43.75 87.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.983 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.33 -24.24 42.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.545 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.65 -38.76 90.24 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.057 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.8 mp -56.57 -40.86 75.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.298 0.571 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -70.89 -56.38 6.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.803 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -55.25 -50.45 69.44 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 45.1 mmm -65.02 -51.53 61.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.498 HD11 HD22 ' A' ' 32' ' ' LEU . 30.1 mm -59.54 -48.14 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.821 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -58.37 -33.51 69.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -65.68 -39.62 91.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.215 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.31 -19.43 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.276 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.2 t0 -78.01 86.59 4.19 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 -174.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.35 90.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.234 -1.803 . . . . 0.0 113.988 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -86.33 -2.76 58.69 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.0 23.66 61.88 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 118.467 0.576 . . . . 0.0 112.988 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -87.91 3.14 49.62 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.257 0.528 . . . . 0.0 110.333 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.63 0.54 87.9 Favored Glycine 0 CA--C 1.52 0.361 0 O-C-N 121.586 -0.696 . . . . 0.0 114.569 175.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.2 p -147.66 169.22 20.13 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.8 mt -112.79 128.51 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 65' ' ' PHE . 23.6 t0 -103.16 -177.19 3.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.639 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.553 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -56.71 -47.94 98.12 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -176.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.3 -49.54 14.83 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.215 1.277 . . . . 0.0 111.889 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.21 -19.63 64.69 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.476 0.655 . . . . 0.0 110.927 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -74.43 -59.63 2.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.752 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.47 -43.44 79.59 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.0 m -45.59 -48.47 14.53 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.607 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.8 mtm -67.09 -45.59 76.8 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.0 mmm -61.4 -39.2 89.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.02 79.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.644 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -93.6 -14.56 26.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.572 0.225 . . . . 0.0 111.304 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' O ' ' NZ ' ' B' 1105 ' ' LYS . 0.0 OUTLIER -83.1 64.64 7.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.218 0.532 . . . . 0.0 110.49 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.3 mmt -107.5 16.53 23.72 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.801 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -38.7 141.41 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.357 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.54 -70.43 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.831 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.5 m 58.99 77.27 0.31 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 82' ' ' GLU . 98.8 m-20 -57.61 126.0 25.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.3 m -38.99 -18.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.835 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 80' ' ' ASP . 72.4 mm-40 -68.38 -36.38 79.08 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.936 0.398 . . . . 0.0 111.757 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -51.37 -39.25 56.73 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.418 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 12.3 pt-20 -86.12 -4.33 59.15 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.3 mm -69.56 -73.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.883 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -60.29 -51.96 67.31 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 88' ' ' ALA . 3.1 pp20? -55.35 -37.6 67.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.007 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -60.51 -22.31 63.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.932 0.396 . . . . 0.0 110.902 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -73.76 -48.61 30.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.304 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -55.29 -42.27 73.42 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.587 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.13 -44.75 97.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.421 ' CE2' HG21 ' A' ' 108' ' ' VAL . 8.3 m-85 -69.33 -39.07 78.4 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.456 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.523 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 27.9 t0 -88.29 83.49 6.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -59.17 -48.67 80.75 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -90.9 5.06 50.14 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.66 0.267 . . . . 0.0 111.631 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.76 48.42 50.6 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.733 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -91.43 4.61 52.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.567 0.223 . . . . 0.0 110.697 179.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.471 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 86.21 0.89 86.71 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.733 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 90.5 m-85 -139.19 152.28 47.26 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.838 0.827 . . . . 0.0 111.622 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.4 mt -94.12 115.57 33.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.3 t -88.46 150.52 23.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.555 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.33 -45.79 83.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 119.167 0.894 . . . . 0.0 110.741 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.89 -40.86 66.98 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.984 0.421 . . . . 0.0 110.588 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -65.3 -41.35 94.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.956 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.402 ' CD2' HD11 ' A' ' 125' ' ' ILE . 59.4 tp -63.71 -44.36 93.86 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.605 0.716 . . . . 0.0 111.207 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -45.7 -44.6 13.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.499 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -62.35 -29.0 70.15 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 121.207 -0.197 . . . . 0.0 110.605 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.421 HG21 ' CE2' ' A' ' 92' ' ' PHE . 84.6 t -58.32 -41.24 80.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.87 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.626 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -51.59 -46.54 63.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.179 0.99 . . . . 0.0 111.446 -177.214 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -56.97 -41.42 78.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.442 -1.708 . . . . 0.0 110.675 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -65.2 -40.8 94.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.768 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.535 ' O ' ' NH1' ' B' 1099 ' ' ARG . 76.6 mt -81.5 -14.5 56.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.788 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.11 30.33 57.4 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 118.566 -1.13 . . . . 0.0 110.366 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -86.49 -22.86 26.19 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.749 2.275 . . . . 0.0 110.75 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 43.43 60.83 2.44 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 122.31 1.052 . . . . 0.0 110.089 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.8 mt -79.06 148.22 32.53 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 113.417 -1.719 . . . . 0.0 112.637 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 121' ' ' VAL . 62.2 p -82.46 174.99 10.57 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.383 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -57.83 -44.53 86.52 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -57.84 -50.67 72.51 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.56 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -68.3 -30.79 69.87 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.826 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 117' ' ' THR . 47.5 t -64.18 -42.46 95.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.396 0.617 . . . . 0.0 109.342 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 67.8 t0 -67.03 -37.77 84.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.722 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.28 -48.01 83.21 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.449 ' SD ' ' CD1' ' B' 1093 ' ' TRP . 20.2 mmm -54.96 -45.69 74.97 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.808 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 105' ' ' LEU . 46.5 mm -59.62 -44.88 94.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.35 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -58.37 -40.11 81.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.955 0.407 . . . . 0.0 111.371 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.69 -41.0 76.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.073 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.445 ' HB2' ' HG3' ' A' ' 144' ' ' MET . . . -92.67 -16.99 24.86 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.5 t0 -73.41 87.97 1.57 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.457 0.646 . . . . 0.0 112.076 -177.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 tt -70.78 -14.79 18.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.531 1.158 . . . . 0.0 113.241 -177.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 53.5 p-10 -142.9 144.6 32.5 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.31 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.53 52.49 1.16 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.709 -0.282 . . . . 0.0 113.175 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -91.14 -9.97 43.59 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.098 0.449 . . . . 0.0 110.119 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.66 2.09 74.31 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.162 -0.542 . . . . 0.0 114.293 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -134.57 154.27 51.56 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.413 0.607 . . . . 0.0 110.435 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.49 118.51 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.272 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.459 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 46.8 t30 -85.17 175.24 9.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.917 0.389 . . . . 0.0 110.962 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.459 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 74.2 t80 -61.59 -41.02 96.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.492 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 140' ' ' GLU . 13.1 pt-20 -62.23 -44.45 96.53 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.839 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 139' ' ' GLU . 96.8 mt-10 -64.39 -37.66 88.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.892 0.377 . . . . 0.0 110.566 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -61.12 -45.63 93.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.594 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.65 -47.79 84.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.681 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 71.5 tp60 -47.27 -50.04 22.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.115 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.445 ' HG3' ' HB2' ' A' ' 128' ' ' ALA . 91.7 mmm -70.04 -35.47 74.32 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -176.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.452 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 22.7 mmt -71.79 -43.21 66.07 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.861 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.7 m -85.11 -32.84 22.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.628 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -53.54 133.37 41.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.181 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.39 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . 0.518 ' N ' HD22 ' B' 1086 ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -134.52 139.04 45.15 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.545 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.556 ' NE ' HD11 ' B' 1091 ' ' ILE . 55.2 ttp180 57.56 42.52 24.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.622 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -61.96 2.15 1.07 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.537 ' H ' ' C ' ' B' 1088 ' ' ARG . 84.4 mt-30 -61.2 -44.65 96.94 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . 0.556 HD11 ' NE ' ' B' 1088 ' ' ARG . 57.8 mt -48.7 -58.76 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 10.3 mt -55.4 -52.21 64.31 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.722 -176.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . 0.449 ' CD1' ' SD ' ' A' ' 124' ' ' MET . 5.5 m95 -60.95 -57.5 12.36 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.587 0.708 . . . . 0.0 112.095 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . 0.452 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 17.5 m-85 -57.61 -43.99 85.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -40.05 -51.98 2.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.11 99.72 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.371 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 53.9 tp -57.23 -44.86 84.18 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.856 -0.737 . . . . 0.0 109.507 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 16.1 m120 -59.17 -47.32 85.74 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.691 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . 0.535 ' NH1' ' O ' ' A' ' 112' ' ' LEU . 79.5 mtp180 -65.16 -37.94 88.99 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 4.0 mm -60.58 -41.86 89.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.436 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . 0.462 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 81.8 mt-30 -52.0 -49.28 63.64 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.468 ' O ' ' N ' ' B' 1105 ' ' LYS . 21.3 m -64.98 -47.81 76.23 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.415 ' C ' ' O ' ' B' 1102 ' ' THR . 36.6 mm-40 -28.18 -59.86 0.12 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.758 1.266 . . . . 0.0 112.324 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.5 mt -83.94 -15.9 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 111.716 -2.493 . . . . 0.0 112.471 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 75' ' ' LYS . 66.1 tttm -59.39 -44.41 92.78 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.009 -1.477 . . . . 0.0 107.838 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 61.6 t -61.49 -48.98 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.4 m -66.36 -36.89 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.161 -177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 91.6 mttt -49.77 -38.11 32.68 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.661 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.03 62.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.27 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -63.35 -50.0 71.69 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -67.92 -42.06 81.67 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.9 58.83 0.37 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.47 0.57 0 CA-C-N 123.728 2.967 . . . . 0.0 112.264 179.408 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 3' ' ' GLN . 33.4 p-10 -90.87 6.03 46.1 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.539 ' OE1' ' CE2' ' A' ' 12' ' ' PHE . 60.3 tt0 51.65 103.44 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.393 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.79 -14.34 8.55 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.041 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -80.02 135.4 36.36 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.512 1.051 . . . . 0.0 110.055 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.8 tt0 -51.04 -60.2 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.029 0.918 . . . . 0.0 111.373 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 44.7 tp10 -34.55 -38.03 0.07 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.933 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -70.35 -31.63 68.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.647 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.2 mt -57.22 -44.09 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 121.922 2.146 . . . . 0.0 105.355 176.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -53.55 -51.61 62.37 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.286 -178.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -62.29 -46.48 88.6 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.411 0.624 . . . . 0.0 112.312 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.539 ' CE2' ' OE1' ' A' ' 3' ' ' GLN . 10.0 m-85 -61.68 -40.67 95.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.9 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -52.19 -56.15 16.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.235 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -48.7 -42.69 35.73 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.254 -0.579 . . . . 0.0 110.102 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.36 -37.32 69.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.201 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 2.0 m-85 -56.42 -40.79 75.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.0 p -65.9 -15.61 63.1 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.428 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.34 -43.26 98.22 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.427 ' CZ ' ' HA ' ' A' ' 16' ' ' PHE . 0.9 OUTLIER -106.41 -14.51 15.06 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.871 -178.685 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -75.37 96.11 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.252 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -67.96 -48.13 66.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.229 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.2 p-10 -102.89 14.48 31.86 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.96 48.72 1.41 Allowed Glycine 0 N--CA 1.468 0.83 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.091 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 24' ' ' ASP . 36.1 p-10 -86.49 -4.77 59.22 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.71 0.29 . . . . 0.0 111.237 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.51 -1.55 79.25 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.8 p -139.41 156.11 47.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.22 0.534 . . . . 0.0 109.732 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 mm -93.02 124.34 45.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.522 HG23 ' H ' ' A' ' 30' ' ' LYS . 1.2 t -115.0 165.52 12.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.8 -177.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.0 p -58.04 -39.52 78.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.439 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.522 ' H ' HG23 ' A' ' 28' ' ' THR . 62.4 tttp -58.67 -59.93 4.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.724 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -63.11 -30.71 71.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 119.598 -0.239 . . . . 0.0 111.51 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.412 HD22 HD11 ' A' ' 52' ' ' ILE . 3.3 tp -59.73 -56.39 22.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.501 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.84 -38.96 94.79 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 113.757 -1.565 . . . . 0.0 112.037 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.5 m -58.52 -53.44 58.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.107 1.454 . . . . 0.0 108.656 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.86 -46.23 87.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 118.991 0.814 . . . . 0.0 111.457 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.0 tpt -59.45 -41.84 90.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 120.112 1.324 . . . . 0.0 109.839 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -54.21 -41.98 69.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.602 0.715 . . . . 0.0 110.27 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -64.35 -22.75 67.06 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.944 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 tp -73.04 -3.41 26.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.666 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.09 13.56 58.76 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.547 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -107.75 155.41 20.24 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.66 0.73 . . . . 0.0 109.789 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.542 HD22 ' C ' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -117.17 65.19 3.87 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.357 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.05 145.49 85.15 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.172 1.915 . . . . 0.0 112.215 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.1 p -79.86 167.25 20.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.092 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 16.6 pt-20 -57.8 -44.26 86.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.014 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 45' ' ' GLU . . . -55.19 -23.15 20.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.489 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -66.79 -38.81 87.26 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.254 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.8 mp -56.08 -40.59 73.86 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -72.08 -57.08 4.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.057 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -54.13 -49.49 69.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 41.7 mmm -66.19 -52.23 50.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 52' ' ' ILE . 25.9 mm -57.92 -48.21 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.476 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -56.71 -33.97 67.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -66.45 -40.05 89.19 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.668 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.25 -20.29 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.404 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 41.1 t0 -78.01 86.85 4.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -174.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.74 86.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.377 -1.738 . . . . 0.0 114.302 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 37.7 p-10 -87.62 -2.65 58.76 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.28 23.22 64.08 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 118.632 0.651 . . . . 0.0 112.721 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.42 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.0 p-10 -88.04 2.02 52.85 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.393 0.597 . . . . 0.0 110.688 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.432 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 85.65 0.85 87.76 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 175.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.6 p -148.62 171.39 16.24 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.8 mt -115.21 129.2 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -104.33 -173.65 2.36 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.734 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -59.68 -48.58 94.98 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -177.287 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.66 -53.22 5.97 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.183 1.255 . . . . 0.0 111.66 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.62 -16.77 41.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.594 0.711 . . . . 0.0 110.312 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -76.08 -58.17 3.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.16 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' THR . 77.4 mt -56.99 -45.36 83.02 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.2 p -44.07 -49.76 8.69 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.459 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.4 mtm -67.55 -45.43 75.68 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.4 mmt -58.45 -38.78 78.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.95 76.62 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.683 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -94.87 -11.19 29.22 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.8 0.333 . . . . 0.0 111.453 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.45 67.44 8.49 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.278 0.561 . . . . 0.0 110.337 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.2 mmt -109.26 15.66 22.99 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.747 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -52.31 132.28 33.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.418 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -106.63 159.4 16.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.959 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.9 136.08 25.03 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 82' ' ' GLU . 41.8 t0 -61.55 116.16 4.5 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 174.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.6 m -36.94 -19.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 80' ' ' ASP . 94.8 mt-10 -69.02 -35.21 76.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -48.7 -38.37 21.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.487 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -86.49 -17.66 33.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.305 0.574 . . . . 0.0 111.761 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 mm -61.37 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.116 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -62.21 -40.8 97.31 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.98 -42.11 97.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.811 0.338 . . . . 0.0 111.679 -178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.98 -19.51 52.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -75.44 -49.05 20.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.985 0.421 . . . . 0.0 111.233 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -55.49 -42.52 74.51 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.607 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.7 -44.47 96.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 108' ' ' VAL . 7.9 m-85 -69.19 -38.25 78.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.553 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -85.94 81.22 8.61 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -58.32 -48.99 78.77 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -176.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.2 p30 -90.99 5.53 48.43 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.471 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.39 48.33 48.55 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -92.16 6.81 45.2 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.597 0.237 . . . . 0.0 110.603 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.62 1.42 89.14 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -141.12 154.05 45.71 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.893 0.854 . . . . 0.0 111.725 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 97.7 mt -95.09 115.85 35.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.6 p -90.58 153.05 20.62 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.31 82.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.28 0.945 . . . . 0.0 110.946 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -53.41 -43.81 68.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.946 0.403 . . . . 0.0 110.711 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.31 -42.54 99.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.596 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.2 tt -63.93 -45.28 89.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.226 0.536 . . . . 0.0 111.608 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -41.99 -45.01 3.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.61 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.44 ' CE1' HD21 ' A' ' 111' ' ' ASN . 56.9 t-80 -59.73 -26.88 66.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.714 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.582 HG21 ' CE2' ' A' ' 92' ' ' PHE . 86.6 t -57.95 -42.97 83.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.671 -178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.703 ' HG2' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -51.17 -49.22 61.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.15 0.976 . . . . 0.0 111.89 -177.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.8 p -52.65 -38.89 61.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.622 -1.627 . . . . 0.0 110.901 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.44 HD21 ' CE1' ' A' ' 107' ' ' HIS . 1.8 m120 -65.76 -39.08 90.69 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.495 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.2 mt -83.95 -12.96 54.57 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.76 38.24 50.29 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.353 -1.248 . . . . 0.0 110.196 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -89.45 -22.79 22.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.913 2.357 . . . . 0.0 111.118 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt 45.01 58.41 4.05 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.611 1.196 . . . . 0.0 110.065 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.853 HD23 ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -75.63 149.74 38.14 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 112.952 -1.931 . . . . 0.0 112.982 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 33.4 p -84.07 174.67 10.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 110.349 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.86 -44.73 74.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -55.3 -41.57 72.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.123 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.17 -28.64 65.48 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.519 -0.472 . . . . 0.0 112.037 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 49.2 t -64.03 -43.68 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.297 0.57 . . . . 0.0 109.63 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -74.62 -36.15 62.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.204 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.62 ' CG ' HH22 ' B' 1087 ' ' ARG . 82.5 tt0 -60.0 -54.11 49.92 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.8 mmm -51.27 -52.15 47.64 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.01 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.9 mm -56.22 -42.58 73.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.582 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -60.02 -36.97 78.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.643 0.259 . . . . 0.0 111.428 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -57.62 -40.78 79.95 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.717 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.71 -15.01 25.67 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 20.6 t0 -77.57 82.73 3.99 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.642 0.734 . . . . 0.0 111.682 -177.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.7 pt -70.89 -7.56 9.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 122.622 1.201 . . . . 0.0 113.351 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 52.9 p-10 -144.45 143.32 30.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 112.458 -2.156 . . . . 0.0 109.171 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.13 51.46 1.67 Allowed Glycine 0 CA--C 1.529 0.965 0 O-C-N 122.202 -0.311 . . . . 0.0 113.41 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -90.72 -10.59 42.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.274 0.537 . . . . 0.0 109.835 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.6 -0.45 64.89 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 114.54 0.576 . . . . 0.0 114.54 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -132.73 153.17 51.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.339 0.57 . . . . 0.0 110.471 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.45 117.96 45.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.087 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.232 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.413 ' CG ' ' N ' ' A' ' 138' ' ' TYR . 53.8 t30 -83.99 173.07 11.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.934 0.397 . . . . 0.0 110.949 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.413 ' N ' ' CG ' ' A' ' 137' ' ' ASN . 80.5 t80 -61.16 -39.56 90.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.998 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.23 -44.51 96.39 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.854 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.98 -37.82 88.82 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.626 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -61.21 -44.87 96.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.706 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 77.7 t -65.1 -47.42 87.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.365 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -50.58 -42.74 56.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.736 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.2 mmt -74.64 -40.13 61.67 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 4.5 mmt -77.2 -44.57 29.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.884 -0.144 . . . . 0.0 111.27 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 m -88.74 31.8 0.83 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.587 0.232 . . . . 0.0 111.335 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -44.76 -45.48 9.98 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.825 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.8 tttm . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.372 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . 0.538 ' N ' HD22 ' B' 1086 ' ' LEU . 3.8 mm? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . 0.62 HH22 ' CG ' ' A' ' 123' ' ' GLU . 34.2 ptt180 -161.48 46.02 0.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.459 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.528 ' C ' ' H ' ' B' 1090 ' ' GLN . 35.9 ttm180 48.2 45.79 19.85 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -59.2 1.74 0.35 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.617 ' NE2' ' N ' ' B' 1090 ' ' GLN . 0.1 OUTLIER -59.16 -42.9 91.85 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.559 0.219 . . . . 0.0 111.374 -178.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 57.0 mt -57.29 -51.49 68.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 11.1 mt -56.42 -62.08 1.97 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 6.1 m95 -61.68 -56.6 18.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.289 0.566 . . . . 0.0 112.357 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . 0.528 ' CE2' ' OD1' ' B' 1098 ' ' ASN . 11.8 t80 -59.83 -48.47 81.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -174.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -39.33 -51.92 2.04 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.0 -39.39 96.99 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.027 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 54.1 tp -57.15 -41.95 80.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 118.322 1.061 . . . . 0.0 109.559 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' B' 1094 ' ' PHE . 6.2 m-20 -59.85 -51.58 69.11 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 76.0 mmt-85 -65.47 -39.81 92.41 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 85.7 mt -59.21 -41.35 83.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.422 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -50.4 -45.36 55.53 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.534 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.3 m -63.69 -47.98 78.98 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.434 ' C ' ' O ' ' B' 1102 ' ' THR . 23.9 mt-30 -27.64 -57.54 0.1 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.61 1.195 . . . . 0.0 112.31 -176.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.8 mt -84.77 -13.81 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 112.56 -2.109 . . . . 0.0 112.437 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.534 ' N ' ' O ' ' B' 1102 ' ' THR . 38.3 ttmt -59.85 -45.66 91.71 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 118.181 -1.408 . . . . 0.0 108.069 176.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 94.6 t -60.52 -49.78 83.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.7 m -65.8 -36.0 76.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.967 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 86.6 mttt -50.12 -37.69 35.33 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.608 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -51.59 -45.62 63.21 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.202 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.99 -49.65 73.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -68.45 -41.69 79.89 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . 0.464 ' OG ' ' O ' ' B' 1112 ' ' SER . 5.6 p 68.32 59.44 0.42 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 117.358 -1.306 . . . . 0.0 107.48 -177.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . 0.4 ' C ' ' O ' ' B' 1112 ' ' SER . 17.9 t . . . . . 0 C--O 1.22 -0.499 0 CA-C-N 123.75 2.977 . . . . 0.0 111.709 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 3' ' ' GLN . 46.5 t0 -104.74 15.27 28.23 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 2' ' ' ASP . 2.5 mp0 51.67 104.29 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.219 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.4 mt -109.5 -22.27 12.08 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.62 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 m -78.92 136.19 37.19 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.386 0.994 . . . . 0.0 110.138 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 9' ' ' ILE . 9.4 tm-20 -51.43 -55.47 18.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.893 0.854 . . . . 0.0 111.089 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -37.62 -36.89 0.19 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.648 -1.615 . . . . 0.0 110.576 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -70.25 -32.4 70.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 118.45 -0.785 . . . . 0.0 110.723 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 6' ' ' GLU . 96.7 mt -59.54 -45.26 94.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 175.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.23 -49.4 64.05 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.617 -177.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.36 -46.56 88.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.359 0.599 . . . . 0.0 111.923 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.3 m-85 -62.83 -39.3 93.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.812 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -52.64 -53.2 50.26 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.56 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.26 -39.77 60.81 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.059 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.24 -37.67 70.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.084 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.441 ' CZ ' ' CE1' ' A' ' 65' ' ' PHE . 3.8 m-85 -58.49 -40.85 83.92 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.5 m -65.29 -14.61 61.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.782 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.22 -41.64 94.25 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -105.64 -13.56 15.54 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -74.61 93.14 2.48 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.26 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -69.28 -47.24 65.14 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.96 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 23' ' ' GLY . 39.5 p-10 -102.19 13.64 34.13 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.945 -0.472 . . . . 0.0 112.195 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.98 46.64 1.23 Allowed Glycine 0 CA--C 1.533 1.199 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.996 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -86.18 -4.19 59.12 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.637 -0.331 . . . . 0.0 110.957 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.53 -2.12 84.51 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.9 p -137.3 152.13 49.42 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.105 0.479 . . . . 0.0 109.982 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.7 mp -92.93 124.36 45.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.419 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 19.7 p -113.48 164.52 13.51 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.941 0.877 . . . . 0.0 112.194 -177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.9 p -59.2 -38.25 79.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.541 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -62.1 -56.63 16.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.556 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 28' ' ' THR . 16.0 pt-20 -64.24 -30.23 71.29 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.37 -52.25 65.4 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.264 1.031 . . . . 0.0 109.515 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.85 -35.61 87.26 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.865 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -58.22 -53.14 61.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.09 1.445 . . . . 0.0 108.661 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.44 -45.66 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 120.731 -1.23 . . . . 0.0 111.636 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 26.6 ttt -59.06 -40.91 86.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 120.064 1.302 . . . . 0.0 109.643 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.2 ttt85 -53.16 -37.02 61.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.556 0.693 . . . . 0.0 110.48 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.5 t -62.39 -20.25 64.25 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.735 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.4 mt -75.82 2.9 11.09 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.1 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.58 16.16 74.09 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.91 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -109.55 160.31 16.35 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.582 0.691 . . . . 0.0 109.872 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -112.82 69.2 1.1 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.085 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.7 141.84 67.81 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.845 1.697 . . . . 0.0 112.181 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -81.58 157.36 24.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.029 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.0 -42.13 68.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.762 0.315 . . . . 0.0 110.572 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.9 -25.64 43.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.346 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -65.63 -39.48 91.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.816 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 48' ' ' LEU . 8.2 mp -56.06 -40.96 74.34 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.492 0.663 . . . . 0.0 109.847 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -69.12 -56.49 7.53 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.655 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -53.13 -48.69 67.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.412 ' SD ' ' NE2' ' B' 1111 ' ' HIS . 1.5 mtm -71.44 -44.51 64.68 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 52' ' ' ILE . 12.1 mm -58.57 -48.41 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -56.58 -34.34 67.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -66.11 -40.41 90.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.669 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.406 HG21 ' CE2' ' B' 1110 ' ' PHE . 50.1 t -85.52 -21.43 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.275 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.405 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.5 t0 -78.45 86.12 4.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 -175.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.28 89.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.179 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 36.4 p-10 -85.58 -3.25 58.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.62 23.73 61.12 Favored Glycine 0 CA--C 1.533 1.217 0 O-C-N 121.872 -0.518 . . . . 0.0 113.029 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.4 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 52.1 p-10 -87.51 4.65 42.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.046 0.423 . . . . 0.0 110.348 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.405 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.03 0.66 89.7 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.871 -0.681 . . . . 0.0 114.38 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.4 p -147.79 167.49 24.6 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.2 mt -112.62 128.4 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -103.82 -174.57 2.58 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.66 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.441 ' CE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -58.63 -47.28 99.03 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -176.655 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -56.61 -51.38 9.26 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.415 1.41 . . . . 0.0 111.354 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.95 -20.51 65.3 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.372 0.606 . . . . 0.0 111.097 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -71.24 -58.33 3.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.871 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.76 -44.3 86.06 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 m -40.5 -59.09 1.42 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.665 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -64.8 -41.6 95.68 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -176.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 98.2 mmm -59.44 -39.6 84.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.18 -34.36 78.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.286 0.235 . . . . 0.0 111.499 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -96.65 -8.48 31.48 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.228 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 67.18 7.24 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.169 0.509 . . . . 0.0 110.24 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 19.8 mmt -108.54 16.41 23.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.782 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -52.67 130.99 34.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.674 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 54.3 p-10 -105.57 148.07 27.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.781 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 62.1 p -133.65 134.1 42.75 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 82' ' ' GLU . 22.7 t0 -62.05 117.17 5.62 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 175.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.9 m -37.45 -20.49 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.615 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 80' ' ' ASP . 71.3 mm-40 -69.36 -34.32 74.4 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 111.616 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -49.1 -37.88 22.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.596 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 tp10 -86.87 -19.28 29.15 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.132 0.491 . . . . 0.0 111.671 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.36 -74.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.853 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -62.39 -40.58 96.93 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.98 -40.91 97.23 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.665 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.07 -21.19 63.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.104 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -71.44 -50.55 30.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.091 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -55.28 -43.03 74.37 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.79 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.37 -44.13 94.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.548 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.4 m-85 -68.22 -38.21 81.66 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.244 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -85.28 81.51 8.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -58.81 -48.76 80.17 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -91.29 4.56 52.03 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 122.236 -0.29 . . . . 0.0 111.274 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.13 46.22 56.56 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -90.08 6.75 41.11 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.679 0.276 . . . . 0.0 110.739 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.26 2.0 89.33 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -140.14 152.52 46.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.747 0.784 . . . . 0.0 111.688 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -93.46 114.84 30.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 m -88.03 150.0 23.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.299 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.71 -45.39 85.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.17 0.896 . . . . 0.0 110.586 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.74 -40.66 72.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.912 0.386 . . . . 0.0 110.568 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.68 -42.54 91.17 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.261 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 108' ' ' VAL . 6.8 tt -63.4 -44.9 93.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.309 0.576 . . . . 0.0 111.052 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -41.25 -44.18 2.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.63 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.25 -25.8 65.95 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.616 0.246 . . . . 0.0 110.998 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.548 HG21 ' CE2' ' A' ' 92' ' ' PHE . 67.7 t -58.59 -43.14 86.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.551 -178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.646 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -52.26 -45.92 65.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.911 0.863 . . . . 0.0 111.554 -176.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.6 p -62.1 -36.22 81.07 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 113.778 -1.555 . . . . 0.0 111.178 -176.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.554 ' ND2' ' N ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -65.09 -41.05 95.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.66 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.838 ' O ' HD12 ' A' ' 112' ' ' LEU . 0.5 OUTLIER -89.01 -8.6 53.73 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -178.678 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.87 40.41 36.3 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.532 -1.149 . . . . 0.0 111.08 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.579 ' HB2' HD11 ' A' ' 112' ' ' LEU . 36.8 tp10 -89.96 -25.87 20.69 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 121.036 2.418 . . . . 0.0 110.741 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 46.52 63.42 1.9 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 122.242 1.02 . . . . 0.0 110.494 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.509 HD12 ' CG ' ' A' ' 109' ' ' MET . 82.3 mt -81.99 147.63 29.09 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.255 -1.793 . . . . 0.0 113.568 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 121' ' ' VAL . 81.4 p -83.16 175.74 9.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -58.29 -46.07 86.77 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 176.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -57.54 -48.32 79.62 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -69.15 -30.81 69.13 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.891 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 117' ' ' THR . 42.3 t -63.75 -41.75 93.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.483 0.659 . . . . 0.0 109.297 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -67.72 -36.98 81.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.299 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -59.65 -51.48 69.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 91.6 mtp -57.1 -43.33 82.15 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.001 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.0 mm -59.56 -44.29 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.559 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.78 -35.65 78.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 111.463 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.21 -40.71 82.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.712 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.48 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -91.06 -20.61 21.87 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.679 0.276 . . . . 0.0 111.637 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 19.3 t0 -77.63 83.16 4.02 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.469 0.652 . . . . 0.0 112.195 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.6 pt -71.02 -9.66 13.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.496 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 54.7 p-10 -142.8 144.1 32.44 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 112.621 -2.082 . . . . 0.0 109.054 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -73.28 51.04 1.7 Allowed Glycine 0 CA--C 1.532 1.147 0 CA-C-N 116.741 -0.209 . . . . 0.0 113.533 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -90.48 -9.87 45.77 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.159 0.48 . . . . 0.0 110.135 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.95 0.13 68.32 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.873 -0.679 . . . . 0.0 114.376 176.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -133.78 154.18 51.18 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.206 0.503 . . . . 0.0 110.606 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.2 t -101.14 118.03 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.928 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -84.39 174.51 10.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.938 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -61.15 -40.52 94.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.292 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -62.35 -44.26 96.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.68 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.47 -37.2 86.7 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.532 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -61.26 -45.22 95.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.135 0.493 . . . . 0.0 110.69 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.45 -47.21 87.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.286 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.69 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 52.0 tt0 -49.14 -46.5 45.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.085 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.48 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 1.4 mmt -71.97 -36.88 69.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -177.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.483 ' O ' ' CZ ' ' B' 1094 ' ' PHE . 24.5 mmt -71.85 -44.21 64.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.785 -0.189 . . . . 0.0 110.606 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 147' ' ' ALA . 88.7 m -83.71 -30.63 26.59 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.503 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -39.45 108.4 0.08 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.979 0.418 . . . . 0.0 111.398 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 54.6 tttp . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.284 179.765 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.34 -38.57 91.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.377 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.506 ' C ' ' H ' ' B' 1090 ' ' GLN . 68.1 ttt180 58.8 41.46 21.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -64.33 4.15 1.48 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.536 ' N ' ' OE1' ' B' 1090 ' ' GLN . 0.9 OUTLIER -59.45 -41.9 90.73 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -177.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 77.5 mt -38.79 -67.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.017 0.437 . . . . 0.0 111.449 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 13.5 mt -53.61 -47.89 69.8 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.461 -0.495 . . . . 0.0 112.161 -175.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 8.2 m95 -60.0 -58.86 6.72 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.792 0.806 . . . . 0.0 111.973 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . 0.483 ' CZ ' ' O ' ' A' ' 145' ' ' MET . 29.3 m-85 -59.81 -46.66 88.53 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -174.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -42.2 -52.06 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.68 -40.97 99.49 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.779 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 56.8 tp -57.57 -45.28 85.38 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.196 0.998 . . . . 0.0 109.73 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 15.3 m120 -61.33 -51.75 67.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -65.66 -38.81 90.36 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 88.6 mt -60.96 -42.35 92.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.765 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -52.11 -45.33 64.87 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.537 ' O ' ' N ' ' B' 1105 ' ' LYS . 90.9 m -63.1 -48.01 80.4 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.699 -0.626 . . . . 0.0 111.502 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.449 ' C ' ' O ' ' B' 1102 ' ' THR . 24.8 mt-30 -27.97 -55.91 0.11 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.541 1.163 . . . . 0.0 112.65 -176.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . 0.402 HG21 HD13 ' B' 1104 ' ' ILE . 2.0 mt -83.53 -15.04 11.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 112.165 -2.289 . . . . 0.0 112.602 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.537 ' N ' ' O ' ' B' 1102 ' ' THR . 64.0 tttp -59.53 -44.41 93.2 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 118.063 -1.455 . . . . 0.0 108.259 176.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 80.5 t -61.39 -48.85 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.3 m -65.78 -35.98 76.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.198 -178.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . . . . . . . . . 92.8 mttt -49.92 -36.72 28.73 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.796 0.726 . . . . 0.0 109.756 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -53.76 -45.75 70.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.247 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . 0.406 ' CE2' HG21 ' A' ' 55' ' ' VAL . 51.7 m-85 -63.07 -48.91 76.64 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.229 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . 0.412 ' NE2' ' SD ' ' A' ' 51' ' ' MET . 83.3 m-70 -71.53 17.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.119 -0.363 . . . . 0.0 111.963 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 73.29 73.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.716 0.689 . . . . 0.0 109.884 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 87.0 p . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.524 -179.594 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.01 -44.99 95.54 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -110.0 122.23 47.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.055 0.389 . . . . 0.0 110.426 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.7 tp 172.35 -36.93 0.0 OUTLIER 'General case' 0 C--N 1.341 0.224 0 O-C-N 124.033 0.833 . . . . 0.0 109.836 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -73.75 141.13 46.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.203 0.911 . . . . 0.0 109.653 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 9' ' ' ILE . 81.0 tt0 -45.26 -61.68 1.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 122.064 0.935 . . . . 0.0 110.375 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -34.1 -36.14 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 113.627 -1.624 . . . . 0.0 111.18 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.621 ' NE2' ' CD1' ' A' ' 12' ' ' PHE . 1.2 tm0? -69.11 -38.75 79.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.414 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' GLU . 95.1 mt -59.68 -44.39 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.431 ' O ' ' OE2' ' A' ' 14' ' ' GLU . . . -53.31 -52.16 60.03 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.238 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.53 -45.49 93.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.531 0.682 . . . . 0.0 112.596 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.621 ' CD1' ' NE2' ' A' ' 8' ' ' GLN . 5.2 m-85 -62.67 -38.55 90.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.705 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -53.03 -53.8 44.81 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.432 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 10' ' ' ALA . 1.9 mp0 -48.38 -41.31 28.51 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.199 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 12' ' ' PHE . . . -56.53 -39.06 72.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.237 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -57.64 -42.0 82.56 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 m -64.88 -14.54 59.95 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.469 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.63 -43.15 97.67 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -105.96 -13.34 15.52 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -74.34 93.77 2.44 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.263 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -68.78 -48.0 64.77 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.791 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 23' ' ' GLY . 38.0 p-10 -102.61 13.74 33.72 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 22' ' ' ASP . . . 36.66 48.02 1.26 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.157 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -85.32 -4.33 59.12 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.749 0.309 . . . . 0.0 110.904 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.49 -2.3 82.75 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.7 p -137.37 152.52 49.76 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.642 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.8 mp -91.81 123.59 43.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.433 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 19.0 p -113.76 166.18 11.81 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.539 0.685 . . . . 0.0 112.418 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.3 p -58.99 -37.3 76.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.372 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -61.22 -60.62 3.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.263 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 28' ' ' THR . 15.5 pt-20 -61.1 -30.45 70.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.518 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.408 HD22 HD11 ' A' ' 52' ' ' ILE . 2.9 tp -60.76 -53.68 54.44 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.727 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.52 -37.97 94.16 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 113.786 -1.552 . . . . 0.0 112.242 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 m -58.68 -52.0 67.56 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.782 1.291 . . . . 0.0 108.919 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.17 -45.26 88.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 119.303 0.956 . . . . 0.0 111.275 -177.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 28.2 ttt -59.31 -39.33 82.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 119.805 1.184 . . . . 0.0 109.917 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -52.29 -39.88 61.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.738 0.78 . . . . 0.0 110.259 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.1 p -62.52 -20.64 64.83 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.21 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.95 -0.33 15.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.959 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.06 25.39 44.93 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.183 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -124.97 165.12 18.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.317 0.558 . . . . 0.0 109.772 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -125.62 77.09 69.68 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.278 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.37 147.87 72.52 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.99 1.794 . . . . 0.0 112.119 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.4 p -79.4 162.76 25.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.103 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -57.19 -43.15 82.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.996 -179.177 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.489 ' H ' ' CD ' ' A' ' 45' ' ' GLU . . . -57.19 -25.32 58.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.368 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -65.26 -40.72 94.33 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.088 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.3 mp -55.06 -38.63 68.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.565 0.698 . . . . 0.0 109.46 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -72.97 -55.42 6.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.187 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.41 -49.61 69.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.414 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 63.7 mtp -66.9 -48.98 67.03 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 52' ' ' ILE . 24.4 mm -58.54 -45.23 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.433 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -56.42 -35.42 67.8 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.57 -40.63 89.07 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.507 -0.477 . . . . 0.0 112.076 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.452 HG21 ' CE2' ' B' 1110 ' ' PHE . 75.4 t -85.53 -21.74 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.651 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.476 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 42.0 t0 -78.69 86.75 4.63 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -175.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.78 87.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.367 -1.742 . . . . 0.0 114.27 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.471 ' OD2' ' ND2' ' A' ' 60' ' ' ASN . 39.5 p-10 -86.14 -2.95 58.82 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.26 23.17 63.99 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 118.548 0.613 . . . . 0.0 112.795 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.471 ' ND2' ' OD2' ' A' ' 58' ' ' ASP . 53.2 p-10 -88.04 2.16 52.53 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.392 0.596 . . . . 0.0 110.66 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.476 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 84.6 1.75 89.05 Favored Glycine 0 CA--C 1.522 0.499 0 O-C-N 121.701 -0.625 . . . . 0.0 114.586 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.4 p -145.78 166.56 25.55 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.1 mm -109.7 126.5 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.85 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -102.78 -176.98 3.25 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.907 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.93 -47.39 98.77 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -56.21 -51.39 9.53 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.1 1.2 . . . . 0.0 111.613 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.72 -18.33 53.77 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.648 0.737 . . . . 0.0 110.586 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -77.17 -56.75 4.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.441 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.4 mt -58.49 -46.16 87.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.7 p -46.24 -47.33 18.04 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.104 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 55.7 mtp -66.83 -45.45 78.23 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.6 mmt -59.78 -39.74 85.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.58 78.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.242 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.9 mtp85 -94.76 -10.66 30.88 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.727 0.299 . . . . 0.0 111.561 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.31 68.22 8.64 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.13 0.49 . . . . 0.0 110.613 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.5 mmt -107.26 18.62 21.41 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.389 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -50.17 130.43 22.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.239 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -93.57 106.02 18.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.799 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.515 ' OG1' ' NZ ' ' B' 1108 ' ' LYS . 2.8 m -90.26 122.08 32.85 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 82' ' ' GLU . 90.3 m-20 -69.66 112.14 5.93 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.0 m -37.58 -21.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.694 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 80' ' ' ASP . 53.4 mp0 -68.88 -37.24 78.91 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -47.69 -35.67 9.99 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.266 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -88.97 -17.45 29.45 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.307 0.575 . . . . 0.0 112.039 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 85' ' ' ILE . 27.7 mm -60.87 -74.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.959 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -62.61 -39.1 92.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -62.7 -40.88 98.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.371 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.59 -19.53 62.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -72.92 -50.77 21.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.955 0.407 . . . . 0.0 111.317 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -55.5 -42.48 74.51 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.42 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.23 -43.73 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.605 ' CE2' HG21 ' A' ' 108' ' ' VAL . 6.3 m-85 -68.29 -38.97 82.21 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.475 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -89.22 84.03 6.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -60.7 -46.19 91.33 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -92.15 4.41 53.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.294 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 52.43 50.35 48.01 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -92.24 5.72 49.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.637 0.256 . . . . 0.0 110.576 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.98 0.76 89.76 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -139.55 153.07 47.35 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.649 0.738 . . . . 0.0 111.545 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.46 115.32 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.4 m -89.82 153.23 20.82 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.35 -47.79 80.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 119.039 0.836 . . . . 0.0 110.986 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.01 -40.17 60.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.994 0.426 . . . . 0.0 110.461 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -66.22 -41.43 90.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.383 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 tp -63.5 -46.33 86.61 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.37 0.605 . . . . 0.0 111.422 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -44.22 -36.89 2.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.753 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -69.33 -27.6 65.5 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.717 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.605 HG21 ' CE2' ' A' ' 92' ' ' PHE . 94.8 t -58.76 -43.08 87.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.03 -178.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.57 ' SD ' HD13 ' A' ' 116' ' ' LEU . 8.7 mmt -51.89 -49.69 62.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.219 1.009 . . . . 0.0 111.879 -176.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 65.9 p -52.78 -37.14 59.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.245 -1.798 . . . . 0.0 110.817 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -66.3 -39.6 89.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.949 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.0 mt -82.83 -13.81 55.5 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.49 37.6 53.06 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.26 -1.3 . . . . 0.0 110.058 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -85.12 -20.57 30.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 121.021 2.411 . . . . 0.0 110.976 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt 42.38 50.6 4.68 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.723 1.249 . . . . 0.0 110.367 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.57 HD13 ' SD ' ' A' ' 109' ' ' MET . 0.9 OUTLIER -74.23 153.47 39.42 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.957 -1.928 . . . . 0.0 112.701 -178.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 61.3 p -85.64 174.14 9.63 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -55.93 -43.97 77.88 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -55.59 -41.87 73.99 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.051 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.09 -29.95 68.15 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.979 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.408 HG22 HD11 ' A' ' 116' ' ' LEU . 43.8 t -62.75 -43.95 99.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.466 0.651 . . . . 0.0 109.593 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -72.83 -36.45 67.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.994 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -59.22 -54.89 41.72 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 83.9 mtp -56.74 -43.25 80.49 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.645 -1.162 . . . . 0.0 109.812 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 93.8 mt -59.28 -43.74 90.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.243 -178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -59.26 -39.44 82.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.828 0.347 . . . . 0.0 111.106 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.31 -41.28 84.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.187 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.65 -24.88 21.51 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 131' ' ' ASP . 21.1 t0 -71.77 88.73 1.01 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.651 0.739 . . . . 0.0 111.933 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 72.3 mt -70.06 -15.88 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.703 1.24 . . . . 0.0 113.208 -178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 44.7 p-10 -141.53 144.4 34.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 112.295 -2.23 . . . . 0.0 109.522 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.59 52.28 1.17 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.604 -0.331 . . . . 0.0 112.947 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 32.1 p-10 -91.37 -9.91 43.11 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.187 0.494 . . . . 0.0 110.19 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.82 2.49 76.9 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.218 -0.515 . . . . 0.0 114.268 176.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -135.04 154.5 51.69 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 117.198 0.499 . . . . 0.0 110.445 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.5 t -100.9 118.94 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.357 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -84.55 174.44 10.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.85 0.357 . . . . 0.0 110.816 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -61.24 -40.3 93.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.24 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.1 -44.51 96.5 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.34 -38.49 90.28 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.763 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -61.16 -45.4 94.8 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.054 0.454 . . . . 0.0 110.849 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.9 t -65.23 -46.21 91.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.353 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.734 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 51.6 tt0 -49.8 -45.02 49.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.611 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.6 mmt -72.7 -38.44 67.51 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 20.4 mmt -71.93 -46.89 55.95 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 121.341 -0.144 . . . . 0.0 110.909 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 147' ' ' ALA . 22.0 m -80.28 -29.65 38.28 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.725 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -40.81 110.58 0.16 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.022 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.198 179.726 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B 1086 ' ' LEU . . . . . . . . . . . . . 71.0 mt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B 1087 ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -148.34 173.15 13.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.433 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1088 ' ' ARG . . . . . 0.592 ' C ' ' H ' ' B' 1090 ' ' GLN . 0.0 OUTLIER -131.18 106.66 8.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.6 -179.576 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B 1089 ' ' GLY . . . . . . . . . . . . . . . -58.85 2.85 0.18 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.15 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1090 ' ' GLN . . . . . 0.592 ' H ' ' C ' ' B' 1088 ' ' ARG . 70.9 mt-30 -61.96 -46.2 90.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.787 0.327 . . . . 0.0 111.483 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B 1091 ' ' ILE . . . . . . . . . . . . . 56.3 mt -58.04 -49.89 79.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1092 ' ' LEU . . . . . . . . . . . . . 12.8 mt -56.72 -62.04 2.01 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1093 ' ' TRP . . . . . . . . . . . . . 7.6 m95 -62.34 -54.57 38.56 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.57 0.7 . . . . 0.0 112.244 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1094 ' ' PHE . . . . . . . . . . . . . 8.3 t80 -59.44 -46.6 88.3 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -173.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1095 ' ' ARG . . . . . . . . . . . . . 18.6 mmm-85 -40.69 -51.3 3.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1096 ' ' GLY . . . . . . . . . . . . . . . -61.28 -39.58 97.4 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1097 ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.33 -44.03 83.9 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.697 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1098 ' ' ASN . . . . . . . . . . . . . 39.7 t30 -59.46 -49.78 76.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.631 -1.168 . . . . 0.0 114.118 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1099 ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -65.58 -37.83 87.78 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1100 ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.7 -41.68 89.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.889 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1101 ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -51.39 -46.02 62.69 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1102 ' ' THR . . . . . 0.527 ' O ' ' N ' ' B' 1105 ' ' LYS . 20.5 m -63.89 -48.18 77.68 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.886 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B 1103 ' ' GLN . . . . . 0.436 ' C ' ' O ' ' B' 1102 ' ' THR . 83.8 mt-30 -27.47 -56.91 0.1 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.638 1.209 . . . . 0.0 112.569 -176.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B 1104 ' ' ILE . . . . . . . . . . . . . 1.3 mt -85.84 -14.17 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.453 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1105 ' ' LYS . . . . . 0.527 ' N ' ' O ' ' B' 1102 ' ' THR . 78.5 tttt -60.32 -45.93 91.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 118.341 -1.344 . . . . 0.0 108.012 176.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B 1106 ' ' VAL . . . . . . . . . . . . . 96.1 t -61.57 -49.06 85.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1107 ' ' VAL . . . . . . . . . . . . . 1.7 m -66.04 -35.89 76.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.013 -177.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1108 ' ' LYS . . . . . 0.515 ' NZ ' ' OG1' ' A' ' 79' ' ' THR . 87.0 mttt -49.62 -38.65 32.89 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.571 0.7 . . . . 0.0 109.727 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B 1109 ' ' ALA . . . . . . . . . . . . . . . -52.71 -45.92 67.12 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.355 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B 1110 ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 55' ' ' VAL . 49.7 m-85 -63.41 -49.4 73.91 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B 1111 ' ' HIS . . . . . 0.459 ' O ' ' OG ' ' B' 1112 ' ' SER . 68.1 m-70 -70.36 20.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B 1112 ' ' SER . . . . . 0.506 ' OG ' ' O ' ' B' 1112 ' ' SER . 5.1 p 68.12 77.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.001 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B 1113 ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.751 -179.269 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_